peptide_id	sequence	cancer_type	cancer_subtype	tissue_type	associated_transcript_id	associated_gene_id	related_gene_name	log2_fold_change	expression_group	t_value	p_value	adjusted_p_value	study	study_description	instrument	quantification	study_pubmed	validation	validation_method	validation_pubmed	immunogenicity	associated_ms_id	orf_id	simultaneous_expression
SPENP000145	YMDGMTVGVVR	Colon cancer	Colon cancer	Liver	SPENT005796	SPENG001958	FBLN1	-0.9972	Others	-5.233	4.94e-06	3.69e-05	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020442	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP015753
SPENP000146	DKLNNLVLFDK	Colon cancer	Colon cancer	Liver	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	-0.0976	Others	-0.8784	0.3828	0.5162	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020354	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP000178	GQAGVMGFPGPK	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020486	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP010138,SPENP010137,SPENP023956
SPENP000179	NQSLIPLLLEAR	Colon cancer	Colon cancer	Liver	SPENT000215	SPENG001615	lnc-ACTA2-2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020541	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP000193	NALDPMSVLLAR	Colon cancer	Colon cancer	Liver	SPENT002530,SPENT002607,SPENT002606	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5	1.0061	Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020480	SPENO001285,SPENO003025,SPENO003487	Breast cancer:SPENP023318;Bladder cancer:SPENP028687;Colon cancer:SPENP007011;Gastric cancer:SPENP009496
SPENP000194	YQLDPTASISAK	Colon cancer	Colon cancer	Liver	SPENT000102	SPENG002045	lnc-ACTR2-11	-0.03	Others	-0.2732	0.7851	0.8513	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020714	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP000212	LTTAFEEVWGVI	Colon cancer	Colon cancer	Liver	SPENT000432	SPENG003561	HSALNG0088954		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020309	SPENO000058	
SPENP000222	VPFLVLECPNLK	Colon cancer	Colon cancer	Liver	SPENT000354	SPENG002378	HSALNG0036293	0.3519	Others	4.3871	2.5e-05	0.0001	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020708	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP000225	AALPEGLPEASR	Colon cancer	Colon cancer	Liver	SPENT001199	SPENG002441	NONHSAG025130.2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020635	SPENO006044	Gastric cancer:SPENP003541;Lung cancer:SPENP002342
SPENP000233	FLTDLEAQMEIK	Colon cancer	Colon cancer	Liver	SPENT006084	SPENG003763	HSALNG0056307		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020803	SPENO006244	
SPENP000248	LPSEPGMTLLTIR	Colon cancer	Colon cancer	Liver	SPENT001009	SPENG001238	lnc-USP33-3		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020859	SPENO005521	Lung cancer:SPENP002395;Prostate cancer:SPENP023633
SPENP000267	TTAAMWALQTVEK	Colon cancer	Colon cancer	Liver	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2	0.1638	Others	2.3188	0.0226	0.0587	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020657	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP007089,SPENP006488
SPENP000269	TQTHATLCSTSAK	Colon cancer	Colon cancer	Liver	SPENT004951	SPENG000993	lnc-PLPPR5-13		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020853	SPENO003638	Prostate cancer:SPENP023627
SPENP000273	MYISTTSVEIVWR	Colon cancer	Colon cancer	Liver	SPENT006049	SPENG003858	HSALNG0089645		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020820	SPENO004062	
SPENP000281	GNSIIMLEALERV	Colon cancer	Colon cancer	Liver	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020455	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP015902
SPENP000293	VTDATETTITISWR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020801	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP000296	MSTDNICPWIEQQK	Colon cancer	Colon cancer	Liver	SPENT006044,SPENT005996,SPENT006032	SPENG003787	HSALNG0061087	-0.5135	Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020733	SPENO000969,SPENO002150,SPENO002253	
SPENP000301	MELENIVANTVLLK	Colon cancer	Colon cancer	Liver	SPENT001256	SPENG001321	NONHSAG042355.2	-2.183	Others	-1.1	0.2875	0.4118	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020613	SPENO002906	Lung cancer:SPENP002477,SPENP025913
SPENP000310	TPTEALASFDYIVR	Colon cancer	Colon cancer	Liver	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1	-0.058	Others	-0.4111	0.6826	0.7907	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020833	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022755,SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP004163,SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP024064,SPENP007144
SPENP000314	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020889	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP000320	IDDILQTLLDATYK	Colon cancer	Colon cancer	Liver	SPENT000775	SPENG001919	lnc-LRRD1-2	0.0655	Others	0.3278	0.7442	0.8333	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020608	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP025776,SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP001612
SPENP000323	EVVIFGAASELFTK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL	0.9682	Others	3.1105	0.0051	0.0169	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020768	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP008399,SPENP026813,SPENP010376
SPENP000333	MLVASWLQYGCHSSR	Colon cancer	Colon cancer	Liver	SPENT006043	SPENG003809	lnc-ZNF521-2	-0.1211	Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020721	SPENO005288	
SPENP000334	VLFGCVLYWDTVRGK	Colon cancer	Colon cancer	Liver	SPENT003180	SPENG001801	AC106799.2	0.9799	Others	4.8759	3.61e-06	2.88e-05	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020568	SPENO005953	Breast cancer:SPENP022789,SPENP022788;Bladder cancer:SPENP011505;Lung cancer:SPENP026135;Prostate cancer:SPENP009234;Colon cancer:SPENP010492,SPENP010491
SPENP000343	MTQSPSSLSASVGDR	Colon cancer	Colon cancer	Liver	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020414	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553
SPENP000349	SSTSRPDAYEHTQMK	Colon cancer	Colon cancer	Liver	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2	0.6534	Others	2.2357	0.0451	0.1029	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020439	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP000379	ISLPGQMAGTPITPLK	Colon cancer	Colon cancer	Liver	SPENT000725,SPENT000615	SPENG001618	NONHSAG029796.2	-0.599	Others	-2.872	0.0098	0.029	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	sORF.org_record	26527729	Immunogenic	SPENM020932	SPENO000363,SPENO003428	Breast cancer:SPENP022897,SPENP022896;Colon cancer:SPENP006591;Lung cancer:SPENP025800;Prostate cancer:SPENP012075
SPENP000393	MKTNEAVAENINYFFK	Colon cancer	Colon cancer	Liver	SPENT003408	SPENG003128	HSALNG0019460	-0.2648	Others	-0.8959	0.4043	0.5315	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020591	SPENO005437	Breast cancer:SPENP022845,SPENP022844;Bladder cancer:SPENP011540
SPENP000394	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Liver	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731	-0.0181	Others	-0.0943	0.9263	0.9451	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020667	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP024149,SPENP001661,SPENP010616,SPENP010615,SPENP014365;Lung cancer:SPENP025534
SPENP000395	EEAVQQMADALQYLQK	Colon cancer	Colon cancer	Liver	SPENT005987,SPENT005961,SPENT006051,SPENT006092,SPENT005958,SPENT006011,SPENT006073,SPENT005978,SPENT006104,SPENT005985,SPENT006033,SPENT006074,SPENT005965,SPENT006053,SPENT006048,SPENT005999	SPENG003792,SPENG003766,SPENG003798,SPENG003847,SPENG003783,SPENG003856,SPENG003757,SPENG003815	lnc-WASHC1-4,WASH3P,NONHSAG000002.2,lnc-PLPP2-5,lnc-OR4F29-11,AL627309.1,lnc-OR4F15-4,lnc-SLC6A12-12		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	SmProt_literiture_mining	28137767	Immunogenic	SPENM020495	SPENO000743,SPENO000992,SPENO001063,SPENO001196,SPENO001397,SPENO002392,SPENO002797,SPENO003609,SPENO003731,SPENO003772,SPENO003821,SPENO003922,SPENO004505,SPENO004913,SPENO005042,SPENO006318	Lung cancer:SPENP025618
SPENP000400	IQLSNATLYMYQALLR	Colon cancer	Colon cancer	Liver	SPENT006034	SPENG003780	lnc-C11orf1-1	1.3761	Others	2.329	0.0432	0.1001	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020428	SPENO004768	Lung cancer:SPENP025795
SPENP000410	GADPGMPEPTVLSLLWG	Colon cancer	Colon cancer	Liver	SPENT000828	SPENG000141	HSALNG0056619	-0.3553	Others	-3.26	0.0015	0.0059	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020830	SPENO004991	Anal canal cancer:SPENP024826;Colon cancer:SPENP001668,SPENP007309,SPENP014405;Lung cancer:SPENP025703;Kidney cancer:SPENP020455
SPENP000417	CPSIAAAIAAVNALHGR	Colon cancer	Colon cancer	Liver	SPENT000221,SPENT000220,SPENT000234	SPENG000739,SPENG000807	RBM39,lnc-NFS1-1	-0.056	Others	-0.1718	0.8654	0.9122	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020756	SPENO005081,SPENO005525,SPENO006140	Bile duct cancer:SPENP013527;Colon cancer:SPENP001673,SPENP026729;Lung cancer:SPENP004381;Kidney cancer:SPENP020438
SPENP000418	FLDGDELTLADCNLLPK	Colon cancer	Colon cancer	Liver	SPENT003277,SPENT003276,SPENT003278	SPENG000877	lnc-ENPP5-2	-0.353	Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020935	SPENO000101,SPENO002105,SPENO004019	
SPENP000423	ALIGATNPADAPPGTIR	Colon cancer	Colon cancer	Liver	SPENT002171	SPENG000588	HSALNG0108933	0.0638	Others	0.4497	0.659	0.7762	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020564	SPENO005632	Anal canal cancer:SPENP024812;Colon cancer:SPENP024169,SPENP010698,SPENP010697;Bladder cancer:SPENP011597;Prostate cancer:SPENP013041
SPENP000424	ISSTLYQAAAPVLTPAK	Colon cancer	Colon cancer	Liver	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020413	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP001671
SPENP000428	EAQAQHNNSEFTEEQKK	Colon cancer	Colon cancer	Liver	SPENT001330,SPENT001009	SPENG001238,SPENG001518	lnc-USP33-3,lnc-TMEM144-3		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020324	SPENO004170,SPENO005521	Colon cancer:SPENP007320;Lung cancer:SPENP002661;Prostate cancer:SPENP023734
SPENP000431	ETPLPIDPSMFPTWPAK	Colon cancer	Colon cancer	Liver	SPENT000136,SPENT000135,SPENT000138,SPENT000137,SPENT000139	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2	-1.213	Down-regulated in tumors	-4.437	0.0004	0.0018	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM020590	SPENO000257,SPENO002156,SPENO003659,SPENO005654,SPENO006064	Bladder cancer:SPENP011592,SPENP017665;Colon cancer:SPENP008539;Lung cancer:SPENP025658,SPENP002667;Kidney cancer:SPENP020456
SPENP000433	ALALAALAAVEPACGSR	Colon cancer	Colon cancer	Liver	SPENT004057	SPENG000928	NONHSAG041785.2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020872	SPENO001591	Bladder cancer:SPENP017666;Kidney cancer:SPENP020433;Prostate cancer:SPENP012080
SPENP000435	DRLPFPLLLLLPEGPLK	Colon cancer	Colon cancer	Liver	SPENT006050	SPENG003793	HSALNG0016439	2.4688	Up-regulated in tumors	4.8515	0.0028	0.0101	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020501	SPENO000131	Lung cancer:SPENP025602
SPENP000441	AWQGLAAEFLQVPAVTR	Colon cancer	Colon cancer	Liver	SPENT000869,SPENT000870	SPENG002286	lnc-DERL3-1	-0.1667	Others	-0.4393	0.6693	0.7857	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020519	SPENO000186,SPENO001045	
SPENP000442	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	0.4255	Others	0.471	0.652	0.7705	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020686	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP000444	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Liver	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	1.1452	Up-regulated in tumors	6.5474	2.37e-09	4.63e-08	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020403	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP000454	QTLSTPGTIILGTIPVPK	Colon cancer	Colon cancer	Liver	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020368	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP004453,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP001697
SPENP000458	ILYSHLVDYFPEFDGPQR	Colon cancer	Colon cancer	Liver	SPENT001990	SPENG001368	NONHSAG024464.2		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020691	SPENO005646	
SPENP000460	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	1.2058	Up-regulated in tumors	5.9014	3.28e-08	5e-07	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020751	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP000469	PLTCLLVGWTWPTNSELK	Colon cancer	Colon cancer	Liver	SPENT006087	SPENG003831	HSALNG0032778	0.6402	Others	1.0234	0.364	0.4952	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020656	SPENO005421	Lung cancer:SPENP025975
SPENP000479	NNQLVAGYLQGPNVNLEEK	Colon cancer	Colon cancer	Liver	SPENT001357	SPENG002580	NONHSAG028996.2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020563	SPENO002732	Colon cancer:SPENP014503;Lung cancer:SPENP028356,SPENP002759,SPENP025965
SPENP000481	ADEALFLLLHNEMVSGVYK	Colon cancer	Colon cancer	Liver	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767	-0.2035	Others	-0.7145	0.4867	0.6123	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020864	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP006659,SPENP016178,SPENP014479;Lung cancer:SPENP004493,SPENP002731;Kidney cancer:SPENP020515
SPENP000486	ILPFLSTEQAADILMTTAR	Colon cancer	Colon cancer	Liver	SPENT006030	SPENG003805	lnc-OSBP-2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020463	SPENO002215	
SPENP000488	TTVLLADINDFNTVNEIYK	Colon cancer	Colon cancer	Liver	SPENT003329,SPENT003330	SPENG001096	HSALNG0067190	-0.4219	Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	sORF.org_record	26527729	Immunogenic	SPENM020843	SPENO004169,SPENO004502	Thyroid cancer:SPENP012540,SPENP012541;Colon cancer:SPENP012838;Bladder cancer:SPENP017762;Liver cancer:SPENP000735
SPENP000490	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020861	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP000494	VVLATCVAGVGGSPESQSSK	Colon cancer	Colon cancer	Liver	SPENT006023	SPENG003782	NONHSAG043059.3	-0.5713	Others	-2.001	0.0733	0.1513	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020320	SPENO003090	
SPENP000498	TYLVSGQPLEEIITYYPAMK	Colon cancer	Colon cancer	Liver	SPENT000965	SPENG000698	SLC25A25-AS1	-0.3147	Others	-1.457	0.1593	0.2713	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020522	SPENO005957	Breast cancer:SPENP023054,SPENP023055;Colon cancer:SPENP012846,SPENP007384;Lung cancer:SPENP026112
SPENP000506	MSAAVQTTNLQVYGHSDFLF	Colon cancer	Colon cancer	Liver	SPENT005009	SPENG000819	HSALNG0044274	-0.021	Others	-0.0201	0.9842	0.9898	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020433	SPENO000637	Colon cancer:SPENP024236;Lung cancer:SPENP025943
SPENP000507	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	1.0938	Up-regulated in tumors	6.7525	4.19e-10	1.23e-08	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020531	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244
SPENP000509	FCGDLDCPDWVLAEISTLAK	Colon cancer	Colon cancer	Liver	SPENT002210,SPENT002211,SPENT002208,SPENT002207,SPENT002209	SPENG001443	HSALNG0107277		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020806	SPENO001585,SPENO002078,SPENO003211,SPENO003669,SPENO005108	Anal canal cancer:SPENP024888
SPENP000511	YIMVPSGNMGVFDPTEIHNR	Colon cancer	Colon cancer	Liver	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	-0.6382	Others	-5.21	1.34e-06	1.35e-05	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020882	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP027477
SPENP000513	CHDSPILHNSCVLLWFEPSK	Colon cancer	Colon cancer	Liver	SPENT006021	SPENG003830	HSALNG0107533	-0.0154	Others	-0.0833	0.9341	0.9503	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020473	SPENO000456	
SPENP000514	GAEDDLNTVAAGTMTGMLYK	Colon cancer	Colon cancer	Liver	SPENT005942,SPENT005908,SPENT005909,SPENT005907,SPENT005941,SPENT005905,SPENT005906,SPENT005910,SPENT005904	SPENG001535	TIMM23B-AGAP6		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020429	SPENO000399,SPENO001791,SPENO002243,SPENO002429,SPENO003041,SPENO004258,SPENO004770,SPENO004905,SPENO005638	Lung cancer:SPENP025704
SPENP000519	AITYNAMLAETSTVFHQNDVK	Colon cancer	Colon cancer	Liver	SPENT000648	SPENG002439	NONHSAG050528.2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020339	SPENO003505	Bladder cancer:SPENP017810;Colon cancer:SPENP026679;Lung cancer:SPENP004559
SPENP000520	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-1.287	Others	-1.409	0.1779	0.2878	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020650	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP000521	STAAMSTYTGIFTDQVLSVLK	Colon cancer	Colon cancer	Liver	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	0.1512	Others	0.5274	0.601	0.7249	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020471	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP021580,SPENP029445,SPENP016232
SPENP000522	MCHDSPILHNSCVLLWFEPSK	Colon cancer	Colon cancer	Liver	SPENT006021	SPENG003830	HSALNG0107533		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020533	SPENO000456	
SPENP000530	ETSVTPSNLWGGQGLLGVSIR	Colon cancer	Colon cancer	Liver	SPENT000615	SPENG001618	NONHSAG029796.2	-0.0912	Others	-0.362	0.7208	0.8162	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM020787	SPENO003428	Breast cancer:SPENP023091,SPENP023090;Colon cancer:SPENP001727,SPENP006694;Lung cancer:SPENP025659,SPENP028262;Prostate cancer:SPENP012117
SPENP000532	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	1.193	Up-regulated in tumors	3.9383	0.0002	0.0007	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020664	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP000534	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020915	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP000536	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.34	Down-regulated in tumors	-5.147	2.45e-06	2.15e-05	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020357	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP000537	DMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Liver	SPENT005788	SPENG002233	AP001931.2	0.6631	Others	2.8856	0.005	0.0168	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020587	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP000538	LQAAQLPHTGVFGQSFSCPSDR	Colon cancer	Colon cancer	Liver	SPENT000855	SPENG000474	AC016876.2	-0.1229	Others	-0.7363	0.5387	0.6588	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM020645	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP027092,SPENP001740
SPENP000542	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL	0.6161	Others	1.7766	0.0878	0.1741	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020678	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941
SPENP000554	QGLYELSASNFELHVAQGDHFIK	Colon cancer	Colon cancer	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	1.0055	Others	2.3101	0.0254	0.0642	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020791	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP001744
SPENP000556	MNSGNLVSVLTQAEGAFVASLIK	Colon cancer	Colon cancer	Liver	SPENT002599,SPENT005711,SPENT005710,SPENT005712	SPENG003424,SPENG001293,SPENG001359	HSALNG0016278,lnc-REG3A-3,lnc-REG3A-4		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020497	SPENO000553,SPENO003300,SPENO003866,SPENO004764	
SPENP000559	GTVLALTENNFDDTIAEGITFIK	Colon cancer	Colon cancer	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.9656	Others	2.8796	0.0051	0.0169	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020772	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP002850,SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP008691
SPENP000560	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020628	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP000562	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.719	Others	-0.938	0.3548	0.4846	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020606	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP000569	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated	ribosome profiling	31155234	Immunogenic	SPENM020905	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP000570	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.95	Down-regulated in tumors	-4.744	3.35e-05	0.0002	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020883	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP000573	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020553	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP000575	STAAMSTYTGIFTDQVLSVLKGEE	Colon cancer	Colon cancer	Liver	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020319	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP016302
SPENP000577	DLVHTEGQLQNEEIVAHDGSATYLR	Colon cancer	Colon cancer	Liver	SPENT002082	SPENG002114	lnc-YIPF1-2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020684	SPENO000824	Anal canal cancer:SPENP024942;Colon cancer:SPENP006734,SPENP007463,SPENP014621;Lung cancer:SPENP025597
SPENP000584	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.1084	Others	-0.2915	0.7781	0.8513	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020540	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP008725
SPENP000587	PRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020711	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526
SPENP000588	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.7834	Others	-1.343	0.1855	0.2984	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020848	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP000589	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	1.1223	Up-regulated in tumors	4.8735	3.18e-06	2.66e-05	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020641	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP000591	STNLLAAETASLEEQLQGWGEVMLMADK	Colon cancer	Colon cancer	Liver	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	-0.0834	Others	-0.1837	0.8549	0.9065	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020539	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656
SPENP000593	YIKDDVILNEPSADAPAALYQTIEENIK	Colon cancer	Colon cancer	Liver	SPENT003450	SPENG003122	NONHSAG013474.2	-0.7717	Others	-1.657	0.1197	0.2177	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020839	SPENO005443	Bladder cancer:SPENP011767
SPENP000594	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020335	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892
SPENP000598	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Liver	SPENT005913	SPENG001766	AL662884.2	0.4597	Others	1.6105	0.1171	0.2151	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020816	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743
SPENP000599	TLTQESCDVSPVLTQAMEALQDRPVLYK	Colon cancer	Colon cancer	Liver	SPENT006025	SPENG003760	HSALNG0096505		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020866	SPENO001730	Lung cancer:SPENP026093
SPENP000605	LEVPPEADGTLLTDLMPGVEYVVTVTAER	Colon cancer	Colon cancer	Liver	SPENT005913	SPENG001766	AL662884.2		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020470	SPENO002584	Lung cancer:SPENP025838
SPENP000607	AVSLVTDSTSTFLSQTTYALIEAITEYTK	Colon cancer	Colon cancer	Liver	SPENT001334,SPENT000988	SPENG000380	lnc-DIABLO-1	-0.1045	Others	-0.2123	0.8372	0.8932	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020307	SPENO001827,SPENO003093	Colon cancer:SPENP014674,SPENP016372;Lung cancer:SPENP002938;Kidney cancer:SPENP020675
SPENP000608	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Liver	SPENT005757,SPENT005755	SPENG000084	FN1	-0.9739	Others	-1.558	0.1248	0.2211	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020917	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP011123
SPENP000609	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.687	Others	1.4935	0.16	0.2713	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020604	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139
SPENP000610	SLLNFCGQFLYISNGFVCFFVCAIAQAGVQ	Colon cancer	Colon cancer	Liver	SPENT006098	SPENG003820	HSALNG0018862	1.5197	Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020416	SPENO004126	
SPENP000611	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Liver	SPENT005757,SPENT005755	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020583	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP008757
SPENP000615	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Liver	SPENT005757,SPENT005755	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020648	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP011147
SPENP000617	NSPVFELLPCGIIQGEPGAQPQLITFHPSFNK	Colon cancer	Colon cancer	Liver	SPENT006083	SPENG003808	AAAS		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020434	SPENO003520	
SPENP000619	HLPTSSPPPPTLAHLPQLFFFFFFEMESCSVTR	Colon cancer	Colon cancer	Liver	SPENT002583	SPENG000029	lnc-CDON-2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020476	SPENO002895	
SPENP000622	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Colon cancer	Colon cancer	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	1.0986	Up-regulated in tumors	4.0562	0.0002	0.0007	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020321	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP008765
SPENP000623	STIQNLQSFDPFADATKGDDLLPAGTEDYIHIR	Colon cancer	Colon cancer	Liver	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020441	SPENO002523,SPENO004443	Colon cancer:SPENP011173,SPENP011174;Bladder cancer:SPENP017971,SPENP011803;Kidney cancer:SPENP020700
SPENP000627	EATPENDPNYFMNEPTFYTSDGVPFTAADPDYQEK	Colon cancer	Colon cancer	Liver	SPENT000390	SPENG002704	lnc-TRIM16L-2		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020856	SPENO003522	Anal canal cancer:SPENP024969;Colon cancer:SPENP008771,SPENP007502,SPENP006777
SPENP000628	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020508	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP011216,SPENP024347
SPENP000630	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Liver	SPENT005752	SPENG000084	FN1	-1.056	Others	-1.246	0.2259	0.3517	IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020925	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP022124,SPENP016430
SPENP000631	MQYGGAPGGPAFPGQTQDPLYGYFAAVAGQDGQIDADELQR	Colon cancer	Colon cancer	Liver	SPENT005536	SPENG000963	lnc-STEAP4-2		Tumor-specific				IPX0000832010	Proteogenomic characterization analysis of human colorectal cancer liver metastasis	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020629	SPENO006104	
SPENP000646	LGELPSWILMR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.0325	Others	0.0974	0.9262	0.9463	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020203	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP000684	WEAAEGLLQEALDK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006106,SPENT006001,SPENT006080,SPENT005969	SPENG003777	NONHSAG025152.2	0.2576	Others	1.019	0.3421	0.5182	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	MS	28137767	Immunogenic	SPENM020166	SPENO001170,SPENO004492,SPENO004699,SPENO004994	Lung cancer:SPENP026634
SPENP000690	VLLESEQFLTELTR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020210	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP000691	FNLSSFNILEHYWK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT005972,SPENT006041	SPENG003829,SPENG003826	LINC00882,NONHSAG035677.3		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020199	SPENO004572,SPENO005660	
SPENP000692	IDDILQTLLDATYK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020303	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Kidney cancer:SPENP020245;Lung cancer:SPENP025776,SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP001612,SPENP000320
SPENP000701	MTIPSLFLLQPAFLL	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006031	SPENG003781	HSALNG0053483		Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020194	SPENO004158	
SPENP000705	AELTALESLIEMGFPR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020207	SPENO001893,SPENO004906	Breast cancer:SPENP005736,SPENP008940,SPENP005734,SPENP005735,SPENP005737,SPENP005738
SPENP000712	MLTLSLAFLGLSHSCR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006019	SPENG003799	lnc-CELSR1-2		Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020171	SPENO004441	
SPENP000713	MGDFLHSIQVLISNEK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT005953,SPENT005968	SPENG003791	HSALNG0031616	-0.6192	Others	-1.64	0.1205	0.2681	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020174	SPENO000989,SPENO001204	
SPENP000716	GTGLDEAMEWLVETLK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT003106,SPENT003105,SPENT003104	SPENG001388,SPENG002402	HSALNG0093495,NONHSAG012072.2	1.4894	Others	1.0969	0.3528	0.5182	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020256	SPENO001292,SPENO002789,SPENO002969	Breast cancer:SPENP008941;Lung cancer:SPENP026547
SPENP000718	FIYITPEELAAVANFIR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002729	SPENG003021	NONHSAG031147.2	-0.3032	Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	MS	28137767	Immunogenic	SPENM020186	SPENO002390	Lung cancer:SPENP026517
SPENP000722	QWLIDTLYAFNSGNVER	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006090	SPENG003812	NONHSAG007292.2	0.1319	Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	MS	28137767	Immunogenic	SPENM020275	SPENO004702	
SPENP000731	DIQMTQSPSSLSASVGDR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020241	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP000733	GETGPAGPAGPVGPVGAR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT005758	SPENG002845	COL1A1	0.0663	Others	0.2301	0.8328	0.8896	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020216	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP000735	TTVLLADINDFNTVNEIYK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT003329,SPENT003330	SPENG001096	HSALNG0067190	-0.6739	Others	-5.526	0.0052	0.0308	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	sORF.org_record	26527729	Immunogenic	SPENM020235	SPENO004169,SPENO004502	Thyroid cancer:SPENP012540,SPENP012541;Colon cancer:SPENP012838,SPENP000488;Bladder cancer:SPENP017762
SPENP000737	TGVHHYSGNNIELGTACGK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.2433	Others	0.832	0.4664	0.5769	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	MS	28137767	Immunogenic	SPENM020260	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP000745	GLLQNVHLVFENSVEDILSK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006078	SPENG003779	HSALNG0055337		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020217	SPENO002834	
SPENP000748	TIFLPWTMSSLPTSTAVSGF	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006020	SPENG003786	HSALNG0096881		Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020183	SPENO003450	
SPENP000750	ALAPTWEQLALGLEHSETVK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.3377	Others	1.6109	0.154	0.2681	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020268	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP000755	MSLVVPATWEAEIGGLLEPGR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006075	SPENG003853	HSALNG0016948		Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020280	SPENO003974	
SPENP000760	EEPFFPPPEEFVFIHAVPVEER	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000628	SPENG001755	lnc-HNRNPUL2-BSCL2-1		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	MS	28137767	Immunogenic	SPENM020258	SPENO003259	Colon cancer:SPENP001736
SPENP000761	MSSPITLLFSASNETVNVSPPL	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006068	SPENG003822	lnc-C11orf95-1		Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020253	SPENO004995	
SPENP000762	LIDMLSEAGLSVIETTSFVSPK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000018	SPENG003202	HMGCL	-0.9979	Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020295	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP000764	EKPYFPIPEEYTFIQNVPLEDR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000348	SPENG000430	lnc-HNRNPU-1		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	sORF.org_record	26527729	Immunogenic	SPENM020176	SPENO006036	Colon cancer:SPENP012855
SPENP000765	QGLYELSASNFELHVAQGDHFIK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020237	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP000766	GTVLALTENNFDDTIAEGITFIK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.8385	Others	6.8255	0.0024	0.0191	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Non-validated			Immunogenic	SPENM020204	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP002850,SPENP025752;Colon cancer:SPENP000559,SPENP008691
SPENP000768	ITGMLLEIDNSELLHMLESPESLR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT005966,SPENT005983	SPENG003796	lnc-PABPC4-4		Tumor-specific				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	MS	28137767	Immunogenic	SPENM020244	SPENO002195,SPENO003308	
SPENP000773	MQDLDEDATLTQLATAWVSLATGGEK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT006106,SPENT006080,SPENT005969	SPENG003777	NONHSAG025152.2	0.9721	Others	3.3921	0.0095	0.0443	IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020267	SPENO001170,SPENO004699,SPENO004994	
SPENP000777	GQSALVGSSYMSALEVGGLVGSIAAGYLSDR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002643,SPENT002636,SPENT002640,SPENT002642,SPENT003247,SPENT002641,SPENT002644,SPENT002638,SPENT002645,SPENT002646,SPENT003248	SPENG000179	lnc-SLC37A4-1	-1.218	Others				IPX0000859001	Quantitative proteomics analysis of hepatocellular carcinoma tissues	TripleTOF 5600	Label free	28378759	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020239	SPENO000406,SPENO000777,SPENO001603,SPENO001727,SPENO003889,SPENO004043,SPENO004785,SPENO004947,SPENO005304,SPENO005593,SPENO005971	Kidney cancer:SPENP020690
SPENP001004	DKLNNLVLFDK	Leukemia	Acute leukemia	Blood	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	MS	28137767	Immunogenic	SPENM001067	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755
SPENP001036	YQLDPTASISAK	Leukemia	Acute leukemia	Blood	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001107	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820
SPENP001045	VPFLVLECPNLK	Leukemia	Acute leukemia	Blood	SPENT000354	SPENG002378	HSALNG0036293	-4.249	Others	-3.691	0.0651	0.189	PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	MS	28137767	Immunogenic	SPENM001106	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429
SPENP001056	NQSLIPLLLEAR	Leukemia	Acute leukemia	Blood	SPENT000215	SPENG001615	lnc-ACTA2-2		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001108	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP014158,SPENP008231
SPENP001064	QVILTHTCPYIR	Leukemia	Acute leukemia	Blood	SPENT000379	SPENG002753	HSALNG0137576		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001128	SPENO001457	
SPENP001136	MLFATPPSSTYEK	Leukemia	Acute leukemia	Blood	SPENT000423,SPENT000341,SPENT000340,SPENT000424	SPENG002338,SPENG001579	HSALNG0066743,lnc-CNGB3-2		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001206	SPENO001191,SPENO002821,SPENO005013,SPENO006196	
SPENP001139	LMIETDAPWCGVK	Leukemia	Acute leukemia	Blood	SPENT000426	SPENG003524	lnc-MTSS1-5		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001209	SPENO002686	
SPENP001146	GYVSCALGCPYEGK	Leukemia	Acute leukemia	Blood	SPENT000018	SPENG003202	HMGCL	1.7901	Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001247	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449
SPENP001148	QYNVGPSVSKYPLR	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001213	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967
SPENP001154	FLSPAFQEFLAGMR	Leukemia	Acute leukemia	Blood	SPENT000364	SPENG000638	lnc-AK6-10		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001226	SPENO000330	
SPENP001173	MLLLKSFKDSHWEK	Leukemia	Acute leukemia	Blood	SPENT000467	SPENG003186	HSALNG0050106		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001261	SPENO003553	
SPENP001176	MLSNIIISFNMCIR	Leukemia	Acute leukemia	Blood	SPENT000461	SPENG001752	HSALNG0044141		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001254	SPENO000428	
SPENP001198	VLSVPESTPFTAVLK	Leukemia	Acute leukemia	Blood	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001266	SPENO001471,SPENO001798	Skin cancer:SPENP019405,SPENP019404,SPENP019403;Colon cancer:SPENP008424,SPENP024129;Prostate cancer:SPENP023686
SPENP001199	YAASSYLSLTPEQWK	Leukemia	Acute leukemia	Blood	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.367	Others	-1.292	0.2868	0.486	PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	MS	28137767	Immunogenic	SPENM001296	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466
SPENP001202	TTAAMWALQTVEKER	Leukemia	Acute leukemia	Blood	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001275	SPENO000218,SPENO001883	Lung cancer:SPENP004252;Bladder cancer:SPENP011501;Skin cancer:SPENP025282
SPENP001222	MIPMMDTGHGALEAK	Leukemia	Acute leukemia	Blood	SPENT000476	SPENG000929	HSALNG0034496		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001279	SPENO006065	
SPENP001237	EALCGCSINVPTLDGR	Leukemia	Acute leukemia	Blood	SPENT000515	SPENG000486	NONHSAG001879.2		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001315	SPENO000704	Bile duct cancer:SPENP013493;Tongue cancer:SPENP027603;Lung cancer:SPENP007733;Prostate cancer:SPENP018322,SPENP012067;Colon cancer:SPENP016075,SPENP007276
SPENP001257	MSGEGPFLDGNSYILK	Leukemia	Acute leukemia	Blood	SPENT000505	SPENG002356	lnc-HMGXB4-8		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001305	SPENO005789	
SPENP001289	TPIGSFLGSLSLLPATK	Leukemia	Acute leukemia	Blood	SPENT000014	SPENG003410	ACAT1	-3.809	Others	-3.549	0.0121	0.082	PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001345	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823
SPENP001293	ATSATSPHAPGFPAEGR	Leukemia	Acute leukemia	Blood	SPENT000539	SPENG002038	HSALNG0005507		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001356	SPENO000712	
SPENP001302	GETGPAGPAGPVGPVGAR	Leukemia	Acute leukemia	Blood	SPENT005758	SPENG002845	COL1A1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001376	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124
SPENP001311	METLYRVPFLVLECPNLK	Leukemia	Acute leukemia	Blood	SPENT000354	SPENG002378	HSALNG0036293		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001372	SPENO003709	
SPENP001313	MHLVPRRCSFLFELPTQGN	Leukemia	Acute leukemia	Blood	SPENT000565,SPENT000564,SPENT000566	SPENG000337	HSALNG0079355		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001401	SPENO000288,SPENO001982,SPENO003729	
SPENP001323	RPHETGGYMLECVCLGNGK	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001390	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825
SPENP001330	MLNIYQMFVMKYILLIDNT	Leukemia	Acute leukemia	Blood	SPENT000563	SPENG002900	HSALNG0017528		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001400	SPENO000226	
SPENP001342	SGRPAAERSYPLQGFLSAES	Leukemia	Acute leukemia	Blood	SPENT000568	SPENG002858	HSALNG0133705		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001407	SPENO003676	
SPENP001352	ADRDESSPYAAMLAAQDVAQR	Leukemia	Acute leukemia	Blood	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	-0.8337	Others	-1.326	0.2142	0.4361	PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001421	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928
SPENP001353	RNPSYPWLWEDGSPLMPHLFR	Leukemia	Acute leukemia	Blood	SPENT000573,SPENT000572	SPENG000791,SPENG002681	HSALNG0089207,lnc-CLEC7A-2		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001426	SPENO003720,SPENO004266	
SPENP001356	LLDGEAALPAVVFLHGLFGSK	Leukemia	Acute leukemia	Blood	SPENT000073,SPENT000074,SPENT000072	SPENG002534,SPENG000354	NONHSAG047943.2,lnc-STX1A-1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001422	SPENO004128,SPENO004153,SPENO004171	Lung cancer:SPENP028320,SPENP026570
SPENP001359	MMNVMMMTTVIVMVMMMVIVM	Leukemia	Acute leukemia	Blood	SPENT000576,SPENT000577,SPENT000575,SPENT000574	SPENG000777	lnc-STK32C-2		Tumor-specific				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Non-validated			Immunogenic	SPENM001430	SPENO000103,SPENO000176,SPENO001884,SPENO005523	
SPENP001364	SGDRGETGPAGPAGPVGPVGAR	Leukemia	Acute leukemia	Blood	SPENT005758	SPENG002845	COL1A1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001439	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579
SPENP001370	MESPIPILPLPTPDAETEKLIR	Leukemia	Acute leukemia	Blood	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001438	SPENO004356,SPENO005697	
SPENP001373	VKADRDESSPYAAMLAAQDVAQR	Leukemia	Acute leukemia	Blood	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001442	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401
SPENP001374	DTLTSRPAQGVVTTLENVSPPRR	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001444	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975
SPENP001379	MELGELLYNKSEYIETASGNKVSR	Leukemia	Acute leukemia	Blood	SPENT000216,SPENT000217,SPENT000218	SPENG002974,SPENG001837	HSALNG0110268,NONHSAG018904.2		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001447	SPENO004244,SPENO004278,SPENO004951	Lung cancer:SPENP004633,SPENP007874
SPENP001380	STATISGLKPGVDYTITVYAVTGR	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001450	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011
SPENP001390	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Leukemia	Acute leukemia	Blood	SPENT000014	SPENG003410	ACAT1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001459	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063
SPENP001395	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001464	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108
SPENP001396	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001467	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP007913,SPENP021966,SPENP004706;Colon cancer:SPENP021964;Breast cancer:SPENP021965,SPENP021967
SPENP001397	CDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Leukemia	Acute leukemia	Blood	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD001170	AML_profiling - Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome and tyrosine-phosphatome in acute myeloid leukemia	LTQ Orbitrap Elite	TIC	28176486	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001466	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Gastric cancer:SPENP009715,SPENP015467;Tongue cancer:SPENP027542;Colon cancer:SPENP026725
SPENP001444	HVFTTFYAK	Colon cancer	Colon cancer	Colon	SPENT000648	SPENG002439	NONHSAG050528.2	-0.3599	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014405	SPENO003505	Colon cancer:SPENP026950;Bladder cancer:SPENP017134
SPENP001447	ALLPHVLCK	Colon cancer	Colon cancer	Colon	SPENT000628	SPENG001755	lnc-HNRNPUL2-BSCL2-1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014417	SPENO003259	
SPENP001475	CLIGVSLEVR	Colon cancer	Colon cancer	Colon	SPENT000671	SPENG003417	HSALNG0070933	0.0123	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014442	SPENO000118	
SPENP001493	MVLVNYIFFK	Colon cancer	Colon cancer	Colon	SPENT000688	SPENG001829	NONHSAG015779.2	0.2893	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014459	SPENO001705	Breast cancer:SPENP020845,SPENP020847;Colon cancer:SPENP020844;Gastric cancer:SPENP003481;Lung cancer:SPENP020846
SPENP001505	MLLLEILHEIK	Colon cancer	Colon cancer	Colon	SPENT000700	SPENG002800	HSALNG0101299		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014479	SPENO004064	
SPENP001506	TAVAHRPGAFK	Colon cancer	Colon cancer	Colon	SPENT000153	SPENG003407	NONHSAG024537.2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014469	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP001523	GAPNSRLSLPR	Colon cancer	Colon cancer	Colon	SPENT000701	SPENG003636	HSALNG0103157	0.6017	Others	1.3844	0.2155	0.5367	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014483	SPENO003853	
SPENP001531	DKLNNLVLFDK	Colon cancer	Colon cancer	Colon	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014492	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP001541	GILLFGPPGTGK	Colon cancer	Colon cancer	Colon	SPENT000721	SPENG000438	lnc-KDSR-3		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014506	SPENO005169	
SPENP001542	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon	SPENT000354	SPENG002378	HSALNG0036293	0.4078	Others	1.4363	0.1729	0.5367	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014503	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP001545	LTTAFEEVWGVI	Colon cancer	Colon cancer	Colon	SPENT000432	SPENG003561	HSALNG0088954		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014507	SPENO000058	
SPENP001551	VVLDDKDYFLFR	Colon cancer	Colon cancer	Colon	SPENT000668,SPENT000737,SPENT000738,SPENT000740,SPENT000736,SPENT000739,SPENT000735,SPENT000741	SPENG001548,SPENG001699,SPENG001263,SPENG000451,SPENG001761,SPENG001842,SPENG002051	HSALNG0093536,lnc-ETNK2-4,lnc-GNPTAB-1,lnc-ARL4C-4,HSALNG0021384,HSALNG0009837,lnc-PABPC4-7	1.3409	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014517	SPENO000488,SPENO001622,SPENO002018,SPENO002762,SPENO004177,SPENO004759,SPENO004760,SPENO005600	Breast cancer:SPENP008856;Thyroid cancer:SPENP012309,SPENP012308;Gastric cancer:SPENP003148;Lung cancer:SPENP001845
SPENP001556	YQLDPTASISAK	Colon cancer	Colon cancer	Colon	SPENT000102	SPENG002045	lnc-ACTR2-11	0.4892	Others	1.0608	0.3067	0.5845	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014518	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP001570	SFHFSLPSSWYYR	Colon cancer	Colon cancer	Colon	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014542	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP010328,SPENP010327,SPENP024046
SPENP001574	AAALVLQTIWGYK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	0.1616	Others	0.2215	0.8335	0.9072	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014536	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642
SPENP001582	IPLLSDLTHQISK	Colon cancer	Colon cancer	Colon	SPENT000669	SPENG001255	NONHSAG054153.2	-0.3214	Others	-0.449	0.6722	0.7832	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014544	SPENO005158	Lung cancer:SPENP026557
SPENP001591	MTQSPASLSLSLEK	Colon cancer	Colon cancer	Colon	SPENT000767,SPENT000765,SPENT000766,SPENT000768	SPENG000020,SPENG000372,SPENG000283,SPENG002726	HSALNG0016776,lnc-EIF2AK3-7,lnc-RPIA-14,HSALNG0016743		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014554	SPENO001500,SPENO001871,SPENO002846,SPENO003064	
SPENP001599	VLQATVVAVGSGSK	Colon cancer	Colon cancer	Colon	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4	0.3033	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014566	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP012793,SPENP026461
SPENP001600	VLLESEQFLTELTR	Colon cancer	Colon cancer	Colon	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3	1.13	Others	2.4706	0.0387	0.409	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014565	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790
SPENP001606	LAGVTALSCWLPLR	Colon cancer	Colon cancer	Colon	SPENT000779	SPENG000351	lnc-TCEA1-1	0.3827	Others	1.0835	0.3579	0.6041	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014577	SPENO005550	Lung cancer:SPENP007670;Prostate cancer:SPENP012966
SPENP001608	LVVPASQCGSLIGK	Colon cancer	Colon cancer	Colon	SPENT000780,SPENT000381,SPENT000781	SPENG002127,SPENG002276,SPENG000649	lnc-JPH1-12,HSALNG0091275,AC023509.1	0.1618	Others	0.2152	0.8357	0.9072	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014578	SPENO000396,SPENO001115,SPENO001674	Prostate cancer:SPENP012968
SPENP001612	IDDILQTLLDATYK	Colon cancer	Colon cancer	Colon	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014570	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP025776,SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP000320
SPENP001632	MSVMLNNLMSFSVPR	Colon cancer	Colon cancer	Colon	SPENT000794	SPENG003365	LINC02175	0.0208	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014596	SPENO003405	
SPENP001636	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-1.073	Others	-1.865	0.1045	0.4423	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014595	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP001648	HHFLHSLALLGVPHCR	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000621	SPENG002150	lnc-PLSCR3-1		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014624	SPENO000755,SPENO005859	
SPENP001651	MVSLFCQQLLLCCLRK	Colon cancer	Colon cancer	Colon	SPENT000803	SPENG002280	HSALNG0039423		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014622	SPENO002112	
SPENP001653	GSGQGDSLYPVGYLDK	Colon cancer	Colon cancer	Colon	SPENT000814	SPENG001638	HSALNG0104943	-0.0832	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014627	SPENO005134	Kidney cancer:SPENP020374;Anal canal cancer:SPENP024782;Lung cancer:SPENP025746;Prostate cancer:SPENP018335;Colon cancer:SPENP008500,SPENP014345,SPENP016058
SPENP001660	MYSFTKRQMLCVITHM	Colon cancer	Colon cancer	Colon	SPENT000802	SPENG003232	HSALNG0009221		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014621	SPENO001639	
SPENP001661	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Colon	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731	0.6944	Others	3.3064	0.0455	0.409	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014614	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP024149,SPENP010616,SPENP000394,SPENP010615,SPENP014365;Lung cancer:SPENP025534
SPENP001662	FALVFPLMYHTWNGIR	Colon cancer	Colon cancer	Colon	SPENT000626	SPENG001862	HSALNG0007932	-0.1999	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014629	SPENO003610	Colon cancer:SPENP026821;Kidney cancer:SPENP020411
SPENP001668	GADPGMPEPTVLSLLWG	Colon cancer	Colon cancer	Colon	SPENT000828	SPENG000141	HSALNG0056619	0.2288	Others	0.626	0.5587	0.7386	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014640	SPENO004991	Anal canal cancer:SPENP024826;Colon cancer:SPENP007309,SPENP014405,SPENP000410;Lung cancer:SPENP025703;Kidney cancer:SPENP020455
SPENP001670	SALLLPGNFESYLELVK	Colon cancer	Colon cancer	Colon	SPENT000626	SPENG001862	HSALNG0007932	-1.217	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014639	SPENO003610	
SPENP001671	ISSTLYQAAAPVLTPAK	Colon cancer	Colon cancer	Colon	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474	0.0307	Others	0.0724	0.9439	0.9596	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014636	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424
SPENP001672	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014641	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP001673	CPSIAAAIAAVNALHGR	Colon cancer	Colon cancer	Colon	SPENT000221,SPENT000220,SPENT000234	SPENG000739,SPENG000807	RBM39,lnc-NFS1-1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014635	SPENO005081,SPENO005525,SPENO006140	Bile duct cancer:SPENP013527;Colon cancer:SPENP026729,SPENP000417;Lung cancer:SPENP004381;Kidney cancer:SPENP020438
SPENP001686	PGSFGMDLAMSGGLGFAR	Colon cancer	Colon cancer	Colon	SPENT000839	SPENG003053	HSALNG0125274	-1.408	Others	-1.87	0.1107	0.4533	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014654	SPENO003504	
SPENP001690	MSVLGEGSTQVSEGAGDR	Colon cancer	Colon cancer	Colon	SPENT005760	SPENG000518	OPA3	1.05	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014652	SPENO002877	
SPENP001692	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.63	Others	-0.353	0.7322	0.8378	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014656	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP001694	GAHLTALEMLTAFASHIR	Colon cancer	Colon cancer	Colon	SPENT000791	SPENG000975	HSALNG0016057		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014659	SPENO001666	Lung cancer:SPENP002695
SPENP001696	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014660	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP001697	QTLSTPGTIILGTIPVPK	Colon cancer	Colon cancer	Colon	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014658	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP004453,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP000454
SPENP001705	NVQLLSQFVSPFTGCIYGR	Colon cancer	Colon cancer	Colon	SPENT000847	SPENG000825	HSALNG0035586		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014670	SPENO003852	Colon cancer:SPENP016180,SPENP014507;Lung cancer:SPENP028362;Kidney cancer:SPENP020507
SPENP001707	MILLPSILITVNSPILENK	Colon cancer	Colon cancer	Colon	SPENT000848	SPENG003217	AC106865.2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014671	SPENO006082	
SPENP001713	MITGFLLSFVTYENLMGSVR	Colon cancer	Colon cancer	Colon	SPENT000849	SPENG000938	HSALNG0096155		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014674	SPENO003685	
SPENP001715	SPPYIFSPIPFLGHAIAFGK	Colon cancer	Colon cancer	Colon	SPENT000775	SPENG001919	lnc-LRRD1-2	1.5453	Others	3.6156	0.0153	0.409	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014683	SPENO003078	Breast cancer:SPENP023049,SPENP023048;Kidney cancer:SPENP020556;Lung cancer:SPENP002761;Prostate cancer:SPENP018441
SPENP001720	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.7274	Others	0.669	0.5284	0.7386	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014677	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP001724	TYLGDPIPYDPQITAEELAEK	Colon cancer	Colon cancer	Colon	SPENT000853	SPENG001681	lnc-RPS20-4		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014690	SPENO003529	Lung cancer:SPENP026110
SPENP001725	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.596	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014687	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP001727	ETSVTPSNLWGGQGLLGVSIR	Colon cancer	Colon cancer	Colon	SPENT000615	SPENG001618	NONHSAG029796.2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014688	SPENO003428	Breast cancer:SPENP023091,SPENP023090;Colon cancer:SPENP000530,SPENP006694;Lung cancer:SPENP025659,SPENP028262;Prostate cancer:SPENP012117
SPENP001733	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.7183	Others	-0.6133	0.5503	0.7386	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014698	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP001734	DMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	-1.166	Others	-1.884	0.1327	0.4955	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014703	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP014577,SPENP006704,SPENP016247
SPENP001736	EEPFFPPPEEFVFIHAVPVEER	Colon cancer	Colon cancer	Colon	SPENT000628	SPENG001755	lnc-HNRNPUL2-BSCL2-1	1.1212	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014704	SPENO003259	Liver cancer:SPENP000760
SPENP001737	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014702	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP016253,SPENP006702
SPENP001740	LQAAQLPHTGVFGQSFSCPSDR	Colon cancer	Colon cancer	Colon	SPENT000855	SPENG000474	AC016876.2	-0.4771	Others	-0.61	0.5643	0.7386	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM014697	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092
SPENP001742	MGELGLLNYMDMILEKLLSLSQR	Colon cancer	Colon cancer	Colon	SPENT000857,SPENT000858,SPENT005761	SPENG002978,SPENG001156,SPENG003406	lnc-FBXO17-5,ERVK9-11,ZNF433-AS1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014712	SPENO000522,SPENO004622,SPENO005531	
SPENP001744	QGLYELSASNFELHVAQGDHFIK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014707	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554
SPENP001748	VKADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014709	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP001749	MTVLIFIHMNVPPSTPLSFCSFI	Colon cancer	Colon cancer	Colon	SPENT000856	SPENG003290	HSALNG0014904	1.8042	Others	1.6609	0.1311	0.4955	PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014708	SPENO004092	
SPENP001750	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014719	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP011011;Leukemia:SPENP001380
SPENP001753	MSIILLSMSPCVQIIQFPLRTCSI	Colon cancer	Colon cancer	Colon	SPENT000859	SPENG000240	lnc-LMO7DN-6		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014714	SPENO003488	
SPENP001754	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014716	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP021712,SPENP024293,SPENP007456
SPENP001762	SSQSLVHSDGNTYLSWLQQRPGQPPR	Colon cancer	Colon cancer	Colon	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Non-validated			Immunogenic	SPENM014725	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP021824
SPENP001767	TLEEGHDFIQEFPGSPAFAALTSIAQK	Colon cancer	Colon cancer	Colon	SPENT000868	SPENG001300	NONHSAG018279.2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	MS	28137767	Immunogenic	SPENM014732	SPENO000920	Bladder cancer:SPENP011759;Lung cancer:SPENP007895;Prostate cancer:SPENP023789
SPENP001768	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014727	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP001770	LGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014734	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP011098,SPENP011097,SPENP016349
SPENP001773	RLGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	-1.024	Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014736	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	
SPENP001774	LLLDAPAEDPNYLPLPEEQPGPHLPPPQQ	Colon cancer	Colon cancer	Colon	SPENT000869,SPENT000871,SPENT000870	SPENG002286	lnc-DERL3-1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014737	SPENO000187,SPENO001044,SPENO005977	Lung cancer:SPENP025861,SPENP004693
SPENP001775	FIGAGAATVGVAGSGAGIGTVFGSLIIGYAR	Colon cancer	Colon cancer	Colon	SPENT000872	SPENG002982	NONHSAG011251.2		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014738	SPENO000183	Prostate cancer:SPENP013115
SPENP001778	LGALSGAAALGFASYGAHGAQFPDAYGKELFDK	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000621	SPENG002150	lnc-PLSCR3-1		Others				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014741	SPENO000755,SPENO005859	Kidney cancer:SPENP020703
SPENP001779	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181
SPENP001780	AGPAAAFRRLGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Tumor-specific				PXD001676	Quantitative proteomics analysis of paired colorectal cancer and non-tumorigenic tissues reveal proteins and pathways perturbed in colorectal cancer	LTQ Orbitrap Elite	Spectrum counting	26054787	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014743	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Prostate cancer:SPENP013117
SPENP001825	TAVAHRPGAFK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000153	SPENG003407	NONHSAG024537.2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007617	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP001831	YLNVTSPPANDK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000904	SPENG001704	HSALNG0136200		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007622	SPENO002314	
SPENP001832	YQLDPTASISAK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007625	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP001834	IQEWIPPSTPYK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000910,SPENT000914,SPENT000911,SPENT000912,SPENT000913	SPENG000342,SPENG002791	HSALNG0093211,lnc-NR2C1-4		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007629	SPENO000089,SPENO002032,SPENO005256,SPENO005714,SPENO006035	
SPENP001837	LVILANNCPALR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007628	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP001844	VYYTAGYNSPVK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000754	SPENG000115	HSALNG0053823		Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007621	SPENO001372	Gastric cancer:SPENP003529;Tongue cancer:SPENP028184;Lung cancer:SPENP028417
SPENP001845	VVLDDKDYFLFR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000668,SPENT000737,SPENT000738,SPENT000740,SPENT000736,SPENT000739,SPENT000735,SPENT000741	SPENG001548,SPENG001699,SPENG001263,SPENG000451,SPENG001761,SPENG001842,SPENG002051	HSALNG0093536,lnc-ETNK2-4,lnc-GNPTAB-1,lnc-ARL4C-4,HSALNG0021384,HSALNG0009837,lnc-PABPC4-7	-0.0723	Others	-0.1253	0.9082	0.991	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	MS	28137767	Immunogenic	SPENM007631	SPENO000488,SPENO001622,SPENO002018,SPENO002762,SPENO004177,SPENO004759,SPENO004760,SPENO005600	Breast cancer:SPENP008856;Thyroid cancer:SPENP012309,SPENP012308;Gastric cancer:SPENP003148;Colon cancer:SPENP001551
SPENP001851	LTLMEEVLLLGLK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000919	SPENG002370	lnc-HORMAD1-2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007647	SPENO003260	
SPENP001858	YAMVYGYNAAYNR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007656	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP001862	ELSELVYTDVLDR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1	3.3156	Others	1.2138	0.4386	0.7914	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007644	SPENO002416,SPENO005649	Breast cancer:SPENP008874;Ovary cancer:SPENP029484;Colon cancer:SPENP026279,SPENP007120;Lung cancer:SPENP026506
SPENP001874	NSIAYMDQASGNVK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007666	SPENO002694,SPENO004565,SPENO006050	Gastric cancer:SPENP003173,SPENP003573;Colon cancer:SPENP027186,SPENP006520,SPENP007133;Lung cancer:SPENP004134
SPENP001878	GPVYIGELPQDFLR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000947,SPENT000946	SPENG002912	lnc-MOB2-2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007674	SPENO000523,SPENO003769	Breast cancer:SPENP008901;Gastric cancer:SPENP009539;Bladder cancer:SPENP011475
SPENP001879	EVVIFGAASELFTK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007671	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP001882	VLQATVVAVGSGSK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4	-1.413	Others	-1.707	0.1486	0.5199	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	MS	28137767	Immunogenic	SPENM007664	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP001895	MLQREEAENTLQSFR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000948	SPENG002072	NONHSAG005322.2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007681	SPENO004324	
SPENP001896	MLITILGTVKPNANR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-1.115	Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007683	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP001897	YAASSYLSLTPEQWK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.3364	Others	-0.4914	0.6406	0.7914	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	MS	28137767	Immunogenic	SPENM007680	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP001909	AAGVNVEPFWPGLFAK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000958,SPENT000959,SPENT000956,SPENT000957	SPENG002082,SPENG000412,SPENG001664,SPENG001785	NONHSAG017284.2,HSALNG0011930,lnc-GREM2-13,lnc-EVX2-8	0.0113	Others	0.0109	0.9918	0.9918	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	MS	28137767	Immunogenic	SPENM007702	SPENO002111,SPENO003329,SPENO004329,SPENO006018	Breast cancer:SPENP008943;Prostate cancer:SPENP009247,SPENP023710;Lung cancer:SPENP026477;Liver cancer:SPENP004882
SPENP001925	TPIGSFLGSLSLLPATK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000014	SPENG003410	ACAT1		Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007716	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP001934	GETGPAGPAGPVGPVGAR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007719	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP001940	TGVHHYSGNNIELGTACGK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	MS	28137767	Immunogenic	SPENM007735	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP001946	YFILPDSLPLDTLLVDVEPK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000928	SPENG002213	HSALNG0120314	3.4818	Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007739	SPENO000238	Bile duct cancer:SPENP013597;Tongue cancer:SPENP028202;Lung cancer:SPENP026636,SPENP026177;Skin cancer:SPENP025399
SPENP001949	ATLVCLISDFYPGAVTVAWK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007742	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP001950	QSNNKYAASSYLSLTPEQWK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.0028	Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007738	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP001951	GLAFIQDPDGYWIEILNPNK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000966	SPENG003502	HSALNG0049885	1.1727	Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007737	SPENO001520	Breast cancer:SPENP008993
SPENP001958	IHVYGYSMAYGPAQHAISTEK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000950,SPENT000949	SPENG000389,SPENG001205	HSALNG0075308,NONHSAG053817.2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007743	SPENO001784,SPENO004447	Prostate cancer:SPENP023771;Liver cancer:SPENP004929
SPENP001959	ADRDESSPYAAMLAAQDVAQR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.4721	Others	0.8505	0.5225	0.7914	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007746	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP001961	AGTELVNFLSYFVELGTQPATQ	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007752	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006047,SPENP006044,SPENP009020,SPENP006046,SPENP006045;Ovary cancer:SPENP011850
SPENP001962	TCLHYLGEFGEDQIYEAHQQGR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007755	SPENO002417,SPENO005649	Thyroid cancer:SPENP012600,SPENP012601;Colon cancer:SPENP012856,SPENP026436
SPENP001964	SGDRGETGPAGPAGPVGPVGAR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005758	SPENG002845	COL1A1	-3.451	Others	-0.9105	0.4043	0.7914	PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007750	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP001965	DMDLTEVITGTLWNLSSHDSIK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007751	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP001966	VKADRDESSPYAAMLAAQDVAQR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007756	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP001967	TKTETITGFQVDAVPANGQTPIQR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007757	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP001970	STATISGLKPGVDYTITVYAVTGR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007758	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP001973	LTGPGLSEGPEPSISVMVTGGPWPTR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007764	SPENO002416,SPENO005649	Breast cancer:SPENP009052
SPENP001975	TGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007769	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP001976	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000014	SPENG003410	ACAT1		Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007768	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP001977	IVAFADAAVEPIDFPIAPVYAASMVLK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000014	SPENG003410	ACAT1		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007767	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP001979	SVHPYEVAEVIALPVEQGNFPYLQWVR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000978	SPENG002106	lnc-DAXX-2		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Validated	MS	28137767	Immunogenic	SPENM007765	SPENO003629	Breast cancer:SPENP009055
SPENP001981	IIGFGSALLEEVDPNPANFVGAGIIHTK	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT000981,SPENT000979,SPENT000980	SPENG000772	HSALNG0082062		Tumor-specific				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007771	SPENO001278,SPENO001519,SPENO001895	
SPENP001983	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Lung cancer	Lung adenocarcinoma	Lung epithelium	SPENT005797,SPENT005805	SPENG002649	FGA		Others				PXD002523	Human lung adenocarcinoma tissue LC-MS/MS	LTQ Orbitrap	Spectrum counting	26584007	Non-validated			Immunogenic	SPENM007773	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP007924;Colon cancer:SPENP024345,SPENP011202,SPENP011201
SPENP002154	AVYTLTSLYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000988	SPENG000380	lnc-DIABLO-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM007964	SPENO003093	Bladder cancer:SPENP017167;Kidney cancer:SPENP019937;Prostate cancer:SPENP018082;Colon cancer:SPENP014012,SPENP008071,SPENP026722,SPENP015676
SPENP002165	FTLFGIANKK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM007932	SPENO002584	Colon cancer:SPENP015611,SPENP026852
SPENP002187	LLLYGLHHGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	0.4774	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM007956	SPENO002584	Colon cancer:SPENP013978,SPENP027082,SPENP015665
SPENP002204	TAVAHRPGAFK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000153	SPENG003407	NONHSAG024537.2	1.0094	Others	1.6179	0.1321	0.3215	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008025	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP002252	RFVNVVPTFGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008045	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP002273	YMDGMTVGVVR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005796	SPENG001958	FBLN1	0.0304	Others	0.1905	0.8493	0.9088	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008007	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP002274	DKLNNLVLFDK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	1.0258	Up-regulated in tumors	4.3058	0.0001	0.0026	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008070	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP002286	YRDPTTVTTLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000087	SPENG002460	PPP2R2A		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007988	SPENO004740	Tongue cancer:SPENP028220
SPENP002297	GQAGVMGFPGPK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005758	SPENG002845	COL1A1	-0.6525	Others	-2.964	0.0034	0.0237	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008149	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP002319	NQSLIPLLLEAR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008134	SPENO004045	Lung cancer:SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP002324	VPFLVLECPNLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000354	SPENG002378	HSALNG0036293	0.1574	Others	1.1129	0.2682	0.4743	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008113	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP002339	YQLDPTASISAK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000102	SPENG002045	lnc-ACTR2-11	0.3942	Others	3.817	0.0002	0.0033	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008123	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP002342	AALPEGLPEASR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001199	SPENG002441	NONHSAG025130.2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008119	SPENO006044	Gastric cancer:SPENP003541;Colon cancer:SPENP000225
SPENP002371	VRDKLNNLVLFDK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008207	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP023352;Anal canal cancer:SPENP024649;Tongue cancer:SPENP028159;Prostate cancer:SPENP018239;Colon cancer:SPENP027424
SPENP002375	NEQSLQEIWDYVK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001225,SPENT001223,SPENT001018,SPENT001226,SPENT001224,SPENT001227,SPENT001221,SPENT001172,SPENT001020,SPENT001222,SPENT001019,SPENT001021,SPENT001220	SPENG000692,SPENG003279,SPENG002107,SPENG000730,SPENG003168,SPENG001071,SPENG002783,SPENG003471,SPENG003240,SPENG002830,SPENG000109	lnc-LRP5L-14,AL360020.1,LINC02569,AC097532.3,lnc-TSHZ2-15,Z82195.3,lnc-KRBOX4-4,AC092445.1,LINC01949,lnc-SLC35B3-4,lnc-FBXO11-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM008195	SPENO000166,SPENO000440,SPENO000689,SPENO001532,SPENO001739,SPENO001792,SPENO001875,SPENO002117,SPENO002350,SPENO003055,SPENO003744,SPENO004543,SPENO004677	Bladder cancer:SPENP017447
SPENP002395	LPSEPGMTLLTIR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001009	SPENG001238	lnc-USP33-3		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008208	SPENO005521	Colon cancer:SPENP000248;Prostate cancer:SPENP023633
SPENP002400	DLFTASNDPLLWR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001218	SPENG003441	NONHSAG033755.2	-1.302	Others	-1.876	0.1573	0.3441	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008192	SPENO005358	Lung cancer:SPENP025590;Kidney cancer:SPENP020168;Prostate cancer:SPENP012012
SPENP002407	GNSIIMLEALERV	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	-0.2588	Others	-1.284	0.2067	0.3994	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008191	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP002408	SFHFSLPSSWYYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2	-0.1521	Others	-0.8366	0.4042	0.5889	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008228	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP002411	SGTLYSLTLYGLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-1.039	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008223	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP002412	YAMVYGYNAAYNR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	-0.4817	Others	-1.61	0.1222	0.3074	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008169	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP002422	YKWCEYGLTFTEK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008222	SPENO000884	Skin cancer:SPENP025208;Kidney cancer:SPENP020206;Prostate cancer:SPENP018224
SPENP002434	AAALVLQTIWGYK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005788	SPENG002233	AP001931.2	-0.5476	Others	-4.718	6.09e-06	0.0004	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008233	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP002464	LLLLESVSGLLQPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001258	SPENG001048	lnc-CXCL16-3	-0.0232	Others	-0.0703	0.9455	0.9742	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008269	SPENO003005	Colon cancer:SPENP010362,SPENP006509,SPENP010361;Lung cancer:SPENP028325
SPENP002469	RSFHFSLPSSWYYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008287	SPENO003826,SPENO004614	Colon cancer:SPENP015938
SPENP002475	RNEQSLQEIWDYVK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001225,SPENT001223,SPENT001018,SPENT001224,SPENT001227,SPENT001221,SPENT001172,SPENT001020,SPENT001222,SPENT001019,SPENT001021,SPENT001220	SPENG000692,SPENG003279,SPENG002107,SPENG003168,SPENG001071,SPENG002783,SPENG003471,SPENG003240,SPENG002830,SPENG000109	lnc-LRP5L-14,AL360020.1,LINC02569,lnc-TSHZ2-15,Z82195.3,lnc-KRBOX4-4,AC092445.1,LINC01949,lnc-SLC35B3-4,lnc-FBXO11-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM008281	SPENO000166,SPENO000440,SPENO001532,SPENO001739,SPENO001792,SPENO001875,SPENO002117,SPENO002350,SPENO003055,SPENO003744,SPENO004543,SPENO004677	Colon cancer:SPENP014256
SPENP002477	MELENIVANTVLLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001256	SPENG001321	NONHSAG042355.2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008261	SPENO002906	Colon cancer:SPENP000301;Lung cancer:SPENP025913
SPENP002484	SHTVCIYTHSHSFL	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001263	SPENG001834	HSALNG0022489	0.4874	Others	0.4534	0.6599	0.7883	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008286	SPENO000462	Prostate cancer:SPENP012030
SPENP002485	QYNVGPSVSKYPLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2388	Others	-1.453	0.1495	0.3411	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008302	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP002486	QVRPIVGPFHAVLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005796	SPENG001958	FBLN1	-0.7978	Others	-1.018	0.3353	0.5387	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008304	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331,SPENP003568;Colon cancer:SPENP006511,SPENP014237,SPENP015976
SPENP002487	SKESVPEFPLSPPK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001112	SPENG003381	lnc-PAQR7-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008308	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP002501	IDDILQTLLDATYK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000775	SPENG001919	lnc-LRRD1-2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008243	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP025776;Prostate cancer:SPENP018266;Colon cancer:SPENP001612,SPENP000320
SPENP002504	VTDATETTITISWR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4271	Others	-0.3892	0.7009	0.8159	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008262	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP002520	EVVIFGAASELFTK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000018	SPENG003202	HMGCL		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008249	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP002532	MLLQMTGFHFFLMAK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001272,SPENT001271	SPENG001828,SPENG003491	lnc-MTHFD1-3,HSALNG0101865	0.4984	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008329	SPENO002273,SPENO003340	
SPENP002533	MLITILGTVKPNANR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.0858	Others	-0.5234	0.6012	0.7414	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008331	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP002543	EVVIFGAASELFTKK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008373	SPENO002963	Colon cancer:SPENP026814,SPENP008419;Lung cancer:SPENP007731,SPENP004268;Kidney cancer:SPENP020351;Prostate cancer:SPENP018293
SPENP002546	VKEVLPHVPLGVIQR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001183,SPENT001274,SPENT001182	SPENG000169	lnc-DQX1-1		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008340	SPENO001535,SPENO004354,SPENO005264	Colon cancer:SPENP027402;Kidney cancer:SPENP020312;Prostate cancer:SPENP018303
SPENP002547	SSTSRPDAYEHTQMK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2	-0.707	Others	-0.7961	0.4563	0.6304	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008325	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP026055,SPENP004254
SPENP002563	YAASSYLSLTPEQWK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.5403	Others	4.451	1.42e-05	0.0006	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008350	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP002589	AAALVLQTIWGYKELR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005788	SPENG002233	AP001931.2	0.5962	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008409	SPENO005858	Skin cancer:SPENP025298;Colon cancer:SPENP026643
SPENP002602	FYTAEIVSALEYLHGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001325	SPENG001510	lnc-PRSS27-4	0.1564	Others	0.6048	0.5644	0.7187	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008431	SPENO005598	
SPENP002603	SDYNIQKESTLHLVLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000983	SPENG001213	lnc-RPN2-4		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008374	SPENO004739	
SPENP002622	DELLSSSDALFCLEFK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001295,SPENT001298,SPENT001308,SPENT001315,SPENT001312,SPENT001317,SPENT001301,SPENT001299,SPENT001306,SPENT001307,SPENT001314,SPENT001302,SPENT001309,SPENT001310,SPENT001303,SPENT001313,SPENT001318,SPENT001316,SPENT001300,SPENT001311,SPENT001304,SPENT001320,SPENT001319,SPENT001296,SPENT001305,SPENT001321,SPENT001297	SPENG000209,SPENG000110,SPENG000508	HSALNG0033312,AC097512.1,lnc-SOD3-5		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008394	SPENO000758,SPENO000775,SPENO000948,SPENO000958,SPENO001020,SPENO001419,SPENO001965,SPENO002099,SPENO002217,SPENO003001,SPENO003091,SPENO003126,SPENO003237,SPENO003475,SPENO003707,SPENO003952,SPENO004165,SPENO004732,SPENO005022,SPENO005243,SPENO005685,SPENO005757,SPENO006076,SPENO006098,SPENO006108,SPENO006114,SPENO006269	
SPENP002633	AFPHLQQPSFLLASLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001324	SPENG003020	HSALNG0018780		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008425	SPENO005958	Bladder cancer:SPENP017641;Colon cancer:SPENP014363;Lung cancer:SPENP004356
SPENP002640	DRDPNSLLISCAVSYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008416	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP002642	LLEHGSIYVELNAVLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001111	SPENG000900	lnc-LIFR-4		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008383	SPENO004786	
SPENP002647	LLGGQLGLEDFIFAHVK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001329	SPENG000766	HSALNG0004615	-0.4103	Others	-1.389	0.1947	0.3897	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008456	SPENO001612	Breast cancer:SPENP021319,SPENP021317;Bladder cancer:SPENP017681;Lung cancer:SPENP021318;Prostate cancer:SPENP018369;Colon cancer:SPENP021316
SPENP002651	TPIGSFLGSLSLLPATK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000014	SPENG003410	ACAT1	0.0433	Others	0.4367	0.6628	0.7903	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008440	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP002661	EAQAQHNNSEFTEEQKK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001330,SPENT001009	SPENG001238,SPENG001518	lnc-USP33-3,lnc-TMEM144-3	0.4667	Others	0.6523	0.543	0.7037	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008457	SPENO004170,SPENO005521	Colon cancer:SPENP007320,SPENP000428;Prostate cancer:SPENP023734
SPENP002663	ISSTLYQAAAPVLTPAK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008449	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP002667	ETPLPIDPSMFPTWPAK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000136,SPENT000135,SPENT000138,SPENT000137,SPENT000139	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM008446	SPENO000257,SPENO002156,SPENO003659,SPENO005654,SPENO006064	Bladder cancer:SPENP011592,SPENP017665;Colon cancer:SPENP008539,SPENP000431;Lung cancer:SPENP025658;Kidney cancer:SPENP020456
SPENP002673	LAALTNYLQPQLDWQAR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001327	SPENG000904	NONHSAG033296.2	-0.7116	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008445	SPENO001469	
SPENP002675	LATLACQGCGWEPLPMK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001326	SPENG002913	lnc-CCDC13-1	-0.0511	Others	-0.2746	0.7946	0.8774	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008436	SPENO000649	
SPENP002686	GIQKFPGINYPVLTPNLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000018,SPENT000457,SPENT000458	SPENG001448,SPENG003202	HMGCL,lnc-GALE-2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008511	SPENO000742,SPENO001216,SPENO002963	Colon cancer:SPENP014465,SPENP026891,SPENP016121,SPENP010748,SPENP010747;Prostate cancer:SPENP018387
SPENP002694	QTLSTPGTIILGTIPVPK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2	0.7584	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	MS	28137767	Immunogenic	SPENM008515	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP004453,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP001697,SPENP000454
SPENP002695	GAHLTALEMLTAFASHIR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000791	SPENG000975	HSALNG0016057	0.222	Others	1.0352	0.335	0.5387	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008514	SPENO001666	Colon cancer:SPENP001694
SPENP002696	VSPHSGVVALTKPVPEPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005785	SPENG001958	FBLN1	0.7239	Others	1.9468	0.0596	0.1969	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008483	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP002709	TFTYLLGSDAAALLFNSK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008490	SPENO003078	Breast cancer:SPENP022991,SPENP022990;Prostate cancer:SPENP018397
SPENP002716	GETGPAGPAGPVGPVGAR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005758	SPENG002845	COL1A1	-1.176	Down-regulated in tumors	-4.249	4.05e-05	0.0011	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008498	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP002719	DIQMTQSPSSLSASVGDR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.351	Others	2.0019	0.0471	0.1661	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008502	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP002728	LSWTVPEGQFDSFVVQFK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	-0.7185	Others	-2.932	0.0043	0.0278	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008485	SPENO002584	Bladder cancer:SPENP017719;Kidney cancer:SPENP020466;Tongue cancer:SPENP027882;Colon cancer:SPENP014455,SPENP016143
SPENP002731	ADEALFLLLHNEMVSGVYK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767	0.1348	Others	0.4561	0.6498	0.7791	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008542	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP006659,SPENP000481,SPENP016178,SPENP014479;Lung cancer:SPENP004493;Kidney cancer:SPENP020515
SPENP002741	NDSSFLSTLHEVYLQVLTK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001364,SPENT001366,SPENT001365	SPENG001284	lnc-TKT-3		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008548	SPENO000280,SPENO000301,SPENO002274	
SPENP002749	QALNLPDVFGLVVLPLELK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001218	SPENG003441	NONHSAG033755.2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008520	SPENO005358	Breast cancer:SPENP008975;Colon cancer:SPENP016179;Lung cancer:SPENP025980;Kidney cancer:SPENP020505
SPENP002754	KVSPHSGVVALTKPVPEPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005785	SPENG001958	FBLN1	-0.3198	Others	-0.8547	0.4054	0.5889	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008539	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP002755	RQDSIPAFLSSLTLELFSR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001363,SPENT001361,SPENT001360,SPENT001359,SPENT001362	SPENG000471,SPENG001927	lnc-MAD1L1-6,HSALNG0055686		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008547	SPENO001112,SPENO002176,SPENO002244,SPENO004603,SPENO006230	
SPENP002759	NNQLVAGYLQGPNVNLEEK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001357	SPENG002580	NONHSAG028996.2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008540	SPENO002732	Colon cancer:SPENP000479,SPENP014503;Lung cancer:SPENP028356,SPENP025965
SPENP002761	SPPYIFSPIPFLGHAIAFGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000775	SPENG001919	lnc-LRRD1-2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008555	SPENO003078	Breast cancer:SPENP023049,SPENP023048;Kidney cancer:SPENP020556;Prostate cancer:SPENP018441;Colon cancer:SPENP001715
SPENP002766	ALAPTWEQLALGLEHSETVK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.7541	Others	3.2203	0.0015	0.0135	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008567	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP002767	VGQYVVDLTSFEQLALPVLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001191,SPENT000714	SPENG002182	NONHSAG004654.2	0.2644	Others	0.3151	0.7558	0.8522	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008574	SPENO002934,SPENO005968	Breast cancer:SPENP023074,SPENP023075;Bladder cancer:SPENP017780
SPENP002770	YIMVPSGNMGVFDPTEIHNR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.667	Others	2.4338	0.0196	0.0937	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008583	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP002771	ATLVCLISDFYPGAVTVAWK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.5865	Others	2.6623	0.0086	0.0473	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008588	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP002772	MHITLCDFIVPWDTLSTTQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001377,SPENT001376,SPENT001375	SPENG001805,SPENG003577,SPENG001555	lnc-CEP295NL-1,NONHSAG022904.2,HSALNG0119072		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008584	SPENO002297,SPENO004184,SPENO004286	
SPENP002774	QSNNKYAASSYLSLTPEQWK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008575	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP002779	RDPFIGEHTEEILEEFGFSR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001369	SPENG002989	lnc-C1QTNF3-AMACR-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008557	SPENO003957	
SPENP002801	STAAMSTYTGIFTDQVLSVLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008611	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP002810	HRPRPYPPNVGEEIQIGHIPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005757	SPENG000084	FN1	0.2005	Others	0.6622	0.511	0.6701	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008601	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP002818	TNTNVNCPIECFMPLDVQADR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.4132	Others	-1.6	0.1705	0.3589	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008599	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP002823	LRECDGLVDALIFIVQAEIGQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005788	SPENG002233	AP001931.2	-0.2989	Others	-0.8747	0.4005	0.5886	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008630	SPENO005858	Anal canal cancer:SPENP024912;Colon cancer:SPENP014582,SPENP016259
SPENP002825	DTLTSRPAQGVVTTLENVSPPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2873	Others	-2.033	0.0436	0.1611	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008620	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP002829	DMDLTEVITGTLWNLSSHDSIK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005788	SPENG002233	AP001931.2	-0.5587	Others	-2.764	0.0066	0.0389	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008617	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP002830	LIDMLSEAGLSVIETTSFVSPK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008633	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP002831	TETITGFQVDAVPANGQTPIQR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0618	Others	-0.2592	0.7976	0.8777	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008634	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP002835	TSSLHGPSFFLGLIIAFFLSSV	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001407,SPENT001406,SPENT001405	SPENG000242,SPENG003171	lnc-AAMP-2,HSALNG0022233	-0.0692	Others	-0.2031	0.8404	0.9043	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008631	SPENO003460,SPENO003917,SPENO004333	
SPENP002840	SGDRGETGPAGPAGPVGPVGAR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005758	SPENG002845	COL1A1	-0.8923	Others	-4.308	2.99e-05	0.0009	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008624	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP002846	FKPLWIEEPTSPDDILGHATISK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001202,SPENT001201	SPENG003388,SPENG002104	HSALNG0119574,lnc-YES1-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008648	SPENO004359,SPENO006042	
SPENP002847	QGLYELSASNFELHVAQGDHFIK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.0157	Others	-0.0534	0.9575	0.9742	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008642	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP002848	FLSGKCLYFSDQVHILYFVSELF	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005789	SPENG001983	CNOT2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008647	SPENO005500	
SPENP002849	ATFYTPQNPSSLAPAPLRPLEDR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001336	SPENG001086	HSALNG0049384	0.416	Others	0.3919	0.7151	0.8259	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008654	SPENO005428	Bladder cancer:SPENP017857;Kidney cancer:SPENP020611;Bile duct cancer:SPENP013627;Colon cancer:SPENP024279,SPENP016277
SPENP002850	GTVLALTENNFDDTIAEGITFIK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.4953	Others	-1.093	0.288	0.4941	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008650	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP000559,SPENP008691
SPENP002851	YGVAARPGFGLSPIFPGGACLGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001282,SPENT005790,SPENT005791,SPENT005787	SPENG001189,SPENG001044	NONHSAG047951.2,ELN	0.0977	Others	0.276	0.783	0.869	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008637	SPENO000856,SPENO001279,SPENO002475,SPENO006039	Skin cancer:SPENP025436;Lung cancer:SPENP004630
SPENP002852	MFLSFYMMLICREIHLSFLIFLS	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001410	SPENG002737	HSALNG0100866	-1.935	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008651	SPENO004523	
SPENP002858	DTLTSRPAQGVVTTLENVSPPRR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0968	Others	-0.4977	0.6196	0.7504	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008643	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP002859	LQAMWGQSLLPPVSTSFTTGGLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.4538	Others	-1.707	0.0929	0.2618	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008645	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012626,SPENP012627;Bladder cancer:SPENP017847;Kidney cancer:SPENP020599;Colon cancer:SPENP014588,SPENP016279
SPENP002867	MFLSGKCLYFSDQVHILYFVSELF	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005789	SPENG001983	CNOT2	-0.799	Others	-2.155	0.0354	0.1352	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008669	SPENO005500	Colon cancer:SPENP006720,SPENP014606,SPENP016291
SPENP002869	DLEVVAATPTSLLISWDAPAVTVR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.3062	Others	-1.586	0.1147	0.2991	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008667	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP002872	NSITLTNLTPGTEYVVSIVALNGR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0874	Others	-0.4429	0.6586	0.7881	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008658	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP002874	ARDMDLTEVITGTLWNLSSHDSIK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005788	SPENG002233	AP001931.2	-0.8068	Others	-1.495	0.1589	0.3441	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008670	SPENO005858	Colon cancer:SPENP014616,SPENP016292,SPENP026702,SPENP008706
SPENP002878	STAAMSTYTGIFTDQVLSVLKGEE	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.5545	Others	-1.401	0.1725	0.3609	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008664	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP002879	STATISGLKPGVDYTITVYAVTGR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6554	Others	-2.365	0.0226	0.1029	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008663	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP002881	TKTETITGFQVDAVPANGQTPIQR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.029	Others	0.1974	0.8438	0.9043	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008656	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP002882	IKLIDMLSEAGLSVIETTSFVSPK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008672	SPENO002963	Kidney cancer:SPENP020621
SPENP002891	LHLEGYHGTAGDSMSYHSGSVFSAR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.5439	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008677	SPENO002584,SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012644,SPENP012645;Bladder cancer:SPENP017892;Gastric cancer:SPENP003348;Colon cancer:SPENP016316,SPENP027069
SPENP002902	SSQSLVHSDGNTYLSWLQQRPGQPPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008696	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP002906	DITSDSLSLSWTVPEGQFDHFLVQFK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	-0.572	Others	-2.669	0.0256	0.1101	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008688	SPENO002584	Colon cancer:SPENP014640,SPENP016327
SPENP002907	TNTNVNCPIECFMPLDVQADREDSRE	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.2411	Others	1.0669	0.2924	0.4977	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008695	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP002908	SSQSLVYSDGNTYLNWFQQRPGQSPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008697	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP002911	IVAFADAAVEPIDFPIAPVYAASMVLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000014	SPENG003410	ACAT1	1.1059	Others	1.7979	0.0781	0.2333	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008700	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP002913	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000014	SPENG003410	ACAT1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008703	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP002914	NIAPHTVVDSIMTALSPYASLAVNNIR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001412	SPENG003545	NONHSAG035102.2	1.7916	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008701	SPENO001698	
SPENP002915	ACEDIDECSLPNICVFGTCHNLPGLFR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005892	SPENG001317	HSALNG0105758	-0.3298	Others	-1.496	0.1424	0.3329	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008702	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP008730,SPENP016345;Thyroid cancer:SPENP012658,SPENP012659
SPENP002918	TGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2036	Others	-1.214	0.2264	0.4181	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008706	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP002921	IQDAGVYLLYSQVLFQDVTFTMGQVVSR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001135,SPENT001137,SPENT001136	SPENG000387	NONHSAG020715.2	-0.311	Others	-0.3583	0.7294	0.8363	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008713	SPENO002459,SPENO005445,SPENO006147	
SPENP002925	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0178	Others	-0.0591	0.953	0.9742	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008712	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP002927	LGALSGAAALGFASYGAHGAQFPDAYGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	0.3982	Others	0.9428	0.3822	0.5785	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008715	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP002928	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	-0.8222	Others	-4.71	6.83e-06	0.0004	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008719	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP002933	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	-0.4094	Others	-1.773	0.079	0.2347	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008739	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP002934	IYYINSAASFFAFIATLLYILHAFSIYYH	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001422,SPENT001423	SPENG002569,SPENG002031	AC140479.4,HSALNG0017824	0.5823	Others	0.6839	0.5096	0.6701	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM008740	SPENO000356,SPENO002692	
SPENP002935	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005757,SPENT005755	SPENG000084	FN1	0.1895	Others	0.9288	0.3548	0.5549	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008730	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP002936	ASADELTFHEFEEATNLLADTPDAATTSR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001420	SPENG000627	lnc-TMED1-2	1.0831	Others	1.7209	0.0941	0.2631	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008732	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP002938	AVSLVTDSTSTFLSQTTYALIEAITEYTK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001334,SPENT000988	SPENG000380	lnc-DIABLO-1	2.1512	Others	2.0997	0.0898	0.2543	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008723	SPENO001827,SPENO003093	Colon cancer:SPENP014674,SPENP016372,SPENP000607;Kidney cancer:SPENP020675
SPENP002941	LDNFPTNLHPMSQLSAAVTALNSESNFAR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001421	SPENG002247	HSALNG0091524	-0.024	Others	-0.132	0.8955	0.9383	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008738	SPENO000474	
SPENP002942	EAITAATCLTEALVDHLNVGVAQAYMNQR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005900	SPENG003688	AC009779.3		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008724	SPENO005417	Colon cancer:SPENP014679
SPENP002944	GSFITSEEQDVSPRPAPLLLNTPAIPSFK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001369	SPENG002989	lnc-C1QTNF3-AMACR-1		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008736	SPENO003957	
SPENP002945	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0467	Others	0.198	0.8435	0.9043	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008729	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP002947	QFQADLQTAVVIANDIKSEAQEEIGDLKR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005916	SPENG003866	SPECC1L-ADORA2A	-1.447	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008735	SPENO002262	
SPENP002956	FSPHFLDWAAFGVMTLPSIGIPLLLWYSSK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001424	SPENG000230	lnc-ARHGEF2-3		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008744	SPENO000111	
SPENP002958	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.0243	Others	-0.124	0.9017	0.9433	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008750	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP002960	IIFFGSTTILMNFLYLLGEVLNNYIWDTQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001425	SPENG001587	NONHSAG045042.2		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008747	SPENO003912	
SPENP002962	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005757,SPENT005755	SPENG000084	FN1	0.5241	Others	1.6569	0.108	0.2898	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008752	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP002963	SGDRGETGPAGPAGPVGPVGARGPAGPQGPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005758	SPENG002845	COL1A1	-0.5349	Others	-0.7859	0.4485	0.6256	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008761	SPENO004941	Colon cancer:SPENP011159,SPENP024331,SPENP011160
SPENP002965	VRLEVPPEADGTLLTDLMPGVEYVVTVTAER	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	-1.487	Others	-1.628	0.1161	0.3006	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008759	SPENO002584	Colon cancer:SPENP014695
SPENP002966	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.4467	Others	1.9132	0.0608	0.1989	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008762	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP002967	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005757,SPENT005755	SPENG000084	FN1	0.2878	Others	0.9606	0.3406	0.5405	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008753	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP002973	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1839	Others	0.7691	0.4477	0.6256	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008754	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Colon cancer:SPENP014687,SPENP024330,SPENP016392,SPENP027468
SPENP002974	FMVQSMFAPTDTSDMEAVVSTECFLFFSVTII	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000368	SPENG003734	HSALNG0131252		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM008765	SPENO002994	
SPENP002975	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000855	SPENG000474	AC016876.2	-0.8205	Others	-2.863	0.0353	0.1352	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM008767	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP002976	YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1262	Others	-0.3538	0.7339	0.8385	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008768	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009079;Ovary cancer:SPENP016675;Colon cancer:SPENP027469,SPENP014701;Lung cancer:SPENP004715
SPENP002977	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.593	Others	3.2101	0.0018	0.0158	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008764	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP002979	LEELTVTDATPDSLSLSWTVPEGQFDHFLVQYK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008775	SPENO002584	Colon cancer:SPENP016404,SPENP014708
SPENP002981	LGELTVTDATPDSLSLSWMVPEGQFDHFLVQYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2	-0.73	Others	-1.022	0.3818	0.5785	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008776	SPENO002584	Colon cancer:SPENP014713,SPENP016410;Lung cancer:SPENP025842
SPENP002982	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.0915	Others	0.1583	0.8759	0.9296	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008773	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP025576;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP002987	LGELTMTDATPDSLSLSWTVPEGQFDHFLVQYR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005913	SPENG001766	AL662884.2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008777	SPENO002584	Bladder cancer:SPENP017972;Colon cancer:SPENP016409,SPENP014711
SPENP002989	VDIVAINDPFIDLNYMVYMFLYDSTHGKFHGTVK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001429	SPENG002242	lnc-PCLAF-6		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008782	SPENO004688	
SPENP002992	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.4269	Others	1.1815	0.2446	0.4439	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008781	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP002993	LLDPRIYYINSAASFFAFIATLLYILHAFSIYYH	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001422,SPENT001423	SPENG002569,SPENG002031	AC140479.4,HSALNG0017824		Tumor-specific				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM008779	SPENO000356,SPENO002692	
SPENP002994	VQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000873	SPENG003737	AC098588.3		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008787	SPENO000659	
SPENP002996	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005892	SPENG001317	HSALNG0105758	0.5303	Others	1.2912	0.2034	0.3942	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008784	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP008769,SPENP011193,SPENP014722,SPENP011194,SPENP016417
SPENP002997	ATPYNYPVPVRDDGNMPDVPSHPQDPQGPSLEWLK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT001430	SPENG001666	HSALNG0127466	0.9096	Others	2.8898	0.0081	0.0456	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008785	SPENO004370	Colon cancer:SPENP008770
SPENP002998	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.0631	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008786	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP003000	VQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIRR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT000873	SPENG003737	AC098588.3	0.1369	Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Non-validated			Immunogenic	SPENM008790	SPENO000659	
SPENP003001	NLPGGQQNSSWNFSEDTVISILNTINEVIAENLEAAK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005788	SPENG002233	AP001931.2		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008791	SPENO005858	Colon cancer:SPENP014730,SPENP016426
SPENP003004	AGAGLGGVPGVGGLGVSAAPSVPGAVVPQPGAGVKPGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005790,SPENT005787	SPENG001189	ELN	-0.4092	Others	-1.303	0.2009	0.3941	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008793	SPENO000856,SPENO006039	
SPENP003008	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752	SPENG000084	FN1	-0.5083	Others	-0.8759	0.4305	0.6122	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008797	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP003010	KTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752	SPENG000084	FN1		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008799	SPENO001233	Bladder cancer:SPENP017992;Tongue cancer:SPENP027837;Gastric cancer:SPENP015491;Colon cancer:SPENP016433
SPENP003011	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008801	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP022142
SPENP003012	YGAAGLGGVLGGAGQFPLGGVAARPGFGLSPIFPGGACLGK	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005792,SPENT005786	SPENG001189	ELN	-0.2177	Others	-0.7376	0.4633	0.6316	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008802	SPENO001289,SPENO003914	Skin cancer:SPENP025495
SPENP003013	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Lung cancer	Non-small cell lung carcinoma	Lung	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0741	Others	-0.3842	0.7017	0.8159	PXD002612	LC7 Proteomic Analysis of Matched Control and NSCLC Lung Adenocarcinoma Tissue.	Q Exactive	MS1 intensity based label-free quantification method	27799870	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008803	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP003063	IVFSFMHFK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001440,SPENT001438,SPENT001439,SPENT001441	SPENG001558,SPENG001035	lnc-PTPN14-2,HSALNG0010482	0.4949	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016250	SPENO000939,SPENO002693,SPENO002992,SPENO006337	
SPENP003089	IVFSFMHFKK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001440,SPENT001438,SPENT001439,SPENT001441	SPENG001558,SPENG001035	lnc-PTPN14-2,HSALNG0010482		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016304	SPENO000939,SPENO002693,SPENO002992,SPENO006337	
SPENP003118	ALLSAPWYLNR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001450	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016330	SPENO003868	Skin cancer:SPENP019006,SPENP019005,SPENP019004;Prostate cancer:SPENP023559;Breast cancer:SPENP022450,SPENP022451
SPENP003120	YMDGMTVGVVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005796	SPENG001958	FBLN1	-0.2845	Others	-0.4517	0.663	0.7746	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016334	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP003136	TLMNLGGLAVAR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001451	SPENG001511	HSALNG0007796		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	MS	28137767	Immunogenic	SPENM016342	SPENO005561	Thyroid cancer:SPENP012332,SPENP012333;Prostate cancer:SPENP009173
SPENP003139	TALLTWTEPPVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016343	SPENO002584,SPENO006142	
SPENP003141	MAPVSWITPGLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001457,SPENT001458	SPENG000652	AC012313.3	-2.655	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM016355	SPENO002381,SPENO003501	Colon cancer:SPENP029418;Gastric cancer:SPENP003523
SPENP003144	VSPHSGVVALTK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005785	SPENG001958	FBLN1	0.0796	Others	0.0827	0.9368	0.9738	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016356	SPENO005034	
SPENP003148	VVLDDKDYFLFR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000668,SPENT000737,SPENT000738,SPENT000740,SPENT000736,SPENT000739,SPENT000735,SPENT000741	SPENG001548,SPENG001699,SPENG001263,SPENG000451,SPENG001761,SPENG001842,SPENG002051	HSALNG0093536,lnc-ETNK2-4,lnc-GNPTAB-1,lnc-ARL4C-4,HSALNG0021384,HSALNG0009837,lnc-PABPC4-7		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	MS	28137767	Immunogenic	SPENM016361	SPENO000488,SPENO001622,SPENO002018,SPENO002762,SPENO004177,SPENO004759,SPENO004760,SPENO005600	Breast cancer:SPENP008856;Thyroid cancer:SPENP012309,SPENP012308;Lung cancer:SPENP001845;Colon cancer:SPENP001551
SPENP003155	KVSPHSGVVALTK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005785	SPENG001958	FBLN1		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016376	SPENO005034	Tongue cancer:SPENP027840
SPENP003160	PSASSLLSHVFFK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001460,SPENT001459	SPENG001410,SPENG000853	lnc-SLC5A9-8,lnc-GIMAP6-4		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016368	SPENO001993,SPENO003847	Tongue cancer:SPENP027983
SPENP003164	YAMVYGYNAAYNR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016373	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP003167	SGTLYSLTLYGLR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	0.1312	Others	0.2828	0.7837	0.8609	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016385	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP003171	QVELVMIDVNLHVK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001467	SPENG003680	NONHSAG054033.2		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016391	SPENO005564	
SPENP003173	NSIAYMDQASGNVK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2	-0.3513	Others	-1.148	0.2777	0.5323	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016394	SPENO002694,SPENO004565,SPENO006050	Gastric cancer:SPENP003573;Colon cancer:SPENP027186,SPENP006520,SPENP007133;Lung cancer:SPENP004134,SPENP001874
SPENP003179	QYNVGPSVSKYPLR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	0.602	Others	1.221	0.2891	0.5413	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016392	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP003183	CRFMVFAPVNFYPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001474,SPENT001475	SPENG001184	HSALNG0051356		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016402	SPENO000224,SPENO000715	Lung cancer:SPENP021086,SPENP004209;Colon cancer:SPENP021084;Breast cancer:SPENP021085,SPENP021087
SPENP003185	TQSPSSLSASVGDR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	0.0023	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016401	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP022756,SPENP022757;Gastric cancer:SPENP015328,SPENP003575
SPENP003192	VTDATETTITISWR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	-0.546	Others	-0.7691	0.4639	0.6729	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016400	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP003194	MTQSPSSLSASVGDR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	1.1577	Up-regulated in tumors	8.7273	0.0009	0.0195	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016419	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP003198	ASQGISNYLAWYQQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000960,SPENT001472,SPENT001469	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	1.9571	Up-regulated in tumors	8.0232	0.0013	0.0223	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016415	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005614,SPENP005617,SPENP005616,SPENP005615,SPENP005618;Gastric cancer:SPENP015343
SPENP003199	APSTYGGGLSVSSSR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005917	SPENG000821	lnc-KRT9-2	1.2577	Others	1.652	0.1594	0.4117	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016421	SPENO000477	
SPENP003208	PGQSPQLLIYEVSSR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000749,SPENT000751,SPENT000747	SPENG000409,SPENG003372	lnc-EIF2AK3-22,HSALNG0016748		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016413	SPENO002509,SPENO002945,SPENO005142	
SPENP003213	NSIAYMDQASGNVKK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2	0.904	Others	2.272	0.0464	0.2318	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016417	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004216;Colon cancer:SPENP006562,SPENP007201,SPENP027187;Gastric cancer:SPENP003588
SPENP003239	DRDPNSLLISCAVSYR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.6779	Others	-1.611	0.168	0.4155	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016462	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP003260	AAPEVYAFATPEWPGSR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001437	SPENG000079	lnc-BRF1-4	-0.7213	Others	-1.78	0.1253	0.3742	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016472	SPENO005655	
SPENP003268	VSPHSGVVALTKPVPEPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005785	SPENG001958	FBLN1	-0.1564	Others	-0.3549	0.7318	0.8374	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016492	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP003271	TYTCQVTYQGHTFEDSTK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016485	SPENO005655	Ovary cancer:SPENP016593
SPENP003280	GETGPAGPAGPVGPVGAR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005758	SPENG002845	COL1A1	-2.792	Others	-2.534	0.0445	0.2272	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016484	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP003283	ASQGISNYLAWYQQKPGK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000960,SPENT001472,SPENT001469	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	1.8726	Others	2.2034	0.2145	0.4655	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016495	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381;Colon cancer:SPENP021408,SPENP016141
SPENP003285	DIQMTQSPSSLSASVGDR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	1.0175	Others	1.0292	0.3376	0.5882	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016493	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP003288	KVSPHSGVVALTKPVPEPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016512	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP003290	TYTCQVTYQGHTFEDSTKK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016505	SPENO005655	
SPENP003295	RPHETGGYMLECVCLGNGK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754,SPENT005793	SPENG000084	FN1	-1.447	Others	-2.878	0.0347	0.2064	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016513	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP003304	ALAPTWEQLALGLEHSETVK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016518	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP003306	SSQSLVYSDGNTYLNWFQQR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.885	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016522	SPENO001239,SPENO005201	
SPENP003307	SSQSLVHSDGNTYLSWLQQR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	1.5759	Others	3.7143	0.0099	0.0818	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016515	SPENO000369,SPENO003879	
SPENP003308	VFQSLPHENKPLTLSNYQTNK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005918,SPENT001509	SPENG001954,SPENG000527	lnc-HSF2BP-3,NONHSAG032994.2	-1.047	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	MS	28137767	Immunogenic	SPENM016527	SPENO004262,SPENO005568	Breast cancer:SPENP023426
SPENP003309	VFCNMETGETCISANPLNVPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2	0.9615	Others	6.8077	4.7e-05	0.0054	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016525	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004558;Colon cancer:SPENP006692,SPENP007418;Gastric cancer:SPENP003663
SPENP003310	HRPRPYPPNVGEEIQIGHIPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005753	SPENG000084	FN1	0.2783	Others	0.5345	0.6213	0.7561	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016533	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP003312	TNTNVNCPIECFMPLDVQADR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-2.258	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016531	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP003315	STAAMSTYTGIFTDQVLSVLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016532	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP003317	TETITGFQVDAVPANGQTPIQR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	-1.241	Others	-1.711	0.1212	0.3667	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016542	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP003322	SGDRGETGPAGPAGPVGPVGAR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005758	SPENG002845	COL1A1	-1.896	Down-regulated in tumors	-7.199	0.0002	0.0086	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016539	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP003325	DTLTSRPAQGVVTTLENVSPPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	-0.2923	Others	-0.518	0.6239	0.7561	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016535	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP003326	QGLYELSASNFELHVAQGDHFIK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016548	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP003331	DTLTSRPAQGVVTTLENVSPPRR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	1.559	Others	2.674	0.0233	0.1626	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016550	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP003335	CDPHEATCYDDGKTYHVGEQWQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	1.7331	Up-regulated in tumors	5.7836	0.0002	0.0086	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016545	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP003336	TKTETITGFQVDAVPANGQTPIQR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	0.1094	Others	0.3386	0.7419	0.8412	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016557	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP003339	AAQAQGQSCEYSLMVGYQCGQVFR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.7058	Others	0.92	0.3941	0.642	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM016563	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP003343	STAAMSTYTGIFTDQVLSVLKGEE	Gastric cancer	Gastric carcinoma	Ascites	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.6239	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016564	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP003345	DLEVVAATPTSLLISWDAPAVTVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	-0.6515	Others	-2.66	0.0564	0.2543	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016556	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP003347	STATISGLKPGVDYTITVYAVTGR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	1.0487	Others	1.9998	0.0734	0.2862	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016555	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP003348	LHLEGYHGTAGDSMSYHSGSVFSAR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016565	SPENO002584,SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012644,SPENP012645;Bladder cancer:SPENP017892;Lung cancer:SPENP002891;Colon cancer:SPENP016316,SPENP027069
SPENP003351	SSQSLVHSDGNTYLSWLQQRPGQPPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	1.4386	Others	1.5548	0.1544	0.4082	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016569	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP003355	MVLVNYIFFKAKWEMPFDPQDTHQSR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000688	SPENG001829	NONHSAG015779.2		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016573	SPENO001705	
SPENP003356	TNTNVNCPIECFMPLDVQADREDSRE	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.5959	Others	1.1651	0.2761	0.5323	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016572	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP003357	SSQSLVYSDGNTYLNWFQQRPGQSPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.778	Others	-2.426	0.0723	0.2862	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016570	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP003358	TGLDSPTGIDFSDITANSFTVHWIAPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	-0.7341	Others	-0.8782	0.4294	0.6629	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016576	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP003359	PRPGVTEATITGLEPGTEYTIYVIALK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016575	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP003364	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016579	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP003365	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005753,SPENT005755	SPENG000084	FN1	-1.011	Others	-1.155	0.3052	0.5572	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016583	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP003366	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016585	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP003369	AGVETTTPSKQSNNKYAASSYLSLTPEQWK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.5481	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Non-validated			Immunogenic	SPENM016587	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Lung cancer:SPENP007915,SPENP004704;Ovary cancer:SPENP018709;Gastric cancer:SPENP015465;Breast cancer:SPENP018708
SPENP003370	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.044	Others	0.1012	0.9214	0.9676	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016586	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP003371	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005753,SPENT005755	SPENG000084	FN1	-1.924	Others	-3.619	0.0152	0.1168	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016588	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP003372	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	2.8101	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016592	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP016392,SPENP027468
SPENP003373	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.5069	Others	-0.7887	0.4486	0.6699	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016591	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP003375	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005753,SPENT005755	SPENG000084	FN1	-0.9117	Others	-1.177	0.2739	0.5323	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016590	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP003379	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754,SPENT005793	SPENG000084	FN1	-0.0146	Others	-0.0424	0.967	0.9798	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016597	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP003382	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1		Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016601	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP003385	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016602	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP003386	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754,SPENT005793	SPENG000084	FN1	-0.9041	Others	-4.014	0.0025	0.0318	PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016603	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP003388	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005754	SPENG000084	FN1	-0.621	Others				PXD003351	In-depth proteome analysis of human ascites using high-pH peptide fractionation	Q Exactive	TIC	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016605	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP003481	MVLVNYIFFK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000688	SPENG001829	NONHSAG015779.2		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015043	SPENO001705	Breast cancer:SPENP020845,SPENP020847;Colon cancer:SPENP001493,SPENP020844;Lung cancer:SPENP020846
SPENP003501	YMDGMTVGVVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005796	SPENG001958	FBLN1	-0.7107	Others	-1.619	0.1808	0.4275	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015077	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP003513	APVSWITPGLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001457,SPENT001458	SPENG000652	AC012313.3	0.4948	Others	2.4482	0.0706	0.3494	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM015085	SPENO002381,SPENO003501	Ovary cancer:SPENP016479;Colon cancer:SPENP029369
SPENP003523	MAPVSWITPGLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001457,SPENT001458	SPENG000652	AC012313.3	2.6439	Others	1.9597	0.2778	0.5203	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM015090	SPENO002381,SPENO003501	Colon cancer:SPENP029418;Gastric cancer:SPENP003141
SPENP003524	RYMDGMTVGVVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005796	SPENG001958	FBLN1		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015103	SPENO003698	Ovary cancer:SPENP016486;Colon cancer:SPENP008201,SPENP015769,SPENP014156
SPENP003529	VYYTAGYNSPVK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000754	SPENG000115	HSALNG0053823	-0.7023	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015096	SPENO001372	Tongue cancer:SPENP028184;Lung cancer:SPENP001844,SPENP028417
SPENP003541	AALPEGLPEASR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001199	SPENG002441	NONHSAG025130.2		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015095	SPENO006044	Colon cancer:SPENP000225;Lung cancer:SPENP002342
SPENP003550	FQSAVLYAAQQSK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001589	SPENG000968	HSALNG0036094		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015117	SPENO005086	
SPENP003567	DDQLVVLFPVQKPK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001569	SPENG000472	NONHSAG007255.2	-2.007	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015150	SPENO004393	Ovary cancer:SPENP016533
SPENP003568	QVRPIVGPFHAVLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005796	SPENG001958	FBLN1	-1.395	Others	-1.792	0.1476	0.4192	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015132	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP014237,SPENP015976
SPENP003573	NSIAYMDQASGNVK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2	-0.6563	Others	-1.28	0.2696	0.5202	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015138	SPENO002694,SPENO004565,SPENO006050	Gastric cancer:SPENP003173;Colon cancer:SPENP027186,SPENP006520,SPENP007133;Lung cancer:SPENP004134,SPENP001874
SPENP003574	TQSSLVPALTDFVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2	-0.5183	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	MS	28137767	Immunogenic	SPENM015143	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP003575	TQSPSSLSASVGDR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	-1.629	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015137	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP022756,SPENP022757;Gastric cancer:SPENP015328,SPENP003185
SPENP003581	VLQATVVAVGSGSK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	MS	28137767	Immunogenic	SPENM015133	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP003582	VTDATETTITISWR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.168	Others	-1.097	0.3529	0.5771	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015136	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP003588	NSIAYMDQASGNVKK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2	-1.641	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015162	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004216;Colon cancer:SPENP006562,SPENP007201,SPENP027187;Gastric cancer:SPENP003213
SPENP003594	MTQSPSSLSASVGDR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	-2.349	Others	-1.348	0.2705	0.5202	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015155	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP003595	MTQSPSSLTASVGER	Gastric cancer	Gastric carcinoma	Ascites	SPENT001602,SPENT001603,SPENT005860	SPENG001838,SPENG001283,SPENG002825	lnc-EIF2AK3-13,NONHSAG028479.2,lnc-RPIA-16		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015164	SPENO002203,SPENO005557,SPENO005825	
SPENP003596	LVSPEHQCQHPLTTR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001594	SPENG003708	NONHSAG008681.2		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015168	SPENO002562	Kidney cancer:SPENP020346
SPENP003612	DRDPNSLLISCAVSYR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	0.1437	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015175	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP003628	NSCDFCTLILYPETLLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001618,SPENT001598	SPENG002055,SPENG003750	HSALNG0084682,HSALNG0027155		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015189	SPENO000368,SPENO002654	
SPENP003632	VSPHSGVVALTKPVPEPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005785	SPENG001958	FBLN1	-1.203	Others	-2.092	0.1045	0.4044	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015198	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP003633	ASQGISNYLAWYQQKPGK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015203	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP003641	GETGPAGPAGPVGPVGAR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005758	SPENG002845	COL1A1	-1.147	Others	-1.656	0.1731	0.4207	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015209	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP003642	RPSTDTITVMVENSHGLR	Gastric cancer	Gastric carcinoma	Ascites	SPENT001619	SPENG003051	NONHSAG045779.2	1.0442	Others	1.9971	0.1165	0.4052	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015210	SPENO003352	Colon cancer:SPENP029439
SPENP003645	DIQMTQSPSSLSASVGDR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-4.494	Others	-3.93	0.0293	0.2054	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015202	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP003652	ALAPTWEQLALGLEHSETVK	Gastric cancer	Gastric carcinoma	Ascites	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.6108	Others	-0.6838	0.5432	0.7312	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015226	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP003662	STAAMSTYTGIFTDQVLSVLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	3.0184	Others	2.342	0.0792	0.3554	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015236	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP003663	VFCNMETGETCISANPLNVPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2	-0.2526	Others	-0.778	0.48	0.7044	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015231	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004558;Colon cancer:SPENP006692,SPENP007418;Gastric cancer:SPENP003309
SPENP003668	MSFDMHAFWRCIEILVMTFLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001625,SPENT001624	SPENG001605	HSALNG0079768	1.9936	Others	6.2658	0.0033	0.0651	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015230	SPENO002322,SPENO003456	
SPENP003669	VVEPPEKDDQLVVLFPVQKPK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001569	SPENG000472	NONHSAG007255.2	-0.8361	Others	-1.503	0.2074	0.4508	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015237	SPENO004393	Ovary cancer:SPENP016634;Colon cancer:SPENP016240
SPENP003670	TNTNVNCPIECFMPLDVQADR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015238	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP003676	SGDRGETGPAGPAGPVGPVGAR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005758	SPENG002845	COL1A1	-1.617	Others	-3.509	0.0247	0.2039	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015241	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP003677	TETITGFQVDAVPANGQTPIQR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1482	Others	-0.3531	0.7474	0.8484	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015242	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP003679	DTLTSRPAQGVVTTLENVSPPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0618	Others	-0.1774	0.8678	0.9094	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015239	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP003682	VYLQGLIDCYLFGNSSTVLEDSK	Gastric cancer	Gastric carcinoma	Ascites	SPENT001011	SPENG001668	lnc-SAA2-SAA4-1		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015247	SPENO004112	
SPENP003683	DTLTSRPAQGVVTTLENVSPPRR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1692	Others	0.368	0.7315	0.8478	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015250	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP003686	AAQAQGQSCEYSLMVGYQCGQVFR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.6339	Others	-4.035	0.0157	0.1524	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM015258	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP003688	DLEVVAATPTSLLISWDAPAVTVR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9066	Others	0.9624	0.3904	0.6202	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015254	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP003691	STAAMSTYTGIFTDQVLSVLKGEE	Gastric cancer	Gastric carcinoma	Ascites	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	2.4242	Others	4.2398	0.0133	0.1366	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015257	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP003694	SSQSLVHSDGNTYLSWLQQRPGQPPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Non-validated			Immunogenic	SPENM015264	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP003696	TNTNVNCPIECFMPLDVQADREDSRE	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-1.097	Others	-2.167	0.0961	0.3913	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015261	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP003698	TGLDSPTGIDFSDITANSFTVHWIAPR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015265	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP003699	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5884	Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015268	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP003707	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.2149	Others	-0.3565	0.7395	0.8484	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015274	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP003708	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.4441	Others	4.8678	0.1272	0.4052	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015276	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP003709	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-2.403	Down-regulated in tumors	-8.646	0.001	0.0386	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015275	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP003710	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015277	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP003713	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.854	Others	0.611	0.5844	0.752	PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015280	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP003715	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015282	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP003716	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Gastric cancer	Gastric carcinoma	Ascites	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD004501	Quantitative proteomic analysis of human malignant ascites	Q Exactive	MS1 intensity based label-free quantification method	29654727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015283	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP003897	RFVNVVPTFGK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	-0.8463	Others	-5.547	0.0026	0.0294	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001657	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP003914	GLIDYNFHCFR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000363,SPENT000362	SPENG001077,SPENG000076	AL139260.2,lnc-GJA9-1	-0.0395	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM001647	SPENO000647,SPENO002720	
SPENP003940	SIMDNFTEIIK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001696	SPENG003362	lnc-SURF1-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001713	SPENO002021	
SPENP003960	DKLNNLVLFDK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	0.5392	Others	3.4073	0.0422	0.1514	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001659	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP003961	TAVAHRPGAFK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000153	SPENG003407	NONHSAG024537.2	1.0155	Others	2.323	0.0426	0.1514	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001680	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP003965	LGELPSWILMR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001703	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP003970	YMDGMTVGVVR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005796	SPENG001958	FBLN1	1.4525	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001705	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP003978	YQLDPTASISAK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11	0.8572	Others	3.6552	0.0026	0.0294	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001756	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP003993	MMLMSTATAFYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000416,SPENT001710,SPENT001709	SPENG000832	NONHSAG010597.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001752	SPENO002231,SPENO002917,SPENO003714	Breast cancer:SPENP008840;Anal canal cancer:SPENP024571;Kidney cancer:SPENP014943
SPENP004010	GQAGVMGFPGPK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005758	SPENG002845	COL1A1	-0.6072	Others	-1.806	0.1011	0.2544	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001746	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP004012	YMGAAAMYLISK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001729	SPENO003587,SPENO005877,SPENO005957	
SPENP004013	QLGEANEEFALR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001183,SPENT001719,SPENT001182	SPENG000169	lnc-DQX1-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001775	SPENO000751,SPENO001535,SPENO004354	Bladder cancer:SPENP011366,SPENP017394;Colon cancer:SPENP008207;Anal canal cancer:SPENP024596
SPENP004022	VPFLVLECPNLK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000354	SPENG002378	HSALNG0036293	1.2955	Up-regulated in tumors	6.2582	6.19e-05	0.0039	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001750	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP004025	KGLIDYNFHCFR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000363,SPENT000362	SPENG001077,SPENG000076	AL139260.2,lnc-GJA9-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM001763	SPENO000647,SPENO002720	
SPENP004035	NQSLIPLLLEAR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001788	SPENO004045	Lung cancer:SPENP002319,SPENP025968;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP004045	MFLLHRSSFLPSY	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001727,SPENT001728	SPENG000058	HSALNG0121081		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001836	SPENO001081,SPENO004115	
SPENP004055	YAMVYGYNAAYNR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	-0.5623	Others	-1.76	0.1062	0.2606	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001822	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP004059	HVISYSLSPFEQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001666	SPENG002113	HSALNG0044883	0.5434	Others	1.3278	0.2339	0.4408	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001817	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP004065	AAALVLQTIWGYK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005788	SPENG002233	AP001931.2	0.9551	Others	3.4922	0.1769	0.3628	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001825	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP004072	DFSPSGIFGAFQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001681	SPENG001530	lnc-ATP5MF-1	0.4018	Others	1.3479	0.2149	0.4132	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001879	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP004077	TSNLLLSHAGILK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000136,SPENT000135,SPENT000137	SPENG000848	lnc-CDK11A-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM001846	SPENO002156,SPENO003659,SPENO006064	Bladder cancer:SPENP017399;Colon cancer:SPENP008305,SPENP012777,SPENP027360;Anal canal cancer:SPENP024668
SPENP004086	TLGDAYEFAVDVR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001725	SPENG003418	lnc-HSPB7-2		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001827	SPENO000209	Tongue cancer:SPENP028100
SPENP004106	TTAAMWALQTVEK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2	-0.322	Others	-1.409	0.1923	0.3806	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001857	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP004126	GNSIIMLEALERV	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	-0.5039	Others	-1.28	0.2247	0.4285	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001869	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP004130	VIEKVQHIQLLQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005797,SPENT005805	SPENG002649	FGA		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001854	SPENO001505,SPENO002211	Breast cancer:SPENP018628;Ovary cancer:SPENP018629;Tongue cancer:SPENP028137;Liver cancer:SPENP004831;Colon cancer:SPENP007070,SPENP027398
SPENP004134	NSIAYMDQASGNVK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001900	SPENO002694,SPENO004565,SPENO006050	Gastric cancer:SPENP003173,SPENP003573;Colon cancer:SPENP027186,SPENP006520,SPENP007133;Lung cancer:SPENP001874
SPENP004155	TQSSLVPALTDFVR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2	0.0704	Others	0.2564	0.8014	0.8819	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001904	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP004156	QYNVGPSVSKYPLR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9259	Others	1.7955	0.0942	0.2408	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001908	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP004157	MSSSVPASQEMIFR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001752	SPENG000377	HSALNG0122481		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001898	SPENO003909	
SPENP004159	RLVQSPNSYFMDVK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000414,SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001911	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP010432,SPENP014253,SPENP006523
SPENP004163	TPTEALASFDYIVR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1	0.2411	Others	0.5261	0.6151	0.7718	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001912	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022755,SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP024064,SPENP007144
SPENP004171	VFVDGHQLFDFYHR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001695	SPENG003497	HSALNG0015478	-1.067	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001896	SPENO003932	Breast cancer:SPENP022683,SPENP022682
SPENP004190	EVVIFGAASELFTK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001930	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP004194	GYVSCALGCPYEGK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000018	SPENG003202	HMGCL	0.0932	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001954	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP004209	CRFMVFAPVNFYPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001474,SPENT001475	SPENG001184	HSALNG0051356	-0.694	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001936	SPENO000224,SPENO000715	Lung cancer:SPENP021086;Colon cancer:SPENP021084;Gastric cancer:SPENP003183;Breast cancer:SPENP021085,SPENP021087
SPENP004216	NSIAYMDQASGNVKK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001987	SPENO002694,SPENO004565,SPENO006050	Colon cancer:SPENP006562,SPENP007201,SPENP027187;Gastric cancer:SPENP003588,SPENP003213
SPENP004226	FTVDGIPYFVDHNRR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001816	SPENG000359	ITCH		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001984	SPENO000128	
SPENP004231	MSPEDGIEAVWAQTR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001824,SPENT001825,SPENT001821,SPENT001820,SPENT001822,SPENT001819,SPENT001823,SPENT001818	SPENG000995,SPENG000170,SPENG001519	NONHSAG006263.2,,HSALNG0078947,ZNF503-AS1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM001986	SPENO000079,SPENO001345,SPENO001841,SPENO002124,SPENO003476,SPENO003499,SPENO004016,SPENO004306	
SPENP004239	MLITILGTVKPNANR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-1.849	Down-regulated in tumors	-3.857	0.0046	0.0423	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001990	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP004249	DREGFFTNGLTLGAK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000938,SPENT000937,SPENT000932,SPENT000934,SPENT000931,SPENT000933,SPENT000935,SPENT000936	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760	1.551	Others	2.6309	0.0298	0.1255	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002051	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	Kidney cancer:SPENP015068,SPENP020332;Anal canal cancer:SPENP024753;Prostate cancer:SPENP018284;Colon cancer:SPENP006579
SPENP004252	TTAAMWALQTVEKER	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001976	SPENO000218,SPENO001883	Bladder cancer:SPENP011501;Leukemia:SPENP001202;Skin cancer:SPENP025282
SPENP004254	SSTSRPDAYEHTQMK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2	-0.2072	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002019	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055
SPENP004268	EVVIFGAASELFTKK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000018	SPENG003202	HMGCL	-0.6939	Others	-0.8568	0.4165	0.6062	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM001992	SPENO002963	Colon cancer:SPENP026814,SPENP008419;Lung cancer:SPENP002543,SPENP007731;Kidney cancer:SPENP020351;Prostate cancer:SPENP018293
SPENP004271	VLSVLLNELDGVGLK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001826	SPENG003280	NONHSAG016782.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001994	SPENO001548	
SPENP004285	LLLSMFVMSCHYSIK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001837	SPENG000407	HSALNG0052274		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002041	SPENO003915	
SPENP004286	YAASSYLSLTPEQWK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	2.0711	Others	2.0609	0.075	0.2086	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM001988	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP004303	TAVAHRPGAFKAELSK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000153	SPENG003407	NONHSAG024537.2	1.7948	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002057	SPENO003100	Bladder cancer:SPENP011552;Colon cancer:SPENP027316
SPENP004306	EVQIKITMRYYLTPIR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001850	SPENG002218	lnc-ALDH1L2-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002087	SPENO000185	
SPENP004309	QIYYSDKYDDEEFEYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001847,SPENT001846	SPENG000457,SPENG001118	lnc-GK-6,HSALNG0007450	1.9714	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	smprot_low_throughput	18056467	Immunogenic	SPENM002070	SPENO000915,SPENO002380	
SPENP004327	DRDPNSLLISCAVSYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-1.88	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002083	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP004328	DREGFFTNGLTLGAKK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000938,SPENT000937,SPENT000932,SPENT000934,SPENT000931,SPENT000933,SPENT000935,SPENT000936	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002079	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	
SPENP004334	STLVHSLFLTDLYKDR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002088	SPENO001224,SPENO004356,SPENO005697	Colon cancer:SPENP027301
SPENP004344	EIMEFPRLLGMSEIRI	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001849	SPENG001665	HSALNG0130809	0.5453	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002077	SPENO002236	
SPENP004348	EITNGKPFFKDINECK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002080	SPENO000957	
SPENP004352	ALDDISESIKELQFYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001698,SPENT001699,SPENT001700,SPENT006008,SPENT001697	SPENG003864	HSALNG0087308	0.0637	Others	0.1355	0.8956	0.9477	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002125	SPENO001359,SPENO003408,SPENO003992,SPENO004226,SPENO005257	
SPENP004355	WLKKEPGAYDWTPAVK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005919	SPENG001429	INMT-MINDY4		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002115	SPENO000813	
SPENP004356	AFPHLQQPSFLLASLK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001324	SPENG003020	HSALNG0018780		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002120	SPENO005958	Bladder cancer:SPENP017641;Colon cancer:SPENP014363;Lung cancer:SPENP002633
SPENP004362	MVAGTSIPSYLGGQGR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001864	SPENG001047	lnc-TMEM52-2		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002112	SPENO002545	
SPENP004367	GGGDGMMNISSGALER	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001859,SPENT001860	SPENG000786,SPENG002632	lnc-ZMYND19-8,HSALNG0075462	-1.588	Others	-2.564	0.0248	0.1124	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002102	SPENO000024,SPENO006015	Colon cancer:SPENP014346
SPENP004375	CIDVRPGYCYTALTNGR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005892	SPENG001317	HSALNG0105758	0.8481	Others	1.6959	0.118	0.2786	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002141	SPENO000957	Colon cancer:SPENP008534,SPENP010683,SPENP010684;Lung cancer:SPENP007782
SPENP004381	CPSIAAAIAAVNALHGR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000221,SPENT000220,SPENT000234	SPENG000739,SPENG000807	RBM39,lnc-NFS1-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002155	SPENO005081,SPENO005525,SPENO006140	Bile duct cancer:SPENP013527;Colon cancer:SPENP001673,SPENP026729,SPENP000417;Kidney cancer:SPENP020438
SPENP004386	ILQMAYHSYFFEILLLK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001889	SPENG003276	HSALNG0065862	0.5234	Others	0.5433	0.6103	0.7718	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002171	SPENO004687	Colon cancer:SPENP026986
SPENP004408	ISSTLYQAAAPVLTPAK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002170	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP004418	TPIGSFLGSLSLLPATK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000014	SPENG003410	ACAT1	0.7265	Others	1.3271	0.2092	0.4071	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002130	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP004421	MATHQKDCSLPYATESK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002143	SPENO000501,SPENO003429,SPENO003698,SPENO005034	
SPENP004435	MAPRTQSPGVLGGTLWEA	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001896	SPENG002717	ADORA2A-AS1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002201	SPENO003767	Colon cancer:SPENP007339
SPENP004437	STDTGVSLPSYEEDQGSK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	1.2006	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM002220	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP004440	LDKEMIHVLGGMEQKGAR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001899	SPENG001253	lnc-FANCC-1	-1.481	Others	-1.974	0.074	0.2078	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002218	SPENO003147	Colon cancer:SPENP008569,SPENP007355;Lung cancer:SPENP007809;Prostate cancer:SPENP023741
SPENP004444	DIQMTQSPSSLSASVGDR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.0289	Others	-0.0759	0.9406	0.9588	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002219	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP004452	ASQGISNYLAWYQQKPGK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	0.0548	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002217	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP004453	QTLSTPGTIILGTIPVPK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM002215	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP001697,SPENP000454
SPENP004465	GETGPAGPAGPVGPVGAR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005758	SPENG002845	COL1A1	-0.9556	Others	-2.218	0.0436	0.1539	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002184	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP004468	VSPHSGVVALTKPVPEPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002226	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP004475	NGLVNYGIDIQMLFHLQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001891,SPENT001894,SPENT001892,SPENT001895,SPENT001893	SPENG000325,SPENG003283,SPENG002901	lnc-ERC1-1,HSALNG0088540,NONHSAG010163.3	0.5758	Others	1.4989	0.162	0.3422	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002194	SPENO000005,SPENO001340,SPENO003919,SPENO004196,SPENO005828	
SPENP004478	LCNYLSHHLTISPQSGNFR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000390	SPENG002704	lnc-TRIM16L-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002242	SPENO003522	Kidney cancer:SPENP020514;Prostate cancer:SPENP012109
SPENP004484	VQASLAANTFTITGHTEAK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005801	SPENG002115	AL136361.1	-0.5832	Others	-1.105	0.3194	0.5227	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002256	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP004493	ADEALFLLLHNEMVSGVYK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002233	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP006659,SPENP000481,SPENP016178,SPENP014479;Lung cancer:SPENP002731;Kidney cancer:SPENP020515
SPENP004505	YQAEFPMSPVTSAHAGTYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005922,SPENT001905,SPENT001906,SPENT001904	SPENG003216,SPENG001692,SPENG003328	AC245884.11,lnc-LILRA4-1,ENSG00000275893		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002231	SPENO000020,SPENO001455,SPENO001575,SPENO004778	
SPENP004508	NFQCVDASVLNYDCDVQKK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001916,SPENT001917	SPENG001163	NONHSAG050036.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002260	SPENO002449,SPENO002696	
SPENP004509	GNILVCSYLDIFRHHFSIR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001913	SPENG003602	LINC02228		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002255	SPENO002761	
SPENP004512	MQVLHACWLCIAGAQPVYGR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001927	SPENG002223	HSALNG0122901		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002277	SPENO001272	
SPENP004513	ALAPTWEQLALGLEHSETVK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002264	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP004516	YIMVPSGNMGVFDPTEIHNR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.1955	Others	0.6708	0.5212	0.7064	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002309	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP004533	SALIPPVEETVFYPSPYPIR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001931	SPENG003149	NONHSAG036830.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM002293	SPENO002063	
SPENP004548	QSNNKYAASSYLSLTPEQWK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.3716	Others	1.7317	0.1108	0.2661	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002302	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP004558	VFCNMETGETCISANPLNVPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002316	SPENO002694,SPENO004565,SPENO006050	Colon cancer:SPENP006692,SPENP007418;Gastric cancer:SPENP003309,SPENP003663
SPENP004559	AITYNAMLAETSTVFHQNDVK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000648	SPENG002439	NONHSAG050528.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002318	SPENO003505	Bladder cancer:SPENP017810;Colon cancer:SPENP000519,SPENP026679
SPENP004564	ADRDESSPYAAMLAAQDVAQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	1.7302	Others	3.4261	0.0065	0.0504	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002320	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP004573	MLPSKSTVMLPTSAHGEAYWR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001943,SPENT001941,SPENT001942	SPENG001687,SPENG001304	HSALNG0056731,lnc-MPP6-3		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002327	SPENO002401,SPENO003310,SPENO004417	
SPENP004575	STDTGVSLPSYEEDQGSKLIR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM002329	SPENO000724,SPENO001854	Colon cancer:SPENP027297
SPENP004584	MALLVQELSSHRWDAADDIHR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001950,SPENT001949,SPENT005920	SPENG002248,SPENG000432	HSALNG0045327,lnc-APBB3-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002338	SPENO002480,SPENO003150,SPENO005465	
SPENP004588	MDHARNVILLYNDGWMAPSLR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001951	SPENG002143	HSALNG0139036		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002342	SPENO000175	
SPENP004594	SGDRGETGPAGPAGPVGPVGAR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005758	SPENG002845	COL1A1	-0.3069	Others	-0.6292	0.5394	0.7187	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002348	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP004598	NTLYLQMNSLRAEDTAVYYCAR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000901	SPENG001252	lnc-BRF1-31		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002352	SPENO003112	
SPENP004605	EEVKEAYMGNVLQGGEGQAPTR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000014	SPENG003410	ACAT1	-0.4397	Others	-1.55	0.1817	0.3653	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002359	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP010933,SPENP014573,SPENP007438,SPENP026787;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP004606	DTLTSRPAQGVVTTLENVSPPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6542	Others	1.233	0.2526	0.4666	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002360	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP004608	TETITGFQVDAVPANGQTPIQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1886	Others	0.6012	0.5573	0.7322	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002362	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP004610	SSASVSDSSGFSDSESADSLYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001955	SPENG002812	NONHSAG013330.2		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002364	SPENO002136	
SPENP004616	QGLYELSASNFELHVAQGDHFIK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002370	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP004617	QFLECAQNQGDIKLCEGFNEVLK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000246	SPENG003286	lnc-NUPR2-6		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002371	SPENO000500	
SPENP004622	VKADRDESSPYAAMLAAQDVAQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	1.8264	Up-regulated in tumors	5.1044	0.0005	0.0116	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002376	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP004625	DTLTSRPAQGVVTTLENVSPPRR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8861	Others	4.4965	0.0005	0.0116	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002379	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP004626	CDPHEATCYDDGKTYHVGEQWQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.676	Others	1.7111	0.1254	0.2852	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002380	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP004630	YGVAARPGFGLSPIFPGGACLGK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001282,SPENT005790,SPENT005791,SPENT005787	SPENG001189,SPENG001044	NONHSAG047951.2,ELN		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002384	SPENO000856,SPENO001279,SPENO002475,SPENO006039	Skin cancer:SPENP025436;Lung cancer:SPENP002851
SPENP004633	MELGELLYNKSEYIETASGNKVSR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000216,SPENT000217,SPENT000218	SPENG002974,SPENG001837	HSALNG0110268,NONHSAG018904.2	0.9337	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002387	SPENO004244,SPENO004278,SPENO004951	Lung cancer:SPENP007874;Leukemia:SPENP001379
SPENP004635	AAQAQGQSCEYSLMVGYQCGQVFR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM002389	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP004637	TKTETITGFQVDAVPANGQTPIQR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0842	Others	-0.417	0.683	0.815	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002391	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP004650	SYTITGLQPGTDYKIYLYTLNDNAR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002404	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP004655	HRMDACCCSVGAAWGTEECEECPMR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002409	SPENO000957	Colon cancer:SPENP008714,SPENP011042,SPENP016317,SPENP011041
SPENP004665	TNTNVNCPIECFMPLDVQADREDSRE	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002419	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP004666	SSQSLVYSDGNTYLNWFQQRPGQSPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.7896	Others	2.1647	0.119	0.2788	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002420	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP004667	SSQSLVHSDGNTYLSWLQQRPGQPPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.2187	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002421	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP004678	ASLTLSGGPSALAFDLSKVPGPEAAPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000386	SPENG002131	NONHSAG053828.2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002432	SPENO003267	
SPENP004680	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000014	SPENG003410	ACAT1	0.1179	Others	0.2309	0.8221	0.8918	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002434	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP004687	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002441	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP004692	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002446	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP004693	LLLDAPAEDPNYLPLPEEQPGPHLPPPQQ	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000869,SPENT000871,SPENT000870	SPENG002286	lnc-DERL3-1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002447	SPENO000187,SPENO001044,SPENO005977	Colon cancer:SPENP001774;Lung cancer:SPENP025861
SPENP004695	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002449	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP004697	ASADELTFHEFEEATNLLADTPDAATTSR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001420	SPENG000627	lnc-TMED1-2		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002451	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP004698	NSFSFSDEKLNSPTDSTPALLSATVTPQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT001955	SPENG002812	NONHSAG013330.2	-1.171	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002452	SPENO002136	
SPENP004703	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.1957	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002457	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP004704	AGVETTTPSKQSNNKYAASSYLSLTPEQWK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002458	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Lung cancer:SPENP007915;Ovary cancer:SPENP018709;Gastric cancer:SPENP003369,SPENP015465;Breast cancer:SPENP018708
SPENP004706	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.0969	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002460	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP007913,SPENP021966;Colon cancer:SPENP021964;Leukemia:SPENP001396;Breast cancer:SPENP021965,SPENP021967
SPENP004707	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.8737	Others	-1.993	0.0742	0.2078	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002461	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP004710	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	2.3632	Others	2.2396	0.0664	0.1975	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002464	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP004712	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.7113	Others	1.5771	0.336	0.5401	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002466	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP004715	YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6584	Others				PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002469	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009079;Ovary cancer:SPENP016675;Colon cancer:SPENP027469,SPENP014701;Lung cancer:SPENP002976
SPENP004718	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-2.433	Others	-1.21	0.3129	0.5183	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002472	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP004723	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Lung cancer	Non-small cell lung cancer	Lung epithelium	SPENT005797,SPENT005805	SPENG002649	FGA	-1.284	Others	-2.457	0.0521	0.1722	PXD004682	Comparison of Lung Cancer Proteome Profiles 1: Label Free Quantification	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM002477	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP007924,SPENP001983;Colon cancer:SPENP024345,SPENP011202,SPENP011201
SPENP004782	IKYPENFFLLR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002262,SPENT002263	SPENG000453	NONHSAG027364.2	0.5631	Others				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	MS	28137767	Immunogenic	SPENM008863	SPENO001687,SPENO005516	
SPENP004791	NRIAIYELLFK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002249,SPENT002251,SPENT002250,SPENT002252,SPENT002248	SPENG000736,SPENG002626,SPENG000219,SPENG003401,SPENG002857	lnc-FOXB1-9,lnc-NAA50-4,HSALNG0028127,lnc-RPS10-NUDT3-3,lnc-SPATA31E1-7		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Non-validated			Immunogenic	SPENM008872	SPENO003663,SPENO003677,SPENO003808,SPENO004822,SPENO005784	
SPENP004794	VMVQPINLIFR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002273,SPENT002272,SPENT002270,SPENT002271,SPENT002267,SPENT002269,SPENT002268	SPENG003098,SPENG003309,SPENG003607,SPENG001915,SPENG000941,SPENG003601,SPENG000906	lnc-ID2-3,lnc-ZC3H12D-15,HSALNG0054220,HSALNG0012839,lnc-FABP6-3,HSALNG0046238,lnc-GLDC-5		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	MS	28137767	Immunogenic	SPENM008875	SPENO000391,SPENO001158,SPENO001668,SPENO002054,SPENO002219,SPENO003493,SPENO004771	Breast cancer:SPENP008819;Kidney cancer:SPENP014910;Tongue cancer:SPENP028143;Lung cancer:SPENP026626;Prostate cancer:SPENP012898
SPENP004799	GAYKYIQELWR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002278,SPENT002279,SPENT002280	SPENG000606,SPENG003001,SPENG000365	lnc-GSC-1,NONHSAG034609.2,lnc-ATP10D-1		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008880	SPENO001406,SPENO002496,SPENO005371	
SPENP004801	DKLNNLVLFDK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	MS	28137767	Immunogenic	SPENM008882	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP004809	TQVVAGTNYYIK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002285	SPENG002633	HSALNG0028487		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Non-validated			Immunogenic	SPENM008890	SPENO000213	Breast cancer:SPENP008849,SPENP023317;Colon cancer:SPENP029452
SPENP004811	VAYVSFGPHAGK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002284	SPENG000495	HSALNG0025321		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008892	SPENO000938	Bladder cancer:SPENP011360
SPENP004816	YLRPPNTSLFVR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000955	SPENG001418	lnc-CNR2-1	0.6552	Others	1.2847	0.2348	0.4103	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008897	SPENO002744	
SPENP004826	SAISLAEDEEWKR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002293	SPENG000741	HSALNG0059919	1.2258	Up-regulated in tumors	3.6086	0.0026	0.0141	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Non-validated			Immunogenic	SPENM008907	SPENO000032	
SPENP004831	VIEKVQHIQLLQK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Non-validated			Immunogenic	SPENM008912	SPENO001505,SPENO002211	Breast cancer:SPENP018628;Ovary cancer:SPENP018629;Tongue cancer:SPENP028137;Lung cancer:SPENP004130;Colon cancer:SPENP007070,SPENP027398
SPENP004833	AAALVLQTIWGYK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT005788	SPENG002233	AP001931.2	0.0256	Others				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008914	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP004846	EVVIFGAASELFTK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000018	SPENG003202	HMGCL	-0.1815	Others	-1.135	0.2697	0.4537	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008927	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP004856	TQSSLVPALTDFVR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2	1.2752	Others	2.2735	0.0306	0.0889	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	MS	28137767	Immunogenic	SPENM008937	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP004858	VLLESEQFLTELTR	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3	1.7869	Up-regulated in tumors	3.0411	0.0103	0.0397	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008939	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP004877	GFSEGLWEIENNPTVK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002307	SPENG001166	lnc-MRPL24-2	1.1207	Others	1.5888	0.1317	0.2586	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	MS	28137767	Immunogenic	SPENM008958	SPENO001915	
SPENP004878	GATYGKPVHHGVNQLK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002308,SPENT002278,SPENT002280	SPENG000606,SPENG000365,SPENG001174	NONHSAG034609.2,lnc-SHOX2-7,lnc-ATP10D-1		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008959	SPENO001406,SPENO001628,SPENO005371	
SPENP004879	VAVNDAHLLQYNHRVK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008960	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005335	Colon cancer:SPENP027376
SPENP004882	AAGVNVEPFWPGLFAK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000958,SPENT000959,SPENT000956,SPENT000957	SPENG002082,SPENG000412,SPENG001664,SPENG001785	NONHSAG017284.2,HSALNG0011930,lnc-GREM2-13,lnc-EVX2-8	0.4868	Others	3.8379	0.0004	0.0036	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	MS	28137767	Immunogenic	SPENM008963	SPENO002111,SPENO003329,SPENO004329,SPENO006018	Breast cancer:SPENP008943;Prostate cancer:SPENP009247,SPENP023710;Lung cancer:SPENP026477,SPENP001909
SPENP004891	GVQVETISPGDGRTFPK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002298,SPENT002297	SPENG002110	lnc-SDCBP2-4		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008972	SPENO004469,SPENO005189	
SPENP004896	KGFSEGLWEIENNPTVK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002307	SPENG001166	lnc-MRPL24-2	0.8858	Others	2.0998	0.0651	0.1553	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM008977	SPENO001915	
SPENP004929	IHVYGYSMAYGPAQHAISTEK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000950,SPENT000949	SPENG000389,SPENG001205	HSALNG0075308,NONHSAG053817.2	1.0236	Others				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009010	SPENO001784,SPENO004447	Prostate cancer:SPENP023771;Lung cancer:SPENP001958
SPENP004931	STDTGVSLPSYEEDQGSKLIRK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM009012	SPENO000724,SPENO001854	Colon cancer:SPENP027298
SPENP004933	QGLYELSASNFELHVAQGDHFIK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Non-validated			Immunogenic	SPENM009014	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP004939	GSTSVYLGIIEFIKVNTLMPTESMKVG	Liver cancer	Hepatocellular carcinoma	Liver	SPENT002329	SPENG003154	NONHSAG072945.2	0.2249	Others	0.1831	0.8619	0.9047	PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Non-validated			Immunogenic	SPENM009020	SPENO006067	
SPENP004942	GIQKFPGINYPVLTPNLKGFEAAVAAGAK	Liver cancer	Hepatocellular carcinoma	Liver	SPENT000018	SPENG003202	HMGCL		Others				PXD004873	76 human liver tissue proteomes by PCT-SWATH	TripleTOF 5600	TIC	30365225	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009023	SPENO002963	Colon cancer:SPENP026892
SPENP005059	STATISGLK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003556	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP005063,SPENP005062,SPENP005060,SPENP005061;Colon cancer:SPENP029446
SPENP005060	STATISGLK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003556	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP005063,SPENP005062,SPENP005059,SPENP005061;Colon cancer:SPENP029446
SPENP005061	STATISGLK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003556	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP005063,SPENP005062,SPENP005059,SPENP005060;Colon cancer:SPENP029446
SPENP005062	STATISGLK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4473	Others	-3.833	0.0186	0.0878	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003556	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP005063,SPENP005059,SPENP005060,SPENP005061;Colon cancer:SPENP029446
SPENP005063	STATISGLK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003556	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP005062,SPENP005059,SPENP005060,SPENP005061;Colon cancer:SPENP029446
SPENP005204	MENILYLSLK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002349	SPENG001178	HSALNG0058760		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003572	SPENO003652	
SPENP005205	MENILYLSLK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002349	SPENG001178	HSALNG0058760		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003572	SPENO003652	
SPENP005206	MENILYLSLK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002349	SPENG001178	HSALNG0058760		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003572	SPENO003652	
SPENP005207	MENILYLSLK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002349	SPENG001178	HSALNG0058760		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003572	SPENO003652	
SPENP005208	MENILYLSLK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002349	SPENG001178	HSALNG0058760	0.4843	Others	2.0903	0.1752	0.368	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003572	SPENO003652	
SPENP005244	LGELPSWILMR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003591	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP005245	LGELPSWILMR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003591	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP005246	LGELPSWILMR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003591	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP005247	LGELPSWILMR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003591	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP005248	LGELPSWILMR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.2616	Others	2.4924	0.0883	0.2325	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003591	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP005364	ALLANALTSALR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002117	SPENG003627	NONHSAG037834.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003603	SPENO005301	Breast cancer:SPENP022500,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP005365	ALLANALTSALR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002117	SPENG003627	NONHSAG037834.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003603	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP005366	ALLANALTSALR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002117	SPENG003627	NONHSAG037834.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003603	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP005367	ALLANALTSALR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002117	SPENG003627	NONHSAG037834.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003603	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP005368	ALLANALTSALR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002117	SPENG003627	NONHSAG037834.2	-0.019	Others	-0.5739	0.5968	0.771	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003603	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP005369	HVISYSLSPFEQR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003615	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP005370	HVISYSLSPFEQR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003615	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP005371	HVISYSLSPFEQR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003615	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP005372	HVISYSLSPFEQR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003615	SPENO003843	Breast cancer:SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP005373	HVISYSLSPFEQR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT001666	SPENG002113	HSALNG0044883	0.0241	Others	0.0778	0.9418	0.9792	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003615	SPENO003843	Breast cancer:SPENP005372,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP005429	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003614	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP005430	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003614	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP005431	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003614	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP005432	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003614	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP005433	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.2928	Others	-2.442	0.0923	0.2401	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003614	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP005484	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003640	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005486,SPENP022736,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP005485	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003640	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP022737,SPENP005484,SPENP005486,SPENP022736,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP005486	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003640	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP022736,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP005487	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003640	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP005486,SPENP022736,SPENP005488;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP005488	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042	-0.5058	Others	-1.869	0.135	0.3119	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003640	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP005486,SPENP022736,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP005504	VTDATETTITISWR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003641	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP005505	VTDATETTITISWR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.8871	Others	2.0792	0.2815	0.4879	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003641	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP005506	VTDATETTITISWR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003641	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP005507	VTDATETTITISWR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1234	Others	0.3504	0.7437	0.8521	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003641	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP005508	VTDATETTITISWR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003641	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP005534	VLQATVVAVGSGSK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003649	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP005535	VLQATVVAVGSGSK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003649	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP005536	VLQATVVAVGSGSK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003649	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP005537	VLQATVVAVGSGSK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003649	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP005538	VLQATVVAVGSGSK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4	-0.0572	Others	-0.2848	0.79	0.8718	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003649	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP005569	PGQSPQLLIYTLSYR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000748	SPENG002879	NONHSAG028492.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003661	SPENO001643	
SPENP005570	PGQSPQLLIYTLSYR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000748	SPENG002879	NONHSAG028492.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003661	SPENO001643	
SPENP005571	PGQSPQLLIYTLSYR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000748	SPENG002879	NONHSAG028492.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003661	SPENO001643	
SPENP005572	PGQSPQLLIYTLSYR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000748	SPENG002879	NONHSAG028492.2	0.7336	Others	7.2032	0.002	0.0263	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003661	SPENO001643	
SPENP005573	PGQSPQLLIYTLSYR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000748	SPENG002879	NONHSAG028492.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003661	SPENO001643	
SPENP005599	MTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG003099,SPENG000381,SPENG000040,SPENG000667	HSALNG0141192,lnc-RPIA-13,NONHSAG028467.3,lnc-GAB4-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003657	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP005600	MTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG003099,SPENG000381,SPENG000040,SPENG000667	HSALNG0141192,lnc-RPIA-13,NONHSAG028467.3,lnc-GAB4-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003657	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP005601	MTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG003099,SPENG000381,SPENG000040,SPENG000667	HSALNG0141192,lnc-RPIA-13,NONHSAG028467.3,lnc-GAB4-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003657	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP005602	MTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG003099,SPENG000381,SPENG000040,SPENG000667	HSALNG0141192,lnc-RPIA-13,NONHSAG028467.3,lnc-GAB4-1	0.2424	Others	2.3367	0.0797	0.2209	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003657	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP005603	MTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG003099,SPENG000381,SPENG000040,SPENG000667	HSALNG0141192,lnc-RPIA-13,NONHSAG028467.3,lnc-GAB4-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003657	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP005609	ALAVTFTTFVTEPLK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002406	SPENG001918	lnc-WDR47-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003678	SPENO005639	
SPENP005610	ALAVTFTTFVTEPLK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002406	SPENG001918	lnc-WDR47-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003678	SPENO005639	
SPENP005611	ALAVTFTTFVTEPLK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002406	SPENG001918	lnc-WDR47-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003678	SPENO005639	
SPENP005612	ALAVTFTTFVTEPLK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002406	SPENG001918	lnc-WDR47-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003678	SPENO005639	
SPENP005613	ALAVTFTTFVTEPLK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002406	SPENG001918	lnc-WDR47-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003678	SPENO005639	
SPENP005614	ASQGISNYLAWYQQK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003669	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005617,SPENP005616,SPENP005615,SPENP005618;Gastric cancer:SPENP003198,SPENP015343
SPENP005615	ASQGISNYLAWYQQK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003669	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005614,SPENP005617,SPENP005616,SPENP005618;Gastric cancer:SPENP003198,SPENP015343
SPENP005616	ASQGISNYLAWYQQK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003669	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005614,SPENP005617,SPENP005615,SPENP005618;Gastric cancer:SPENP003198,SPENP015343
SPENP005617	ASQGISNYLAWYQQK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	-2.737	Down-regulated in tumors	-12.86	0.001	0.0218	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003669	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005614,SPENP005616,SPENP005615,SPENP005618;Gastric cancer:SPENP003198,SPENP015343
SPENP005618	ASQGISNYLAWYQQK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003669	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005614,SPENP005617,SPENP005616,SPENP005615;Gastric cancer:SPENP003198,SPENP015343
SPENP005619	MQTIQGSGAFCFGLK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002392	SPENG000051	HSALNG0128814		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003654	SPENO002276	
SPENP005620	MQTIQGSGAFCFGLK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002392	SPENG000051	HSALNG0128814		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003654	SPENO002276	
SPENP005621	MQTIQGSGAFCFGLK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002392	SPENG000051	HSALNG0128814		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003654	SPENO002276	
SPENP005622	MQTIQGSGAFCFGLK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002392	SPENG000051	HSALNG0128814		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003654	SPENO002276	
SPENP005623	MQTIQGSGAFCFGLK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002392	SPENG000051	HSALNG0128814		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003654	SPENO002276	
SPENP005629	MGIDYMLIIVVSMYK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002401,SPENT002399,SPENT002400,SPENT002402,SPENT002403	SPENG000688	HSALNG0028061		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003666	SPENO001499,SPENO002165,SPENO004555,SPENO004965,SPENO005515	
SPENP005630	MGIDYMLIIVVSMYK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002401,SPENT002399,SPENT002400,SPENT002402,SPENT002403	SPENG000688	HSALNG0028061		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003666	SPENO001499,SPENO002165,SPENO004555,SPENO004965,SPENO005515	
SPENP005631	MGIDYMLIIVVSMYK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002401,SPENT002399,SPENT002400,SPENT002402,SPENT002403	SPENG000688	HSALNG0028061		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003666	SPENO001499,SPENO002165,SPENO004555,SPENO004965,SPENO005515	
SPENP005632	MGIDYMLIIVVSMYK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002401,SPENT002399,SPENT002400,SPENT002402,SPENT002403	SPENG000688	HSALNG0028061		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003666	SPENO001499,SPENO002165,SPENO004555,SPENO004965,SPENO005515	
SPENP005633	MGIDYMLIIVVSMYK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002401,SPENT002399,SPENT002400,SPENT002402,SPENT002403	SPENG000688	HSALNG0028061	1.0543	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003666	SPENO001499,SPENO002165,SPENO004555,SPENO004965,SPENO005515	
SPENP005634	ASQSFTNQLAWYQQK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002393,SPENT002394	SPENG001682,SPENG002308	lnc-ANKRD36-10,HSALNG0017131		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003655	SPENO004872,SPENO005405	
SPENP005635	ASQSFTNQLAWYQQK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002393,SPENT002394	SPENG001682,SPENG002308	lnc-ANKRD36-10,HSALNG0017131		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003655	SPENO004872,SPENO005405	
SPENP005636	ASQSFTNQLAWYQQK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002393,SPENT002394	SPENG001682,SPENG002308	lnc-ANKRD36-10,HSALNG0017131		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003655	SPENO004872,SPENO005405	
SPENP005637	ASQSFTNQLAWYQQK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002393,SPENT002394	SPENG001682,SPENG002308	lnc-ANKRD36-10,HSALNG0017131	-0.5699	Others	-3.519	0.0245	0.1081	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003655	SPENO004872,SPENO005405	
SPENP005638	ASQSFTNQLAWYQQK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002393,SPENT002394	SPENG001682,SPENG002308	lnc-ANKRD36-10,HSALNG0017131		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003655	SPENO004872,SPENO005405	
SPENP005639	PITDYVDQQFEQYFR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003653	SPENO004356,SPENO005697	
SPENP005640	PITDYVDQQFEQYFR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003653	SPENO004356,SPENO005697	
SPENP005641	PITDYVDQQFEQYFR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003653	SPENO004356,SPENO005697	
SPENP005642	PITDYVDQQFEQYFR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003653	SPENO004356,SPENO005697	
SPENP005643	PITDYVDQQFEQYFR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005893,SPENT005806	SPENG002111	AC000093.1	-0.6042	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003653	SPENO004356,SPENO005697	
SPENP005654	FQEYHIQQNEALAAK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002396,SPENT002397,SPENT002398	SPENG002059,SPENG002201	HSALNG0101630,lnc-C14orf37-3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	smprot_low_throughput	10552927	Immunogenic	SPENM003660	SPENO003500,SPENO005152,SPENO005986	Breast cancer:SPENP005655,SPENP005658,SPENP005657,SPENP005656;Colon cancer:SPENP024109
SPENP005655	FQEYHIQQNEALAAK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002396,SPENT002397,SPENT002398	SPENG002059,SPENG002201	HSALNG0101630,lnc-C14orf37-3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	smprot_low_throughput	10552927	Immunogenic	SPENM003660	SPENO003500,SPENO005152,SPENO005986	Breast cancer:SPENP005658,SPENP005654,SPENP005657,SPENP005656;Colon cancer:SPENP024109
SPENP005656	FQEYHIQQNEALAAK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002396,SPENT002397,SPENT002398	SPENG002059,SPENG002201	HSALNG0101630,lnc-C14orf37-3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	smprot_low_throughput	10552927	Immunogenic	SPENM003660	SPENO003500,SPENO005152,SPENO005986	Breast cancer:SPENP005655,SPENP005658,SPENP005654,SPENP005657;Colon cancer:SPENP024109
SPENP005657	FQEYHIQQNEALAAK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002396,SPENT002397,SPENT002398	SPENG002059,SPENG002201	HSALNG0101630,lnc-C14orf37-3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	smprot_low_throughput	10552927	Immunogenic	SPENM003660	SPENO003500,SPENO005152,SPENO005986	Breast cancer:SPENP005655,SPENP005658,SPENP005654,SPENP005656;Colon cancer:SPENP024109
SPENP005658	FQEYHIQQNEALAAK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002396,SPENT002397,SPENT002398	SPENG002059,SPENG002201	HSALNG0101630,lnc-C14orf37-3	-0.0874	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	smprot_low_throughput	10552927	Immunogenic	SPENM003660	SPENO003500,SPENO005152,SPENO005986	Breast cancer:SPENP005655,SPENP005654,SPENP005657,SPENP005656;Colon cancer:SPENP024109
SPENP005659	HEVTILGGLNEFVVK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002405	SPENG002844	HSALNG0061330		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003668	SPENO003324	Breast cancer:SPENP005660,SPENP005662,SPENP005661,SPENP005663;Colon cancer:SPENP008447;Lung cancer:SPENP028288
SPENP005660	HEVTILGGLNEFVVK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002405	SPENG002844	HSALNG0061330		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003668	SPENO003324	Breast cancer:SPENP005662,SPENP005661,SPENP005659,SPENP005663;Colon cancer:SPENP008447;Lung cancer:SPENP028288
SPENP005661	HEVTILGGLNEFVVK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002405	SPENG002844	HSALNG0061330		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003668	SPENO003324	Breast cancer:SPENP005660,SPENP005662,SPENP005659,SPENP005663;Colon cancer:SPENP008447;Lung cancer:SPENP028288
SPENP005662	HEVTILGGLNEFVVK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002405	SPENG002844	HSALNG0061330		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003668	SPENO003324	Breast cancer:SPENP005660,SPENP005661,SPENP005659,SPENP005663;Colon cancer:SPENP008447;Lung cancer:SPENP028288
SPENP005663	HEVTILGGLNEFVVK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002405	SPENG002844	HSALNG0061330	1.4264	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003668	SPENO003324	Breast cancer:SPENP005660,SPENP005662,SPENP005661,SPENP005659;Colon cancer:SPENP008447;Lung cancer:SPENP028288
SPENP005684	SSTSRPDAYEHTQMK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003672	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP005685	SSTSRPDAYEHTQMK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003672	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP005686	SSTSRPDAYEHTQMK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003672	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP005687	SSTSRPDAYEHTQMK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003672	SPENO002621,SPENO004421	Breast cancer:SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP005688	SSTSRPDAYEHTQMK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2	0.1596	Others	0.1545	0.887	0.9413	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003672	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP005699	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003677	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP005700	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.4192	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003677	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP005701	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003677	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP005702	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.2327	Others	5.8884	0.0042	0.0333	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003677	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP005703	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.0521	Others	-1.209	0.2932	0.4999	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003677	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP005734	AELTALESLIEMGFPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003686	SPENO001893,SPENO004906	Breast cancer:SPENP005736,SPENP008940,SPENP005735,SPENP005737,SPENP005738;Liver cancer:SPENP000705
SPENP005735	AELTALESLIEMGFPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003686	SPENO001893,SPENO004906	Breast cancer:SPENP005736,SPENP008940,SPENP005734,SPENP005737,SPENP005738;Liver cancer:SPENP000705
SPENP005736	AELTALESLIEMGFPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003686	SPENO001893,SPENO004906	Breast cancer:SPENP008940,SPENP005734,SPENP005735,SPENP005737,SPENP005738;Liver cancer:SPENP000705
SPENP005737	AELTALESLIEMGFPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003686	SPENO001893,SPENO004906	Breast cancer:SPENP005736,SPENP008940,SPENP005734,SPENP005735,SPENP005738;Liver cancer:SPENP000705
SPENP005738	AELTALESLIEMGFPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2	-0.1809	Others	-0.4587	0.6777	0.8243	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003686	SPENO001893,SPENO004906	Breast cancer:SPENP005736,SPENP008940,SPENP005734,SPENP005735,SPENP005737;Liver cancer:SPENP000705
SPENP005839	CFDHAAGTSYVVGETWEK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP005841,SPENP005843,SPENP005842,SPENP005840;Tongue cancer:SPENP027544;Gastric cancer:SPENP015390
SPENP005840	CFDHAAGTSYVVGETWEK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP005841,SPENP005839,SPENP005843,SPENP005842;Tongue cancer:SPENP027544;Gastric cancer:SPENP015390
SPENP005841	CFDHAAGTSYVVGETWEK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP005839,SPENP005843,SPENP005842,SPENP005840;Tongue cancer:SPENP027544;Gastric cancer:SPENP015390
SPENP005842	CFDHAAGTSYVVGETWEK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP005841,SPENP005839,SPENP005843,SPENP005840;Tongue cancer:SPENP027544;Gastric cancer:SPENP015390
SPENP005843	CFDHAAGTSYVVGETWEK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP005841,SPENP005839,SPENP005842,SPENP005840;Tongue cancer:SPENP027544;Gastric cancer:SPENP015390
SPENP005869	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003708	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP005870	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003708	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP005871	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003708	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP005872	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.8542	Others	1.8356	0.1403	0.3176	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003708	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP005873	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.6146	Others	-10.9	0.0004	0.0197	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003708	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP005884	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003714	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP005885	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003714	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP005886	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003714	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP005887	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003714	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005886;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP005888	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005893,SPENT005806	SPENG002111	AC000093.1	-0.0926	Others	-0.615	0.5718	0.7516	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003714	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005885,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP005894	LHDVEHVLIDVGTGYYVEK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002156	SPENG002374	NONHSAG011229.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003716	SPENO002604	Breast cancer:SPENP005896,SPENP005898,SPENP005895,SPENP005897;Lung cancer:SPENP028315
SPENP005895	LHDVEHVLIDVGTGYYVEK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002156	SPENG002374	NONHSAG011229.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003716	SPENO002604	Breast cancer:SPENP005896,SPENP005898,SPENP005894,SPENP005897;Lung cancer:SPENP028315
SPENP005896	LHDVEHVLIDVGTGYYVEK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002156	SPENG002374	NONHSAG011229.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003716	SPENO002604	Breast cancer:SPENP005898,SPENP005894,SPENP005895,SPENP005897;Lung cancer:SPENP028315
SPENP005897	LHDVEHVLIDVGTGYYVEK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002156	SPENG002374	NONHSAG011229.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003716	SPENO002604	Breast cancer:SPENP005896,SPENP005898,SPENP005894,SPENP005895;Lung cancer:SPENP028315
SPENP005898	LHDVEHVLIDVGTGYYVEK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002156	SPENG002374	NONHSAG011229.2	-0.4081	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	MS	28137767	Immunogenic	SPENM003716	SPENO002604	Breast cancer:SPENP005896,SPENP005894,SPENP005895,SPENP005897;Lung cancer:SPENP028315
SPENP005944	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003723	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP005945	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003723	SPENO005833	Breast cancer:SPENP021551,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP005946	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003723	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP005947	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003723	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP005948	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.4835	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003723	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP005979	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003735	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP005980	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.1722	Others	-0.3942	0.7392	0.8521	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003735	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP005981	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.5477	Others	-1.87	0.2863	0.4922	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003735	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP005982	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.897	Others	-2.409	0.0737	0.2128	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003735	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP005983	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.0547	Others	-0.2803	0.7931	0.8718	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003735	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP005989	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000901	SPENG001252	lnc-BRF1-31		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003736	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP021611,SPENP005993,SPENP005992,SPENP005990;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP005990	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000901	SPENG001252	lnc-BRF1-31		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003736	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP021611,SPENP005993,SPENP005992,SPENP005989;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP005991	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000901	SPENG001252	lnc-BRF1-31		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003736	SPENO003112	Breast cancer:SPENP021609,SPENP021611,SPENP005993,SPENP005992,SPENP005989,SPENP005990;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP005992	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000901	SPENG001252	lnc-BRF1-31	0.4922	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003736	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP021611,SPENP005993,SPENP005989,SPENP005990;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP005993	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000901	SPENG001252	lnc-BRF1-31		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003736	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP021611,SPENP005992,SPENP005989,SPENP005990;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP005999	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005837	SPENG001212	COPDA1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003741	SPENO000573	Breast cancer:SPENP021637,SPENP006000,SPENP006001,SPENP006003,SPENP021639,SPENP006002;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP006000	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005837	SPENG001212	COPDA1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003741	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006001,SPENP006003,SPENP021639,SPENP006002;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP006001	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005837	SPENG001212	COPDA1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003741	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006000,SPENP006003,SPENP021639,SPENP006002;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP006002	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005837	SPENG001212	COPDA1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003741	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006000,SPENP006001,SPENP006003,SPENP021639;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP006003	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005837	SPENG001212	COPDA1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003741	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006000,SPENP006001,SPENP021639,SPENP006002;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP006014	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003738	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP006015	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.462	Others	-1.486	0.3366	0.5381	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003738	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP006016	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003738	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP006017	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.71	Down-regulated in tumors	-6.334	0.0032	0.0265	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003738	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP006018	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1957	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003738	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP006024	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP006025	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP006026	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP006027	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0373	Others	-0.0539	0.9604	0.9792	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP006028	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP006034	LTGDLSHLAAIVILLLKIWKTR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003744	SPENO001805,SPENO003193	
SPENP006035	LTGDLSHLAAIVILLLKIWKTR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003744	SPENO001805,SPENO003193	
SPENP006036	LTGDLSHLAAIVILLLKIWKTR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003744	SPENO001805,SPENO003193	
SPENP006037	LTGDLSHLAAIVILLLKIWKTR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003744	SPENO001805,SPENO003193	
SPENP006038	LTGDLSHLAAIVILLLKIWKTR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1	0.6939	Others	2.8846	0.0448	0.1664	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003744	SPENO001805,SPENO003193	
SPENP006044	AGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003746	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006047,SPENP009020,SPENP006046,SPENP006045;Ovary cancer:SPENP011850;Lung cancer:SPENP001961
SPENP006045	AGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003746	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006047,SPENP006044,SPENP009020,SPENP006046;Ovary cancer:SPENP011850;Lung cancer:SPENP001961
SPENP006046	AGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1	-1.894	Others	-2.947	0.032	0.1256	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003746	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006047,SPENP006044,SPENP009020,SPENP006045;Ovary cancer:SPENP011850;Lung cancer:SPENP001961
SPENP006047	AGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1	0.4968	Others	1.7999	0.1463	0.3176	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003746	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006044,SPENP009020,SPENP006046,SPENP006045;Ovary cancer:SPENP011850;Lung cancer:SPENP001961
SPENP006048	AGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1	0.5748	Others	2.7258	0.0527	0.1744	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003746	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006047,SPENP006044,SPENP009020,SPENP006046,SPENP006045;Ovary cancer:SPENP011850;Lung cancer:SPENP001961
SPENP006059	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003752	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP006060	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003752	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP006061	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003752	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP006062	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1769	Others	-0.5184	0.6316	0.7961	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003752	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP006063	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4152	Others	0.8989	0.5329	0.7425	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003752	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP006064	KAGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003748	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006066,SPENP006067,SPENP006068,SPENP009030,SPENP006065;Ovary cancer:SPENP011852
SPENP006065	KAGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003748	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006066,SPENP006067,SPENP006064,SPENP006068,SPENP009030;Ovary cancer:SPENP011852
SPENP006066	KAGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003748	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006067,SPENP006064,SPENP006068,SPENP009030,SPENP006065;Ovary cancer:SPENP011852
SPENP006067	KAGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1	-0.3424	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003748	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006066,SPENP006064,SPENP006068,SPENP009030,SPENP006065;Ovary cancer:SPENP011852
SPENP006068	KAGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003748	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006066,SPENP006067,SPENP006064,SPENP009030,SPENP006065;Ovary cancer:SPENP011852
SPENP006079	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003754	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP006080	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003754	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP006081	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003754	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP006082	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0545	Others	0.2905	0.7858	0.8718	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003754	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP006083	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003754	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP006114	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP006115	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP006116	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP006117	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0279	Others	0.0696	0.9479	0.9792	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP006118	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP006119	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003761	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP006120	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003761	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP006121	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003761	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP006122	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003761	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP006123	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003761	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP006124	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP006125	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP006126	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP006127	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3218	Others	1.8116	0.3152	0.5288	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP006128	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP006129	PGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006133,SPENP006130,SPENP006132,SPENP006131;Tongue cancer:SPENP027973;Gastric cancer:SPENP015445
SPENP006130	PGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006133,SPENP006132,SPENP006131,SPENP006129;Tongue cancer:SPENP027973;Gastric cancer:SPENP015445
SPENP006131	PGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006133,SPENP006130,SPENP006132,SPENP006129;Tongue cancer:SPENP027973;Gastric cancer:SPENP015445
SPENP006132	PGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6798	Others	1.5044	0.2295	0.4305	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006133,SPENP006130,SPENP006131,SPENP006129;Tongue cancer:SPENP027973;Gastric cancer:SPENP015445
SPENP006133	PGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006130,SPENP006132,SPENP006131,SPENP006129;Tongue cancer:SPENP027973;Gastric cancer:SPENP015445
SPENP006149	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003768	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP006150	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003768	SPENO000369,SPENO003879	Breast cancer:SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP006151	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003768	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP006152	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.641	Others	-4.978	0.0076	0.0518	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003768	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP006153	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003768	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP006154	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003767	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP006155	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003767	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP006156	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003767	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP006157	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.0693	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003767	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP006158	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Non-validated			Immunogenic	SPENM003767	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP006159	PRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003771	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP006160	PRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003771	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006163,SPENP006161,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP006161	PRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003771	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP006162	PRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1702	Others	0.3687	0.731	0.8521	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003771	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006159;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP006163	PRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4715	Others	-4.17	0.014	0.0776	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003771	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006161,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP006164	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003770	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP006165	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003770	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP006166	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003770	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP006167	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.317	Others	-2.284	0.0845	0.2282	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003770	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP006168	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003770	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP006174	LGALSGAAALGFASYGAHGAQFPDAYGK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003773	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP006175	LGALSGAAALGFASYGAHGAQFPDAYGK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003773	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP006176	LGALSGAAALGFASYGAHGAQFPDAYGK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003773	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP006177	LGALSGAAALGFASYGAHGAQFPDAYGK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003773	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP006178	LGALSGAAALGFASYGAHGAQFPDAYGK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003773	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP006179	STNLLAAETASLEEQLQGWGEVMLMADK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003774	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP006180	STNLLAAETASLEEQLQGWGEVMLMADK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003774	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP006181	STNLLAAETASLEEQLQGWGEVMLMADK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003774	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP006182	STNLLAAETASLEEQLQGWGEVMLMADK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003774	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP006183	STNLLAAETASLEEQLQGWGEVMLMADK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	0.298	Others	0.8177	0.4734	0.6838	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003774	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP006189	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP006190	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP006191	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP006192	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.481	Others	-0.9601	0.3914	0.5942	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP006193	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP006204	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003777	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP006205	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003777	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP006206	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003777	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP006207	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-1.021	Others	-1.314	0.4009	0.6042	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003777	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP006208	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.2789	Others	-0.6909	0.5617	0.7516	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003777	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP006214	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003782	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP006215	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003782	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP006216	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003782	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP006217	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.4164	Others	4.379	0.022	0.1019	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003782	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP006218	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.6633	Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003782	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP006239	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003786	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP006240	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003786	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP006241	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003786	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP006242	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.5263	Others	-1.502	0.2076	0.4077	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003786	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP006243	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9692	Others	3.9818	0.0164	0.0819	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003786	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP006244	STATISGLKPGVDYTITVYAVTGRGDSPASSK	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003785	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP006245	STATISGLKPGVDYTITVYAVTGRGDSPASSK	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003785	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP006246	STATISGLKPGVDYTITVYAVTGRGDSPASSK	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003785	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP006247	STATISGLKPGVDYTITVYAVTGRGDSPASSK	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6213	Others	0.8921	0.4381	0.6406	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003785	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP006248	STATISGLKPGVDYTITVYAVTGRGDSPASSK	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003785	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP006254	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003788	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP006255	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003788	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP006256	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003788	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP006257	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3545	Others	0.8604	0.4381	0.6406	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003788	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP006258	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003788	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP006269	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003791	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP006270	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003791	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP006271	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003791	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP006272	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2829	Others	0.6425	0.5555	0.7503	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003791	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP006273	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003791	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP006274	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003792	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP006275	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003792	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP006276	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003792	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP006277	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0573	Others	-0.1771	0.8758	0.9342	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003792	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP006278	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003792	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP006279	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003793	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP006280	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum exosomes phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003793	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP006281	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum microvesicles phosphoproteomic	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003793	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP006282	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6419	Others	1.1371	0.319	0.5308	PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003793	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP006283	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Blood serum microvesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005214	Phosphoproteins in extracellular vehicles as candidate markers for breast cancer	LTQ Orbitrap Velos, Q Exactive	TIC	28270605	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003793	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP006393	LGELPSWILMR	Colon cancer	Colon cancer	Colon	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.706	Others	-0.9864	0.3693	0.6155	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003147	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP010048
SPENP006409	RFVNVVPTFGK	Colon cancer	Colon cancer	Colon	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	-0.019	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003153	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP014099
SPENP006418	ASGIYSCLQLNK	Colon cancer	Colon cancer	Colon	SPENT002465	SPENG000424	HSALNG0020817	-0.6648	Others	-1.014	0.3368	0.6068	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003198	SPENO005910	
SPENP006429	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon	SPENT000354	SPENG002378	HSALNG0036293	0.8458	Others	1.3756	0.2627	0.5834	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003193	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200;Leukemia:SPENP001045
SPENP006443	MALLASNSCFIR	Colon cancer	Colon cancer	Colon	SPENT002463,SPENT005926	SPENG003862,SPENG003871	lnc-DEFB115-5,Lnc-DEFB115-5		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003188	SPENO001998,SPENO004229	
SPENP006445	YQLDPTASISAK	Colon cancer	Colon cancer	Colon	SPENT000102	SPENG002045	lnc-ACTR2-11	0.9387	Others	1.0565	0.3258	0.6068	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003207	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP006468	AAALVLQTIWGYK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	0.3546	Others	0.8446	0.4604	0.6662	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003213	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP006485	DFSPSGIFGAFQR	Colon cancer	Colon cancer	Colon	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	1.1619	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003235	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP006488	TTAAMWALQTVEK	Colon cancer	Colon cancer	Colon	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003217	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089
SPENP006490	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003226	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP006509	LLLLESVSGLLQPR	Colon cancer	Colon cancer	Colon	SPENT001258	SPENG001048	lnc-CXCL16-3		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003288	SPENO003005	Colon cancer:SPENP010362,SPENP010361;Lung cancer:SPENP028325,SPENP002464
SPENP006511	QVRPIVGPFHAVLK	Colon cancer	Colon cancer	Colon	SPENT005796	SPENG001958	FBLN1	0.2752	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003271	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331,SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP014237,SPENP015976
SPENP006520	NSIAYMDQASGNVK	Colon cancer	Colon cancer	Colon	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003264	SPENO002694,SPENO004565,SPENO006050	Gastric cancer:SPENP003173,SPENP003573;Colon cancer:SPENP027186,SPENP007133;Lung cancer:SPENP004134,SPENP001874
SPENP006523	RLVQSPNSYFMDVK	Colon cancer	Colon cancer	Colon	SPENT000414,SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003268	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP010432,SPENP014253
SPENP006528	SKESVPEFPLSPPK	Colon cancer	Colon cancer	Colon	SPENT001112	SPENG003381	lnc-PAQR7-1	1.9017	Others	2.3496	0.0407	0.2508	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003270	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409
SPENP006549	SQGKPIELTPLPLLK	Colon cancer	Colon cancer	Colon	SPENT002485,SPENT002484,SPENT002483	SPENG003159,SPENG000098	NONHSAG015196.2,lnc-WDR89-4		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003310	SPENO002146,SPENO002388,SPENO006126	
SPENP006550	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.7013	Others	-1.887	0.1081	0.4368	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003305	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP006553	MTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	0.2485	Others	0.6984	0.5047	0.6866	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003302	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP000343
SPENP006562	NSIAYMDQASGNVKK	Colon cancer	Colon cancer	Colon	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003308	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004216;Colon cancer:SPENP007201,SPENP027187;Gastric cancer:SPENP003588,SPENP003213
SPENP006567	IREIADGLCLEVEGK	Colon cancer	Colon cancer	Colon	SPENT001715	SPENG001516	NONHSAG013412.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003306	SPENO003305	Colon cancer:SPENP024113,SPENP010553,SPENP010554;Bladder cancer:SPENP011515
SPENP006572	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Colon	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.4972	Others	-1.104	0.2896	0.5834	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003324	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP027466;Leukemia:SPENP001199
SPENP006579	DREGFFTNGLTLGAK	Colon cancer	Colon cancer	Colon	SPENT000938,SPENT000937,SPENT000932,SPENT000934,SPENT000931,SPENT000933,SPENT000935,SPENT000936	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003315	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	Kidney cancer:SPENP015068,SPENP020332;Anal canal cancer:SPENP024753;Lung cancer:SPENP004249;Prostate cancer:SPENP018284
SPENP006586	LQIAQLYPISIFIKPK	Colon cancer	Colon cancer	Colon	SPENT002500,SPENT002499	SPENG001391	DLG1		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003355	SPENO002952,SPENO003690	
SPENP006591	ISLPGQMAGTPITPLK	Colon cancer	Colon cancer	Colon	SPENT000725,SPENT000615	SPENG001618	NONHSAG029796.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	sORF.org_record	26527729	Immunogenic	SPENM003346	SPENO000363,SPENO003428	Breast cancer:SPENP022897,SPENP022896;Colon cancer:SPENP000379;Lung cancer:SPENP025800;Prostate cancer:SPENP012075
SPENP006600	DRDPNSLLISCAVSYR	Colon cancer	Colon cancer	Colon	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003340	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507
SPENP006610	QWADDWLVHLISPNVYR	Colon cancer	Colon cancer	Colon	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1	-0.2686	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003361	SPENO003587,SPENO005877,SPENO005957	Prostate cancer:SPENP023735
SPENP006622	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1	0.6812	Others	1.2326	0.2725	0.5834	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003367	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP006634	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Colon	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003382	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP008567
SPENP006639	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-1.206	Others	-2.395	0.0338	0.2234	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003392	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP006641	NPDGTMNLMNWECAIPGK	Colon cancer	Colon cancer	Colon	SPENT000199,SPENT002108	SPENG000037	HSALNG0108878		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003399	SPENO000865,SPENO003564	
SPENP006646	ACLDYPVTSVLPPASLCK	Colon cancer	Colon cancer	Colon	SPENT002507	SPENG002379	NONHSAG033050.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003377	SPENO004482	Lung cancer:SPENP025512,SPENP028228;Colon cancer:SPENP007326;Bladder cancer:SPENP017716,SPENP011635,SPENP028438;Prostate cancer:SPENP009279
SPENP006647	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1	-0.6721	Others	-0.9365	0.4771	0.6738	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003385	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP006648	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	0.1195	Others	0.3126	0.7637	0.8546	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003390	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP006658	NPDGTMNLMNWECAIPGKK	Colon cancer	Colon cancer	Colon	SPENT000199,SPENT002108	SPENG000037	HSALNG0108878		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003414	SPENO000865,SPENO003564	
SPENP006659	ADEALFLLLHNEMVSGVYK	Colon cancer	Colon cancer	Colon	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003408	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP000481,SPENP016178,SPENP014479;Lung cancer:SPENP004493,SPENP002731;Kidney cancer:SPENP020515
SPENP006664	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Colon	SPENT005801	SPENG002115	AL136361.1		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003406	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP010795,SPENP024214
SPENP006666	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003419	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP006668	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1	-0.5083	Others	-2.361	0.0776	0.3681	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003405	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223
SPENP006671	FFDHSGTLVMDAYEPEISR	Colon cancer	Colon cancer	Colon	SPENT002510,SPENT002512,SPENT002511	SPENG003726,SPENG002325,SPENG000279	HSALNG0002035,lnc-EYA3-2,HSALNG0085740	0.3505	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003410	SPENO000773,SPENO002918,SPENO004290	Breast cancer:SPENP008981;Kidney cancer:SPENP015159
SPENP006678	VVSSVSKSAWLWPSCGLIPR	Colon cancer	Colon cancer	Colon	SPENT002514,SPENT002515	SPENG003593,SPENG001534	HSALNG0037864,lnc-FAM160A1-1	-2.214	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003420	SPENO002552,SPENO006211	
SPENP006681	ATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Colon	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-2.325	Others	-1.022	0.3308	0.6068	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003430	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP010878,SPENP007406
SPENP006682	QSNNKYAASSYLSLTPEQWK	Colon cancer	Colon cancer	Colon	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.2605	Others	0.2422	0.8482	0.9018	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003422	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP027212,SPENP010882
SPENP006684	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.4704	Others	0.7459	0.4729	0.673	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003423	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP026681,SPENP024244,SPENP000507
SPENP006690	VYEDPALSAIFLHNNYNYILK	Colon cancer	Colon cancer	Colon	SPENT002517	SPENG000271	lnc-SRP68-4		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003438	SPENO002665	
SPENP006692	VFCNMETGETCISANPLNVPR	Colon cancer	Colon cancer	Colon	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003436	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004558;Colon cancer:SPENP007418;Gastric cancer:SPENP003309,SPENP003663
SPENP006694	ETSVTPSNLWGGQGLLGVSIR	Colon cancer	Colon cancer	Colon	SPENT000615	SPENG001618	NONHSAG029796.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM003440	SPENO003428	Breast cancer:SPENP023091,SPENP023090;Colon cancer:SPENP001727,SPENP000530;Lung cancer:SPENP025659,SPENP028262;Prostate cancer:SPENP012117
SPENP006701	SIITGEAMSQAQNPWLTLPSWK	Colon cancer	Colon cancer	Colon	SPENT002518	SPENG001034	lnc-KIF16B-7		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003447	SPENO005486	
SPENP006702	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1889	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003454	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253
SPENP006703	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	0.0433	Others	0.0912	0.929	0.971	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003457	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP006704	DMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	0.0253	Others	0.0588	0.9625	0.9842	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003456	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP016247
SPENP006707	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003452	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP006711	QGLYELSASNFELHVAQGDHFIK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2	2.3913	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003458	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP006715	KTDPWSLLAVLGAPVPSDLQAQR	Colon cancer	Colon cancer	Colon	SPENT002519	SPENG000194	NONHSAG045776.2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003461	SPENO000390	
SPENP006719	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003463	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP006720	MFLSGKCLYFSDQVHILYFVSELF	Colon cancer	Colon cancer	Colon	SPENT005789	SPENG001983	CNOT2		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003474	SPENO005500	Colon cancer:SPENP014606,SPENP016291;Lung cancer:SPENP002867
SPENP006724	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM003468	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699
SPENP006727	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1951	Others	0.3922	0.7024	0.8081	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003473	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP006732	YICPYSHKFLLSINSSQGEGSVHTR	Colon cancer	Colon cancer	Colon	SPENT002521,SPENT002522	SPENG001311,SPENG002027	HSALNG0140391,lnc-MCF2-4	-0.9986	Others	-0.984	0.3631	0.6155	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003486	SPENO000102,SPENO001447	
SPENP006734	DLVHTEGQLQNEEIVAHDGSATYLR	Colon cancer	Colon cancer	Colon	SPENT002082	SPENG002114	lnc-YIPF1-2	-1.984	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003484	SPENO000824	Anal canal cancer:SPENP024942;Colon cancer:SPENP000577,SPENP007463,SPENP014621;Lung cancer:SPENP025597
SPENP006743	SSQSLVHSDGNTYLSWLQQRPGQPPR	Colon cancer	Colon cancer	Colon	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.88	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003494	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP014639,SPENP001762,SPENP021824
SPENP006744	SSQSLVYSDGNTYLNWFQQRPGQSPR	Colon cancer	Colon cancer	Colon	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.671	Others	-1.128	0.2884	0.5834	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003489	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630
SPENP006745	EAPFVPVGIAGFAAIVAYGLYKLKSR	Colon cancer	Colon cancer	Colon	SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM003490	SPENO000724	
SPENP006746	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.6116	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003491	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP014637,SPENP000584,SPENP008725
SPENP006747	MLSGGFGYSPFLSITDGNMPGTRPASR	Colon cancer	Colon cancer	Colon	SPENT002523,SPENT002524	SPENG000400	lnc-PIANP-3		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003499	SPENO001572,SPENO003716	
SPENP006748	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1	1.0246	Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003498	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP006750	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.211	Others	-2.171	0.1184	0.4368	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003500	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP011074,SPENP008729,SPENP024310
SPENP006753	SGLAIVSQHDLDQLQADAINAFGESLQK	Colon cancer	Colon cancer	Colon	SPENT002525	SPENG001064	HSALNG0061573		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003510	SPENO004542	Bladder cancer:SPENP011768,SPENP028737
SPENP006757	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon	SPENT005913	SPENG001766	AL662884.2		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM003507	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP006758	LQAMWGQSLLPPVSTSFTTGGLRIPFPR	Colon cancer	Colon cancer	Colon	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003512	SPENO002584,SPENO006142	
SPENP006768	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.1917	Others	0.7019	0.4961	0.6866	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003516	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP006770	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.0077	Others	0.0218	0.9832	0.994	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003518	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP008758
SPENP006771	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003519	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP000615,SPENP011147
SPENP006776	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-1.083	Others	-1.732	0.1438	0.4588	PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003524	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP006777	EATPENDPNYFMNEPTFYTSDGVPFTAADPDYQEK	Colon cancer	Colon cancer	Colon	SPENT000390	SPENG002704	lnc-TRIM16L-2		Tumor-specific				PXD005693	Biomarkers discovery for Colorectal cancer	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003525	SPENO003522	Anal canal cancer:SPENP024969;Colon cancer:SPENP008771,SPENP007502,SPENP000627
SPENP006874	MVVFGSFLEK	Colon cancer	Colon cancer	Liver	SPENT002578	SPENG003674	HSALNG0089357		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004698	SPENO001355	
SPENP006919	LTSDLTFAYER	Colon cancer	Colon cancer	Liver	SPENT001450,SPENT002601,SPENT002602	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004816	SPENO002631,SPENO003868,SPENO005694	Breast cancer:SPENP022421,SPENP008837,SPENP022420
SPENP006947	LLTGVEYVVGR	Colon cancer	Colon cancer	Liver	SPENT002604,SPENT002603	SPENG002156,SPENG002677	NONHSAG050708.2,lnc-CALB1-2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004817	SPENO000857,SPENO005705	
SPENP006955	DKLNNLVLFDK	Colon cancer	Colon cancer	Liver	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004786	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP006972	TDSTFNQVVLK	Colon cancer	Colon cancer	Liver	SPENT002071	SPENG001428	lnc-CPHXL-5		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004759	SPENO004801	Bladder cancer:SPENP017275;Kidney cancer:SPENP019976;Anal canal cancer:SPENP024517;Lung cancer:SPENP026072;Colon cancer:SPENP010062,SPENP010061
SPENP006973	TAVAHRPGAFK	Colon cancer	Colon cancer	Liver	SPENT000153	SPENG003407	NONHSAG024537.2	0.6902	Others	0.7853	0.4896	0.6378	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004763	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP010065,SPENP023922
SPENP006984	YMDGMTVGVVR	Colon cancer	Colon cancer	Liver	SPENT005796	SPENG001958	FBLN1	1.3768	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004783	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP010024,SPENP000145,SPENP015753
SPENP006989	YQLDPTASISAK	Colon cancer	Colon cancer	Liver	SPENT000102	SPENG002045	lnc-ACTR2-11	3.2695	Others	2.6372	0.027	0.2729	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004829	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP007000	VPFLVLECPNLK	Colon cancer	Colon cancer	Liver	SPENT000354	SPENG002378	HSALNG0036293	1.7413	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004858	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP007005	ASGIYSCLQLNK	Colon cancer	Colon cancer	Liver	SPENT002465	SPENG000424	HSALNG0020817	1.9505	Others	2.4767	0.0383	0.2958	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004878	SPENO005910	
SPENP007006	TMTNFYSLFAWR	Colon cancer	Colon cancer	Liver	SPENT002612	SPENG003197	HSALNG0096906		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004830	SPENO002862	
SPENP007007	NKTDLAQTHLYR	Colon cancer	Colon cancer	Liver	SPENT002613,SPENT002614	SPENG002688,SPENG003108	lnc-RPS6KL1-2,HSALNG0102460	-1.309	Others	-0.9898	0.3481	0.551	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004834	SPENO001209,SPENO001336	Prostate cancer:SPENP011965
SPENP007011	NALDPMSVLLAR	Colon cancer	Colon cancer	Liver	SPENT002530,SPENT002607,SPENT002606	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004826	SPENO001285,SPENO003025,SPENO003487	Breast cancer:SPENP023318;Bladder cancer:SPENP028687;Colon cancer:SPENP000193;Gastric cancer:SPENP009496
SPENP007031	TDSTFNQVVLKR	Colon cancer	Colon cancer	Liver	SPENT002071	SPENG001428	lnc-CPHXL-5		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004845	SPENO004801	
SPENP007035	MEINPCTVLSTQ	Colon cancer	Colon cancer	Liver	SPENT002623,SPENT002620,SPENT002626,SPENT002624,SPENT002619,SPENT002621,SPENT002625,SPENT002622	SPENG000162	HSALNG0041080	-5.629	Others	-0.7903	0.4553	0.6216	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004854	SPENO000278,SPENO001741,SPENO002384,SPENO002904,SPENO003624,SPENO005425,SPENO006081,SPENO006350	Prostate cancer:SPENP011980
SPENP007055	TYCMLHVVMWELK	Colon cancer	Colon cancer	Liver	SPENT002632,SPENT002634,SPENT002633,SPENT002629,SPENT002627,SPENT002631,SPENT002628,SPENT002630	SPENG000363	HSALNG0094191		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004886	SPENO001148,SPENO001341,SPENO001574,SPENO002564,SPENO002687,SPENO002981,SPENO003665,SPENO003830	
SPENP007062	VLVDGEEHVGFLK	Colon cancer	Colon cancer	Liver	SPENT002650	SPENG003359	NONHSAG016482.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004901	SPENO002947	Bladder cancer:SPENP028801
SPENP007065	GNSIIMLEALERV	Colon cancer	Colon cancer	Liver	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004936	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP007070	VIEKVQHIQLLQK	Colon cancer	Colon cancer	Liver	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004902	SPENO001505,SPENO002211	Breast cancer:SPENP018628;Ovary cancer:SPENP018629;Tongue cancer:SPENP028137;Lung cancer:SPENP004130;Liver cancer:SPENP004831;Colon cancer:SPENP027398
SPENP007073	VLSGISFEVPAGK	Colon cancer	Colon cancer	Liver	SPENT002651,SPENT002652	SPENG000893	ABCB7		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004903	SPENO000694,SPENO005643	
SPENP007089	TTAAMWALQTVEK	Colon cancer	Colon cancer	Liver	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004933	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP006488
SPENP007097	TEVLSEDLLQIER	Colon cancer	Colon cancer	Liver	SPENT005992	SPENG003790	ARHGAP17	1.122	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004925	SPENO004570	Bile duct cancer:SPENP013402;Ovary cancer:SPENP016510;Colon cancer:SPENP024018
SPENP007102	KNKTDLAQTHLYR	Colon cancer	Colon cancer	Liver	SPENT002613,SPENT002614	SPENG002688,SPENG003108	lnc-RPS6KL1-2,HSALNG0102460		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004954	SPENO001209,SPENO001336	Prostate cancer:SPENP012018
SPENP007116	HVISYSLSPFEQR	Colon cancer	Colon cancer	Liver	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004918	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP007120	ELSELVYTDVLDR	Colon cancer	Colon cancer	Liver	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004919	SPENO002416,SPENO005649	Breast cancer:SPENP008874;Ovary cancer:SPENP029484;Colon cancer:SPENP026279;Lung cancer:SPENP001862,SPENP026506
SPENP007125	LLLCYCDEVYLLLR	Colon cancer	Colon cancer	Liver	SPENT002673	SPENG002442	HSALNG0097374	1.7698	Others	1.1896	0.3198	0.5482	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005012	SPENO005708	
SPENP007128	MLLACFSNSFNAIK	Colon cancer	Colon cancer	Liver	SPENT002664,SPENT002663	SPENG002096,SPENG001341	RMST	-0.3958	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM004967	SPENO001715,SPENO004958	
SPENP007133	NSIAYMDQASGNVK	Colon cancer	Colon cancer	Liver	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005009	SPENO002694,SPENO004565,SPENO006050	Gastric cancer:SPENP003173,SPENP003573;Colon cancer:SPENP027186,SPENP006520;Lung cancer:SPENP004134,SPENP001874
SPENP007143	ATEVAADALGEEWK	Colon cancer	Colon cancer	Liver	SPENT002669	SPENG001922	lnc-PLEKHA3-17		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004991	SPENO006282	
SPENP007144	TPTEALASFDYIVR	Colon cancer	Colon cancer	Liver	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004960	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022755,SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP004163,SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP024064
SPENP007157	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL	0.034	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004957	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP007158	KVIEKVQHIQLLQK	Colon cancer	Colon cancer	Liver	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005007	SPENO001505,SPENO002211	Breast cancer:SPENP018642;Ovary cancer:SPENP018643;Colon cancer:SPENP027042;Tongue cancer:SPENP027839
SPENP007163	SKESVPEFPLSPPK	Colon cancer	Colon cancer	Liver	SPENT001112	SPENG003381	lnc-PAQR7-1	1.2195	Others	1.7494	0.1723	0.4317	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM004998	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP010409,SPENP006528
SPENP007165	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004990	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP007174	VTDATETTITISWR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005004	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP027438,SPENP014254,SPENP015931
SPENP007181	MLITILGTVKPNANR	Colon cancer	Colon cancer	Liver	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005013	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133
SPENP007195	MTQSPSSLSASVGDR	Colon cancer	Colon cancer	Liver	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	1.3284	Others	2.4628	0.0433	0.2958	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005036	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP015983,SPENP006553,SPENP000343
SPENP007200	SWDILCYPLTFLMIR	Colon cancer	Colon cancer	Liver	SPENT002677	SPENG000952	HSALNG0012576		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005033	SPENO000110	
SPENP007201	NSIAYMDQASGNVKK	Colon cancer	Colon cancer	Liver	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005031	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004216;Colon cancer:SPENP006562,SPENP027187;Gastric cancer:SPENP003588,SPENP003213
SPENP007203	IILMNQIFFTIMNQL	Colon cancer	Colon cancer	Liver	SPENT002678	SPENG001218	HSALNG0066374		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005037	SPENO004072	
SPENP007211	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Liver	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.2197	Others	1.8566	0.0963	0.3328	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM005015	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP007228	EPLMEEYSIATQVWK	Colon cancer	Colon cancer	Liver	SPENT001640	SPENG000521	AMPD2		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005024	SPENO000624	
SPENP007234	AGYEYVSPEQLAGFDK	Colon cancer	Colon cancer	Liver	SPENT005924	SPENG003747	HSALNG0013722	0.7873	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005107	SPENO004898	Anal canal cancer:SPENP024784;Bladder cancer:SPENP028447,SPENP017634
SPENP007238	SILSSGFSGASDTWPR	Colon cancer	Colon cancer	Liver	SPENT002688	SPENG003555	NONHSAG033645.2	0.2668	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005084	SPENO004589	
SPENP007254	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Liver	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM005082	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP024149,SPENP001661,SPENP010616,SPENP000394,SPENP010615,SPENP014365;Lung cancer:SPENP025534
SPENP007276	EALCGCSINVPTLDGR	Colon cancer	Colon cancer	Liver	SPENT000515	SPENG000486	NONHSAG001879.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005083	SPENO000704	Bile duct cancer:SPENP013493;Tongue cancer:SPENP027603;Lung cancer:SPENP007733;Prostate cancer:SPENP018322,SPENP012067;Colon cancer:SPENP016075;Leukemia:SPENP001237
SPENP007288	MLMYIVIEVENVRYKQK	Colon cancer	Colon cancer	Liver	SPENT002713	SPENG002147	HSALNG0133181	-0.384	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005137	SPENO001758	Lung cancer:SPENP007779
SPENP007302	FMPAGLIAGASLLMVAK	Colon cancer	Colon cancer	Liver	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005138	SPENO000972,SPENO005766	Breast cancer:SPENP022925,SPENP022924;Colon cancer:SPENP026841;Kidney cancer:SPENP020457,SPENP015125;Prostate cancer:SPENP018363
SPENP007309	GADPGMPEPTVLSLLWG	Colon cancer	Colon cancer	Liver	SPENT000828	SPENG000141	HSALNG0056619		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005144	SPENO004991	Anal canal cancer:SPENP024826;Colon cancer:SPENP001668,SPENP014405,SPENP000410;Lung cancer:SPENP025703;Kidney cancer:SPENP020455
SPENP007314	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	-4.584	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005121	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP012823;Leukemia:SPENP001289
SPENP007320	EAQAQHNNSEFTEEQKK	Colon cancer	Colon cancer	Liver	SPENT001330,SPENT001009	SPENG001238,SPENG001518	lnc-USP33-3,lnc-TMEM144-3		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005124	SPENO004170,SPENO005521	Colon cancer:SPENP000428;Lung cancer:SPENP002661;Prostate cancer:SPENP023734
SPENP007326	ACLDYPVTSVLPPASLCK	Colon cancer	Colon cancer	Liver	SPENT002507	SPENG002379	NONHSAG033050.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM005161	SPENO004482	Lung cancer:SPENP025512,SPENP028228;Colon cancer:SPENP006646;Bladder cancer:SPENP017716,SPENP011635,SPENP028438;Prostate cancer:SPENP009279
SPENP007328	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Liver	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	0.151	Others	0.3358	0.7485	0.849	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	MS	28137767	Immunogenic	SPENM005174	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP006634,SPENP008567
SPENP007334	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	2.0283	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005163	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP007339	MAPRTQSPGVLGGTLWEA	Colon cancer	Colon cancer	Liver	SPENT001896	SPENG002717	ADORA2A-AS1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005158	SPENO003767	Lung cancer:SPENP004435
SPENP007344	DESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Liver	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	1.4092	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005162	SPENO000942,SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP010781
SPENP007353	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Liver	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	1.3873	Others	2.2927	0.0448	0.2958	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005165	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111
SPENP007354	EAALSYGFYGCHCGVGGR	Colon cancer	Colon cancer	Liver	SPENT002189,SPENT002190,SPENT002191	SPENG000309,SPENG002571	HSALNG0001408,lnc-PLA2G2E-1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005181	SPENO000180,SPENO002012,SPENO006290	Anal canal cancer:SPENP024845;Colon cancer:SPENP014449
SPENP007355	LDKEMIHVLGGMEQKGAR	Colon cancer	Colon cancer	Liver	SPENT001899	SPENG001253	lnc-FANCC-1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005172	SPENO003147	Colon cancer:SPENP008569;Lung cancer:SPENP007809,SPENP004440;Prostate cancer:SPENP023741
SPENP007359	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Liver	SPENT005785	SPENG001958	FBLN1	-0.2934	Others	-0.4243	0.6862	0.7901	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005195	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP010805,SPENP024223,SPENP006668
SPENP007364	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Liver	SPENT005801	SPENG002115	AL136361.1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005206	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP007374	NPDGTMNLMNWECAIPGKK	Colon cancer	Colon cancer	Liver	SPENT000199,SPENT002108	SPENG000037	HSALNG0108878		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005210	SPENO000865,SPENO003564	
SPENP007376	PQTDTAAILETSPWSNQGR	Colon cancer	Colon cancer	Liver	SPENT002198,SPENT002199	SPENG000174,SPENG003609	lnc-AP3M2-86,HSALNG0064850		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005215	SPENO002226,SPENO005579	Anal canal cancer:SPENP024864
SPENP007384	TYLVSGQPLEEIITYYPAMK	Colon cancer	Colon cancer	Liver	SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005221	SPENO005957	Breast cancer:SPENP023054,SPENP023055;Colon cancer:SPENP012846,SPENP000498;Lung cancer:SPENP026112
SPENP007391	YIMVPSGNMGVFDPTEIHNR	Colon cancer	Colon cancer	Liver	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005237	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP014512,SPENP000511,SPENP027477
SPENP007393	LIIGGGVCCISWVPWNYIFK	Colon cancer	Colon cancer	Liver	SPENT002730,SPENT002731	SPENG001454,SPENG003666	HSALNG0066955,lnc-FAM92A-6	-3.138	Others	-1.318	0.2356	0.4713	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005217	SPENO002782,SPENO004863	
SPENP007394	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.0081	Others	0.0172	0.9867	0.9911	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005220	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP007398	VVSSVSKSAWLWPSCGLIPR	Colon cancer	Colon cancer	Liver	SPENT002514,SPENT002515	SPENG003593,SPENG001534	HSALNG0037864,lnc-FAM160A1-1	-7.864	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005224	SPENO002552,SPENO006211	
SPENP007406	ATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Liver	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.5658	Others	-0.6869	0.5227	0.6658	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005225	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878
SPENP007417	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005253	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP024251,SPENP010929,SPENP008656
SPENP007418	VFCNMETGETCISANPLNVPR	Colon cancer	Colon cancer	Liver	SPENT005912,SPENT000926,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005246	SPENO002694,SPENO004565,SPENO006050	Lung cancer:SPENP004558;Colon cancer:SPENP006692;Gastric cancer:SPENP003309,SPENP003663
SPENP007423	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Liver	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.7112	Others	0.9843	0.3507	0.551	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005258	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP010928;Leukemia:SPENP001352
SPENP007426	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005259	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP007431	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005263	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP007432	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005267	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP007433	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	1.4258	Others	2.0524	0.0742	0.3328	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005265	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP014579;Leukemia:SPENP001364
SPENP007435	MYSTYSKNISAFMLCSRHYAQW	Colon cancer	Colon cancer	Liver	SPENT002739	SPENG000423	HSALNG0137582		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005272	SPENO003956	
SPENP007438	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	-2.76	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005270	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP010933,SPENP014573,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP007444	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005275	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP007451	VKADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Liver	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	-0.1659	Others	-0.2696	0.7965	0.8731	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005276	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP007456	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005293	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293
SPENP007463	DLVHTEGQLQNEEIVAHDGSATYLR	Colon cancer	Colon cancer	Liver	SPENT002082	SPENG002114	lnc-YIPF1-2	-0.6647	Others	-1.367	0.2158	0.4599	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005297	SPENO000824	Anal canal cancer:SPENP024942;Colon cancer:SPENP006734,SPENP000577,SPENP014621;Lung cancer:SPENP025597
SPENP007468	MLETCGDAENQLALELSQHEVFVEK	Colon cancer	Colon cancer	Liver	SPENT005992	SPENG003790	ARHGAP17		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005303	SPENO004570	
SPENP007472	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	2.6507	Others	0.9712	0.3864	0.5835	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005307	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP007476	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005312	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP011061,SPENP016339
SPENP007477	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005311	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP007478	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005309	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP011063;Leukemia:SPENP001390
SPENP007480	MFTEFFLTFPQIHSASQLRPSANTCYTR	Colon cancer	Colon cancer	Liver	SPENT002746	SPENG000769	HSALNG0105478		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005321	SPENO002485	
SPENP007484	STNLLAAETASLEEQLQGWGEVMLMADK	Colon cancer	Colon cancer	Liver	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005317	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP014656,SPENP000591
SPENP007492	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.8666	Others	1.3167	0.2244	0.4627	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005326	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP007493	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.1278	Others	-0.2305	0.8325	0.8912	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005327	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP007496	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Colon cancer	Colon cancer	Liver	SPENT000040	SPENG000572	lnc-EEF1E1-2	-1.745	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated			Immunogenic	SPENM005331	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP008765,SPENP000622
SPENP007499	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.8591	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005332	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP011181,SPENP001779
SPENP007502	EATPENDPNYFMNEPTFYTSDGVPFTAADPDYQEK	Colon cancer	Colon cancer	Liver	SPENT000390	SPENG002704	lnc-TRIM16L-2	-0.6279	Others	-2.487	0.0887	0.3328	PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005336	SPENO003522	Anal canal cancer:SPENP024969;Colon cancer:SPENP008771,SPENP006777,SPENP000627
SPENP007503	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005338	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP000628,SPENP011216,SPENP024347
SPENP007504	AAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Liver	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.877	Others				PXD005709	Biomarkers discovery for Colorectal cancer liver metastasis	Q Exactive	TIC	29535834	Non-validated	MS	28137767	Immunogenic	SPENM005337	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Skin cancer:SPENP025494;Gastric cancer:SPENP015488;Colon cancer:SPENP011209,SPENP011210;Bladder cancer:SPENP011817
SPENP007578	YMDGMTVGVVR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016694	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP007580	LGELPSWILMR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016690	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP007581	RFVNVVPTFGK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016683	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP007606	KSEIEYYAMLAK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016728	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP010164,SPENP008226
SPENP007608	LVILANNCPALR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	-0.1007	Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016726	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP007614	FLEEYLSSTPQR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002760	SPENG002531	NONHSAG014457.2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016729	SPENO003138	Skin cancer:SPENP025159;Kidney cancer:SPENP014941;Bile duct cancer:SPENP013357;Tongue cancer:SPENP027660;Lung cancer:SPENP028269,SPENP026519;Prostate cancer:SPENP012927
SPENP007619	YQLDPTASISAK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016727	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP007620	VIEGDVVSALNK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT001808,SPENT005921	SPENG001016,SPENG001705	AC112229.4,lnc-LIMS4-1		Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016709	SPENO000049,SPENO000476	Breast cancer:SPENP022574,SPENP022575;Gastric cancer:SPENP015298;Bladder cancer:SPENP011358
SPENP007621	VPFLVLECPNLK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000354	SPENG002378	HSALNG0036293		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016714	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP007632	HVISYSLSPFEQR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016740	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP007645	YAMVYGYNAAYNR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	-0.4545	Others	-5.01	0.0024	0.034	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016745	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP007650	DFSPSGIFGAFQR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.9404	Others	2.6025	0.0423	0.1901	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016755	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP007658	GNSIIMLEALERV	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016769	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP007669	QYNVGPSVSKYPLR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016795	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP007670	LAGVTALSCWLPLR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000779	SPENG000351	lnc-TCEA1-1	1.1528	Others	3.4687	0.0133	0.1162	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016782	SPENO005550	Colon cancer:SPENP001606;Prostate cancer:SPENP012966
SPENP007677	ENCLDSLSMGTFYK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002789,SPENT002788	SPENG002019,SPENG001251	lnc-HLF-3,HSALNG0117505	-0.3268	Others	-1.343	0.2503	0.4367	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016788	SPENO000674,SPENO005127	
SPENP007696	TQSSLVPALTDFVR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016775	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP007708	MLITILGTVKPNANR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.2799	Others	-1.007	0.3498	0.5662	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016809	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP007710	YAASSYLSLTPEQWK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.0574	Others	-0.2348	0.8177	0.8854	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016807	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP007731	EVVIFGAASELFTKK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000018	SPENG003202	HMGCL		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016825	SPENO002963	Colon cancer:SPENP026814,SPENP008419;Lung cancer:SPENP002543,SPENP004268;Kidney cancer:SPENP020351;Prostate cancer:SPENP018293
SPENP007733	EALCGCSINVPTLDGR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000515	SPENG000486	NONHSAG001879.2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016854	SPENO000704	Bile duct cancer:SPENP013493;Tongue cancer:SPENP027603;Prostate cancer:SPENP018322,SPENP012067;Colon cancer:SPENP016075,SPENP007276;Leukemia:SPENP001237
SPENP007778	TPIGSFLGSLSLLPATK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000014	SPENG003410	ACAT1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016872	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP007779	MLMYIVIEVENVRYKQK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002713	SPENG002147	HSALNG0133181		Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016865	SPENO001758	Colon cancer:SPENP007288
SPENP007780	MPYECGPSLDVCAQDER	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002782,SPENT005928	SPENG001130	NONHSAG040260.2	0.1869	Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016885	SPENO003088,SPENO003747	
SPENP007782	CIDVRPGYCYTALTNGR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005892	SPENG001317	HSALNG0105758	1.3471	Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016873	SPENO000957	Colon cancer:SPENP008534,SPENP010683,SPENP010684;Lung cancer:SPENP004375
SPENP007793	DIQMTQSPSSLSASVGDR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-2.105	Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016896	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP007795	GETGPAGPAGPVGPVGAR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016900	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP007809	LDKEMIHVLGGMEQKGAR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT001899	SPENG001253	lnc-FANCC-1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016904	SPENO003147	Colon cancer:SPENP008569,SPENP007355;Lung cancer:SPENP004440;Prostate cancer:SPENP023741
SPENP007817	TGVHHYSGNNIELGTACGK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	1.5565	Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016922	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP007823	YGGQPLFSEKFPTLWSGAR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000628	SPENG001755	lnc-HNRNPUL2-BSCL2-1	0.8642	Others	4.178	0.0024	0.034	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016912	SPENO003259	
SPENP007824	TPVLCETSSPISHSFMPFK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002812	SPENG001584	XACT	-0.6353	Others	-8.3	0.0037	0.0411	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016914	SPENO000899	
SPENP007827	QSNNKYAASSYLSLTPEQWK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.3623	Others	0.7343	0.4749	0.6654	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016938	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP007835	ISQAEEEDQQLLGHLLLVAK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002815	SPENG000837	lnc-HINT2-1	0.0449	Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016934	SPENO001580	Breast cancer:SPENP008997;Skin cancer:SPENP025405;Bladder cancer:SPENP028609;Lung cancer:SPENP028299;Prostate cancer:SPENP023755;Colon cancer:SPENP012845
SPENP007839	ALAPTWEQLALGLEHSETVK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016932	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP007848	ADRDESSPYAAMLAAQDVAQR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016951	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP007851	FHDPDSAVVAQHLTNTVFVDR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002817	SPENG000847	NONHSAG001792.2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016949	SPENO001701	
SPENP007853	SGDRGETGPAGPAGPVGPVGAR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005758	SPENG002845	COL1A1	0.0668	Others	0.1733	0.8651	0.9116	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016957	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP007855	DTLTSRPAQGVVTTLENVSPPR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016958	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP007858	LGSPDYGNSALLSLPGYRPTTR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT002818	SPENG003672	HSALNG0085517		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016960	SPENO005962	
SPENP007862	VKADRDESSPYAAMLAAQDVAQR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016971	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP007863	CDPHEATCYDDGKTYHVGEQWQK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016974	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP007869	QGLYELSASNFELHVAQGDHFIK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM016966	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP007872	DTLTSRPAQGVVTTLENVSPPRR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016967	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP007874	MELGELLYNKSEYIETASGNKVSR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000216,SPENT000217,SPENT000218	SPENG002974,SPENG001837	HSALNG0110268,NONHSAG018904.2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016979	SPENO004244,SPENO004278,SPENO004951	Lung cancer:SPENP004633;Leukemia:SPENP001379
SPENP007875	TKTETITGFQVDAVPANGQTPIQR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6289	Others	1.6285	0.145	0.3612	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016983	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP007881	AAQAQGQSCEYSLMVGYQCGQVFR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM016980	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP007890	TNTNVNCPIECFMPLDVQADREDSRE	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.714	Others	1.0838	0.3201	0.5404	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016994	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP007895	TLEEGHDFIQEFPGSPAFAALTSIAQK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000868	SPENG001300	NONHSAG018279.2		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	MS	28137767	Immunogenic	SPENM016998	SPENO000920	Bladder cancer:SPENP011759;Colon cancer:SPENP001767;Prostate cancer:SPENP023789
SPENP007899	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017001	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP007913	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017017	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP021966,SPENP004706;Colon cancer:SPENP021964;Leukemia:SPENP001396;Breast cancer:SPENP021965,SPENP021967
SPENP007914	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017016	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP007915	AGVETTTPSKQSNNKYAASSYLSLTPEQWK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM017014	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Lung cancer:SPENP004704;Ovary cancer:SPENP018709;Gastric cancer:SPENP003369,SPENP015465;Breast cancer:SPENP018708
SPENP007916	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017019	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP007918	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.5962	Others	1.3083	0.2174	0.4215	PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017020	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP007921	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017024	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP007924	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Lung cancer	Lung squamous cell carcinomas	Lung	SPENT005797,SPENT005805	SPENG002649	FGA		Others				PXD005733	Comparison of Lung Cancer Proteome Profiles 4: DDA	Q Exactive	TIC	28195392	Non-validated			Immunogenic	SPENM017026	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP001983;Colon cancer:SPENP024345,SPENP011202,SPENP011201
SPENP007989	VLMFMYTLK	Colon cancer	Colon cancer	Colon	SPENT002847,SPENT002848	SPENG003146	HSALNG0051921	-0.0774	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017606	SPENO001874,SPENO005050	
SPENP008071	AVYTLTSLYR	Colon cancer	Colon cancer	Colon	SPENT000988	SPENG000380	lnc-DIABLO-1	1.0034	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM017683	SPENO003093	Bladder cancer:SPENP017167;Kidney cancer:SPENP019937;Lung cancer:SPENP002154;Prostate cancer:SPENP018082;Colon cancer:SPENP014012,SPENP026722,SPENP015676
SPENP008125	GSLASLDSLRK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	-0.2415	Others	-1.291	0.3818	0.7331	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017716	SPENO005858	Colon cancer:SPENP026916,SPENP014054,SPENP015749;Bladder cancer:SPENP017222;Kidney cancer:SPENP020052;Prostate cancer:SPENP011932
SPENP008128	TAVAHRPGAFK	Colon cancer	Colon cancer	Colon	SPENT000153	SPENG003407	NONHSAG024537.2	0.1152	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017703	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP008174	SEIEYYAMLAK	Colon cancer	Colon cancer	Colon	SPENT000907	SPENG001277	HSALNG0067186	-0.2804	Others	-1.138	0.273	0.6705	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM017740	SPENO000929	Breast cancer:SPENP022399,SPENP022398;Colon cancer:SPENP010027,SPENP010028;Bladder cancer:SPENP028732;Skin cancer:SPENP025097
SPENP008178	DKLNNLVLFDK	Colon cancer	Colon cancer	Colon	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM017700	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP008189	YMDGMTVGVVR	Colon cancer	Colon cancer	Colon	SPENT005796	SPENG001958	FBLN1	-0.1684	Others	-0.1753	0.8677	0.9819	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017727	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP008201	RYMDGMTVGVVR	Colon cancer	Colon cancer	Colon	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017823	SPENO003698	Ovary cancer:SPENP016486;Colon cancer:SPENP015769,SPENP014156;Gastric cancer:SPENP003524
SPENP008202	LVILANNCPALR	Colon cancer	Colon cancer	Colon	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	-0.1177	Others	-0.3115	0.7592	0.9416	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017786	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167
SPENP008207	QLGEANEEFALR	Colon cancer	Colon cancer	Colon	SPENT001719,SPENT001183,SPENT001182	SPENG000169	lnc-DQX1-1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017850	SPENO000751,SPENO001535,SPENO004354	Bladder cancer:SPENP011366,SPENP017394;Lung cancer:SPENP004013;Anal canal cancer:SPENP024596
SPENP008210	YQLDPTASISAK	Colon cancer	Colon cancer	Colon	SPENT000102	SPENG002045	lnc-ACTR2-11	0.1979	Others	1.0253	0.3169	0.6914	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017829	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP008217	AGLSESLAAISK	Colon cancer	Colon cancer	Colon	SPENT002883,SPENT002882	SPENG003578,SPENG002245	AC099398.1,HSALNG0058883		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017833	SPENO003412,SPENO004294	
SPENP008226	KSEIEYYAMLAK	Colon cancer	Colon cancer	Colon	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM017780	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP010164
SPENP008231	NQSLIPLLLEAR	Colon cancer	Colon cancer	Colon	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017841	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP014158;Leukemia:SPENP001056
SPENP008244	GQAGVMGFPGPK	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-1.859	Others	-3.707	0.0024	0.1608	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017791	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP008250	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon	SPENT000354	SPENG002378	HSALNG0036293	-0.2042	Others	-0.701	0.4922	0.8009	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM017822	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP008289	MSISSAWSGAEFK	Colon cancer	Colon cancer	Colon	SPENT002873	SPENG003103	HSALNG0077152		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017867	SPENO001648	
SPENP008305	TSNLLLSHAGILK	Colon cancer	Colon cancer	Colon	SPENT000136,SPENT000135,SPENT000137	SPENG000848	lnc-CDK11A-2		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM017891	SPENO002156,SPENO003659,SPENO006064	Bladder cancer:SPENP017399;Colon cancer:SPENP012777,SPENP027360;Lung cancer:SPENP004077;Anal canal cancer:SPENP024668
SPENP008308	TLSLSSLFQIPVR	Colon cancer	Colon cancer	Colon	SPENT002429	SPENG001980	HSALNG0025086		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017890	SPENO000154	
SPENP008312	LVILANNCPALRK	Colon cancer	Colon cancer	Colon	SPENT000907	SPENG001277	HSALNG0067186	-0.6747	Others	-0.918	0.3891	0.7338	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017869	SPENO000929	
SPENP008313	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.0071	Others	0.0111	0.9913	0.9998	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017904	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP008320	HVISYSLSPFEQR	Colon cancer	Colon cancer	Colon	SPENT001666	SPENG002113	HSALNG0044883	-0.2005	Others	-0.3253	0.7517	0.9347	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017895	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181
SPENP008329	WLGQAAVTCVPWR	Colon cancer	Colon cancer	Colon	SPENT002890	SPENG003284	HSALNG0033509	0.4466	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM017857	SPENO001243	
SPENP008345	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1181	Others	-0.1734	0.8666	0.9819	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017957	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP008365	SKESVPEFPLSPPK	Colon cancer	Colon cancer	Colon	SPENT001112	SPENG003381	lnc-PAQR7-1	3.0277	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM017938	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP007163,SPENP010409,SPENP006528
SPENP008384	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL	-0.5596	Others	-2.807	0.014	0.2858	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017935	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP008391	VTDATETTITISWR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0003	Others	-0.0003	0.9998	0.9998	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017981	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP008395	ADGQMPFSCHYPSR	Colon cancer	Colon cancer	Colon	SPENT001996,SPENT001995	SPENG000039	NONHSAG012478.2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017986	SPENO000668,SPENO002663	Colon cancer:SPENP014250,SPENP015956;Bladder cancer:SPENP017518;Kidney cancer:SPENP020300
SPENP008399	EVVIFGAASELFTK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL	-0.2472	Others	-0.5481	0.5912	0.8573	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017950	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP026813,SPENP010376
SPENP008419	EVVIFGAASELFTKK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL	0.0164	Others	0.0367	0.9716	0.9965	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018028	SPENO002963	Colon cancer:SPENP026814;Lung cancer:SPENP002543,SPENP007731,SPENP004268;Kidney cancer:SPENP020351;Prostate cancer:SPENP018293
SPENP008424	VLSVPESTPFTAVLK	Colon cancer	Colon cancer	Colon	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2	-0.023	Others	-0.0572	0.958	0.9965	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018025	SPENO001471,SPENO001798	Skin cancer:SPENP019405,SPENP019404,SPENP019403;Colon cancer:SPENP024129;Leukemia:SPENP001198;Prostate cancer:SPENP023686
SPENP008427	AMTEDGFLAVCSEAK	Colon cancer	Colon cancer	Colon	SPENT005929,SPENT002838	SPENG001292	AC079781.5	-0.6066	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018008	SPENO002624,SPENO003829	
SPENP008444	TLSAPSLVTVWLGPQ	Colon cancer	Colon cancer	Colon	SPENT002948,SPENT002949	SPENG001651,SPENG000299	HSALNG0023315,lnc-COL6A3-10	1.2864	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018015	SPENO002951,SPENO004086	
SPENP008447	HEVTILGGLNEFVVK	Colon cancer	Colon cancer	Colon	SPENT002405	SPENG002844	HSALNG0061330		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM018048	SPENO003324	Breast cancer:SPENP005660,SPENP005662,SPENP005661,SPENP005659,SPENP005663;Lung cancer:SPENP028288
SPENP008454	SSTSRPDAYEHTQMK	Colon cancer	Colon cancer	Colon	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2	2.0504	Others	3.3436	0.169	0.5755	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018032	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP008461	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	0.182	Others	0.3905	0.7007	0.9197	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018039	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP010502,SPENP024133,SPENP007181
SPENP008467	MIFSVGHPFTASYLR	Colon cancer	Colon cancer	Colon	SPENT002953	SPENG001625	HSALNG0038306	0.2793	Others	0.7975	0.5097	0.8155	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018044	SPENO005702	
SPENP008483	LEAELGNMPGLVEDFK	Colon cancer	Colon cancer	Colon	SPENT002956	SPENG002514	lnc-UBE2D3-3		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018086	SPENO002526	
SPENP008488	MLSTLHSNFENLACSE	Colon cancer	Colon cancer	Colon	SPENT002957	SPENG000891	lnc-ATP6V1G3-4		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018087	SPENO000620	
SPENP008500	GSGQGDSLYPVGYLDK	Colon cancer	Colon cancer	Colon	SPENT000814	SPENG001638	HSALNG0104943	-0.2127	Others	-0.6084	0.6487	0.8984	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM018074	SPENO005134	Kidney cancer:SPENP020374;Anal canal cancer:SPENP024782;Lung cancer:SPENP025746;Prostate cancer:SPENP018335;Colon cancer:SPENP001653,SPENP014345,SPENP016058
SPENP008501	MDGAVMEGPLFLQSQR	Colon cancer	Colon cancer	Colon	SPENT002955,SPENT002954	SPENG000054	HSALNG0016078		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018071	SPENO004554,SPENO006131	
SPENP008507	DRDPNSLLISCAVSYR	Colon cancer	Colon cancer	Colon	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018076	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP006600
SPENP008520	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1	-0.1068	Others	-0.1433	0.8908	0.9875	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018114	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP008530	NDAQTPGPLYASPALMS	Colon cancer	Colon cancer	Colon	SPENT002961	SPENG002297	lnc-MAP1LC3B2-28	0.072	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018127	SPENO005876	Kidney cancer:SPENP020425
SPENP008532	NFRPGTENTPMIAGLGK	Colon cancer	Colon cancer	Colon	SPENT005895	SPENG001468	UBE2F-SCLY		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018122	SPENO006040	Prostate cancer:SPENP018381
SPENP008534	CIDVRPGYCYTALTNGR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758	0.9238	Others	1.6994	0.1398	0.5595	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018112	SPENO000957	Colon cancer:SPENP010683,SPENP010684;Lung cancer:SPENP007782,SPENP004375
SPENP008535	AWQGLAAEFLQVPAVTR	Colon cancer	Colon cancer	Colon	SPENT000869,SPENT000870	SPENG002286	lnc-DERL3-1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018100	SPENO000186,SPENO001045	
SPENP008536	ISSTLYQAAAPVLTPAK	Colon cancer	Colon cancer	Colon	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474	-0.3204	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018118	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP000424,SPENP001671
SPENP008539	ETPLPIDPSMFPTWPAK	Colon cancer	Colon cancer	Colon	SPENT000136,SPENT000135,SPENT000138,SPENT000137,SPENT000139	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM018128	SPENO000257,SPENO002156,SPENO003659,SPENO005654,SPENO006064	Bladder cancer:SPENP011592,SPENP017665;Colon cancer:SPENP000431;Lung cancer:SPENP025658,SPENP002667;Kidney cancer:SPENP020456
SPENP008554	SLMVDHVTEVSQWMVGVK	Colon cancer	Colon cancer	Colon	SPENT001949,SPENT005920	SPENG000432	lnc-APBB3-1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018150	SPENO002480,SPENO003150	Prostate cancer:SPENP018390
SPENP008555	LGSAPAASPALASPEGPK	Colon cancer	Colon cancer	Colon	SPENT002963	SPENG002091	lnc-CCDC9B-3		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018151	SPENO004033	Bile duct cancer:SPENP013547
SPENP008560	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-1.067	Others	-2.591	0.0167	0.2858	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018163	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP016124;Leukemia:SPENP001302
SPENP008567	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Colon	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	-0.4748	Others	-2.47	0.0244	0.3166	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM018165	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634
SPENP008568	IALDFQRGNDVAFHFNPR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000026,SPENT000024,SPENT000025	SPENG001332	NONHSAG015030.2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018146	SPENO000887,SPENO001262,SPENO001624,SPENO005116	
SPENP008569	LDKEMIHVLGGMEQKGAR	Colon cancer	Colon cancer	Colon	SPENT001899	SPENG001253	lnc-FANCC-1	-3.496	Others	-1.262	0.2425	0.6407	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018161	SPENO003147	Colon cancer:SPENP007355;Lung cancer:SPENP007809,SPENP004440;Prostate cancer:SPENP023741
SPENP008580	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1	-0.522	Others	-1.069	0.3102	0.6914	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018172	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150
SPENP008583	DLSLGGVLLFPVDDKESR	Colon cancer	Colon cancer	Colon	SPENT002176	SPENG002576	AC242426.2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018162	SPENO002839	
SPENP008585	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-1.164	Others	-2.744	0.0151	0.2858	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018147	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP008590	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018186	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP008595	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Colon	SPENT005801	SPENG002115	AL136361.1	-0.0049	Others	-0.0613	0.9522	0.9965	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018176	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP008606	TDQALAGSLVSSTCGVCGK	Colon cancer	Colon cancer	Colon	SPENT002964	SPENG002165	lnc-MICALL2-1		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018174	SPENO003793	
SPENP008607	TGVHHYSGNNIELGTACGK	Colon cancer	Colon cancer	Colon	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	-0.4157	Others	-1.29	0.2166	0.6379	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM018184	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP010819,SPENP012841,SPENP024218
SPENP008610	VGSQHTMWLSAELVESWSL	Colon cancer	Colon cancer	Colon	SPENT000938,SPENT000937,SPENT000934,SPENT000935,SPENT000936	SPENG000021	HSALNG0029760	-1.042	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018175	SPENO001252,SPENO001838,SPENO003392,SPENO004534,SPENO005775	
SPENP008614	YIMVPSGNMGVFDPTEIHNR	Colon cancer	Colon cancer	Colon	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.6062	Others	1.3752	0.2182	0.6387	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018221	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP008616	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.7723	Others	-1.372	0.1944	0.606	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018229	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP008625	EILSNLGSPVVLCHNDLLCK	Colon cancer	Colon cancer	Colon	SPENT002959,SPENT002958	SPENG003700,SPENG002003	HSALNG0089832,ETNK1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018224	SPENO000590,SPENO003978	
SPENP008656	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018244	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929
SPENP008661	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.517	Others	1.8994	0.0728	0.4063	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018234	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP008667	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5087	Others	0.8793	0.3931	0.7371	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018251	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP008668	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL	-1.178	Others	-1.738	0.1162	0.503	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018253	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP016255,SPENP010941,SPENP000542
SPENP008670	VEANLHGLTLYDTAPCPINNER	Colon cancer	Colon cancer	Colon	SPENT002972,SPENT002973	SPENG002559,SPENG000238	HSALNG0006018,lnc-DENND2D-2	-0.6761	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018252	SPENO002284,SPENO003339	Prostate cancer:SPENP018481
SPENP008671	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1	-0.0713	Others	-0.3558	0.7273	0.9197	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018258	SPENO003940	Colon cancer:SPENP010934,SPENP016258,SPENP010933,SPENP014573,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP008673	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.7682	Others	-2.299	0.0314	0.3494	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018256	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP008675	DMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	1.1381	Others	0.927	0.3708	0.7177	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018255	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP008676	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9603	Others	0.9265	0.3672	0.7177	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018263	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP008681	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5505	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018279	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP010975;Leukemia:SPENP001374
SPENP008688	HAAYILLTGPADSEAPGLVSVIK	Colon cancer	Colon cancer	Colon	SPENT002910	SPENG002256	HSALNG0108712		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	MS	28137767	Immunogenic	SPENM018273	SPENO005963	
SPENP008691	GTVLALTENNFDDTIAEGITFIK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018270	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP002850,SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP000559
SPENP008693	QGLYELSASNFELHVAQGDHFIK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.9491	Others	-2.192	0.0435	0.3494	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018280	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP008699	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM018291	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP006724
SPENP008701	DDGNMPDVPSHPQDPQGPSLEWLK	Colon cancer	Colon cancer	Colon	SPENT001430	SPENG001666	HSALNG0127466		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018285	SPENO004370	
SPENP008706	ARDMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	-0.0541	Others	-0.2393	0.8169	0.9603	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018286	SPENO005858	Colon cancer:SPENP014616,SPENP016292,SPENP026702;Lung cancer:SPENP002874
SPENP008709	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018294	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP008712	EAQVQYPLQTFAIGMEDSPDLLAAR	Colon cancer	Colon cancer	Colon	SPENT005929,SPENT002838	SPENG001292	AC079781.5		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018303	SPENO002624,SPENO003829	
SPENP008714	HRMDACCCSVGAAWGTEECEECPMR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018299	SPENO000957	Colon cancer:SPENP011042,SPENP016317,SPENP011041;Lung cancer:SPENP004655
SPENP008725	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-1.802	Others	-3.194	0.0109	0.2633	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018306	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584
SPENP008728	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018314	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP008729	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.9323	Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018313	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP024310
SPENP008730	ACEDIDECSLPNICVFGTCHNLPGLFR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758	0.0819	Others	0.2843	0.7811	0.9502	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018312	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP008740	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018326	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367
SPENP008743	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon	SPENT005913	SPENG001766	AL662884.2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018327	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP000598
SPENP008745	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.1553	Others	-0.3659	0.727	0.9197	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018332	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP008747	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon	SPENT005913	SPENG001766	AL662884.2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018336	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP016368,SPENP014668
SPENP008750	ASADELTFHEFEEATNLLADTPDAATTSR	Colon cancer	Colon cancer	Colon	SPENT001420	SPENG000627	lnc-TMED1-2	-0.0238	Others	-0.106	0.9223	0.9957	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018331	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP011104
SPENP008755	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.1916	Others	1.8643	0.09	0.433	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018339	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP008757	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018337	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611
SPENP008758	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.6604	Others	2.2223	0.0546	0.3663	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018345	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770
SPENP008765	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Non-validated			Immunogenic	SPENM018352	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP000622
SPENP008769	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758	0.3454	Others	0.9295	0.3674	0.7177	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018354	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP011193,SPENP014722,SPENP011194,SPENP016417;Lung cancer:SPENP002996
SPENP008770	ATPYNYPVPVRDDGNMPDVPSHPQDPQGPSLEWLK	Colon cancer	Colon cancer	Colon	SPENT001430	SPENG001666	HSALNG0127466	-1.472	Others	-3.599	0.0156	0.2858	PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018355	SPENO004370	Lung cancer:SPENP002997
SPENP008771	EATPENDPNYFMNEPTFYTSDGVPFTAADPDYQEK	Colon cancer	Colon cancer	Colon	SPENT000390	SPENG002704	lnc-TRIM16L-2		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018356	SPENO003522	Anal canal cancer:SPENP024969;Colon cancer:SPENP007502,SPENP006777,SPENP000627
SPENP008772	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018358	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198
SPENP008773	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018357	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP008774	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Colon	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD006776	Proteome Profiling Identifies Markers for Inflammation-Related Tumor-Fibroblast Interaction in Colorectal Cancer	Q Exactive	Label free	29176937	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018359	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP008819	VMVQPINLIFR	Breast cancer	Breast cancer	Breast epithelium	SPENT002273,SPENT002272,SPENT002270,SPENT002271,SPENT002267,SPENT002269,SPENT002268	SPENG003098,SPENG003309,SPENG003607,SPENG001915,SPENG000941,SPENG003601,SPENG000906	lnc-ID2-3,lnc-ZC3H12D-15,HSALNG0054220,HSALNG0012839,lnc-FABP6-3,HSALNG0046238,lnc-GLDC-5	0.0256	Others	0.0338	0.9739	0.9975	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000578	SPENO000391,SPENO001158,SPENO001668,SPENO002054,SPENO002219,SPENO003493,SPENO004771	Liver cancer:SPENP004794;Kidney cancer:SPENP014910;Tongue cancer:SPENP028143;Lung cancer:SPENP026626;Prostate cancer:SPENP012898
SPENP008837	LTSDLTFAYER	Breast cancer	Breast cancer	Breast epithelium	SPENT001450,SPENT002601,SPENT002602	SPENG000375	lnc-CELF6-1	1.3335	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000585	SPENO002631,SPENO003868,SPENO005694	Breast cancer:SPENP022421,SPENP022420;Colon cancer:SPENP006919
SPENP008838	LGELPSWILMR	Breast cancer	Breast cancer	Breast epithelium	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000588	SPENO004812,SPENO005239	Breast cancer:SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP008840	MMLMSTATAFYR	Breast cancer	Breast cancer	Breast epithelium	SPENT000416,SPENT001710,SPENT001709	SPENG000832	NONHSAG010597.2		Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000597	SPENO002231,SPENO002917,SPENO003714	Anal canal cancer:SPENP024571;Lung cancer:SPENP003993;Kidney cancer:SPENP014943
SPENP008844	GQAGVMGFPGPK	Breast cancer	Breast cancer	Breast epithelium	SPENT005758	SPENG002845	COL1A1	-1.03	Others	-1.713	0.095	0.6588	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000598	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP008847	YQLDPTASISAK	Breast cancer	Breast cancer	Breast epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000603	SPENO000884	Breast cancer:SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP008849	TQVVAGTNYYIK	Breast cancer	Breast cancer	Breast epithelium	SPENT002285	SPENG002633	HSALNG0028487		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000592	SPENO000213	Breast cancer:SPENP023317;Colon cancer:SPENP029452;Liver cancer:SPENP004809
SPENP008856	VVLDDKDYFLFR	Breast cancer	Breast cancer	Breast epithelium	SPENT000668,SPENT000737,SPENT000738,SPENT000740,SPENT000736,SPENT000739,SPENT000735,SPENT000741	SPENG001548,SPENG001699,SPENG001263,SPENG000451,SPENG001761,SPENG001842,SPENG002051	HSALNG0093536,lnc-ETNK2-4,lnc-GNPTAB-1,lnc-ARL4C-4,HSALNG0021384,HSALNG0009837,lnc-PABPC4-7	0.4415	Others	0.8628	0.3949	0.7216	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000594	SPENO000488,SPENO001622,SPENO002018,SPENO002762,SPENO004177,SPENO004759,SPENO004760,SPENO005600	Thyroid cancer:SPENP012309,SPENP012308;Gastric cancer:SPENP003148;Lung cancer:SPENP001845;Colon cancer:SPENP001551
SPENP008864	YAMVYGYNAAYNR	Breast cancer	Breast cancer	Breast epithelium	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	-2.62	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000618	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP008868	YEEIIKEVSTYIK	Breast cancer	Breast cancer	Breast epithelium	SPENT002126	SPENG003586	lnc-FOXL2NB-4		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000615	SPENO001634	Skin cancer:SPENP025217;Kidney cancer:SPENP020227;Bile duct cancer:SPENP013410;Anal canal cancer:SPENP024645
SPENP008871	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Breast epithelium	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.6028	Others	-1.685	0.1141	0.6588	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000626	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP008873	SGTLYSLTLYGLR	Breast cancer	Breast cancer	Breast epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000623	SPENO002584,SPENO006142	Breast cancer:SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP008874	ELSELVYTDVLDR	Breast cancer	Breast cancer	Breast epithelium	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1	1.4608	Others	1.9771	0.0794	0.6588	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000613	SPENO002416,SPENO005649	Ovary cancer:SPENP029484;Colon cancer:SPENP026279,SPENP007120;Lung cancer:SPENP001862,SPENP026506
SPENP008879	MSLYLSIHLFNTK	Breast cancer	Breast cancer	Breast epithelium	SPENT003073,SPENT003072,SPENT003074,SPENT003076,SPENT003075	SPENG000059	NONHSAG017108.2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000632	SPENO002437,SPENO003578,SPENO004756,SPENO005045,SPENO005384	
SPENP008886	VTDATETTITISWR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.8273	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000636	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP008889	NSNILIADWVLILR	Breast cancer	Breast cancer	Breast epithelium	SPENT003085,SPENT003081,SPENT003084,SPENT003090,SPENT003083,SPENT003086,SPENT003087,SPENT003089,SPENT003082,SPENT003088	SPENG000164,SPENG003241	HSALNG0112047,LINC00922	0.35	Others	0.3385	0.7488	0.8787	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000649	SPENO000648,SPENO000750,SPENO001270,SPENO002362,SPENO002474,SPENO003373,SPENO004810,SPENO005609,SPENO005695,SPENO005943	
SPENP008891	VLQATVVAVGSGSK	Breast cancer	Breast cancer	Breast epithelium	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4	1.6161	Others	0.9147	0.3713	0.7216	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000645	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP008897	VLLESEQFLTELTR	Breast cancer	Breast cancer	Breast epithelium	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000637	SPENO000598,SPENO003633	Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP008901	GPVYIGELPQDFLR	Breast cancer	Breast cancer	Breast epithelium	SPENT000947,SPENT000946	SPENG002912	lnc-MOB2-2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000651	SPENO000523,SPENO003769	Gastric cancer:SPENP009539;Bladder cancer:SPENP011475;Lung cancer:SPENP001878
SPENP008903	LILYGSLSEVSPMIR	Breast cancer	Breast cancer	Breast epithelium	SPENT005817	SPENG003872	MN309077		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000661	SPENO004083	
SPENP008905	TQFLPPNLLALFAPR	Breast cancer	Breast cancer	Breast epithelium	SPENT000899	SPENG001988	NONHSAG026220.2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000663	SPENO004425	Tongue cancer:SPENP028110
SPENP008909	FTDLLFSQNFINLSR	Breast cancer	Breast cancer	Breast epithelium	SPENT003096	SPENG001900	HSALNG0058054		Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000667	SPENO004711	
SPENP008910	IPAFLNVVDIAGLVK	Breast cancer	Breast cancer	Breast epithelium	SPENT002261	SPENG002542	lnc-NDUFA6-1	0.4948	Others	1.0562	0.2969	0.6963	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000664	SPENO005863	Colon cancer:SPENP012810;Lung cancer:SPENP026556;Prostate cancer:SPENP012998
SPENP008913	MLITILGTVKPNANR	Breast cancer	Breast cancer	Breast epithelium	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	0.5421	Others	1.3048	0.2026	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000660	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP008914	GNEFLFSHLWPLIEK	Breast cancer	Breast cancer	Breast epithelium	SPENT002175	SPENG000523	NONHSAG026963.2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000668	SPENO003701	Breast cancer:SPENP022826,SPENP022827;Lung cancer:SPENP028280;Kidney cancer:SPENP015069;Prostate cancer:SPENP023684
SPENP008932	YFLVFGNVCVLPTSWR	Breast cancer	Breast cancer	Breast epithelium	SPENT003099,SPENT003100	SPENG000605,SPENG003268	HSALNG0018113,lnc-SLC35F5-4	1.0625	Others	1.0173	0.3177	0.6963	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000683	SPENO002503,SPENO003626	Bladder cancer:SPENP017660
SPENP008940	AELTALESLIEMGFPR	Breast cancer	Breast cancer	Breast epithelium	SPENT002411,SPENT002410	SPENG000362	lnc-LBHD1-2	1.821	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000693	SPENO001893,SPENO004906	Breast cancer:SPENP005736,SPENP005734,SPENP005735,SPENP005737,SPENP005738;Liver cancer:SPENP000705
SPENP008941	GTGLDEAMEWLVETLK	Breast cancer	Breast cancer	Breast epithelium	SPENT003106,SPENT003105,SPENT003104	SPENG001388,SPENG002402	HSALNG0093495,NONHSAG012072.2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000695	SPENO001292,SPENO002789,SPENO002969	Lung cancer:SPENP026547;Liver cancer:SPENP000716
SPENP008943	AAGVNVEPFWPGLFAK	Breast cancer	Breast cancer	Breast epithelium	SPENT000958,SPENT000959,SPENT000956,SPENT000957	SPENG002082,SPENG000412,SPENG001664,SPENG001785	NONHSAG017284.2,HSALNG0011930,lnc-GREM2-13,lnc-EVX2-8	0.1973	Others	0.3009	0.766	0.8787	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000694	SPENO002111,SPENO003329,SPENO004329,SPENO006018	Prostate cancer:SPENP009247,SPENP023710;Lung cancer:SPENP026477,SPENP001909;Liver cancer:SPENP004882
SPENP008950	QLLDQVEQIQKEQDYQR	Breast cancer	Breast cancer	Breast epithelium	SPENT002330	SPENG003513	lnc-DDX56-1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000707	SPENO004588	
SPENP008956	MSNRYPEVELLIYMHPK	Breast cancer	Breast cancer	Breast epithelium	SPENT003108	SPENG001498	lnc-CADM1-4	-0.3367	Others	-0.5136	0.6294	0.834	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000698	SPENO001959	
SPENP008957	TPIGSFLGSLSLLPATK	Breast cancer	Breast cancer	Breast epithelium	SPENT000014	SPENG003410	ACAT1	0.0957	Others	0.3346	0.7398	0.8787	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000704	SPENO003940	Breast cancer:SPENP022961,SPENP022960;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP008959	TLSDYNIQKESTLHLVLR	Breast cancer	Breast cancer	Breast epithelium	SPENT002337,SPENT002335	SPENG001112	lnc-CDH8-4	-2.521	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000724	SPENO004206,SPENO005136	Prostate cancer:SPENP013045
SPENP008961	GETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Breast epithelium	SPENT005758	SPENG002845	COL1A1	-0.4471	Others	-0.8612	0.3948	0.7216	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000719	SPENO004941	Breast cancer:SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP008965	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Breast epithelium	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.8499	Others	-1.478	0.1499	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000721	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP008975	QALNLPDVFGLVVLPLELK	Breast cancer	Breast cancer	Breast epithelium	SPENT001218	SPENG003441	NONHSAG033755.2		Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000727	SPENO005358	Colon cancer:SPENP016179;Lung cancer:SPENP025980,SPENP002749;Kidney cancer:SPENP020505
SPENP008979	VQASLAANTFTITGHTEAK	Breast cancer	Breast cancer	Breast epithelium	SPENT005801	SPENG002115	AL136361.1	0.007	Others	0.022	0.9844	0.9975	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000731	SPENO005109	Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP008981	FFDHSGTLVMDAYEPEISR	Breast cancer	Breast cancer	Breast epithelium	SPENT002510,SPENT002512,SPENT002511	SPENG003726,SPENG002325,SPENG000279	HSALNG0002035,lnc-EYA3-2,HSALNG0085740		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000729	SPENO000773,SPENO002918,SPENO004290	Colon cancer:SPENP006671;Kidney cancer:SPENP015159
SPENP008988	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Breast epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.5387	Others	1.1361	0.2649	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000749	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP008989	VHLDIQVGEHANNYPEIAAK	Breast cancer	Breast cancer	Breast epithelium	SPENT002330	SPENG003513	lnc-DDX56-1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000740	SPENO004588	
SPENP008993	GLAFIQDPDGYWIEILNPNK	Breast cancer	Breast cancer	Breast epithelium	SPENT000966	SPENG003502	HSALNG0049885	-0.7314	Others	-1.676	0.111	0.6588	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000745	SPENO001520	Lung cancer:SPENP001951
SPENP008997	ISQAEEEDQQLLGHLLLVAK	Breast cancer	Breast cancer	Breast epithelium	SPENT002815	SPENG000837	lnc-HINT2-1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000738	SPENO001580	Skin cancer:SPENP025405;Bladder cancer:SPENP028609;Lung cancer:SPENP028299,SPENP007835;Prostate cancer:SPENP023755;Colon cancer:SPENP012845
SPENP009003	ADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Breast epithelium	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000762	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP009004	HRPRPYPPNVGEEIQIGHIPR	Breast cancer	Breast cancer	Breast epithelium	SPENT005757	SPENG000084	FN1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000754	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP009014	DMDLTEVITGTLWNLSSHDSIK	Breast cancer	Breast cancer	Breast epithelium	SPENT005788	SPENG002233	AP001931.2	0.5282	Others	0.3617	0.723	0.8787	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000769	SPENO005858	Breast cancer:SPENP023114,SPENP023115;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP009020	AGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Breast epithelium	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1	-1.347	Others	-1.413	0.173	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000768	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006047,SPENP006044,SPENP006046,SPENP006045;Ovary cancer:SPENP011850;Lung cancer:SPENP001961
SPENP009022	SGDRGETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Breast epithelium	SPENT005758	SPENG002845	COL1A1	-0.8149	Others	-1.275	0.2083	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000772	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP009023	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.705	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000770	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP009029	LQAMWGQSLLPPVSTSFTTGGLR	Breast cancer	Breast cancer	Breast epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.7622	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000783	SPENO002584,SPENO006142	Thyroid cancer:SPENP012626,SPENP012627;Bladder cancer:SPENP017847;Kidney cancer:SPENP020599;Lung cancer:SPENP002859;Colon cancer:SPENP014588,SPENP016279
SPENP009030	KAGTELVNFLSYFVELGTQPATQ	Breast cancer	Breast cancer	Breast epithelium	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1	-1.308	Others	-1.788	0.1338	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000780	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006066,SPENP006067,SPENP006064,SPENP006068,SPENP006065;Ovary cancer:SPENP011852
SPENP009031	QGLYELSASNFELHVAQGDHFIK	Breast cancer	Breast cancer	Breast epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2	1.7458	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000782	SPENO005833	Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP009033	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1716	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000781	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP009034	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	4.2868	Others	1.1592	0.2645	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000789	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP009036	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.052	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000793	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP009038	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6177	Others	0.8855	0.389	0.7216	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000790	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP009039	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3466	Others	0.7777	0.4518	0.7303	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000788	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP009044	LHLEGYHGTAGDSMSYHSGSVFSAR	Breast cancer	Breast cancer	Breast epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000796	SPENO002584,SPENO006142	Thyroid cancer:SPENP012644,SPENP012645;Bladder cancer:SPENP017892;Gastric cancer:SPENP003348;Lung cancer:SPENP002891;Colon cancer:SPENP016316,SPENP027069
SPENP009047	KGISLNPEQWSQLKEQISDIDDAVR	Breast cancer	Breast cancer	Breast epithelium	SPENT000973,SPENT000974,SPENT000972,SPENT000975,SPENT000971	SPENG000628,SPENG001266	HSALNG0041010,NONHSAG040140.2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000798	SPENO002730,SPENO003256,SPENO003407,SPENO003661,SPENO004705	
SPENP009050	DLFAEGLLEFLRPAVQQLDSHVHAVR	Breast cancer	Breast cancer	Breast epithelium	SPENT003119	SPENG001279	HSALNG0007329		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000806	SPENO005841	
SPENP009052	LTGPGLSEGPEPSISVMVTGGPWPTR	Breast cancer	Breast cancer	Breast epithelium	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000803	SPENO002416,SPENO005649	Lung cancer:SPENP001973
SPENP009054	DFPGIYTTINAHQWSETVQPIMEALR	Breast cancer	Breast cancer	Breast epithelium	SPENT002389	SPENG001521	NONHSAG030895.2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000805	SPENO001286	
SPENP009055	SVHPYEVAEVIALPVEQGNFPYLQWVR	Breast cancer	Breast cancer	Breast epithelium	SPENT000978	SPENG002106	lnc-DAXX-2	-1.233	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000807	SPENO003629	Lung cancer:SPENP001979
SPENP009056	VIGEPTSLMDVFPTVVQLVGGEVPQDR	Breast cancer	Breast cancer	Breast epithelium	SPENT003120	SPENG003604	lnc-USP9Y-2		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000810	SPENO005181	
SPENP009057	IVAFADAAVEPIDFPIAPVYAASMVLK	Breast cancer	Breast cancer	Breast epithelium	SPENT000014	SPENG003410	ACAT1	-2.056	Others	-1.509	0.1698	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000808	SPENO003940	Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP009058	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.4903	Others	1.1983	0.2405	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000809	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP009059	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Breast cancer	Breast cancer	Breast epithelium	SPENT005913	SPENG001766	AL662884.2	-2.232	Others	-1.625	0.2027	0.6599	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000813	SPENO002584	Breast cancer:SPENP023189,SPENP023188;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP009060	STNLLAAETASLEEQLQGWGEVMLMADK	Breast cancer	Breast cancer	Breast epithelium	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	-0.4735	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000814	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP009061	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6859	Others	0.7529	0.4731	0.7484	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000812	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP009063	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Breast cancer	Breast cancer	Breast epithelium	SPENT005913	SPENG001766	AL662884.2	-1.872	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Non-validated			Immunogenic	SPENM000816	SPENO002584	Breast cancer:SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP009064	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.282	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000818	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP009065	QLLSNPEMMVQIMENPFVQSMLSNPDLMR	Breast cancer	Breast cancer	Breast epithelium	SPENT003031	SPENG003422	lnc-GKAP1-1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	MS	28137767	Immunogenic	SPENM000819	SPENO004026	
SPENP009066	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Breast epithelium	SPENT005757,SPENT005755	SPENG000084	FN1	0.532	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000817	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP009067	IPDRPYSLFEGMAGAIHFLSDVLGPETSR	Breast cancer	Breast cancer	Breast epithelium	SPENT003121	SPENG002658	HSALNG0058183		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000815	SPENO000163	
SPENP009069	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Breast epithelium	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000820	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP009073	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Breast epithelium	SPENT005757,SPENT005755	SPENG000084	FN1	1.0438	Others	0.6722	0.5142	0.7786	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000824	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP009076	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000825	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP016392,SPENP027468
SPENP009078	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000829	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP009079	YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.1218	Others				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000831	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016675;Colon cancer:SPENP027469,SPENP014701;Lung cancer:SPENP004715,SPENP002976
SPENP009082	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Breast cancer	Breast cancer	Breast epithelium	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	0.1562	Others	0.2624	0.7962	0.8884	PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000832	SPENO000819,SPENO002753	Breast cancer:SPENP023209,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP009093	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Breast epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD007088	Proteomic profiles of FFPE breast normal and tumor tissue	Q Exactive	Spectrum counting	32663359	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000845	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP009099	VSPHSGVVALTKPVPEPR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005785	SPENG001958	FBLN1		Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013706	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP009150	GSYPWQVSLK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003153,SPENT003151,SPENT003150,SPENT003152	SPENG000186	lnc-CYB5R2-1	-0.0836	Others	-0.095	0.928	0.9644	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013561	SPENO001632,SPENO001850,SPENO004682,SPENO005981	
SPENP009171	QLLDQVEQIQK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT002330	SPENG003513	lnc-DDX56-1		Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013581	SPENO004588	Lung cancer:SPENP026594
SPENP009173	TLMNLGGLAVAR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT001451	SPENG001511	HSALNG0007796	0.0614	Others	0.1619	0.8778	0.9642	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	MS	28137767	Immunogenic	SPENM013618	SPENO005561	Thyroid cancer:SPENP012332,SPENP012333;Gastric cancer:SPENP003136
SPENP009175	MLSSLYLNSQPK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003168	SPENG001106	HSALNG0020616	-0.2907	Others	-0.3994	0.7015	0.9642	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013615	SPENO002573	
SPENP009178	MLAVLGTPMWKK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT001788	SPENG002226	LINC01979	0.4859	Others	1.2953	0.2363	0.764	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	MS	31340039	Immunogenic	SPENM013622	SPENO004365	
SPENP009181	KYNPTWHCIVGR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005960	SPENG003857	DYNLL1		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	MS	28137767	Immunogenic	SPENM013608	SPENO000943	
SPENP009217	MEQMMIHKTVMMKK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003172	SPENG002387	NONHSAG011391.2		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013649	SPENO004611	
SPENP009221	TQSSLVPALTDFVR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2	-0.4191	Others	-1.276	0.2425	0.764	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	MS	28137767	Immunogenic	SPENM013640	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Colon cancer:SPENP024050,SPENP012789
SPENP009224	QYNVGPSVSKYPLR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8467	Others	2.1647	0.0671	0.7445	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013644	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP009230	MLITILGTVKPNANR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013659	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP009234	VLFGCVLYWDTVRGK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003180	SPENG001801	AC106799.2	0.2459	Others	0.4202	0.6915	0.9642	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013668	SPENO005953	Breast cancer:SPENP022789,SPENP022788;Bladder cancer:SPENP011505;Lung cancer:SPENP026135;Colon cancer:SPENP010492,SPENP000334,SPENP010491
SPENP009247	AAGVNVEPFWPGLFAK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT000958,SPENT000959,SPENT000956,SPENT000957	SPENG002082,SPENG000412,SPENG001664,SPENG001785	NONHSAG017284.2,HSALNG0011930,lnc-GREM2-13,lnc-EVX2-8	-0.0144	Others	-0.0167	0.9872	0.9872	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	MS	28137767	Immunogenic	SPENM013676	SPENO002111,SPENO003329,SPENO004329,SPENO006018	Breast cancer:SPENP008943;Prostate cancer:SPENP023710;Lung cancer:SPENP026477,SPENP001909;Liver cancer:SPENP004882
SPENP009261	LCVGNMVIQIITGGSMK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003187,SPENT003185,SPENT003188,SPENT003190,SPENT003186,SPENT003189	SPENG000286,SPENG000065,SPENG000712	AC010105.1,lnc-SUCLG1-3,HSALNG0016352	0.878	Others	1.484	0.1883	0.7445	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013700	SPENO001058,SPENO001309,SPENO002159,SPENO003562,SPENO005141,SPENO005302	
SPENP009275	DQCIVDDITYNVNDTFHK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028500;Tongue cancer:SPENP027585;Gastric cancer:SPENP009622,SPENP015378
SPENP009279	ACLDYPVTSVLPPASLCK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT002507	SPENG002379	NONHSAG033050.2	0.9418	Others	1.43	0.2027	0.7445	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	MS	28137767	Immunogenic	SPENM013704	SPENO004482	Lung cancer:SPENP025512,SPENP028228;Colon cancer:SPENP007326,SPENP006646;Bladder cancer:SPENP017716,SPENP011635,SPENP028438
SPENP009281	DSIVQLCTARPERPMAFLR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003129	SPENG002251	HSALNG0118372		Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013714	SPENO004510	
SPENP009283	DQCIVDDITYNVNDTFHKR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-1.082	Others	-1.783	0.1249	0.7445	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013720	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410	Gastric cancer:SPENP009643
SPENP009284	FLEYNYINTVYQNMCAVDR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003195	SPENG002257	HSALNG0035167		Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013712	SPENO005413	
SPENP009286	RPHETGGYMLECVCLGNGK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.5393	Others	-1.404	0.2031	0.7445	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013717	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP009297	HRPRPYPPNVGEEIQIGHIPR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005757	SPENG000084	FN1	-1.474	Others	-1.968	0.1061	0.7445	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013731	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP009298	TNTNVNCPIECFMPLDVQADR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.3414	Others	0.7296	0.4968	0.8943	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013729	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP009301	TETITGFQVDAVPANGQTPIQR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3778	Others	0.5843	0.5803	0.9213	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013734	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP009302	DTLTSRPAQGVVTTLENVSPPR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0266	Others	-0.0566	0.9567	0.9644	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013736	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP009303	MQTGRDMSLLLLSVFPPSLGLH	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003203,SPENT003204	SPENG000278	HSALNG0046801	-2.37	Others	-0.8905	0.4388	0.8506	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013737	SPENO004014,SPENO005558	
SPENP009308	CDPHEATCYDDGKTYHVGEQWQK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4279	Others	1.0943	0.31	0.7855	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP018487;Colon cancer:SPENP021672
SPENP009309	HICGGSIVSPQWVITAAHCIANR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003153,SPENT003151,SPENT003150,SPENT003152	SPENG000186	lnc-CYB5R2-1		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013740	SPENO001632,SPENO001850,SPENO004682,SPENO005981	
SPENP009310	DTLTSRPAQGVVTTLENVSPPRR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.224	Others	-0.4587	0.6604	0.9642	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013741	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP009312	STATISGLKPGVDYTITVYAVTGR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013744	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP009314	TKTETITGFQVDAVPANGQTPIQR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0306	Others	0.0833	0.9366	0.9644	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013748	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP009317	QKHICGGSIVSPQWVITAAHCIANR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT003153,SPENT003151,SPENT003150,SPENT003152	SPENG000186	lnc-CYB5R2-1		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Non-validated			Immunogenic	SPENM013752	SPENO001632,SPENO001850,SPENO004682,SPENO005981	
SPENP009320	TNTNVNCPIECFMPLDVQADREDSR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.1372	Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013750	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245	Tongue cancer:SPENP028104;Gastric cancer:SPENP009699
SPENP009325	GGNSNGALCHFPFLYNNHNYTDCTSEGRR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013758	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410	
SPENP009326	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005757,SPENT005755	SPENG000084	FN1	-2.154	Others	-2.771	0.0324	0.6808	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013759	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP009327	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013761	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP009328	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013760	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP009329	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Prostate cancer	Prostate adenocarcinoma	Seminal plasma	SPENT005757,SPENT005755	SPENG000084	FN1	-1.351	Others	-3.564	0.0092	0.2887	PXD007657	Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients	LTQ Orbitrap	Label free	31249104	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013762	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP009460	YMDGMTVGVVR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005796	SPENG001958	FBLN1	0.191	Others	0.5131	0.6236	0.7251	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009139	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP009474	GQAGVMGFPGPK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005758	SPENG002845	COL1A1	1.1844	Others	2.172	0.055	0.1316	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009163	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP009493	LVILANNCPALR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009170	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP009496	NALDPMSVLLAR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT002530,SPENT002607,SPENT002606	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5	-0.1934	Others	-0.5187	0.6261	0.7251	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	MS	28137767	Immunogenic	SPENM009173	SPENO001285,SPENO003025,SPENO003487	Breast cancer:SPENP023318;Bladder cancer:SPENP028687;Colon cancer:SPENP007011,SPENP000193
SPENP009513	GNSIIMLEALERV	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Non-validated			Immunogenic	SPENM009210	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP009528	VTDATETTITISWR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6386	Others	2.7268	0.0378	0.1137	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009223	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP009529	VLLESEQFLTELTR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3	-0.9439	Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009241	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP009539	GPVYIGELPQDFLR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000947,SPENT000946	SPENG002912	lnc-MOB2-2		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009226	SPENO000523,SPENO003769	Breast cancer:SPENP008901;Bladder cancer:SPENP011475;Lung cancer:SPENP001878
SPENP009568	MLITILGTVKPNANR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	0.8147	Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009265	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP009570	VEDLTFTSPFCLQVK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000235	SPENG001145	NONHSAG026259.2		Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	MS	28137767	Immunogenic	SPENM009264	SPENO000998	
SPENP009622	DQCIVDDITYNVNDTFHK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.7259	Others	6.3025	0.0002	0.0578	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009333	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028500;Tongue cancer:SPENP027585;Gastric cancer:SPENP015378;Prostate cancer:SPENP009275
SPENP009632	FGDFDIEDSDSCHFNYLR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT003205	SPENG003065	lnc-CPOX-3		Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009325	SPENO005478	
SPENP009636	GETGPAGPAGPVGPVGAR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005758	SPENG002845	COL1A1	1.5198	Others	3.1898	0.0097	0.072	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009316	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP009642	RPHETGGYMLECVCLGNGK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.6207	Others	1.3279	0.2259	0.3585	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009343	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP009643	DQCIVDDITYNVNDTFHKR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009337	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410	Prostate cancer:SPENP009283
SPENP009657	ALAPTWEQLALGLEHSETVK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.2769	Others	-0.7348	0.4794	0.5998	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Non-validated			Immunogenic	SPENM009346	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP009661	ADRDESSPYAAMLAAQDVAQR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009356	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP009662	HRPRPYPPNVGEEIQIGHIPR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005757	SPENG000084	FN1		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009355	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP009663	TNTNVNCPIECFMPLDVQADR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	1.2395	Others	3.1318	0.0107	0.072	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009360	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP009671	DTLTSRPAQGVVTTLENVSPPR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.0258	Others	1.0435	0.324	0.4384	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009364	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP009676	TETITGFQVDAVPANGQTPIQR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3979	Others	3.4406	0.0063	0.072	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009371	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP009677	QGLYELSASNFELHVAQGDHFIK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Non-validated			Immunogenic	SPENM009377	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP009679	CDPHEATCYDDGKTYHVGEQWQK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.4778	Others	1.8514	0.1211	0.2394	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009378	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP009687	TKTETITGFQVDAVPANGQTPIQR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2332	Others	2.3527	0.0405	0.1137	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009385	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP009691	AAQAQGQSCEYSLMVGYQCGQVFR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.5073	Others	-1.1	0.3	0.4312	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM009387	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP009695	NSITLTNLTPGTEYVVSIVALNGR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6074	Others	2.4513	0.044	0.1166	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009386	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP009697	DLEVVAATPTSLLISWDAPAVTVR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.3437	Others	2.6783	0.0232	0.0915	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009389	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP009699	TNTNVNCPIECFMPLDVQADREDSR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009393	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245	Tongue cancer:SPENP028104;Prostate cancer:SPENP009320
SPENP009703	TNTNVNCPIECFMPLDVQADREDSRE	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	1.3231	Others	2.6156	0.0427	0.1161	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009400	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP009706	TGLDSPTGIDFSDITANSFTVHWIAPR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6768	Others				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009402	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP009713	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009408	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP009714	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.1784	Others	0.6155	0.552	0.6576	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009410	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP009715	CDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.4975	Others	6.1447	0.0687	0.1514	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009409	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Gastric cancer:SPENP015467;Tongue cancer:SPENP027542;Colon cancer:SPENP026725;Leukemia:SPENP001397
SPENP009717	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.1056	Others	-0.1983	0.8468	0.8898	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009412	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP009722	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.666	Others	1.1941	0.2984	0.4312	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009418	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP009723	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-1.321	Others	-1.538	0.1627	0.2906	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009417	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP009724	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3821	Others	2.5051	0.0521	0.1272	PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009420	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP009725	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Gastric cancer	Gastric adenocarcinoma	Myofibroblast	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD008104	Secretomes of Cancer-Associated Myofibroblasts and Normal Tissue Myofibroblasts in hypoxia and normoxia C4PR_LIV	Q Exactive	MS1 intensity based label-free quantification method	30813438	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009421	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP010023	YMDGMTVGVVR	Colon cancer	Colon cancer	Liver	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012969	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP010024	YMDGMTVGVVR	Colon cancer	Colon cancer	Colon	SPENT005796	SPENG001958	FBLN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012969	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP000145,SPENP015753
SPENP010027	SEIEYYAMLAK	Colon cancer	Colon cancer	Liver	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012946	SPENO000929	Breast cancer:SPENP022399,SPENP022398;Colon cancer:SPENP008174,SPENP010028;Bladder cancer:SPENP028732;Skin cancer:SPENP025097
SPENP010028	SEIEYYAMLAK	Colon cancer	Colon cancer	Colon	SPENT000907	SPENG001277	HSALNG0067186		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012946	SPENO000929	Breast cancer:SPENP022399,SPENP022398;Colon cancer:SPENP010027,SPENP008174;Bladder cancer:SPENP028732;Skin cancer:SPENP025097
SPENP010047	LGELPSWILMR	Colon cancer	Colon cancer	Liver	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.3566	Others	-0.7975	0.4309	0.5628	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012921	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP010048	LGELPSWILMR	Colon cancer	Colon cancer	Colon	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.8695	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012921	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393
SPENP010061	TDSTFNQVVLK	Colon cancer	Colon cancer	Liver	SPENT002071	SPENG001428	lnc-CPHXL-5		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012936	SPENO004801	Bladder cancer:SPENP017275;Kidney cancer:SPENP019976;Anal canal cancer:SPENP024517;Lung cancer:SPENP026072;Colon cancer:SPENP006972,SPENP010062
SPENP010062	TDSTFNQVVLK	Colon cancer	Colon cancer	Colon	SPENT002071	SPENG001428	lnc-CPHXL-5	0.3778	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012936	SPENO004801	Bladder cancer:SPENP017275;Kidney cancer:SPENP019976;Anal canal cancer:SPENP024517;Lung cancer:SPENP026072;Colon cancer:SPENP006972,SPENP010061
SPENP010063	LLTGVEYVVGR	Colon cancer	Colon cancer	Liver	SPENT002604,SPENT002603	SPENG002156,SPENG002677	NONHSAG050708.2,lnc-CALB1-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012953	SPENO000857,SPENO005705	
SPENP010064	LLTGVEYVVGR	Colon cancer	Colon cancer	Colon	SPENT002604,SPENT002603	SPENG002156,SPENG002677	NONHSAG050708.2,lnc-CALB1-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012953	SPENO000857,SPENO005705	
SPENP010065	TAVAHRPGAFK	Colon cancer	Colon cancer	Liver	SPENT000153	SPENG003407	NONHSAG024537.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012934	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP023922
SPENP010066	TAVAHRPGAFK	Colon cancer	Colon cancer	Colon	SPENT000153	SPENG003407	NONHSAG024537.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012934	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP010085	MSLPTLFHIIR	Colon cancer	Colon cancer	Liver	SPENT003251	SPENG002130	HSALNG0094307		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012945	SPENO004061	
SPENP010086	MSLPTLFHIIR	Colon cancer	Colon cancer	Colon	SPENT003251	SPENG002130	HSALNG0094307		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012945	SPENO004061	
SPENP010115	DKLNNLVLFDK	Colon cancer	Colon cancer	Liver	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	0.1458	Others	0.3712	0.7233	0.8009	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012966	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP010116	DKLNNLVLFDK	Colon cancer	Colon cancer	Colon	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012966	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP010137	GQAGVMGFPGPK	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	1.9792	Others	1.5904	0.1462	0.2849	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012993	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP023956
SPENP010138	GQAGVMGFPGPK	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.7373	Others	-1.113	0.3164	0.4662	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012993	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010137,SPENP023956
SPENP010145	TDSTFNQVVLKR	Colon cancer	Colon cancer	Liver	SPENT002071	SPENG001428	lnc-CPHXL-5		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012998	SPENO004801	
SPENP010146	TDSTFNQVVLKR	Colon cancer	Colon cancer	Colon	SPENT002071	SPENG001428	lnc-CPHXL-5		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012998	SPENO004801	
SPENP010163	KSEIEYYAMLAK	Colon cancer	Colon cancer	Liver	SPENT000907	SPENG001277	HSALNG0067186	0.6214	Others	2.6528	0.0123	0.0492	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013026	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010164,SPENP008226
SPENP010164	KSEIEYYAMLAK	Colon cancer	Colon cancer	Colon	SPENT000907	SPENG001277	HSALNG0067186		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013026	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP008226
SPENP010167	LVILANNCPALR	Colon cancer	Colon cancer	Liver	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.783	Others	2.4968	0.0218	0.0775	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013027	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP008202
SPENP010168	LVILANNCPALR	Colon cancer	Colon cancer	Colon	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.1632	Others	0.3977	0.7027	0.7854	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013027	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010167,SPENP008202
SPENP010169	NQSLIPLLLEAR	Colon cancer	Colon cancer	Liver	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012979	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010170,SPENP000179,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP010170	NQSLIPLLLEAR	Colon cancer	Colon cancer	Colon	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM012979	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP000179,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP010185	GILLFGPPGTGK	Colon cancer	Colon cancer	Liver	SPENT000721	SPENG000438	lnc-KDSR-3	1.1361	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013008	SPENO005169	
SPENP010186	GILLFGPPGTGK	Colon cancer	Colon cancer	Colon	SPENT000721	SPENG000438	lnc-KDSR-3	-0.252	Others	-1.465	0.217	0.3696	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013008	SPENO005169	
SPENP010197	YQLDPTASISAK	Colon cancer	Colon cancer	Liver	SPENT000102	SPENG002045	lnc-ACTR2-11	0.6613	Others	1.9772	0.0583	0.1543	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013000	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP010198	YQLDPTASISAK	Colon cancer	Colon cancer	Colon	SPENT000102	SPENG002045	lnc-ACTR2-11	0.0867	Others	0.2242	0.857	0.9103	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013000	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP010199	VPFLVLECPNLK	Colon cancer	Colon cancer	Liver	SPENT000354	SPENG002378	HSALNG0036293	0.1601	Others	0.8464	0.4026	0.5337	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012997	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP010200	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon	SPENT000354	SPENG002378	HSALNG0036293	0.7037	Others	3.2072	0.0491	0.138	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM012997	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP006429;Leukemia:SPENP001045
SPENP010217	ALLANALTSALR	Colon cancer	Colon cancer	Liver	SPENT002117	SPENG003627	NONHSAG037834.2	1.4113	Others	2.2818	0.1473	0.286	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013005	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010218,SPENP023992
SPENP010218	ALLANALTSALR	Colon cancer	Colon cancer	Colon	SPENT002117	SPENG003627	NONHSAG037834.2	0.3883	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013005	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP023992
SPENP010253	HVISYSLSPFEQR	Colon cancer	Colon cancer	Liver	SPENT001666	SPENG002113	HSALNG0044883	0.3383	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013040	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010254,SPENP014181,SPENP008320
SPENP010254	HVISYSLSPFEQR	Colon cancer	Colon cancer	Colon	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013040	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP014181,SPENP008320
SPENP010273	DFSPSGIFGAFQR	Colon cancer	Colon cancer	Liver	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.0278	Others	0.0774	0.9388	0.9641	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013048	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP026745,SPENP024039,SPENP010274
SPENP010274	DFSPSGIFGAFQR	Colon cancer	Colon cancer	Colon	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.7416	Others	-1.254	0.2783	0.4278	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013048	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039
SPENP010283	GNSIIMLEALERV	Colon cancer	Colon cancer	Liver	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.4346	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013064	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP014226,SPENP000281,SPENP015902
SPENP010284	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013064	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP010293	AAALVLQTIWGYK	Colon cancer	Colon cancer	Liver	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013066	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP024020,SPENP026642,SPENP001574
SPENP010294	AAALVLQTIWGYK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013066	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP010319	TTAAMWALQTVEK	Colon cancer	Colon cancer	Liver	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2	-0.8774	Others	-5.697	5.4e-06	0.0003	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013086	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP010320	TTAAMWALQTVEK	Colon cancer	Colon cancer	Colon	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013086	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP000267,SPENP007089,SPENP006488
SPENP010327	SFHFSLPSSWYYR	Colon cancer	Colon cancer	Liver	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013060	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP024046
SPENP010328	SFHFSLPSSWYYR	Colon cancer	Colon cancer	Colon	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013060	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010327,SPENP024046
SPENP010335	VALAGLLGFGLGK	Colon cancer	Colon cancer	Liver	SPENT003237	SPENG001444	lnc-OCIAD2-2	0.5264	Others	2.1262	0.0431	0.1286	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013068	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010336,SPENP024026;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP018206,SPENP012954
SPENP010336	VALAGLLGFGLGK	Colon cancer	Colon cancer	Colon	SPENT003237	SPENG001444	lnc-OCIAD2-2	0.3463	Others	0.6308	0.5624	0.6814	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013068	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010335,SPENP024026;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP018206,SPENP012954
SPENP010351	MNTIIAMFSYTAEK	Colon cancer	Colon cancer	Liver	SPENT003258	SPENG000328	HSALNG0098871		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013088	SPENO000438	
SPENP010352	MNTIIAMFSYTAEK	Colon cancer	Colon cancer	Colon	SPENT003258	SPENG000328	HSALNG0098871		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013088	SPENO000438	
SPENP010361	LLLLESVSGLLQPR	Colon cancer	Colon cancer	Liver	SPENT001258	SPENG001048	lnc-CXCL16-3		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013113	SPENO003005	Colon cancer:SPENP010362,SPENP006509;Lung cancer:SPENP028325,SPENP002464
SPENP010362	LLLLESVSGLLQPR	Colon cancer	Colon cancer	Colon	SPENT001258	SPENG001048	lnc-CXCL16-3		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013113	SPENO003005	Colon cancer:SPENP006509,SPENP010361;Lung cancer:SPENP028325,SPENP002464
SPENP010365	IMMMMMMIIFVILR	Colon cancer	Colon cancer	Liver	SPENT003259	SPENG002905	HSALNG0031521	-0.3107	Others	-0.6027	0.5616	0.6814	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013117	SPENO000478	
SPENP010366	IMMMMMMIIFVILR	Colon cancer	Colon cancer	Colon	SPENT003259	SPENG002905	HSALNG0031521		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013117	SPENO000478	
SPENP010375	EVVIFGAASELFTK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL	-0.8722	Others	-3.599	0.0018	0.0108	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013146	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP010376	EVVIFGAASELFTK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013146	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813
SPENP010409	SKESVPEFPLSPPK	Colon cancer	Colon cancer	Liver	SPENT001112	SPENG003381	lnc-PAQR7-1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013110	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP006528
SPENP010410	SKESVPEFPLSPPK	Colon cancer	Colon cancer	Colon	SPENT001112	SPENG003381	lnc-PAQR7-1	0.8775	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013110	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP010417	STLNELVDYITISR	Colon cancer	Colon cancer	Liver	SPENT002483	SPENG000098	lnc-WDR89-4		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013120	SPENO002146	Colon cancer:SPENP010418;Bladder cancer:SPENP028751
SPENP010418	STLNELVDYITISR	Colon cancer	Colon cancer	Colon	SPENT002483	SPENG000098	lnc-WDR89-4		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013120	SPENO002146	Colon cancer:SPENP010417;Bladder cancer:SPENP028751
SPENP010425	TKNALDPMSVLLAR	Colon cancer	Colon cancer	Liver	SPENT002530,SPENT002607,SPENT002606	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013091	SPENO001285,SPENO003025,SPENO003487	
SPENP010426	TKNALDPMSVLLAR	Colon cancer	Colon cancer	Colon	SPENT002530,SPENT002607,SPENT002606	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013091	SPENO001285,SPENO003025,SPENO003487	
SPENP010431	RLVQSPNSYFMDVK	Colon cancer	Colon cancer	Liver	SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051	1.459	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013129	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP015936,SPENP027224,SPENP010432,SPENP014253,SPENP006523
SPENP010432	RLVQSPNSYFMDVK	Colon cancer	Colon cancer	Colon	SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013129	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP014253,SPENP006523
SPENP010441	VTDATETTITISWR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.137	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013094	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP010442	VTDATETTITISWR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2311	Others	0.4338	0.6825	0.7784	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013094	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP010449	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL	-0.8638	Others	-3.489	0.0016	0.0102	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013139	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251;Leukemia:SPENP001146
SPENP010450	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013139	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP010465	SQGKPIELTPLPLLK	Colon cancer	Colon cancer	Liver	SPENT002485,SPENT002484,SPENT002483	SPENG003159,SPENG000098	NONHSAG015196.2,lnc-WDR89-4		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013187	SPENO002146,SPENO002388,SPENO006126	
SPENP010466	SQGKPIELTPLPLLK	Colon cancer	Colon cancer	Colon	SPENT002485,SPENT002484,SPENT002483	SPENG003159,SPENG000098	NONHSAG015196.2,lnc-WDR89-4		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013187	SPENO002146,SPENO002388,SPENO006126	
SPENP010491	VLFGCVLYWDTVRGK	Colon cancer	Colon cancer	Liver	SPENT003180	SPENG001801	AC106799.2	-0.3864	Others	-0.8683	0.4022	0.5337	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013180	SPENO005953	Breast cancer:SPENP022789,SPENP022788;Bladder cancer:SPENP011505;Lung cancer:SPENP026135;Prostate cancer:SPENP009234;Colon cancer:SPENP010492,SPENP000334
SPENP010492	VLFGCVLYWDTVRGK	Colon cancer	Colon cancer	Colon	SPENT003180	SPENG001801	AC106799.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013180	SPENO005953	Breast cancer:SPENP022789,SPENP022788;Bladder cancer:SPENP011505;Lung cancer:SPENP026135;Prostate cancer:SPENP009234;Colon cancer:SPENP000334,SPENP010491
SPENP010499	MRHVISYSLSPFEQR	Colon cancer	Colon cancer	Liver	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013191	SPENO003843	
SPENP010500	MRHVISYSLSPFEQR	Colon cancer	Colon cancer	Colon	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013191	SPENO003843	
SPENP010501	MLITILGTVKPNANR	Colon cancer	Colon cancer	Liver	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	2.975	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013161	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP010502	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.7645	Others	-1.432	0.1952	0.3438	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013161	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP024133,SPENP007181
SPENP010519	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Liver	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.2641	Up-regulated in tumors	3.6097	0.0007	0.0053	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013165	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP010520	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Colon	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.2393	Others	0.514	0.6256	0.7302	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013165	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP010521	MITGLQLSVSPFPTR	Colon cancer	Colon cancer	Liver	SPENT003264	SPENG001596	HSALNG0041188	1.3386	Others	1.852	0.0838	0.1929	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013174	SPENO002490	
SPENP010522	MITGLQLSVSPFPTR	Colon cancer	Colon cancer	Colon	SPENT003264	SPENG001596	HSALNG0041188	0.4201	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013174	SPENO002490	
SPENP010529	IVSGIITPIHEQWEK	Colon cancer	Colon cancer	Liver	SPENT003267	SPENG002163	NONHSAG031094.2	0.4702	Others	1.7471	0.094	0.2086	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013188	SPENO005967	Colon cancer:SPENP024108,SPENP010530;Kidney cancer:SPENP015051
SPENP010530	IVSGIITPIHEQWEK	Colon cancer	Colon cancer	Colon	SPENT003267	SPENG002163	NONHSAG031094.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013188	SPENO005967	Colon cancer:SPENP024108,SPENP010529;Kidney cancer:SPENP015051
SPENP010553	IREIADGLCLEVEGK	Colon cancer	Colon cancer	Liver	SPENT001715	SPENG001516	NONHSAG013412.2	0.6371	Others	2.659	0.0447	0.1314	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013186	SPENO003305	Colon cancer:SPENP024113,SPENP010554,SPENP006567;Bladder cancer:SPENP011515
SPENP010554	IREIADGLCLEVEGK	Colon cancer	Colon cancer	Colon	SPENT001715	SPENG001516	NONHSAG013412.2	-0.7578	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013186	SPENO003305	Colon cancer:SPENP024113,SPENP010553,SPENP006567;Bladder cancer:SPENP011515
SPENP010579	MLCGNQFPSSVTVELK	Colon cancer	Colon cancer	Liver	SPENT003272,SPENT003273	SPENG000414	lnc-CHSY1-5	0.3097	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013212	SPENO000830,SPENO002473	
SPENP010580	MLCGNQFPSSVTVELK	Colon cancer	Colon cancer	Colon	SPENT003272,SPENT003273	SPENG000414	lnc-CHSY1-5		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013212	SPENO000830,SPENO002473	
SPENP010595	AQQEFAAGVFSNPAVR	Colon cancer	Colon cancer	Liver	SPENT002814,SPENT003026	SPENG001802	NONHSAG003062.2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013207	SPENO003986,SPENO006093	Breast cancer:SPENP023399;Colon cancer:SPENP010596;Kidney cancer:SPENP015087;Skin cancer:SPENP025312
SPENP010596	AQQEFAAGVFSNPAVR	Colon cancer	Colon cancer	Colon	SPENT002814,SPENT003026	SPENG001802	NONHSAG003062.2	-0.2684	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013207	SPENO003986,SPENO006093	Breast cancer:SPENP023399;Colon cancer:SPENP010595;Kidney cancer:SPENP015087;Skin cancer:SPENP025312
SPENP010615	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Liver	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013219	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP024149,SPENP001661,SPENP010616,SPENP000394,SPENP014365;Lung cancer:SPENP025534
SPENP010616	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Colon	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013219	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP024149,SPENP001661,SPENP000394,SPENP010615,SPENP014365;Lung cancer:SPENP025534
SPENP010647	FLDGDELTLADCNLLPK	Colon cancer	Colon cancer	Liver	SPENT003277,SPENT003276,SPENT003278	SPENG000877	lnc-ENPP5-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013261	SPENO000101,SPENO002105,SPENO004019	
SPENP010648	FLDGDELTLADCNLLPK	Colon cancer	Colon cancer	Colon	SPENT003277,SPENT003276,SPENT003278	SPENG000877	lnc-ENPP5-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013261	SPENO000101,SPENO002105,SPENO004019	
SPENP010655	PSQMEHAMETMMFTFHK	Colon cancer	Colon cancer	Liver	SPENT003243,SPENT003245,SPENT003246,SPENT003244	SPENG001771,SPENG002637	NONHSAG002942.2,lnc-S100A11-2	1.8991	Up-regulated in tumors	4.5402	0.0002	0.0023	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013244	SPENO002135,SPENO002854,SPENO003972,SPENO005389	
SPENP010656	PSQMEHAMETMMFTFHK	Colon cancer	Colon cancer	Colon	SPENT003243,SPENT003245,SPENT003246,SPENT003244	SPENG001771,SPENG002637	NONHSAG002942.2,lnc-S100A11-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013244	SPENO002135,SPENO002854,SPENO003972,SPENO005389	
SPENP010659	GMTAANAYLVLPVGWTR	Colon cancer	Colon cancer	Liver	SPENT003275	SPENG001734	HSALNG0094834		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013260	SPENO003030	
SPENP010660	GMTAANAYLVLPVGWTR	Colon cancer	Colon cancer	Colon	SPENT003275	SPENG001734	HSALNG0094834		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013260	SPENO003030	
SPENP010683	CIDVRPGYCYTALTNGR	Colon cancer	Colon cancer	Liver	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013270	SPENO000957	Colon cancer:SPENP008534,SPENP010684;Lung cancer:SPENP007782,SPENP004375
SPENP010684	CIDVRPGYCYTALTNGR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013270	SPENO000957	Colon cancer:SPENP008534,SPENP010683;Lung cancer:SPENP007782,SPENP004375
SPENP010697	ALIGATNPADAPPGTIR	Colon cancer	Colon cancer	Liver	SPENT002171	SPENG000588	HSALNG0108933	0.6182	Others	1.4904	0.16	0.3034	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013255	SPENO005632	Anal canal cancer:SPENP024812;Colon cancer:SPENP024169,SPENP010698,SPENP000423;Bladder cancer:SPENP011597;Prostate cancer:SPENP013041
SPENP010698	ALIGATNPADAPPGTIR	Colon cancer	Colon cancer	Colon	SPENT002171	SPENG000588	HSALNG0108933	-0.2982	Others	-1.454	0.2196	0.3705	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013255	SPENO005632	Anal canal cancer:SPENP024812;Colon cancer:SPENP024169,SPENP000423,SPENP010697;Bladder cancer:SPENP011597;Prostate cancer:SPENP013041
SPENP010705	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	-1.979	Down-regulated in tumors	-4.015	0.0002	0.0025	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013256	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP010706	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1	-0.4153	Others	-0.748	0.4827	0.6085	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013256	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP010735	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Liver	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013289	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP010736	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013289	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP010747	GIQKFPGINYPVLTPNLK	Colon cancer	Colon cancer	Liver	SPENT000018,SPENT000457,SPENT000458	SPENG001448,SPENG003202	HMGCL,lnc-GALE-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013314	SPENO000742,SPENO001216,SPENO002963	Colon cancer:SPENP014465,SPENP026891,SPENP016121,SPENP010748;Lung cancer:SPENP002686;Prostate cancer:SPENP018387
SPENP010748	GIQKFPGINYPVLTPNLK	Colon cancer	Colon cancer	Colon	SPENT000018,SPENT000457,SPENT000458	SPENG001448,SPENG003202	HMGCL,lnc-GALE-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013314	SPENO000742,SPENO001216,SPENO002963	Colon cancer:SPENP014465,SPENP026891,SPENP016121,SPENP010747;Lung cancer:SPENP002686;Prostate cancer:SPENP018387
SPENP010755	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Liver	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	-0.3254	Others	-1.965	0.0579	0.154	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013282	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP007328,SPENP006634,SPENP008567
SPENP010756	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Colon	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	-1.112	Others	-1.268	0.2944	0.4443	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013282	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP010761	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	1.7614	Up-regulated in tumors	4.089	0.0002	0.0024	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013293	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP010762	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	0.0177	Others	0.1188	0.9088	0.9451	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013293	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP010779	KFLDGDELTLADCNLLPK	Colon cancer	Colon cancer	Liver	SPENT003277,SPENT003276,SPENT003278	SPENG000877	lnc-ENPP5-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013307	SPENO000101,SPENO002105,SPENO004019	
SPENP010780	KFLDGDELTLADCNLLPK	Colon cancer	Colon cancer	Colon	SPENT003277,SPENT003276,SPENT003278	SPENG000877	lnc-ENPP5-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013307	SPENO000101,SPENO002105,SPENO004019	
SPENP010781	DESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Liver	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.8364	Others	2.4957	0.0413	0.1238	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013303	SPENO000942,SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP007344
SPENP010782	DESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013303	SPENO000942,SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP024212,SPENP010781,SPENP007344
SPENP010783	MILDNLLHQSQSQFPICK	Colon cancer	Colon cancer	Liver	SPENT003283	SPENG001833	HSALNG0066397		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013311	SPENO004561	
SPENP010784	MILDNLLHQSQSQFPICK	Colon cancer	Colon cancer	Colon	SPENT003283	SPENG001833	HSALNG0066397		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013311	SPENO004561	
SPENP010789	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Liver	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.8884	Others	2.5325	0.0155	0.0582	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013306	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010790,SPENP016111,SPENP007353
SPENP010790	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-1.14	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013306	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP016111,SPENP007353
SPENP010795	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Liver	SPENT005801	SPENG002115	AL136361.1	0.7074	Others	1.3468	0.211	0.3651	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013322	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP024214
SPENP010796	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Colon	SPENT005801	SPENG002115	AL136361.1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013322	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP010805	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Liver	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013321	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP024223,SPENP006668
SPENP010806	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013321	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP010815	NPDGTMNLMNWECAIPGKK	Colon cancer	Colon cancer	Liver	SPENT000199,SPENT002108	SPENG000037	HSALNG0108878		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013316	SPENO000865,SPENO003564	
SPENP010816	NPDGTMNLMNWECAIPGKK	Colon cancer	Colon cancer	Colon	SPENT000199,SPENT002108	SPENG000037	HSALNG0108878		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013316	SPENO000865,SPENO003564	
SPENP010819	TGVHHYSGNNIELGTACGK	Colon cancer	Colon cancer	Liver	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	1.8436	Others	1.4537	0.1841	0.329	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013337	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP012841,SPENP024218
SPENP010820	TGVHHYSGNNIELGTACGK	Colon cancer	Colon cancer	Colon	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.8446	Others	0.8241	0.4968	0.621	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013337	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP010825	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.8952	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013335	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428;Leukemia:SPENP001323
SPENP010826	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013335	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP010853	MIQGGEMLTGTSFPLVFPRP	Colon cancer	Colon cancer	Liver	SPENT003289	SPENG002954	HSALNG0060001		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013361	SPENO000465	
SPENP010854	MIQGGEMLTGTSFPLVFPRP	Colon cancer	Colon cancer	Colon	SPENT003289	SPENG002954	HSALNG0060001		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013361	SPENO000465	
SPENP010873	AITTGLQEYVEAVSFQHFIK	Colon cancer	Colon cancer	Liver	SPENT005933,SPENT003034,SPENT005932,SPENT005931	SPENG001725,SPENG000148	NONHSAG004620.3,TSNAX-DISC1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013349	SPENO001778,SPENO004607,SPENO004969,SPENO005212	Skin cancer:SPENP025389;Colon cancer:SPENP010874,SPENP024235;Kidney cancer:SPENP015184
SPENP010874	AITTGLQEYVEAVSFQHFIK	Colon cancer	Colon cancer	Colon	SPENT005933,SPENT003034,SPENT005932,SPENT005931	SPENG001725,SPENG000148	NONHSAG004620.3,TSNAX-DISC1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013349	SPENO001778,SPENO004607,SPENO004969,SPENO005212	Skin cancer:SPENP025389;Colon cancer:SPENP024235,SPENP010873;Kidney cancer:SPENP015184
SPENP010877	ATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Liver	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.9365	Others	0.9036	0.3856	0.5144	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013353	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP010878	ATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Colon	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.4341	Others	-0.6554	0.5365	0.6639	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013353	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP007406
SPENP010881	QSNNKYAASSYLSLTPEQWK	Colon cancer	Colon cancer	Liver	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013354	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP006682,SPENP027212,SPENP010882
SPENP010882	QSNNKYAASSYLSLTPEQWK	Colon cancer	Colon cancer	Colon	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013354	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212
SPENP010919	HRPRPYPPNVGEEIQIGHIPR	Colon cancer	Colon cancer	Liver	SPENT005757	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013365	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP010920	HRPRPYPPNVGEEIQIGHIPR	Colon cancer	Colon cancer	Colon	SPENT005757	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013365	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255
SPENP010927	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Liver	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.1262	Others	0.8106	0.4268	0.5589	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013383	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP010928	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.1666	Others	0.4716	0.6571	0.7599	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013383	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423;Leukemia:SPENP001352
SPENP010929	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013372	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP008656
SPENP010930	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013372	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP010933	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	-0.9437	Others	-1.892	0.0689	0.1739	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013394	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP014573,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP010934	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013394	SPENO003940	Colon cancer:SPENP008671,SPENP016258,SPENP010933,SPENP014573,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP010941	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Liver	SPENT000018	SPENG003202	HMGCL		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013396	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP000542
SPENP010942	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Colon	SPENT000018	SPENG003202	HMGCL		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013396	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP010943	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013385	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449
SPENP010944	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013385	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP010959	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013398	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP010960	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013398	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP010963	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	0.9481	Others	2.592	0.0135	0.0526	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013400	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP010964	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	1.7989	Others	1.6465	0.1383	0.2738	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013400	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP010969	VKADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Liver	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.1136	Others	0.4027	0.6901	0.7835	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013413	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP010970	VKADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013413	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP010975	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013412	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681;Leukemia:SPENP001374
SPENP010976	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013412	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP010983	ALIDPSSGLPNRLPPGAVPPGAR	Colon cancer	Colon cancer	Liver	SPENT003267	SPENG002163	NONHSAG031094.2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013406	SPENO005967	
SPENP010984	ALIDPSSGLPNRLPPGAVPPGAR	Colon cancer	Colon cancer	Colon	SPENT003267	SPENG002163	NONHSAG031094.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	MS	28137767	Immunogenic	SPENM013406	SPENO005967	
SPENP010999	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.1366	Up-regulated in tumors	4.1266	0.0007	0.0055	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013422	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP011000	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.7263	Others	1.6271	0.1646	0.3099	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013422	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP029429
SPENP011003	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.3684	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013418	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP029376,SPENP016295,SPENP026761
SPENP011004	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8837	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013418	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP011011	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.4024	Others	1.2641	0.2201	0.3705	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013427	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750;Leukemia:SPENP001380
SPENP011012	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1913	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013427	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP011021	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated	ribosome profiling	31155234	Immunogenic	SPENM013421	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP014605,SPENP008699,SPENP006724
SPENP011022	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated	ribosome profiling	31155234	Immunogenic	SPENM013421	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP011025	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.1871	Up-regulated in tumors	5.104	0.0001	0.0015	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013424	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP011026	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.879	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013424	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP011035	SYTITGLQPGTDYKIYLYTLNDNAR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013438	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP011036	SYTITGLQPGTDYKIYLYTLNDNAR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013438	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313
SPENP011041	HRMDACCCSVGAAWGTEECEECPMR	Colon cancer	Colon cancer	Liver	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013436	SPENO000957	Colon cancer:SPENP008714,SPENP011042,SPENP016317;Lung cancer:SPENP004655
SPENP011042	HRMDACCCSVGAAWGTEECEECPMR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013436	SPENO000957	Colon cancer:SPENP008714,SPENP016317,SPENP011041;Lung cancer:SPENP004655
SPENP011047	HRHSYTPTIDKQSQIINELPFTSATK	Colon cancer	Colon cancer	Liver	SPENT003298	SPENG002797	lnc-VAV3-11	0.3156	Others	0.9203	0.3648	0.5047	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013445	SPENO002151	
SPENP011048	HRHSYTPTIDKQSQIINELPFTSATK	Colon cancer	Colon cancer	Colon	SPENT003298	SPENG002797	lnc-VAV3-11	1.6217	Others	2.1555	0.0745	0.1818	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013445	SPENO002151	
SPENP011053	PFSSKSSAGQGHTWGVLFGAVTYDLK	Colon cancer	Colon cancer	Liver	SPENT003299	SPENG001513	HSALNG0039137	-0.0809	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013446	SPENO004509	
SPENP011054	PFSSKSSAGQGHTWGVLFGAVTYDLK	Colon cancer	Colon cancer	Colon	SPENT003299	SPENG001513	HSALNG0039137		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013446	SPENO004509	
SPENP011057	MECSGMIILHYSLQLPGSSNPSTSAF	Colon cancer	Colon cancer	Liver	SPENT003297,SPENT003296	SPENG001960	HSALNG0121853		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013442	SPENO001672,SPENO004848	
SPENP011058	MECSGMIILHYSLQLPGSSNPSTSAF	Colon cancer	Colon cancer	Colon	SPENT003297,SPENT003296	SPENG001960	HSALNG0121853		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013442	SPENO001672,SPENO004848	
SPENP011059	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	3.1219	Others	1.2348	0.232	0.3853	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013447	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP011060	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013447	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP011061	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	-1.55	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013449	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP016339
SPENP011062	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013449	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP011063	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1	-0.2314	Others	-0.3752	0.7111	0.7908	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013451	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478;Leukemia:SPENP001390
SPENP011064	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013451	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP011065	ACEDIDECSLPNICVFGTCHNLPGLFR	Colon cancer	Colon cancer	Liver	SPENT005892	SPENG001317	HSALNG0105758	2.597	Others	1.5544	0.1322	0.2671	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013452	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011066,SPENP014642,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP011066	ACEDIDECSLPNICVFGTCHNLPGLFR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758	0.6028	Others	2.2076	0.0694	0.174	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013452	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP014642,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP011073	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.2285	Others	1.9512	0.0728	0.1794	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013455	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP011074	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.7001	Others	1.0799	0.4746	0.6055	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013455	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP008729,SPENP024310
SPENP011079	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Liver	SPENT005913	SPENG001766	AL662884.2	-0.3708	Others	-1.196	0.4397	0.5719	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013469	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP011080	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon	SPENT005913	SPENG001766	AL662884.2	0.5065	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013469	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP011087	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.1945	Up-regulated in tumors	4.4862	0.0002	0.0023	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013468	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP011088	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1602	Others	1.2369	0.2512	0.4028	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013468	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP011097	LGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Liver	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	0.1213	Others	0.6075	0.549	0.6743	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013463	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP016349
SPENP011098	LGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013463	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011097,SPENP016349
SPENP011103	ASADELTFHEFEEATNLLADTPDAATTSR	Colon cancer	Colon cancer	Liver	SPENT001420	SPENG000627	lnc-TMED1-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013473	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP008750,SPENP011104
SPENP011104	ASADELTFHEFEEATNLLADTPDAATTSR	Colon cancer	Colon cancer	Colon	SPENT001420	SPENG000627	lnc-TMED1-2		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013473	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750
SPENP011107	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013478	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP011108	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013478	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203;Leukemia:SPENP001395
SPENP011121	TPIGSFLGSLSLLPATKLGSIAIQGAIEK	Colon cancer	Colon cancer	Liver	SPENT000014	SPENG003410	ACAT1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013475	SPENO003940	
SPENP011122	TPIGSFLGSLSLLPATKLGSIAIQGAIEK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013475	SPENO003940	
SPENP011123	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Liver	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013477	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608
SPENP011124	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013477	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP011125	ASSPHQAGLGLSLTPSPESPPLPDVSAFSR	Colon cancer	Colon cancer	Liver	SPENT003311,SPENT003310,SPENT003309,SPENT003312,SPENT003308,SPENT003307	SPENG000297,SPENG002092	lnc-SEC16B-2,CRYZL2P-SEC16B		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013482	SPENO001399,SPENO002889,SPENO003190,SPENO003864,SPENO005193,SPENO005904	
SPENP011126	ASSPHQAGLGLSLTPSPESPPLPDVSAFSR	Colon cancer	Colon cancer	Colon	SPENT003311,SPENT003310,SPENT003309,SPENT003312,SPENT003308,SPENT003307	SPENG000297,SPENG002092	lnc-SEC16B-2,CRYZL2P-SEC16B		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013482	SPENO001399,SPENO002889,SPENO003190,SPENO003864,SPENO005193,SPENO005904	
SPENP011127	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Liver	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013487	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP011128	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013487	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP011139	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.4043	Up-regulated in tumors	3.8813	0.001	0.0068	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013488	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP000609
SPENP011140	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.7709	Others	0.9616	0.3804	0.5131	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013488	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP011143	CRIRDYQTMNISYMLNTIIMSASSFSFSCR	Colon cancer	Colon cancer	Liver	SPENT003313	SPENG003379	HSALNG0092820		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013486	SPENO003118	
SPENP011144	CRIRDYQTMNISYMLNTIIMSASSFSFSCR	Colon cancer	Colon cancer	Colon	SPENT003313	SPENG003379	HSALNG0092820		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013486	SPENO003118	
SPENP011145	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013494	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP011146	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.6657	Others	1.5527	0.3567	0.5002	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013494	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP011147	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Liver	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013496	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615
SPENP011148	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013496	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP006771,SPENP000615,SPENP011147
SPENP011159	SGDRGETGPAGPAGPVGPVGARGPAGPQGPR	Colon cancer	Colon cancer	Liver	SPENT005758	SPENG002845	COL1A1	1.5323	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013499	SPENO004941	Colon cancer:SPENP024331,SPENP011160;Lung cancer:SPENP002963
SPENP011160	SGDRGETGPAGPAGPVGPVGARGPAGPQGPR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013499	SPENO004941	Colon cancer:SPENP011159,SPENP024331;Lung cancer:SPENP002963
SPENP011165	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.364	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013500	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP016403,SPENP014704
SPENP011166	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013500	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP011167	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Colon cancer	Colon cancer	Liver	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	0.1793	Others	0.8405	0.4054	0.5337	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013507	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP027236,SPENP011168
SPENP011168	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Colon cancer	Colon cancer	Colon	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	0.0822	Others	0.3864	0.7125	0.7908	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013507	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236
SPENP011173	STIQNLQSFDPFADATKGDDLLPAGTEDYIHIR	Colon cancer	Colon cancer	Liver	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2	0.1799	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013502	SPENO002523,SPENO004443	Colon cancer:SPENP011174,SPENP000623;Bladder cancer:SPENP017971,SPENP011803;Kidney cancer:SPENP020700
SPENP011174	STIQNLQSFDPFADATKGDDLLPAGTEDYIHIR	Colon cancer	Colon cancer	Colon	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013502	SPENO002523,SPENO004443	Colon cancer:SPENP011173,SPENP000623;Bladder cancer:SPENP017971,SPENP011803;Kidney cancer:SPENP020700
SPENP011181	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	3.3013	Up-regulated in tumors	3.0979	0.0085	0.0368	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013509	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP001779
SPENP011182	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013509	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP007499,SPENP011181,SPENP001779
SPENP011185	AIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNR	Colon cancer	Colon cancer	Liver	SPENT000014,SPENT000015	SPENG003410,SPENG003123	ACAT1,HSALNG0086980	-1.343	Down-regulated in tumors	-4.329	0.0002	0.0024	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013510	SPENO003940,SPENO004992	Colon cancer:SPENP016415,SPENP011186;Kidney cancer:SPENP020707;Prostate cancer:SPENP018556
SPENP011186	AIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNR	Colon cancer	Colon cancer	Colon	SPENT000014,SPENT000015	SPENG003410,SPENG003123	ACAT1,HSALNG0086980		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013510	SPENO003940,SPENO004992	Colon cancer:SPENP016415,SPENP011185;Kidney cancer:SPENP020707;Prostate cancer:SPENP018556
SPENP011187	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013515	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP022064,SPENP011188
SPENP011188	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013515	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064
SPENP011193	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Colon cancer	Colon cancer	Liver	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013512	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP008769,SPENP014722,SPENP011194,SPENP016417;Lung cancer:SPENP002996
SPENP011194	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758	0.7009	Others	1.2365	0.3043	0.4536	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013512	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP008769,SPENP011193,SPENP014722,SPENP016417;Lung cancer:SPENP002996
SPENP011197	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013516	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP016424,SPENP011198,SPENP008772
SPENP011198	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013516	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP008772
SPENP011199	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Colon cancer	Colon cancer	Liver	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013519	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP014729,SPENP024344,SPENP011200
SPENP011200	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.0995	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013519	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344
SPENP011201	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Colon cancer	Colon cancer	Liver	SPENT005797,SPENT005805	SPENG002649	FGA	0.8201	Others	2.492	0.0256	0.0866	PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013518	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP007924,SPENP001983;Colon cancer:SPENP024345,SPENP011202
SPENP011202	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Colon cancer	Colon cancer	Colon	SPENT005797,SPENT005805	SPENG002649	FGA	-0.5827	Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013518	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP007924,SPENP001983;Colon cancer:SPENP024345,SPENP011201
SPENP011205	NVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR	Colon cancer	Colon cancer	Liver	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013520	SPENO000957	Colon cancer:SPENP014731,SPENP011206,SPENP016429;Bladder cancer:SPENP017988
SPENP011206	NVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR	Colon cancer	Colon cancer	Colon	SPENT005892	SPENG001317	HSALNG0105758		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013520	SPENO000957	Colon cancer:SPENP011205,SPENP014731,SPENP016429;Bladder cancer:SPENP017988
SPENP011209	AAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Liver	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated	MS	28137767	Immunogenic	SPENM013522	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Skin cancer:SPENP025494;Gastric cancer:SPENP015488;Colon cancer:SPENP011210,SPENP007504;Bladder cancer:SPENP011817
SPENP011210	AAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Colon	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated	MS	28137767	Immunogenic	SPENM013522	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Skin cancer:SPENP025494;Gastric cancer:SPENP015488;Colon cancer:SPENP011209,SPENP007504;Bladder cancer:SPENP011817
SPENP011211	MILAHCNLHLPSSSHSPALASQVAEITGMHQHTWLILYF	Colon cancer	Colon cancer	Liver	SPENT003315	SPENG002157	HSALNG0037582		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013524	SPENO000034	
SPENP011212	MILAHCNLHLPSSSHSPALASQVAEITGMHQHTWLILYF	Colon cancer	Colon cancer	Colon	SPENT003315	SPENG002157	HSALNG0037582		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Non-validated			Immunogenic	SPENM013524	SPENO000034	
SPENP011213	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Liver	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013526	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP000630,SPENP022124,SPENP016430
SPENP011214	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Colon	SPENT005752	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013526	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP011215	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013525	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP011216	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013525	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP024347
SPENP011217	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Colon cancer	Colon cancer	Liver	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013527	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP011218	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD008383	Distribution of Collagen in Colorectal Liver Metastasis and Normal Liver tissue	Orbitrap Fusion Lumos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013527	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739
SPENP011343	KSEIEYYAMLAK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000907	SPENG001277	HSALNG0067186	-0.7718	Others	-2.312	0.0601	0.5314	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM013924	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP010164,SPENP008226
SPENP011354	VPFLVLECPNLK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000354	SPENG002378	HSALNG0036293	-0.0619	Others	-0.2494	0.8064	0.9346	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM013894	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP011358	VIEGDVVSALNK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001808,SPENT005921	SPENG001016,SPENG001705	AC112229.4,lnc-LIMS4-1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013908	SPENO000049,SPENO000476	Breast cancer:SPENP022574,SPENP022575;Gastric cancer:SPENP015298;Lung cancer:SPENP007620
SPENP011359	LVILANNCPALR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.1665	Others	0.6832	0.5086	0.8449	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013898	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP011360	VAYVSFGPHAGK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002284	SPENG000495	HSALNG0025321		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013897	SPENO000938	Liver cancer:SPENP004811
SPENP011366	QLGEANEEFALR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001183,SPENT001719,SPENT001182	SPENG000169	lnc-DQX1-1	0.0395	Others	0.0801	0.9462	0.9864	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013890	SPENO000751,SPENO001535,SPENO004354	Bladder cancer:SPENP017394;Colon cancer:SPENP008207;Lung cancer:SPENP004013;Anal canal cancer:SPENP024596
SPENP011367	YQLDPTASISAK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000102	SPENG002045	lnc-ACTR2-11	-0.1617	Others	-0.4838	0.6355	0.8681	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013884	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP011378	NQSLIPLLLEAR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000215	SPENG001615	lnc-ACTA2-2	-0.8486	Others	-2.988	0.0244	0.369	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM013909	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP011386	TTAAMWALQTVEK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM013937	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP011395	HVISYSLSPFEQR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001666	SPENG002113	HSALNG0044883	-0.2108	Others	-0.1999	0.8482	0.938	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013939	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP011404	GNSIIMLEALERV	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.0721	Others	0.2637	0.8237	0.9353	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM013931	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP011409	SDVQIHVPTFTFR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000226	SPENG002670	HSALNG0020703	0.3727	Others	2.458	0.0338	0.441	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013975	SPENO000150	Prostate cancer:SPENP011996
SPENP011415	MLINIMSLVLSGN	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003366,SPENT003368,SPENT003367	SPENG002506,SPENG003357,SPENG002720	lnc-EXOC2-6,HSALNG0047272,AL035696.3	0.0091	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM013929	SPENO004819,SPENO006120,SPENO006261	
SPENP011440	SKESVPEFPLSPPK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001112	SPENG003381	lnc-PAQR7-1	-0.6774	Others	-0.7033	0.4965	0.8449	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014017	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP011444	QYNVGPSVSKYPLR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014002	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP011457	VTDATETTITISWR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014006	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP011475	GPVYIGELPQDFLR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000947,SPENT000946	SPENG002912	lnc-MOB2-2	-0.1318	Others	-0.3796	0.7109	0.8922	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014030	SPENO000523,SPENO003769	Breast cancer:SPENP008901;Gastric cancer:SPENP009539;Lung cancer:SPENP001878
SPENP011477	HHNQPYCGIAPYIR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000899	SPENG001988	NONHSAG026220.2	0.5121	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014024	SPENO004425	Tongue cancer:SPENP027777
SPENP011482	EHHLMELWSMHKTR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003388,SPENT003387,SPENT003386	SPENG002404,SPENG001159,SPENG002790	lnc-TMEM272-2,HSALNG0097195,NONHSAG013562.2	-1.06	Others	-1.959	0.0719	0.5314	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014012	SPENO004779,SPENO005166,SPENO005187	
SPENP011491	AKLVILANNCPALR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.2259	Others	0.6406	0.5362	0.8449	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM013991	SPENO000929,SPENO002667,SPENO003136,SPENO006213	
SPENP011497	ELLFLSNANPSLLER	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003403	SPENG001621	HSALNG0007523	0.1187	Others	0.3796	0.7155	0.8922	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014073	SPENO003029	
SPENP011501	TTAAMWALQTVEKER	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2	-2.111	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014065	SPENO000218,SPENO001883	Lung cancer:SPENP004252;Leukemia:SPENP001202;Skin cancer:SPENP025282
SPENP011505	VLFGCVLYWDTVRGK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003180	SPENG001801	AC106799.2	-0.8683	Others	-1.802	0.1162	0.5831	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014062	SPENO005953	Breast cancer:SPENP022789,SPENP022788;Lung cancer:SPENP026135;Prostate cancer:SPENP009234;Colon cancer:SPENP010492,SPENP000334,SPENP010491
SPENP011507	AFSYYGPLRTVWIAR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000005,SPENT000179	SPENG002035	NONHSAG027524.2	-0.6335	Others	-1.792	0.1108	0.5831	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014038	SPENO002250,SPENO005934	
SPENP011515	IREIADGLCLEVEGK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001715	SPENG001516	NONHSAG013412.2	0.2869	Others	0.6115	0.556	0.8449	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014059	SPENO003305	Colon cancer:SPENP024113,SPENP010553,SPENP010554,SPENP006567
SPENP011516	AAGARPLTSPESLSR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003356,SPENT003355	SPENG001442,SPENG000870	lnc-BAG6-1,NONHSAG046457.2		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014042	SPENO001876,SPENO002955	
SPENP011524	YAASSYLSLTPEQWK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.5566	Others	-1.203	0.2476	0.696	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014041	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP011525	NYLEGIYNVPVAAVR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014039	SPENO001980,SPENO002623	Skin cancer:SPENP019416,SPENP019417,SPENP019415;Breast cancer:SPENP022770,SPENP022771
SPENP011530	KPRIMSCDLDEENSK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003397	SPENG003333	AL079303.1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014066	SPENO005316	
SPENP011540	MKTNEAVAENINYFFK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003408	SPENG003128	HSALNG0019460		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014080	SPENO005437	Breast cancer:SPENP022845,SPENP022844;Colon cancer:SPENP000393
SPENP011552	TAVAHRPGAFKAELSK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000153	SPENG003407	NONHSAG024537.2	0.8804	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014089	SPENO003100	Colon cancer:SPENP027316;Lung cancer:SPENP004303
SPENP011592	ETPLPIDPSMFPTWPAK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000136,SPENT000135,SPENT000138,SPENT000137,SPENT000139	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM014144	SPENO000257,SPENO002156,SPENO003659,SPENO005654,SPENO006064	Bladder cancer:SPENP017665;Colon cancer:SPENP008539,SPENP000431;Lung cancer:SPENP025658,SPENP002667;Kidney cancer:SPENP020456
SPENP011597	ALIGATNPADAPPGTIR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002171	SPENG000588	HSALNG0108933	0.2188	Others	0.4603	0.6543	0.8753	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014129	SPENO005632	Anal canal cancer:SPENP024812;Colon cancer:SPENP024169,SPENP010698,SPENP000423,SPENP010697;Prostate cancer:SPENP013041
SPENP011622	DIQMTQSPSSLSASVGDR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.5191	Others	-0.937	0.3732	0.7713	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014162	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP011631	NQLDQEVEFLSTSIAQLK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002156	SPENG002374	NONHSAG011229.2	0.6311	Others	1.9397	0.0811	0.5429	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014174	SPENO002603	Colon cancer:SPENP012830;Bladder cancer:SPENP028700
SPENP011633	GETGPAGPAGPVGPVGAR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005758	SPENG002845	COL1A1	-0.3371	Others	-0.2473	0.8092	0.9346	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014160	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP011635	ACLDYPVTSVLPPASLCK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002507	SPENG002379	NONHSAG033050.2	0.3905	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014173	SPENO004482	Lung cancer:SPENP025512,SPENP028228;Colon cancer:SPENP007326,SPENP006646;Bladder cancer:SPENP017716,SPENP028438;Prostate cancer:SPENP009279
SPENP011637	STDTGVSLPSYEEDQGSK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	0.2724	Others	0.8655	0.4071	0.7776	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014158	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP011645	TGVHHYSGNNIELGTACGK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	-0.0858	Others	-0.381	0.7085	0.8922	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014184	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP011646	KVSPHSGVVALTKPVPEPR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014188	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP011659	ALAPTWEQLALGLEHSETVK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.1086	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014210	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP011660	ATLVCLISDFYPGAVTVAWK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.0277	Others	0.9261	0.3742	0.7713	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014209	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP011667	QSNNKYAASSYLSLTPEQWK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.774	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014207	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP011676	DGVNKDYEETELISTTANYR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003424,SPENT003423	SPENG000500,SPENG002350	HSALNG0045349,NONHSAG112446.1		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014216	SPENO000063,SPENO002413	
SPENP011682	METLYRVPFLVLECPNLKLK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000354	SPENG002378	HSALNG0036293	-0.2027	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014215	SPENO003709	
SPENP011683	DMENEITDIEDSERWEGVKG	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003422	SPENG003452	HSALNG0074029	0.2406	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014211	SPENO001861	
SPENP011684	LASLFSSLEPQIQPVYVPVPK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003430	SPENG000464	HSALNG0011689		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014229	SPENO001978	
SPENP011687	ADRDESSPYAAMLAAQDVAQR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	-0.5531	Others	-1.679	0.1343	0.5975	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014240	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP011699	LIDMLSEAGLSVIETTSFVSPK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000018	SPENG003202	HMGCL	-0.3852	Others	-0.6428	0.5487	0.8449	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014243	SPENO002963	Bladder cancer:SPENP017838;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP011700	VSGWELTAGGLQGTFWAVASVL	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003431	SPENG003208	HSALNG0028724		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014241	SPENO001436	
SPENP011705	SGDRGETGPAGPAGPVGPVGAR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005758	SPENG002845	COL1A1	-0.8879	Others	-0.5657	0.5799	0.8538	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014246	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP011707	YGELEEGIDVLDSDGNLVGSSK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003432	SPENG003398	lnc-SFXN5-1		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014249	SPENO001747	
SPENP011709	STLILVCGPPPLIQTAAHPNLEK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003443,SPENT003445,SPENT003151,SPENT003444	SPENG000186,SPENG001683	HSALNG0082507,lnc-CYB5R2-1	0.277	Others	0.5984	0.6357	0.8681	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014260	SPENO000307,SPENO000947,SPENO001633,SPENO005154	
SPENP011711	GFGFVTYSCVEEVDAAMCARPHK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000663	SPENG002730	lnc-FRG2C-16	-0.2076	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014255	SPENO005517	Prostate cancer:SPENP023779
SPENP011714	VKADRDESSPYAAMLAAQDVAQR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	-0.7782	Others	-2.077	0.1018	0.5778	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014256	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP011715	QVQLDAQAAQQLQYGGAVGTVGR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000947,SPENT000946	SPENG002912	lnc-MOB2-2		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014264	SPENO000523,SPENO003769	
SPENP011716	CDPHEATCYDDGKTYHVGEQWQK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014262	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP011725	TKTETITGFQVDAVPANGQTPIQR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014271	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP011728	DLEVVAATPTSLLISWDAPAVTVR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014279	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP011729	NSITLTNLTPGTEYVVSIVALNGR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014265	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP011733	FLGATTDTTVLEANAVLLGIQESK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003319	SPENG003432	HSALNG0066476	0.8445	Others	2.2696	0.0443	0.4575	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014270	SPENO000001	
SPENP011736	AAQAQGQSCEYSLMVGYQCGQVFR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.0509	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM014268	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP011750	TNTNVNCPIECFMPLDVQADREDSRE	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014287	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP011751	VLSGQDDEEQGLTAQVLDASSLSFNTR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003449	SPENG001155	NONHSAG045391.2	0.8326	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014294	SPENO005894	
SPENP011753	ACEDIDECSLPNICVFGTCHNLPGLFR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005892	SPENG001317	HSALNG0105758	-0.2057	Others	-0.2038	0.8452	0.938	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014295	SPENO000957	Bladder cancer:SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP011757	ATLVCLISDFYPGAVTVAWKADSSPVK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014293	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP021839,SPENP021837;Gastric cancer:SPENP015453;Lung cancer:SPENP021838;Colon cancer:SPENP026715,SPENP021836
SPENP011759	TLEEGHDFIQEFPGSPAFAALTSIAQK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000868	SPENG001300	NONHSAG018279.2	-0.5437	Others	-1.656	0.1585	0.6128	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	MS	28137767	Immunogenic	SPENM014302	SPENO000920	Colon cancer:SPENP001767;Lung cancer:SPENP007895;Prostate cancer:SPENP023789
SPENP011760	SGVISDTELQQALSNGTWTPFNPVTVR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005938,SPENT005937	SPENG001217	PDCD6-AHRR	0.685	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014296	SPENO002640,SPENO002946	
SPENP011764	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014311	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP011767	YIKDDVILNEPSADAPAALYQTIEENIK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003450	SPENG003122	NONHSAG013474.2		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014305	SPENO005443	Colon cancer:SPENP000593
SPENP011768	SGLAIVSQHDLDQLQADAINAFGESLQK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002525	SPENG001064	HSALNG0061573	-0.1271	Others	-1.408	0.3793	0.7713	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014304	SPENO004542	Colon cancer:SPENP006753;Bladder cancer:SPENP028737
SPENP011773	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014308	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP011774	SGLAIVSQHDLDQLQADAINAFGESLQKK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002525	SPENG001064	HSALNG0061573	0.1016	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014316	SPENO004542	
SPENP011775	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014321	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP011780	ASADELTFHEFEEATNLLADTPDAATTSR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT001420	SPENG000627	lnc-TMED1-2	0.5363	Others	0.9538	0.3942	0.7736	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014320	SPENO002869	Bladder cancer:SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP011784	VNNSSLIGVGYTQTLRPGVKLTLSALVDGK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000102	SPENG002045	lnc-ACTR2-11	1.3711	Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014323	SPENO000884	
SPENP011785	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.273	Others	0.3571	0.7391	0.8945	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014327	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP011792	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.1007	Others	0.1561	0.8794	0.9407	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014335	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP011793	ASPFSGALQLTDLDDFIGPSQECIKPVKVEK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003456,SPENT003457,SPENT003458,SPENT003455	SPENG000025	lnc-CCDC78-3		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014337	SPENO001664,SPENO002544,SPENO002921,SPENO003506	
SPENP011794	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014333	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP011797	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014341	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP011799	MLLSPGVTSIPATMATLFMGPLGDDRGGWEKR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT003459	SPENG003687	lnc-WDR70-5		Others				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014338	SPENO001869	
SPENP011801	AAYSYRPGPGAGPGPAAGAALPDQSFLWNVFQR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005938,SPENT003460,SPENT005937	SPENG003414,SPENG001217	HSALNG0039431,PDCD6-AHRR	1.3075	Others	1.8147	0.1124	0.5831	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014342	SPENO002469,SPENO002640,SPENO002946	
SPENP011802	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	0.7592	Others	1.7302	0.1092	0.5831	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014345	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Skin cancer:SPENP025485;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP011803	STIQNLQSFDPFADATKGDDLLPAGTEDYIHIR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2	0.0692	Others	0.1388	0.8941	0.9448	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014344	SPENO002523,SPENO004443	Colon cancer:SPENP011173,SPENP011174,SPENP000623;Bladder cancer:SPENP017971;Kidney cancer:SPENP020700
SPENP011805	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014347	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP011807	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014350	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP011808	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005892	SPENG001317	HSALNG0105758	2.3649	Others	1.7388	0.1256	0.5975	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014349	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP017982;Colon cancer:SPENP008769,SPENP011193,SPENP014722,SPENP011194,SPENP016417;Lung cancer:SPENP002996
SPENP011810	EVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014351	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Colon cancer:SPENP026817
SPENP011811	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated			Immunogenic	SPENM014353	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP007924,SPENP001983;Colon cancer:SPENP024345,SPENP011202,SPENP011201
SPENP011813	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.4537	Others	2.5251	0.0395	0.4575	PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014355	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP011815	AAYSYRPGPGAGPGPAAGAALPDQSFLWNVFQRVDKDR	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005938,SPENT003460,SPENT005937	SPENG003414,SPENG001217	HSALNG0039431,PDCD6-AHRR		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014358	SPENO002469,SPENO002640,SPENO002946	
SPENP011816	SSEEGKLFVGGLNFNTDEQALEDHFSSFGPISEVVVVK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT002418	SPENG003212	NONHSAG054424.2		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014356	SPENO004616	
SPENP011817	AAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWK	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Non-validated	MS	28137767	Immunogenic	SPENM014359	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Skin cancer:SPENP025494;Gastric cancer:SPENP015488;Colon cancer:SPENP011209,SPENP011210,SPENP007504
SPENP011818	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Bladder cancer	Bladder transitional carcinoma	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009203	ntegrated FTIR imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer	LTQ Orbitrap Elite	MS1 intensity based label-free quantification mehtod	30770125	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014360	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP011840	MYSIITCTLKICTSIMCNK	Ovary cancer	Ovary cancer	Blood serum	SPENT003475,SPENT003472,SPENT003473,SPENT003474,SPENT003470,SPENT003471	SPENG003014,SPENG000395	HSALNG0099182,LINC00460		Tumor-specific				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017049	SPENO000217,SPENO000995,SPENO003539,SPENO003671,SPENO005426,SPENO005769	
SPENP011849	ALTDMPQMRMELERPGGNEITR	Ovary cancer	Ovary cancer	Blood serum	SPENT005797,SPENT005805	SPENG002649	FGA		Others				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017058	SPENO001505,SPENO002211	
SPENP011850	AGTELVNFLSYFVELGTQPATQ	Ovary cancer	Ovary cancer	Blood serum	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Others				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017059	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006048,SPENP006047,SPENP006044,SPENP009020,SPENP006046,SPENP006045;Lung cancer:SPENP001961
SPENP011852	KAGTELVNFLSYFVELGTQPATQ	Ovary cancer	Ovary cancer	Blood serum	SPENT000876,SPENT000877,SPENT000878	SPENG000319	lnc-APOA2-1		Tumor-specific				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017063	SPENO003688,SPENO004136,SPENO005023	Breast cancer:SPENP006066,SPENP006067,SPENP006064,SPENP006068,SPENP009030,SPENP006065
SPENP011855	STAAMSTYTGIFTDQVLSVLKGEE	Ovary cancer	Ovary cancer	Blood serum	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017065	SPENO003134,SPENO005747	Ovary cancer:SPENP016654;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP011859	GSAGHWTSESSVSGSTGQWHSESGSFR	Ovary cancer	Ovary cancer	Blood serum	SPENT005797,SPENT005805	SPENG002649	FGA		Others				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017068	SPENO001505,SPENO002211	
SPENP011861	DLYSKSTAAMSTYTGIFTDQVLSVLKGEE	Ovary cancer	Ovary cancer	Blood serum	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD009382	Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera	TripleTOF 5600	Spectrum counting	30627607	Non-validated			Immunogenic	SPENM017070	SPENO003134,SPENO005747	
SPENP011932	GSLASLDSLRK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017144	SPENO005858	Colon cancer:SPENP026916,SPENP014054,SPENP008125,SPENP015749;Bladder cancer:SPENP017222;Kidney cancer:SPENP020052
SPENP011958	YQLDPTASISAK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017179	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP011959	ALLANALTSALR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT002117	SPENG003627	NONHSAG037834.2	-0.46	Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017186	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP011960	LLFGSGLPPALF	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005078,SPENT005077	SPENG001314	HSALNG0120124	-2.211	Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017193	SPENO001379,SPENO003462	
SPENP011965	NKTDLAQTHLYR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT002613,SPENT002614	SPENG002688,SPENG003108	lnc-RPS6KL1-2,HSALNG0102460	-0.6586	Others	-7.12	0.0801	0.1486	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017196	SPENO001209,SPENO001336	Colon cancer:SPENP007007
SPENP011971	MQPQESHVHYSR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT002409	SPENG002995	HSALNG0000347	-0.0076	Others	-0.0571	0.9548	0.9578	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017166	SPENO004438	Kidney cancer:SPENP013774,SPENP013773,SPENP020095
SPENP011976	AATLDPGYYTYR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT006027	SPENG003861	STRA6		Tumor-specific				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017181	SPENO003228	Kidney cancer:SPENP020118
SPENP011980	MEINPCTVLSTQ	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT002623,SPENT002620,SPENT002626,SPENT002624,SPENT002619,SPENT002621,SPENT002625,SPENT002622	SPENG000162	HSALNG0041080	3.3145	Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017172	SPENO000278,SPENO001741,SPENO002384,SPENO002904,SPENO003624,SPENO005425,SPENO006081,SPENO006350	Colon cancer:SPENP007035
SPENP011983	GLQSSYSEEYLR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT006027	SPENG003861	STRA6	1.4226	Others	1.5415	0.1472	0.2356	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017202	SPENO003228	Kidney cancer:SPENP020144
SPENP011987	ALSRLASLLSPR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT003036,SPENT001545	SPENG000097	lnc-RWDD3-1		Tumor-specific				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017187	SPENO000383,SPENO002979	
SPENP011996	SDVQIHVPTFTFR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000226	SPENG002670	HSALNG0020703		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017213	SPENO000150	Bladder cancer:SPENP011409
SPENP012012	DLFTASNDPLLWR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT001218	SPENG003441	NONHSAG033755.2	-0.1132	Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017205	SPENO005358	Lung cancer:SPENP002400,SPENP025590;Kidney cancer:SPENP020168
SPENP012015	YAMVYGYNAAYNR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Tumor-specific				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017219	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Colon cancer:SPENP015869
SPENP012018	KNKTDLAQTHLYR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT002613,SPENT002614	SPENG002688,SPENG003108	lnc-RPS6KL1-2,HSALNG0102460		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017225	SPENO001209,SPENO001336	Colon cancer:SPENP007102
SPENP012026	VLLESEQFLTELTR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3	-0.5196	Others	-1.734	0.1804	0.2775	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017233	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976;Colon cancer:SPENP012790,SPENP001600
SPENP012030	SHTVCIYTHSHSFL	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT001263	SPENG001834	HSALNG0022489	2.7352	Up-regulated in tumors	3.432	0.005	0.0199	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017234	SPENO000462	Lung cancer:SPENP002484
SPENP012047	MLITILGTVKPNANR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.8425	Others	-2.881	0.0059	0.0219	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017268	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP012048	NILAVSFAPLVQPSK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005120	SPENG001629	HSALNG0065241	-0.1177	Others	-0.4613	0.6528	0.7254	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017266	SPENO005251	Kidney cancer:SPENP015085
SPENP012054	YAASSYLSLTPEQWK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.8787	Others	0.5008	0.622	0.7041	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017260	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP012066	VLAGGVICLVNSDNER	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005847	SPENG002707	RF01960-008	-0.6536	Others	-1.427	0.1689	0.2632	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017284	SPENO004681	
SPENP012067	EALCGCSINVPTLDGR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000515	SPENG000486	NONHSAG001879.2	-0.3287	Others	-1.088	0.3082	0.3993	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017282	SPENO000704	Bile duct cancer:SPENP013493;Tongue cancer:SPENP027603;Lung cancer:SPENP007733;Prostate cancer:SPENP018322;Colon cancer:SPENP016075,SPENP007276;Leukemia:SPENP001237
SPENP012075	ISLPGQMAGTPITPLK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000725,SPENT000615	SPENG001618	NONHSAG029796.2	-0.4099	Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	sORF.org_record	26527729	Immunogenic	SPENM017275	SPENO000363,SPENO003428	Breast cancer:SPENP022897,SPENP022896;Colon cancer:SPENP006591,SPENP000379;Lung cancer:SPENP025800
SPENP012079	LQDLLHSAVQAHGFYTK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005134	SPENG002969	PTENP1-AS	-0.7737	Others	-1.099	0.2816	0.3797	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017292	SPENO000351	
SPENP012080	ALALAALAAVEPACGSR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT004057	SPENG000928	NONHSAG041785.2	-0.5521	Others	-1.456	0.1524	0.2406	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017287	SPENO001591	Colon cancer:SPENP000433;Bladder cancer:SPENP017666;Kidney cancer:SPENP020433
SPENP012081	MEVLLEALFLTVDPYMR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000383	SPENG003576	HSALNG0073697		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017295	SPENO001174	Kidney cancer:SPENP020444
SPENP012083	GWVEWLMPVIPALWEAK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005133	SPENG003141	HSALNG0137707	-0.0294	Others	-0.0532	0.9578	0.9578	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017289	SPENO006215	
SPENP012089	STIQNLQSFDPFADATK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017294	SPENO002523,SPENO004443	
SPENP012093	DIQMTQSPSSLSASVGDR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	1.2424	Up-regulated in tumors	3.8171	0.0011	0.0047	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017302	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP012096	QTLSTPGTIILGTIPVPK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2	0.0885	Others	0.304	0.7633	0.8252	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017308	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP004453,SPENP026000;Colon cancer:SPENP001697,SPENP000454
SPENP012102	TFLALPPHGSVAAQTPCR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005137,SPENT005138	SPENG003109	HSALNG0044482	0.4853	Others	1.0705	0.3073	0.3993	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017307	SPENO001656,SPENO005871	
SPENP012105	LQLMWFSFLMFILKENLVN	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005141	SPENG002902	lnc-ZNF33B-6		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017313	SPENO004096	
SPENP012109	LCNYLSHHLTISPQSGNFR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000390	SPENG002704	lnc-TRIM16L-2		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017314	SPENO003522	Lung cancer:SPENP004478;Kidney cancer:SPENP020514
SPENP012110	TGVHHYSGNNIELGTACGK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	-1.594	Down-regulated in tumors	-3.498	0.0171	0.0487	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017317	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP012115	LNGLLADIVHACLQIDPADR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005148,SPENT005149	SPENG000030	lnc-CDKL3-2		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM017321	SPENO001765,SPENO003350	
SPENP012117	ETSVTPSNLWGGQGLLGVSIR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000615	SPENG001618	NONHSAG029796.2		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	MS	28137767	Immunogenic	SPENM017325	SPENO003428	Breast cancer:SPENP023091,SPENP023090;Colon cancer:SPENP001727,SPENP000530,SPENP006694;Lung cancer:SPENP025659,SPENP028262
SPENP012122	SGDRGETGPAGPAGPVGPVGAR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017333	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP012123	VLETLTMPQVVPSSLNLVENAR	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005108,SPENT005107,SPENT005105,SPENT005106,SPENT005104,SPENT005109	SPENG000298	lnc-CEACAM20-1		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017330	SPENO000197,SPENO002152,SPENO002169,SPENO003976,SPENO004319,SPENO005100	
SPENP012134	LGALSGAAALGFASYGAHGAQFPDAYGK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	0.5507	Others	1.3768	0.2059	0.3013	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017343	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP012135	IGYNPDTVAFVPISGWNGNNMLEPSANMPWFK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT005153	SPENG001303	lnc-ANKH-1		Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017344	SPENO003081	Colon cancer:SPENP026980
SPENP012136	HPINSEWQTDNCETCTCYETEISCCTLVSTPVGYDK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT003135,SPENT003136,SPENT003137	SPENG001959,SPENG000191	lnc-MSMB-1,HSALNG0077921	-0.0499	Others	-0.09	0.9293	0.945	PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017345	SPENO001283,SPENO002427,SPENO003438	
SPENP012137	GPSDFNGLPMGTYQAFPNIYPSQIPATPPSYESVDDINADK	Prostate cancer	Prostate cancer	Urinary extracellular vesicles	SPENT004469	SPENG000589	lnc-SIPA1L3-4	2.5124	Others				PXD015289	Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine	Q Exactive	Label free	32284825	Non-validated			Immunogenic	SPENM017346	SPENO001145	
SPENP012238	MPEMMMEMAWK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005162,SPENT005160,SPENT005159,SPENT005161	SPENG001088	HSALNG0109648		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004342	SPENO000566,SPENO001653,SPENO002913,SPENO003347	
SPENP012239	MPEMMMEMAWK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005162,SPENT005160,SPENT005159,SPENT005161	SPENG001088	HSALNG0109648		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004342	SPENO000566,SPENO001653,SPENO002913,SPENO003347	
SPENP012240	MQKEMWQEMGK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005164	SPENG003210	HSALNG0049287		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004356	SPENO005856	
SPENP012241	MQKEMWQEMGK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005164	SPENG003210	HSALNG0049287		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004356	SPENO005856	
SPENP012272	TAVAHRPGAFK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000153	SPENG003407	NONHSAG024537.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004370	SPENO003100	Thyroid cancer:SPENP012273;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP012273	TAVAHRPGAFK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000153	SPENG003407	NONHSAG024537.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004370	SPENO003100	Thyroid cancer:SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP012302	YQLDPTASISAK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000102	SPENG002045	lnc-ACTR2-11		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004372	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP012303	YQLDPTASISAK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004372	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP012308	VVLDDKDYFLFR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000668,SPENT000737,SPENT000738,SPENT000740,SPENT000736,SPENT000739,SPENT000735,SPENT000741	SPENG001548,SPENG001699,SPENG001263,SPENG000451,SPENG001761,SPENG001842,SPENG002051	HSALNG0093536,lnc-ETNK2-4,lnc-GNPTAB-1,lnc-ARL4C-4,HSALNG0021384,HSALNG0009837,lnc-PABPC4-7		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	MS	28137767	Immunogenic	SPENM004389	SPENO000488,SPENO001622,SPENO002018,SPENO002762,SPENO004177,SPENO004759,SPENO004760,SPENO005600	Breast cancer:SPENP008856;Thyroid cancer:SPENP012309;Gastric cancer:SPENP003148;Lung cancer:SPENP001845;Colon cancer:SPENP001551
SPENP012309	VVLDDKDYFLFR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000668,SPENT000737,SPENT000738,SPENT000740,SPENT000736,SPENT000739,SPENT000735,SPENT000741	SPENG001548,SPENG001699,SPENG001263,SPENG000451,SPENG001761,SPENG001842,SPENG002051	HSALNG0093536,lnc-ETNK2-4,lnc-GNPTAB-1,lnc-ARL4C-4,HSALNG0021384,HSALNG0009837,lnc-PABPC4-7		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	MS	28137767	Immunogenic	SPENM004389	SPENO000488,SPENO001622,SPENO002018,SPENO002762,SPENO004177,SPENO004759,SPENO004760,SPENO005600	Breast cancer:SPENP008856;Thyroid cancer:SPENP012308;Gastric cancer:SPENP003148;Lung cancer:SPENP001845;Colon cancer:SPENP001551
SPENP012332	TLMNLGGLAVAR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT001451	SPENG001511	HSALNG0007796		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	MS	28137767	Immunogenic	SPENM004384	SPENO005561	Thyroid cancer:SPENP012333;Gastric cancer:SPENP003136;Prostate cancer:SPENP009173
SPENP012333	TLMNLGGLAVAR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT001451	SPENG001511	HSALNG0007796		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	MS	28137767	Immunogenic	SPENM004384	SPENO005561	Thyroid cancer:SPENP012332;Gastric cancer:SPENP003136;Prostate cancer:SPENP009173
SPENP012416	YAASSYLSLTPEQWK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.1556	Others	0.3915	0.7023	0.8871	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	MS	28137767	Immunogenic	SPENM004445	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP012417	YAASSYLSLTPEQWK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.1187	Others	0.673	0.5308	0.825	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	MS	28137767	Immunogenic	SPENM004445	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP012420	MTQSPSSLSASVGDR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004433	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP012421	MTQSPSSLSASVGDR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	-0.0333	Others	-0.068	0.9493	0.9573	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004433	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP012454	MSLPSMKMALRMTHSW	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT003032	SPENG000857	HSALNG0087614		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004449	SPENO003649	
SPENP012455	MSLPSMKMALRMTHSW	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT003032	SPENG000857	HSALNG0087614		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004449	SPENO003649	
SPENP012462	MPEMMMEMAWKIVRTK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005162,SPENT005160,SPENT005159,SPENT005161	SPENG001088	HSALNG0109648		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004454	SPENO000566,SPENO001653,SPENO002913,SPENO003347	
SPENP012463	MPEMMMEMAWKIVRTK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005162,SPENT005160,SPENT005159,SPENT005161	SPENG001088	HSALNG0109648		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004454	SPENO000566,SPENO001653,SPENO002913,SPENO003347	
SPENP012484	DRDPNSLLISCAVSYR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004462	SPENO002584,SPENO006142	Thyroid cancer:SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP012485	DRDPNSLLISCAVSYR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-1.197	Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004462	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP012508	VSPHSGVVALTKPVPEPR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005785	SPENG001958	FBLN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004491	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP012509	VSPHSGVVALTKPVPEPR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005785	SPENG001958	FBLN1	1.154	Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004491	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP012520	ASQGISNYLAWYQQKPGK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004476	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP012521	ASQGISNYLAWYQQKPGK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	0.1085	Others	0.2232	0.8343	0.9326	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004476	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP012536	DIQMTQSPSSLSASVGDR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.3564	Others	1.4336	0.1772	0.6303	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004477	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP012537	DIQMTQSPSSLSASVGDR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.5315	Others	-0.8087	0.4344	0.7899	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004477	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP012540	TTVLLADINDFNTVNEIYK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT003329,SPENT003330	SPENG001096	HSALNG0067190		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	sORF.org_record	26527729	Immunogenic	SPENM004494	SPENO004169,SPENO004502	Thyroid cancer:SPENP012541;Colon cancer:SPENP012838,SPENP000488;Bladder cancer:SPENP017762;Liver cancer:SPENP000735
SPENP012541	TTVLLADINDFNTVNEIYK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT003329,SPENT003330	SPENG001096	HSALNG0067190	1.0855	Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	sORF.org_record	26527729	Immunogenic	SPENM004494	SPENO004169,SPENO004502	Thyroid cancer:SPENP012540;Colon cancer:SPENP012838,SPENP000488;Bladder cancer:SPENP017762;Liver cancer:SPENP000735
SPENP012562	KVSPHSGVVALTKPVPEPR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005785	SPENG001958	FBLN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004498	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP012563	KVSPHSGVVALTKPVPEPR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005785	SPENG001958	FBLN1	2.0619	Others	0.942	0.4157	0.7878	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004498	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP012564	QSNNKYAASSYLSLTPEQWK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004505	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP012565	QSNNKYAASSYLSLTPEQWK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004505	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP012576	ALAPTWEQLALGLEHSETVK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004506	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP012577	ALAPTWEQLALGLEHSETVK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000040	SPENG000572	lnc-EEF1E1-2	1.446	Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004506	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP012580	ATLVCLISDFYPGAVTVAWK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004511	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP012581	ATLVCLISDFYPGAVTVAWK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004511	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP012590	TNTNVNCPIECFMPLDVQADR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.4667	Others	0.4644	0.6588	0.8871	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004517	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP012591	TNTNVNCPIECFMPLDVQADR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004517	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP012592	LQAAQLPHTGVFGQSFSCPSDR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000855	SPENG000474	AC016876.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM004520	SPENO004050	Thyroid cancer:SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP012593	LQAAQLPHTGVFGQSFSCPSDR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000855	SPENG000474	AC016876.2		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM004520	SPENO004050	Thyroid cancer:SPENP012592;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP012594	TETITGFQVDAVPANGQTPIQR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3862	Others	1.4978	0.1651	0.6303	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP012595	TETITGFQVDAVPANGQTPIQR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP012600	TCLHYLGEFGEDQIYEAHQQGR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004523	SPENO002417,SPENO005649	Thyroid cancer:SPENP012601;Colon cancer:SPENP012856,SPENP026436;Lung cancer:SPENP001962
SPENP012601	TCLHYLGEFGEDQIYEAHQQGR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004523	SPENO002417,SPENO005649	Thyroid cancer:SPENP012600;Colon cancer:SPENP012856,SPENP026436;Lung cancer:SPENP001962
SPENP012608	SGDRGETGPAGPAGPVGPVGAR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005758	SPENG002845	COL1A1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004526	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP012609	SGDRGETGPAGPAGPVGPVGAR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004526	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP012614	MVWWPQPGSGMLGTAPSPGRANT	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005176,SPENT005177	SPENG000312,SPENG001849	lnc-TPST1-1,HSALNG0058603		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004536	SPENO002743,SPENO003174	
SPENP012615	MVWWPQPGSGMLGTAPSPGRANT	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005176,SPENT005177	SPENG000312,SPENG001849	lnc-TPST1-1,HSALNG0058603		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004536	SPENO002743,SPENO003174	
SPENP012616	IQDSPVAHLVAIDSNTGEVTAQR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT001464	SPENG002664	lnc-GNPDA1-2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004530	SPENO000631	
SPENP012617	IQDSPVAHLVAIDSNTGEVTAQR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT001464	SPENG002664	lnc-GNPDA1-2	-2.406	Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004530	SPENO000631	
SPENP012626	LQAMWGQSLLPPVSTSFTTGGLR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004532	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012627;Bladder cancer:SPENP017847;Kidney cancer:SPENP020599;Lung cancer:SPENP002859;Colon cancer:SPENP014588,SPENP016279
SPENP012627	LQAMWGQSLLPPVSTSFTTGGLR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004532	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012626;Bladder cancer:SPENP017847;Kidney cancer:SPENP020599;Lung cancer:SPENP002859;Colon cancer:SPENP014588,SPENP016279
SPENP012628	AAQAQGQSCEYSLMVGYQCGQVFR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM004537	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP012629	AAQAQGQSCEYSLMVGYQCGQVFR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM004537	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP012638	TKTETITGFQVDAVPANGQTPIQR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1909	Others	0.5407	0.6006	0.8579	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004540	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP012639	TKTETITGFQVDAVPANGQTPIQR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004540	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP012644	LHLEGYHGTAGDSMSYHSGSVFSAR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004547	SPENO002584,SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012645;Bladder cancer:SPENP017892;Gastric cancer:SPENP003348;Lung cancer:SPENP002891;Colon cancer:SPENP016316,SPENP027069
SPENP012645	LHLEGYHGTAGDSMSYHSGSVFSAR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004547	SPENO002584,SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012644;Bladder cancer:SPENP017892;Gastric cancer:SPENP003348;Lung cancer:SPENP002891;Colon cancer:SPENP016316,SPENP027069
SPENP012646	IGEHSIYCTVNNDEGEWSGPPPECR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005178,SPENT000757	SPENG002919	NONHSAG004121.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004545	SPENO003377,SPENO004614	
SPENP012647	IGEHSIYCTVNNDEGEWSGPPPECR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005178,SPENT000757	SPENG002919	NONHSAG004121.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004545	SPENO003377,SPENO004614	
SPENP012652	SSQSLVYSDGNTYLNWFQQRPGQSPR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004548	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP012653	SSQSLVYSDGNTYLNWFQQRPGQSPR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004548	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP012654	SSQSLVHSDGNTYLSWLQQRPGQPPR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004549	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP012655	SSQSLVHSDGNTYLSWLQQRPGQPPR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004549	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP012658	ACEDIDECSLPNICVFGTCHNLPGLFR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005892	SPENG001317	HSALNG0105758		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004552	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012659
SPENP012659	ACEDIDECSLPNICVFGTCHNLPGLFR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004552	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658
SPENP012672	LGALSGAAALGFASYGAHGAQFPDAYGK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004557	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP012673	LGALSGAAALGFASYGAHGAQFPDAYGK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	2.1606	Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004557	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP012682	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.6489	Others	1.8238	0.118	0.6303	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004564	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP012683	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004564	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP012684	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.5753	Others	1.4188	0.1837	0.6303	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004565	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP012685	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.2762	Others	0.3988	0.7004	0.8871	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004565	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP012686	DGILLCQIPIDLTLQNCSGGAEYVDCSDPK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005172,SPENT005173	SPENG003156,SPENG002760	lnc-MUC19-1,NONHSAG010914.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004566	SPENO000762,SPENO004076	
SPENP012687	DGILLCQIPIDLTLQNCSGGAEYVDCSDPK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005172,SPENT005173	SPENG003156,SPENG002760	lnc-MUC19-1,NONHSAG010914.2		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Non-validated			Immunogenic	SPENM004566	SPENO000762,SPENO004076	
SPENP012690	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004569	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP012691	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004569	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP012692	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004568	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP012693	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004568	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP012700	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Thyroid cancer	Papillary thyroid carcinoma	Blood serum	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.4199	Others	1.5888	0.1432	0.6303	PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004574	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP012701	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Thyroid cancer	Papillary thyroid carcinoma	Urine	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD015360	Comparative glycoproteomic profiling of human body fluid between healthy controls and patients with papillary thyroid carcinoma	Orbitrap Fusion Lumos	TIC	31800250	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004574	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP012746	DIVAAIQHNYK	Colon cancer	Colon cancer	Colon	SPENT005242	SPENG002723	HSALNG0052984	0.2853	Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017393	SPENO005641	
SPENP012760	AYVVLGQFLVLK	Colon cancer	Colon cancer	Colon	SPENT005251	SPENG001089	lnc-MRPS14-5	-0.4723	Others	-2.608	0.2219	0.2988	PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	MS	28137767	Immunogenic	SPENM017410	SPENO001202	Kidney cancer:SPENP014922
SPENP012763	MKTLQYVAFSKK	Colon cancer	Colon cancer	Colon	SPENT005246,SPENT005245	SPENG001876	HSALNG0099826		Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Non-validated			Immunogenic	SPENM017398	SPENO002646,SPENO004878	
SPENP012770	VITTMIYMFKSK	Colon cancer	Colon cancer	Colon	SPENT005250	SPENG001839	lnc-IRS2-1		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Non-validated			Immunogenic	SPENM017408	SPENO001910	
SPENP012777	TSNLLLSHAGILK	Colon cancer	Colon cancer	Colon	SPENT000136,SPENT000135,SPENT000137	SPENG000848	lnc-CDK11A-2		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM017414	SPENO002156,SPENO003659,SPENO006064	Bladder cancer:SPENP017399;Colon cancer:SPENP008305,SPENP027360;Lung cancer:SPENP004077;Anal canal cancer:SPENP024668
SPENP012786	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.649	Others	1.3708	0.3191	0.3863	PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Non-validated			Immunogenic	SPENM017426	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP012789	TQSSLVPALTDFVR	Colon cancer	Colon cancer	Colon	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2	1.8607	Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	MS	28137767	Immunogenic	SPENM017439	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050
SPENP012790	VLLESEQFLTELTR	Colon cancer	Colon cancer	Colon	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017430	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP001600
SPENP012793	VLQATVVAVGSGSK	Colon cancer	Colon cancer	Colon	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	MS	28137767	Immunogenic	SPENM017433	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP026461
SPENP012809	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017449	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP012810	IPAFLNVVDIAGLVK	Colon cancer	Colon cancer	Colon	SPENT002261	SPENG002542	lnc-NDUFA6-1	-0.81	Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017452	SPENO005863	Breast cancer:SPENP008910;Lung cancer:SPENP026556;Prostate cancer:SPENP012998
SPENP012817	TYYMSGGLQPVPIVFR	Colon cancer	Colon cancer	Colon	SPENT005260	SPENG001570	lnc-ACOX2-2	0.3654	Others	0.9975	0.4571	0.5161	PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017458	SPENO003207	Lung cancer:SPENP028393
SPENP012823	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon	SPENT000014	SPENG003410	ACAT1	-0.5984	Others	-5.348	0.0332	0.1304	PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017465	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314;Leukemia:SPENP001289
SPENP012826	TFDFWKDIVAAIQHNYK	Colon cancer	Colon cancer	Colon	SPENT005242	SPENG002723	HSALNG0052984		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017462	SPENO005641	
SPENP012827	SWNSWQGFNPFSSGGPFR	Colon cancer	Colon cancer	Colon	SPENT005266	SPENG000990	NONHSAG013996.2		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	MS	28137767	Immunogenic	SPENM017474	SPENO002349	
SPENP012829	TVAFLNQFVVHTVQFLNR	Colon cancer	Colon cancer	Colon	SPENT005265	SPENG003671	HSALNG0093548	-0.6083	Others	-2.496	0.1344	0.2352	PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017468	SPENO000993	
SPENP012830	NQLDQEVEFLSTSIAQLK	Colon cancer	Colon cancer	Colon	SPENT002156	SPENG002374	NONHSAG011229.2	-0.471	Others	-1.635	0.3494	0.4077	PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017471	SPENO002603	Bladder cancer:SPENP028700,SPENP011631
SPENP012838	TTVLLADINDFNTVNEIYK	Colon cancer	Colon cancer	Colon	SPENT003329,SPENT003330	SPENG001096	HSALNG0067190		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	sORF.org_record	26527729	Immunogenic	SPENM017478	SPENO004169,SPENO004502	Thyroid cancer:SPENP012540,SPENP012541;Colon cancer:SPENP000488;Bladder cancer:SPENP017762;Liver cancer:SPENP000735
SPENP012841	TGVHHYSGNNIELGTACGK	Colon cancer	Colon cancer	Colon	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	5.714	Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	MS	28137767	Immunogenic	SPENM017480	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP024218
SPENP012845	ISQAEEEDQQLLGHLLLVAK	Colon cancer	Colon cancer	Colon	SPENT002815	SPENG000837	lnc-HINT2-1		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017484	SPENO001580	Breast cancer:SPENP008997;Skin cancer:SPENP025405;Bladder cancer:SPENP028609;Lung cancer:SPENP028299,SPENP007835;Prostate cancer:SPENP023755
SPENP012846	TYLVSGQPLEEIITYYPAMK	Colon cancer	Colon cancer	Colon	SPENT000965	SPENG000698	SLC25A25-AS1	-0.154	Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017492	SPENO005957	Breast cancer:SPENP023054,SPENP023055;Colon cancer:SPENP007384,SPENP000498;Lung cancer:SPENP026112
SPENP012852	MYGECMATFLDQIVSFLWPR	Colon cancer	Colon cancer	Colon	SPENT005274	SPENG000924	HSALNG0117567		Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Non-validated			Immunogenic	SPENM017483	SPENO002570	
SPENP012854	QVTITGSAASISLAQYLINVR	Colon cancer	Colon cancer	Colon	SPENT000780,SPENT005279	SPENG002270,SPENG002127	lnc-JPH1-12,HSALNG0091279		Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017493	SPENO001675,SPENO004718	
SPENP012855	EKPYFPIPEEYTFIQNVPLEDR	Colon cancer	Colon cancer	Colon	SPENT000348	SPENG000430	lnc-HNRNPU-1		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	sORF.org_record	26527729	Immunogenic	SPENM017495	SPENO006036	Liver cancer:SPENP000764
SPENP012856	TCLHYLGEFGEDQIYEAHQQGR	Colon cancer	Colon cancer	Colon	SPENT000917,SPENT000916	SPENG003022	lnc-PROB1-1	2.6656	Others				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Non-validated			Immunogenic	SPENM017496	SPENO002417,SPENO005649	Thyroid cancer:SPENP012600,SPENP012601;Colon cancer:SPENP026436;Lung cancer:SPENP001962
SPENP012857	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017494	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP012865	GQGNWNMGPPGGLQEFNFIVPTGK	Colon cancer	Colon cancer	Colon	SPENT000067,SPENT000066	SPENG001084	NONHSAG001878.3		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017504	SPENO002062,SPENO002283	
SPENP012873	NQSQGYNQWQQGQFWGQKPWSQHYHQGYY	Colon cancer	Colon cancer	Colon	SPENT000348	SPENG000430	lnc-HNRNPU-1		Tumor-specific				PXD015653	Comprehensive analysis of symmetric arginine dimethylation in colorectal cancer tissues from patients using immuniaffinity enrichment followed by LC-MS/MS analysis	LTQ Orbitrap Velos	MS1 intensity label-free quantification method 	32468700	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM017511	SPENO006036	
SPENP012875	DIQMTQSPSSLSASVGDR	Prostate cancer	Prostate cancer	Kidney	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.3376	Others	1.623	0.2031	0.6533	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Non-validated			Immunogenic	SPENM020090	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP012898	VMVQPINLIFR	Prostate cancer	Prostate cancer	Kidney	SPENT002273,SPENT002272,SPENT002270,SPENT002271,SPENT002267,SPENT002269,SPENT002268	SPENG003098,SPENG003309,SPENG003607,SPENG001915,SPENG000941,SPENG003601,SPENG000906	lnc-ID2-3,lnc-ZC3H12D-15,HSALNG0054220,HSALNG0012839,lnc-FABP6-3,HSALNG0046238,lnc-GLDC-5	-0.0572	Others	-0.2594	0.8006	0.8463	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM019955	SPENO000391,SPENO001158,SPENO001668,SPENO002054,SPENO002219,SPENO003493,SPENO004771	Breast cancer:SPENP008819;Liver cancer:SPENP004794;Kidney cancer:SPENP014910;Tongue cancer:SPENP028143;Lung cancer:SPENP026626
SPENP012900	DKLNNLVLFDK	Prostate cancer	Prostate cancer	Kidney	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	1.0787	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM019938	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP012902	FVFDRPLPVSR	Prostate cancer	Prostate cancer	Kidney	SPENT005285,SPENT002750,SPENT002749,SPENT002747,SPENT002748	SPENG000915,SPENG001756	NONHSAG007721.2,lnc-PSMA1-2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019944	SPENO001983,SPENO003367,SPENO003461,SPENO004631,SPENO005941	
SPENP012916	YLLLSDLPGVR	Prostate cancer	Prostate cancer	Kidney	SPENT000174	SPENG000603	DMAC2L		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019952	SPENO004847	Colon cancer:SPENP015693;Kidney cancer:SPENP020025
SPENP012926	LALFNPDVCWDR	Prostate cancer	Prostate cancer	Kidney	SPENT000882,SPENT005291	SPENG001524,SPENG000168	lnc-THSD7A-3,HSALNG0056169		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019977	SPENO002858,SPENO003888	
SPENP012927	FLEEYLSSTPQR	Prostate cancer	Prostate cancer	Kidney	SPENT002760	SPENG002531	NONHSAG014457.2	0.3555	Others	0.3833	0.7173	0.8413	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM019966	SPENO003138	Skin cancer:SPENP025159;Kidney cancer:SPENP014941;Bile duct cancer:SPENP013357;Tongue cancer:SPENP027660;Lung cancer:SPENP007614,SPENP028269,SPENP026519
SPENP012928	LVILANNCPALR	Prostate cancer	Prostate cancer	Kidney	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	1.2744	Others	2.3398	0.0579	0.4773	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019982	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP012932	VPFLVLECPNLK	Prostate cancer	Prostate cancer	Kidney	SPENT000354	SPENG002378	HSALNG0036293	1.7628	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM019975	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP012937	YQLDPTASISAK	Prostate cancer	Prostate cancer	Kidney	SPENT000102	SPENG002045	lnc-ACTR2-11	-0.4406	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019960	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP012938	ALLANALTSALR	Prostate cancer	Prostate cancer	Kidney	SPENT002117	SPENG003627	NONHSAG037834.2	0.2388	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM019968	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP012947	MQAGKPILYSYFR	Prostate cancer	Prostate cancer	Kidney	SPENT002649,SPENT005295	SPENG002277	HSALNG0102648	0.9915	Others	2.0128	0.2892	0.7546	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019999	SPENO000954,SPENO004485	
SPENP012954	VALAGLLGFGLGK	Prostate cancer	Prostate cancer	Kidney	SPENT003237	SPENG001444	lnc-OCIAD2-2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019995	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010336,SPENP010335,SPENP024026;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP018206
SPENP012965	SFHFSLPSSWYYR	Prostate cancer	Prostate cancer	Kidney	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019994	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP012966	LAGVTALSCWLPLR	Prostate cancer	Prostate cancer	Kidney	SPENT000779	SPENG000351	lnc-TCEA1-1		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM020006	SPENO005550	Colon cancer:SPENP001606;Lung cancer:SPENP007670
SPENP012968	LVVPASQCGSLIGK	Prostate cancer	Prostate cancer	Kidney	SPENT000780,SPENT000381,SPENT000781	SPENG002127,SPENG002276,SPENG000649	lnc-JPH1-12,HSALNG0091275,AC023509.1	1.1682	Others	2.5213	0.0452	0.4773	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020011	SPENO000396,SPENO001115,SPENO001674	Colon cancer:SPENP001608
SPENP012976	VLLESEQFLTELTR	Prostate cancer	Prostate cancer	Kidney	SPENT000771,SPENT000770	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3	0.4656	Others	0.8641	0.406	0.7799	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020015	SPENO000598,SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401,SPENP026623;Prostate cancer:SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP012977	DYGVYLEDSGHTLR	Prostate cancer	Prostate cancer	Kidney	SPENT000669	SPENG001255	NONHSAG054153.2	-0.2463	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020026	SPENO005158	
SPENP012991	MLITILGTVKPNANR	Prostate cancer	Prostate cancer	Kidney	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020030	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP012998	IPAFLNVVDIAGLVK	Prostate cancer	Prostate cancer	Kidney	SPENT002261	SPENG002542	lnc-NDUFA6-1	-0.0294	Others	-0.1311	0.8986	0.9109	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020036	SPENO005863	Breast cancer:SPENP008910;Colon cancer:SPENP012810;Lung cancer:SPENP026556
SPENP013002	ALAQEILPQAPIAVR	Prostate cancer	Prostate cancer	Kidney	SPENT005311,SPENT005310	SPENG001634	NONHSAG001488.2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020041	SPENO000720,SPENO005888	
SPENP013016	DDPSKPVHLTAFLGYK	Prostate cancer	Prostate cancer	Kidney	SPENT005314	SPENG001619	lnc-PDGFB-2	-1.054	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020049	SPENO006265	
SPENP013030	TPIGSFLGSLSLLPATK	Prostate cancer	Prostate cancer	Kidney	SPENT000014	SPENG003410	ACAT1	0.2799	Others	0.6108	0.5583	0.8413	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020079	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP013039	KLFIGGLSFETTDDSLR	Prostate cancer	Prostate cancer	Kidney	SPENT000852,SPENT000663	SPENG002730,SPENG003748	lnc-LRIG2-10,lnc-FRG2C-16		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	31340039	Immunogenic	SPENM020074	SPENO000364,SPENO005517	
SPENP013041	ALIGATNPADAPPGTIR	Prostate cancer	Prostate cancer	Kidney	SPENT002171	SPENG000588	HSALNG0108933	0.1353	Others	0.4484	0.6674	0.8413	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020072	SPENO005632	Anal canal cancer:SPENP024812;Colon cancer:SPENP024169,SPENP010698,SPENP000423,SPENP010697;Bladder cancer:SPENP011597
SPENP013045	TLSDYNIQKESTLHLVLR	Prostate cancer	Prostate cancer	Kidney	SPENT002337,SPENT002335	SPENG001112	lnc-CDH8-4	1.1848	Others	1.7907	0.1165	0.5386	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM020086	SPENO004206,SPENO005136	Breast cancer:SPENP008959
SPENP013048	STDTGVSLPSYEEDQGSK	Prostate cancer	Prostate cancer	Kidney	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	0.9599	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM020085	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP013056	PTPQSLGEPTECWWEEINR	Prostate cancer	Prostate cancer	Kidney	SPENT005318	SPENG002151	lnc-DPT-2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020097	SPENO004569	
SPENP013057	TGVHHYSGNNIELGTACGK	Prostate cancer	Prostate cancer	Kidney	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM020093	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP013061	AAWFLQELPSFAVPAGILAR	Prostate cancer	Prostate cancer	Kidney	SPENT004083,SPENT004084	SPENG000868	lnc-SRD5A2-3		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Non-validated			Immunogenic	SPENM020107	SPENO000852,SPENO003723	Bladder cancer:SPENP017788
SPENP013066	AFVFDVIHEGCLVTPPELLR	Prostate cancer	Prostate cancer	Kidney	SPENT005327	SPENG001031	HSALNG0059380		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020109	SPENO003080	
SPENP013068	ALAPTWEQLALGLEHSETVK	Prostate cancer	Prostate cancer	Kidney	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Non-validated			Immunogenic	SPENM020110	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP013075	ADRDESSPYAAMLAAQDVAQR	Prostate cancer	Prostate cancer	Kidney	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.5016	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020121	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP013084	SGDRGETGPAGPAGPVGPVGAR	Prostate cancer	Prostate cancer	Kidney	SPENT005758	SPENG002845	COL1A1	2.3205	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020128	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP013085	LQAAQLPHTGVFGQSFSCPSDR	Prostate cancer	Prostate cancer	Kidney	SPENT000855	SPENG000474	AC016876.2		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM020127	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP013086	EAPFVPVGIAGFAAIVAYGLYK	Prostate cancer	Prostate cancer	Kidney	SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	MS	28137767	Immunogenic	SPENM020126	SPENO000724	Bladder cancer:SPENP017836;Kidney cancer:SPENP020577
SPENP013091	NSITLTNLTPGTEYVVSIVALNGR	Prostate cancer	Prostate cancer	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020139	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP013095	AAQAQGQSCEYSLMVGYQCGQVFR	Prostate cancer	Prostate cancer	Kidney	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM020131	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP013097	STATISGLKPGVDYTITVYAVTGR	Prostate cancer	Prostate cancer	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020140	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP013098	DLEVVAATPTSLLISWDAPAVTVR	Prostate cancer	Prostate cancer	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.585	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020132	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP013099	TKTETITGFQVDAVPANGQTPIQR	Prostate cancer	Prostate cancer	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.196	Others	-0.5312	0.6321	0.8413	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020133	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP013104	GVTVFAGVIDPDYQDEISLLLHSGGK	Prostate cancer	Prostate cancer	Kidney	SPENT005331,SPENT005332	SPENG001097	HSALNG0139048	-1.203	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Non-validated			Immunogenic	SPENM020146	SPENO002421,SPENO002863	
SPENP013105	TGLDSPTGIDFSDITANSFTVHWIAPR	Prostate cancer	Prostate cancer	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.18	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020147	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP013109	LGALSGAAALGFASYGAHGAQFPDAYGK	Prostate cancer	Prostate cancer	Kidney	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	0.3598	Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020151	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP013112	AGSVPSLAAGLLFGSLAGLGAYQLSQDPR	Prostate cancer	Prostate cancer	Kidney	SPENT002586	SPENG000664	HSALNG0048031	-0.6996	Others	-1.325	0.2219	0.6841	PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020154	SPENO005017	Tongue cancer:SPENP027510;Colon cancer:SPENP014672
SPENP013113	RPQYSNPPVQGEVMEGADNQGAGEQGRPVR	Prostate cancer	Prostate cancer	Kidney	SPENT003109,SPENT005333	SPENG000587,SPENG003642	lnc-OR2S2-1,lnc-MAX-16		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020155	SPENO001559,SPENO005559	
SPENP013115	FIGAGAATVGVAGSGAGIGTVFGSLIIGYAR	Prostate cancer	Prostate cancer	Kidney	SPENT000872	SPENG002982	NONHSAG011251.2		Others				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020157	SPENO000183	Colon cancer:SPENP001775
SPENP013117	AGPAAAFRRLGALSGAAALGFASYGAHGAQFPDAYGK	Prostate cancer	Prostate cancer	Kidney	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Tumor-specific				PXD015981	Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer	LTQ Orbitrap Elite, Q Exactive	MS1 intensity based label-free quantification method	31682457	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020158	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Colon cancer:SPENP001780
SPENP013218	ITDVALDFWR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005341,SPENT005342	SPENG000350,SPENG001483	lnc-C9orf78-1,HSALNG0074770		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018464	SPENO000849,SPENO005455	
SPENP013219	ALDDISESIK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT001698,SPENT001699,SPENT001700,SPENT006008,SPENT001697	SPENG003864	HSALNG0087308	0.2326	Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018442	SPENO001359,SPENO003408,SPENO003992,SPENO004226,SPENO005257	
SPENP013272	DKLNNLVLFDK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	0.5577	Others	1.882	0.0666	0.2041	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018515	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP013299	RFVNVVPTFGK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	0.6155	Others	1.001	0.3233	0.5433	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018546	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP013307	YQLDPTASISAK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000102	SPENG002045	lnc-ACTR2-11	0.4569	Others	1.5932	0.122	0.2883	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018558	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP013313	YLYNMIMLLSIM	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005350	SPENG003269	HSALNG0102963		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018557	SPENO002386	Colon cancer:SPENP015809;Kidney cancer:SPENP014955
SPENP013315	IDSLMDEISFLK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT002534	SPENG002447	lnc-NEFL-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018584	SPENO001836	
SPENP013321	LCTMNTQILTVK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005359	SPENG003019	HSALNG0021128	0.7378	Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018577	SPENO002307	
SPENP013344	VPFLVLECPNLK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000354	SPENG002378	HSALNG0036293	0.8054	Others	1.0047	0.3251	0.5433	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018549	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP013348	GQAGVMGFPGPK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005758	SPENG002845	COL1A1	-3.255	Down-regulated in tumors	-3.676	0.0051	0.0476	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018594	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP013357	FLEEYLSSTPQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT002760	SPENG002531	NONHSAG014457.2	0.2737	Others	0.9725	0.3371	0.5595	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018588	SPENO003138	Skin cancer:SPENP025159;Kidney cancer:SPENP014941;Tongue cancer:SPENP027660;Lung cancer:SPENP007614,SPENP028269,SPENP026519;Prostate cancer:SPENP012927
SPENP013386	TTAAMWALQTVEK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018604	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP013392	HVISYSLSPFEQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018614	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP013396	IASGLGLAWIVGR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000591,SPENT000592	SPENG002721	HSALNG0008146		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018622	SPENO001126,SPENO004752	Anal canal cancer:SPENP024640;Lung cancer:SPENP026552
SPENP013399	YISPHNGPVVPLM	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005365,SPENT005364,SPENT005361,SPENT005363,SPENT005362	SPENG002180	HSALNG0010247		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018644	SPENO000040,SPENO002024,SPENO002055,SPENO005266,SPENO005723	
SPENP013402	TEVLSEDLLQIER	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005992	SPENG003790	ARHGAP17		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018652	SPENO004570	Ovary cancer:SPENP016510;Colon cancer:SPENP024018,SPENP007097
SPENP013403	YAMVYGYNAAYNR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018647	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP013410	YEEIIKEVSTYIK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT002126	SPENG003586	lnc-FOXL2NB-4	0.5232	Others	1.4318	0.1629	0.3562	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018637	SPENO001634	Breast cancer:SPENP008868;Skin cancer:SPENP025217;Kidney cancer:SPENP020227;Anal canal cancer:SPENP024645
SPENP013416	SSFSYEPYYSTSYK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT002534	SPENG002447	lnc-NEFL-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018658	SPENO001836	
SPENP013419	FLFENQTPAHVYYR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005000	SPENG003253	NONHSAG036275.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018667	SPENO004275	Colon cancer:SPENP024072
SPENP013435	QYNVGPSVSKYPLR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.079	Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018660	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP013448	MLITILGTVKPNANR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	0.9132	Others	2.7837	0.0084	0.0597	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018729	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP013455	YAASSYLSLTPEQWK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.164	Others	-1.965	0.077	0.2121	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018694	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP013469	VLYAYGYYTGEPSKR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000591,SPENT000592,SPENT000590	SPENG002721,SPENG002503	HSALNG0008146,NONHSAG003338.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018714	SPENO000007,SPENO001126,SPENO004752	Anal canal cancer:SPENP024773
SPENP013488	LQGALHSAEMAPYSL	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005368	SPENG001453	HSALNG0048644		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018697	SPENO002577	
SPENP013493	EALCGCSINVPTLDGR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000515	SPENG000486	NONHSAG001879.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018739	SPENO000704	Tongue cancer:SPENP027603;Lung cancer:SPENP007733;Prostate cancer:SPENP018322,SPENP012067;Colon cancer:SPENP016075,SPENP007276;Leukemia:SPENP001237
SPENP013499	SGANAATSQASATWAR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005377,SPENT005376,SPENT005375	SPENG000725,SPENG001724	NONHSAG032280.2,AL121827.1	-1.75	Others	-2.148	0.0982	0.2532	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018741	SPENO001679,SPENO005191,SPENO005469	
SPENP013505	DLMELQALIDSHFEAR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005378	SPENG003425	NONHSAG007402.2	-0.5418	Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018743	SPENO002428	
SPENP013521	SAYSSYSAPVSSSLSVR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT002534	SPENG002447	lnc-NEFL-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018759	SPENO001836	Kidney cancer:SPENP020422;Prostate cancer:SPENP018353
SPENP013527	CPSIAAAIAAVNALHGR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000221,SPENT000220,SPENT000234	SPENG000739,SPENG000807	RBM39,lnc-NFS1-1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018769	SPENO005081,SPENO005525,SPENO006140	Colon cancer:SPENP001673,SPENP026729,SPENP000417;Lung cancer:SPENP004381;Kidney cancer:SPENP020438
SPENP013537	TPIGSFLGSLSLLPATK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000014	SPENG003410	ACAT1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018768	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP013541	DIQMTQSPSSLSASVGDR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-1.674	Others	-3.4	0.0079	0.0597	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018786	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP013543	GETGPAGPAGPVGPVGAR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005758	SPENG002845	COL1A1	-2.469	Down-regulated in tumors	-4.272	0.0013	0.0177	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018793	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP013547	LGSAPAASPALASPEGPK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT002963	SPENG002091	lnc-CCDC9B-3		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018798	SPENO004033	Colon cancer:SPENP008555
SPENP013549	VSPHSGVVALTKPVPEPR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018784	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP013550	STDTGVSLPSYEEDQGSK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018788	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP013551	YLMKADLMPFLYWNMMLR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005381	SPENG001036	HSALNG0105661	-2.244	Others	-1.191	0.3194	0.5433	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018783	SPENO002360	
SPENP013558	DESSPYAAMLAAQDVAQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.7454	Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018790	SPENO000942,SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP010781,SPENP007344
SPENP013562	YAASSYLSLTPEQWKSHR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000202,SPENT000080,SPENT000201,SPENT000081,SPENT000204	SPENG000666	NONHSAG033390.3		Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated	MS	28137767	Immunogenic	SPENM018782	SPENO000395,SPENO003620,SPENO004364,SPENO004816,SPENO005374	Gastric cancer:SPENP015380;Kidney cancer:SPENP020459;Skin cancer:SPENP025360
SPENP013564	QTLSTPGTIILGTIPVPK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	MS	28137767	Immunogenic	SPENM018799	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Lung cancer:SPENP002694,SPENP004453,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP001697,SPENP000454
SPENP013572	APSLTGPSVGLEAGQGPTK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT004074	SPENG000459	lnc-ANGPTL2-7	-0.1297	Others	-0.2794	0.7828	0.9252	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018823	SPENO004233	Bladder cancer:SPENP017770
SPENP013580	KVSPHSGVVALTKPVPEPR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018807	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP013588	ATLVCLISDFYPGAVTVAWK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.5922	Others	-0.791	0.4405	0.6566	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018827	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP013591	ALAPTWEQLALGLEHSETVK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.2612	Others	-0.8169	0.4186	0.6367	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018836	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP013595	QSNNKYAASSYLSLTPEQWK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018842	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP013597	YFILPDSLPLDTLLVDVEPK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000928	SPENG002213	HSALNG0120314	0.6928	Others	0.5847	0.5638	0.7626	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018837	SPENO000238	Tongue cancer:SPENP028202;Lung cancer:SPENP026636,SPENP026177,SPENP001946;Skin cancer:SPENP025399
SPENP013610	ADRDESSPYAAMLAAQDVAQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	1.0104	Others	1.2723	0.2141	0.4385	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018845	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP013612	TNTNVNCPIECFMPLDVQADR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-1.513	Others	-3.483	0.04	0.1599	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018851	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP013614	HRPRPYPPNVGEEIQIGHIPR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005757	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018844	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP013618	DTLTSRPAQGVVTTLENVSPPR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6324	Others	1.1973	0.2445	0.4707	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018861	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP013619	TETITGFQVDAVPANGQTPIQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018862	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP013622	SGDRGETGPAGPAGPVGPVGAR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005758	SPENG002845	COL1A1	-1.953	Down-regulated in tumors	-3.624	0.0039	0.0394	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018864	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP013624	LQAAQLPHTGVFGQSFSCPSDR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000855	SPENG000474	AC016876.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM018860	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP013626	VKADRDESSPYAAMLAAQDVAQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018870	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP013627	ATFYTPQNPSSLAPAPLRPLEDR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT001336	SPENG001086	HSALNG0049384		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018873	SPENO005428	Bladder cancer:SPENP017857;Kidney cancer:SPENP020611;Lung cancer:SPENP002849;Colon cancer:SPENP024279,SPENP016277
SPENP013631	QGLYELSASNFELHVAQGDHFIK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018866	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP013634	DTLTSRPAQGVVTTLENVSPPRR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2113	Others	-0.3746	0.7121	0.8724	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018876	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP013637	DLEVVAATPTSLLISWDAPAVTVR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018883	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP013642	TKTETITGFQVDAVPANGQTPIQR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018884	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP013645	SYTITGLQPGTDYKIYLYTLNDNAR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018886	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP013646	IGPHDSITSLGPSHNMWEFWEIQFK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005391	SPENG000289	HSALNG0057782		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018894	SPENO005429	
SPENP013649	RCIQLSLQSQDKPAPTHYWLNLTNR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005881,SPENT005880,SPENT005388,SPENT005389,SPENT005390	SPENG001462,SPENG000903,SPENG002769,SPENG000997	F11-AS1,HSALNG0039173,NONHSAG039542.2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018891	SPENO000968,SPENO002393,SPENO004194,SPENO004749,SPENO006057	
SPENP013653	MSGANAATSQASATWARLPAHEYSR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005377,SPENT005376,SPENT005375	SPENG000725,SPENG001724	NONHSAG032280.2,AL121827.1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018893	SPENO001679,SPENO005191,SPENO005469	
SPENP013655	TNTNVNCPIECFMPLDVQADREDSRE	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018895	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP013657	TGLDSPTGIDFSDITANSFTVHWIAPR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018898	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP013662	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005913	SPENG001766	AL662884.2		Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018902	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP013665	EFDYVINDLTAVPISTSPEEDSTWEFLR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005334	SPENG003619	lnc-LY9-3	0.5325	Others				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018903	SPENO001607	
SPENP013669	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018912	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP013670	ASADELTFHEFEEATNLLADTPDAATTSR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT001420	SPENG000627	lnc-TMED1-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018911	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP013673	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.7907	Others	2.1119	0.041	0.1599	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018917	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP013677	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018913	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP013678	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018921	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP013680	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.0668	Others	-0.1447	0.8859	0.9597	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018922	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP013685	EIPAPGTLGPLHIPGHTLSPAPAPAPSRPALGK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005380	SPENG001435	lnc-PPY-1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018929	SPENO002398	
SPENP013687	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018926	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP013690	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018931	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP013696	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005797,SPENT005805	SPENG002649	FGA	1.8931	Others	5.5417	0.1011	0.2532	PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Non-validated			Immunogenic	SPENM018937	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Lung cancer:SPENP004723,SPENP007924,SPENP001983;Colon cancer:SPENP024345,SPENP011202,SPENP011201
SPENP013697	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018938	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP013698	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Bile duct cancer	Distal cholangiocarcinoma	Bile duct	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD017906	Proteomic analysis of distal cholangiocarcinoma	Q Exactive	Label free	32887625	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM018939	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP013761	MVIFSPPNSCK	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT005403,SPENT005407,SPENT005405,SPENT005411,SPENT005406,SPENT005412,SPENT005409,SPENT005408,SPENT005404,SPENT005410	SPENG003339,SPENG000883,SPENG001065,SPENG003376,SPENG002469,SPENG003281,SPENG000970,SPENG001049,SPENG003329	NONHSAG029018.2,,FAM138A,HSALNG0018067,FAM138F,FAM138B,NONHSAG024270.2,FAM138C,FAM138E,FAM138D		Tumor-specific				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Non-validated			Immunogenic	SPENM011502	SPENO000489,SPENO000568,SPENO000855,SPENO002106,SPENO003913,SPENO004102,SPENO005228,SPENO005476,SPENO005809,SPENO006086	
SPENP013762	MVIFSPPNSCK	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT005403,SPENT005407,SPENT005405,SPENT005411,SPENT005406,SPENT005412,SPENT005409,SPENT005408,SPENT005404,SPENT005410	SPENG003339,SPENG000883,SPENG001065,SPENG003376,SPENG002469,SPENG003281,SPENG000970,SPENG001049,SPENG003329	NONHSAG029018.2,,FAM138A,HSALNG0018067,FAM138F,FAM138B,NONHSAG024270.2,FAM138C,FAM138E,FAM138D		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Non-validated			Immunogenic	SPENM011502	SPENO000489,SPENO000568,SPENO000855,SPENO002106,SPENO003913,SPENO004102,SPENO005228,SPENO005476,SPENO005809,SPENO006086	
SPENP013773	MQPQESHVHYSR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT002409	SPENG002995	HSALNG0000347	0.2093	Others	0.3721	0.7314	0.9686	PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011510	SPENO004438	Kidney cancer:SPENP013774,SPENP020095;Prostate cancer:SPENP011971
SPENP013774	MQPQESHVHYSR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT002409	SPENG002995	HSALNG0000347		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011510	SPENO004438	Kidney cancer:SPENP013773,SPENP020095;Prostate cancer:SPENP011971
SPENP013801	VLQATVVAVGSGSK	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4	0.2007	Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	MS	28137767	Immunogenic	SPENM011524	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP013802	VLQATVVAVGSGSK	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	MS	28137767	Immunogenic	SPENM011524	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP013813	ILIMWQAELQICQR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT005421	SPENG002004	HSALNG0135587		Tumor-specific				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Non-validated			Immunogenic	SPENM011530	SPENO000294	
SPENP013814	ILIMWQAELQICQR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT005421	SPENG002004	HSALNG0135587		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Non-validated			Immunogenic	SPENM011530	SPENO000294	
SPENP013863	DIQMTQSPSSLSASVGDR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	2.2305	Others	0.7733	0.4825	0.965	PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Non-validated			Immunogenic	SPENM011555	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP013864	DIQMTQSPSSLSASVGDR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Tumor-specific				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Non-validated			Immunogenic	SPENM011555	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP013867	LVQYRGEVQAMLGQSTEELR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT001557	SPENG000516	NONHSAG026010.2		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011558	SPENO004790	
SPENP013868	LVQYRGEVQAMLGQSTEELR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT001557	SPENG000516	NONHSAG026010.2		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011558	SPENO004790	
SPENP013877	LVQYRGEVQAMLGQSTEELRVR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles	SPENT001557	SPENG000516	NONHSAG026010.2		Others				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011562	SPENO004790	
SPENP013878	LVQYRGEVQAMLGQSTEELRVR	Kidney cancer	Renal cell carcinoma	Blood plasma extracellular vesicles phosphoproteomic	SPENT001557	SPENG000516	NONHSAG026010.2		Tumor-specific				PXD017994	Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification	Q Exactive	Normalized Spectral Abundance Factor-NSAF	32396726	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011562	SPENO004790	
SPENP013978	LLLYGLHHGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-1.848	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011675	SPENO002584	Colon cancer:SPENP027082,SPENP015665;Lung cancer:SPENP002187
SPENP013994	VVFSQQELRK	Colon cancer	Colon cancer	Colon epithelium	SPENT002442	SPENG001308	NONHSAG011552.2	-0.6249	Others	-1.614	0.1818	0.4386	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011698	SPENO004839	
SPENP014012	AVYTLTSLYR	Colon cancer	Colon cancer	Colon epithelium	SPENT000988	SPENG000380	lnc-DIABLO-1		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM011689	SPENO003093	Bladder cancer:SPENP017167;Kidney cancer:SPENP019937;Lung cancer:SPENP002154;Prostate cancer:SPENP018082;Colon cancer:SPENP008071,SPENP026722,SPENP015676
SPENP014033	NSVLMSGFSHK	Colon cancer	Colon cancer	Colon epithelium	SPENT001640	SPENG000521	AMPD2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011776	SPENO000624	Lung cancer:SPENP025971
SPENP014054	GSLASLDSLRK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	0.7602	Others	1.4004	0.2559	0.5059	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011730	SPENO005858	Colon cancer:SPENP026916,SPENP008125,SPENP015749;Bladder cancer:SPENP017222;Kidney cancer:SPENP020052;Prostate cancer:SPENP011932
SPENP014099	RFVNVVPTFGK	Colon cancer	Colon cancer	Colon epithelium	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	-1.196	Down-regulated in tumors	-5.307	0.0001	0.0331	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM011758	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409
SPENP014108	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000354	SPENG002378	HSALNG0036293	0.915	Others	1.8475	0.0845	0.3133	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM011803	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP014118	ASGIYSCLQLNK	Colon cancer	Colon cancer	Colon epithelium	SPENT002465	SPENG000424	HSALNG0020817	-1.236	Others	-1.952	0.0794	0.3111	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011800	SPENO005910	
SPENP014122	GQAGVMGFPGPK	Colon cancer	Colon cancer	Colon epithelium	SPENT005758	SPENG002845	COL1A1	-0.5799	Others	-0.9565	0.3827	0.6108	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011795	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP014146	YQLDPTASISAK	Colon cancer	Colon cancer	Colon epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11	0.0962	Others	0.4274	0.6742	0.8294	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011836	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP015820;Leukemia:SPENP001036
SPENP014153	LTTAFEEVWGVI	Colon cancer	Colon cancer	Colon epithelium	SPENT000432	SPENG003561	HSALNG0088954		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011833	SPENO000058	
SPENP014156	RYMDGMTVGVVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005796	SPENG001958	FBLN1	1.8031	Others	0.8259	0.4405	0.6686	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011817	SPENO003698	Ovary cancer:SPENP016486;Colon cancer:SPENP008201,SPENP015769;Gastric cancer:SPENP003524
SPENP014158	NQSLIPLLLEAR	Colon cancer	Colon cancer	Colon epithelium	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011805	SPENO004045	Lung cancer:SPENP002319,SPENP025968,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP008231;Leukemia:SPENP001056
SPENP014174	AAALVLQTIWGYK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	0.0808	Others	0.2556	0.8068	0.9081	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011901	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP014181	HVISYSLSPFEQR	Colon cancer	Colon cancer	Colon epithelium	SPENT001666	SPENG002113	HSALNG0044883	-0.8603	Others	-2.101	0.0557	0.257	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011913	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP008320
SPENP014217	RLTPLQYHVTQEK	Colon cancer	Colon cancer	Colon epithelium	SPENT002442	SPENG001308	NONHSAG011552.2	-0.192	Others	-0.2091	0.8396	0.9329	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011877	SPENO004839	
SPENP014226	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon epithelium	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.4831	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011899	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP000281,SPENP015902
SPENP014229	SGTLYSLTLYGLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011881	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013
SPENP014230	MSISSAWSGAEFK	Colon cancer	Colon cancer	Colon epithelium	SPENT002873	SPENG003103	HSALNG0077152	3.0983	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011871	SPENO001648	
SPENP014237	QVRPIVGPFHAVLK	Colon cancer	Colon cancer	Colon epithelium	SPENT005796	SPENG001958	FBLN1	0.5659	Others	0.6383	0.5392	0.7559	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011923	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331,SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP015976
SPENP014245	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5776	Others	0.5608	0.5952	0.777	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011927	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP014250	ADGQMPFSCHYPSR	Colon cancer	Colon cancer	Colon epithelium	SPENT001996,SPENT001995	SPENG000039	NONHSAG012478.2	0.2364	Others	0.2796	0.7937	0.8999	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011958	SPENO000668,SPENO002663	Colon cancer:SPENP015956,SPENP008395;Bladder cancer:SPENP017518;Kidney cancer:SPENP020300
SPENP014251	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018	SPENG003202	HMGCL	-0.2535	Others	-0.5972	0.5593	0.7688	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011951	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP010449;Leukemia:SPENP001146
SPENP014252	LQREEAENTLQSFR	Colon cancer	Colon cancer	Colon epithelium	SPENT000948	SPENG002072	NONHSAG005322.2		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011920	SPENO004324	
SPENP014253	RLVQSPNSYFMDVK	Colon cancer	Colon cancer	Colon epithelium	SPENT000414,SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051	0.7907	Others	1.2983	0.2265	0.474	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM011937	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP010432,SPENP006523
SPENP014254	VTDATETTITISWR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2303	Others	0.9468	0.361	0.5997	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011928	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP015931
SPENP014256	RNEQSLQEIWDYVK	Colon cancer	Colon cancer	Colon epithelium	SPENT001225,SPENT001223,SPENT001018,SPENT001224,SPENT001227,SPENT001221,SPENT001172,SPENT001020,SPENT001222,SPENT001019,SPENT001021,SPENT001220	SPENG000692,SPENG003279,SPENG002107,SPENG003168,SPENG001071,SPENG002783,SPENG003471,SPENG003240,SPENG002830,SPENG000109	lnc-LRP5L-14,AL360020.1,LINC02569,lnc-TSHZ2-15,Z82195.3,lnc-KRBOX4-4,AC092445.1,LINC01949,lnc-SLC35B3-4,lnc-FBXO11-1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM011932	SPENO000166,SPENO000440,SPENO001532,SPENO001739,SPENO001792,SPENO001875,SPENO002117,SPENO002350,SPENO003055,SPENO003744,SPENO004543,SPENO004677	Lung cancer:SPENP002475
SPENP014262	EVVIFGAASELFTK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018	SPENG003202	HMGCL	-0.6424	Others	-1.116	0.454	0.684	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011949	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP014270	STLVHSLFLTDLYK	Colon cancer	Colon cancer	Colon epithelium	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011918	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP005486,SPENP022736,SPENP005488,SPENP005487;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP014302	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon epithelium	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-1.513	Others	-2.523	0.0226	0.2115	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011987	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP014306	MTLLWLSGLPFVVIR	Colon cancer	Colon cancer	Colon epithelium	SPENT005485	SPENG000166	HSALNG0084747	-0.3097	Others	-0.6381	0.5413	0.7559	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011981	SPENO005624	
SPENP014308	MTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon epithelium	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	-0.0046	Others	-0.0122	0.9906	0.992	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011977	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP014309	MFAPYLPPSHPMLHR	Colon cancer	Colon cancer	Colon epithelium	SPENT005487	SPENG002622	HSALNG0112074		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011989	SPENO002615	
SPENP014321	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Colon epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.5006	Others	-1.312	0.206	0.463	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM011982	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP014325	YFVQGMGYSEYGIPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005488	SPENG002075	lnc-NDRG1-1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM011996	SPENO001835	
SPENP014345	GSGQGDSLYPVGYLDK	Colon cancer	Colon cancer	Colon epithelium	SPENT000814	SPENG001638	HSALNG0104943	-0.342	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM012029	SPENO005134	Kidney cancer:SPENP020374;Anal canal cancer:SPENP024782;Lung cancer:SPENP025746;Prostate cancer:SPENP018335;Colon cancer:SPENP001653,SPENP008500,SPENP016058
SPENP014346	GGGDGMMNISSGALER	Colon cancer	Colon cancer	Colon epithelium	SPENT001859,SPENT001860	SPENG000786,SPENG002632	lnc-ZMYND19-8,HSALNG0075462	-0.4197	Others	-1.155	0.2919	0.5475	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012051	SPENO000024,SPENO006015	Lung cancer:SPENP004367
SPENP014363	AFPHLQQPSFLLASLK	Colon cancer	Colon cancer	Colon epithelium	SPENT001324	SPENG003020	HSALNG0018780		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012024	SPENO005958	Bladder cancer:SPENP017641;Lung cancer:SPENP004356,SPENP002633
SPENP014365	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Colon epithelium	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731	0.9355	Others	3.7473	0.0028	0.1165	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	MS	28137767	Immunogenic	SPENM012027	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP024149,SPENP001661,SPENP010616,SPENP000394,SPENP010615;Lung cancer:SPENP025534
SPENP014375	DRDPNSLLISCAVSYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.0313	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012033	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP008507,SPENP006600
SPENP014401	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1	-1.274	Others	-2.634	0.0223	0.2115	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012088	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP014405	GADPGMPEPTVLSLLWG	Colon cancer	Colon cancer	Colon epithelium	SPENT000828	SPENG000141	HSALNG0056619	0.3428	Others	1.2152	0.2589	0.507	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012098	SPENO004991	Anal canal cancer:SPENP024826;Colon cancer:SPENP001668,SPENP007309,SPENP000410;Lung cancer:SPENP025703;Kidney cancer:SPENP020455
SPENP014420	LTGDLSHLAAIVILLLK	Colon cancer	Colon cancer	Colon epithelium	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1	0.3422	Others	0.4652	0.6501	0.8166	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012096	SPENO001805,SPENO003193	
SPENP014442	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005785	SPENG001958	FBLN1	-0.3278	Others	-0.6047	0.5675	0.7705	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012113	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP014443	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon epithelium	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.734	Others	-1.966	0.0649	0.2809	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012133	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP014446	DGAWSLGHYLAAVGGGER	Colon cancer	Colon cancer	Colon epithelium	SPENT005495,SPENT005494	SPENG002515	HSALNG0115335	-2.992	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012107	SPENO002478,SPENO005466	
SPENP014449	EAALSYGFYGCHCGVGGR	Colon cancer	Colon cancer	Colon epithelium	SPENT002189,SPENT002190,SPENT002191	SPENG000309,SPENG002571	HSALNG0001408,lnc-PLA2G2E-1	1.0311	Others	1.1219	0.3129	0.5619	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012149	SPENO000180,SPENO002012,SPENO006290	Anal canal cancer:SPENP024845;Colon cancer:SPENP007354
SPENP014454	RGADPGMPEPTVLSLLWG	Colon cancer	Colon cancer	Colon epithelium	SPENT000828	SPENG000141	HSALNG0056619	-0.2504	Others	-0.4411	0.6746	0.8294	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012114	SPENO004991	
SPENP014455	LSWTVPEGQFDSFVVQFK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-1.114	Others	-3.224	0.0091	0.1898	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012135	SPENO002584	Bladder cancer:SPENP017719;Kidney cancer:SPENP020466;Tongue cancer:SPENP027882;Lung cancer:SPENP002728;Colon cancer:SPENP016143
SPENP014465	GIQKFPGINYPVLTPNLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018,SPENT000457,SPENT000458	SPENG001448,SPENG003202	HMGCL,lnc-GALE-2	0.456	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012110	SPENO000742,SPENO001216,SPENO002963	Colon cancer:SPENP026891,SPENP016121,SPENP010748,SPENP010747;Lung cancer:SPENP002686;Prostate cancer:SPENP018387
SPENP014468	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon epithelium	SPENT005758	SPENG002845	COL1A1	-0.103	Others	-0.1467	0.8881	0.9501	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012120	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP014478	GGYGGGMPANVQMQLVDTK	Colon cancer	Colon cancer	Colon epithelium	SPENT005513,SPENT005514	SPENG001926	NONHSAG112416.1	-1.267	Others	-5.287	0.0879	0.3159	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	smprot_low_throughput	10816584	Immunogenic	SPENM012173	SPENO002750,SPENO002990	Kidney cancer:SPENP015169
SPENP014479	ADEALFLLLHNEMVSGVYK	Colon cancer	Colon cancer	Colon epithelium	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767	0.2615	Others	0.3648	0.7395	0.8779	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012162	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP006659,SPENP000481,SPENP016178;Lung cancer:SPENP004493,SPENP002731;Kidney cancer:SPENP020515
SPENP014486	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012171	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP014493	YWLLPIFSSLGDGCSFPTR	Colon cancer	Colon cancer	Colon epithelium	SPENT004055	SPENG003433	lnc-MICU2-7		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012161	SPENO004176	
SPENP014495	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Colon epithelium	SPENT005801	SPENG002115	AL136361.1	-0.3093	Others	-1.181	0.2561	0.5059	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012186	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP014503	NNQLVAGYLQGPNVNLEEK	Colon cancer	Colon cancer	Colon epithelium	SPENT001357	SPENG002580	NONHSAG028996.2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012180	SPENO002732	Colon cancer:SPENP000479;Lung cancer:SPENP028356,SPENP002759,SPENP025965
SPENP014506	LQHFSQNNSHLLFSLNFLS	Colon cancer	Colon cancer	Colon epithelium	SPENT004081	SPENG002271	HSALNG0011249	-1.842	Others	-2.956	0.0317	0.2115	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012164	SPENO003770	Bladder cancer:SPENP017755
SPENP014507	NVQLLSQFVSPFTGCIYGR	Colon cancer	Colon cancer	Colon epithelium	SPENT000847	SPENG000825	HSALNG0035586		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012174	SPENO003852	Colon cancer:SPENP016180,SPENP001705;Lung cancer:SPENP028362;Kidney cancer:SPENP020507
SPENP014512	YIMVPSGNMGVFDPTEIHNR	Colon cancer	Colon cancer	Colon epithelium	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.5955	Others	1.7264	0.1226	0.3708	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012200	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP000511,SPENP027477
SPENP014520	VVSSVSKSAWLWPSCGLIPR	Colon cancer	Colon cancer	Colon epithelium	SPENT002514,SPENT002515	SPENG003593,SPENG001534	HSALNG0037864,lnc-FAM160A1-1	-0.8134	Others	-0.7351	0.4764	0.7025	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012201	SPENO002552,SPENO006211	
SPENP014528	ATLVCLISDFYPGAVTVAWK	Colon cancer	Colon cancer	Colon epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.973	Others	-3.82	0.0013	0.0975	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012192	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP006681,SPENP010878,SPENP007406
SPENP014534	REMEENFAVEAANYQDTIGR	Colon cancer	Colon cancer	Colon epithelium	SPENT003464	SPENG002072	NONHSAG005322.2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012213	SPENO001440	
SPENP014543	VLSPEYLWDQQLLGWPAVLR	Colon cancer	Colon cancer	Colon epithelium	SPENT000795	SPENG002103	lnc-ABO-33	0.648	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012224	SPENO001263	Bladder cancer:SPENP017779;Kidney cancer:SPENP020528
SPENP014549	HRPRPYPPNVGEEIQIGHIPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005757	SPENG000084	FN1	-0.813	Others	-1.034	0.3597	0.5997	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012226	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP024255,SPENP010920
SPENP014553	MWGLSSDFWGEKPNLSYIIGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005521	SPENG003064	lnc-TNFSF14-4		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012241	SPENO003467	
SPENP014557	FMNLVSLQYIELFMSFYAEKR	Colon cancer	Colon cancer	Colon epithelium	SPENT005517,SPENT005518,SPENT005519	SPENG000126	HSALNG0021273	-0.9568	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012236	SPENO000853,SPENO003268,SPENO003484	
SPENP014564	AAGMYLEHYLDSIENLPFELQR	Colon cancer	Colon cancer	Colon epithelium	SPENT002218,SPENT002217	SPENG000236,SPENG002804	HSALNG0088886,lnc-ACRBP-2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012264	SPENO003471,SPENO004291	Anal canal cancer:SPENP024922;Colon cancer:SPENP016248
SPENP014565	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018	SPENG003202	HMGCL	-0.7338	Others	-1.594	0.1392	0.3937	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012261	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP014568	VFLYNSVSLQNHSMETIFQAAR	Colon cancer	Colon cancer	Colon epithelium	SPENT005522	SPENG002795	HSALNG0140620	-0.2634	Others	-0.3528	0.7476	0.8797	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012245	SPENO003076	
SPENP014569	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.74	Others	1.1244	0.2774	0.5299	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012247	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP016246,SPENP029449,SPENP010943
SPENP014570	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.2975	Others	1.698	0.1067	0.3436	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012254	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP014573	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1	-0.9328	Others	-4.133	0.001	0.0975	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012250	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP010933,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP014577	DMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.7374	Others	-1.586	0.1439	0.3986	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012252	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP006704,SPENP016247
SPENP014579	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon epithelium	SPENT005758	SPENG002845	COL1A1	0.1446	Others	0.276	0.7857	0.8974	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012266	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433;Leukemia:SPENP001364
SPENP014580	GGDGPSHESEDFPRPLVTLPGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005523	SPENG001672	NONHSAG008623.2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012265	SPENO000362	
SPENP014582	LRECDGLVDALIFIVQAEIGQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.1567	Others	-0.2114	0.8368	0.9329	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012255	SPENO005858	Anal canal cancer:SPENP024912;Colon cancer:SPENP016259;Lung cancer:SPENP002823
SPENP014588	LQAMWGQSLLPPVSTSFTTGGLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	1.0562	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012275	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012626,SPENP012627;Bladder cancer:SPENP017847;Kidney cancer:SPENP020599;Lung cancer:SPENP002859;Colon cancer:SPENP016279
SPENP014589	VCFSCCSDGNIAVWDLHNQTLVR	Colon cancer	Colon cancer	Colon epithelium	SPENT001691	SPENG003411	TLE3	0.5703	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012280	SPENO004865	
SPENP014592	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.2977	Others	2.0248	0.058	0.2623	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012281	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP014594	MANGTLMAEGQLAFLNPTWIRIR	Colon cancer	Colon cancer	Colon epithelium	SPENT005525,SPENT005524	SPENG002734,SPENG000317	AC010624.5,lnc-IZUMO2-2	0.3776	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012277	SPENO003095,SPENO003581	
SPENP014604	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012296	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP021716,SPENP011000,SPENP029429
SPENP014605	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.2133	Others	1.1831	0.2552	0.5059	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM012289	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP008699,SPENP006724
SPENP014606	MFLSGKCLYFSDQVHILYFVSELF	Colon cancer	Colon cancer	Colon epithelium	SPENT005789	SPENG001983	CNOT2	-0.0337	Others	-0.0566	0.956	0.9771	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012287	SPENO005500	Colon cancer:SPENP006720,SPENP016291;Lung cancer:SPENP002867
SPENP014612	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.6045	Others	2.3576	0.0315	0.2115	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012291	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP014613	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6424	Others	1.7827	0.1022	0.3378	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012295	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP014614	STAAMSTYTGIFTDQVLSVLKGEE	Colon cancer	Colon cancer	Colon epithelium	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.4058	Others	-0.7829	0.4594	0.6842	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012290	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP000575,SPENP016302
SPENP014616	ARDMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.6723	Others	-1.324	0.2149	0.468	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012298	SPENO005858	Colon cancer:SPENP016292,SPENP026702,SPENP008706;Lung cancer:SPENP002874
SPENP014621	DLVHTEGQLQNEEIVAHDGSATYLR	Colon cancer	Colon cancer	Colon epithelium	SPENT002082	SPENG002114	lnc-YIPF1-2	-0.1856	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012305	SPENO000824	Anal canal cancer:SPENP024942;Colon cancer:SPENP006734,SPENP000577,SPENP007463;Lung cancer:SPENP025597
SPENP014622	IALYPIPCISPYASLHLCPLQHSLE	Colon cancer	Colon cancer	Colon epithelium	SPENT005527,SPENT005526	SPENG002183,SPENG002696	HSALNG0075966,PRKCQ-AS1		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012299	SPENO000240,SPENO005499	
SPENP014629	VDEFPLCGHMVSDEYEQLSSEALEAA	Colon cancer	Colon cancer	Colon epithelium	SPENT005529,SPENT005530	SPENG002411,SPENG003436	HSALNG0028334,lnc-POPDC2-2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012318	SPENO004340,SPENO004484	
SPENP014630	SSQSLVYSDGNTYLNWFQQRPGQSPR	Colon cancer	Colon cancer	Colon epithelium	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	3.1747	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012316	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP006744
SPENP014632	STQCLSYPLTIATLLTSASWCLYGFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005528	SPENG002938	HSALNG0007472		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012317	SPENO001540	
SPENP014637	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.3292	Others	0.5689	0.5808	0.7709	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012311	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP000584,SPENP008725
SPENP014639	SSQSLVHSDGNTYLSWLQQRPGQPPR	Colon cancer	Colon cancer	Colon epithelium	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.127	Others	0.6083	0.6397	0.8101	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012314	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP001762,SPENP021824
SPENP014640	DITSDSLSLSWTVPEGQFDHFLVQFK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012312	SPENO002584	Colon cancer:SPENP016327;Lung cancer:SPENP002906
SPENP014642	ACEDIDECSLPNICVFGTCHNLPGLFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758	-0.6261	Others	-1.255	0.2335	0.4857	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012326	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP014644	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1	-1.166	Others	-3.535	0.003	0.1165	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012323	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP007476,SPENP011061,SPENP016339
SPENP014645	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.5925	Others	2.0095	0.0617	0.2737	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012325	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP014647	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-2.502	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012337	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP016352,SPENP008743,SPENP000598
SPENP014650	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6181	Others	1.0562	0.3065	0.5574	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012335	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP016351,SPENP021892,SPENP000594
SPENP014656	STNLLAAETASLEEQLQGWGEVMLMADK	Colon cancer	Colon cancer	Colon epithelium	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	-0.6471	Others	-3.101	0.0127	0.204	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012339	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP000591
SPENP014658	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012341	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP016367,SPENP008740
SPENP014668	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012347	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368
SPENP014672	AGSVPSLAAGLLFGSLAGLGAYQLSQDPR	Colon cancer	Colon cancer	Colon epithelium	SPENT002586	SPENG000664	HSALNG0048031		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012358	SPENO005017	Tongue cancer:SPENP027510;Prostate cancer:SPENP013112
SPENP014673	ASADELTFHEFEEATNLLADTPDAATTSR	Colon cancer	Colon cancer	Colon epithelium	SPENT001420	SPENG000627	lnc-TMED1-2	0.5823	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012353	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP011103,SPENP008750,SPENP011104
SPENP014674	AVSLVTDSTSTFLSQTTYALIEAITEYTK	Colon cancer	Colon cancer	Colon epithelium	SPENT001334,SPENT000988	SPENG000380	lnc-DIABLO-1	-0.0682	Others	-0.1648	0.8721	0.9436	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012349	SPENO001827,SPENO003093	Colon cancer:SPENP016372,SPENP000607;Lung cancer:SPENP002938;Kidney cancer:SPENP020675
SPENP014676	SLSLNPFLWSPFESLCEIGEKPDPDQTFK	Colon cancer	Colon cancer	Colon epithelium	SPENT005452	SPENG002651	lnc-CDC27-7		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012356	SPENO005295	Tongue cancer:SPENP028052;Colon cancer:SPENP016377
SPENP014677	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005757,SPENT005755	SPENG000084	FN1	1.8619	Others	1.3325	0.2003	0.4621	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012360	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP014678	DSACCPLLEQPNIVHDLPAAVLSYCQVWK	Colon cancer	Colon cancer	Colon epithelium	SPENT000451	SPENG000333	lnc-BRWD1-2		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012350	SPENO005700	
SPENP014679	EAITAATCLTEALVDHLNVGVAQAYMNQR	Colon cancer	Colon cancer	Colon epithelium	SPENT005900	SPENG003688	AC009779.3		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012348	SPENO005417	Lung cancer:SPENP002942
SPENP014681	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.8904	Others	1.7977	0.089	0.3159	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012366	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP021948,SPENP011139,SPENP000609
SPENP014685	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012361	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP024325,SPENP000611,SPENP008757
SPENP014686	FDSGSGWPSFHDVINSEAITFTDDFSYGMHR	Colon cancer	Colon cancer	Colon epithelium	SPENT002442	SPENG001308	NONHSAG011552.2	-2.549	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012369	SPENO004839	
SPENP014687	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012367	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP024330,SPENP016392,SPENP027468
SPENP014688	GFDPFMNLVIDECVEMATSGQQNNIGMVVIR	Colon cancer	Colon cancer	Colon epithelium	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	-0.2028	Others	-0.503	0.6304	0.8048	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012368	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP023439;Colon cancer:SPENP016391;Bladder cancer:SPENP017959
SPENP014690	FAHTNVESLVNEYDDNGDGIILFRPSHLTNK	Colon cancer	Colon cancer	Colon epithelium	SPENT002324,SPENT002326,SPENT002327,SPENT002325	SPENG002120	lnc-CHD1L-5	1.3894	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012370	SPENO000645,SPENO001124,SPENO001677,SPENO004060	
SPENP014693	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.346	Others	1.1292	0.2745	0.5286	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012374	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP014695	VRLEVPPEADGTLLTDLMPGVEYVVTVTAER	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012376	SPENO002584	Lung cancer:SPENP002965
SPENP014696	TPVVTGTGPNFSLGELQGHLAYDLNPASTGLR	Colon cancer	Colon cancer	Colon epithelium	SPENT001829	SPENG001187	NONHSAG024474.2	-0.2376	Others	-1.284	0.2232	0.474	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012378	SPENO005220	Skin cancer:SPENP025481
SPENP014701	YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012381	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009079;Ovary cancer:SPENP016675;Colon cancer:SPENP027469;Lung cancer:SPENP004715,SPENP002976
SPENP014703	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Colon cancer	Colon cancer	Colon epithelium	SPENT000855	SPENG000474	AC016876.2	0.4192	Others	0.6378	0.5379	0.7559	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM012377	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP016399,SPENP022020
SPENP014704	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.7303	Others	-0.9355	0.3807	0.6096	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012380	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403
SPENP014708	LEELTVTDATPDSLSLSWTVPEGQFDHFLVQYK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-1.301	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012394	SPENO002584	Colon cancer:SPENP016404;Lung cancer:SPENP002979
SPENP014709	LGELTVTDATPDSLSLSWTVPEGQFDHFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-0.0261	Others	-0.0542	0.9583	0.9771	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012388	SPENO002584	
SPENP014710	LGELAVAAVTSDSVGLSWTVAQGPFDSFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2		Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012391	SPENO002584	
SPENP014711	LGELTMTDATPDSLSLSWTVPEGQFDHFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-0.0525	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012387	SPENO002584	Bladder cancer:SPENP017972;Colon cancer:SPENP016409;Lung cancer:SPENP002987
SPENP014713	LGELTVTDATPDSLSLSWMVPEGQFDHFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-1.863	Others	-2.843	0.0175	0.2115	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Non-validated			Immunogenic	SPENM012386	SPENO002584	Colon cancer:SPENP016410;Lung cancer:SPENP002981,SPENP025842
SPENP014717	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.4706	Others	1.801	0.0895	0.3159	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012397	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP014719	LTIVDTPGFGDAVNNTECWKPITDYVDQQFEQYFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012403	SPENO004356,SPENO005697	
SPENP014720	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4025	Others	-0.5655	0.5842	0.7709	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012401	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP011187,SPENP022064,SPENP011188
SPENP014722	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758	-0.0544	Others	-0.0951	0.9255	0.9606	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012399	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP008769,SPENP011193,SPENP011194,SPENP016417;Lung cancer:SPENP002996
SPENP014725	IVLGNFSSGPVDPMMADAIDFMVDRLESLGQSELASR	Colon cancer	Colon cancer	Colon epithelium	SPENT003731	SPENG002763	HSALNG0106597		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012408	SPENO000996	
SPENP014726	ATFYTPQNPSSLAPAPLRPLEDREQLYSTILSHQCQR	Colon cancer	Colon cancer	Colon epithelium	SPENT001336	SPENG001086	HSALNG0049384		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012411	SPENO005428	
SPENP014727	GFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWK	Colon cancer	Colon cancer	Colon epithelium	SPENT005534,SPENT005535	SPENG001633	HSALNG0064888		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012407	SPENO000667,SPENO004480	
SPENP014729	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.01	Others	-0.0103	0.992	0.992	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012406	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP024344,SPENP011200
SPENP014730	NLPGGQQNSSWNFSEDTVISILNTINEVIAENLEAAK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.9131	Others	-1.422	0.2143	0.468	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012410	SPENO005858	Colon cancer:SPENP016426;Lung cancer:SPENP003001
SPENP014731	NVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758	-1.072	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012413	SPENO000957	Colon cancer:SPENP011205,SPENP011206,SPENP016429;Bladder cancer:SPENP017988
SPENP014733	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012415	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP014734	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752	SPENG000084	FN1	2.7377	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012414	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP014737	MQYGGAPGGPAFPGQTQDPLYGYFAAVAGQDGQIDADELQR	Colon cancer	Colon cancer	Colon epithelium	SPENT005536	SPENG000963	lnc-STEAP4-2	0.1863	Others	0.2003	0.8469	0.9352	PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012418	SPENO006104	
SPENP014738	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2188	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012419	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP014739	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0889	Others				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012421	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP011218
SPENP014740	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019103	Colorectal cancer proteome project for biomarke search and development of clinical test	Orbitrap Fusion Lumos	Label free	32587829	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012420	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438
SPENP014830	MLMDSQVLQK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005556	SPENG000335	HSALNG0049968	-0.0279	Others	-0.0902	0.9303	0.9384	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM003887	SPENO001542	
SPENP014854	LGILGHTVSV	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT004298	SPENG001951	HSALNG0137753		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM003895	SPENO001590	
SPENP014877	LLMLGLDNAGK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005944,SPENT003327	SPENG000584,SPENG002171	ARL2-SNX15,NONHSAG008644.2	-0.3382	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003952	SPENO000453,SPENO005309	Colon cancer:SPENP015744;Prostate cancer:SPENP018103
SPENP014895	YMDGMTVGVVR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003953	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP014903	MLLCMSLTGRK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005567,SPENT005566	SPENG000135,SPENG000920	lnc-DGKB-1,HSALNG0056302		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM003944	SPENO002313,SPENO006169	
SPENP014910	VMVQPINLIFR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002273,SPENT002272,SPENT002270,SPENT002271,SPENT002267,SPENT002269,SPENT002268	SPENG003098,SPENG003309,SPENG003607,SPENG001915,SPENG000941,SPENG003601,SPENG000906	lnc-ID2-3,lnc-ZC3H12D-15,HSALNG0054220,HSALNG0012839,lnc-FABP6-3,HSALNG0046238,lnc-GLDC-5	0.1458	Others	0.7569	0.4601	0.6233	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM003957	SPENO000391,SPENO001158,SPENO001668,SPENO002054,SPENO002219,SPENO003493,SPENO004771	Breast cancer:SPENP008819;Liver cancer:SPENP004794;Tongue cancer:SPENP028143;Lung cancer:SPENP026626;Prostate cancer:SPENP012898
SPENP014911	DLLSELCIMIF	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005568,SPENT005570,SPENT005569	SPENG000643	HSALNG0101140		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM003948	SPENO001311,SPENO001554,SPENO003067	
SPENP014922	AYVVLGQFLVLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005251	SPENG001089	lnc-MRPS14-5	0.7949	Others	3.0052	0.0084	0.0735	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM003962	SPENO001202	Colon cancer:SPENP012760
SPENP014934	VPFLVLECPNLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000354	SPENG002378	HSALNG0036293	0.4977	Others	1.4091	0.1842	0.3937	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM003982	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP014941	FLEEYLSSTPQR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002760	SPENG002531	NONHSAG014457.2	-0.1858	Others	-0.7057	0.5032	0.6504	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004007	SPENO003138	Skin cancer:SPENP025159;Bile duct cancer:SPENP013357;Tongue cancer:SPENP027660;Lung cancer:SPENP007614,SPENP028269,SPENP026519;Prostate cancer:SPENP012927
SPENP014943	MMLMSTATAFYR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000416,SPENT001710,SPENT001709	SPENG000832	NONHSAG010597.2		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM003977	SPENO002231,SPENO002917,SPENO003714	Breast cancer:SPENP008840;Anal canal cancer:SPENP024571;Lung cancer:SPENP003993
SPENP014951	MQPAVNQGSLIK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005582	SPENG001355	lnc-LINC02210-CRHR1-52		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM003979	SPENO004609	
SPENP014955	YLYNMIMLLSIM	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005350	SPENG003269	HSALNG0102963	1.3362	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM003999	SPENO002386	Bile duct cancer:SPENP013313;Colon cancer:SPENP015809
SPENP014958	YQLDPTASISAK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000102	SPENG002045	lnc-ACTR2-11	0.3419	Others	1.5651	0.1499	0.3582	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003998	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP014959	MELQMEAHLLIMR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005585,SPENT005586	SPENG002359	lnc-LARP1B-1	1.0928	Others	1.643	0.1515	0.3582	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004015	SPENO003086,SPENO005851	
SPENP014971	AAALVLQTIWGYK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005788	SPENG002233	AP001931.2	0.4363	Others	1.3175	0.2104	0.4271	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004038	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP014973	TTAAMWALQTVEK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2	-1.362	Others	-4.62	0.0057	0.0557	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004029	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP014990	YAMVYGYNAAYNR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	1.4167	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004014	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP015004	HVISYSLSPFEQR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT001666	SPENG002113	HSALNG0044883	-0.1414	Others	-0.6171	0.5458	0.6624	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004039	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP015016	QALIDMNTLFTLLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002651,SPENT002652	SPENG000893	ABCB7		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004080	SPENO000694,SPENO005643	
SPENP015018	VTDATETTITISWR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004099	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP015038	EVVIFGAASELFTK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000018	SPENG003202	HMGCL	-2.133	Down-regulated in tumors	-6.439	0.0001	0.0075	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004059	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP015051	IVSGIITPIHEQWEK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT003267	SPENG002163	NONHSAG031094.2		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004131	SPENO005967	Colon cancer:SPENP024108,SPENP010529,SPENP010530
SPENP015052	YAASSYLSLTPEQWK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.2105	Others	0.2516	0.8045	0.8599	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004103	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP015068	DREGFFTNGLTLGAK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000938,SPENT000937,SPENT000932,SPENT000934,SPENT000931,SPENT000933,SPENT000935,SPENT000936	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004126	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	Kidney cancer:SPENP020332;Anal canal cancer:SPENP024753;Lung cancer:SPENP004249;Prostate cancer:SPENP018284;Colon cancer:SPENP006579
SPENP015069	GNEFLFSHLWPLIEK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002175	SPENG000523	NONHSAG026963.2	1.0777	Others	0.9651	0.3891	0.5667	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004110	SPENO003701	Breast cancer:SPENP008914,SPENP022826,SPENP022827;Lung cancer:SPENP028280;Prostate cancer:SPENP023684
SPENP015075	LVIPALWEAEVGGSR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005627,SPENT005628	SPENG003185,SPENG003250	HSALNG0072309,HSALNG0114172	1.2005	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004122	SPENO000910,SPENO003165	
SPENP015081	LQSPEFQSLFTEGLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005952	SPENG001697	HSALNG0023837	0.8432	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004128	SPENO001761	
SPENP015085	NILAVSFAPLVQPSK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005120	SPENG001629	HSALNG0065241		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004124	SPENO005251	Prostate cancer:SPENP012048
SPENP015087	AQQEFAAGVFSNPAVR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002814,SPENT003026	SPENG001802	NONHSAG003062.2		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004146	SPENO003986,SPENO006093	Breast cancer:SPENP023399;Colon cancer:SPENP010595,SPENP010596;Skin cancer:SPENP025312
SPENP015108	QGAMMELIRPAEGMQR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005634	SPENG003620	HSALNG0005121	-0.1134	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004153	SPENO003715	
SPENP015119	TPQLCMYYCGFWSVEPK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005642,SPENT005641,SPENT005854,SPENT005639,SPENT005640	SPENG001914,SPENG000604,SPENG002039	HSALNG0107406,LINGO1-AS1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004170	SPENO003232,SPENO003517,SPENO003942,SPENO004445,SPENO004901	
SPENP015123	TPIGSFLGSLSLLPATK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000014	SPENG003410	ACAT1	0.7013	Others	1.8524	0.0852	0.2694	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004169	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP015125	FMPAGLIAGASLLMVAK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031	0.1412	Others	0.2302	0.8293	0.8743	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004168	SPENO000972,SPENO005766	Breast cancer:SPENP022925,SPENP022924;Colon cancer:SPENP007302,SPENP026841;Kidney cancer:SPENP020457;Prostate cancer:SPENP018363
SPENP015131	ACVQRTLMNLGGLAVAR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT001451	SPENG001511	HSALNG0007796		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004176	SPENO005561	
SPENP015144	GETGPAGPAGPVGPVGAR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005758	SPENG002845	COL1A1	-1.281	Others	-2.09	0.0553	0.2051	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004203	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP015147	DIQMTQSPSSLSASVGDR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.5091	Others	-0.9951	0.3411	0.5406	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004198	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP015156	STDTGVSLPSYEEDQGSK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004196	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP015158	QTLSTPGTIILGTIPVPK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2	0.0335	Others	0.1029	0.924	0.9361	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004195	SPENO004961,SPENO005968	Bladder cancer:SPENP017735;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP004453,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP001697,SPENP000454
SPENP015159	FFDHSGTLVMDAYEPEISR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002510,SPENT002512,SPENT002511	SPENG003726,SPENG002325,SPENG000279	HSALNG0002035,lnc-EYA3-2,HSALNG0085740	1.0611	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004211	SPENO000773,SPENO002918,SPENO004290	Breast cancer:SPENP008981;Colon cancer:SPENP006671
SPENP015163	MPVILTLWEAEMGGSPEVR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005644	SPENG001056	HSALNG0040704		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004216	SPENO005788	
SPENP015167	SAIAIQGGLTELPWDGGLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000385	SPENG000940	NONHSAG038348.2	-0.1194	Others	-0.5681	0.5877	0.6881	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004222	SPENO004334	Colon cancer:SPENP016161
SPENP015169	GGYGGGMPANVQMQLVDTK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005513,SPENT005514	SPENG001926	NONHSAG112416.1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	smprot_low_throughput	10816584	Immunogenic	SPENM004218	SPENO002750,SPENO002990	Colon cancer:SPENP014478
SPENP015174	GSIYLAGQNIQDVSLESLR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002651,SPENT002652	SPENG000893	ABCB7		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004217	SPENO000694,SPENO005643	
SPENP015175	TFGCGSAIASSSLATEWVK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005538	SPENG000041	HSALNG0093830		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004221	SPENO005114	
SPENP015176	TGVHHYSGNNIELGTACGK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004219	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP015181	ATLVCLISDFYPGAVTVAWK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004235	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP015183	ALAPTWEQLALGLEHSETVK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000040	SPENG000572	lnc-EEF1E1-2	-1.061	Down-regulated in tumors	-5.337	0.0002	0.0083	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004236	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP015184	AITTGLQEYVEAVSFQHFIK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005933,SPENT003034,SPENT005932,SPENT005931	SPENG001725,SPENG000148	NONHSAG004620.3,TSNAX-DISC1	-2.003	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004234	SPENO001778,SPENO004607,SPENO004969,SPENO005212	Skin cancer:SPENP025389;Colon cancer:SPENP010874,SPENP024235,SPENP010873
SPENP015189	YIMVPSGNMGVFDPTEIHNR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.7967	Others	4.0583	0.0097	0.0783	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004237	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP015193	YLADPSNLFVVSSDFCHWGQR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005649	SPENG000280	lnc-CBR3-2		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004243	SPENO002745	
SPENP015194	KLDSLGLCSVSCALEFIPNSK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT002046	SPENG003565	NONHSAG022459.2		Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	MS	28137767	Immunogenic	SPENM004251	SPENO002636	
SPENP015200	STAAMSTYTGIFTDQVLSVLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	1.3074	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004247	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP015202	VAYVQLAHGQTFTFPDLFPEK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT006013	SPENG003837	MRPL23	0.3705	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004250	SPENO001980	
SPENP015204	SGDRGETGPAGPAGPVGPVGAR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005758	SPENG002845	COL1A1	-1.09	Others	-0.9513	0.3639	0.5488	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004258	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP015205	TETITGFQVDAVPANGQTPIQR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.1711	Others	1.0933	0.3162	0.5121	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004257	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP015208	DTLTSRPAQGVVTTLENVSPPR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004255	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP015209	LIDMLSEAGLSVIETTSFVSPK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000018	SPENG003202	HMGCL	-2.434	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004259	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP015212	QGLYELSASNFELHVAQGDHFIK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000040	SPENG000572	lnc-EEF1E1-2	-1.94	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004266	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP015216	STNNNMIQGGEQKAQEEIYMWQK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005652	SPENG003125	LURAP1L-AS1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Non-validated			Immunogenic	SPENM004264	SPENO004793	
SPENP015221	NSITLTNLTPGTEYVVSIVALNGR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004267	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP015222	STATISGLKPGVDYTITVYAVTGR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004270	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP015227	TGLDSPTGIDFSDITANSFTVHWIAPR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8294	Others				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004276	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP015228	IVAFADAAVEPIDFPIAPVYAASMVLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000014	SPENG003410	ACAT1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004277	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP015230	LGALSGAAALGFASYGAHGAQFPDAYGK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004281	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP015234	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.3734	Others	0.6567	0.5324	0.6585	PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004283	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP015237	EINLAPDSSSVVVSGLMVATKYEVSVYALK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004287	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021943,SPENP021941;Tongue cancer:SPENP027619;Lung cancer:SPENP021942;Colon cancer:SPENP021940
SPENP015239	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004286	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP015241	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004290	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP015242	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Kidney cancer	Chromophobe renal cell carcinoma	Kidney	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019123	Proteome profilling of chromophobe renal cell carcinomas	Q Exactive HF	MS1 intensity based label-free quantification method	32694149	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM004291	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP015294	YMDGMTVGVVR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014792	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP015298	VIEGDVVSALNK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT001808,SPENT005921	SPENG001016,SPENG001705	AC112229.4,lnc-LIMS4-1		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014801	SPENO000049,SPENO000476	Breast cancer:SPENP022574,SPENP022575;Bladder cancer:SPENP011358;Lung cancer:SPENP007620
SPENP015314	MRWQVMGYIFYPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005855	SPENG002679	DHFR	-0.4428	Others	-0.4266	0.7127	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014809	SPENO004032	
SPENP015322	QYNVGPSVSKYPLR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.203	Others	-0.7357	0.5734	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014835	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP015325	VTDATETTITISWR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014837	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP015328	TQSPSSLSASVGDR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Tumor-specific				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014832	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP022756,SPENP022757;Gastric cancer:SPENP003185,SPENP003575
SPENP015331	QVRPIVGPFHAVLK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005796	SPENG001958	FBLN1		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014821	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP014237,SPENP015976
SPENP015340	MTQSPSSLSASVGDR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	-0.4926	Others	-1.005	0.4774	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014846	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP015343	ASQGISNYLAWYQQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014839	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP005614,SPENP005617,SPENP005616,SPENP005615,SPENP005618;Gastric cancer:SPENP003198
SPENP015345	YAASSYLSLTPEQWK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.2056	Others	-0.1109	0.917	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM014842	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP015350	CHEGGQSYKIGDTWR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.6205	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014844	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	
SPENP015378	DQCIVDDITYNVNDTFHK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.245	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014887	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028500;Tongue cancer:SPENP027585;Gastric cancer:SPENP009622;Prostate cancer:SPENP009275
SPENP015380	YAASSYLSLTPEQWKSHR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000080,SPENT000201,SPENT000081,SPENT000204	SPENG000666	NONHSAG033390.3	1.6729	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated	MS	28137767	Immunogenic	SPENM014881	SPENO000395,SPENO003620,SPENO004364,SPENO004816,SPENO005374	Bile duct cancer:SPENP013562;Kidney cancer:SPENP020459;Skin cancer:SPENP025360
SPENP015381	ASQGISNYLAWYQQKPGK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	-0.5889	Others	-0.3107	0.7898	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014883	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP015383	VSPHSGVVALTKPVPEPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005785	SPENG001958	FBLN1	-0.8112	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014886	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP015385	DIQMTQSPSSLSASVGDR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.0937	Others	-0.0802	0.9399	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014890	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP015390	CFDHAAGTSYVVGETWEK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.1272	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014878	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP005841,SPENP005839,SPENP005843,SPENP005842,SPENP005840;Tongue cancer:SPENP027544
SPENP015393	KVSPHSGVVALTKPVPEPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005785	SPENG001958	FBLN1	-0.9084	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014900	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP015395	RPHETGGYMLECVCLGNGK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014894	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP015400	SSQSLVHSDGNTYLSWLQQR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.6252	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014909	SPENO000369,SPENO003879	
SPENP015402	ATLVCLISDFYPGAVTVAWK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.1195	Others	-0.0592	0.9557	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014911	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP015405	SSQSLVYSDGNTYLNWFQQR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.9498	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014907	SPENO001239,SPENO005201	
SPENP015407	QSNNKYAASSYLSLTPEQWK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.0061	Others	0.0051	0.9962	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014901	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP015413	MTLLEADGVFALRPALQEMLK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005666,SPENT005668,SPENT005663,SPENT005667,SPENT005664,SPENT005856,SPENT005670,SPENT005669,SPENT005665	SPENG000916,SPENG000159	HSALNG0125316,LINC01791		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014918	SPENO000030,SPENO000759,SPENO001238,SPENO001909,SPENO002581,SPENO002656,SPENO002788,SPENO003297,SPENO005214	
SPENP015414	HRPRPYPPNVGEEIQIGHIPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005753,SPENT005757	SPENG000084	FN1	0.1336	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014916	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP015415	ASQGISNYLAWYQQKPGKVPK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3	-0.4598	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014915	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021585,SPENP021587;Colon cancer:SPENP021584;Lung cancer:SPENP021586
SPENP015417	TNTNVNCPIECFMPLDVQADR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.1592	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014919	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP015424	YLLQYQEPIPCEQLVTALCDIK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005671	SPENG002779	HSALNG0107479		Tumor-specific				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014925	SPENO001075	
SPENP015426	DTLTSRPAQGVVTTLENVSPPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.087	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014927	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP015427	CDPHEATCYDDGKTYHVGEQWQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.9939	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014928	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP015432	QSNNKYAASSYLSLTPEQWKSHR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000080,SPENT000201,SPENT000081,SPENT000204	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014935	SPENO000395,SPENO003620,SPENO004364,SPENO004816,SPENO005374	
SPENP015435	STATISGLKPGVDYTITVYAVTGR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.6002	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014940	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP015436	STAAMSTYTGIFTDQVLSVLKGEE	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014941	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP015437	TYLYWYLQKPGQSPQLLIYEVSSR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000749,SPENT000751,SPENT000747	SPENG000409,SPENG003372	lnc-EIF2AK3-22,HSALNG0016748	0.1756	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014943	SPENO002509,SPENO002945,SPENO005142	
SPENP015443	DLEVVAATPTSLLISWDAPAVTVR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.4356	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014937	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP015445	PGVTEATITGLEPGTEYTIYVIALK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9649	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014945	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006133,SPENP006130,SPENP006132,SPENP006131,SPENP006129;Tongue cancer:SPENP027973
SPENP015446	SSQSLVHSDGNTYLSWLQQRPGQPPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.542	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014950	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP015447	TNTNVNCPIECFMPLDVQADREDSRE	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.1718	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014947	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP015450	SSQSLVYSDGNTYLNWFQQRPGQSPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.111	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014949	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP015453	ATLVCLISDFYPGAVTVAWKADSSPVK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.9805	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014955	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP021839,SPENP021837;Bladder cancer:SPENP011757;Lung cancer:SPENP021838;Colon cancer:SPENP026715,SPENP021836
SPENP015454	TGLDSPTGIDFSDITANSFTVHWIAPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6815	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014957	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP015456	PRPGVTEATITGLEPGTEYTIYVIALK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.58	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014956	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP015457	GEFKCDPHEATCYDDGKTYHVGEQWQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.9331	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014953	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Tongue cancer:SPENP027698
SPENP015460	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-2.124	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014959	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP015462	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-1.957	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014964	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP015463	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.7042	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014963	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP015464	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.6723	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014965	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP015465	AGVETTTPSKQSNNKYAASSYLSLTPEQWK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.4957	Others	0.4409	0.6821	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014967	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Lung cancer:SPENP007915,SPENP004704;Ovary cancer:SPENP018709;Gastric cancer:SPENP003369;Breast cancer:SPENP018708
SPENP015466	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.2875	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014966	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP015467	CDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.5204	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014969	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Gastric cancer:SPENP009715;Tongue cancer:SPENP027542;Colon cancer:SPENP026725;Leukemia:SPENP001397
SPENP015469	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.0937	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014974	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP015470	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.5496	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014970	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP016392,SPENP027468
SPENP015471	PRPGVTEATITGLEPGTEYTIYVIALKNNQK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014972	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Tongue cancer:SPENP027981
SPENP015473	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.65	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014971	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP015474	WKCDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.3884	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014976	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Tongue cancer:SPENP028188
SPENP015476	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.064	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014975	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP015480	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.2747	Others	-0.1784	0.8671	0.9962	PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014980	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP015483	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014983	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP015485	GSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNAR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014986	SPENO001505,SPENO002211	Tongue cancer:SPENP027756
SPENP015486	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.8549	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014988	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP015487	ATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.0273	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM014987	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	
SPENP015488	AAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWK	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.1611	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Non-validated	MS	28137767	Immunogenic	SPENM014991	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Skin cancer:SPENP025494;Colon cancer:SPENP011209,SPENP011210,SPENP007504;Bladder cancer:SPENP011817
SPENP015489	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752	SPENG000084	FN1	0.1647	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014990	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP015490	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1341	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014989	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP015491	KTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Gastric cancer	Gastric body carcinoma	Blood serum exosomes	SPENT005752	SPENG000084	FN1	-0.2849	Others				PXD019387	Proteomic Profiling of Serum Exosomes from Patients with Metastatic Gastric Cancer	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM014992	SPENO001233	Bladder cancer:SPENP017992;Tongue cancer:SPENP027837;Lung cancer:SPENP003010;Colon cancer:SPENP016433
SPENP015611	FTLFGIANKK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-0.9854	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015409	SPENO002584	Colon cancer:SPENP026852;Lung cancer:SPENP002165
SPENP015662	VVFSQQELRK	Colon cancer	Colon cancer	Colon epithelium	SPENT002442	SPENG001308	NONHSAG011552.2	-0.4892	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015445	SPENO004839	
SPENP015665	LLLYGLHHGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	2.1702	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015451	SPENO002584	Colon cancer:SPENP013978,SPENP027082;Lung cancer:SPENP002187
SPENP015676	AVYTLTSLYR	Colon cancer	Colon cancer	Colon epithelium	SPENT000988	SPENG000380	lnc-DIABLO-1	-0.1006	Others	-0.3441	0.7363	0.8764	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	MS	28137767	Immunogenic	SPENM015444	SPENO003093	Bladder cancer:SPENP017167;Kidney cancer:SPENP019937;Lung cancer:SPENP002154;Prostate cancer:SPENP018082;Colon cancer:SPENP014012,SPENP008071,SPENP026722
SPENP015686	TAVAHRPGAFK	Colon cancer	Colon cancer	Colon epithelium	SPENT000153	SPENG003407	NONHSAG024537.2		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015515	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP015693	YLLLSDLPGVR	Colon cancer	Colon cancer	Colon epithelium	SPENT000174	SPENG000603	DMAC2L		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015525	SPENO004847	Kidney cancer:SPENP020025;Prostate cancer:SPENP012916
SPENP015717	RFVNVVPTFGK	Colon cancer	Colon cancer	Colon epithelium	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	-0.6013	Others	-1.855	0.0745	0.305	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	MS	28137767	Immunogenic	SPENM015523	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP006409,SPENP014099
SPENP015744	LLMLGLDNAGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005944,SPENT003327	SPENG000584,SPENG002171	ARL2-SNX15,NONHSAG008644.2	0.886	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015492	SPENO000453,SPENO005309	Kidney cancer:SPENP014877;Prostate cancer:SPENP018103
SPENP015749	GSLASLDSLRK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	0.5384	Others	1.1501	0.2769	0.5917	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015472	SPENO005858	Colon cancer:SPENP026916,SPENP014054,SPENP008125;Bladder cancer:SPENP017222;Kidney cancer:SPENP020052;Prostate cancer:SPENP011932
SPENP015753	YMDGMTVGVVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005796	SPENG001958	FBLN1	2.1181	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015547	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145
SPENP015758	VSLYSSVEWDR	Colon cancer	Colon cancer	Colon epithelium	SPENT005679	SPENG000007	lnc-PCSK4-2	1.0705	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015500	SPENO002227	
SPENP015764	AGLSESLAAISK	Colon cancer	Colon cancer	Colon epithelium	SPENT002883,SPENT002882	SPENG003578,SPENG002245	AC099398.1,HSALNG0058883		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015570	SPENO003412,SPENO004294	
SPENP015769	RYMDGMTVGVVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005796	SPENG001958	FBLN1	1.93	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015622	SPENO003698	Ovary cancer:SPENP016486;Colon cancer:SPENP008201,SPENP014156;Gastric cancer:SPENP003524
SPENP015771	GLHEDLQGVPER	Colon cancer	Colon cancer	Colon epithelium	SPENT001903	SPENG002122	HSALNG0102054		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015619	SPENO003910	
SPENP015773	GQAGVMGFPGPK	Colon cancer	Colon cancer	Colon epithelium	SPENT005758	SPENG002845	COL1A1	-0.769	Others	-0.8643	0.3956	0.6754	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015628	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP015787	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000354	SPENG002378	HSALNG0036293	0.1232	Others	0.3957	0.6951	0.8676	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	MS	28137767	Immunogenic	SPENM015626	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP015790	ASGIYSCLQLNK	Colon cancer	Colon cancer	Colon epithelium	SPENT002465	SPENG000424	HSALNG0020817	0.4029	Others	0.8574	0.4031	0.6812	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015585	SPENO005910	
SPENP015809	YLYNMIMLLSIM	Colon cancer	Colon cancer	Colon epithelium	SPENT005350	SPENG003269	HSALNG0102963		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015630	SPENO002386	Bile duct cancer:SPENP013313;Kidney cancer:SPENP014955
SPENP015820	YQLDPTASISAK	Colon cancer	Colon cancer	Colon epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11	-0.1371	Others	-0.6641	0.5115	0.7686	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015584	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146;Leukemia:SPENP001036
SPENP015869	YAMVYGYNAAYNR	Colon cancer	Colon cancer	Colon epithelium	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015678	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015
SPENP015886	AAALVLQTIWGYK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-1.073	Others	-2.149	0.0484	0.2359	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015688	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP015890	SGTLYSLTLYGLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	0.762	Others	1.1938	0.2861	0.599	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015664	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP027254,SPENP024013,SPENP014229
SPENP015895	RLTPLQYHVTQEK	Colon cancer	Colon cancer	Colon epithelium	SPENT002442	SPENG001308	NONHSAG011552.2	-1.032	Others	-0.8599	0.4291	0.6978	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015650	SPENO004839	
SPENP015902	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon epithelium	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.3158	Others	0.8942	0.3867	0.6754	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015696	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281
SPENP015909	SFHFSLPSSWYYR	Colon cancer	Colon cancer	Colon epithelium	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015644	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP015931	VTDATETTITISWR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.9438	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015706	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254
SPENP015935	GYVSCALGCPYEGK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018	SPENG003202	HMGCL	-0.7601	Others	-2.439	0.0213	0.1494	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015752	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP015936	RLVQSPNSYFMDVK	Colon cancer	Colon cancer	Colon epithelium	SPENT000414,SPENT000332,SPENT000061,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051	0.4249	Others	0.8851	0.3834	0.6728	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	MS	28137767	Immunogenic	SPENM015732	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP027224,SPENP010432,SPENP014253,SPENP006523
SPENP015938	RSFHFSLPSSWYYR	Colon cancer	Colon cancer	Colon epithelium	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015731	SPENO003826,SPENO004614	Lung cancer:SPENP002469
SPENP015942	VLGVHSVMWAWLTR	Colon cancer	Colon cancer	Colon epithelium	SPENT005703	SPENG003503	HSALNG0065113	-0.6109	Others	-0.9102	0.3708	0.6641	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015747	SPENO002832	
SPENP015954	EVVIFGAASELFTK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018	SPENG003202	HMGCL	0.2992	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015716	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP015956	ADGQMPFSCHYPSR	Colon cancer	Colon cancer	Colon epithelium	SPENT001996,SPENT001995	SPENG000039	NONHSAG012478.2	-1.027	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015713	SPENO000668,SPENO002663	Colon cancer:SPENP014250,SPENP008395;Bladder cancer:SPENP017518;Kidney cancer:SPENP020300
SPENP015967	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7277	Others	1.7167	0.1066	0.3909	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015749	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096;Leukemia:SPENP001148
SPENP015976	QVRPIVGPFHAVLK	Colon cancer	Colon cancer	Colon epithelium	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015735	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331,SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP014237
SPENP015983	MTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon epithelium	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	1.0536	Others	3.6228	0.0047	0.0582	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015786	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP006553,SPENP000343
SPENP015993	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon epithelium	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-2.192	Down-regulated in tumors	-5.952	9.42e-06	0.0005	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015781	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP016022	MIFSVGHPFTASYLR	Colon cancer	Colon cancer	Colon epithelium	SPENT002953	SPENG001625	HSALNG0038306	-0.3052	Others	-1.298	0.214	0.526	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015785	SPENO005702	
SPENP016047	YTRPGLPTFSQEVLHK	Colon cancer	Colon cancer	Colon epithelium	SPENT005706	SPENG002661	AC074091.2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM015856	SPENO005905	
SPENP016058	GSGQGDSLYPVGYLDK	Colon cancer	Colon cancer	Colon epithelium	SPENT000814	SPENG001638	HSALNG0104943	0.0842	Others	0.314	0.7641	0.8968	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	MS	28137767	Immunogenic	SPENM015849	SPENO005134	Kidney cancer:SPENP020374;Anal canal cancer:SPENP024782;Lung cancer:SPENP025746;Prostate cancer:SPENP018335;Colon cancer:SPENP001653,SPENP008500,SPENP014345
SPENP016075	EALCGCSINVPTLDGR	Colon cancer	Colon cancer	Colon epithelium	SPENT000515	SPENG000486	NONHSAG001879.2	-0.1267	Others	-0.3621	0.7297	0.8764	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015867	SPENO000704	Bile duct cancer:SPENP013493;Tongue cancer:SPENP027603;Lung cancer:SPENP007733;Prostate cancer:SPENP018322,SPENP012067;Colon cancer:SPENP007276;Leukemia:SPENP001237
SPENP016077	DRDPNSLLISCAVSYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	0.1577	Others	0.3716	0.7212	0.8764	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015853	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP014375,SPENP008507,SPENP006600
SPENP016082	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1	-0.9881	Others	-3.833	0.0006	0.0157	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015874	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP016093	YLDLFTNYISLYNTCMK	Colon cancer	Colon cancer	Colon epithelium	SPENT005708	SPENG002394	lnc-TMEM143-1	0.669	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015880	SPENO001037	
SPENP016099	MTLPSIGIPLLLWYSSK	Colon cancer	Colon cancer	Colon epithelium	SPENT000799,SPENT000798	SPENG000230,SPENG001912	lnc-ARHGEF2-3,NONHSAG003096.2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015893	SPENO002183,SPENO005372	
SPENP016107	LTGDLSHLAAIVILLLK	Colon cancer	Colon cancer	Colon epithelium	SPENT002425,SPENT002424	SPENG002398	lnc-KDELR2-1	-0.1551	Others	-0.3601	0.7311	0.8764	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015877	SPENO001805,SPENO003193	
SPENP016111	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon epithelium	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.0421	Others	0.1221	0.9035	0.9655	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015916	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP007353
SPENP016121	GIQKFPGINYPVLTPNLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018,SPENT000457,SPENT000458	SPENG001448,SPENG003202	HMGCL,lnc-GALE-2	-0.3543	Others	-1.321	0.2032	0.526	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015910	SPENO000742,SPENO001216,SPENO002963	Colon cancer:SPENP014465,SPENP026891,SPENP010748,SPENP010747;Lung cancer:SPENP002686;Prostate cancer:SPENP018387
SPENP016124	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon epithelium	SPENT005758	SPENG002845	COL1A1	-0.3028	Others	-0.421	0.6785	0.8547	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015920	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560;Leukemia:SPENP001302
SPENP016132	SPRPAGPQLFLPDPDPQR	Colon cancer	Colon cancer	Colon epithelium	SPENT000386	SPENG002131	NONHSAG053828.2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015904	SPENO003267	
SPENP016141	ASQGISNYLAWYQQKPGK	Colon cancer	Colon cancer	Colon epithelium	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015934	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408
SPENP016143	LSWTVPEGQFDSFVVQFK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	0.272	Others	0.3863	0.7107	0.8744	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015912	SPENO002584	Bladder cancer:SPENP017719;Kidney cancer:SPENP020466;Tongue cancer:SPENP027882;Lung cancer:SPENP002728;Colon cancer:SPENP014455
SPENP016150	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005785	SPENG001958	FBLN1	1.6452	Others	2.2643	0.0321	0.1959	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015924	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP008580
SPENP016154	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015947	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP016161	SAIAIQGGLTELPWDGGLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000385	SPENG000940	NONHSAG038348.2		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015958	SPENO004334	Kidney cancer:SPENP015167
SPENP016178	ADEALFLLLHNEMVSGVYK	Colon cancer	Colon cancer	Colon epithelium	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767	-0.0085	Others	-0.0263	0.9793	0.9881	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015948	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP006659,SPENP000481,SPENP014479;Lung cancer:SPENP004493,SPENP002731;Kidney cancer:SPENP020515
SPENP016179	QALNLPDVFGLVVLPLELK	Colon cancer	Colon cancer	Colon epithelium	SPENT001218	SPENG003441	NONHSAG033755.2	1.0669	Others	3.1822	0.05	0.2375	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015961	SPENO005358	Breast cancer:SPENP008975;Lung cancer:SPENP025980,SPENP002749;Kidney cancer:SPENP020505
SPENP016180	NVQLLSQFVSPFTGCIYGR	Colon cancer	Colon cancer	Colon epithelium	SPENT000847	SPENG000825	HSALNG0035586	0.2755	Others	0.6838	0.5196	0.7772	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015963	SPENO003852	Colon cancer:SPENP014507,SPENP001705;Lung cancer:SPENP028362;Kidney cancer:SPENP020507
SPENP016183	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Colon epithelium	SPENT005801	SPENG002115	AL136361.1	-0.7921	Others	-3.433	0.0034	0.0491	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM015974	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP016197	EILSNLGSPVVLCHNDLLCK	Colon cancer	Colon cancer	Colon epithelium	SPENT002959,SPENT002958	SPENG003700,SPENG002003	HSALNG0089832,ETNK1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM015996	SPENO000590,SPENO003978	
SPENP016201	AELTSSAPACYALAISPDAK	Colon cancer	Colon cancer	Colon epithelium	SPENT001691	SPENG003411	TLE3		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016003	SPENO004865	
SPENP016203	YIMVPSGNMGVFDPTEIHNR	Colon cancer	Colon cancer	Colon epithelium	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.4917	Others	1.9434	0.0617	0.2727	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016007	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP016227	QLFELLCYAESIDDQLNTLLK	Colon cancer	Colon cancer	Colon epithelium	SPENT002180	SPENG002358	lnc-MTPAP-6		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016026	SPENO003605	
SPENP016232	STAAMSTYTGIFTDQVLSVLK	Colon cancer	Colon cancer	Colon epithelium	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016016	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445
SPENP016234	YVSLVMPVALFNLIDTFPLRK	Colon cancer	Colon cancer	Colon epithelium	SPENT004200	SPENG000180	lnc-RPGR-4		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016020	SPENO005927	
SPENP016235	HRPRPYPPNVGEEIQIGHIPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005757	SPENG000084	FN1	-0.8047	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016032	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP014549,SPENP024255,SPENP010920
SPENP016240	VVEPPEKDDQLVVLFPVQKPK	Colon cancer	Colon cancer	Colon epithelium	SPENT001569	SPENG000472	NONHSAG007255.2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016028	SPENO004393	Ovary cancer:SPENP016634;Gastric cancer:SPENP003669
SPENP016246	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3575	Others	2.0835	0.048	0.2359	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016043	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP029449,SPENP010943
SPENP016247	DMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.5729	Others	-1.578	0.1267	0.4233	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016053	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704
SPENP016248	AAGMYLEHYLDSIENLPFELQR	Colon cancer	Colon cancer	Colon epithelium	SPENT002218,SPENT002217	SPENG000236,SPENG002804	HSALNG0088886,lnc-ACRBP-2	0.8761	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016056	SPENO003471,SPENO004291	Anal canal cancer:SPENP024922;Colon cancer:SPENP014564
SPENP016253	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1611	Others	1.2397	0.2409	0.5516	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016048	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP006702
SPENP016255	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Colon epithelium	SPENT000018	SPENG003202	HMGCL	-0.6223	Others	-1.3	0.2108	0.526	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016054	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP010941,SPENP000542
SPENP016256	NSGNLVSVLTQAEGAFVASLIK	Colon cancer	Colon cancer	Colon epithelium	SPENT002599,SPENT005711,SPENT005710,SPENT005712	SPENG003424,SPENG001293,SPENG001359	HSALNG0016278,lnc-REG3A-3,lnc-REG3A-4		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016035	SPENO000553,SPENO003300,SPENO003866,SPENO004764	
SPENP016257	GSWSEWSTWGLCMPPCGPNPTR	Colon cancer	Colon cancer	Colon epithelium	SPENT002430,SPENT002382,SPENT002381,SPENT002431	SPENG002762,SPENG003101	lnc-SYN1-1,NONHSAG054391.2	1.9039	Others	1.3704	0.3961	0.6754	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016037	SPENO002535,SPENO002774,SPENO003398,SPENO005938	
SPENP016258	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1	-0.8846	Others	-4.834	3.45e-05	0.0016	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016042	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP010933,SPENP014573,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP016259	LRECDGLVDALIFIVQAEIGQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.3664	Others	-0.8076	0.4276	0.6973	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016052	SPENO005858	Anal canal cancer:SPENP024912;Colon cancer:SPENP014582;Lung cancer:SPENP002823
SPENP016262	GGDGPSHESEDFPRPLVTLPGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005523	SPENG001672	NONHSAG008623.2	0.076	Others	0.3881	0.7636	0.8968	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016036	SPENO000362	
SPENP016263	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon epithelium	SPENT005758	SPENG002845	COL1A1	-0.0004	Others	-0.0005	0.9996	0.9996	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016045	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP016267	EHLALLAVPMVPLQIILPLIISK	Colon cancer	Colon cancer	Colon epithelium	SPENT000324,SPENT005676	SPENG000770	NONHSAG036466.2	0.1645	Others	0.7103	0.4857	0.7547	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016063	SPENO001111,SPENO002620	
SPENP016274	MNSGNLVSVLTQAEGAFVASLIK	Colon cancer	Colon cancer	Colon epithelium	SPENT002599,SPENT005711,SPENT005710,SPENT005712	SPENG003424,SPENG001293,SPENG001359	HSALNG0016278,lnc-REG3A-3,lnc-REG3A-4		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016059	SPENO000553,SPENO003300,SPENO003866,SPENO004764	
SPENP016275	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.5473	Others	3.3205	0.0036	0.0506	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016070	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP016277	ATFYTPQNPSSLAPAPLRPLEDR	Colon cancer	Colon cancer	Colon epithelium	SPENT001336	SPENG001086	HSALNG0049384		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016072	SPENO005428	Bladder cancer:SPENP017857;Kidney cancer:SPENP020611;Bile duct cancer:SPENP013627;Lung cancer:SPENP002849;Colon cancer:SPENP024279
SPENP016279	LQAMWGQSLLPPVSTSFTTGGLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	1.3741	Others	3.3234	0.0183	0.1335	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016066	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012626,SPENP012627;Bladder cancer:SPENP017847;Kidney cancer:SPENP020599;Lung cancer:SPENP002859;Colon cancer:SPENP014588
SPENP016284	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1583	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016084	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP016285	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.1828	Others	0.7267	0.4803	0.7495	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM016078	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP016291	MFLSGKCLYFSDQVHILYFVSELF	Colon cancer	Colon cancer	Colon epithelium	SPENT005789	SPENG001983	CNOT2	0.6569	Others	0.6775	0.51	0.7686	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016090	SPENO005500	Colon cancer:SPENP006720,SPENP014606;Lung cancer:SPENP002867
SPENP016292	ARDMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	-0.6048	Others	-1.323	0.1989	0.525	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016094	SPENO005858	Colon cancer:SPENP014616,SPENP026702,SPENP008706;Lung cancer:SPENP002874
SPENP016295	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6271	Others	0.7024	0.4932	0.758	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016086	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP026761
SPENP016301	GTYSHMWHLFSDPYSTIAPFTGNR	Colon cancer	Colon cancer	Colon epithelium	SPENT005713,SPENT005714	SPENG000922	HSALNG0016092		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016081	SPENO000982,SPENO005982	
SPENP016302	STAAMSTYTGIFTDQVLSVLKGEE	Colon cancer	Colon cancer	Colon epithelium	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	0.4495	Others	0.4887	0.6585	0.8455	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016087	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575
SPENP016304	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7386	Others	1.021	0.3234	0.6355	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016088	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP016312	ISTPQTNTVPIKPLISTPPVSSQPK	Colon cancer	Colon cancer	Colon epithelium	SPENT003716,SPENT003715	SPENG000155	NONHSAG005483.2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016100	SPENO004860,SPENO006185	
SPENP016314	AFTLYSLLQAALLCVNAIAVLHEER	Colon cancer	Colon cancer	Colon epithelium	SPENT000850	SPENG002318	HSALNG0121379		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016102	SPENO001996	
SPENP016316	LHLEGYHGTAGDSMSYHSGSVFSAR	Colon cancer	Colon cancer	Colon epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016099	SPENO002584,SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012644,SPENP012645;Bladder cancer:SPENP017892;Gastric cancer:SPENP003348;Lung cancer:SPENP002891;Colon cancer:SPENP027069
SPENP016317	HRMDACCCSVGAAWGTEECEECPMR	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016104	SPENO000957	Colon cancer:SPENP008714,SPENP011042,SPENP011041;Lung cancer:SPENP004655
SPENP016318	VDEFPLCGHMVSDEYEQLSSEALEAA	Colon cancer	Colon cancer	Colon epithelium	SPENT005529,SPENT005530	SPENG002411,SPENG003436	HSALNG0028334,lnc-POPDC2-2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016114	SPENO004340,SPENO004484	
SPENP016325	SSQSLVYSDGNTYLNWFQQRPGQSPR	Colon cancer	Colon cancer	Colon epithelium	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.7455	Others	0.9474	0.38	0.6711	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016117	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP014630,SPENP006744
SPENP016326	SSQSLVHSDGNTYLSWLQQRPGQPPR	Colon cancer	Colon cancer	Colon epithelium	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.1994	Others	0.5329	0.601	0.8145	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016116	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP016327	DITSDSLSLSWTVPEGQFDHFLVQFK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	0.8133	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016126	SPENO002584	Colon cancer:SPENP014640;Lung cancer:SPENP002906
SPENP016334	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.9132	Others	1.227	0.2322	0.5451	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016122	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP016336	YTFHGDPHATFAAFFGGSNPFEIFFGR	Colon cancer	Colon cancer	Colon epithelium	SPENT000515	SPENG000486	NONHSAG001879.2		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016128	SPENO000704	
SPENP016338	RLNTILAQIMPFLSQEHQQQVAQAVER	Colon cancer	Colon cancer	Colon epithelium	SPENT001691	SPENG003411	TLE3	0.1996	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016130	SPENO004865	
SPENP016339	IVAFADAAVEPIDFPIAPVYAASMVLK	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1	-1.566	Down-regulated in tumors	-3.887	0.0005	0.0142	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016137	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061
SPENP016341	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.719	Others	1.757	0.0902	0.3468	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016136	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP016342	ALEGLGEGVTFPAMHAMWSSWAPPLER	Colon cancer	Colon cancer	Colon epithelium	SPENT005719	SPENG003455	lnc-EEF1A1-2		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016134	SPENO003052	
SPENP016343	MLSGGFGYSPFLSITDGNMPGTRPASR	Colon cancer	Colon cancer	Colon epithelium	SPENT002523,SPENT002524	SPENG000400	lnc-PIANP-3		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016135	SPENO001572,SPENO003716	
SPENP016344	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Colon epithelium	SPENT000014	SPENG003410	ACAT1		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016133	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP016345	ACEDIDECSLPNICVFGTCHNLPGLFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758	0.5961	Others	0.8628	0.3961	0.6754	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016132	SPENO000957	Bladder cancer:SPENP011753,SPENP017913;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP008730;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP016349	LGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Colon epithelium	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	-0.7004	Others	-1.488	0.1874	0.5077	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016141	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097
SPENP016351	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5451	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016145	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP021892,SPENP000594
SPENP016352	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-0.0303	Others	-0.0753	0.941	0.9752	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016146	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP008743,SPENP000598
SPENP016359	LEDSLWIGLTDQHVQLPMAMTAENLAVK	Colon cancer	Colon cancer	Colon epithelium	SPENT005721,SPENT005720	SPENG001831	lnc-PCSK1N-3	1.9143	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016138	SPENO001851,SPENO004224	
SPENP016365	STNLLAAETASLEEQLQGWGEVMLMADK	Colon cancer	Colon cancer	Colon epithelium	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	-0.104	Others	-0.3564	0.7247	0.8764	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016155	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP007484,SPENP014656,SPENP000591
SPENP016367	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016157	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP008740
SPENP016368	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	0.3583	Others	0.7389	0.4932	0.758	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016169	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP014668
SPENP016370	ASADELTFHEFEEATNLLADTPDAATTSR	Colon cancer	Colon cancer	Colon epithelium	SPENT001420	SPENG000627	lnc-TMED1-2	0.1045	Others	0.3953	0.7009	0.8685	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016166	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP016372	AVSLVTDSTSTFLSQTTYALIEAITEYTK	Colon cancer	Colon cancer	Colon epithelium	SPENT001334,SPENT000988	SPENG000380	lnc-DIABLO-1	0.0824	Others	0.2304	0.8199	0.9173	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016165	SPENO001827,SPENO003093	Colon cancer:SPENP014674,SPENP000607;Lung cancer:SPENP002938;Kidney cancer:SPENP020675
SPENP016375	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005757,SPENT005755	SPENG000084	FN1	1.1302	Others	1.6209	0.1215	0.4203	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016172	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP016377	SLSLNPFLWSPFESLCEIGEKPDPDQTFK	Colon cancer	Colon cancer	Colon epithelium	SPENT005452	SPENG002651	lnc-CDC27-7		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016167	SPENO005295	Tongue cancer:SPENP028052;Colon cancer:SPENP014676
SPENP016379	QRWSGPSESTRPSSWKLDAGWDAQDTAVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005858,SPENT005723,SPENT005722	SPENG000119,SPENG002906,SPENG001776	AC091196.1,BRSK2,HSALNG0082113	2.0706	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016168	SPENO002927,SPENO003301,SPENO004931	
SPENP016381	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	2.0765	Others	3.0871	0.0055	0.0638	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016174	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP016385	RAVSLVTDSTSTFLSQTTYALIEAITEYTK	Colon cancer	Colon cancer	Colon epithelium	SPENT001334,SPENT000988	SPENG000380	lnc-DIABLO-1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016176	SPENO001827,SPENO003093	
SPENP016390	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon epithelium	SPENT005757,SPENT005755	SPENG000084	FN1	0.2125	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016173	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP016391	GFDPFMNLVIDECVEMATSGQQNNIGMVVIR	Colon cancer	Colon cancer	Colon epithelium	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	-1.04	Others	-2.822	0.0477	0.2359	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016189	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP023439;Colon cancer:SPENP014688;Bladder cancer:SPENP017959
SPENP016392	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016188	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP027468
SPENP016397	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	2.6556	Up-regulated in tumors	3.5133	0.0027	0.0434	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016185	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP024332,SPENP006770,SPENP008758
SPENP016399	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Colon cancer	Colon cancer	Colon epithelium	SPENT000855	SPENG000474	AC016876.2	-0.3407	Others	-0.698	0.4928	0.758	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM016190	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP022020
SPENP016403	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.1372	Others	2.7084	0.0179	0.1322	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016195	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP014704
SPENP016404	LEELTVTDATPDSLSLSWTVPEGQFDHFLVQYK	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	1.3899	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016198	SPENO002584	Colon cancer:SPENP014708;Lung cancer:SPENP002979
SPENP016408	LGELTVTDATPDSLSLSWTVPEGQFDHFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	1.0762	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016202	SPENO002584	
SPENP016409	LGELTMTDATPDSLSLSWTVPEGQFDHFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	-0.0526	Others	-0.0569	0.9582	0.98	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016200	SPENO002584	Bladder cancer:SPENP017972;Colon cancer:SPENP014711;Lung cancer:SPENP002987
SPENP016410	LGELTVTDATPDSLSLSWMVPEGQFDHFLVQYR	Colon cancer	Colon cancer	Colon epithelium	SPENT005913	SPENG001766	AL662884.2	0.5723	Others	1.5857	0.1312	0.4305	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Non-validated			Immunogenic	SPENM016201	SPENO002584	Colon cancer:SPENP014713;Lung cancer:SPENP002981,SPENP025842
SPENP016413	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.877	Others	2.9045	0.0073	0.075	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016205	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP016415	AIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNR	Colon cancer	Colon cancer	Colon epithelium	SPENT000014,SPENT000015	SPENG003410,SPENG003123	ACAT1,HSALNG0086980		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016207	SPENO003940,SPENO004992	Colon cancer:SPENP011185,SPENP011186;Kidney cancer:SPENP020707;Prostate cancer:SPENP018556
SPENP016416	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1146	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016208	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP016417	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758	0.7164	Others	0.9702	0.339	0.644	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016212	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP008769,SPENP011193,SPENP014722,SPENP011194;Lung cancer:SPENP002996
SPENP016419	NTTLGNSLQESLDELIQSQQITPQLALQVLLQFDK	Colon cancer	Colon cancer	Colon epithelium	SPENT005673	SPENG002521	HSALNG0106302	1.6339	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016209	SPENO002942	
SPENP016422	LQLVLAPLHSLASQALEHGLPDPGSLLVHSFQQLGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005724	SPENG001982	NONHSAG114701.1		Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016214	SPENO000300	
SPENP016424	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.9073	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016220	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP011198,SPENP008772
SPENP016426	NLPGGQQNSSWNFSEDTVISILNTINEVIAENLEAAK	Colon cancer	Colon cancer	Colon epithelium	SPENT005788	SPENG002233	AP001931.2	0.6096	Others	1.224	0.2376	0.5486	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016219	SPENO005858	Colon cancer:SPENP014730;Lung cancer:SPENP003001
SPENP016427	GFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWK	Colon cancer	Colon cancer	Colon epithelium	SPENT005534,SPENT005535	SPENG001633	HSALNG0064888		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016218	SPENO000667,SPENO004480	
SPENP016429	NVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005892	SPENG001317	HSALNG0105758	2.0901	Others	1.4802	0.1627	0.475	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016221	SPENO000957	Colon cancer:SPENP011205,SPENP014731,SPENP011206;Bladder cancer:SPENP017988
SPENP016430	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752	SPENG000084	FN1	0.9695	Others	1.0917	0.2934	0.6043	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016223	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124
SPENP016432	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016222	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP016433	KTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016225	SPENO001233	Bladder cancer:SPENP017992;Tongue cancer:SPENP027837;Gastric cancer:SPENP015491;Lung cancer:SPENP003010
SPENP016435	MQYGGAPGGPAFPGQTQDPLYGYFAAVAGQDGQIDADELQR	Colon cancer	Colon cancer	Colon epithelium	SPENT005536	SPENG000963	lnc-STEAP4-2	-1.708	Others	-1.986	0.0602	0.2682	PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016227	SPENO006104	
SPENP016436	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016228	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140;Lung cancer:SPENP003011,SPENP022142
SPENP016437	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016229	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP014739,SPENP011218
SPENP016438	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Colon epithelium	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.0868	Others				PXD019504	Global proteome analysis of paired colorectal cancer sample using LC-MS/MS	Orbitrap Fusion Lumos	Label free	32166002	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM016230	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP014740
SPENP016479	APVSWITPGLK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001457,SPENT001458	SPENG000652	AC012313.3		Tumor-specific				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM006471	SPENO002381,SPENO003501	Colon cancer:SPENP029369;Gastric cancer:SPENP003513
SPENP016480	YMDGMTVGVVR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005796	SPENG001958	FBLN1	-0.6741	Others	-1.693	0.1306	0.6638	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006478	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP016486	RYMDGMTVGVVR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005796	SPENG001958	FBLN1	-1.536	Others	-1.581	0.165	0.6638	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006483	SPENO003698	Colon cancer:SPENP008201,SPENP015769,SPENP014156;Gastric cancer:SPENP003524
SPENP016489	SQVMWGSTSQNK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005734,SPENT005733	SPENG002685	HSALNG0130209	0.0724	Others	0.1715	0.8681	0.9843	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006497	SPENO002266,SPENO005843	
SPENP016510	TEVLSEDLLQIER	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005992	SPENG003790	ARHGAP17		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006509	SPENO004570	Bile duct cancer:SPENP013402;Colon cancer:SPENP024018,SPENP007097
SPENP016524	VTDATETTITISWR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9734	Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006524	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP016533	DDQLVVLFPVQKPK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001569	SPENG000472	NONHSAG007255.2	-0.2098	Others	-0.5743	0.5749	0.9757	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006518	SPENO004393	Gastric cancer:SPENP003567
SPENP016534	VLQATVVAVGSGSK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT000772,SPENT000668,SPENT000773	SPENG000579,SPENG001842,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	MS	28137767	Immunogenic	SPENM006528	SPENO001211,SPENO004078,SPENO004760	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793,SPENP026461
SPENP016539	QYNVGPSVSKYPLR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.25	Others	-2.703	0.0157	0.3823	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006532	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP016543	MTQSPSSLSASVGDR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006547	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP016545	MDLSRHGTVSSFVAK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005785	SPENG001958	FBLN1		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006544	SPENO005034	Breast cancer:SPENP021195,SPENP021193;Colon cancer:SPENP021192;Lung cancer:SPENP021194
SPENP016552	AQITGYRLTVGLTRR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006541	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021201,SPENP021203;Colon cancer:SPENP021200;Lung cancer:SPENP021202
SPENP016562	DRDPNSLLISCAVSYR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.3986	Others	-1.057	0.3311	0.6928	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006564	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Kidney cancer:SPENP020383;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP016593	TYTCQVTYQGHTFEDSTK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001437	SPENG000079	lnc-BRF1-4	0.6933	Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006599	SPENO005655	Gastric cancer:SPENP003271
SPENP016597	VSPHSGVVALTKPVPEPR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005785	SPENG001958	FBLN1	-0.5877	Others	-1.144	0.2776	0.6919	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006594	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP016598	ASQGISNYLAWYQQKPGK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006600	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP016602	DIQMTQSPSSLSASVGDR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.6268	Others	0.5065	0.619	0.9757	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006595	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP016611	RPHETGGYMLECVCLGNGK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.6142	Others	1.2896	0.2155	0.6638	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006605	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP016612	KVSPHSGVVALTKPVPEPR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006606	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP016616	MESPIPILPLPTPDAETEK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006612	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP016626	LNSPTDSTPALLSATVTPQK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001955	SPENG002812	NONHSAG013330.2		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006617	SPENO002136	
SPENP016631	MASAPASYGSTTTKPMGLLSR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005744	SPENG001051	HSALNG0100365		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006630	SPENO001660	
SPENP016632	TNTNVNCPIECFMPLDVQADR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006631	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP016634	VVEPPEKDDQLVVLFPVQKPK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001569	SPENG000472	NONHSAG007255.2		Tumor-specific				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006632	SPENO004393	Colon cancer:SPENP016240;Gastric cancer:SPENP003669
SPENP016637	STAAMSTYTGIFTDQVLSVLK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006633	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP016640	DTLTSRPAQGVVTTLENVSPPR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.3407	Others	-0.445	0.662	0.9757	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006640	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP016641	TETITGFQVDAVPANGQTPIQR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0815	Others	-0.1859	0.8547	0.9843	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006638	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP016645	DTLTSRPAQGVVTTLENVSPPRR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0758	Others	0.1398	0.8904	0.9843	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006641	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP016651	AAQAQGQSCEYSLMVGYQCGQVFR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.3947	Others	1.1571	0.2995	0.6919	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM006647	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP016654	STAAMSTYTGIFTDQVLSVLKGEE	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Non-validated			Immunogenic	SPENM006650	SPENO003134,SPENO005747	Ovary cancer:SPENP011855;Bladder cancer:SPENP017881;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP016663	TNTNVNCPIECFMPLDVQADREDSRE	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.1668	Others	0.297	0.7784	0.9757	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006659	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP016671	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.7971	Others	-0.8737	0.397	0.7735	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006667	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP016673	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.0154	Others	0.0527	0.9587	0.9848	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006669	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP016674	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.5626	Others	-0.6018	0.5736	0.9757	PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006670	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP016675	YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006671	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009079;Colon cancer:SPENP027469,SPENP014701;Lung cancer:SPENP004715,SPENP002976
SPENP016679	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.9887	Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006675	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP016680	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-1.372	Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006676	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP016681	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Ovary cancer	Ovary malignant neoplasm	Blood plasma	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.048	Others				PXD020557	Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer	Q Exactive	Label free	33228226	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006677	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP016686	KVFNSSHSF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003482,SPENT003481	SPENG000748	HSALNG0024157		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000004	SPENO002560,SPENO006056	
SPENP016687	KVWKAPSSW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003483	SPENG001976	lnc-ABCA12-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000005	SPENO003485	
SPENP016692	KYNANFVTF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005939	SPENG003732	NONHSAG008781.1	1.5079	Others				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000011	SPENO001890	
SPENP016700	LLDRFLATV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003502,SPENT003501,SPENT003505,SPENT003504,SPENT003503	SPENG000681,SPENG002145	NONHSAG038266.2,HSALNG0035344	1.8516	Up-regulated in tumors	3.1371	0.0095	0.031	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000019	SPENO001086,SPENO002221,SPENO003521,SPENO004011,SPENO004097	
SPENP016701	LMVDHVTEV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT001949,SPENT005920	SPENG000432	lnc-APBB3-1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000020	SPENO002480,SPENO003150	
SPENP016702	LPKEHAASL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003507,SPENT003506	SPENG001286	lnc-TBC1D2B-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000021	SPENO000916,SPENO001013	
SPENP016703	LQLKELPSV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003508	SPENG001236	HSALNG0075091		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000022	SPENO003075	
SPENP016707	MYLKTVDKF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003512	SPENG003612	lnc-GPM6B-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000055	SPENO000384	
SPENP016708	KTVDKFNEW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003512	SPENG003612	lnc-GPM6B-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000026	SPENO000384	
SPENP016712	ILDQKINEV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003526,SPENT003527	SPENG003371,SPENG002287	HSALNG0012976,lnc-NOL10-3	1.7516	Up-regulated in tumors	3.3344	0.0076	0.0272	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000032	SPENO005573,SPENO006259	
SPENP016713	ILHDDEVTV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000959,SPENT000956	SPENG001664,SPENG001785	NONHSAG017284.2,lnc-EVX2-8	2.2782	Up-regulated in tumors	6.6877	1.89e-05	0.0003	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	MS	28137767	Immunogenic	SPENM000033	SPENO002111,SPENO003329	
SPENP016715	IYIKQIKTF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003528	SPENG002979	HSALNG0111510	1.9049	Others	3.7309	0.1062	0.238	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000035	SPENO002618	
SPENP016716	KEIGAVKYL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003529	SPENG001169	HSALNG0055961		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000036	SPENO003653	
SPENP016718	KIFERATSF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003530	SPENG003235	lnc-ABCA4-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000038	SPENO003022	
SPENP016719	KIFSGVFVK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003533,SPENT003534,SPENT003531,SPENT003532	SPENG000559,SPENG002597,SPENG003583,SPENG002415	lnc-DIRC3-2,lnc-DTWD2-12,HSALNG0044360,HSALNG0022203		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000039	SPENO000959,SPENO002641,SPENO003129,SPENO006178	
SPENP016723	KLNNRQLNY	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003071	SPENG002474	lnc-MYO18A-4		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000043	SPENO004781	
SPENP016725	KLPEKWESV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003542	SPENG001935	lnc-GSPT1-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000045	SPENO001306	
SPENP016727	KLTYIYIQK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003544	SPENG003234	HSALNG0025533		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000047	SPENO005475	
SPENP016728	KLWEAESKL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003545	SPENG003597	NONHSAG032663.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000048	SPENO002240	
SPENP016729	KPNANRIAL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000023,SPENT000026,SPENT000024,SPENT000025	SPENG001332	NONHSAG015030.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000002	SPENO000887,SPENO001262,SPENO001624,SPENO005116	
SPENP016732	KSFEKSNSW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003547	SPENG002874	lnc-SPON2-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000051	SPENO003107	
SPENP016733	KSFENISKW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003548	SPENG003482	NONHSAG027270.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000052	SPENO002718	
SPENP016735	KTFQFLHQF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003549	SPENG002399	lnc-SERINC1-7		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000054	SPENO003031	
SPENP016736	KTNAIISLK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003514,SPENT003513	SPENG000198	lnc-CLEC2A-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000028	SPENO002418,SPENO005811	
SPENP016739	NYLSHHLTI	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000390	SPENG002704	lnc-TRIM16L-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000087	SPENO003522	
SPENP016743	TLADVLYHV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003553	SPENG001340	HSALNG0064615		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000063	SPENO004788	
SPENP016744	TLYEHNNEL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003554	SPENG001571	lnc-SP7-1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000064	SPENO004940	
SPENP016745	TMKDFNHSY	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003557,SPENT003556,SPENT003555	SPENG000171	NONHSAG000729.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000065	SPENO000436,SPENO002197,SPENO005032	
SPENP016748	TYMKDLYQL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT002121	SPENG003307	lnc-TMEM244-3	-0.4393	Others	-0.7258	0.5055	0.5687	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000068	SPENO002997	
SPENP016749	TYVRWYTQL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT002406	SPENG001918	lnc-WDR47-1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000069	SPENO005639	
SPENP016754	VLAHTILGV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003573,SPENT003574	SPENG003387,SPENG003056	lnc-LRP2BP-2,HSALNG0039095		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000074	SPENO001229,SPENO005137	
SPENP016757	VLIDYQRNV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003576,SPENT003577,SPENT003578	SPENG001301,SPENG002770	lnc-USP34-2,NONHSAG027883.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000077	SPENO000272,SPENO003464,SPENO003756	
SPENP016758	VLYHVETEV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003553	SPENG001340	HSALNG0064615		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000078	SPENO004788	
SPENP016761	VQSNARLLY	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003583	SPENG001947	HSALNG0056393	2.6915	Others				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000081	SPENO003261	
SPENP016762	VQVGLHSTM	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT002442	SPENG001308	NONHSAG011552.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000082	SPENO004838	
SPENP016766	SYAKSTQRF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003561,SPENT003563,SPENT003560,SPENT003562,SPENT003559,SPENT003564,SPENT003565	SPENG001254	lnc-NBPF1-2	0.0289	Others				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000070	SPENO000585,SPENO001183,SPENO001496,SPENO002232,SPENO002454,SPENO004227,SPENO006058	
SPENP016771	QLNEKIFNI	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003591	SPENG002595	HSALNG0057035		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000091	SPENO000426	
SPENP016772	REAEFTKSI	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT002510,SPENT002512,SPENT002511	SPENG003726,SPENG002325,SPENG000279	HSALNG0002035,lnc-EYA3-2,HSALNG0085740		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000092	SPENO000773,SPENO002918,SPENO004290	
SPENP016773	REMDEQIRL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000007	SPENG001563	lnc-NUP210L-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000093	SPENO004921	
SPENP016778	RLVQSPNSY	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000414,SPENT000057,SPENT000332,SPENT000061,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG001333,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG000161,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-DNALI1-1,lnc-PACRGL-9,HSALNG0005848,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	MS	28137767	Immunogenic	SPENM000098	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO004350,SPENO005865,SPENO006016,SPENO006324	
SPENP016779	RRFTEIYEF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003593	SPENG001352	lnc-FKBP6-4		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000099	SPENO004483	
SPENP016780	RTVIIEQSW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003594	SPENG003474	lnc-RBMS2-4		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000100	SPENO001214	
SPENP016786	SILHDVVEV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003598	SPENG003132	lnc-CAMTA2-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000106	SPENO005955	
SPENP016787	SLMHSFILK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003599	SPENG003575	HSALNG0129717		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	MS	28137767	Immunogenic	SPENM000107	SPENO002371	
SPENP016788	SLYQTIRLK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003600,SPENT003601	SPENG000925	HSALNG0056290		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000108	SPENO003596,SPENO004709	
SPENP016789	SPRSPSPSL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003604,SPENT003623,SPENT003612,SPENT003625,SPENT003619,SPENT003616,SPENT003602,SPENT003621,SPENT003603,SPENT003617,SPENT003614,SPENT003622,SPENT003607,SPENT003611,SPENT003620,SPENT003618,SPENT003606,SPENT003615,SPENT003609,SPENT003624,SPENT003613,SPENT003610,SPENT003605,SPENT003608	SPENG001531,SPENG002390,SPENG002126,SPENG000633,SPENG000781,SPENG000774,SPENG003102,SPENG000936,SPENG000771,SPENG001778,SPENG001353,SPENG003354,SPENG000306	HSALNG0007937,lnc-ZNF382-5,lnc-POLR3A-8,AC092295.2,HSALNG0041937,AL162311.3,HSALNG0091905,HSALNG0001815,AL592295.4,lnc-DEFB115-3,lnc-RALGAPA1-1,lnc-DDX51-3,HSALNG0129470		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM000109	SPENO000182,SPENO000233,SPENO000658,SPENO000795,SPENO001193,SPENO001840,SPENO001863,SPENO002260,SPENO002321,SPENO002520,SPENO002534,SPENO002580,SPENO002726,SPENO003146,SPENO003513,SPENO003759,SPENO003861,SPENO004433,SPENO004444,SPENO004650,SPENO005213,SPENO005731,SPENO006012,SPENO006220	
SPENP016792	SVASISLTK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT001974,SPENT001970,SPENT003587	SPENG001091,SPENG003623,SPENG002239	HSALNG0107261,lnc-FUT8-5,lnc-MAN2C1-10		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated	MS	32157095	Immunogenic	SPENM000086	SPENO001521,SPENO002754,SPENO006289	
SPENP016795	KTFSHMSSF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005823,SPENT003515	SPENG000695,SPENG002022	AC022150.4,ZNF83		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM000029	SPENO003619,SPENO004038	
SPENP016796	HIIENIVAV	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003542	SPENG001935	lnc-GSPT1-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000139	SPENO001306	
SPENP016806	EYNNIFHTF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005824,SPENT003656,SPENT003654,SPENT003652,SPENT003658,SPENT003657,SPENT003653,SPENT003659,SPENT003655	SPENG001899,SPENG002943,SPENG003057	AC092821.3,lnc-CLEC2D-8,HSALNG0089161		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000126	SPENO000046,SPENO000507,SPENO000701,SPENO001043,SPENO001498,SPENO001870,SPENO002842,SPENO003318,SPENO005068	
SPENP016809	HQVTVAQSY	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003626	SPENG003242	lnc-CACNB4-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000113	SPENO005337	
SPENP016811	EPRHGGLTL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT001991	SPENG003709	NONHSAG024326.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000121	SPENO001232	
SPENP016829	GLNDFIQKI	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003710,SPENT003711,SPENT003712	SPENG001593	lnc-SLC2A12-7	-0.0433	Others	-0.1175	0.9078	0.9078	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000174	SPENO001662,SPENO003841,SPENO004526	
SPENP016831	AEIDSIHQL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003671	SPENG001282	lnc-LYAR-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000137	SPENO001381	
SPENP016838	ALYDNVEKL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005929,SPENT002838	SPENG001292	AC079781.5		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000136	SPENO002624,SPENO003829	
SPENP016839	GTMTGMLYK	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005942,SPENT005908,SPENT005909,SPENT005907,SPENT005941,SPENT005905,SPENT005906,SPENT005910,SPENT005904	SPENG001535	TIMM23B-AGAP6	0.1914	Others	0.2435	0.8158	0.8637	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	MS	28137767	Immunogenic	SPENM000156	SPENO000399,SPENO001791,SPENO002243,SPENO002429,SPENO003041,SPENO004258,SPENO004770,SPENO004905,SPENO005638	
SPENP016841	APHLVGPHL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003694	SPENG001949	lnc-CIAO1-6		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000157	SPENO005244	
SPENP016842	APKRPPSAF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003696,SPENT000881,SPENT003695	SPENG002981,SPENG001905,SPENG003170	HSALNG0050660,lnc-CT62-3,lnc-ELOVL5-3	2.8318	Up-regulated in tumors	11.1727	0.0001	0.0009	PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000159	SPENO000974,SPENO004410,SPENO004742	
SPENP016844	APRPPPKPM	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003642	SPENG002754	lnc-PIN4-1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000161	SPENO004201	
SPENP016852	GQVKLIQGF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT002684	SPENG003374	lnc-DPP4-8		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000162	SPENO006020	
SPENP016853	APRQPGLMA	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000242,SPENT000245,SPENT000600,SPENT000243,SPENT000244,SPENT000246	SPENG003206,SPENG002813,SPENG003286	lnc-NUPR2-6,lnc-DNAJC16-1,NONHSAG000439.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000163	SPENO000500,SPENO001335,SPENO001467,SPENO002899,SPENO003479,SPENO006135	
SPENP016856	GQFSKPFSF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003708	SPENG003214	HSALNG0074851		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000171	SPENO002593	
SPENP016864	RPQRATSNVF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003713	SPENG003592	HSALNG0119690		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000179	SPENO005520	
SPENP016871	KLWEAESKLSF	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003545	SPENG003597	NONHSAG032663.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000210	SPENO002240	
SPENP016873	GQSELASRLTL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003731	SPENG002763	HSALNG0106597		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000211	SPENO000996	
SPENP016877	RLLTKNNRWTW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003583	SPENG001947	HSALNG0056393		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000201	SPENO003261	
SPENP016879	APRQPGLMAQM	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000242,SPENT000245,SPENT000600,SPENT000243,SPENT000244,SPENT000246	SPENG003206,SPENG002813,SPENG003286	lnc-NUPR2-6,lnc-DNAJC16-1,NONHSAG000439.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000193	SPENO000500,SPENO001335,SPENO001467,SPENO002899,SPENO003479,SPENO006135	
SPENP016881	APRLNSADRPM	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003720,SPENT003721	SPENG002916,SPENG000172	HSALNG0072517,lnc-GDAP2-3		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	MS	31844290	Immunogenic	SPENM000194	SPENO002479,SPENO003681	
SPENP016902	SEGSLQEGHRLW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003745	SPENG000645	lnc-RBM18-1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000231	SPENO002423	
SPENP016912	AEFDTPGHTLSW	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT001450	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000230	SPENO003868	
SPENP016916	ILIQYDRTLLVAD	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003055	SPENG003050	HSALNG0126009		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	SmProt_literiture_mining	28137767	Immunogenic	SPENM000244	SPENO006079	
SPENP016939	VSSVYEQHESTPLR	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000258	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP016951	ARLGYSDITIFEKQEY	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003665	SPENG002485	lnc-PLPPR5-5		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000274	SPENO001038	
SPENP016956	LDSLHRFVLSQAKDEL	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000270	SPENO005833	
SPENP016965	LPGTEYVVSVSSVYEQH	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000282	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	
SPENP016970	SESSSKSSQPLASKQEKD	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT000460	SPENG003337	NONHSAG043626.2		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000289	SPENO005810	
SPENP016973	SFPKYKPSSLRTLPETLD	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003648,SPENT003649	SPENG001585	HSALNG0028397		Others				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000288	SPENO002705,SPENO003570	
SPENP016981	LYSLFHQQTFWLFLHQNTRRQ	Breast cancer	Triple-receptor negative breast cancer	Breast	SPENT003774	SPENG003178	HSALNG0016180		Tumor-specific				PXD009738	Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer	Orbitrap Fusion Lumos	Label free	29786170	Non-validated			Immunogenic	SPENM000298	SPENO003645	
SPENP017134	HVFTTFYAK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000648	SPENG002439	NONHSAG050528.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009546	SPENO003505	Colon cancer:SPENP001444,SPENP026950
SPENP017167	AVYTLTSLYR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000988	SPENG000380	lnc-DIABLO-1	1.1603	Up-regulated in tumors	3.4851	0.0083	0.0227	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009629	SPENO003093	Kidney cancer:SPENP019937;Lung cancer:SPENP002154;Prostate cancer:SPENP018082;Colon cancer:SPENP014012,SPENP008071,SPENP026722,SPENP015676
SPENP017174	KAYELALYLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000931,SPENT000932	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009610	SPENO000344,SPENO002685	
SPENP017215	RFVNVVPTFGK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	-0.2743	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009660	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP017222	GSLASLDSLRK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009683	SPENO005858	Colon cancer:SPENP026916,SPENP014054,SPENP008125,SPENP015749;Kidney cancer:SPENP020052;Prostate cancer:SPENP011932
SPENP017228	LGELPSWILMR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002364	SPENG001530	lnc-ATP5MF-1	0.5428	Others	3.3319	0.0037	0.0129	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009744	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP017255	ALSEYLAVFAR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002069	SPENG001770	NONHSAG021787.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009706	SPENO002442	Anal canal cancer:SPENP024533
SPENP017275	TDSTFNQVVLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002071	SPENG001428	lnc-CPHXL-5		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM009680	SPENO004801	Kidney cancer:SPENP019976;Anal canal cancer:SPENP024517;Lung cancer:SPENP026072;Colon cancer:SPENP006972,SPENP010062,SPENP010061
SPENP017281	YMDGMTVGVVR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005796	SPENG001958	FBLN1	-1.46	Down-regulated in tumors	-2.825	0.0199	0.0443	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009698	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP017298	TDSDSDLQLYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001640	SPENG000521	AMPD2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009685	SPENO000624	
SPENP017300	TAVAHRPGAFK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000153	SPENG003407	NONHSAG024537.2	0.3088	Others	0.6699	0.5114	0.5962	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009688	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP017308	DKLNNLVLFDK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	0.9509	Others	4.6459	0.0003	0.0029	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009670	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP017324	NFFTDVYDLYIK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003512	SPENG003612	lnc-GPM6B-3		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009757	SPENO000384	
SPENP017332	GQAGVMGFPGPK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005758	SPENG002845	COL1A1	-2.742	Down-regulated in tumors	-3.765	0.0014	0.0067	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009822	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP017340	CIGENFAYVQIK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM009804	SPENO003078	Prostate cancer:SPENP018182
SPENP017351	VPFLVLECPNLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000354	SPENG002378	HSALNG0036293	0.7736	Others	2.0826	0.0593	0.1064	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009774	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP017361	SSDSADPFYWMR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004002	SPENG001765	HSALNG0076212		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009765	SPENO003721	
SPENP017387	QAGLYSISLPNK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004005	SPENG000014	HSALNG0028544		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009790	SPENO002030	
SPENP017394	QLGEANEEFALR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001183,SPENT001719,SPENT001182	SPENG000169	lnc-DQX1-1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009773	SPENO000751,SPENO001535,SPENO004354	Bladder cancer:SPENP011366;Colon cancer:SPENP008207;Lung cancer:SPENP004013;Anal canal cancer:SPENP024596
SPENP017395	YQLDPTASISAK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000102	SPENG002045	lnc-ACTR2-11	0.3993	Others	4.2641	0.013	0.0315	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009759	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP017399	TSNLLLSHAGILK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000136,SPENT000135,SPENT000137	SPENG000848	lnc-CDK11A-2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM009877	SPENO002156,SPENO003659,SPENO006064	Colon cancer:SPENP008305,SPENP012777,SPENP027360;Lung cancer:SPENP004077;Anal canal cancer:SPENP024668
SPENP017405	DFSPSGIFGAFQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002364	SPENG001530	lnc-ATP5MF-1	0.4296	Others	3.0835	0.0064	0.0188	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009891	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP017408	AAALVLQTIWGYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005788	SPENG002233	AP001931.2	1.9523	Up-regulated in tumors	4.2123	0.0021	0.0088	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009895	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP017428	YAMVYGYNAAYNR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	0.471	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009847	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP017447	NEQSLQEIWDYVK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001225,SPENT001223,SPENT001018,SPENT001226,SPENT001224,SPENT001227,SPENT001221,SPENT001172,SPENT001020,SPENT001222,SPENT001019,SPENT001021,SPENT001220	SPENG000692,SPENG003279,SPENG002107,SPENG000730,SPENG003168,SPENG001071,SPENG002783,SPENG003471,SPENG003240,SPENG002830,SPENG000109	lnc-LRP5L-14,AL360020.1,LINC02569,AC097532.3,lnc-TSHZ2-15,Z82195.3,lnc-KRBOX4-4,AC092445.1,LINC01949,lnc-SLC35B3-4,lnc-FBXO11-1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM009861	SPENO000166,SPENO000440,SPENO000689,SPENO001532,SPENO001739,SPENO001792,SPENO001875,SPENO002117,SPENO002350,SPENO003055,SPENO003744,SPENO004543,SPENO004677	Lung cancer:SPENP002375
SPENP017449	GNSIIMLEALERV	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM009896	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP017462	SLNPATIYPVLPK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003998	SPENG002061	lnc-SLC5A6-1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009913	SPENO000638	
SPENP017466	HVISYSLSPFEQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001666	SPENG002113	HSALNG0044883	0.4335	Others	1.5856	0.1473	0.2187	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009911	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP017472	SFHFSLPSSWYYR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2	-0.8746	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009898	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP017475	SGTLYSLTLYGLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009879	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP017483	STLVHSLFLTDLYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009935	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP005486,SPENP022736,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Kidney cancer:SPENP020236
SPENP017484	YMALSLQSFCPTTR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001640	SPENG000521	AMPD2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009958	SPENO000624	Tongue cancer:SPENP028213;Kidney cancer:SPENP020270
SPENP017489	RLVQSPNSYFMDVK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000414,SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009944	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP010432,SPENP014253,SPENP006523
SPENP017498	VTDATETTITISWR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.9507	Others	-2.142	0.0645	0.1121	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009959	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP017501	QVRPIVGPFHAVLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005796	SPENG001958	FBLN1	-0.0515	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009962	SPENO003698	Breast cancer:SPENP022729,SPENP022728;Gastric cancer:SPENP015331,SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP014237,SPENP015976
SPENP017516	IDDILQTLLDATYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000775	SPENG001919	lnc-LRRD1-2	1.1923	Up-regulated in tumors	3.3773	0.0094	0.0245	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM009932	SPENO003078	Bladder cancer:SPENP028593;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP025776,SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP001612,SPENP000320
SPENP017518	ADGQMPFSCHYPSR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001996,SPENT001995	SPENG000039	NONHSAG012478.2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009917	SPENO000668,SPENO002663	Colon cancer:SPENP014250,SPENP015956,SPENP008395;Kidney cancer:SPENP020300
SPENP017520	DPWYSTVGLLPPVR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004024,SPENT005829,SPENT004025,SPENT005828,SPENT005827	SPENG002775,SPENG001268	ZNF8-ERVK3-1,HSALNG0127945		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009957	SPENO000065,SPENO000815,SPENO001153,SPENO002568,SPENO005345	
SPENP017521	GYVSCALGCPYEGK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000018	SPENG003202	HMGCL	1.0497	Up-regulated in tumors	3.7866	0.0036	0.0127	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009948	SPENO002963	Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP017523	AVAAAAAAGPVFWR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004026	SPENG003738	NONHSAG022890.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009961	SPENO000310	
SPENP017524	EVVIFGAASELFTK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000018	SPENG003202	HMGCL	0.7756	Others	3.579	0.0048	0.0156	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009936	SPENO002963	Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP017527	GLQWIIDTTIAYPK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003781	SPENG000288	NONHSAG004212.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009965	SPENO001433	
SPENP017549	MTQSPSSLSASVGDR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010004	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP017563	MLITILGTVKPNANR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	1.001	Others	1.2088	0.2443	0.3331	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM009997	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP017569	YAASSYLSLTPEQWK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.8037	Others	-1.828	0.0842	0.1393	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM009991	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP017577	NIETLYMISLESLHK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004036,SPENT004031,SPENT004035,SPENT004033,SPENT004032,SPENT004034	SPENG001774,SPENG000128,SPENG000607	LINC02209,HSALNG0064321	-0.0987	Others	-0.2852	0.8042	0.8425	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010010	SPENO000970,SPENO001234,SPENO002352,SPENO003024,SPENO005418,SPENO005862	Kidney cancer:SPENP020337
SPENP017600	SSTSRPDAYEHTQMK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000096,SPENT000097	SPENG000914	NONHSAG048518.2	-0.9528	Others	-2.233	0.0893	0.145	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010015	SPENO002621,SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP017602	LPFLSSSNLSLDVLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001815,SPENT001814,SPENT004039,SPENT004038	SPENG002392,SPENG002412	NONHSAG013108.2,HSALNG0096025		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010028	SPENO000086,SPENO004087,SPENO005518,SPENO006268	
SPENP017604	KPSPQEVSELQATYR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004040	SPENG000060	HSALNG0106553		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010031	SPENO000753	
SPENP017613	EVELQEQRPRPRAFK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004046	SPENG000405	HSALNG0133060		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010047	SPENO003518	
SPENP017634	AGYEYVSPEQLAGFDK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005924	SPENG003747	HSALNG0013722		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010051	SPENO004898	Anal canal cancer:SPENP024784;Colon cancer:SPENP007234;Bladder cancer:SPENP028447
SPENP017641	AFPHLQQPSFLLASLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001324	SPENG003020	HSALNG0018780		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010088	SPENO005958	Colon cancer:SPENP014363;Lung cancer:SPENP004356,SPENP002633
SPENP017660	YFLVFGNVCVLPTSWR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003099,SPENT003100	SPENG000605,SPENG003268	HSALNG0018113,lnc-SLC35F5-4	-0.0392	Others	-0.072	0.9444	0.9614	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010087	SPENO002503,SPENO003626	Breast cancer:SPENP008932
SPENP017665	ETPLPIDPSMFPTWPAK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000136,SPENT000135,SPENT000138,SPENT000137,SPENT000139	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM010119	SPENO000257,SPENO002156,SPENO003659,SPENO005654,SPENO006064	Bladder cancer:SPENP011592;Colon cancer:SPENP008539,SPENP000431;Lung cancer:SPENP025658,SPENP002667;Kidney cancer:SPENP020456
SPENP017666	ALALAALAAVEPACGSR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004057	SPENG000928	NONHSAG041785.2	0.476	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010122	SPENO001591	Colon cancer:SPENP000433;Kidney cancer:SPENP020433;Prostate cancer:SPENP012080
SPENP017676	TTLIPILSTFLFEDFSK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004058	SPENG002443	HSALNG0115452		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010123	SPENO002539	
SPENP017678	YGALVNNFAAWDHVSAK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004059	SPENG002727	HSALNG0003323		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010130	SPENO006072	
SPENP017681	LLGGQLGLEDFIFAHVK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001329	SPENG000766	HSALNG0004615	2.3532	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010107	SPENO001612	Breast cancer:SPENP021319,SPENP021317;Lung cancer:SPENP021318,SPENP002647;Prostate cancer:SPENP018369;Colon cancer:SPENP021316
SPENP017691	ISSTLYQAAAPVLTPAK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474	-0.0225	Others	-0.0645	0.9501	0.9652	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010103	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP017697	LQILNSIFPGIGCPVPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000801,SPENT000753	SPENG001514	NONHSAG006530.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010126	SPENO005534,SPENO005937	
SPENP017698	DFYPAIADLFAESLQCK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002069	SPENG001770	NONHSAG021787.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010116	SPENO002442	Lung cancer:SPENP025578
SPENP017700	TPIGSFLGSLSLLPATK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000014	SPENG003410	ACAT1	-1.057	Down-regulated in tumors	-5.005	0.0002	0.0023	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010118	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP017707	STDTGVSLPSYEEDQGSK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	1.7937	Up-regulated in tumors	5.9436	0.0001	0.0022	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010157	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP017716	ACLDYPVTSVLPPASLCK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002507	SPENG002379	NONHSAG033050.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010154	SPENO004482	Lung cancer:SPENP025512,SPENP028228;Colon cancer:SPENP007326,SPENP006646;Bladder cancer:SPENP011635,SPENP028438;Prostate cancer:SPENP009279
SPENP017719	LSWTVPEGQFDSFVVQFK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005913	SPENG001766	AL662884.2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010146	SPENO002584	Kidney cancer:SPENP020466;Tongue cancer:SPENP027882;Lung cancer:SPENP002728;Colon cancer:SPENP014455,SPENP016143
SPENP017727	DAAEPGAAVPSLFSGPLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004071	SPENG001863	lnc-RPS27A-2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010152	SPENO005620	
SPENP017728	DIQMTQSPSSLSASVGDR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-1.148	Down-regulated in tumors	-3.003	0.0076	0.0218	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010176	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP017729	MLDDNNHLIQCIMDSQNK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004065,SPENT004070,SPENT004069,SPENT004064,SPENT004061,SPENT004067,SPENT004062,SPENT004068,SPENT004063,SPENT004066	SPENG002705,SPENG000215	HSALNG0120556,lnc-KCTD1-4		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010145	SPENO001281,SPENO001512,SPENO001946,SPENO003901,SPENO004403,SPENO004449,SPENO004520,SPENO004796,SPENO004971,SPENO005890	Prostate cancer:SPENP018405
SPENP017732	VSPHSGVVALTKPVPEPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005785	SPENG001958	FBLN1	0.4721	Others	1.0928	0.2978	0.3874	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010142	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP017735	QTLSTPGTIILGTIPVPK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000713,SPENT000714	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2	0.8854	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010180	SPENO004961,SPENO005968	Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP004453,SPENP026000;Prostate cancer:SPENP012096;Colon cancer:SPENP001697,SPENP000454
SPENP017744	GETGPAGPAGPVGPVGAR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005758	SPENG002845	COL1A1	-2.499	Down-regulated in tumors	-4.305	0.0005	0.0038	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010177	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP017749	KVSPHSGVVALTKPVPEPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005785	SPENG001958	FBLN1		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010201	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP017750	SLQHTHSTFSSGSFHPPER	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004076,SPENT004075	SPENG000255,SPENG002964	lnc-PARD3B-4,HSALNG0021747		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010191	SPENO001405,SPENO004172	
SPENP017755	LQHFSQNNSHLLFSLNFLS	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004081	SPENG002271	HSALNG0011249		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010211	SPENO003770	Colon cancer:SPENP014506
SPENP017761	VQASLAANTFTITGHTEAK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005801	SPENG002115	AL136361.1	-0.0282	Others	-0.0395	0.9704	0.9775	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010207	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP017762	TTVLLADINDFNTVNEIYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003329,SPENT003330	SPENG001096	HSALNG0067190		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	sORF.org_record	26527729	Immunogenic	SPENM010188	SPENO004169,SPENO004502	Thyroid cancer:SPENP012540,SPENP012541;Colon cancer:SPENP012838,SPENP000488;Liver cancer:SPENP000735
SPENP017766	GTLEPLVGYIMAVSHCFSL	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004077,SPENT004079,SPENT004078	SPENG002732,SPENG001344,SPENG000737	HSALNG0097678,lnc-TDRD3-18,AL158038.1	1.1329	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010194	SPENO001096,SPENO003923,SPENO004391	
SPENP017768	ADEALFLLLHNEMVSGVYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767	0.6568	Others	1.5048	0.1563	0.2313	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010202	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Colon cancer:SPENP006659,SPENP000481,SPENP016178,SPENP014479;Lung cancer:SPENP004493,SPENP002731;Kidney cancer:SPENP020515
SPENP017770	APSLTGPSVGLEAGQGPTK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004074	SPENG000459	lnc-ANGPTL2-7	2.9443	Others	1.6622	0.1204	0.183	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010189	SPENO004233	Bile duct cancer:SPENP013572
SPENP017777	ATLVCLISDFYPGAVTVAWK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.7352	Others	1.0857	0.2919	0.3819	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010216	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP017779	VLSPEYLWDQQLLGWPAVLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000795	SPENG002103	lnc-ABO-33		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010221	SPENO001263	Colon cancer:SPENP014543;Kidney cancer:SPENP020528
SPENP017780	VGQYVVDLTSFEQLALPVLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001191,SPENT000714	SPENG002182	NONHSAG004654.2	0.8144	Others	1.5575	0.1453	0.2169	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010213	SPENO002934,SPENO005968	Breast cancer:SPENP023074,SPENP023075;Lung cancer:SPENP002767
SPENP017783	LLEIDNSELLHMLESPESLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004082	SPENG001703	HSALNG0067302		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010230	SPENO006263	Lung cancer:SPENP025859;Bladder cancer:SPENP028642
SPENP017787	YIMVPSGNMGVFDPTEIHNR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	1.2436	Others	2.5807	0.0274	0.0576	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010238	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP017788	AAWFLQELPSFAVPAGILAR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004083,SPENT004084	SPENG000868	lnc-SRD5A2-3		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010240	SPENO000852,SPENO003723	Prostate cancer:SPENP013061
SPENP017792	KLPGEVTETEVIALGLPFGK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004085	SPENG003336	NONHSAG002166.2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010241	SPENO002481	
SPENP017794	NPSYPWLWEDGSPLMPHLFR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000573,SPENT000572	SPENG000791,SPENG002681	HSALNG0089207,lnc-CLEC7A-2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010229	SPENO003720,SPENO004266	
SPENP017799	ALAPTWEQLALGLEHSETVK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.2566	Others	0.4746	0.6411	0.7003	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010217	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP017805	TEQGPTGVTMTSNPITWGQIK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004024,SPENT005829,SPENT004025,SPENT005828,SPENT005827,SPENT005831	SPENG002775,SPENG001268	ZNF8-ERVK3-1,HSALNG0127945		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	SmProt_literiture_mining	28137767	Immunogenic	SPENM010263	SPENO000065,SPENO000815,SPENO001153,SPENO001369,SPENO002568,SPENO005345	Lung cancer:SPENP026076
SPENP017810	AITYNAMLAETSTVFHQNDVK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000648	SPENG002439	NONHSAG050528.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010257	SPENO003505	Colon cancer:SPENP000519,SPENP026679;Lung cancer:SPENP004559
SPENP017815	TPYQFTTLGQATAEFSKPLGR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002056,SPENT002216	SPENG001417	lnc-NECTIN1-4		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010261	SPENO002683,SPENO003894	Skin cancer:SPENP025411,SPENP019658,SPENP019660,SPENP019659;Anal canal cancer:SPENP024904
SPENP017816	TNTNVNCPIECFMPLDVQADR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.8807	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010251	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP017825	IFPIKDVPLETDDLTTWLYQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003781	SPENG000288	NONHSAG004212.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010260	SPENO001433	
SPENP017826	STAAMSTYTGIFTDQVLSVLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.4884	Others	-0.6778	0.5231	0.6052	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010243	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP017828	DTLTSRPAQGVVTTLENVSPPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.539	Down-regulated in tumors	-3.318	0.0056	0.0172	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010264	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP017832	SGDRGETGPAGPAGPVGPVGAR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005758	SPENG002845	COL1A1	-2.668	Down-regulated in tumors	-4.016	0.0008	0.0049	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010271	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP017836	EAPFVPVGIAGFAAIVAYGLYK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001900	SPENG002105	NONHSAG034881.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	28137767	Immunogenic	SPENM010276	SPENO000724	Kidney cancer:SPENP020577;Prostate cancer:SPENP013086
SPENP017838	LIDMLSEAGLSVIETTSFVSPK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000018	SPENG003202	HMGCL	1.1037	Others	2.634	0.0274	0.0576	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010283	SPENO002963	Bladder cancer:SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP017841	LQAAQLPHTGVFGQSFSCPSDR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000855	SPENG000474	AC016876.2	-0.967	Others	-1.115	0.291	0.3818	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM010278	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP017843	DMDLTEVITGTLWNLSSHDSIK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005788	SPENG002233	AP001931.2	1.6198	Up-regulated in tumors	4.31	0.0006	0.004	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010277	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP017845	TETITGFQVDAVPANGQTPIQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010269	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP017847	LQAMWGQSLLPPVSTSFTTGGLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010288	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012626,SPENP012627;Kidney cancer:SPENP020599;Lung cancer:SPENP002859;Colon cancer:SPENP014588,SPENP016279
SPENP017850	GTVLALTENNFDDTIAEGITFIK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.329	Others	0.4894	0.6327	0.6945	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010302	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP028573;Lung cancer:SPENP002850,SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP000559,SPENP008691
SPENP017851	KPSVPETEADGFVLLGDTTDEQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004088,SPENT004087	SPENG001565,SPENG001726	HSALNG0056067,AC007161.3		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	MS	31340039	Immunogenic	SPENM010289	SPENO000152,SPENO005786	Tongue cancer:SPENP027833
SPENP017857	ATFYTPQNPSSLAPAPLRPLEDR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001336	SPENG001086	HSALNG0049384		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010298	SPENO005428	Kidney cancer:SPENP020611;Bile duct cancer:SPENP013627;Lung cancer:SPENP002849;Colon cancer:SPENP024279,SPENP016277
SPENP017859	QGLYELSASNFELHVAQGDHFIK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000040	SPENG000572	lnc-EEF1E1-2	1.092	Others	1.3931	0.1815	0.2627	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010290	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP017869	MGQVIPEAAPELQIIILHSQHTVF	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004089	SPENG000810	HSALNG0038994	0.648	Others	1.5145	0.1608	0.2373	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010313	SPENO000088	
SPENP017876	DLEVVAATPTSLLISWDAPAVTVR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.179	Others	-2.349	0.0311	0.0637	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010317	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP017881	STAAMSTYTGIFTDQVLSVLKGEE	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010312	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Kidney cancer:SPENP020626;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP017882	NSITLTNLTPGTEYVVSIVALNGR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.504	Others	-2.199	0.0465	0.0869	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010315	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP017885	TKTETITGFQVDAVPANGQTPIQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2983	Others	-0.358	0.7309	0.7739	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010316	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP017888	STATISGLKPGVDYTITVYAVTGR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.465	Down-regulated in tumors	-4.502	0.0003	0.0029	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010325	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP017889	AAQAQGQSCEYSLMVGYQCGQVFR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-1.698	Down-regulated in tumors	-3.4	0.0073	0.0209	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM010311	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP017892	LHLEGYHGTAGDSMSYHSGSVFSAR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010337	SPENO002584,SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012644,SPENP012645;Gastric cancer:SPENP003348;Lung cancer:SPENP002891;Colon cancer:SPENP016316,SPENP027069
SPENP017898	WFTPASEVPLCGHATLASAAVLFHK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004006	SPENG001540	HSALNG0078512		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010332	SPENO000251	
SPENP017905	TNTNVNCPIECFMPLDVQADREDSRE	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-1.664	Others	-1.727	0.1182	0.1809	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010343	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP017913	ACEDIDECSLPNICVFGTCHNLPGLFR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005892	SPENG001317	HSALNG0105758	-1.066	Others	-1.736	0.1332	0.2011	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010351	SPENO000957	Bladder cancer:SPENP011753;Colon cancer:SPENP011065,SPENP011066,SPENP014642,SPENP008730,SPENP016345;Lung cancer:SPENP002915;Thyroid cancer:SPENP012658,SPENP012659
SPENP017916	IVAFADAAVEPIDFPIAPVYAASMVLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000014	SPENG003410	ACAT1	-0.6341	Others	-2.216	0.0398	0.0776	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010357	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP017917	VLSGQDDEEQGLTAQVLDASSLSFNTR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT003449	SPENG001155	NONHSAG045391.2	0.8817	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010354	SPENO005894	
SPENP017920	TGLDSPTGIDFSDITANSFTVHWIAPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.058	Down-regulated in tumors	-4.537	0.0003	0.0029	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010353	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP017921	NQAFLELATEEAAITMVNYYSAVTPHLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT004085	SPENG003336	NONHSAG002166.2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010367	SPENO002481	
SPENP017924	STNLLAAETASLEEQLQGWGEVMLMADK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010362	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP017929	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010375	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP017930	LRPQSAQSSFPPSPGPSPDVQLATLAQR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001183,SPENT001274,SPENT001182	SPENG000169	lnc-DQX1-1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010369	SPENO001535,SPENO004354,SPENO005264	
SPENP017937	LGALSGAAALGFASYGAHGAQFPDAYGK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010372	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP017939	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005913	SPENG001766	AL662884.2	-0.8716	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010361	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP017940	ASADELTFHEFEEATNLLADTPDAATTSR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001420	SPENG000627	lnc-TMED1-2	0.663	Others	1.9203	0.0838	0.1391	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010381	SPENO002869	Bladder cancer:SPENP011780;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP017941	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.311	Others	-0.9127	0.3829	0.4786	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010378	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP017945	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005913	SPENG001766	AL662884.2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010379	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP017947	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-2.237	Others	-2.133	0.0563	0.1017	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010382	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP017950	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-2.508	Others	-1.311	0.2264	0.315	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010387	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP017952	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-1.796	Others	-2.496	0.0231	0.0501	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010390	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP017957	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-1.885	Others	-2.188	0.0449	0.0846	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010394	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP017959	GFDPFMNLVIDECVEMATSGQQNNIGMVVIR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010393	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP023439;Colon cancer:SPENP014688,SPENP016391
SPENP017962	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-1.408	Others	-1.693	0.1213	0.1838	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010395	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP017965	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010400	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP017970	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.8195	Others	0.6665	0.5346	0.6133	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010404	SPENO005833	Bladder cancer:SPENP028478;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP017971	STIQNLQSFDPFADATKGDDLLPAGTEDYIHIR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010407	SPENO002523,SPENO004443	Colon cancer:SPENP011173,SPENP011174,SPENP000623;Bladder cancer:SPENP011803;Kidney cancer:SPENP020700
SPENP017972	LGELTMTDATPDSLSLSWTVPEGQFDHFLVQYR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005913	SPENG001766	AL662884.2		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Non-validated			Immunogenic	SPENM010405	SPENO002584	Colon cancer:SPENP016409,SPENP014711;Lung cancer:SPENP002987
SPENP017975	LAEGTGLQIPPAAQQALQMSGSLAFGAVADLQTR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000220	SPENG000739	RBM39	0.2747	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010412	SPENO005525	
SPENP017977	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-1.459	Down-regulated in tumors	-3.123	0.0066	0.0192	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010415	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP017982	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005892	SPENG001317	HSALNG0105758	-1.933	Down-regulated in tumors	-4.813	0.0002	0.0028	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010416	SPENO000957	Skin cancer:SPENP025490;Bladder cancer:SPENP011808;Colon cancer:SPENP008769,SPENP011193,SPENP014722,SPENP011194,SPENP016417;Lung cancer:SPENP002996
SPENP017983	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.203	Others	-0.3892	0.7106	0.7654	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010417	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP017984	SGFENLNTDFYQTSYSIDDQSQQSYDYGGSGGPYSK	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT000373	SPENG002692	lnc-NR3C1-2		Tumor-specific				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010421	SPENO003349	
SPENP017986	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.0918	Others	0.203	0.8437	0.8788	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010424	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP017987	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.0227	Others	-0.029	0.9775	0.9797	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010422	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP017988	NVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005892	SPENG001317	HSALNG0105758		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010425	SPENO000957	Colon cancer:SPENP011205,SPENP014731,SPENP011206,SPENP016429
SPENP017990	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752	SPENG000084	FN1	-1.204	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010428	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP017991	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.8263	Others	-1.302	0.2155	0.305	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010426	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP017992	KTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752	SPENG000084	FN1	0.1296	Others	0.6189	0.5587	0.6281	PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010429	SPENO001233	Tongue cancer:SPENP027837;Gastric cancer:SPENP015491;Lung cancer:SPENP003010;Colon cancer:SPENP016433
SPENP017993	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010430	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP028515;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP017994	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Bladder cancer	Urinary bladder cancer	Urinary bladder	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2016	Others				PXD010260	Muscular invasiveness in bladder cancer	Q Exactive HF	MS1 intensity based label-free quantification method	30419021	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010431	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP018056	NLLELLINIK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT003450	SPENG003122	NONHSAG013474.2	-1.426	Others	-1.184	0.3021	0.5978	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005396	SPENO005443	
SPENP018082	AVYTLTSLYR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000988	SPENG000380	lnc-DIABLO-1	-0.7174	Others	-1.164	0.4147	0.686	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005428	SPENO003093	Bladder cancer:SPENP017167;Kidney cancer:SPENP019937;Lung cancer:SPENP002154;Colon cancer:SPENP014012,SPENP008071,SPENP026722,SPENP015676
SPENP018098	DKLNNLVLFDK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	0.6377	Others	1.0037	0.3338	0.6305	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005468	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP018103	LLMLGLDNAGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005944,SPENT003327	SPENG000584,SPENG002171	ARL2-SNX15,NONHSAG008644.2	-0.1866	Others	-0.9175	0.3786	0.6657	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005450	SPENO000453,SPENO005309	Colon cancer:SPENP015744;Kidney cancer:SPENP014877
SPENP018134	RFVNVVPTFGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	-0.4799	Others	-1.366	0.2019	0.4952	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005478	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP018137	VPFLVLECPNLK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000354	SPENG002378	HSALNG0036293	0.1753	Others	0.5357	0.6	0.7945	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005496	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP018140	YQLDPTASISAK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000102	SPENG002045	lnc-ACTR2-11	-0.0133	Others	-0.0728	0.9429	0.9618	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005480	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP018149	GQAGVMGFPGPK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005758	SPENG002845	COL1A1	2.6916	Others	0.6919	0.5198	0.7496	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005505	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP018160	PWLIYNGTSVMK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004103	SPENG000463	lnc-PLA2G4A-7		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005524	SPENO004954	
SPENP018182	CIGENFAYVQIK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005493	SPENO003078	Bladder cancer:SPENP017340
SPENP018183	YLETLAFPVDPS	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004133,SPENT004132	SPENG000537	HSALNG0058267	-0.6837	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005511	SPENO000260,SPENO000846	
SPENP018187	QPSVIYSWIQNK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000306	SPENG000052	NONHSAG001520.2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005481	SPENO001975	
SPENP018193	RLALLQEQWAGGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005920	SPENG000432	lnc-APBB3-1	-0.0274	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005561	SPENO002480	
SPENP018206	VALAGLLGFGLGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT003237	SPENG001444	lnc-OCIAD2-2		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005556	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010336,SPENP010335,SPENP024026;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP012954
SPENP018210	TTAAMWALQTVEK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005554	SPENO000218,SPENO001883	Skin cancer:SPENP025207;Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP018213	PWLIYNGTSVMKK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004103	SPENG000463	lnc-PLA2G4A-7	-0.5213	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005542	SPENO004954	Tongue cancer:SPENP027985
SPENP018214	AAALVLQTIWGYK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005788	SPENG002233	AP001931.2	0.5327	Others	2.8448	0.0148	0.1882	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005562	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP018216	GNSIIMLEALERV	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	-0.2733	Others	-0.652	0.5243	0.7496	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005580	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP018220	HVISYSLSPFEQR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001666	SPENG002113	HSALNG0044883	0.1999	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005571	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP018224	YKWCEYGLTFTEK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000102	SPENG002045	lnc-ACTR2-11	0.0307	Others	0.068	0.947	0.9627	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005533	SPENO000884	Skin cancer:SPENP025208;Lung cancer:SPENP002422;Kidney cancer:SPENP020206
SPENP018230	IDSLMDEISFLKK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT002534	SPENG002447	lnc-NEFL-2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005563	SPENO001836	
SPENP018239	VRDKLNNLVLFDK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	-0.1104	Others	-0.4468	0.6646	0.8239	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005558	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP023352;Anal canal cancer:SPENP024649;Tongue cancer:SPENP028159;Lung cancer:SPENP002371;Colon cancer:SPENP027424
SPENP018264	CFEMTIPQFQNFYR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT002005,SPENT002006,SPENT002007	SPENG002553,SPENG001185	HSALNG0097982,lnc-COMMD6-2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005595	SPENO001277,SPENO002864,SPENO004113	
SPENP018266	IDDILQTLLDATYK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000775	SPENG001919	lnc-LRRD1-2	-0.2698	Others	-0.7072	0.4911	0.7439	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005612	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP025776,SPENP002501;Colon cancer:SPENP001612,SPENP000320
SPENP018272	GYVSCALGCPYEGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000018	SPENG003202	HMGCL	0.2509	Others	0.8057	0.4339	0.6988	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005594	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194,SPENP025757;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP018273	RLVQSPNSYFMDVK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000414,SPENT000061,SPENT000332,SPENT000411,SPENT000058,SPENT000046,SPENT000413,SPENT000050,SPENT000054,SPENT000059,SPENT000333,SPENT000053,SPENT000051,SPENT000045,SPENT000065,SPENT000334,SPENT000412	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005621	SPENO000003,SPENO000219,SPENO000630,SPENO001545,SPENO001969,SPENO002033,SPENO002574,SPENO002649,SPENO002944,SPENO003713,SPENO003814,SPENO003973,SPENO004204,SPENO004215,SPENO005865,SPENO006016,SPENO006324	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP010432,SPENP014253,SPENP006523
SPENP018279	EVVIFGAASELFTK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000018	SPENG003202	HMGCL	-0.2274	Others	-0.6336	0.5421	0.7645	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005608	SPENO002963	Bladder cancer:SPENP017524;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP018284	DREGFFTNGLTLGAK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000932	SPENG000021	HSALNG0029760	0.3591	Others	1.5116	0.1514	0.4672	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005627	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	Kidney cancer:SPENP015068,SPENP020332;Anal canal cancer:SPENP024753;Lung cancer:SPENP004249;Colon cancer:SPENP006579
SPENP018287	MLITILGTVKPNANR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.2013	Others	-1.191	0.2521	0.551	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005630	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP018293	EVVIFGAASELFTKK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000018	SPENG003202	HMGCL	-0.0363	Others	-0.0865	0.9334	0.9618	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005646	SPENO002963	Colon cancer:SPENP026814,SPENP008419;Lung cancer:SPENP002543,SPENP007731,SPENP004268;Kidney cancer:SPENP020351
SPENP018303	VKEVLPHVPLGVIQR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001183,SPENT001274,SPENT001182	SPENG000169	lnc-DQX1-1	-0.0578	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005633	SPENO001535,SPENO004354,SPENO005264	Colon cancer:SPENP027402;Lung cancer:SPENP002546;Kidney cancer:SPENP020312
SPENP018306	SLIDLLHEVCCSSPR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005832,SPENT004151,SPENT004149,SPENT004150	SPENG000541,SPENG002579	LINC01813	0.1503	Others	0.6903	0.5207	0.7496	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005642	SPENO000329,SPENO000781,SPENO005693,SPENO006236	
SPENP018322	EALCGCSINVPTLDGR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000515	SPENG000486	NONHSAG001879.2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005662	SPENO000704	Bile duct cancer:SPENP013493;Tongue cancer:SPENP027603;Lung cancer:SPENP007733;Prostate cancer:SPENP012067;Colon cancer:SPENP016075,SPENP007276;Leukemia:SPENP001237
SPENP018335	GSGQGDSLYPVGYLDK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000814	SPENG001638	HSALNG0104943	0.0861	Others	0.2034	0.8446	0.9297	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005683	SPENO005134	Kidney cancer:SPENP020374;Anal canal cancer:SPENP024782;Lung cancer:SPENP025746;Colon cancer:SPENP001653,SPENP008500,SPENP014345,SPENP016058
SPENP018352	SLLDEHHISYVIDEDVK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005916	SPENG003866	SPECC1L-ADORA2A	0.0768	Others	0.382	0.7113	0.8633	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005705	SPENO002262	
SPENP018353	SAYSSYSAPVSSSLSVR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT002534	SPENG002447	lnc-NEFL-2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005700	SPENO001836	Bile duct cancer:SPENP013521;Kidney cancer:SPENP020422
SPENP018355	TPIGSFLGSLSLLPATK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000014	SPENG003410	ACAT1	-0.5103	Others	-0.9628	0.3564	0.6504	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005696	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP018363	FMPAGLIAGASLLMVAK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031	0.0178	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005688	SPENO000972,SPENO005766	Breast cancer:SPENP022925,SPENP022924;Colon cancer:SPENP007302,SPENP026841;Kidney cancer:SPENP020457,SPENP015125
SPENP018366	VSPQDANPLMANGTLTR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005720	SPENO005858	
SPENP018369	LLGGQLGLEDFIFAHVK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001329	SPENG000766	HSALNG0004615	-2.289	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005711	SPENO001612	Breast cancer:SPENP021319,SPENP021317;Bladder cancer:SPENP017681;Lung cancer:SPENP021318,SPENP002647;Colon cancer:SPENP021316
SPENP018373	VLSMTGVGQTLVWCLHK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004157	SPENG003670	NONHSAG016614.2		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005715	SPENO002837	
SPENP018374	ISSTLYQAAAPVLTPAK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474	0.3864	Others	1.15	0.2709	0.5725	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005707	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP018380	WGLAYTLLHNPTLQVFR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT006027	SPENG003861	STRA6		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005690	SPENO003228	
SPENP018381	NFRPGTENTPMIAGLGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005895	SPENG001468	UBE2F-SCLY		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005723	SPENO006040	Colon cancer:SPENP008532
SPENP018387	GIQKFPGINYPVLTPNLK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000018,SPENT000457,SPENT000458	SPENG001448,SPENG003202	HMGCL,lnc-GALE-2		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005731	SPENO000742,SPENO001216,SPENO002963	Colon cancer:SPENP014465,SPENP026891,SPENP016121,SPENP010748,SPENP010747;Lung cancer:SPENP002686
SPENP018390	SLMVDHVTEVSQWMVGVK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001949,SPENT005920	SPENG000432	lnc-APBB3-1	-0.0253	Others	-0.1508	0.8824	0.9441	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005745	SPENO002480,SPENO003150	Colon cancer:SPENP008554
SPENP018391	AGYEYVSPEQLAGFDKYK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005924	SPENG003747	HSALNG0013722	-0.2068	Others	-0.5544	0.5945	0.7945	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005740	SPENO004898	
SPENP018397	TFTYLLGSDAAALLFNSK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000775	SPENG001919	lnc-LRRD1-2	0.3874	Others	1.4499	0.3603	0.6524	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005755	SPENO003078	Breast cancer:SPENP022991,SPENP022990;Lung cancer:SPENP002709
SPENP018398	STDTGVSLPSYEEDQGSK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	0.0024	Others	0.014	0.9891	0.9956	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005730	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP018399	VSPHSGVVALTKPVPEPR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005785	SPENG001958	FBLN1	0.7165	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005754	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP018402	DESSPYAAMLAAQDVAQR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	-0.4815	Others	-1.675	0.1222	0.4556	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005753	SPENO000942,SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Colon cancer:SPENP010782,SPENP024212,SPENP010781,SPENP007344
SPENP018405	MLDDNNHLIQCIMDSQNK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004065,SPENT004070,SPENT004069,SPENT004064,SPENT004061,SPENT004067,SPENT004062,SPENT004068,SPENT004063,SPENT004066	SPENG002705,SPENG000215	HSALNG0120556,lnc-KCTD1-4	0.7323	Others	2.1618	0.0739	0.3647	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005750	SPENO001281,SPENO001512,SPENO001946,SPENO003901,SPENO004403,SPENO004449,SPENO004520,SPENO004796,SPENO004971,SPENO005890	Bladder cancer:SPENP017729
SPENP018406	TPLLDDPVFIHPSSVLFK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004159	SPENG002162	lnc-DHX37-12	-0.0976	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005747	SPENO000159	
SPENP018407	RVEPVCSGLQAQILHCYR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004158	SPENG001601	HSALNG0028711		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005736	SPENO006005	
SPENP018410	GETGPAGPAGPVGPVGAR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005758	SPENG002845	COL1A1	0.9709	Others	0.5941	0.5783	0.7945	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005748	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP018415	MESPIPILPLPTPDAETEK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005768	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915
SPENP018420	RPHETGGYMLECVCLGNGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005764	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP018425	VQASLAANTFTITGHTEAK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005801	SPENG002115	AL136361.1	1.4116	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005772	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP018438	EFETAETLLNSEVHMLLEHR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004162,SPENT004161	SPENG001588,SPENG001430	lnc-IL36A-1,HSALNG0018023		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005778	SPENO001106,SPENO004138	
SPENP018439	YIMVPSGNMGVFDPTEIHNR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.1417	Others	0.5412	0.5963	0.7945	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005777	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP018441	SPPYIFSPIPFLGHAIAFGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000775	SPENG001919	lnc-LRRD1-2	-0.636	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005790	SPENO003078	Breast cancer:SPENP023049,SPENP023048;Kidney cancer:SPENP020556;Lung cancer:SPENP002761;Colon cancer:SPENP001715
SPENP018453	LSTPDVVSPFGTPFGSSVMNR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000306	SPENG000052	NONHSAG001520.2	-0.0706	Others	-0.5864	0.5988	0.7945	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	MS	28137767	Immunogenic	SPENM005791	SPENO001975	
SPENP018456	ADRDESSPYAAMLAAQDVAQR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.2383	Others	1.3116	0.2094	0.4952	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005794	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP018468	EEVKEAYMGNVLQGGEGQAPTR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000014	SPENG003410	ACAT1	0.319	Others	1.9018	0.1156	0.4556	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005816	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP010933,SPENP014573,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Kidney cancer:SPENP020571
SPENP018475	SGDRGETGPAGPAGPVGPVGAR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005758	SPENG002845	COL1A1	1.9039	Others	1.5732	0.1365	0.4556	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005817	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP018480	SSPSLDQMFDAEILGFSTPPGR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005946	SPENG003499	SYS1-DBNDD2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005822	SPENO002319	
SPENP018481	VEANLHGLTLYDTAPCPINNER	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT002972,SPENT002973	SPENG002559,SPENG000238	HSALNG0006018,lnc-DENND2D-2		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005814	SPENO002284,SPENO003339	Colon cancer:SPENP008670
SPENP018482	DTLTSRPAQGVVTTLENVSPPRR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005829	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP018483	VKADRDESSPYAAMLAAQDVAQR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.0788	Others	0.3429	0.7364	0.8734	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005826	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP018487	CDPHEATCYDDGKTYHVGEQWQK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.8979	Others	3.5665	0.0235	0.2242	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005833	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308;Colon cancer:SPENP021672
SPENP018498	TKTETITGFQVDAVPANGQTPIQR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.8593	Others	2.2301	0.0608	0.3419	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005844	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP018511	KLFVSNSRQFWESAFSIFANLMCQK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004175	SPENG000035	HSALNG0047822	-1.311	Others	-1.511	0.1693	0.4798	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Non-validated			Immunogenic	SPENM005853	SPENO000160	
SPENP018520	TNTNVNCPIECFMPLDVQADREDSRE	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	1.9711	Others	2.3712	0.0552	0.3376	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005862	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP018522	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000014	SPENG003410	ACAT1	-1.175	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005865	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP018526	PRPGVTEATITGLEPGTEYTIYVIALK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005868	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006159,SPENP006162;Tongue cancer:SPENP027980;Gastric cancer:SPENP003359,SPENP015456;Colon cancer:SPENP000587
SPENP018527	SYMLPHLHNGWQVDQAILSEEDRVVVIR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004125	SPENG002414	HSALNG0122808	0.1095	Others	0.4302	0.6753	0.8239	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005872	SPENO004152	
SPENP018531	LGALSGAAALGFASYGAHGAQFPDAYGK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	-0.7264	Others	-1.851	0.1612	0.4744	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005870	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP018537	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005879	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP018543	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.0184	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005886	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP018546	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.4483	Others	1.1982	0.2585	0.561	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005888	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP018548	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005890	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP018549	RGQLTAPACSQVPLQDYQSALEASMKPFISSK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004176,SPENT004177	SPENG003259,SPENG000125	lnc-SRSF4-2,NONHSAG000856.2	-0.0942	Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005893	SPENO002245,SPENO002815	
SPENP018550	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000855	SPENG000474	AC016876.2	-0.6932	Others	-1.099	0.2918	0.5913	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM005891	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP018551	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005892	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP018556	AIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT000014,SPENT000015	SPENG003410,SPENG003123	ACAT1,HSALNG0086980	-0.0838	Others	-0.2607	0.8031	0.9161	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005898	SPENO003940,SPENO004992	Colon cancer:SPENP016415,SPENP011185,SPENP011186;Kidney cancer:SPENP020707
SPENP018558	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.7532	Others	3.0264	0.0232	0.2242	PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005900	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP018560	ETMNPHDIVQDAIHNFSPAYQQYTQQSTLEPGPTWR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT004178	SPENG001581	lnc-PLA2G6-1		Others				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005902	SPENO003959	
SPENP018562	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005904	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP018563	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Prostate cancer	Prostate adenocarcinoma	Fibroblast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD010611	Proteomic profiling of human prostate cancer-associated fibroblasts identifies LOXL2 promotes tumour migration in the extracellular matrix	Q Exactive HF	Label free	31061140	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM005905	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP018568	DIQMTQSPSSLSASVGDR	Breast cancer	Breat cancer	Saliva	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.7178	Others	-2.852	0.1922	0.5233	PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011109	SPENO002145,SPENO005255	Breast cancer:SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP018569	DIQMTQSPSSLSASVGDR	Ovary cancer	Ovary cancer	Saliva	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.5512	Others	0.9896	0.3947	0.7187	PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011109	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP018628	VIEKVQHIQLLQK	Breast cancer	Breat cancer	Saliva	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011093	SPENO001505,SPENO002211	Ovary cancer:SPENP018629;Tongue cancer:SPENP028137;Lung cancer:SPENP004130;Liver cancer:SPENP004831;Colon cancer:SPENP007070,SPENP027398
SPENP018629	VIEKVQHIQLLQK	Ovary cancer	Ovary cancer	Saliva	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011093	SPENO001505,SPENO002211	Breast cancer:SPENP018628;Tongue cancer:SPENP028137;Lung cancer:SPENP004130;Liver cancer:SPENP004831;Colon cancer:SPENP007070,SPENP027398
SPENP018642	KVIEKVQHIQLLQK	Breast cancer	Breat cancer	Saliva	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011096	SPENO001505,SPENO002211	Ovary cancer:SPENP018643;Colon cancer:SPENP007158,SPENP027042;Tongue cancer:SPENP027839
SPENP018643	KVIEKVQHIQLLQK	Ovary cancer	Ovary cancer	Saliva	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011096	SPENO001505,SPENO002211	Breast cancer:SPENP018642;Colon cancer:SPENP007158,SPENP027042;Tongue cancer:SPENP027839
SPENP018660	MLITILGTVKPNANR	Breast cancer	Breat cancer	Saliva	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	1.11	Others				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011098	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP018661	MLITILGTVKPNANR	Ovary cancer	Ovary cancer	Saliva	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	0.5717	Others				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011098	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP018696	ASQSVSSYLAWYQQKPGQAPR	Breast cancer	Breat cancer	Saliva	SPENT001433,SPENT001431,SPENT001434,SPENT001432,SPENT001435,SPENT000640	SPENG000040	NONHSAG028467.3	-0.4072	Others	-1.032	0.4694	0.7187	PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011122	SPENO001411,SPENO001888,SPENO002666,SPENO003896,SPENO005350,SPENO006287	Ovary cancer:SPENP018697
SPENP018697	ASQSVSSYLAWYQQKPGQAPR	Ovary cancer	Ovary cancer	Saliva	SPENT001433,SPENT001431,SPENT001434,SPENT001432,SPENT001435,SPENT000640	SPENG000040	NONHSAG028467.3	-0.0369	Others	-0.1055	0.9309	0.9968	PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011122	SPENO001411,SPENO001888,SPENO002666,SPENO003896,SPENO005350,SPENO006287	Breast cancer:SPENP018696
SPENP018700	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breat cancer	Saliva	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.2033	Others				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011124	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP018701	SSQSLVHSDGNTYLSWLQQRPGQPPR	Ovary cancer	Ovary cancer	Saliva	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	1.7086	Others				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011124	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP018702	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breat cancer	Saliva	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011125	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP018703	SSQSLVYSDGNTYLNWFQQRPGQSPR	Ovary cancer	Ovary cancer	Saliva	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011125	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP018708	AGVETTTPSKQSNNKYAASSYLSLTPEQWK	Breast cancer	Breat cancer	Saliva	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.5054	Others	-1.669	0.27	0.6449	PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011128	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Lung cancer:SPENP007915,SPENP004704;Ovary cancer:SPENP018709;Gastric cancer:SPENP003369,SPENP015465
SPENP018709	AGVETTTPSKQSNNKYAASSYLSLTPEQWK	Ovary cancer	Ovary cancer	Saliva	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.099	Others	-2.868	0.0459	0.375	PXD011541	In Search of the Altering Salivary Proteome in Metastatic Breast and Ovarian Cancer	Q Exactive	label free	32123828	Non-validated			Immunogenic	SPENM011128	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Lung cancer:SPENP007915,SPENP004704;Gastric cancer:SPENP003369,SPENP015465;Breast cancer:SPENP018708
SPENP018998	RFVNVVPTFGK	Skin cancer	Actinic keratosis	Skin	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011250	SPENO000042,SPENO005582	Skin cancer:SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP018999	RFVNVVPTFGK	Skin cancer	Bowen's disease	Skin	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011250	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP019000	RFVNVVPTFGK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011250	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP019004	ALLSAPWYLNR	Skin cancer	Actinic keratosis	Skin	SPENT001450	SPENG000375	lnc-CELF6-1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011238	SPENO003868	Skin cancer:SPENP019006,SPENP019005;Prostate cancer:SPENP023559;Gastric cancer:SPENP003118;Breast cancer:SPENP022450,SPENP022451
SPENP019005	ALLSAPWYLNR	Skin cancer	Bowen's disease	Skin	SPENT001450	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011238	SPENO003868	Skin cancer:SPENP019006,SPENP019004;Prostate cancer:SPENP023559;Gastric cancer:SPENP003118;Breast cancer:SPENP022450,SPENP022451
SPENP019006	ALLSAPWYLNR	Skin cancer	Squamous cell carcinoma	Skin	SPENT001450	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011238	SPENO003868	Skin cancer:SPENP019005,SPENP019004;Prostate cancer:SPENP023559;Gastric cancer:SPENP003118;Breast cancer:SPENP022450,SPENP022451
SPENP019091	YQLDPTASISAK	Skin cancer	Actinic keratosis	Skin	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011256	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP019092	YQLDPTASISAK	Skin cancer	Bowen's disease	Skin	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011256	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP019093	YQLDPTASISAK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011256	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP019121	VVLEGPAPWGFR	Skin cancer	Actinic keratosis	Skin	SPENT002976,SPENT002977	SPENG001612,SPENG001042	lnc-PDLIM7-3,NONHSAG042359.2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011292	SPENO003592,SPENO003881	Skin cancer:SPENP019123,SPENP025133,SPENP019122;Lung cancer:SPENP028414
SPENP019122	VVLEGPAPWGFR	Skin cancer	Bowen's disease	Skin	SPENT002976,SPENT002977	SPENG001612,SPENG001042	lnc-PDLIM7-3,NONHSAG042359.2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011292	SPENO003592,SPENO003881	Skin cancer:SPENP019123,SPENP025133,SPENP019121;Lung cancer:SPENP028414
SPENP019123	VVLEGPAPWGFR	Skin cancer	Squamous cell carcinoma	Skin	SPENT002976,SPENT002977	SPENG001612,SPENG001042	lnc-PDLIM7-3,NONHSAG042359.2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011292	SPENO003592,SPENO003881	Skin cancer:SPENP025133,SPENP019122,SPENP019121;Lung cancer:SPENP028414
SPENP019169	RFVNVVPTFGKK	Skin cancer	Actinic keratosis	Skin	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011263	SPENO000042,SPENO005582	
SPENP019170	RFVNVVPTFGKK	Skin cancer	Bowen's disease	Skin	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011263	SPENO000042,SPENO005582	
SPENP019171	RFVNVVPTFGKK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011263	SPENO000042,SPENO005582	
SPENP019205	GQAGVMGFPGPK	Skin cancer	Actinic keratosis	Skin	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011288	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP019206	GQAGVMGFPGPK	Skin cancer	Bowen's disease	Skin	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011288	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP019207	GQAGVMGFPGPK	Skin cancer	Squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011288	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP019250	HVISYSLSPFEQR	Skin cancer	Actinic keratosis	Skin	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011311	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP019251	HVISYSLSPFEQR	Skin cancer	Bowen's disease	Skin	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011311	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP019252	HVISYSLSPFEQR	Skin cancer	Squamous cell carcinoma	Skin	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011311	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP019295	TQSSLVPALTDFVR	Skin cancer	Actinic keratosis	Skin	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011325	SPENO003629,SPENO005960	Skin cancer:SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP019296	TQSSLVPALTDFVR	Skin cancer	Bowen's disease	Skin	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011325	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP019297	TQSSLVPALTDFVR	Skin cancer	Squamous cell carcinoma	Skin	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011325	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP019403	VLSVPESTPFTAVLK	Skin cancer	Actinic keratosis	Skin	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011380	SPENO001471,SPENO001798	Skin cancer:SPENP019405,SPENP019404;Colon cancer:SPENP008424,SPENP024129;Leukemia:SPENP001198;Prostate cancer:SPENP023686
SPENP019404	VLSVPESTPFTAVLK	Skin cancer	Bowen's disease	Skin	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011380	SPENO001471,SPENO001798	Skin cancer:SPENP019405,SPENP019403;Colon cancer:SPENP008424,SPENP024129;Leukemia:SPENP001198;Prostate cancer:SPENP023686
SPENP019405	VLSVPESTPFTAVLK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011380	SPENO001471,SPENO001798	Skin cancer:SPENP019404,SPENP019403;Colon cancer:SPENP008424,SPENP024129;Leukemia:SPENP001198;Prostate cancer:SPENP023686
SPENP019415	NYLEGIYNVPVAAVR	Skin cancer	Actinic keratosis	Skin	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011368	SPENO001980,SPENO002623	Skin cancer:SPENP019416,SPENP019417;Bladder cancer:SPENP011525;Breast cancer:SPENP022770,SPENP022771
SPENP019416	NYLEGIYNVPVAAVR	Skin cancer	Bowen's disease	Skin	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011368	SPENO001980,SPENO002623	Skin cancer:SPENP019417,SPENP019415;Bladder cancer:SPENP011525;Breast cancer:SPENP022770,SPENP022771
SPENP019417	NYLEGIYNVPVAAVR	Skin cancer	Squamous cell carcinoma	Skin	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011368	SPENO001980,SPENO002623	Skin cancer:SPENP019416,SPENP019415;Bladder cancer:SPENP011525;Breast cancer:SPENP022770,SPENP022771
SPENP019445	MLITILGTVKPNANR	Skin cancer	Actinic keratosis	Skin	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011376	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP019446	MLITILGTVKPNANR	Skin cancer	Bowen's disease	Skin	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011376	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP019447	MLITILGTVKPNANR	Skin cancer	Squamous cell carcinoma	Skin	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011376	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP019463	YAASSYLSLTPEQWK	Skin cancer	Actinic keratosis	Skin	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.3113	Others	0.2099	0.844	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011365	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP019464	YAASSYLSLTPEQWK	Skin cancer	Bowen's disease	Skin	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.9983	Others	1.0483	0.3537	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011365	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP019465	YAASSYLSLTPEQWK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	2.6374	Others	0.7504	0.4814	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011365	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP019550	SAIQNLHSFDPFADASK	Skin cancer	Actinic keratosis	Skin	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011406	SPENO000819,SPENO002753	Skin cancer:SPENP019552,SPENP019551;Anal canal cancer:SPENP024827;Colon cancer:SPENP024174;Bladder cancer:SPENP028727
SPENP019551	SAIQNLHSFDPFADASK	Skin cancer	Bowen's disease	Skin	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011406	SPENO000819,SPENO002753	Skin cancer:SPENP019550,SPENP019552;Anal canal cancer:SPENP024827;Colon cancer:SPENP024174;Bladder cancer:SPENP028727
SPENP019552	SAIQNLHSFDPFADASK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011406	SPENO000819,SPENO002753	Skin cancer:SPENP019550,SPENP019551;Anal canal cancer:SPENP024827;Colon cancer:SPENP024174;Bladder cancer:SPENP028727
SPENP019559	DIQMTQSPSSLSASVGDR	Skin cancer	Actinic keratosis	Skin	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011419	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP019560	DIQMTQSPSSLSASVGDR	Skin cancer	Bowen's disease	Skin	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011419	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP019561	DIQMTQSPSSLSASVGDR	Skin cancer	Squamous cell carcinoma	Skin	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011419	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP019562	GETGPAGPAGPVGPVGAR	Skin cancer	Actinic keratosis	Skin	SPENT005758	SPENG002845	COL1A1	0.0389	Others	0.0548	0.9577	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011412	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP019563	GETGPAGPAGPVGPVGAR	Skin cancer	Bowen's disease	Skin	SPENT005758	SPENG002845	COL1A1	-0.6891	Others	-1.256	0.2376	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011412	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP019564	GETGPAGPAGPVGPVGAR	Skin cancer	Squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1	0.395	Others	0.4354	0.6735	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011412	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP019580	STDTGVSLPSYEEDQGSK	Skin cancer	Actinic keratosis	Skin	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011415	SPENO000724,SPENO001854	Skin cancer:SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP019581	STDTGVSLPSYEEDQGSK	Skin cancer	Bowen's disease	Skin	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011415	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP019582	STDTGVSLPSYEEDQGSK	Skin cancer	Squamous cell carcinoma	Skin	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	MS	28137767	Immunogenic	SPENM011415	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP019583	VQASLAANTFTITGHTEAK	Skin cancer	Actinic keratosis	Skin	SPENT005801	SPENG002115	AL136361.1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011420	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP019584	VQASLAANTFTITGHTEAK	Skin cancer	Bowen's disease	Skin	SPENT005801	SPENG002115	AL136361.1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011420	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP019585	VQASLAANTFTITGHTEAK	Skin cancer	Squamous cell carcinoma	Skin	SPENT005801	SPENG002115	AL136361.1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011420	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP019607	LCFLQSSVISFCYQAYKPK	Skin cancer	Actinic keratosis	Skin	SPENT004228,SPENT004229,SPENT004230	SPENG002250	HSALNG0071580	-6.149	Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011432	SPENO001076,SPENO002460,SPENO002517	
SPENP019608	LCFLQSSVISFCYQAYKPK	Skin cancer	Bowen's disease	Skin	SPENT004228,SPENT004229,SPENT004230	SPENG002250	HSALNG0071580		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011432	SPENO001076,SPENO002460,SPENO002517	
SPENP019609	LCFLQSSVISFCYQAYKPK	Skin cancer	Squamous cell carcinoma	Skin	SPENT004228,SPENT004229,SPENT004230	SPENG002250	HSALNG0071580	-3.823	Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011432	SPENO001076,SPENO002460,SPENO002517	
SPENP019655	ADRDESSPYAAMLAAQDVAQR	Skin cancer	Actinic keratosis	Skin	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011445	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP019656	ADRDESSPYAAMLAAQDVAQR	Skin cancer	Bowen's disease	Skin	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011445	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP019657	ADRDESSPYAAMLAAQDVAQR	Skin cancer	Squamous cell carcinoma	Skin	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011445	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP019658	TPYQFTTLGQATAEFSKPLGR	Skin cancer	Actinic keratosis	Skin	SPENT002056,SPENT002216	SPENG001417	lnc-NECTIN1-4		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011446	SPENO002683,SPENO003894	Skin cancer:SPENP025411,SPENP019660,SPENP019659;Anal canal cancer:SPENP024904;Bladder cancer:SPENP017815
SPENP019659	TPYQFTTLGQATAEFSKPLGR	Skin cancer	Bowen's disease	Skin	SPENT002056,SPENT002216	SPENG001417	lnc-NECTIN1-4		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011446	SPENO002683,SPENO003894	Skin cancer:SPENP025411,SPENP019658,SPENP019660;Anal canal cancer:SPENP024904;Bladder cancer:SPENP017815
SPENP019660	TPYQFTTLGQATAEFSKPLGR	Skin cancer	Squamous cell carcinoma	Skin	SPENT002056,SPENT002216	SPENG001417	lnc-NECTIN1-4		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Non-validated			Immunogenic	SPENM011446	SPENO002683,SPENO003894	Skin cancer:SPENP025411,SPENP019658,SPENP019659;Anal canal cancer:SPENP024904;Bladder cancer:SPENP017815
SPENP019670	SGDRGETGPAGPAGPVGPVGAR	Skin cancer	Actinic keratosis	Skin	SPENT005758	SPENG002845	COL1A1	-0.835	Others	-0.9894	0.3483	0.9942	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011450	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP019671	SGDRGETGPAGPAGPVGPVGAR	Skin cancer	Bowen's disease	Skin	SPENT005758	SPENG002845	COL1A1	-2.11	Down-regulated in tumors	-7.688	1.67e-05	0.0018	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011450	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP019672	SGDRGETGPAGPAGPVGPVGAR	Skin cancer	Squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1	-1.269	Others	-3.926	0.0035	0.1253	PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011450	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP019691	TKTETITGFQVDAVPANGQTPIQR	Skin cancer	Actinic keratosis	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011457	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP019692	TKTETITGFQVDAVPANGQTPIQR	Skin cancer	Bowen's disease	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011457	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP019693	TKTETITGFQVDAVPANGQTPIQR	Skin cancer	Squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011457	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP019712	GETGPAGPAGPVGPVGARGPAGPQGPR	Skin cancer	Actinic keratosis	Skin	SPENT005758	SPENG002845	COL1A1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011465	SPENO004941	Skin cancer:SPENP019714,SPENP019713;Anal canal cancer:SPENP024948
SPENP019713	GETGPAGPAGPVGPVGARGPAGPQGPR	Skin cancer	Bowen's disease	Skin	SPENT005758	SPENG002845	COL1A1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011465	SPENO004941	Skin cancer:SPENP019712,SPENP019714;Anal canal cancer:SPENP024948
SPENP019714	GETGPAGPAGPVGPVGARGPAGPQGPR	Skin cancer	Squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011465	SPENO004941	Skin cancer:SPENP019712,SPENP019713;Anal canal cancer:SPENP024948
SPENP019724	LGALSGAAALGFASYGAHGAQFPDAYGK	Skin cancer	Actinic keratosis	Skin	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011466	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP019725	LGALSGAAALGFASYGAHGAQFPDAYGK	Skin cancer	Bowen's disease	Skin	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Tumor-specific				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011466	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP019726	LGALSGAAALGFASYGAHGAQFPDAYGK	Skin cancer	Squamous cell carcinoma	Skin	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1		Others				PXD011609	Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS	LTQ Orbitrap	Spectrum counting/(MS/MS)	29665991	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011466	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP019814	RRPSAYQAL	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000855	SPENG000474	AC016876.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM019036	SPENO004050	
SPENP019909	LGILGHTVSV	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004298	SPENG001951	HSALNG0137753	-1.97	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019087	SPENO001590	
SPENP019933	NIYSNLLPIF	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004299	SPENG003306	HSALNG0050939	-1.072	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019116	SPENO002672	
SPENP019937	AVYTLTSLYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000988	SPENG000380	lnc-DIABLO-1	-0.5809	Others	-2.885	0.0148	0.056	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019159	SPENO003093	Bladder cancer:SPENP017167;Lung cancer:SPENP002154;Prostate cancer:SPENP018082;Colon cancer:SPENP014012,SPENP008071,SPENP026722,SPENP015676
SPENP019966	TAVAHRPGAFK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000153	SPENG003407	NONHSAG024537.2	0.23	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019252	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP019976	TDSTFNQVVLK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002071	SPENG001428	lnc-CPHXL-5	0.268	Others	0.4604	0.655	0.7397	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019249	SPENO004801	Bladder cancer:SPENP017275;Anal canal cancer:SPENP024517;Lung cancer:SPENP026072;Colon cancer:SPENP006972,SPENP010062,SPENP010061
SPENP020004	LGELPSWILMR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-1.62	Down-regulated in tumors	-4.014	0.0014	0.0121	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019257	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP020009	SSHTYLFGITK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004329	SPENG000972	HSALNG0023644		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019217	SPENO006252	
SPENP020025	YLLLSDLPGVR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000174	SPENG000603	DMAC2L		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019237	SPENO004847	Colon cancer:SPENP015693;Prostate cancer:SPENP012916
SPENP020026	YMDGMTVGVVR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005796	SPENG001958	FBLN1	1.2534	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019238	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP020027	MKTKICNMSGK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004310,SPENT004311	SPENG002419,SPENG002018	lnc-CLRN2-3,HSALNG0033124		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019191	SPENO001330,SPENO003993	
SPENP020042	RFVNVVPTFGK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1	0.0211	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019167	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Bile duct cancer:SPENP013299;Anal canal cancer:SPENP024544;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP020052	GSLASLDSLRK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005788	SPENG002233	AP001931.2		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019210	SPENO005858	Colon cancer:SPENP026916,SPENP014054,SPENP008125,SPENP015749;Bladder cancer:SPENP017222;Prostate cancer:SPENP011932
SPENP020067	DKLNNLVLFDK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	-0.2343	Others	-0.8066	0.4289	0.5413	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019248	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP020068	YGLNAEDFFVLK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004337	SPENG000519	lnc-NAPEPLD-1		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019295	SPENO000116	
SPENP020073	YQLDPTASISAK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11	-1.217	Down-regulated in tumors	-6.317	7.73e-06	0.0002	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019299	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP020095	MQPQESHVHYSR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002409	SPENG002995	HSALNG0000347		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019308	SPENO004438	Kidney cancer:SPENP013774,SPENP013773;Prostate cancer:SPENP011971
SPENP020103	VPFLVLECPNLK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000354	SPENG002378	HSALNG0036293	0.4807	Others	2.1622	0.0726	0.1695	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019291	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP020115	IPGNIMSALLER	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000853	SPENG001681	lnc-RPS20-4	0.8256	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019266	SPENO003529	
SPENP020118	AATLDPGYYTYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT006027	SPENG003861	STRA6		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019300	SPENO003228	Prostate cancer:SPENP011976
SPENP020123	GQAGVMGFPGPK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005758	SPENG002845	COL1A1	1.3476	Others	1.4504	0.1617	0.2786	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019344	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP020140	AILFLPLPVSSD	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004338,SPENT004339	SPENG001037,SPENG001461	lnc-SPRY4-5,HSALNG0045510		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019303	SPENO001180,SPENO002357	
SPENP020144	GLQSSYSEEYLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT006027	SPENG003861	STRA6		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019343	SPENO003228	Prostate cancer:SPENP011983
SPENP020155	ELTAFIMASIFFI	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004342	SPENG000992	HSALNG0005952		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019353	SPENO002289	
SPENP020160	SFHFSLPSSWYYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2	1.1023	Others	1.3813	0.2164	0.3339	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019396	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP020161	SFMMIYFPLMNSK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004347,SPENT004346,SPENT004343,SPENT004344,SPENT004345	SPENG000200	HSALNG0071856	0.4984	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019369	SPENO000360,SPENO000660,SPENO001307,SPENO003745,SPENO003806	
SPENP020164	LAEIMPSFCGPSL	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004353	SPENG003613	HSALNG0070388		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019419	SPENO003585	
SPENP020166	SGTLYSLTLYGLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	1.7199	Others	1.5627	0.1568	0.2736	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019363	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP020167	DFSPSGIFGAFQR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-1.596	Down-regulated in tumors	-9.617	3.82e-09	3.61e-07	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019365	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP020168	DLFTASNDPLLWR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001218	SPENG003441	NONHSAG033755.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019428	SPENO005358	Lung cancer:SPENP002400,SPENP025590;Prostate cancer:SPENP012012
SPENP020206	YKWCEYGLTFTEK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000102	SPENG002045	lnc-ACTR2-11		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019409	SPENO000884	Skin cancer:SPENP025208;Lung cancer:SPENP002422;Prostate cancer:SPENP018224
SPENP020217	AAALVLQTIWGYK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005788	SPENG002233	AP001931.2	0.1625	Others	0.4444	0.6647	0.7475	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019425	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP020224	GNSIIMLEALERV	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.3959	Others	1.1993	0.2556	0.3634	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019375	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP020227	YEEIIKEVSTYIK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002126	SPENG003586	lnc-FOXL2NB-4	0.2728	Others	0.7193	0.4803	0.5842	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019403	SPENO001634	Breast cancer:SPENP008868;Skin cancer:SPENP025217;Bile duct cancer:SPENP013410;Anal canal cancer:SPENP024645
SPENP020228	YAMVYGYNAAYNR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	3.141	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019404	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP020236	STLVHSLFLTDLYK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019492	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP005486,SPENP022736,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483
SPENP020245	IDDILQTLLDATYK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000775	SPENG001919	lnc-LRRD1-2		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019464	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Liver cancer:SPENP000692;Lung cancer:SPENP025776,SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP001612,SPENP000320
SPENP020258	GYVSCALGCPYEGK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000018	SPENG003202	HMGCL	-2.099	Down-regulated in tumors	-5.914	4.55e-05	0.0011	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019475	SPENO002963	Bladder cancer:SPENP017521;Lung cancer:SPENP004194,SPENP025757;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP020263	EVVIFGAASELFTK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000018	SPENG003202	HMGCL	-1.236	Others	-2.117	0.0503	0.1364	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019451	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP020270	YMALSLQSFCPTTR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001640	SPENG000521	AMPD2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019462	SPENO000624	Tongue cancer:SPENP028213;Bladder cancer:SPENP017484
SPENP020280	QYNVGPSVSKYPLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0131	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019463	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP020281	GAPVNISSSDLTGR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004363,SPENT004362,SPENT004364,SPENT004365	SPENG000830,SPENG003267	lnc-CCDC57-6,HSALNG0119396		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019469	SPENO001775,SPENO003757,SPENO005571,SPENO005585	
SPENP020293	VLMAPPSMVNNEQR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004367,SPENT004368,SPENT004366	SPENG000814,SPENG002125	HSALNG0095562,lnc-XPO4-1	0.9718	Others	7.0262	0.0059	0.0325	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019481	SPENO000711,SPENO002123,SPENO002453	
SPENP020294	VTDATETTITISWR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4612	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019497	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP020300	ADGQMPFSCHYPSR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001996,SPENT001995	SPENG000039	NONHSAG012478.2	0.6478	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019498	SPENO000668,SPENO002663	Colon cancer:SPENP014250,SPENP015956,SPENP008395;Bladder cancer:SPENP017518
SPENP020310	MTQSPSSLSASVGDR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019516	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Lung cancer:SPENP025946;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP020312	VKEVLPHVPLGVIQR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001183,SPENT001274,SPENT001182	SPENG000169	lnc-DQX1-1		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019507	SPENO001535,SPENO004354,SPENO005264	Colon cancer:SPENP027402;Lung cancer:SPENP002546;Prostate cancer:SPENP018303
SPENP020315	MLITILGTVKPNANR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	1.5561	Others	1.0534	0.3229	0.4405	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019535	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP020328	TSPSILGSVVGIEMR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004371	SPENG001632	HSALNG0088768		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019518	SPENO004295	
SPENP020332	DREGFFTNGLTLGAK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000938,SPENT000937,SPENT000932,SPENT000934,SPENT000931,SPENT000933,SPENT000935,SPENT000936	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019512	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	Kidney cancer:SPENP015068;Anal canal cancer:SPENP024753;Lung cancer:SPENP004249;Prostate cancer:SPENP018284;Colon cancer:SPENP006579
SPENP020337	NIETLYMISLESLHK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004036,SPENT004031,SPENT004035,SPENT004033,SPENT004032,SPENT004034	SPENG001774,SPENG000128,SPENG000607	LINC02209,HSALNG0064321	-0.994	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019533	SPENO000970,SPENO001234,SPENO002352,SPENO003024,SPENO005418,SPENO005862	Bladder cancer:SPENP017577
SPENP020346	LVSPEHQCQHPLTTR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001594	SPENG003708	NONHSAG008681.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019554	SPENO002562	Gastric cancer:SPENP003596
SPENP020351	EVVIFGAASELFTKK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000018	SPENG003202	HMGCL		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019527	SPENO002963	Colon cancer:SPENP026814,SPENP008419;Lung cancer:SPENP002543,SPENP007731,SPENP004268;Prostate cancer:SPENP018293
SPENP020356	YAASSYLSLTPEQWK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.8563	Others	2.018	0.056	0.1484	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019524	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP020374	GSGQGDSLYPVGYLDK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000814	SPENG001638	HSALNG0104943	0.0317	Others	0.0856	0.9453	0.9575	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019606	SPENO005134	Anal canal cancer:SPENP024782;Lung cancer:SPENP025746;Prostate cancer:SPENP018335;Colon cancer:SPENP001653,SPENP008500,SPENP014345,SPENP016058
SPENP020383	DRDPNSLLISCAVSYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	2.1456	Others	7.3987	0.0213	0.0734	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019578	SPENO002584,SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Tongue cancer:SPENP027590;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP020410	MLQELWNPYGSKMLER	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004377,SPENT004378	SPENG002241,SPENG002264	lnc-DGLUCY-6,HSALNG0103193		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019609	SPENO001482,SPENO001553	
SPENP020411	FALVFPLMYHTWNGIR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000626	SPENG001862	HSALNG0007932	-1.123	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019569	SPENO003610	Colon cancer:SPENP026821,SPENP001662
SPENP020416	MVFPEFKNNEMMWIFK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004380	SPENG001886	AL008638.3		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019611	SPENO000625	
SPENP020420	TPIGSFLGSLSLLPATK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000014	SPENG003410	ACAT1	-2.833	Down-regulated in tumors	-5.448	0.0001	0.0026	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019652	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP020422	SAYSSYSAPVSSSLSVR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002534	SPENG002447	lnc-NEFL-2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019654	SPENO001836	Bile duct cancer:SPENP013521;Prostate cancer:SPENP018353
SPENP020425	NDAQTPGPLYASPALMS	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002961	SPENG002297	lnc-MAP1LC3B2-28		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019632	SPENO005876	Colon cancer:SPENP008530
SPENP020430	ISSTLYQAAAPVLTPAK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019641	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP020433	ALALAALAAVEPACGSR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004057	SPENG000928	NONHSAG041785.2	1.0771	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019626	SPENO001591	Colon cancer:SPENP000433;Bladder cancer:SPENP017666;Prostate cancer:SPENP012080
SPENP020438	CPSIAAAIAAVNALHGR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000221,SPENT000220,SPENT000234	SPENG000739,SPENG000807	RBM39,lnc-NFS1-1	0.5121	Others	2.0909	0.0699	0.1667	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019653	SPENO005081,SPENO005525,SPENO006140	Bile duct cancer:SPENP013527;Colon cancer:SPENP001673,SPENP026729,SPENP000417;Lung cancer:SPENP004381
SPENP020444	MEVLLEALFLTVDPYMR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000383	SPENG003576	HSALNG0073697		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019621	SPENO001174	Prostate cancer:SPENP012081
SPENP020455	GADPGMPEPTVLSLLWG	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000828	SPENG000141	HSALNG0056619	-0.0611	Others	-0.2061	0.8387	0.8739	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019618	SPENO004991	Anal canal cancer:SPENP024826;Colon cancer:SPENP001668,SPENP007309,SPENP014405,SPENP000410;Lung cancer:SPENP025703
SPENP020456	ETPLPIDPSMFPTWPAK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000136,SPENT000135,SPENT000138,SPENT000137,SPENT000139	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM019638	SPENO000257,SPENO002156,SPENO003659,SPENO005654,SPENO006064	Bladder cancer:SPENP011592,SPENP017665;Colon cancer:SPENP008539,SPENP000431;Lung cancer:SPENP025658,SPENP002667
SPENP020457	FMPAGLIAGASLLMVAK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019650	SPENO000972,SPENO005766	Breast cancer:SPENP022925,SPENP022924;Colon cancer:SPENP007302,SPENP026841;Kidney cancer:SPENP015125;Prostate cancer:SPENP018363
SPENP020459	YAASSYLSLTPEQWKSHR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000202,SPENT000080,SPENT000201,SPENT000081,SPENT000204	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated	MS	28137767	Immunogenic	SPENM019671	SPENO000395,SPENO003620,SPENO004364,SPENO004816,SPENO005374	Bile duct cancer:SPENP013562;Gastric cancer:SPENP015380;Skin cancer:SPENP025360
SPENP020466	LSWTVPEGQFDSFVVQFK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005913	SPENG001766	AL662884.2	1.849	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019682	SPENO002584	Bladder cancer:SPENP017719;Tongue cancer:SPENP027882;Lung cancer:SPENP002728;Colon cancer:SPENP014455,SPENP016143
SPENP020476	STDTGVSLPSYEEDQGSK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	-1.454	Down-regulated in tumors	-4.517	0.0005	0.0057	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019659	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP020486	SDHEFLFHYCNAYLNAVR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT003993	SPENG000347	STS		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019685	SPENO001507	
SPENP020490	GETGPAGPAGPVGPVGAR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005758	SPENG002845	COL1A1	2.0473	Others	1.9685	0.0617	0.1542	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019656	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP020491	DIQMTQSPSSLSASVGDR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.676	Others	1.9872	0.0595	0.1518	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019677	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP020495	VSPHSGVVALTKPVPEPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019662	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP020498	VQASLAANTFTITGHTEAK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005801	SPENG002115	AL136361.1	0.4171	Others	2.2596	0.0502	0.1364	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019700	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP020503	LGIPGPTPLPLLGNVLSYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004396,SPENT004399,SPENT004395,SPENT004397,SPENT004394,SPENT002293,SPENT004393,SPENT004398	SPENG000741,SPENG002512	lnc-CYP3A7-2,HSALNG0059919		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019707	SPENO000031,SPENO000134,SPENO000279,SPENO002614,SPENO002811,SPENO002891,SPENO003191,SPENO005528	
SPENP020505	QALNLPDVFGLVVLPLELK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001218	SPENG003441	NONHSAG033755.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019705	SPENO005358	Breast cancer:SPENP008975;Colon cancer:SPENP016179;Lung cancer:SPENP025980,SPENP002749
SPENP020507	NVQLLSQFVSPFTGCIYGR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000847	SPENG000825	HSALNG0035586		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019698	SPENO003852	Colon cancer:SPENP016180,SPENP014507,SPENP001705;Lung cancer:SPENP028362
SPENP020514	LCNYLSHHLTISPQSGNFR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000390	SPENG002704	lnc-TRIM16L-2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019706	SPENO003522	Lung cancer:SPENP004478;Prostate cancer:SPENP012109
SPENP020515	ADEALFLLLHNEMVSGVYK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000351,SPENT001358,SPENT000350,SPENT000352	SPENG000565,SPENG001119	lnc-TRAPPC6B-3,HSALNG0100767	0.3245	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019712	SPENO000520,SPENO000894,SPENO003635,SPENO004984	Bladder cancer:SPENP017768;Colon cancer:SPENP006659,SPENP000481,SPENP016178,SPENP014479;Lung cancer:SPENP004493,SPENP002731
SPENP020518	MESPIPILPLPTPDAETEK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019694	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP020523	RPHETGGYMLECVCLGNGK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019704	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP020528	VLSPEYLWDQQLLGWPAVLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000795	SPENG002103	lnc-ABO-33	-0.3123	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019740	SPENO001263	Colon cancer:SPENP014543;Bladder cancer:SPENP017779
SPENP020531	YIMVPSGNMGVFDPTEIHNR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.5191	Others	1.9208	0.0754	0.1741	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019744	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP020534	ATLVCLISDFYPGAVTVAWK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.2473	Others	0.4158	0.6825	0.7562	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019753	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP020535	ALAPTWEQLALGLEHSETVK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.6982	Others	2.3948	0.0265	0.0864	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019733	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP020544	MTMLMSFNLVILSQKFILKQ	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004400	SPENG000026	HSALNG0033908		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019730	SPENO002271	
SPENP020550	GGGLFLLAGPPASVETLGPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004402,SPENT004401	SPENG002489	lnc-PTGES3L-AARSD1-2	0.9067	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019747	SPENO001131,SPENO004743	
SPENP020556	SPPYIFSPIPFLGHAIAFGK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000775	SPENG001919	lnc-LRRD1-2		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019728	SPENO003078	Breast cancer:SPENP023049,SPENP023048;Lung cancer:SPENP002761;Prostate cancer:SPENP018441;Colon cancer:SPENP001715
SPENP020563	TNTNVNCPIECFMPLDVQADR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	2.6668	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019761	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP020564	MGSTLGSIIYTWVLYHRIEIK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004403,SPENT004404,SPENT004405	SPENG000447	HSALNG0066174		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019760	SPENO001616,SPENO001926,SPENO005471	
SPENP020571	EEVKEAYMGNVLQGGEGQAPTR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000014	SPENG003410	ACAT1	-2.438	Down-regulated in tumors	-8.045	6.11e-06	0.0002	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019778	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP010933,SPENP014573,SPENP007438,SPENP026787;Lung cancer:SPENP004605;Prostate cancer:SPENP018468
SPENP020572	DMDLTEVITGTLWNLSSHDSIK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005788	SPENG002233	AP001931.2	-0.4664	Others	-1.3	0.2092	0.3248	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019771	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP020575	DTLTSRPAQGVVTTLENVSPPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7189	Others	2.7231	0.0145	0.0555	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019777	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP020577	EAPFVPVGIAGFAAIVAYGLYK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	MS	28137767	Immunogenic	SPENM019780	SPENO000724	Bladder cancer:SPENP017836;Prostate cancer:SPENP013086
SPENP020579	LQAAQLPHTGVFGQSFSCPSDR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000855	SPENG000474	AC016876.2	1.5381	Others	2.3329	0.0479	0.1323	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM019774	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP020585	SGDRGETGPAGPAGPVGPVGAR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005758	SPENG002845	COL1A1	1.4396	Others	1.6627	0.1106	0.2249	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019784	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP020586	LPLVQAPSLEFLIPALVLTSQK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT004406	SPENG000582	lnc-CNPPD1-1		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019773	SPENO003409	
SPENP020591	LIDMLSEAGLSVIETTSFVSPK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000018	SPENG003202	HMGCL	-1.871	Down-regulated in tumors	-3.952	0.002	0.0145	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019782	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP027070,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP020595	CDPHEATCYDDGKTYHVGEQWQK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019791	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP020599	LQAMWGQSLLPPVSTSFTTGGLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	1.3278	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019790	SPENO002584,SPENO006142	Breast cancer:SPENP009029;Thyroid cancer:SPENP012626,SPENP012627;Bladder cancer:SPENP017847;Lung cancer:SPENP002859;Colon cancer:SPENP014588,SPENP016279
SPENP020606	QGLYELSASNFELHVAQGDHFIK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.6161	Others	2.971	0.0117	0.0475	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019789	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP020607	DTLTSRPAQGVVTTLENVSPPRR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019794	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP020611	ATFYTPQNPSSLAPAPLRPLEDR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001336	SPENG001086	HSALNG0049384		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019801	SPENO005428	Bladder cancer:SPENP017857;Bile duct cancer:SPENP013627;Lung cancer:SPENP002849;Colon cancer:SPENP024279,SPENP016277
SPENP020614	DLEVVAATPTSLLISWDAPAVTVR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.7054	Up-regulated in tumors	5.4398	0.0002	0.0026	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019809	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP020618	STATISGLKPGVDYTITVYAVTGR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.8084	Up-regulated in tumors	4.7568	0.0013	0.0114	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019823	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP020620	AAQAQGQSCEYSLMVGYQCGQVFR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM019810	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP020621	IKLIDMLSEAGLSVIETTSFVSPK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000018	SPENG003202	HMGCL		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019819	SPENO002963	Lung cancer:SPENP002882
SPENP020626	STAAMSTYTGIFTDQVLSVLKGEE	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019824	SPENO003134,SPENO005747	Ovary cancer:SPENP016654,SPENP011855;Bladder cancer:SPENP017881;Gastric cancer:SPENP003343,SPENP015436,SPENP003691;Lung cancer:SPENP002878;Colon cancer:SPENP014614,SPENP000575,SPENP016302
SPENP020628	TKTETITGFQVDAVPANGQTPIQR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7619	Up-regulated in tumors	4.7098	0.0002	0.0026	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019815	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP020630	NSITLTNLTPGTEYVVSIVALNGR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019825	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP020635	MGAPESGLAEYLFDKHTLGESDNES	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002221	SPENG002850	lnc-PKHD1-6		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019831	SPENO005552	Anal canal cancer:SPENP024939
SPENP020640	SSQSLVHSDGNTYLSWLQQRPGQPPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019837	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP020643	SSQSLVYSDGNTYLNWFQQRPGQSPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019838	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP020647	TNTNVNCPIECFMPLDVQADREDSRE	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	2.4354	Others	2.5136	0.0272	0.088	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019839	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP020648	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000014	SPENG003410	ACAT1		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019852	SPENO003940	Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP026668,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP020650	IVAFADAAVEPIDFPIAPVYAASMVLK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000014	SPENG003410	ACAT1	-2.683	Down-regulated in tumors	-4.495	0.0007	0.0078	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019851	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP020652	TGLDSPTGIDFSDITANSFTVHWIAPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.3121	Up-regulated in tumors	3.7853	0.0029	0.0198	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019850	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP020656	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005913	SPENG001766	AL662884.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019856	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP020660	LGALSGAAALGFASYGAHGAQFPDAYGK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	-1.133	Others	-2.307	0.0397	0.1156	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019860	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP020669	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6659	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019857	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP020670	STNLLAAETASLEEQLQGWGEVMLMADK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	-0.6349	Others	-1.571	0.1549	0.2736	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019861	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Anal canal cancer:SPENP024956;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP020672	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019871	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP020673	ASADELTFHEFEEATNLLADTPDAATTSR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001420	SPENG000627	lnc-TMED1-2	0.3398	Others	1.3766	0.1889	0.3073	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019873	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP020674	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005913	SPENG001766	AL662884.2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019874	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP020675	AVSLVTDSTSTFLSQTTYALIEAITEYTK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT001334,SPENT000988	SPENG000380	lnc-DIABLO-1	-0.32	Others	-0.589	0.5721	0.6618	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019870	SPENO001827,SPENO003093	Colon cancer:SPENP014674,SPENP016372,SPENP000607;Lung cancer:SPENP002938
SPENP020676	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7086	Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019869	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP020679	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.5833	Others	2.0495	0.0572	0.1492	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019879	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP020689	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	1.6036	Others	2.5293	0.0216	0.0734	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019885	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP020690	GQSALVGSSYMSALEVGGLVGSIAAGYLSDR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT002643,SPENT002636,SPENT002640,SPENT002642,SPENT003247,SPENT002641,SPENT002644,SPENT002638,SPENT002645,SPENT002646,SPENT003248	SPENG000179	lnc-SLC37A4-1	-1.084	Others	-1.758	0.1167	0.2317	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019884	SPENO000406,SPENO000777,SPENO001603,SPENO001727,SPENO003889,SPENO004043,SPENO004785,SPENO004947,SPENO005304,SPENO005593,SPENO005971	Liver cancer:SPENP000777
SPENP020693	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019889	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP020696	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.351	Others	1.6903	0.1348	0.2514	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019891	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP020699	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	0.4513	Others	3.4907	0.0028	0.0192	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019896	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP020700	STIQNLQSFDPFADATKGDDLLPAGTEDYIHIR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000490,SPENT000492	SPENG003640,SPENG003321	HSALNG0025312,NONHSAG034826.2		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019894	SPENO002523,SPENO004443	Colon cancer:SPENP011173,SPENP011174,SPENP000623;Bladder cancer:SPENP017971,SPENP011803
SPENP020701	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Non-validated			Immunogenic	SPENM019898	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP020703	LGALSGAAALGFASYGAHGAQFPDAYGKELFDK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000623,SPENT000621	SPENG002150	lnc-PLSCR3-1		Others				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019902	SPENO000755,SPENO005859	Colon cancer:SPENP001778
SPENP020707	AIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT000014,SPENT000015	SPENG003410,SPENG003123	ACAT1,HSALNG0086980	-2.46	Down-regulated in tumors	-4.109	0.0023	0.0162	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019906	SPENO003940,SPENO004992	Colon cancer:SPENP016415,SPENP011185,SPENP011186;Prostate cancer:SPENP018556
SPENP020708	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.8008	Up-regulated in tumors	3.6635	0.0048	0.0276	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019904	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP020711	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019908	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP020712	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.6986	Others	2.6552	0.0767	0.1741	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019909	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Bladder cancer:SPENP028467,SPENP017987;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP020713	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1361	Others	1.579	0.1488	0.2701	PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019912	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP020714	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019911	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP020717	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019914	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP020718	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Kidney cancer	Renal cell carcinoma	Kidney epithelium	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD011681	Cross-omics analysis of archival human renal cell carcinoma biopsies to identify emerging treatment avenues	Q Exactive	MS1 intensity based label-free quantification method	30838877	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM019915	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP020844	MVLVNYIFFK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000688	SPENG001829	NONHSAG015779.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012455	SPENO001705	Breast cancer:SPENP020845,SPENP020847;Colon cancer:SPENP001493;Gastric cancer:SPENP003481;Lung cancer:SPENP020846
SPENP020845	MVLVNYIFFK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000688	SPENG001829	NONHSAG015779.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012455	SPENO001705	Breast cancer:SPENP020847;Colon cancer:SPENP001493,SPENP020844;Gastric cancer:SPENP003481;Lung cancer:SPENP020846
SPENP020846	MVLVNYIFFK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000688	SPENG001829	NONHSAG015779.2		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012455	SPENO001705	Breast cancer:SPENP020845,SPENP020847;Colon cancer:SPENP001493,SPENP020844;Gastric cancer:SPENP003481
SPENP020847	MVLVNYIFFK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000688	SPENG001829	NONHSAG015779.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012455	SPENO001705	Breast cancer:SPENP020845;Colon cancer:SPENP001493,SPENP020844;Gastric cancer:SPENP003481;Lung cancer:SPENP020846
SPENP020888	TSYRIGDTWSK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.9396	Others	2.0432	0.0871	0.4589	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012471	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020891,SPENP020889;Lung cancer:SPENP020890
SPENP020889	TSYRIGDTWSK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.6882	Others	2.8921	0.0232	0.3409	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012471	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020891;Colon cancer:SPENP020888;Lung cancer:SPENP020890
SPENP020890	TSYRIGDTWSK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.9346	Others	1.8778	0.1025	0.4963	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012471	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020891,SPENP020889;Colon cancer:SPENP020888
SPENP020891	TSYRIGDTWSK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.1039	Others	1.6338	0.1534	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012471	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020889;Colon cancer:SPENP020888;Lung cancer:SPENP020890
SPENP020952	TSYRIGDTWSKK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.3165	Others	3.132	0.0259	0.3489	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012490	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020955,SPENP020953;Lung cancer:SPENP020954
SPENP020953	TSYRIGDTWSKK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.3068	Others	1.4722	0.1914	0.5359	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012490	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020955;Colon cancer:SPENP020952;Lung cancer:SPENP020954
SPENP020954	TSYRIGDTWSKK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.6611	Others	1.8709	0.1105	0.497	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012490	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020955,SPENP020953;Colon cancer:SPENP020952
SPENP020955	TSYRIGDTWSKK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.8408	Others	1.9979	0.1022	0.4963	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012490	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP020953;Colon cancer:SPENP020952;Lung cancer:SPENP020954
SPENP021084	CRFMVFAPVNFYPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001474,SPENT001475	SPENG001184	HSALNG0051356		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012520	SPENO000224,SPENO000715	Lung cancer:SPENP021086,SPENP004209;Gastric cancer:SPENP003183;Breast cancer:SPENP021085,SPENP021087
SPENP021085	CRFMVFAPVNFYPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT001474,SPENT001475	SPENG001184	HSALNG0051356		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012520	SPENO000224,SPENO000715	Lung cancer:SPENP021086,SPENP004209;Colon cancer:SPENP021084;Gastric cancer:SPENP003183;Breast cancer:SPENP021087
SPENP021086	CRFMVFAPVNFYPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT001474,SPENT001475	SPENG001184	HSALNG0051356		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012520	SPENO000224,SPENO000715	Lung cancer:SPENP004209;Colon cancer:SPENP021084;Gastric cancer:SPENP003183;Breast cancer:SPENP021085,SPENP021087
SPENP021087	CRFMVFAPVNFYPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT001474,SPENT001475	SPENG001184	HSALNG0051356	-2.088	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012520	SPENO000224,SPENO000715	Lung cancer:SPENP021086,SPENP004209;Colon cancer:SPENP021084;Gastric cancer:SPENP003183;Breast cancer:SPENP021085
SPENP021092	VTDATETTITISWR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2625	Others	0.3459	0.7396	0.9119	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012530	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP021093	VTDATETTITISWR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.7078	Others	0.9731	0.3629	0.6852	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012530	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP021094	VTDATETTITISWR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0552	Others	0.0708	0.9453	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012530	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP021095	VTDATETTITISWR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0393	Others	0.0394	0.9697	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012530	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP021096	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.522	Others	-0.7328	0.5931	0.8268	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012522	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP015967;Leukemia:SPENP001148
SPENP021097	QYNVGPSVSKYPLR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0451	Others	-0.0352	0.9733	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012522	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP021098	QYNVGPSVSKYPLR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.408	Others	-0.7061	0.6073	0.8295	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012522	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP021099	QYNVGPSVSKYPLR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0743	Others	-0.0523	0.9649	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012522	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP021100	QHIKPTMSWVLLLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT004449	SPENG002333	HSALNG0029486	-0.5886	Others	-0.9863	0.502	0.7701	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012523	SPENO004131	Breast cancer:SPENP021101,SPENP021103;Lung cancer:SPENP021102
SPENP021101	QHIKPTMSWVLLLR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT004449	SPENG002333	HSALNG0029486	0.4634	Others	0.789	0.4742	0.7622	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012523	SPENO004131	Breast cancer:SPENP021103;Colon cancer:SPENP021100;Lung cancer:SPENP021102
SPENP021102	QHIKPTMSWVLLLR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT004449	SPENG002333	HSALNG0029486		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012523	SPENO004131	Breast cancer:SPENP021101,SPENP021103;Colon cancer:SPENP021100
SPENP021103	QHIKPTMSWVLLLR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT004449	SPENG002333	HSALNG0029486	1.3136	Others	0.8754	0.533	0.7931	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012523	SPENO004131	Breast cancer:SPENP021101;Colon cancer:SPENP021100;Lung cancer:SPENP021102
SPENP021108	AQITGYRLTVGLTR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.0447	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021109,SPENP021111;Lung cancer:SPENP021110
SPENP021109	AQITGYRLTVGLTR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.7599	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021111;Colon cancer:SPENP021108;Lung cancer:SPENP021110
SPENP021110	AQITGYRLTVGLTR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.0269	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021109,SPENP021111;Colon cancer:SPENP021108
SPENP021111	AQITGYRLTVGLTR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3934	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021109;Colon cancer:SPENP021108;Lung cancer:SPENP021110
SPENP021192	MDLSRHGTVSSFVAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	5.0044	Others	0.8996	0.4346	0.7438	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012545	SPENO005034	Breast cancer:SPENP021195,SPENP021193;Ovary cancer:SPENP016545;Lung cancer:SPENP021194
SPENP021193	MDLSRHGTVSSFVAK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	0.3902	Others	0.5996	0.591	0.8268	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012545	SPENO005034	Breast cancer:SPENP021195;Ovary cancer:SPENP016545;Colon cancer:SPENP021192;Lung cancer:SPENP021194
SPENP021194	MDLSRHGTVSSFVAK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	0.4565	Others	0.8896	0.4392	0.7465	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012545	SPENO005034	Breast cancer:SPENP021195,SPENP021193;Ovary cancer:SPENP016545;Colon cancer:SPENP021192
SPENP021195	MDLSRHGTVSSFVAK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	2.0125	Others	1.2061	0.3142	0.6432	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012545	SPENO005034	Breast cancer:SPENP021193;Ovary cancer:SPENP016545;Colon cancer:SPENP021192;Lung cancer:SPENP021194
SPENP021200	AQITGYRLTVGLTRR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012538	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021201,SPENP021203;Ovary cancer:SPENP016552;Lung cancer:SPENP021202
SPENP021201	AQITGYRLTVGLTRR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012538	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021203;Ovary cancer:SPENP016552;Colon cancer:SPENP021200;Lung cancer:SPENP021202
SPENP021202	AQITGYRLTVGLTRR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012538	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021201,SPENP021203;Ovary cancer:SPENP016552;Colon cancer:SPENP021200
SPENP021203	AQITGYRLTVGLTRR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012538	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021201;Ovary cancer:SPENP016552;Colon cancer:SPENP021200;Lung cancer:SPENP021202
SPENP021208	QLEDGRTLSDYNIQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT002337,SPENT002335	SPENG001112	lnc-CDH8-4	-1.445	Others	-3.004	0.0239	0.3409	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012535	SPENO004206,SPENO005136	Breast cancer:SPENP021209,SPENP021211;Lung cancer:SPENP021210
SPENP021209	QLEDGRTLSDYNIQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT002337,SPENT002335	SPENG001112	lnc-CDH8-4	-0.0637	Others	-0.1472	0.8878	0.9809	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012535	SPENO004206,SPENO005136	Breast cancer:SPENP021211;Colon cancer:SPENP021208;Lung cancer:SPENP021210
SPENP021210	QLEDGRTLSDYNIQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT002337,SPENT002335	SPENG001112	lnc-CDH8-4	-0.6371	Others	-1.754	0.1228	0.5021	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012535	SPENO004206,SPENO005136	Breast cancer:SPENP021209,SPENP021211;Colon cancer:SPENP021208
SPENP021211	QLEDGRTLSDYNIQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT002337,SPENT002335	SPENG001112	lnc-CDH8-4	0.187	Others	0.2666	0.7987	0.9306	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012535	SPENO004206,SPENO005136	Breast cancer:SPENP021209;Colon cancer:SPENP021208;Lung cancer:SPENP021210
SPENP021228	VTDATETTITISWRTK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.7615	Others	0.6577	0.5495	0.8024	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012554	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021229,SPENP021231;Lung cancer:SPENP021230
SPENP021229	VTDATETTITISWRTK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.2839	Others	2.0626	0.1081	0.497	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012554	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021231;Colon cancer:SPENP021228;Lung cancer:SPENP021230
SPENP021230	VTDATETTITISWRTK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.5264	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012554	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021229,SPENP021231;Colon cancer:SPENP021228
SPENP021231	VTDATETTITISWRTK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.3104	Others	2.2448	0.2176	0.5576	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012554	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021229;Colon cancer:SPENP021228;Lung cancer:SPENP021230
SPENP021244	ARVTDATETTITISWR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012557	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021247,SPENP021245;Lung cancer:SPENP021246
SPENP021245	ARVTDATETTITISWR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012557	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021247;Colon cancer:SPENP021244;Lung cancer:SPENP021246
SPENP021246	ARVTDATETTITISWR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012557	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021247,SPENP021245;Colon cancer:SPENP021244
SPENP021247	ARVTDATETTITISWR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012557	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021245;Colon cancer:SPENP021244;Lung cancer:SPENP021246
SPENP021316	LLGGQLGLEDFIFAHVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001329	SPENG000766	HSALNG0004615		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012573	SPENO001612	Breast cancer:SPENP021319,SPENP021317;Bladder cancer:SPENP017681;Lung cancer:SPENP021318,SPENP002647;Prostate cancer:SPENP018369
SPENP021317	LLGGQLGLEDFIFAHVK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT001329	SPENG000766	HSALNG0004615		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012573	SPENO001612	Breast cancer:SPENP021319;Bladder cancer:SPENP017681;Lung cancer:SPENP021318,SPENP002647;Prostate cancer:SPENP018369;Colon cancer:SPENP021316
SPENP021318	LLGGQLGLEDFIFAHVK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT001329	SPENG000766	HSALNG0004615		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012573	SPENO001612	Breast cancer:SPENP021319,SPENP021317;Bladder cancer:SPENP017681;Lung cancer:SPENP002647;Prostate cancer:SPENP018369;Colon cancer:SPENP021316
SPENP021319	LLGGQLGLEDFIFAHVK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT001329	SPENG000766	HSALNG0004615		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012573	SPENO001612	Breast cancer:SPENP021317;Bladder cancer:SPENP017681;Lung cancer:SPENP021318,SPENP002647;Prostate cancer:SPENP018369;Colon cancer:SPENP021316
SPENP021368	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-2.971	Others	-1.128	0.3105	0.6408	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012591	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP021369	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-3.056	Others	-1.678	0.1372	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012591	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP021370	DIQMTQSPSSLSASVGDR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-3.687	Others	-1.996	0.081	0.4589	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012591	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP021371	DIQMTQSPSSLSASVGDR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.3653	Others	-0.3326	0.748	0.9157	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012591	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP021372	GQPRQYNVGPSVSKYPLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012594	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021373,SPENP021375;Lung cancer:SPENP021374
SPENP021373	GQPRQYNVGPSVSKYPLR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012594	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021375;Colon cancer:SPENP021372;Lung cancer:SPENP021374
SPENP021374	GQPRQYNVGPSVSKYPLR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012594	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021373,SPENP021375;Colon cancer:SPENP021372
SPENP021375	GQPRQYNVGPSVSKYPLR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012594	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021373;Colon cancer:SPENP021372;Lung cancer:SPENP021374
SPENP021388	CNDQDTRTSYRIGDTWSK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.8446	Others	3.2873	0.0167	0.3176	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012600	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021389,SPENP021391;Lung cancer:SPENP021390
SPENP021389	CNDQDTRTSYRIGDTWSK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	3.4988	Others	2.6048	0.0352	0.3803	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012600	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021391;Colon cancer:SPENP021388;Lung cancer:SPENP021390
SPENP021390	CNDQDTRTSYRIGDTWSK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.5482	Others	1.6435	0.1443	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012600	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021389,SPENP021391;Colon cancer:SPENP021388
SPENP021391	CNDQDTRTSYRIGDTWSK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	2.4417	Others	1.2408	0.2547	0.5865	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012600	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021389;Colon cancer:SPENP021388;Lung cancer:SPENP021390
SPENP021392	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	2.7655	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012598	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP021393	VSPHSGVVALTKPVPEPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012598	SPENO005034	Breast cancer:SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP021394	VSPHSGVVALTKPVPEPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012598	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP021395	VSPHSGVVALTKPVPEPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	0.3156	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012598	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP021404	ARVTDATETTITISWRTK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012601	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021405,SPENP021407;Lung cancer:SPENP021406
SPENP021405	ARVTDATETTITISWRTK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012601	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021407;Colon cancer:SPENP021404;Lung cancer:SPENP021406
SPENP021406	ARVTDATETTITISWRTK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012601	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021405,SPENP021407;Colon cancer:SPENP021404
SPENP021407	ARVTDATETTITISWRTK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012601	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021405;Colon cancer:SPENP021404;Lung cancer:SPENP021406
SPENP021408	ASQGISNYLAWYQQKPGK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012595	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP016141
SPENP021409	ASQGISNYLAWYQQKPGK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012595	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP021410	ASQGISNYLAWYQQKPGK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012595	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021411,SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP021411	ASQGISNYLAWYQQKPGK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012595	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021409;Thyroid cancer:SPENP012520,SPENP012521;Ovary cancer:SPENP016598;Lung cancer:SPENP021410,SPENP004452;Gastric cancer:SPENP003633,SPENP015381,SPENP003283;Colon cancer:SPENP021408,SPENP016141
SPENP021412	YAASSYLSLTPEQWKSHK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.1536	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	MS	28137767	Immunogenic	SPENM012599	SPENO000204,SPENO003223,SPENO003278,SPENO005040,SPENO005507	Breast cancer:SPENP021413,SPENP021415;Lung cancer:SPENP021414
SPENP021413	YAASSYLSLTPEQWKSHK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	MS	28137767	Immunogenic	SPENM012599	SPENO000204,SPENO003223,SPENO003278,SPENO005040,SPENO005507	Breast cancer:SPENP021415;Colon cancer:SPENP021412;Lung cancer:SPENP021414
SPENP021414	YAASSYLSLTPEQWKSHK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.7031	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	MS	28137767	Immunogenic	SPENM012599	SPENO000204,SPENO003223,SPENO003278,SPENO005040,SPENO005507	Breast cancer:SPENP021413,SPENP021415;Colon cancer:SPENP021412
SPENP021415	YAASSYLSLTPEQWKSHK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000083,SPENT000084,SPENT000079,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	1.0316	Others	0.8682	0.5445	0.7974	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	MS	28137767	Immunogenic	SPENM012599	SPENO000204,SPENO003223,SPENO003278,SPENO005040,SPENO005507	Breast cancer:SPENP021413;Colon cancer:SPENP021412;Lung cancer:SPENP021414
SPENP021428	RPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.9393	Others	-1.323	0.2273	0.5642	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012610	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP010825;Leukemia:SPENP001323
SPENP021429	RPHETGGYMLECVCLGNGK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.4963	Others	0.6221	0.5512	0.8024	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012610	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP021430	RPHETGGYMLECVCLGNGK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-1.971	Others	-2.511	0.0403	0.3937	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012610	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP021431	RPHETGGYMLECVCLGNGK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.0433	Others	-0.0825	0.9366	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012610	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP021432	LSCAASGFTFSYYYMSGVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT004280	SPENG001151	lnc-BRF1-24		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012608	SPENO005504	Breast cancer:SPENP021433,SPENP021435;Lung cancer:SPENP021434
SPENP021433	LSCAASGFTFSYYYMSGVR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT004280	SPENG001151	lnc-BRF1-24		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012608	SPENO005504	Breast cancer:SPENP021435;Colon cancer:SPENP021432;Lung cancer:SPENP021434
SPENP021434	LSCAASGFTFSYYYMSGVR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT004280	SPENG001151	lnc-BRF1-24		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012608	SPENO005504	Breast cancer:SPENP021433,SPENP021435;Colon cancer:SPENP021432
SPENP021435	LSCAASGFTFSYYYMSGVR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT004280	SPENG001151	lnc-BRF1-24		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012608	SPENO005504	Breast cancer:SPENP021433;Colon cancer:SPENP021432;Lung cancer:SPENP021434
SPENP021436	LSCAASGFTFSDYYMSWVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT004279	SPENG001932	lnc-BRF1-70		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012607	SPENO005225	Breast cancer:SPENP021439,SPENP021437;Lung cancer:SPENP021438
SPENP021437	LSCAASGFTFSDYYMSWVR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT004279	SPENG001932	lnc-BRF1-70		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012607	SPENO005225	Breast cancer:SPENP021439;Colon cancer:SPENP021436;Lung cancer:SPENP021438
SPENP021438	LSCAASGFTFSDYYMSWVR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT004279	SPENG001932	lnc-BRF1-70		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012607	SPENO005225	Breast cancer:SPENP021439,SPENP021437;Colon cancer:SPENP021436
SPENP021439	LSCAASGFTFSDYYMSWVR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT004279	SPENG001932	lnc-BRF1-70		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012607	SPENO005225	Breast cancer:SPENP021437;Colon cancer:SPENP021436;Lung cancer:SPENP021438
SPENP021452	WTPPRAQITGYRLTVGLTR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.6519	Others	5.1144	0.0119	0.3176	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012605	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021455,SPENP021453;Lung cancer:SPENP021454
SPENP021453	WTPPRAQITGYRLTVGLTR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	4.5654	Others	3.0884	0.0363	0.3803	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012605	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021455;Colon cancer:SPENP021452;Lung cancer:SPENP021454
SPENP021454	WTPPRAQITGYRLTVGLTR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.5165	Others	2.638	0.0335	0.3803	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012605	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021455,SPENP021453;Colon cancer:SPENP021452
SPENP021455	WTPPRAQITGYRLTVGLTR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	3.0492	Others	1.4427	0.1871	0.534	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012605	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021453;Colon cancer:SPENP021452;Lung cancer:SPENP021454
SPENP021484	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012617	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP021485	KVSPHSGVVALTKPVPEPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012617	SPENO005034	Breast cancer:SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP021486	KVSPHSGVVALTKPVPEPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012617	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP021487	KVSPHSGVVALTKPVPEPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012617	SPENO005034	Breast cancer:SPENP021485,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP021548	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012636	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP021549	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012636	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP021550	ALAPTWEQLALGLEHSETVK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012636	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP021551	ALAPTWEQLALGLEHSETVK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012636	SPENO005833	Breast cancer:SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP021580	STAAMSTYTGIFTDQVLSVLK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012648	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP029445,SPENP016232
SPENP021581	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012648	SPENO003134,SPENO005747	Breast cancer:SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP021582	STAAMSTYTGIFTDQVLSVLK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012648	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP021583	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012648	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP021584	ASQGISNYLAWYQQKPGKVPK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012638	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021585,SPENP021587;Gastric cancer:SPENP015415;Lung cancer:SPENP021586
SPENP021585	ASQGISNYLAWYQQKPGKVPK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012638	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021587;Colon cancer:SPENP021584;Gastric cancer:SPENP015415;Lung cancer:SPENP021586
SPENP021586	ASQGISNYLAWYQQKPGKVPK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012638	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021585,SPENP021587;Colon cancer:SPENP021584;Gastric cancer:SPENP015415
SPENP021587	ASQGISNYLAWYQQKPGKVPK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT000961	SPENG000040,SPENG000667	lnc-RPIA-13,NONHSAG028467.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012638	SPENO001118,SPENO001351,SPENO001395,SPENO002538	Breast cancer:SPENP021585;Colon cancer:SPENP021584;Gastric cancer:SPENP015415;Lung cancer:SPENP021586
SPENP021600	MTQSPSSLSASVGDRVTITCR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT001473	SPENG002060,SPENG000040,SPENG000667	lnc-RPIA-13,lnc-GAB4-4,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012650	SPENO001118,SPENO001351,SPENO001395,SPENO005349	Breast cancer:SPENP021603,SPENP021601;Lung cancer:SPENP021602
SPENP021601	MTQSPSSLSASVGDRVTITCR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT001473	SPENG002060,SPENG000040,SPENG000667	lnc-RPIA-13,lnc-GAB4-4,NONHSAG028467.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012650	SPENO001118,SPENO001351,SPENO001395,SPENO005349	Breast cancer:SPENP021603;Colon cancer:SPENP021600;Lung cancer:SPENP021602
SPENP021602	MTQSPSSLSASVGDRVTITCR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT001473	SPENG002060,SPENG000040,SPENG000667	lnc-RPIA-13,lnc-GAB4-4,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012650	SPENO001118,SPENO001351,SPENO001395,SPENO005349	Breast cancer:SPENP021603,SPENP021601;Colon cancer:SPENP021600
SPENP021603	MTQSPSSLSASVGDRVTITCR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000960,SPENT001472,SPENT001469,SPENT001473	SPENG002060,SPENG000040,SPENG000667	lnc-RPIA-13,lnc-GAB4-4,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012650	SPENO001118,SPENO001351,SPENO001395,SPENO005349	Breast cancer:SPENP021601;Colon cancer:SPENP021600;Lung cancer:SPENP021602
SPENP021608	GLEWVSVIYSGGSTYYADSVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000901	SPENG001252	lnc-BRF1-31	1.8343	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012640	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP021611,SPENP005993,SPENP005992,SPENP005989,SPENP005990;Lung cancer:SPENP021610
SPENP021609	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000901	SPENG001252	lnc-BRF1-31	-0.8006	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012640	SPENO003112	Breast cancer:SPENP005991,SPENP021611,SPENP005993,SPENP005992,SPENP005989,SPENP005990;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP021610	GLEWVSVIYSGGSTYYADSVK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000901	SPENG001252	lnc-BRF1-31	1.1575	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012640	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP021611,SPENP005993,SPENP005992,SPENP005989,SPENP005990;Colon cancer:SPENP021608
SPENP021611	GLEWVSVIYSGGSTYYADSVK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000901	SPENG001252	lnc-BRF1-31	-0.7416	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012640	SPENO003112	Breast cancer:SPENP021609,SPENP005991,SPENP005993,SPENP005992,SPENP005989,SPENP005990;Colon cancer:SPENP021608;Lung cancer:SPENP021610
SPENP021632	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4912	Others	-0.9294	0.3836	0.7036	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012652	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP021633	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2959	Others	-0.5173	0.619	0.8352	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012652	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP021634	DTLTSRPAQGVVTTLENVSPPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.092	Others	-2.021	0.078	0.4589	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012652	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP021635	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.7897	Others	-1.307	0.2276	0.5642	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012652	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP021636	GLEWVSSISSSSSYIYYADSVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005837	SPENG001212	COPDA1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012654	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006000,SPENP006001,SPENP006003,SPENP021639,SPENP006002;Lung cancer:SPENP021638
SPENP021637	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005837	SPENG001212	COPDA1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012654	SPENO000573	Breast cancer:SPENP005999,SPENP006000,SPENP006001,SPENP006003,SPENP021639,SPENP006002;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP021638	GLEWVSSISSSSSYIYYADSVK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005837	SPENG001212	COPDA1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012654	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006000,SPENP006001,SPENP006003,SPENP021639,SPENP006002;Colon cancer:SPENP021636
SPENP021639	GLEWVSSISSSSSYIYYADSVK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005837	SPENG001212	COPDA1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012654	SPENO000573	Breast cancer:SPENP005999,SPENP021637,SPENP006000,SPENP006001,SPENP006003,SPENP006002;Colon cancer:SPENP021636;Lung cancer:SPENP021638
SPENP021644	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.0506	Others	-0.1132	0.913	0.9867	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012660	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP021645	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2833	Others	-0.5039	0.6279	0.8383	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012660	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP021646	TETITGFQVDAVPANGQTPIQR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6105	Others	-1.338	0.2177	0.5576	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012660	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP021647	TETITGFQVDAVPANGQTPIQR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1737	Others	-0.3028	0.7698	0.92	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012660	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP021652	NSLYLQMNSLRAGDTAVYYCAR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001585,SPENT005863	SPENG000129	NONHSAG016125.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012656	SPENO004518,SPENO004864	Breast cancer:SPENP021655,SPENP021653;Lung cancer:SPENP021654
SPENP021653	NSLYLQMNSLRAGDTAVYYCAR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT001585,SPENT005863	SPENG000129	NONHSAG016125.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012656	SPENO004518,SPENO004864	Breast cancer:SPENP021655;Colon cancer:SPENP021652;Lung cancer:SPENP021654
SPENP021654	NSLYLQMNSLRAGDTAVYYCAR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT001585,SPENT005863	SPENG000129	NONHSAG016125.2		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012656	SPENO004518,SPENO004864	Breast cancer:SPENP021655,SPENP021653;Colon cancer:SPENP021652
SPENP021655	NSLYLQMNSLRAGDTAVYYCAR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT001585,SPENT005863	SPENG000129	NONHSAG016125.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012656	SPENO004518,SPENO004864	Breast cancer:SPENP021653;Colon cancer:SPENP021652;Lung cancer:SPENP021654
SPENP021656	GTVYAKSYWCYLLKPSQPSPMR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT004459	SPENG000851	HSALNG0074748	0.2559	Others	0.4401	0.6753	0.8677	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012651	SPENO002130	Breast cancer:SPENP021657,SPENP021659;Lung cancer:SPENP021658
SPENP021657	GTVYAKSYWCYLLKPSQPSPMR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT004459	SPENG000851	HSALNG0074748	-0.1502	Others	-0.1858	0.8587	0.9671	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012651	SPENO002130	Breast cancer:SPENP021659;Colon cancer:SPENP021656;Lung cancer:SPENP021658
SPENP021658	GTVYAKSYWCYLLKPSQPSPMR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT004459	SPENG000851	HSALNG0074748	-0.6958	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012651	SPENO002130	Breast cancer:SPENP021657,SPENP021659;Colon cancer:SPENP021656
SPENP021659	GTVYAKSYWCYLLKPSQPSPMR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT004459	SPENG000851	HSALNG0074748	0.5022	Others	0.7974	0.4514	0.756	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012651	SPENO002130	Breast cancer:SPENP021657;Colon cancer:SPENP021656;Lung cancer:SPENP021658
SPENP021672	CDPHEATCYDDGKTYHVGEQWQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012664	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487
SPENP021673	CDPHEATCYDDGKTYHVGEQWQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012664	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP021674	CDPHEATCYDDGKTYHVGEQWQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012664	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP021675	CDPHEATCYDDGKTYHVGEQWQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012664	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Tongue cancer:SPENP027540;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP021676	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.131	Others	-1.608	0.1519	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012665	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP021677	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1297	Others	-0.1981	0.8479	0.9608	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012665	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP021678	DTLTSRPAQGVVTTLENVSPPRR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.9142	Others	-1.582	0.1523	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012665	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP021679	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4918	Others	-0.8163	0.438	0.7465	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012665	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP021684	MESGSTAASEEARSLRECELYVQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT003129	SPENG002251	HSALNG0118372		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012678	SPENO004510	Breast cancer:SPENP021685,SPENP021687;Lung cancer:SPENP021686
SPENP021685	MESGSTAASEEARSLRECELYVQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT003129	SPENG002251	HSALNG0118372		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012678	SPENO004510	Breast cancer:SPENP021687;Colon cancer:SPENP021684;Lung cancer:SPENP021686
SPENP021686	MESGSTAASEEARSLRECELYVQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT003129	SPENG002251	HSALNG0118372		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012678	SPENO004510	Breast cancer:SPENP021685,SPENP021687;Colon cancer:SPENP021684
SPENP021687	MESGSTAASEEARSLRECELYVQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT003129	SPENG002251	HSALNG0118372		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012678	SPENO004510	Breast cancer:SPENP021685;Colon cancer:SPENP021684;Lung cancer:SPENP021686
SPENP021696	HWLSDRTYTCQVTYQGHTFEDSTK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012684	SPENO005655	Breast cancer:SPENP021699,SPENP021697;Lung cancer:SPENP021698
SPENP021697	HWLSDRTYTCQVTYQGHTFEDSTK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012684	SPENO005655	Breast cancer:SPENP021699;Colon cancer:SPENP021696;Lung cancer:SPENP021698
SPENP021698	HWLSDRTYTCQVTYQGHTFEDSTK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012684	SPENO005655	Breast cancer:SPENP021699,SPENP021697;Colon cancer:SPENP021696
SPENP021699	HWLSDRTYTCQVTYQGHTFEDSTK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012684	SPENO005655	Breast cancer:SPENP021697;Colon cancer:SPENP021696;Lung cancer:SPENP021698
SPENP021712	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2603	Others	-0.4167	0.6894	0.8749	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012669	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP024293,SPENP007456
SPENP021713	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2142	Others	0.3119	0.7631	0.9199	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012669	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP021714	TKTETITGFQVDAVPANGQTPIQR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.489	Others	-0.7851	0.455	0.756	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012669	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP021715	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6061	Others	-0.7718	0.4624	0.7598	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012669	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP021716	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012682	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP011000,SPENP029429
SPENP021717	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012682	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP021718	NSITLTNLTPGTEYVVSIVALNGR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012682	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP021719	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012682	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP021740	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4144	Others	0.5062	0.6342	0.8429	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012667	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP021741	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.1412	Others	1.5454	0.2163	0.5576	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012667	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP021742	STATISGLKPGVDYTITVYAVTGR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6052	Others	-1.046	0.3361	0.6606	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012667	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP021743	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7717	Others	0.9055	0.528	0.789	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012667	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP021752	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM012673	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP021753	AAQAQGQSCEYSLMVGYQCGQVFR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM012673	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP021754	AAQAQGQSCEYSLMVGYQCGQVFR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM012673	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP021755	AAQAQGQSCEYSLMVGYQCGQVFR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM012673	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP021764	DTLTSRPAQGVVTTLENVSPPRRAR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.728	Others	3.1784	0.0155	0.3176	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012687	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021767,SPENP021765;Lung cancer:SPENP021766
SPENP021765	DTLTSRPAQGVVTTLENVSPPRRAR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.089	Others	3.2387	0.0119	0.3176	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012687	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021767;Colon cancer:SPENP021764;Lung cancer:SPENP021766
SPENP021766	DTLTSRPAQGVVTTLENVSPPRRAR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.7572	Others	1.3436	0.2159	0.5576	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012687	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021767,SPENP021765;Colon cancer:SPENP021764
SPENP021767	DTLTSRPAQGVVTTLENVSPPRRAR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9006	Others	0.97	0.3605	0.6852	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012687	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021765;Colon cancer:SPENP021764;Lung cancer:SPENP021766
SPENP021768	VSPHSGVVALTKPVPEPRDLLLTVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012691	SPENO005034	Breast cancer:SPENP021769,SPENP021771;Lung cancer:SPENP021770
SPENP021769	VSPHSGVVALTKPVPEPRDLLLTVK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012691	SPENO005034	Breast cancer:SPENP021771;Colon cancer:SPENP021768;Lung cancer:SPENP021770
SPENP021770	VSPHSGVVALTKPVPEPRDLLLTVK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012691	SPENO005034	Breast cancer:SPENP021769,SPENP021771;Colon cancer:SPENP021768
SPENP021771	VSPHSGVVALTKPVPEPRDLLLTVK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012691	SPENO005034	Breast cancer:SPENP021769;Colon cancer:SPENP021768;Lung cancer:SPENP021770
SPENP021772	HWLSDRTYTCQVTYQGHTFEDSTKK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012693	SPENO005655	Breast cancer:SPENP021775,SPENP021773;Lung cancer:SPENP021774
SPENP021773	HWLSDRTYTCQVTYQGHTFEDSTKK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012693	SPENO005655	Breast cancer:SPENP021775;Colon cancer:SPENP021772;Lung cancer:SPENP021774
SPENP021774	HWLSDRTYTCQVTYQGHTFEDSTKK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012693	SPENO005655	Breast cancer:SPENP021775,SPENP021773;Colon cancer:SPENP021772
SPENP021775	HWLSDRTYTCQVTYQGHTFEDSTKK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT001437	SPENG000079	lnc-BRF1-4		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012693	SPENO005655	Breast cancer:SPENP021773;Colon cancer:SPENP021772;Lung cancer:SPENP021774
SPENP021780	IGDTWRRPHETGGYMLECVCLGNGK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.3074	Others	0.688	0.5136	0.7812	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012692	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021783,SPENP021781;Lung cancer:SPENP021782
SPENP021781	IGDTWRRPHETGGYMLECVCLGNGK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.5437	Others	0.9547	0.3677	0.6888	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012692	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021783;Colon cancer:SPENP021780;Lung cancer:SPENP021782
SPENP021782	IGDTWRRPHETGGYMLECVCLGNGK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.628	Others	-1.316	0.2248	0.5642	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012692	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021783,SPENP021781;Colon cancer:SPENP021780
SPENP021783	IGDTWRRPHETGGYMLECVCLGNGK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.0665	Others	0.1121	0.9135	0.9867	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012692	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021781;Colon cancer:SPENP021780;Lung cancer:SPENP021782
SPENP021788	SYTITGLQPGTDYKIYLYTLNDNAR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012688	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP024303,SPENP027313,SPENP011036
SPENP021789	SYTITGLQPGTDYKIYLYTLNDNAR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012688	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP021790	SYTITGLQPGTDYKIYLYTLNDNAR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012688	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP021791	SYTITGLQPGTDYKIYLYTLNDNAR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012688	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP021804	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.1253	Others	-0.2259	0.8277	0.9524	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012696	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP021805	TNTNVNCPIECFMPLDVQADREDSRE	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.2652	Others	-0.4672	0.6528	0.8531	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012696	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP021806	TNTNVNCPIECFMPLDVQADREDSRE	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.5316	Others	-1.153	0.282	0.6239	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012696	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP021807	TNTNVNCPIECFMPLDVQADREDSRE	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.0123	Others	0.0161	0.9875	0.9929	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012696	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP021824	SSQSLVHSDGNTYLSWLQQRPGQPPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.184	Others	-0.9686	0.3701	0.6909	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012700	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762
SPENP021825	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.617	Others	-1.365	0.2144	0.5576	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012700	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP021826	SSQSLVHSDGNTYLSWLQQRPGQPPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.475	Others	-0.5312	0.6117	0.8302	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012700	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP021827	SSQSLVHSDGNTYLSWLQQRPGQPPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	1.0469	Others	0.9629	0.39	0.7063	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012700	SPENO000369,SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP027291,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP021828	SSQSLVYSDGNTYLNWFQQRPGQSPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.7441	Others	-0.9023	0.3969	0.7151	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012702	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP021829	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.3079	Others	-0.5457	0.6002	0.8268	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012702	SPENO001239,SPENO005201	Breast cancer:SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP021830	SSQSLVYSDGNTYLNWFQQRPGQSPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.7173	Others	0.5298	0.6106	0.8302	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012702	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP021831	SSQSLVYSDGNTYLNWFQQRPGQSPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.1549	Others	0.2024	0.8454	0.9608	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012702	SPENO001239,SPENO005201	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP021836	ATLVCLISDFYPGAVTVAWKADSSPVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-3.658	Others	-1.022	0.4928	0.7633	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012709	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP021839,SPENP021837;Bladder cancer:SPENP011757;Gastric cancer:SPENP015453;Lung cancer:SPENP021838;Colon cancer:SPENP026715
SPENP021837	ATLVCLISDFYPGAVTVAWKADSSPVK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.232	Others	-0.6334	0.6382	0.8435	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012709	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP021839;Bladder cancer:SPENP011757;Gastric cancer:SPENP015453;Lung cancer:SPENP021838;Colon cancer:SPENP026715,SPENP021836
SPENP021838	ATLVCLISDFYPGAVTVAWKADSSPVK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.8369	Others	-0.4334	0.7187	0.8981	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012709	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP021839,SPENP021837;Bladder cancer:SPENP011757;Gastric cancer:SPENP015453;Colon cancer:SPENP026715,SPENP021836
SPENP021839	ATLVCLISDFYPGAVTVAWKADSSPVK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-2.253	Others	-0.8616	0.539	0.7964	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012709	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP021837;Bladder cancer:SPENP011757;Gastric cancer:SPENP015453;Lung cancer:SPENP021838;Colon cancer:SPENP026715,SPENP021836
SPENP021848	SSQSLVYSDGNTYLNWFQQRPGQSPRR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.4938	Others	-0.3392	0.7568	0.9193	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012714	SPENO001239,SPENO005201	Breast cancer:SPENP021849,SPENP021851;Lung cancer:SPENP021850
SPENP021849	SSQSLVYSDGNTYLNWFQQRPGQSPRR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-1.065	Others	-0.9504	0.3855	0.7043	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012714	SPENO001239,SPENO005201	Breast cancer:SPENP021851;Colon cancer:SPENP021848;Lung cancer:SPENP021850
SPENP021850	SSQSLVYSDGNTYLNWFQQRPGQSPRR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	1.4261	Others	0.6536	0.5422	0.7972	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012714	SPENO001239,SPENO005201	Breast cancer:SPENP021849,SPENP021851;Colon cancer:SPENP021848
SPENP021851	SSQSLVYSDGNTYLNWFQQRPGQSPRR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.3299	Others	0.3937	0.7139	0.895	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012714	SPENO001239,SPENO005201	Breast cancer:SPENP021849;Colon cancer:SPENP021848;Lung cancer:SPENP021850
SPENP021872	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.5593	Others	3.0169	0.0195	0.34	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP021873	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7854	Others	2.2918	0.0511	0.4117	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP021874	TGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1732	Others	2.5622	0.0335	0.3803	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP021875	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9851	Others	0.9787	0.3564	0.6852	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012710	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP021880	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.6278	Others	0.8555	0.4206	0.7402	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012716	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP014658,SPENP016367,SPENP008740
SPENP021881	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.8269	Others	1.6497	0.1376	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012716	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP021882	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.7207	Others	1.6141	0.1452	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012716	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP021883	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.1828	Others	0.3106	0.764	0.9199	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012716	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021881;Bladder cancer:SPENP011773;Tongue cancer:SPENP028083;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP021892	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012718	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP000594
SPENP021893	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.1389	Others	-0.1529	0.8882	0.9809	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012718	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP021894	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-2.764	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012718	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP021895	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.8317	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012718	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP021908	VTLSCTGNSNNVGSYAVGWYQQISHGAPK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000204,SPENT004450	SPENG001643,SPENG000666	lnc-VPREB1-25,NONHSAG033390.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012724	SPENO003621,SPENO004924	Breast cancer:SPENP021911,SPENP021909;Lung cancer:SPENP021910
SPENP021909	VTLSCTGNSNNVGSYAVGWYQQISHGAPK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000204,SPENT004450	SPENG001643,SPENG000666	lnc-VPREB1-25,NONHSAG033390.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012724	SPENO003621,SPENO004924	Breast cancer:SPENP021911;Colon cancer:SPENP021908;Lung cancer:SPENP021910
SPENP021910	VTLSCTGNSNNVGSYAVGWYQQISHGAPK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000204,SPENT004450	SPENG001643,SPENG000666	lnc-VPREB1-25,NONHSAG033390.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012724	SPENO003621,SPENO004924	Breast cancer:SPENP021911,SPENP021909;Colon cancer:SPENP021908
SPENP021911	VTLSCTGNSNNVGSYAVGWYQQISHGAPK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000204,SPENT004450	SPENG001643,SPENG000666	lnc-VPREB1-25,NONHSAG033390.3		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012724	SPENO003621,SPENO004924	Breast cancer:SPENP021909;Colon cancer:SPENP021908;Lung cancer:SPENP021910
SPENP021912	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012729	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP021913	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012729	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP021914	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012729	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP021915	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012729	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP021928	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.2057	Others	-0.2906	0.7798	0.9211	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012728	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP027319,SPENP000608,SPENP011123
SPENP021929	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.1886	Others	0.2606	0.801	0.9306	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012728	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP021930	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.4946	Others	-0.6537	0.5316	0.7926	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012728	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP021931	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.4232	Others	-0.4394	0.672	0.8677	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012728	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP021932	TETITGFQVDAVPANGQTPIQRTIKPDVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5551	Others	0.7227	0.4933	0.7633	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012727	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021935,SPENP021933;Lung cancer:SPENP021934
SPENP021933	TETITGFQVDAVPANGQTPIQRTIKPDVR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.9342	Others	1.9638	0.0852	0.4589	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012727	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021935;Colon cancer:SPENP021932;Lung cancer:SPENP021934
SPENP021934	TETITGFQVDAVPANGQTPIQRTIKPDVR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2542	Others	-0.3085	0.7667	0.9199	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012727	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021935,SPENP021933;Colon cancer:SPENP021932
SPENP021935	TETITGFQVDAVPANGQTPIQRTIKPDVR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.766	Others	0.633	0.5444	0.7974	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012727	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021933;Colon cancer:SPENP021932;Lung cancer:SPENP021934
SPENP021936	QYNVGPSVSKYPLRNLQPASEYTVSLVAIK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012734	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021937,SPENP021939;Lung cancer:SPENP021938
SPENP021937	QYNVGPSVSKYPLRNLQPASEYTVSLVAIK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.7311	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012734	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021939;Colon cancer:SPENP021936;Lung cancer:SPENP021938
SPENP021938	QYNVGPSVSKYPLRNLQPASEYTVSLVAIK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2487	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012734	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021937,SPENP021939;Colon cancer:SPENP021936
SPENP021939	QYNVGPSVSKYPLRNLQPASEYTVSLVAIK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0894	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012734	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021937;Colon cancer:SPENP021936;Lung cancer:SPENP021938
SPENP021940	EINLAPDSSSVVVSGLMVATKYEVSVYALK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.151	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012740	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021943,SPENP021941;Kidney cancer:SPENP015237;Tongue cancer:SPENP027619;Lung cancer:SPENP021942
SPENP021941	EINLAPDSSSVVVSGLMVATKYEVSVYALK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0096	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012740	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021943;Kidney cancer:SPENP015237;Tongue cancer:SPENP027619;Lung cancer:SPENP021942;Colon cancer:SPENP021940
SPENP021942	EINLAPDSSSVVVSGLMVATKYEVSVYALK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6452	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012740	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021943,SPENP021941;Kidney cancer:SPENP015237;Tongue cancer:SPENP027619;Colon cancer:SPENP021940
SPENP021943	EINLAPDSSSVVVSGLMVATKYEVSVYALK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.183	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012740	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021941;Kidney cancer:SPENP015237;Tongue cancer:SPENP027619;Lung cancer:SPENP021942;Colon cancer:SPENP021940
SPENP021948	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012738	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP011139,SPENP000609
SPENP021949	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012738	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP021950	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012738	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP021951	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012738	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP021952	IYLYTLNDNARSSPVVIDASTAIDAPSNLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6724	Others	3.2114	0.0148	0.3176	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012733	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021955,SPENP021953;Lung cancer:SPENP021954
SPENP021953	IYLYTLNDNARSSPVVIDASTAIDAPSNLR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.4549	Others	2.2618	0.0834	0.4589	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012733	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021955;Colon cancer:SPENP021952;Lung cancer:SPENP021954
SPENP021954	IYLYTLNDNARSSPVVIDASTAIDAPSNLR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2037	Others	2.3747	0.0449	0.3937	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012733	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021955,SPENP021953;Colon cancer:SPENP021952
SPENP021955	IYLYTLNDNARSSPVVIDASTAIDAPSNLR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.4125	Others	1.0782	0.3124	0.6412	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012733	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021953;Colon cancer:SPENP021952;Lung cancer:SPENP021954
SPENP021964	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.379	Others	-0.4123	0.6944	0.879	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012741	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP007913,SPENP021966,SPENP004706;Leukemia:SPENP001396;Breast cancer:SPENP021965,SPENP021967
SPENP021965	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.5789	Others	0.8334	0.4321	0.7412	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012741	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP007913,SPENP021966,SPENP004706;Colon cancer:SPENP021964;Leukemia:SPENP001396;Breast cancer:SPENP021967
SPENP021966	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-1.065	Others	-1.559	0.1629	0.5131	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012741	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP007913,SPENP004706;Colon cancer:SPENP021964;Leukemia:SPENP001396;Breast cancer:SPENP021965,SPENP021967
SPENP021967	RPHETGGYMLECVCLGNGKGEWTCKPIAEK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.0467	Others	-0.0664	0.9492	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012741	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Lung cancer:SPENP007913,SPENP021966,SPENP004706;Colon cancer:SPENP021964;Leukemia:SPENP001396;Breast cancer:SPENP021965
SPENP021972	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-0.2212	Others	-0.3605	0.7291	0.9034	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012739	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP021973	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.5245	Others	0.8069	0.4431	0.749	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012739	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP021974	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	-1.007	Others	-1.487	0.1753	0.5184	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012739	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP021975	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.1611	Others	0.1613	0.8759	0.9745	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012739	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP021996	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012748	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP021997	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012748	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP021998	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012748	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP021999	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012748	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP022000	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.7869	Others	0.9817	0.3589	0.6852	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012750	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP022001	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	1.3133	Others	1.5797	0.1528	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012750	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP022002	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.0785	Others	0.1034	0.9202	0.988	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012750	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP022003	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1	0.6609	Others	0.5851	0.5746	0.8204	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012750	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP022004	SSQSLVYSDGNTYLNWFQQRPGQSPRRLIYK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012746	SPENO001239,SPENO005201	Breast cancer:SPENP022005,SPENP022007;Lung cancer:SPENP022006
SPENP022005	SSQSLVYSDGNTYLNWFQQRPGQSPRRLIYK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012746	SPENO001239,SPENO005201	Breast cancer:SPENP022007;Colon cancer:SPENP022004;Lung cancer:SPENP022006
SPENP022006	SSQSLVYSDGNTYLNWFQQRPGQSPRRLIYK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012746	SPENO001239,SPENO005201	Breast cancer:SPENP022005,SPENP022007;Colon cancer:SPENP022004
SPENP022007	SSQSLVYSDGNTYLNWFQQRPGQSPRRLIYK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	-0.6735	Others	-1.682	0.2861	0.6263	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012746	SPENO001239,SPENO005201	Breast cancer:SPENP022005;Colon cancer:SPENP022004;Lung cancer:SPENP022006
SPENP022008	SSQSLVHSDGNTYLSWLQQRPGQPPRLLIYK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.2523	Others	0.7827	0.4693	0.7622	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012745	SPENO000369,SPENO003879	Breast cancer:SPENP022011,SPENP022009;Lung cancer:SPENP022010
SPENP022009	SSQSLVHSDGNTYLSWLQQRPGQPPRLLIYK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	2.317	Others	1.9431	0.0931	0.4758	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012745	SPENO000369,SPENO003879	Breast cancer:SPENP022011;Colon cancer:SPENP022008;Lung cancer:SPENP022010
SPENP022010	SSQSLVHSDGNTYLSWLQQRPGQPPRLLIYK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	3.2619	Others	2.7773	0.0321	0.3803	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012745	SPENO000369,SPENO003879	Breast cancer:SPENP022011,SPENP022009;Colon cancer:SPENP022008
SPENP022011	SSQSLVHSDGNTYLSWLQQRPGQPPRLLIYK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	3.1422	Others	3.2704	0.0137	0.3176	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Non-validated			Immunogenic	SPENM012745	SPENO000369,SPENO003879	Breast cancer:SPENP022009;Colon cancer:SPENP022008;Lung cancer:SPENP022010
SPENP022016	TKTETITGFQVDAVPANGQTPIQRTIKPDVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022017,SPENP022019;Lung cancer:SPENP022018
SPENP022017	TKTETITGFQVDAVPANGQTPIQRTIKPDVR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022019;Colon cancer:SPENP022016;Lung cancer:SPENP022018
SPENP022018	TKTETITGFQVDAVPANGQTPIQRTIKPDVR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022017,SPENP022019;Colon cancer:SPENP022016
SPENP022019	TKTETITGFQVDAVPANGQTPIQRTIKPDVR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012742	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022017;Colon cancer:SPENP022016;Lung cancer:SPENP022018
SPENP022020	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000855	SPENG000474	AC016876.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM012752	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399
SPENP022021	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT000855	SPENG000474	AC016876.2	-0.5414	Others	-0.7979	0.5692	0.8142	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM012752	SPENO004050	Breast cancer:SPENP022023;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP022022	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT000855	SPENG000474	AC016876.2		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM012752	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP022023	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT000855	SPENG000474	AC016876.2	-0.3995	Others	-0.6196	0.6467	0.8482	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM012752	SPENO004050	Breast cancer:SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP022024	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2705	Others	-0.4084	0.6952	0.879	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012753	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP022025	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2182	Others	1.3944	0.2007	0.546	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012753	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP022026	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.8817	Others	-1.184	0.2705	0.6062	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012753	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP022027	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.599	Others	-0.738	0.4816	0.7622	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012753	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP022040	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQER	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012757	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022043,SPENP022041;Lung cancer:SPENP022042
SPENP022041	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQER	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012757	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022043;Colon cancer:SPENP022040;Lung cancer:SPENP022042
SPENP022042	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQER	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012757	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022043,SPENP022041;Colon cancer:SPENP022040
SPENP022043	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQER	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012757	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022041;Colon cancer:SPENP022040;Lung cancer:SPENP022042
SPENP022052	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.3662	Others	2.3981	0.0476	0.4008	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP022053	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.5121	Others	2.2019	0.0588	0.4307	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP022054	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.8732	Others	1.7381	0.1204	0.4984	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP022055	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.9351	Others	1.058	0.3209	0.6501	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP022060	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3901	Others	2.5057	0.0406	0.3937	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022061,SPENP022063;Bladder cancer:SPENP028765;Tongue cancer:SPENP028086;Lung cancer:SPENP022062
SPENP022061	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.54	Others	2.6576	0.0289	0.3803	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022063;Bladder cancer:SPENP028765;Tongue cancer:SPENP028086;Lung cancer:SPENP022062;Colon cancer:SPENP022060
SPENP022062	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.052	Others	1.4859	0.1756	0.5184	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022061,SPENP022063;Bladder cancer:SPENP028765;Tongue cancer:SPENP028086;Colon cancer:SPENP022060
SPENP022063	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2941	Others	1.1225	0.2942	0.6269	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012760	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022061;Bladder cancer:SPENP028765;Tongue cancer:SPENP028086;Lung cancer:SPENP022062;Colon cancer:SPENP022060
SPENP022064	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9304	Others	0.9519	0.3779	0.7018	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP011188
SPENP022065	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2791	Others	1.0901	0.3118	0.6412	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP022066	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4944	Others	0.6139	0.5587	0.8082	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP022067	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5066	Others	0.4312	0.6814	0.8705	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012763	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP022068	TGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012762	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022069,SPENP022071;Lung cancer:SPENP022070
SPENP022069	TGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012762	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022071;Colon cancer:SPENP022068;Lung cancer:SPENP022070
SPENP022070	TGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012762	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022069,SPENP022071;Colon cancer:SPENP022068
SPENP022071	TGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012762	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022069;Colon cancer:SPENP022068;Lung cancer:SPENP022070
SPENP022072	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2912	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012764	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022075,SPENP022073;Lung cancer:SPENP022074
SPENP022073	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.0214	Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012764	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022075;Colon cancer:SPENP022072;Lung cancer:SPENP022074
SPENP022074	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012764	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022075,SPENP022073;Colon cancer:SPENP022072
SPENP022075	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012764	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022073;Colon cancer:SPENP022072;Lung cancer:SPENP022074
SPENP022076	IGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.6203	Others	1.0668	0.3349	0.6599	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012765	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022079,SPENP022077;Lung cancer:SPENP022078
SPENP022077	IGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.2291	Others	1.3737	0.2187	0.5576	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012765	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022079;Colon cancer:SPENP022076;Lung cancer:SPENP022078
SPENP022078	IGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.1204	Others	0.1958	0.8512	0.9608	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012765	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022079,SPENP022077;Colon cancer:SPENP022076
SPENP022079	IGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.0431	Others	0.0408	0.9688	0.9927	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012765	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022077;Colon cancer:SPENP022076;Lung cancer:SPENP022078
SPENP022108	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLKTQGNK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.5009	Others	0.6815	0.602	0.8268	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012774	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022109,SPENP022111;Lung cancer:SPENP022110
SPENP022109	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLKTQGNK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.3648	Others	1.1273	0.3416	0.6679	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012774	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022111;Colon cancer:SPENP022108;Lung cancer:SPENP022110
SPENP022110	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLKTQGNK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	0.4254	Others	0.5471	0.6079	0.8295	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012774	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022109,SPENP022111;Colon cancer:SPENP022108
SPENP022111	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLKTQGNK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	1.7174	Others	1.3024	0.4131	0.7356	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012774	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP022109;Colon cancer:SPENP022108;Lung cancer:SPENP022110
SPENP022116	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8415	Others	0.4883	0.7085	0.8928	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012777	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022119,SPENP022117;Lung cancer:SPENP022118
SPENP022117	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.4599	Others	1.8121	0.1129	0.497	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012777	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022119;Colon cancer:SPENP022116;Lung cancer:SPENP022118
SPENP022118	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-1.053	Others	-1.368	0.2432	0.5777	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012777	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022119,SPENP022117;Colon cancer:SPENP022116
SPENP022119	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6576	Others	-1.115	0.3272	0.6553	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012777	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022117;Colon cancer:SPENP022116;Lung cancer:SPENP022118
SPENP022120	STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4124	Others	0.6123	0.5628	0.8093	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022121,SPENP022123;Colon cancer:SPENP027295;Lung cancer:SPENP022122
SPENP022121	STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1818	Others	1.4065	0.2024	0.5462	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022123;Colon cancer:SPENP027295,SPENP022120;Lung cancer:SPENP022122
SPENP022122	STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0678	Others	0.1055	0.919	0.988	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022121,SPENP022123;Colon cancer:SPENP027295,SPENP022120
SPENP022123	STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8243	Others	0.9845	0.3629	0.6852	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012775	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022121;Colon cancer:SPENP027295,SPENP022120;Lung cancer:SPENP022122
SPENP022124	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012776	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP016430
SPENP022125	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012776	SPENO001233	Breast cancer:SPENP022127;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP022126	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012776	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP022127	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752	SPENG000084	FN1		Others				PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012776	SPENO001233	Breast cancer:SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP022132	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.1792	Others	1.6912	0.1346	0.5064	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012778	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022135,SPENP022133;Lung cancer:SPENP022134
SPENP022133	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.2018	Others	1.8986	0.0942	0.478	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012778	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022135;Colon cancer:SPENP022132;Lung cancer:SPENP022134
SPENP022134	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3576	Others	0.7182	0.4959	0.764	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012778	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022135,SPENP022133;Colon cancer:SPENP022132
SPENP022135	EVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3424	Others	0.5552	0.5961	0.8268	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012778	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022133;Colon cancer:SPENP022132;Lung cancer:SPENP022134
SPENP022140	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.3844	Others	-0.5631	0.5909	0.8268	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012782	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP022141	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.4327	Others	-0.7331	0.4844	0.7622	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012782	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP022142	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.2389	Others	-0.5147	0.6207	0.8352	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012782	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011
SPENP022143	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.6298	Others	-1.09	0.3076	0.6385	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012782	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006272,SPENP022141,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP027068,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP022144	YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.3979	Others	2.2738	0.0633	0.4307	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012781	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022147,SPENP022145;Colon cancer:SPENP027467;Lung cancer:SPENP022146
SPENP022145	YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Breast cancer HER2	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8543	Others	0.9669	0.3658	0.688	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012781	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022147;Colon cancer:SPENP022144,SPENP027467;Lung cancer:SPENP022146
SPENP022146	YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Lung cancer	Non-small cell lung carcinoma	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.3313	Others	-0.7695	0.4668	0.7609	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012781	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022147,SPENP022145;Colon cancer:SPENP022144,SPENP027467
SPENP022147	YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Breast cancer	Triple-negative breast cancer	Extracellular vesicles	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.2502	Others	0.2344	0.8214	0.9466	PXD012162	Proteomic profiling of breast cancer-derived extracellular vesicles	Q Exactive	MS/MS(label free)	31508500	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM012781	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022145;Colon cancer:SPENP022144,SPENP027467;Lung cancer:SPENP022146
SPENP022320	MLTDTVIIIR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004500,SPENT004498,SPENT005840,SPENT004502,SPENT004486,SPENT004499,SPENT004489,SPENT005839,SPENT004494,SPENT004485,SPENT004501,SPENT004492,SPENT004488,SPENT004487,SPENT004495,SPENT004493,SPENT004490,SPENT004497,SPENT004491,SPENT004496,SPENT004484	SPENG003264,SPENG000413	LINC02525	-3.352	Others	-0.7982	0.4333	0.5095	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007113	SPENO000071,SPENO000336,SPENO000515,SPENO000593,SPENO000999,SPENO001146,SPENO001762,SPENO002505,SPENO002736,SPENO003221,SPENO003435,SPENO003571,SPENO004195,SPENO004640,SPENO004882,SPENO004956,SPENO005132,SPENO005145,SPENO005188,SPENO005234,SPENO006024	
SPENP022321	MLTDTVIIIR	Breast cancer	Breast cancer	Breast	SPENT004500,SPENT004498,SPENT005840,SPENT004502,SPENT004486,SPENT004499,SPENT004489,SPENT005839,SPENT004494,SPENT004485,SPENT004501,SPENT004492,SPENT004488,SPENT004487,SPENT004495,SPENT004493,SPENT004490,SPENT004497,SPENT004491,SPENT004496,SPENT004484	SPENG003264,SPENG000413	LINC02525	-2.004	Others	-1.157	0.258	0.3272	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007113	SPENO000071,SPENO000336,SPENO000515,SPENO000593,SPENO000999,SPENO001146,SPENO001762,SPENO002505,SPENO002736,SPENO003221,SPENO003435,SPENO003571,SPENO004195,SPENO004640,SPENO004882,SPENO004956,SPENO005132,SPENO005145,SPENO005188,SPENO005234,SPENO006024	
SPENP022340	MLICIFETWK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT003615	SPENG000781	HSALNG0007937		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007108	SPENO001192	
SPENP022341	MLICIFETWK	Breast cancer	Breast cancer	Breast	SPENT003615	SPENG000781	HSALNG0007937		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007108	SPENO001192	
SPENP022378	MYLNQNLSSIR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004517	SPENG002099	HSALNG0062484		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007190	SPENO004225	
SPENP022379	MYLNQNLSSIR	Breast cancer	Breast cancer	Breast	SPENT004517	SPENG002099	HSALNG0062484		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007190	SPENO004225	
SPENP022394	MRLLSPSLHFL	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004521	SPENG000397	HSALNG0003829		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007196	SPENO005439	
SPENP022395	MRLLSPSLHFL	Breast cancer	Breast cancer	Breast	SPENT004521	SPENG000397	HSALNG0003829		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007196	SPENO005439	
SPENP022396	LGELPSWILMR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007164	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP022397	LGELPSWILMR	Breast cancer	Breast cancer	Breast	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007164	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP022398	SEIEYYAMLAK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007191	SPENO000929	Breast cancer:SPENP022399;Colon cancer:SPENP010027,SPENP008174,SPENP010028;Bladder cancer:SPENP028732;Skin cancer:SPENP025097
SPENP022399	SEIEYYAMLAK	Breast cancer	Breast cancer	Breast	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007191	SPENO000929	Breast cancer:SPENP022398;Colon cancer:SPENP010027,SPENP008174,SPENP010028;Bladder cancer:SPENP028732;Skin cancer:SPENP025097
SPENP022420	LTSDLTFAYER	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001450,SPENT002601,SPENT002602	SPENG000375	lnc-CELF6-1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007156	SPENO002631,SPENO003868,SPENO005694	Breast cancer:SPENP022421,SPENP008837;Colon cancer:SPENP006919
SPENP022421	LTSDLTFAYER	Breast cancer	Breast cancer	Breast	SPENT001450,SPENT002601,SPENT002602	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007156	SPENO002631,SPENO003868,SPENO005694	Breast cancer:SPENP008837,SPENP022420;Colon cancer:SPENP006919
SPENP022442	DKLNNLVLFDK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007179	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP022443	DKLNNLVLFDK	Breast cancer	Breast cancer	Breast	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007179	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP022450	ALLSAPWYLNR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001450	SPENG000375	lnc-CELF6-1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007183	SPENO003868	Skin cancer:SPENP019006,SPENP019005,SPENP019004;Prostate cancer:SPENP023559;Gastric cancer:SPENP003118;Breast cancer:SPENP022451
SPENP022451	ALLSAPWYLNR	Breast cancer	Breast cancer	Breast	SPENT001450	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007183	SPENO003868	Skin cancer:SPENP019006,SPENP019005,SPENP019004;Prostate cancer:SPENP023559;Gastric cancer:SPENP003118;Breast cancer:SPENP022450
SPENP022460	YMDGMTVGVVR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005796	SPENG001958	FBLN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007188	SPENO003698	Breast cancer:SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP022461	YMDGMTVGVVR	Breast cancer	Breast cancer	Breast	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007188	SPENO003698	Breast cancer:SPENP022460;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP022472	MLLENESILTLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004529	SPENG002467	HSALNG0019272		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007235	SPENO004460	
SPENP022473	MLLENESILTLK	Breast cancer	Breast cancer	Breast	SPENT004529	SPENG002467	HSALNG0019272	-3.013	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007235	SPENO004460	
SPENP022474	LVILANNCPALR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007242	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP022475	LVILANNCPALR	Breast cancer	Breast cancer	Breast	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007242	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP022484	YQLDPTASISAK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000102	SPENG002045	lnc-ACTR2-11	0.6101	Others	3.8586	0.0007	0.0037	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007228	SPENO000884	Breast cancer:SPENP008847,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP022485	YQLDPTASISAK	Breast cancer	Breast cancer	Breast	SPENT000102	SPENG002045	lnc-ACTR2-11	1.0322	Up-regulated in tumors	4.5906	0.0002	0.0012	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007228	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP022486	KSEIEYYAMLAK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007203	SPENO000929	Breast cancer:SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP010164,SPENP008226
SPENP022487	KSEIEYYAMLAK	Breast cancer	Breast cancer	Breast	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007203	SPENO000929	Breast cancer:SPENP022486;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP010164,SPENP008226
SPENP022488	VPFLVLECPNLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000354	SPENG002378	HSALNG0036293		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007229	SPENO003709	Breast cancer:SPENP022489;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP022489	VPFLVLECPNLK	Breast cancer	Breast cancer	Breast	SPENT000354	SPENG002378	HSALNG0036293		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007229	SPENO003709	Breast cancer:SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP022494	QMLGGFIVNYIK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004531,SPENT004533,SPENT004532	SPENG001566,SPENG003040	AL359220.1,lnc-TMEM30B-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007240	SPENO003702,SPENO004252,SPENO005497	
SPENP022495	QMLGGFIVNYIK	Breast cancer	Breast cancer	Breast	SPENT004531,SPENT004533,SPENT004532	SPENG001566,SPENG003040	AL359220.1,lnc-TMEM30B-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007240	SPENO003702,SPENO004252,SPENO005497	
SPENP022500	ALLANALTSALR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT002117	SPENG003627	NONHSAG037834.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007219	SPENO005301	Breast cancer:SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP022501	ALLANALTSALR	Breast cancer	Breast cancer	Breast	SPENT002117	SPENG003627	NONHSAG037834.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007219	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP022518	VSSLPLLLPYWR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT002175	SPENG000523	NONHSAG026963.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007220	SPENO003701	Breast cancer:SPENP022519;Lung cancer:SPENP028411
SPENP022519	VSSLPLLLPYWR	Breast cancer	Breast cancer	Breast	SPENT002175	SPENG000523	NONHSAG026963.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007220	SPENO003701	Breast cancer:SPENP022518;Lung cancer:SPENP028411
SPENP022552	MQTLSFFFVFLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT003316,SPENT004522	SPENG001411,SPENG002046	NONHSAG111360.1,HSALNG0029877	0.0246	Others	0.078	0.9416	0.952	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007199	SPENO001356,SPENO004389	
SPENP022553	MQTLSFFFVFLR	Breast cancer	Breast cancer	Breast	SPENT003316,SPENT004522	SPENG001411,SPENG002046	NONHSAG111360.1,HSALNG0029877	-0.7813	Others	-2.503	0.0665	0.1214	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007199	SPENO001356,SPENO004389	
SPENP022566	GQAGVMGFPGPK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005758	SPENG002845	COL1A1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007236	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP022567	GQAGVMGFPGPK	Breast cancer	Breast cancer	Breast	SPENT005758	SPENG002845	COL1A1	-1.391	Others	-2.195	0.0376	0.0758	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007236	SPENO004941	Breast cancer:SPENP023326,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP022574	VIEGDVVSALNK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001808,SPENT005921	SPENG001016,SPENG001705	AC112229.4,lnc-LIMS4-1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007214	SPENO000049,SPENO000476	Breast cancer:SPENP022575;Gastric cancer:SPENP015298;Bladder cancer:SPENP011358;Lung cancer:SPENP007620
SPENP022575	VIEGDVVSALNK	Breast cancer	Breast cancer	Breast	SPENT001808,SPENT005921	SPENG001016,SPENG001705	AC112229.4,lnc-LIMS4-1	-0.9171	Others	-1.946	0.0675	0.1216	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007214	SPENO000049,SPENO000476	Breast cancer:SPENP022574;Gastric cancer:SPENP015298;Bladder cancer:SPENP011358;Lung cancer:SPENP007620
SPENP022586	MMEHHSLIMLMVK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004552	SPENG002200	HSALNG0098113		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007260	SPENO005726	
SPENP022587	MMEHHSLIMLMVK	Breast cancer	Breast cancer	Breast	SPENT004552	SPENG002200	HSALNG0098113		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007260	SPENO005726	
SPENP022604	MSYSAGLLFILLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004563	SPENG000784	AC117453.1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007275	SPENO004212	
SPENP022605	MSYSAGLLFILLR	Breast cancer	Breast cancer	Breast	SPENT004563	SPENG000784	AC117453.1	-0.8606	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007275	SPENO004212	
SPENP022610	AAALVLQTIWGYK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005788	SPENG002233	AP001931.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007277	SPENO005858	Breast cancer:SPENP022611;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP022611	AAALVLQTIWGYK	Breast cancer	Breast cancer	Breast	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007277	SPENO005858	Breast cancer:SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP022626	SGTLYSLTLYGLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007273	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP022627	SGTLYSLTLYGLR	Breast cancer	Breast cancer	Breast	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	-0.2225	Others	-0.5921	0.5621	0.6179	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007273	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP022628	GNSIIMLEALERV	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007295	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP022629	GNSIIMLEALERV	Breast cancer	Breast cancer	Breast	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007295	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP022630	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.4039	Others	1.6794	0.1002	0.1663	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007286	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP022631	DFSPSGIFGAFQR	Breast cancer	Breast cancer	Breast	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.0396	Others	-0.1928	0.8478	0.88	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007286	SPENO004812,SPENO005239	Breast cancer:SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP022650	VALAGLLGFGLGK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT003237	SPENG001444	lnc-OCIAD2-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007266	SPENO002971	Breast cancer:SPENP022651;Colon cancer:SPENP010336,SPENP010335,SPENP024026;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP018206,SPENP012954
SPENP022651	VALAGLLGFGLGK	Breast cancer	Breast cancer	Breast	SPENT003237	SPENG001444	lnc-OCIAD2-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007266	SPENO002971	Breast cancer:SPENP022650;Colon cancer:SPENP010336,SPENP010335,SPENP024026;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP018206,SPENP012954
SPENP022652	YAMVYGYNAAYNR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	2.8393	Others	2.1912	0.0795	0.1388	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007259	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP022653	YAMVYGYNAAYNR	Breast cancer	Breast cancer	Breast	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530	2.3138	Others	1.5089	0.1595	0.2288	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007259	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP022662	HVISYSLSPFEQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007280	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP022663	HVISYSLSPFEQR	Breast cancer	Breast cancer	Breast	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007280	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP022682	VFVDGHQLFDFYHR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001695	SPENG003497	HSALNG0015478		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007301	SPENO003932	Breast cancer:SPENP022683;Lung cancer:SPENP004171
SPENP022683	VFVDGHQLFDFYHR	Breast cancer	Breast cancer	Breast	SPENT001695	SPENG003497	HSALNG0015478		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007301	SPENO003932	Breast cancer:SPENP022682;Lung cancer:SPENP004171
SPENP022706	VTDATETTITISWR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007334	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP022707	VTDATETTITISWR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007334	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP022728	QVRPIVGPFHAVLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005796	SPENG001958	FBLN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007311	SPENO003698	Breast cancer:SPENP022729;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331,SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP014237,SPENP015976
SPENP022729	QVRPIVGPFHAVLK	Breast cancer	Breast cancer	Breast	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007311	SPENO003698	Breast cancer:SPENP022728;Bladder cancer:SPENP017501;Gastric cancer:SPENP015331,SPENP003568;Lung cancer:SPENP002486;Colon cancer:SPENP006511,SPENP014237,SPENP015976
SPENP022730	SKESVPEFPLSPPK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001112	SPENG003381	lnc-PAQR7-1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007316	SPENO000291	Breast cancer:SPENP022731;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP022731	SKESVPEFPLSPPK	Breast cancer	Breast cancer	Breast	SPENT001112	SPENG003381	lnc-PAQR7-1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007316	SPENO000291	Breast cancer:SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP022736	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007329	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP022737,SPENP005484,SPENP005486,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP022737	STLVHSLFLTDLYK	Breast cancer	Breast cancer	Breast	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007329	SPENO001224,SPENO004356,SPENO005697	Breast cancer:SPENP005485,SPENP005484,SPENP005486,SPENP022736,SPENP005488,SPENP005487;Colon cancer:SPENP014270;Bladder cancer:SPENP017483;Kidney cancer:SPENP020236
SPENP022752	LLLATGLDGSYLLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004582,SPENT004581,SPENT004580	SPENG002232	HSALNG0139965		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007346	SPENO000038,SPENO001197,SPENO002170	
SPENP022753	LLLATGLDGSYLLR	Breast cancer	Breast cancer	Breast	SPENT004582,SPENT004581,SPENT004580	SPENG002232	HSALNG0139965		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007346	SPENO000038,SPENO001197,SPENO002170	
SPENP022754	TPTEALASFDYIVR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007328	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022755;Bladder cancer:SPENP028778;Lung cancer:SPENP004163,SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP024064,SPENP007144
SPENP022755	TPTEALASFDYIVR	Breast cancer	Breast cancer	Breast	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007328	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP004163,SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP024064,SPENP007144
SPENP022756	TQSPSSLSASVGDR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007310	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP022757;Gastric cancer:SPENP015328,SPENP003185,SPENP003575
SPENP022757	TQSPSSLSASVGDR	Breast cancer	Breast cancer	Breast	SPENT001473,SPENT000960,SPENT001471,SPENT001472,SPENT001470,SPENT001469	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007310	SPENO001118,SPENO001351,SPENO001395,SPENO003097,SPENO005349,SPENO006166	Breast cancer:SPENP022756;Gastric cancer:SPENP015328,SPENP003185,SPENP003575
SPENP022758	LNLTGMLNSGLNEK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004577,SPENT004574	SPENG000802	CYTOR		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007333	SPENO000190,SPENO001587	
SPENP022759	LNLTGMLNSGLNEK	Breast cancer	Breast cancer	Breast	SPENT004577,SPENT004574	SPENG000802	CYTOR		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007333	SPENO000190,SPENO001587	
SPENP022768	MLITILGTVKPNANR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-1.398	Down-regulated in tumors	-4.545	6.64e-05	0.0005	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007370	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP022769	MLITILGTVKPNANR	Breast cancer	Breast cancer	Breast	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.0277	Others	-0.1088	0.9138	0.9308	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007370	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP022770	NYLEGIYNVPVAAVR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007363	SPENO001980,SPENO002623	Skin cancer:SPENP019416,SPENP019417,SPENP019415;Bladder cancer:SPENP011525;Breast cancer:SPENP022771
SPENP022771	NYLEGIYNVPVAAVR	Breast cancer	Breast cancer	Breast	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007363	SPENO001980,SPENO002623	Skin cancer:SPENP019416,SPENP019417,SPENP019415;Bladder cancer:SPENP011525;Breast cancer:SPENP022770
SPENP022772	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.301	Down-regulated in tumors	-4.648	3.32e-05	0.0003	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007362	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP022773	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Breast	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-0.7699	Others	-3.167	0.0026	0.0089	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007362	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP022776	MLLNSDTGSLPPYSR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004590	SPENG003130	HSALNG0041778	-1.518	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007381	SPENO005897	
SPENP022777	MLLNSDTGSLPPYSR	Breast cancer	Breast cancer	Breast	SPENT004590	SPENG003130	HSALNG0041778	-0.9246	Others	-1.44	0.1879	0.2575	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007381	SPENO005897	
SPENP022788	VLFGCVLYWDTVRGK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT003180	SPENG001801	AC106799.2	-3.706	Down-regulated in tumors	-11.06	9.98e-12	5.48e-10	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007373	SPENO005953	Breast cancer:SPENP022789;Bladder cancer:SPENP011505;Lung cancer:SPENP026135;Prostate cancer:SPENP009234;Colon cancer:SPENP010492,SPENP000334,SPENP010491
SPENP022789	VLFGCVLYWDTVRGK	Breast cancer	Breast cancer	Breast	SPENT003180	SPENG001801	AC106799.2	-1.253	Down-regulated in tumors	-3.469	0.0014	0.0058	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007373	SPENO005953	Breast cancer:SPENP022788;Bladder cancer:SPENP011505;Lung cancer:SPENP026135;Prostate cancer:SPENP009234;Colon cancer:SPENP010492,SPENP000334,SPENP010491
SPENP022826	GNEFLFSHLWPLIEK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT002175	SPENG000523	NONHSAG026963.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007378	SPENO003701	Breast cancer:SPENP008914,SPENP022827;Lung cancer:SPENP028280;Kidney cancer:SPENP015069;Prostate cancer:SPENP023684
SPENP022827	GNEFLFSHLWPLIEK	Breast cancer	Breast cancer	Breast	SPENT002175	SPENG000523	NONHSAG026963.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007378	SPENO003701	Breast cancer:SPENP008914,SPENP022826;Lung cancer:SPENP028280;Kidney cancer:SPENP015069;Prostate cancer:SPENP023684
SPENP022836	IAAGESLALLFELAR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004589	SPENG000512	NONHSAG048570.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007376	SPENO002893	
SPENP022837	IAAGESLALLFELAR	Breast cancer	Breast cancer	Breast	SPENT004589	SPENG000512	NONHSAG048570.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007376	SPENO002893	
SPENP022838	AVLAPLIALVYSVPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004587,SPENT004588	SPENG000855	HSALNG0084306	0.6391	Others	3.2571	0.0173	0.0442	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007354	SPENO001016,SPENO002367	
SPENP022839	AVLAPLIALVYSVPR	Breast cancer	Breast cancer	Breast	SPENT004587,SPENT004588	SPENG000855	HSALNG0084306	0.7384	Others	1.5681	0.1513	0.2205	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007354	SPENO001016,SPENO002367	
SPENP022844	MKTNEAVAENINYFFK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT003408	SPENG003128	HSALNG0019460		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007412	SPENO005437	Breast cancer:SPENP022845;Colon cancer:SPENP000393;Bladder cancer:SPENP011540
SPENP022845	MKTNEAVAENINYFFK	Breast cancer	Breast cancer	Breast	SPENT003408	SPENG003128	HSALNG0019460		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007412	SPENO005437	Breast cancer:SPENP022844;Colon cancer:SPENP000393;Bladder cancer:SPENP011540
SPENP022896	ISLPGQMAGTPITPLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000725,SPENT000615	SPENG001618	NONHSAG029796.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	sORF.org_record	26527729	Immunogenic	SPENM007415	SPENO000363,SPENO003428	Breast cancer:SPENP022897;Colon cancer:SPENP006591,SPENP000379;Lung cancer:SPENP025800;Prostate cancer:SPENP012075
SPENP022897	ISLPGQMAGTPITPLK	Breast cancer	Breast cancer	Breast	SPENT000725,SPENT000615	SPENG001618	NONHSAG029796.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	sORF.org_record	26527729	Immunogenic	SPENM007415	SPENO000363,SPENO003428	Breast cancer:SPENP022896;Colon cancer:SPENP006591,SPENP000379;Lung cancer:SPENP025800;Prostate cancer:SPENP012075
SPENP022906	MREGCGVMGLASWSRR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004609,SPENT004610	SPENG000950	SNHG17		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007406	SPENO004246,SPENO004580	
SPENP022907	MREGCGVMGLASWSRR	Breast cancer	Breast cancer	Breast	SPENT004609,SPENT004610	SPENG000950	SNHG17		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007406	SPENO004246,SPENO004580	
SPENP022918	ISSTLYQAAAPVLTPAK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007441	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP022919	ISSTLYQAAAPVLTPAK	Breast cancer	Breast cancer	Breast	SPENT000825,SPENT000820,SPENT000826,SPENT000821,SPENT000823,SPENT000824,SPENT000822	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007441	SPENO000551,SPENO001113,SPENO002177,SPENO002406,SPENO002902,SPENO004037,SPENO005321	Breast cancer:SPENP022918;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP025801,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP022924	FMPAGLIAGASLLMVAK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031	-0.0296	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007436	SPENO000972,SPENO005766	Breast cancer:SPENP022925;Colon cancer:SPENP007302,SPENP026841;Kidney cancer:SPENP020457,SPENP015125;Prostate cancer:SPENP018363
SPENP022925	FMPAGLIAGASLLMVAK	Breast cancer	Breast cancer	Breast	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031	0.0157	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007436	SPENO000972,SPENO005766	Breast cancer:SPENP022924;Colon cancer:SPENP007302,SPENP026841;Kidney cancer:SPENP020457,SPENP015125;Prostate cancer:SPENP018363
SPENP022960	TPIGSFLGSLSLLPATK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000014	SPENG003410	ACAT1	0.3558	Others	1.302	0.2002	0.2663	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007424	SPENO003940	Breast cancer:SPENP022961,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP022961	TPIGSFLGSLSLLPATK	Breast cancer	Breast cancer	Breast	SPENT000014	SPENG003410	ACAT1	0.3136	Others	1.4693	0.1479	0.2179	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007424	SPENO003940	Breast cancer:SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP022966	GETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005758	SPENG002845	COL1A1	-3.661	Down-regulated in tumors	-6.255	3.83e-07	5.25e-06	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007451	SPENO004941	Breast cancer:SPENP008961,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP022967	GETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Breast	SPENT005758	SPENG002845	COL1A1	-1.324	Down-regulated in tumors	-3.006	0.004	0.0126	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007451	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP022988	VSPHSGVVALTKPVPEPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005785	SPENG001958	FBLN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007461	SPENO005034	Breast cancer:SPENP021393,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP022989	VSPHSGVVALTKPVPEPR	Breast cancer	Breast cancer	Breast	SPENT005785	SPENG001958	FBLN1	1.1432	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007461	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP022990	TFTYLLGSDAAALLFNSK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007447	SPENO003078	Breast cancer:SPENP022991;Lung cancer:SPENP002709;Prostate cancer:SPENP018397
SPENP022991	TFTYLLGSDAAALLFNSK	Breast cancer	Breast cancer	Breast	SPENT000775	SPENG001919	lnc-LRRD1-2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007447	SPENO003078	Breast cancer:SPENP022990;Lung cancer:SPENP002709;Prostate cancer:SPENP018397
SPENP022994	DESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007452	SPENO000942,SPENO003536	Breast cancer:SPENP022995;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP010781,SPENP007344
SPENP022995	DESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Breast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007452	SPENO000942,SPENO003536	Breast cancer:SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP010781,SPENP007344
SPENP022996	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-2.169	Down-regulated in tumors	-10.13	3.66e-13	5.02e-11	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007446	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP022997	DIQMTQSPSSLSASVGDR	Breast cancer	Breast cancer	Breast	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-1.571	Down-regulated in tumors	-8.808	1.64e-11	7.49e-10	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007446	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP023006	TGVHHYSGNNIELGTACGK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007481	SPENO000929,SPENO004512	Breast cancer:SPENP023007;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP023007	TGVHHYSGNNIELGTACGK	Breast cancer	Breast cancer	Breast	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007481	SPENO000929,SPENO004512	Breast cancer:SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP023012	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007472	SPENO004356,SPENO005697	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP023013	MESPIPILPLPTPDAETEK	Breast cancer	Breast cancer	Breast	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007472	SPENO004356,SPENO005697	Breast cancer:SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Lung cancer:SPENP025915;Prostate cancer:SPENP018415
SPENP023016	MQVTSSFLGNSLFSSIHWG	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004628	SPENG003061	HSALNG0073522	1.5214	Others	2.7413	0.0713	0.1268	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007468	SPENO005562	Breast cancer:SPENP023017;Lung cancer:SPENP026584
SPENP023017	MQVTSSFLGNSLFSSIHWG	Breast cancer	Breast cancer	Breast	SPENT004628	SPENG003061	HSALNG0073522	0.0751	Others	0.1559	0.886	0.9092	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007468	SPENO005562	Breast cancer:SPENP023016;Lung cancer:SPENP026584
SPENP023018	ELDSGLAESVSTLIWAAPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004469	SPENG000589	lnc-SIPA1L3-4		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007466	SPENO001144	
SPENP023019	ELDSGLAESVSTLIWAAPR	Breast cancer	Breast cancer	Breast	SPENT004469	SPENG000589	lnc-SIPA1L3-4		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007466	SPENO001144	
SPENP023022	KVSPHSGVVALTKPVPEPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005785	SPENG001958	FBLN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007467	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP023023	KVSPHSGVVALTKPVPEPR	Breast cancer	Breast cancer	Breast	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007467	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP023040	MQLPGMTPSVSAALGIPLAR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004631	SPENG002680	HSALNG0039514		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007499	SPENO006275	
SPENP023041	MQLPGMTPSVSAALGIPLAR	Breast cancer	Breast cancer	Breast	SPENT004631	SPENG002680	HSALNG0039514		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007499	SPENO006275	
SPENP023048	SPPYIFSPIPFLGHAIAFGK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000775	SPENG001919	lnc-LRRD1-2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007501	SPENO003078	Breast cancer:SPENP023049;Kidney cancer:SPENP020556;Lung cancer:SPENP002761;Prostate cancer:SPENP018441;Colon cancer:SPENP001715
SPENP023049	SPPYIFSPIPFLGHAIAFGK	Breast cancer	Breast cancer	Breast	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007501	SPENO003078	Breast cancer:SPENP023048;Kidney cancer:SPENP020556;Lung cancer:SPENP002761;Prostate cancer:SPENP018441;Colon cancer:SPENP001715
SPENP023050	VLSTAGGMQTSLSSPAPTLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004630	SPENG003177	HSALNG0077457		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007494	SPENO001757	
SPENP023051	VLSTAGGMQTSLSSPAPTLK	Breast cancer	Breast cancer	Breast	SPENT004630	SPENG003177	HSALNG0077457		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007494	SPENO001757	
SPENP023054	TYLVSGQPLEEIITYYPAMK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007487	SPENO005957	Breast cancer:SPENP023055;Colon cancer:SPENP012846,SPENP007384,SPENP000498;Lung cancer:SPENP026112
SPENP023055	TYLVSGQPLEEIITYYPAMK	Breast cancer	Breast cancer	Breast	SPENT000965	SPENG000698	SLC25A25-AS1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007487	SPENO005957	Breast cancer:SPENP023054;Colon cancer:SPENP012846,SPENP007384,SPENP000498;Lung cancer:SPENP026112
SPENP023056	ATLVCLISDFYPGAVTVAWK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-2.243	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007495	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP023057	ATLVCLISDFYPGAVTVAWK	Breast cancer	Breast cancer	Breast	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	-1.265	Others	-2.393	0.0278	0.0614	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007495	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP023068	IGCLLSGGLDSSLVAATLLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005929,SPENT002838	SPENG001292	AC079781.5		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007488	SPENO002624,SPENO003829	
SPENP023069	IGCLLSGGLDSSLVAATLLK	Breast cancer	Breast cancer	Breast	SPENT005929,SPENT002838	SPENG001292	AC079781.5		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007488	SPENO002624,SPENO003829	
SPENP023074	VGQYVVDLTSFEQLALPVLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001191,SPENT000714	SPENG002182	NONHSAG004654.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007493	SPENO002934,SPENO005968	Breast cancer:SPENP023075;Bladder cancer:SPENP017780;Lung cancer:SPENP002767
SPENP023075	VGQYVVDLTSFEQLALPVLR	Breast cancer	Breast cancer	Breast	SPENT001191,SPENT000714	SPENG002182	NONHSAG004654.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007493	SPENO002934,SPENO005968	Breast cancer:SPENP023074;Bladder cancer:SPENP017780;Lung cancer:SPENP002767
SPENP023076	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007490	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP023077	ALAPTWEQLALGLEHSETVK	Breast cancer	Breast cancer	Breast	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007490	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP023086	ADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007510	SPENO000942,SPENO003536	Breast cancer:SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP023087	ADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Breast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007510	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP023090	ETSVTPSNLWGGQGLLGVSIR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000615	SPENG001618	NONHSAG029796.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007509	SPENO003428	Breast cancer:SPENP023091;Colon cancer:SPENP001727,SPENP000530,SPENP006694;Lung cancer:SPENP025659,SPENP028262;Prostate cancer:SPENP012117
SPENP023091	ETSVTPSNLWGGQGLLGVSIR	Breast cancer	Breast cancer	Breast	SPENT000615	SPENG001618	NONHSAG029796.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	MS	28137767	Immunogenic	SPENM007509	SPENO003428	Breast cancer:SPENP023090;Colon cancer:SPENP001727,SPENP000530,SPENP006694;Lung cancer:SPENP025659,SPENP028262;Prostate cancer:SPENP012117
SPENP023094	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007511	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP023095	STAAMSTYTGIFTDQVLSVLK	Breast cancer	Breast cancer	Breast	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007511	SPENO003134,SPENO005747	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP023100	HRPRPYPPNVGEEIQIGHIPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005757	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007508	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP023101	HRPRPYPPNVGEEIQIGHIPR	Breast cancer	Breast cancer	Breast	SPENT005757	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007508	SPENO005245,SPENO005834	Breast cancer:SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP023104	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007518	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP023105	TETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007518	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP023112	MNNMILMPKSHCAEEEVSPLNE	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004633,SPENT004634	SPENG001827	HSALNG0080471		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007517	SPENO001051,SPENO003173	
SPENP023113	MNNMILMPKSHCAEEEVSPLNE	Breast cancer	Breast cancer	Breast	SPENT004633,SPENT004634	SPENG001827	HSALNG0080471		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007517	SPENO001051,SPENO003173	
SPENP023114	DMDLTEVITGTLWNLSSHDSIK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005788	SPENG002233	AP001931.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007514	SPENO005858	Breast cancer:SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP023115	DMDLTEVITGTLWNLSSHDSIK	Breast cancer	Breast cancer	Breast	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007514	SPENO005858	Breast cancer:SPENP023114,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP023116	MLFIHVAPRTMSCLHNPGLISK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004637,SPENT004638,SPENT004639,SPENT004635,SPENT004636	SPENG001549	HSALNG0050448		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007522	SPENO000534,SPENO000737,SPENO001386,SPENO002689,SPENO004824	
SPENP023117	MLFIHVAPRTMSCLHNPGLISK	Breast cancer	Breast cancer	Breast	SPENT004637,SPENT004638,SPENT004639,SPENT004635,SPENT004636	SPENG001549	HSALNG0050448		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007522	SPENO000534,SPENO000737,SPENO001386,SPENO002689,SPENO004824	
SPENP023120	SGDRGETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005758	SPENG002845	COL1A1	-3.263	Down-regulated in tumors	-8.566	2.97e-10	7.39e-09	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007520	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP023121	SGDRGETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Breast	SPENT005758	SPENG002845	COL1A1	-1.123	Down-regulated in tumors	-3.288	0.0018	0.0066	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007520	SPENO004941	Breast cancer:SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP023122	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007523	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP023123	DTLTSRPAQGVVTTLENVSPPR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007523	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP023124	MILISLSVPYRTTFSLLHLEWCN	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT004641,SPENT004642	SPENG002246	HSALNG0043383		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007528	SPENO003955,SPENO004127	
SPENP023125	MILISLSVPYRTTFSLLHLEWCN	Breast cancer	Breast cancer	Breast	SPENT004641,SPENT004642	SPENG002246	HSALNG0043383		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007528	SPENO003955,SPENO004127	
SPENP023130	GTVLALTENNFDDTIAEGITFIK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007530	SPENO005833	Breast cancer:SPENP023131;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP002850,SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP000559,SPENP008691
SPENP023131	GTVLALTENNFDDTIAEGITFIK	Breast cancer	Breast cancer	Breast	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007530	SPENO005833	Breast cancer:SPENP023130;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP002850,SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP000559,SPENP008691
SPENP023136	VKADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007533	SPENO000942,SPENO003536	Breast cancer:SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP023137	VKADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Breast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007533	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP023138	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007525	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP023139	DTLTSRPAQGVVTTLENVSPPRR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007525	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP023152	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.5257	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007538	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP023153	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.7051	Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007538	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP023154	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007540	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP023155	DLEVVAATPTSLLISWDAPAVTVR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007540	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP023156	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.0245	Others	2.9951	0.0236	0.0549	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007537	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP023157	STATISGLKPGVDYTITVYAVTGR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	2.0115	Up-regulated in tumors	3.3836	0.0032	0.0105	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007537	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP023158	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007536	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP023159	NSITLTNLTPGTEYVVSIVALNGR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007536	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP023166	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6666	Others	1.9953	0.1016	0.1666	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007547	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP023167	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.8598	Up-regulated in tumors	3.1798	0.0048	0.0148	PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007547	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP023172	LTVLGQPKAAPSVTLFPPSSEELQANK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000083,SPENT000080,SPENT000084,SPENT000079,SPENT000081,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007549	SPENO000204,SPENO003278,SPENO004364,SPENO005040,SPENO005374,SPENO005507	
SPENP023173	LTVLGQPKAAPSVTLFPPSSEELQANK	Breast cancer	Breast cancer	Breast	SPENT000083,SPENT000080,SPENT000084,SPENT000079,SPENT000081,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007549	SPENO000204,SPENO003278,SPENO004364,SPENO005040,SPENO005374,SPENO005507	
SPENP023174	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007553	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP023175	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007553	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP023188	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005913	SPENG001766	AL662884.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007551	SPENO002584	Breast cancer:SPENP023189,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP023189	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Breast cancer	Breast cancer	Breast	SPENT005913	SPENG001766	AL662884.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007551	SPENO002584	Breast cancer:SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP023192	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005913	SPENG001766	AL662884.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007558	SPENO002584	Breast cancer:SPENP009063,SPENP023193;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP023193	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Breast cancer	Breast cancer	Breast	SPENT005913	SPENG001766	AL662884.2		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Non-validated			Immunogenic	SPENM007558	SPENO002584	Breast cancer:SPENP009063,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP023196	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007559	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP023197	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Breast	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007559	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP023200	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007562	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP023201	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Breast	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007562	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP023202	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007565	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP023203	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Breast cancer	Breast cancer	Breast	SPENT005757,SPENT005755	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007565	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP023208	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007567	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP023209	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Breast cancer	Breast cancer	Breast	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007567	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP023212	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007569	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP023213	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007569	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP023214	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Metastatic lymph nodes	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007570	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP023215	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD012431	High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data	LTQ Orbitrap XL ETD	MS1 intensity based label-free quantification method	31294064	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007570	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP023288	DKLNNLVLFDK	Breast cancer	Breast cancer	Breast	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	MS	28137767	Immunogenic	SPENM000371	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP023317	TQVVAGTNYYIK	Breast cancer	Breast cancer	Breast	SPENT002285	SPENG002633	HSALNG0028487	-2.266	Others	-6.114	0.089	0.1412	PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Non-validated			Immunogenic	SPENM000414	SPENO000213	Breast cancer:SPENP008849;Colon cancer:SPENP029452;Liver cancer:SPENP004809
SPENP023318	NALDPMSVLLAR	Breast cancer	Breast cancer	Breast	SPENT002530,SPENT002607,SPENT002606	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	MS	28137767	Immunogenic	SPENM000411	SPENO001285,SPENO003025,SPENO003487	Bladder cancer:SPENP028687;Colon cancer:SPENP007011,SPENP000193;Gastric cancer:SPENP009496
SPENP023320	YQLDPTASISAK	Breast cancer	Breast cancer	Breast	SPENT000102	SPENG002045	lnc-ACTR2-11	-2.415	Down-regulated in tumors	-34.55	5.33e-05	0.0003	PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000398	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP023326	GQAGVMGFPGPK	Breast cancer	Breast cancer	Breast	SPENT005758	SPENG002845	COL1A1		Others				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000399	SPENO004941	Breast cancer:SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP023352	VRDKLNNLVLFDK	Breast cancer	Breast cancer	Breast	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000440	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Anal canal cancer:SPENP024649;Tongue cancer:SPENP028159;Lung cancer:SPENP002371;Prostate cancer:SPENP018239;Colon cancer:SPENP027424
SPENP023380	YAASSYLSLTPEQWK	Breast cancer	Breast cancer	Breast	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.2724	Others	0.469	0.6483	0.6956	PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	MS	28137767	Immunogenic	SPENM000463	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP023399	AQQEFAAGVFSNPAVR	Breast cancer	Breast cancer	Breast	SPENT002814,SPENT003026	SPENG001802	NONHSAG003062.2		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	MS	28137767	Immunogenic	SPENM000485	SPENO003986,SPENO006093	Colon cancer:SPENP010595,SPENP010596;Kidney cancer:SPENP015087;Skin cancer:SPENP025312
SPENP023406	DKLNNLVLFDKATYDK	Breast cancer	Breast cancer	Breast	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000484	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Colon cancer:SPENP026756
SPENP023415	GETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Breast	SPENT005758	SPENG002845	COL1A1		Others				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000501	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP023422	QSNNKYAASSYLSLTPEQWK	Breast cancer	Breast cancer	Breast	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Non-validated			Immunogenic	SPENM000508	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP027212,SPENP010882
SPENP023423	ADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Breast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000513	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP023426	VFQSLPHENKPLTLSNYQTNK	Breast cancer	Breast cancer	Breast	SPENT005918,SPENT001509	SPENG001954,SPENG000527	lnc-HSF2BP-3,NONHSAG032994.2		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	MS	28137767	Immunogenic	SPENM000510	SPENO004262,SPENO005568	Gastric cancer:SPENP003308
SPENP023427	SGDRGETGPAGPAGPVGPVGAR	Breast cancer	Breast cancer	Breast	SPENT005758	SPENG002845	COL1A1	-1.818	Others	-1.925	0.1122	0.1628	PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000514	SPENO004941	Breast cancer:SPENP023121,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP023430	VKADRDESSPYAAMLAAQDVAQR	Breast cancer	Breast cancer	Breast	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000520	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP023434	TKTETITGFQVDAVPANGQTPIQR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3341	Others				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000521	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP023437	TGLDSPTGIDFSDITANSFTVHWIAPR	Breast cancer	Breast cancer	Breast	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000525	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP023438	LVDISYGGENGFNQAIELSTEVLSNVK	Breast cancer	Breast cancer	Breast	SPENT004675	SPENG002657	lnc-HSPA9-1		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM000524	SPENO004111	
SPENP023439	GFDPFMNLVIDECVEMATSGQQNNIGMVVIR	Breast cancer	Breast cancer	Breast	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Tumor-specific				PXD013795	Multi-omic dissection of oncogenically active epiproteomes identifies drivers of proliferative or invasive breast tumors	LTQ Orbitrap Velos, Q Exactive	MS1 intensity based label-free quantification method	31336272	Non-validated			Immunogenic	SPENM000526	SPENO002369,SPENO002546,SPENO002613	Colon cancer:SPENP014688,SPENP016391;Bladder cancer:SPENP017959
SPENP023559	ALLSAPWYLNR	Prostate cancer	Prostate cancer	Prostate	SPENT001450	SPENG000375	lnc-CELF6-1	0.7737	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006798	SPENO003868	Skin cancer:SPENP019006,SPENP019005,SPENP019004;Gastric cancer:SPENP003118;Breast cancer:SPENP022450,SPENP022451
SPENP023572	YMDGMTVGVVR	Prostate cancer	Prostate cancer	Prostate	SPENT005796	SPENG001958	FBLN1	0.225	Others	0.7078	0.4828	0.6571	PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006811	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP023578	TAVAHRPGAFK	Prostate cancer	Prostate cancer	Prostate	SPENT000153	SPENG003407	NONHSAG024537.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006817	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP023593	YQLDPTASISAK	Prostate cancer	Prostate cancer	Prostate	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006832	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP023627	TQTHATLCSTSAK	Prostate cancer	Prostate cancer	Prostate	SPENT004951	SPENG000993	lnc-PLPPR5-13	0.541	Others	0.5725	0.6071	0.7627	PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006866	SPENO003638	Colon cancer:SPENP000269
SPENP023633	LPSEPGMTLLTIR	Prostate cancer	Prostate cancer	Prostate	SPENT001009	SPENG001238	lnc-USP33-3		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Non-validated			Immunogenic	SPENM006872	SPENO005521	Colon cancer:SPENP000248;Lung cancer:SPENP002395
SPENP023634	AAALVLQTIWGYK	Prostate cancer	Prostate cancer	Prostate	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006873	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP023646	DFSPSGIFGAFQR	Prostate cancer	Prostate cancer	Prostate	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.33	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006885	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP023659	TPTEALASFDYIVR	Prostate cancer	Prostate cancer	Prostate	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006898	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022755,SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP004163,SPENP026100;Colon cancer:SPENP000310,SPENP024064,SPENP007144
SPENP023684	GNEFLFSHLWPLIEK	Prostate cancer	Prostate cancer	Prostate	SPENT002175	SPENG000523	NONHSAG026963.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	MS	28137767	Immunogenic	SPENM006923	SPENO003701	Breast cancer:SPENP008914,SPENP022826,SPENP022827;Lung cancer:SPENP028280;Kidney cancer:SPENP015069
SPENP023686	VLSVPESTPFTAVLK	Prostate cancer	Prostate cancer	Prostate	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2	-0.3626	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006925	SPENO001471,SPENO001798	Skin cancer:SPENP019405,SPENP019404,SPENP019403;Colon cancer:SPENP008424,SPENP024129;Leukemia:SPENP001198
SPENP023698	MLITILGTVKPNANR	Prostate cancer	Prostate cancer	Prostate	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.295	Others	-0.9006	0.3731	0.6311	PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006937	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP023699	YAASSYLSLTPEQWK	Prostate cancer	Prostate cancer	Prostate	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.3696	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	MS	28137767	Immunogenic	SPENM006938	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP023710	AAGVNVEPFWPGLFAK	Prostate cancer	Prostate cancer	Prostate	SPENT000958,SPENT000959,SPENT000956,SPENT000957	SPENG002082,SPENG000412,SPENG001664,SPENG001785	NONHSAG017284.2,HSALNG0011930,lnc-GREM2-13,lnc-EVX2-8	0.9467	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	MS	28137767	Immunogenic	SPENM006949	SPENO002111,SPENO003329,SPENO004329,SPENO006018	Breast cancer:SPENP008943;Prostate cancer:SPENP009247;Lung cancer:SPENP026477,SPENP001909;Liver cancer:SPENP004882
SPENP023729	MVQKSFTENPTSYHVLT	Prostate cancer	Prostate cancer	Prostate	SPENT004962	SPENG003517	HSALNG0093216		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Non-validated			Immunogenic	SPENM006968	SPENO001625	
SPENP023732	TPIGSFLGSLSLLPATK	Prostate cancer	Prostate cancer	Prostate	SPENT000014	SPENG003410	ACAT1	1.1603	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006971	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP023734	EAQAQHNNSEFTEEQKK	Prostate cancer	Prostate cancer	Prostate	SPENT001330,SPENT001009	SPENG001238,SPENG001518	lnc-USP33-3,lnc-TMEM144-3		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Non-validated			Immunogenic	SPENM006973	SPENO004170,SPENO005521	Colon cancer:SPENP007320,SPENP000428;Lung cancer:SPENP002661
SPENP023735	QWADDWLVHLISPNVYR	Prostate cancer	Prostate cancer	Prostate	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006974	SPENO003587,SPENO005877,SPENO005957	Colon cancer:SPENP006610
SPENP023741	LDKEMIHVLGGMEQKGAR	Prostate cancer	Prostate cancer	Prostate	SPENT001899	SPENG001253	lnc-FANCC-1		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Non-validated			Immunogenic	SPENM006980	SPENO003147	Colon cancer:SPENP008569,SPENP007355;Lung cancer:SPENP007809,SPENP004440
SPENP023748	AGATSEGVLANFFNSLLSK	Prostate cancer	Prostate cancer	Prostate	SPENT004970,SPENT004971	SPENG003752,SPENG000907	lnc-CMTM6-1,NONHSAG034705.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006987	SPENO005711,SPENO006223	
SPENP023752	INAGMLAQFIDKPVCFVGR	Prostate cancer	Prostate cancer	Prostate	SPENT004972	SPENG002340	HSALNG0056066		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006991	SPENO004273	
SPENP023755	ISQAEEEDQQLLGHLLLVAK	Prostate cancer	Prostate cancer	Prostate	SPENT002815	SPENG000837	lnc-HINT2-1		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006994	SPENO001580	Breast cancer:SPENP008997;Skin cancer:SPENP025405;Bladder cancer:SPENP028609;Lung cancer:SPENP028299,SPENP007835;Colon cancer:SPENP012845
SPENP023762	ATLVCLISDFYPGAVTVAWK	Prostate cancer	Prostate cancer	Prostate	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Non-validated			Immunogenic	SPENM007001	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP023763	ALAPTWEQLALGLEHSETVK	Prostate cancer	Prostate cancer	Prostate	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Non-validated			Immunogenic	SPENM007002	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP023771	IHVYGYSMAYGPAQHAISTEK	Prostate cancer	Prostate cancer	Prostate	SPENT000950,SPENT000949	SPENG000389,SPENG001205	HSALNG0075308,NONHSAG053817.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007010	SPENO001784,SPENO004447	Lung cancer:SPENP001958;Liver cancer:SPENP004929
SPENP023773	DMDLTEVITGTLWNLSSHDSIK	Prostate cancer	Prostate cancer	Prostate	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007012	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP023774	NQSFCPTVNLDKLWTLVSEQTR	Prostate cancer	Prostate cancer	Prostate	SPENT003057	SPENG002575	NONHSAG007593.2		Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007013	SPENO003019	
SPENP023776	SGDRGETGPAGPAGPVGPVGAR	Prostate cancer	Prostate cancer	Prostate	SPENT005758	SPENG002845	COL1A1	-0.8467	Others	-2.53	0.0209	0.2053	PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007015	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP023779	GFGFVTYSCVEEVDAAMCARPHK	Prostate cancer	Prostate cancer	Prostate	SPENT000663	SPENG002730	lnc-FRG2C-16	0.8476	Others				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007018	SPENO005517	Bladder cancer:SPENP011711
SPENP023787	LNVFHWHLVDDPSFPYESFTFPELMR	Prostate cancer	Prostate cancer	Prostate	SPENT001450	SPENG000375	lnc-CELF6-1		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007026	SPENO003868	
SPENP023789	TLEEGHDFIQEFPGSPAFAALTSIAQK	Prostate cancer	Prostate cancer	Prostate	SPENT000868	SPENG001300	NONHSAG018279.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	MS	28137767	Immunogenic	SPENM007028	SPENO000920	Bladder cancer:SPENP011759;Colon cancer:SPENP001767;Lung cancer:SPENP007895
SPENP023794	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Prostate cancer	Prostate cancer	Prostate	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007033	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP024332,SPENP006770,SPENP008758
SPENP023796	ASVSELACIYSALILHDDEVTVTEDKINALIK	Prostate cancer	Prostate cancer	Prostate	SPENT000956	SPENG001785	NONHSAG017284.2		Tumor-specific				PXD013837	Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia	Q Exactive	MS1 intensity based label-free quantification method	31576646	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM007035	SPENO002111	
SPENP023902	LGELPSWILMR	Colon cancer	Colon cancer	Colon	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.3124	Others	-1.133	0.2731	0.5809	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002616	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP006393,SPENP010048
SPENP023922	TAVAHRPGAFK	Colon cancer	Colon cancer	Colon	SPENT000153	SPENG003407	NONHSAG024537.2	-0.6729	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002613	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065
SPENP023932	YMDGMTVGVVR	Colon cancer	Colon cancer	Colon	SPENT005796	SPENG001958	FBLN1		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002621	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Anal canal cancer:SPENP024515;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP023935	DKLNNLVLFDK	Colon cancer	Colon cancer	Colon	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	1.1371	Others	0.8353	0.4649	0.7278	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002586	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP026755;Leukemia:SPENP001004
SPENP023950	YQLDPTASISAK	Colon cancer	Colon cancer	Colon	SPENT000102	SPENG002045	lnc-ACTR2-11	0.0149	Others	0.0563	0.9562	0.9914	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002636	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP023956	GQAGVMGFPGPK	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.6377	Others	-0.9603	0.3544	0.6522	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002645	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137
SPENP023964	LVILANNCPALR	Colon cancer	Colon cancer	Colon	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.7073	Others	2.588	0.0164	0.1684	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002634	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP010168,SPENP010167,SPENP008202
SPENP023974	KSEIEYYAMLAK	Colon cancer	Colon cancer	Colon	SPENT000907	SPENG001277	HSALNG0067186	-0.04	Others	-0.1087	0.9158	0.983	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002646	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP010163,SPENP010164,SPENP008226
SPENP023975	VPFLVLECPNLK	Colon cancer	Colon cancer	Colon	SPENT000354	SPENG002378	HSALNG0036293	0.6176	Others	2.3172	0.035	0.2209	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002652	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP023992	ALLANALTSALR	Colon cancer	Colon cancer	Colon	SPENT002117	SPENG003627	NONHSAG037834.2		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002644	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218
SPENP024013	SGTLYSLTLYGLR	Colon cancer	Colon cancer	Colon	SPENT005914,SPENT005913	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	1.1388	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002714	SPENO002584,SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP014229
SPENP024018	TEVLSEDLLQIER	Colon cancer	Colon cancer	Colon	SPENT005992	SPENG003790	ARHGAP17	0.7644	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002696	SPENO004570	Bile duct cancer:SPENP013402;Ovary cancer:SPENP016510;Colon cancer:SPENP007097
SPENP024020	AAALVLQTIWGYK	Colon cancer	Colon cancer	Colon	SPENT005788	SPENG002233	AP001931.2	-0.0848	Others	-0.328	0.7525	0.8707	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002682	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP026642,SPENP001574
SPENP024026	VALAGLLGFGLGK	Colon cancer	Colon cancer	Colon	SPENT003237	SPENG001444	lnc-OCIAD2-2	0.6814	Others	1.6253	0.1324	0.4245	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002695	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010336,SPENP010335;Lung cancer:SPENP028394,SPENP026618;Prostate cancer:SPENP018206,SPENP012954
SPENP024034	GNSIIMLEALERV	Colon cancer	Colon cancer	Colon	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.3834	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002718	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP024039	DFSPSGIFGAFQR	Colon cancer	Colon cancer	Colon	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.3121	Others	-1.239	0.257	0.5718	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002713	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP010274
SPENP024046	SFHFSLPSSWYYR	Colon cancer	Colon cancer	Colon	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2	-0.1391	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002724	SPENO003826,SPENO004614	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327
SPENP024049	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002739	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP024050	TQSSLVPALTDFVR	Colon cancer	Colon cancer	Colon	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2	0.3935	Others	1.1478	0.2754	0.5809	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002743	SPENO003629,SPENO005960	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Bladder cancer:SPENP028779;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP012789
SPENP024056	EDSQRPGAHLTLKK	Colon cancer	Colon cancer	Colon	SPENT001717	SPENG002962	lnc-RLIM-5		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002746	SPENO000484	
SPENP024064	TPTEALASFDYIVR	Colon cancer	Colon cancer	Colon	SPENT000964,SPENT001703,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002731	SPENO003587,SPENO005877,SPENO005957	Breast cancer:SPENP022755,SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP004163,SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP007144
SPENP024072	FLFENQTPAHVYYR	Colon cancer	Colon cancer	Colon	SPENT005000	SPENG003253	NONHSAG036275.2		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002763	SPENO004275	Bile duct cancer:SPENP013419
SPENP024081	VTDATETTITISWR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.8783	Others	1.2847	0.2348	0.5339	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002759	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP024086	MVAHACNPHTLGGR	Colon cancer	Colon cancer	Colon	SPENT004996,SPENT004997,SPENT004995	SPENG003118,SPENG002615	HSALNG0123950,ILF3-DT	-0.0006	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002752	SPENO003053,SPENO003784,SPENO006162	
SPENP024106	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Colon	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3	0.3526	Others	1.1477	0.2624	0.5718	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002783	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP024107	MITGLQLSVSPFPTR	Colon cancer	Colon cancer	Colon	SPENT003264	SPENG001596	HSALNG0041188		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002788	SPENO002490	
SPENP024108	IVSGIITPIHEQWEK	Colon cancer	Colon cancer	Colon	SPENT003267	SPENG002163	NONHSAG031094.2	-0.1983	Others	-0.7586	0.4698	0.7278	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002799	SPENO005967	Colon cancer:SPENP010529,SPENP010530;Kidney cancer:SPENP015051
SPENP024109	FQEYHIQQNEALAAK	Colon cancer	Colon cancer	Colon	SPENT002396,SPENT002397,SPENT002398	SPENG002059,SPENG002201	HSALNG0101630,lnc-C14orf37-3		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	smprot_low_throughput	10552927	Immunogenic	SPENM002812	SPENO003500,SPENO005152,SPENO005986	Breast cancer:SPENP005655,SPENP005658,SPENP005654,SPENP005657,SPENP005656
SPENP024113	IREIADGLCLEVEGK	Colon cancer	Colon cancer	Colon	SPENT001715	SPENG001516	NONHSAG013412.2		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002793	SPENO003305	Colon cancer:SPENP010553,SPENP010554,SPENP006567;Bladder cancer:SPENP011515
SPENP024129	VLSVPESTPFTAVLK	Colon cancer	Colon cancer	Colon	SPENT000145,SPENT000146	SPENG001709	NONHSAG013268.2	0.6845	Others	3.6673	0.0015	0.0717	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002787	SPENO001471,SPENO001798	Skin cancer:SPENP019405,SPENP019404,SPENP019403;Colon cancer:SPENP008424;Leukemia:SPENP001198;Prostate cancer:SPENP023686
SPENP024133	MLITILGTVKPNANR	Colon cancer	Colon cancer	Colon	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2	-0.0491	Others	-0.1498	0.8822	0.969	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002772	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP007181
SPENP024149	ALAESWNAAFLESSAK	Colon cancer	Colon cancer	Colon	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002841	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP001661,SPENP010616,SPENP000394,SPENP010615,SPENP014365;Lung cancer:SPENP025534
SPENP024169	ALIGATNPADAPPGTIR	Colon cancer	Colon cancer	Colon	SPENT002171	SPENG000588	HSALNG0108933		Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002862	SPENO005632	Anal canal cancer:SPENP024812;Colon cancer:SPENP010698,SPENP000423,SPENP010697;Bladder cancer:SPENP011597;Prostate cancer:SPENP013041
SPENP024174	SAIQNLHSFDPFADASK	Colon cancer	Colon cancer	Colon	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	0.6403	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002858	SPENO000819,SPENO002753	Skin cancer:SPENP019550,SPENP019552,SPENP019551;Anal canal cancer:SPENP024827;Bladder cancer:SPENP028727
SPENP024196	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Colon	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	-0.1427	Others	-0.7748	0.4534	0.7233	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002889	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP024200	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002887	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP016150,SPENP008580
SPENP024206	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.649	Others	1.7232	0.1041	0.3992	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002891	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP024209	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.1096	Others	-0.2263	0.8229	0.9266	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002875	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP024212	DESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.2536	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002895	SPENO000942,SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP010781,SPENP007344
SPENP024214	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Colon	SPENT005801	SPENG002115	AL136361.1	0.9044	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002897	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795
SPENP024218	TGVHHYSGNNIELGTACGK	Colon cancer	Colon cancer	Colon	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	0.3607	Others	0.9458	0.3689	0.6522	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	MS	28137767	Immunogenic	SPENM002900	SPENO000929,SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841
SPENP024223	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Colon	SPENT005785	SPENG001958	FBLN1	-0.6819	Others	-2.047	0.2726	0.5809	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002911	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP006668
SPENP024225	TRLMCQVIPGAEMLDFLLR	Colon cancer	Colon cancer	Colon	SPENT005006	SPENG001273	NONHSAG040340.2	-1.07	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002901	SPENO006353	
SPENP024235	AITTGLQEYVEAVSFQHFIK	Colon cancer	Colon cancer	Colon	SPENT005933,SPENT003034,SPENT005932,SPENT005931	SPENG001725,SPENG000148	NONHSAG004620.3,TSNAX-DISC1	0.6085	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002929	SPENO001778,SPENO004607,SPENO004969,SPENO005212	Skin cancer:SPENP025389;Colon cancer:SPENP010874,SPENP010873;Kidney cancer:SPENP015184
SPENP024236	MSAAVQTTNLQVYGHSDFLF	Colon cancer	Colon cancer	Colon	SPENT005009	SPENG000819	HSALNG0044274		Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002917	SPENO000637	Colon cancer:SPENP000506;Lung cancer:SPENP025943
SPENP024238	MGTQPNYITTFFYFMIGSVR	Colon cancer	Colon cancer	Colon	SPENT005010	SPENG001364	HSALNG0004466	-0.7582	Others	-1.02	0.3221	0.649	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002918	SPENO001630	
SPENP024244	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.3759	Others	1.1529	0.2603	0.5718	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002927	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP000507
SPENP024245	MCLCNWICILVCLTFPLSFR	Colon cancer	Colon cancer	Colon	SPENT005011	SPENG002953	HSALNG0019704		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002919	SPENO004710	
SPENP024251	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-0.1564	Others	-0.4368	0.7345	0.8595	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002935	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP010929,SPENP008656
SPENP024255	HRPRPYPPNVGEEIQIGHIPR	Colon cancer	Colon cancer	Colon	SPENT005757	SPENG000084	FN1	1.3509	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002940	SPENO005245,SPENO005834	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP010920
SPENP024260	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.564	Others	2.2663	0.0341	0.2209	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002945	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP024268	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	-0.1739	Others	-0.4524	0.6551	0.8242	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002952	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP024270	DTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	-0.3196	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002953	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP001737,SPENP016253,SPENP006702
SPENP024273	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.3831	Others	0.3774	0.731	0.8595	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002966	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP024275	QGLYELSASNFELHVAQGDHFIK	Colon cancer	Colon cancer	Colon	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002962	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP027201,SPENP000554,SPENP001744
SPENP024279	ATFYTPQNPSSLAPAPLRPLEDR	Colon cancer	Colon cancer	Colon	SPENT001336	SPENG001086	HSALNG0049384		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002958	SPENO005428	Bladder cancer:SPENP017857;Kidney cancer:SPENP020611;Bile duct cancer:SPENP013627;Lung cancer:SPENP002849;Colon cancer:SPENP016277
SPENP024282	VKADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002960	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP027401;Leukemia:SPENP001373
SPENP024286	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.1961	Others	0.5807	0.5677	0.7722	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002977	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP024290	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.3817	Others	1.6119	0.151	0.4399	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated	ribosome profiling	31155234	Immunogenic	SPENM002972	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP024293	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.4664	Others	0.8012	0.4386	0.7167	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002971	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP007456
SPENP024301	MESHSVTQAGVQWHNLGSLQPLSPK	Colon cancer	Colon cancer	Colon	SPENT005017,SPENT005018	SPENG001527	lnc-SCAF4-1	-0.1441	Others	-0.4047	0.7128	0.8595	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002983	SPENO002884,SPENO004899	
SPENP024303	SYTITGLQPGTDYKIYLYTLNDNAR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	1.6437	Others	1.1235	0.343	0.652	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002987	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP027313,SPENP011036
SPENP024307	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.4468	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002989	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP024310	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9404	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002993	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729
SPENP024317	TLVGNHGSSTYYVTLGKLPKSLCQFLHK	Colon cancer	Colon cancer	Colon	SPENT005020	SPENG001319	HSALNG0080594		Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM002994	SPENO003257	
SPENP024318	LGALSGAAALGFASYGAHGAQFPDAYGK	Colon cancer	Colon cancer	Colon	SPENT000623,SPENT000622,SPENT000621,SPENT000624,SPENT000620	SPENG002150	lnc-PLSCR3-1	0.2659	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM002995	SPENO000755,SPENO001060,SPENO002067,SPENO003125,SPENO005859	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP028314,SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP024319	MSAYMPMRINQYAQDLFLYSTFNNMFAEK	Colon cancer	Colon cancer	Colon	SPENT005021	SPENG003207	HSALNG0117857		Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM003006	SPENO006267	
SPENP024322	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Colon cancer	Colon cancer	Colon	SPENT005913	SPENG001766	AL662884.2		Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM003003	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Tongue cancer:SPENP027827;Lung cancer:SPENP002933;Colon cancer:SPENP008747,SPENP016368,SPENP014668
SPENP024323	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.0724	Others	0.1413	0.8911	0.9719	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003005	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP024324	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005757,SPENT005755	SPENG000084	FN1	-0.2254	Others	-1.019	0.3381	0.6497	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003002	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP024325	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005757,SPENT005755	SPENG000084	FN1	-0.376	Others	-0.339	0.7569	0.8707	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003011	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP000611,SPENP008757
SPENP024329	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.7692	Others	2.5825	0.017	0.1684	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003012	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP024330	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003013	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP016392,SPENP027468
SPENP024331	SGDRGETGPAGPAGPVGPVGARGPAGPQGPR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1	0.4571	Others	0.5309	0.6236	0.8042	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003017	SPENO004941	Colon cancer:SPENP011159,SPENP011160;Lung cancer:SPENP002963
SPENP024332	RGYQLSDVDGVTCEDIDECALPTGGHICSYR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	0.0494	Others	0.0766	0.9426	0.983	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003014	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021997,SPENP021999;Thyroid cancer:SPENP012690,SPENP012691;Ovary cancer:SPENP016674;Bladder cancer:SPENP017957,SPENP011792;Kidney cancer:SPENP020689;Bile duct cancer:SPENP013680;Gastric cancer:SPENP009717,SPENP003710,SPENP003373,SPENP015473;Lung cancer:SPENP021998,SPENP007918,SPENP002966,SPENP004710;Prostate cancer:SPENP018546,SPENP023794;Colon cancer:SPENP011145,SPENP021996,SPENP007493,SPENP011146,SPENP014693,SPENP016397,SPENP006770,SPENP008758
SPENP024333	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Colon	SPENT005757,SPENT005755	SPENG000084	FN1	0.2543	Others	0.5162	0.6242	0.8042	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003016	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP024335	TIKPDVRSYTITGLQPGTDYKIYLYTLNDNAR	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003018	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245	
SPENP024336	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.9467	Others				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003019	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP024340	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1	-0.3403	Others	-0.4769	0.6503	0.8242	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003023	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP024344	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Colon cancer	Colon cancer	Colon	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1	-0.0657	Others	-0.0917	0.9295	0.983	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003028	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Tongue cancer:SPENP027596;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP011200
SPENP024345	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Colon cancer	Colon cancer	Colon	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM003027	SPENO001505,SPENO002211	Skin cancer:SPENP025491;Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP007924,SPENP001983;Colon cancer:SPENP011202,SPENP011201
SPENP024347	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Colon cancer	Colon cancer	Colon	SPENT005752,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1	0.7553	Others	1.2655	0.2344	0.5339	PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM003029	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216
SPENP024348	ASVGTHPVCDEGVFTHRMALGRASTMPPANGQIWNCSAGT	Colon cancer	Colon cancer	Colon	SPENT005022,SPENT005023	SPENG002368	HSALNG0118207		Tumor-specific				PXD015015	Down-regulation of collagen hydroxylation in colorectal liver metastasis	Orbitrap Fusion	Label free		Non-validated			Immunogenic	SPENM003031	SPENO000376,SPENO003175	
SPENP024465	LEFESLEALK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002054,SPENT002053	SPENG002435	HSALNG0025489		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010567	SPENO002808,SPENO003939	
SPENP024515	YMDGMTVGVVR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005796	SPENG001958	FBLN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010581	SPENO003698	Breast cancer:SPENP022460,SPENP022461;Ovary cancer:SPENP016480;Bladder cancer:SPENP017281;Kidney cancer:SPENP014895,SPENP020026;Gastric cancer:SPENP003501,SPENP009460,SPENP015294,SPENP003120;Lung cancer:SPENP007578,SPENP003970,SPENP002273;Prostate cancer:SPENP023572;Colon cancer:SPENP010023,SPENP023932,SPENP008189,SPENP006984,SPENP010024,SPENP000145,SPENP015753
SPENP024517	TDSTFNQVVLK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002071	SPENG001428	lnc-CPHXL-5		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010611	SPENO004801	Bladder cancer:SPENP017275;Kidney cancer:SPENP019976;Lung cancer:SPENP026072;Colon cancer:SPENP006972,SPENP010062,SPENP010061
SPENP024521	DKLNNLVLFDK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010610	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP024533	ALSEYLAVFAR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002069	SPENG001770	NONHSAG021787.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010607	SPENO002442	Bladder cancer:SPENP017255
SPENP024544	RFVNVVPTFGK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000286,SPENT000287	SPENG000006	lnc-SYVN1-1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010608	SPENO000042,SPENO005582	Skin cancer:SPENP018998,SPENP018999,SPENP019000;Bladder cancer:SPENP017215;Kidney cancer:SPENP020042;Bile duct cancer:SPENP013299;Lung cancer:SPENP002252,SPENP003897,SPENP007581;Prostate cancer:SPENP018134;Colon cancer:SPENP015717,SPENP006409,SPENP014099
SPENP024566	YQLDPTASISAK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000102	SPENG002045	lnc-ACTR2-11		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010637	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP024569	NLGMVMYVFTYK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002099	SPENG001523	HSALNG0070346		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010665	SPENO005547	
SPENP024571	MMLMSTATAFYR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000416,SPENT001710,SPENT001709	SPENG000832	NONHSAG010597.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010655	SPENO002231,SPENO002917,SPENO003714	Breast cancer:SPENP008840;Lung cancer:SPENP003993;Kidney cancer:SPENP014943
SPENP024594	VPFLVLECPNLK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000354	SPENG002378	HSALNG0036293		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010656	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP024596	QLGEANEEFALR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001183,SPENT001719,SPENT001182	SPENG000169	lnc-DQX1-1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010672	SPENO000751,SPENO001535,SPENO004354	Bladder cancer:SPENP011366,SPENP017394;Colon cancer:SPENP008207;Lung cancer:SPENP004013
SPENP024609	GLSLSPACGLGK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002105,SPENT002107,SPENT002106	SPENG001033,SPENG003344	HSALNG0008769,lnc-NPHS2-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010688	SPENO003179,SPENO005190,SPENO005541	
SPENP024613	GQAGVMGFPGPK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005758	SPENG002845	COL1A1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010686	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP024621	ALLANALTSALR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002117	SPENG003627	NONHSAG037834.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010710	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Skin cancer:SPENP025168;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP024640	IASGLGLAWIVGR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000591,SPENT000592	SPENG002721	HSALNG0008146		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010720	SPENO001126,SPENO004752	Bile duct cancer:SPENP013396;Lung cancer:SPENP026552
SPENP024641	QIESLNEELAYMK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002127	SPENG000706	NONHSAG021775.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010747	SPENO001773	
SPENP024642	AAALVLQTIWGYK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005788	SPENG002233	AP001931.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010733	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP024645	YEEIIKEVSTYIK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002126	SPENG003586	lnc-FOXL2NB-4		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010742	SPENO001634	Breast cancer:SPENP008868;Skin cancer:SPENP025217;Kidney cancer:SPENP020227;Bile duct cancer:SPENP013410
SPENP024649	VRDKLNNLVLFDK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010752	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP023352;Tongue cancer:SPENP028159;Lung cancer:SPENP002371;Prostate cancer:SPENP018239;Colon cancer:SPENP027424
SPENP024665	HVISYSLSPFEQR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010722	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP024668	TSNLLLSHAGILK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000136,SPENT000135,SPENT000137	SPENG000848	lnc-CDK11A-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM010761	SPENO002156,SPENO003659,SPENO006064	Bladder cancer:SPENP017399;Colon cancer:SPENP008305,SPENP012777,SPENP027360;Lung cancer:SPENP004077
SPENP024675	GNSIIMLEALERV	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010762	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP024684	GDEAEAEPEPELA	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002069	SPENG001770	NONHSAG021787.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010723	SPENO002442	
SPENP024685	VTDATETTITISWR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010784	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP024686	QYNVGPSVSKYPLR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010805	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP024704	SKESVPEFPLSPPK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001112	SPENG003381	lnc-PAQR7-1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010778	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Skin cancer:SPENP025227;Bladder cancer:SPENP011440;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP024713	TQSQTISTYFYQLF	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002137	SPENG001043	HSALNG0075975		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010791	SPENO006251	
SPENP024721	SLPSPSLCFSILSK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002134,SPENT002133,SPENT002135	SPENG002273	MFSD4B		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010782	SPENO001212,SPENO002912,SPENO004299	
SPENP024723	VLYAYGYYTGEPSK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000591,SPENT000592,SPENT000590	SPENG002721,SPENG002503	HSALNG0008146,NONHSAG003338.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010781	SPENO000007,SPENO001126,SPENO004752	
SPENP024733	LSSAGPSSGPWMHR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002149,SPENT002150,SPENT002145,SPENT002148,SPENT002147,SPENT005804,SPENT002146	SPENG000555,SPENG000348	HSALNG0055531,AC188617.1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010812	SPENO000033,SPENO000801,SPENO001753,SPENO002378,SPENO002903,SPENO005453,SPENO005951	
SPENP024753	DREGFFTNGLTLGAK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000938,SPENT000937,SPENT000932,SPENT000934,SPENT000931,SPENT000933,SPENT000935,SPENT000936	SPENG003468,SPENG000021	lnc-ANKUB1-2,HSALNG0029760		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010838	SPENO000345,SPENO001253,SPENO001839,SPENO002347,SPENO002685,SPENO003393,SPENO004533,SPENO005774	Kidney cancer:SPENP015068,SPENP020332;Lung cancer:SPENP004249;Prostate cancer:SPENP018284;Colon cancer:SPENP006579
SPENP024763	YAASSYLSLTPEQWK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010853	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP024768	MLITILGTVKPNANR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010851	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP024773	VLYAYGYYTGEPSKR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000591,SPENT000592,SPENT000590	SPENG002721,SPENG002503	HSALNG0008146,NONHSAG003338.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010822	SPENO000007,SPENO001126,SPENO004752	Bile duct cancer:SPENP013469
SPENP024782	GSGQGDSLYPVGYLDK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000814	SPENG001638	HSALNG0104943		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010877	SPENO005134	Kidney cancer:SPENP020374;Lung cancer:SPENP025746;Prostate cancer:SPENP018335;Colon cancer:SPENP001653,SPENP008500,SPENP014345,SPENP016058
SPENP024784	AGYEYVSPEQLAGFDK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005924	SPENG003747	HSALNG0013722		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010889	SPENO004898	Colon cancer:SPENP007234;Bladder cancer:SPENP028447,SPENP017634
SPENP024790	ALAESWNAAFLESSAK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000685,SPENT000682,SPENT000800,SPENT000683,SPENT000684,SPENT000681	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010880	SPENO002251,SPENO002860,SPENO002957,SPENO003109,SPENO004435,SPENO006217	Colon cancer:SPENP007254,SPENP024149,SPENP001661,SPENP010616,SPENP000394,SPENP010615,SPENP014365;Lung cancer:SPENP025534
SPENP024802	EPVGEGEALLGMDLLR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002161,SPENT002162	SPENG000408	lnc-SP6-3		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010860	SPENO004910,SPENO004926	
SPENP024812	ALIGATNPADAPPGTIR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002171	SPENG000588	HSALNG0108933		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010891	SPENO005632	Colon cancer:SPENP024169,SPENP010698,SPENP000423,SPENP010697;Bladder cancer:SPENP011597;Prostate cancer:SPENP013041
SPENP024813	NEDGTWLTPNEFEVEGK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002181	SPENG003400	lnc-SLC16A14-3		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010917	SPENO001222	
SPENP024821	TPIGSFLGSLSLLPATK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000014	SPENG003410	ACAT1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010901	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP024826	GADPGMPEPTVLSLLWG	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000828	SPENG000141	HSALNG0056619		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010913	SPENO004991	Colon cancer:SPENP001668,SPENP007309,SPENP014405,SPENP000410;Lung cancer:SPENP025703;Kidney cancer:SPENP020455
SPENP024827	SAIQNLHSFDPFADASK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010910	SPENO000819,SPENO002753	Skin cancer:SPENP019550,SPENP019552,SPENP019551;Colon cancer:SPENP024174;Bladder cancer:SPENP028727
SPENP024828	DVAEAKPELSLLGDGDH	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002175	SPENG000523	NONHSAG026963.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010907	SPENO003701	Lung cancer:SPENP025608
SPENP024845	EAALSYGFYGCHCGVGGR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002189,SPENT002190,SPENT002191	SPENG000309,SPENG002571	HSALNG0001408,lnc-PLA2G2E-1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010937	SPENO000180,SPENO002012,SPENO006290	Colon cancer:SPENP007354,SPENP014449
SPENP024846	GETGPAGPAGPVGPVGAR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005758	SPENG002845	COL1A1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010932	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP024848	VSPHSGVVALTKPVPEPR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005785	SPENG001958	FBLN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010941	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP024851	DIQMTQSPSSLSASVGDR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010927	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP024855	STDTGVSLPSYEEDQGSK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	MS	28137767	Immunogenic	SPENM010939	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP024864	PQTDTAAILETSPWSNQGR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002198,SPENT002199	SPENG000174,SPENG003609	lnc-AP3M2-86,HSALNG0064850		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010954	SPENO002226,SPENO005579	Colon cancer:SPENP007376
SPENP024867	VQASLAANTFTITGHTEAK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005801	SPENG002115	AL136361.1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010957	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP024876	RPHETGGYMLECVCLGNGK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010947	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP024888	FCGDLDCPDWVLAEISTLAK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002210,SPENT002211,SPENT002208,SPENT002207,SPENT002209	SPENG001443	HSALNG0107277		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010970	SPENO001585,SPENO002078,SPENO003211,SPENO003669,SPENO005108	Colon cancer:SPENP000509
SPENP024889	ATLVCLISDFYPGAVTVAWK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010964	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP024890	YIMVPSGNMGVFDPTEIHNR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010975	SPENO003817,SPENO005456	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP024896	ALAPTWEQLALGLEHSETVK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010981	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP024902	TNTNVNCPIECFMPLDVQADR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT000578,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010987	SPENO001233,SPENO001257,SPENO002125,SPENO002376,SPENO002391,SPENO005245,SPENO005834	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP024904	TPYQFTTLGQATAEFSKPLGR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002056,SPENT002216	SPENG001417	lnc-NECTIN1-4		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM010990	SPENO002683,SPENO003894	Skin cancer:SPENP025411,SPENP019658,SPENP019660,SPENP019659;Bladder cancer:SPENP017815
SPENP024912	LRECDGLVDALIFIVQAEIGQK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005788	SPENG002233	AP001931.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011004	SPENO005858	Colon cancer:SPENP014582,SPENP016259;Lung cancer:SPENP002823
SPENP024914	SGDRGETGPAGPAGPVGPVGAR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005758	SPENG002845	COL1A1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011005	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP024915	DMDLTEVITGTLWNLSSHDSIK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005788	SPENG002233	AP001931.2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011006	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP024916	TETITGFQVDAVPANGQTPIQR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011003	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP024918	DTLTSRPAQGVVTTLENVSPPR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011002	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP024922	AAGMYLEHYLDSIENLPFELQR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002218,SPENT002217	SPENG000236,SPENG002804	HSALNG0088886,lnc-ACRBP-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM010997	SPENO003471,SPENO004291	Colon cancer:SPENP014564,SPENP016248
SPENP024931	STATISGLKPGVDYTITVYAVTGR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011020	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP024934	TKTETITGFQVDAVPANGQTPIQR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011016	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP024935	DLEVVAATPTSLLISWDAPAVTVR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011015	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP024939	MGAPESGLAEYLFDKHTLGESDNES	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002221	SPENG002850	lnc-PKHD1-6		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM011029	SPENO005552	Kidney cancer:SPENP020635
SPENP024942	DLVHTEGQLQNEEIVAHDGSATYLR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002082	SPENG002114	lnc-YIPF1-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011027	SPENO000824	Colon cancer:SPENP006734,SPENP000577,SPENP007463,SPENP014621;Lung cancer:SPENP025597
SPENP024948	GETGPAGPAGPVGPVGARGPAGPQGPR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005758	SPENG002845	COL1A1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011035	SPENO004941	Skin cancer:SPENP019712,SPENP019714,SPENP019713
SPENP024949	ELTTENSGKQEHVTVQGEAAIVICLNR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002228	SPENG000201	lnc-EPHA1-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM011038	SPENO002247	
SPENP024950	TGLDSPTGIDFSDITANSFTVHWIAPR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011037	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP024951	IVAFADAAVEPIDFPIAPVYAASMVLK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000014	SPENG003410	ACAT1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011036	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP024953	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011041	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP024956	STNLLAAETASLEEQLQGWGEVMLMADK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011042	SPENO000222,SPENO000600,SPENO001518,SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Lung cancer:SPENP026058;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP024958	ASADELTFHEFEEATNLLADTPDAATTSR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT001420	SPENG000627	lnc-TMED1-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011045	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Tongue cancer:SPENP027525;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP024959	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011044	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP024961	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011048	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Skin cancer:SPENP025474;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP024963	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Non-validated			Immunogenic	SPENM011050	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP024964	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011051	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP024966	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011053	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP024969	EATPENDPNYFMNEPTFYTSDGVPFTAADPDYQEK	Anal canal cancer	Anal canal cancer	Anal canal	SPENT000390	SPENG002704	lnc-TRIM16L-2		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011055	SPENO003522	Colon cancer:SPENP008771,SPENP007502,SPENP006777,SPENP000627
SPENP024970	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Anal canal cancer	Anal canal cancer	Anal canal	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD004859	Anal Canal Cancer : subclassification	Q Exactive	TIC	27976366	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM011056	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP025081	LGELPSWILMR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006040	SPENO004812,SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP025097	SEIEYYAMLAK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000907	SPENG001277	HSALNG0067186		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006024	SPENO000929	Breast cancer:SPENP022399,SPENP022398;Colon cancer:SPENP010027,SPENP008174,SPENP010028;Bladder cancer:SPENP028732
SPENP025112	SSSTLPVPVFK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001693,SPENT001694	SPENG000680	NONHSAG038276.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006021	SPENO002677,SPENO004744	Lung cancer:SPENP026054
SPENP025114	EKIPLHVFSPK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001968	SPENG003334	NONHSAG038451.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006054	SPENO005054	
SPENP025119	DKLNNLVLFDK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000022,SPENT000021,SPENT000043,SPENT000042	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006049	SPENO003205,SPENO004284,SPENO005025,SPENO005502	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP025131	GQAGVMGFPGPK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006096	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP025133	VVLEGPAPWGFR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002976,SPENT002977	SPENG001612,SPENG001042	lnc-PDLIM7-3,NONHSAG042359.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006074	SPENO003592,SPENO003881	Skin cancer:SPENP019123,SPENP019122,SPENP019121;Lung cancer:SPENP028414
SPENP025136	YQLDPTASISAK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000102	SPENG002045	lnc-ACTR2-11		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006106	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP025137	VPFLVLECPNLK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000354	SPENG002378	HSALNG0036293		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006083	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP025140	LVILANNCPALR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000906,SPENT000907,SPENT000908,SPENT000909	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006088	SPENO000929,SPENO002667,SPENO003136,SPENO006213	Breast cancer:SPENP022475,SPENP022474;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP025143	KSEIEYYAMLAK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000907	SPENG001277	HSALNG0067186		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006079	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Bladder cancer:SPENP011343;Lung cancer:SPENP007606,SPENP025818;Colon cancer:SPENP023974,SPENP010163,SPENP010164,SPENP008226
SPENP025159	FLEEYLSSTPQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002760	SPENG002531	NONHSAG014457.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006097	SPENO003138	Kidney cancer:SPENP014941;Bile duct cancer:SPENP013357;Tongue cancer:SPENP027660;Lung cancer:SPENP007614,SPENP028269,SPENP026519;Prostate cancer:SPENP012927
SPENP025168	ALLANALTSALR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002117	SPENG003627	NONHSAG037834.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006091	SPENO005301	Breast cancer:SPENP022500,SPENP005364,SPENP005367,SPENP005368,SPENP022501,SPENP005366,SPENP005365;Anal canal cancer:SPENP024621;Prostate cancer:SPENP012938,SPENP011959;Colon cancer:SPENP010217,SPENP010218,SPENP023992
SPENP025171	DFSPSGIFGAFQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006154	SPENO004812,SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP025179	SFHFSLPSSWYYR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006152	SPENO003826,SPENO004614	Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Tongue cancer:SPENP028035;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP025184	HVISYSLSPFEQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001666	SPENG002113	HSALNG0044883		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006113	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059,SPENP025769;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP025207	TTAAMWALQTVEK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006141	SPENO000218,SPENO001883	Bladder cancer:SPENP011386;Kidney cancer:SPENP014973;Bile duct cancer:SPENP013386;Lung cancer:SPENP004106;Prostate cancer:SPENP018210;Colon cancer:SPENP010319,SPENP010320,SPENP000267,SPENP007089,SPENP006488
SPENP025208	YKWCEYGLTFTEK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000102	SPENG002045	lnc-ACTR2-11		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006115	SPENO000884	Lung cancer:SPENP002422;Kidney cancer:SPENP020206;Prostate cancer:SPENP018224
SPENP025212	GNSIIMLEALERV	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006136	SPENO002369,SPENO002546,SPENO002613	Breast cancer:SPENP022629,SPENP022628;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP025213	AAALVLQTIWGYK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005788	SPENG002233	AP001931.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006126	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP025217	YEEIIKEVSTYIK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002126	SPENG003586	lnc-FOXL2NB-4		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006117	SPENO001634	Breast cancer:SPENP008868;Kidney cancer:SPENP020227;Bile duct cancer:SPENP013410;Anal canal cancer:SPENP024645
SPENP025220	YAMVYGYNAAYNR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000924,SPENT000922,SPENT000921,SPENT000923	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006138	SPENO001107,SPENO003967,SPENO005596,SPENO006048	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP028422,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP025227	SKESVPEFPLSPPK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001112	SPENG003381	lnc-PAQR7-1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006175	SPENO000291	Breast cancer:SPENP022731,SPENP022730;Bladder cancer:SPENP011440;Anal canal cancer:SPENP024704;Lung cancer:SPENP002487;Colon cancer:SPENP010410,SPENP008365,SPENP007163,SPENP010409,SPENP006528
SPENP025235	YEEIIKEVSTYIKK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002126	SPENG003586	lnc-FOXL2NB-4		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006181	SPENO001634	
SPENP025236	QYNVGPSVSKYPLR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006193	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP021099,SPENP021097;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP025261	MLITILGTVKPNANR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000023,SPENT000025,SPENT000026,SPENT000309,SPENT000024	SPENG001332	NONHSAG015030.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006199	SPENO000887,SPENO001262,SPENO001624,SPENO005116,SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP025282	TTAAMWALQTVEKER	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000471,SPENT000472	SPENG002380,SPENG002461	lnc-EPOR-1,NONHSAG024829.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006204	SPENO000218,SPENO001883	Lung cancer:SPENP004252;Bladder cancer:SPENP011501;Leukemia:SPENP001202
SPENP025290	YAASSYLSLTPEQWK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006224	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP025298	AAALVLQTIWGYKELR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005788	SPENG002233	AP001931.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006240	SPENO005858	Colon cancer:SPENP026643;Lung cancer:SPENP002589
SPENP025308	CDPWPGSTGAAVHCSR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT003028	SPENG002818	HSALNG0065299		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006256	SPENO003328	
SPENP025312	AQQEFAAGVFSNPAVR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002814,SPENT003026	SPENG001802	NONHSAG003062.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006242	SPENO003986,SPENO006093	Breast cancer:SPENP023399;Colon cancer:SPENP010595,SPENP010596;Kidney cancer:SPENP015087
SPENP025333	TPIGSFLGSLSLLPATK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000014	SPENG003410	ACAT1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006278	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP025351	STDTGVSLPSYEEDQGSK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	MS	28137767	Immunogenic	SPENM006288	SPENO000724,SPENO001854	Skin cancer:SPENP019580,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP025356	DVEPEDPMFLMDPFAIHR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002523	SPENG000400	lnc-PIANP-3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006307	SPENO003716	
SPENP025357	DIQMTQSPSSLSASVGDR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006302	SPENO002145,SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP025360	YAASSYLSLTPEQWKSHR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000202,SPENT000080,SPENT000201,SPENT000081,SPENT000204	SPENG000666	NONHSAG033390.3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated	MS	28137767	Immunogenic	SPENM006296	SPENO000395,SPENO003620,SPENO004364,SPENO004816,SPENO005374	Bile duct cancer:SPENP013562;Gastric cancer:SPENP015380;Kidney cancer:SPENP020459
SPENP025365	VSPHSGVVALTKPVPEPR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005785	SPENG001958	FBLN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006290	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP025368	GETGPAGPAGPVGPVGAR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006303	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP025371	VQASLAANTFTITGHTEAK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005801	SPENG002115	AL136361.1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006312	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP025382	KVSPHSGVVALTKPVPEPR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005785	SPENG001958	FBLN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006316	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP025389	AITTGLQEYVEAVSFQHFIK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005933,SPENT003034,SPENT005932,SPENT005931	SPENG001725,SPENG000148	NONHSAG004620.3,TSNAX-DISC1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006340	SPENO001778,SPENO004607,SPENO004969,SPENO005212	Colon cancer:SPENP010874,SPENP024235,SPENP010873;Kidney cancer:SPENP015184
SPENP025391	ALAPTWEQLALGLEHSETVK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006339	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP025395	YIMVPSGNMGVFDPTEIHNR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006325	SPENO003817,SPENO005456	Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP025399	YFILPDSLPLDTLLVDVEPK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000928	SPENG002213	HSALNG0120314		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006324	SPENO000238	Bile duct cancer:SPENP013597;Tongue cancer:SPENP028202;Lung cancer:SPENP026636,SPENP026177,SPENP001946
SPENP025405	ISQAEEEDQQLLGHLLLVAK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002815	SPENG000837	lnc-HINT2-1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006331	SPENO001580	Breast cancer:SPENP008997;Bladder cancer:SPENP028609;Lung cancer:SPENP028299,SPENP007835;Prostate cancer:SPENP023755;Colon cancer:SPENP012845
SPENP025406	ATLVCLISDFYPGAVTVAWK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006344	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Breast cancer:SPENP023057,SPENP023056;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP025410	ADRDESSPYAAMLAAQDVAQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006349	SPENO000942,SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP025411	TPYQFTTLGQATAEFSKPLGR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002056,SPENT002216	SPENG001417	lnc-NECTIN1-4		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006351	SPENO002683,SPENO003894	Skin cancer:SPENP019658,SPENP019660,SPENP019659;Anal canal cancer:SPENP024904;Bladder cancer:SPENP017815
SPENP025422	SASVVSVISRFLEEYLSSTPQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002760	SPENG002531	NONHSAG014457.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006357	SPENO003138	
SPENP025425	GVGGKLPNFGFVVFDDSEPVQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT003017	SPENG001913	NONHSAG038227.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006359	SPENO005668	
SPENP025426	SGDRGETGPAGPAGPVGPVGAR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005758	SPENG002845	COL1A1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006364	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP025431	VKADRDESSPYAAMLAAQDVAQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006368	SPENO000942,SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282,SPENP027401;Leukemia:SPENP001373
SPENP025434	QGLYELSASNFELHVAQGDHFIK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006372	SPENO005833	Breast cancer:SPENP009031;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP025436	YGVAARPGFGLSPIFPGGACLGK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001282,SPENT005791	SPENG001189,SPENG001044	NONHSAG047951.2,ELN		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006367	SPENO000856,SPENO001279,SPENO002475,SPENO006039	Lung cancer:SPENP002851,SPENP004630
SPENP025438	STATISGLKPGVDYTITVYAVTGR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006382	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP025441	DLEVVAATPTSLLISWDAPAVTVR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006386	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP025444	LSVNMVPFPRLHFFMPGFAPLTSR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT002029	SPENG001901	HSALNG0141336		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006385	SPENO004586	
SPENP025445	AAQAQGQSCEYSLMVGYQCGQVFR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated	ribosome profiling	31155234	Immunogenic	SPENM006380	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021753,SPENP021755;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP025446	TKTETITGFQVDAVPANGQTPIQR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006381	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP025453	TQFLPPNLLALFAPRDPIPYLPPLEK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000899	SPENG001988	NONHSAG026220.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006391	SPENO004425	
SPENP025459	IVAFADAAVEPIDFPIAPVYAASMVLK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000014	SPENG003410	ACAT1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006398	SPENO003940	Breast cancer:SPENP009057;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP025460	TGLDSPTGIDFSDITANSFTVHWIAPR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006394	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP025469	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006408	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP025474	GYQLSDVDGVTCEDIDECALPTGGHICSYR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005795,SPENT005794,SPENT005785,SPENT005796	SPENG001958	FBLN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006410	SPENO000501,SPENO003429,SPENO003698,SPENO005034	Breast cancer:SPENP021949,SPENP021951;Thyroid cancer:SPENP012684,SPENP012685;Ovary cancer:SPENP016673;Bladder cancer:SPENP011785,SPENP017952;Kidney cancer:SPENP020679;Bile duct cancer:SPENP013673;Anal canal cancer:SPENP024961;Gastric cancer:SPENP009714,SPENP015466,SPENP003370,SPENP003709;Lung cancer:SPENP004707,SPENP002958,SPENP007914,SPENP021950;Prostate cancer:SPENP018543,SPENP009327;Colon cancer:SPENP016381,SPENP024329,SPENP007492,SPENP008755,SPENP006768,SPENP011140,SPENP014681,SPENP021948,SPENP011139,SPENP000609
SPENP025477	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005753,SPENT005757,SPENT005755	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006418	SPENO002125,SPENO005245,SPENO005834	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Tongue cancer:SPENP027831;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP025481	TPVVTGTGPNFSLGELQGHLAYDLNPASTGLR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT001829	SPENG001187	NONHSAG024474.2		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006419	SPENO005220	Colon cancer:SPENP014696
SPENP025482	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006420	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP025485	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006423	SPENO000819,SPENO002753	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP027236,SPENP011168
SPENP025488	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754,SPENT005793	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006427	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005410,SPENO005834	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP025490	ILCPGGEGFRPNPITVILEDIDECQELPGLCQGGK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005892	SPENG001317	HSALNG0105758		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006428	SPENO000957	Bladder cancer:SPENP011808,SPENP017982;Colon cancer:SPENP008769,SPENP011193,SPENP014722,SPENP011194,SPENP016417;Lung cancer:SPENP002996
SPENP025491	GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005797,SPENT005805	SPENG002649	FGA		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated			Immunogenic	SPENM006429	SPENO001505,SPENO002211	Bladder cancer:SPENP011811;Bile duct cancer:SPENP013696;Lung cancer:SPENP004723,SPENP007924,SPENP001983;Colon cancer:SPENP024345,SPENP011202,SPENP011201
SPENP025494	AAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT000202,SPENT000083,SPENT000080,SPENT000084,SPENT000201,SPENT000081,SPENT000079,SPENT000204,SPENT000203,SPENT000082	SPENG000666	NONHSAG033390.3		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Non-validated	MS	28137767	Immunogenic	SPENM006432	SPENO000204,SPENO000395,SPENO003223,SPENO003278,SPENO003620,SPENO004364,SPENO004816,SPENO005040,SPENO005374,SPENO005507	Gastric cancer:SPENP015488;Colon cancer:SPENP011209,SPENP011210,SPENP007504;Bladder cancer:SPENP011817
SPENP025495	YGAAGLGGVLGGAGQFPLGGVAARPGFGLSPIFPGGACLGK	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005792,SPENT005786	SPENG001189	ELN		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006433	SPENO001289,SPENO003914	Lung cancer:SPENP003012
SPENP025496	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Skin cancer	Skin squamous cell carcinoma	Skin	SPENT005752,SPENT005753,SPENT005756,SPENT005755,SPENT005757,SPENT005754	SPENG000084	FN1		Others				PXD006914	Proteomics study of skin tissues from RDEB cSCC, low-risk cSCC and metastasizing cSCC	Q Exactive	Label free	29158163	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM006434	SPENO001233,SPENO001257,SPENO002125,SPENO002391,SPENO005245,SPENO005834	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP025512	ACLDYPVTSVLPPASLCK	Lung cancer	Large cell lung cancer	Lung	SPENT002507	SPENG002379	NONHSAG033050.2	0.5767	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022082	SPENO004482	Lung cancer:SPENP028228;Colon cancer:SPENP007326,SPENP006646;Bladder cancer:SPENP017716,SPENP011635,SPENP028438;Prostate cancer:SPENP009279
SPENP025515	ADRDESSPYAAMLAAQDVAQR	Lung cancer	Large cell lung cancer	Lung	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	1.3587	Up-regulated in tumors	6.7331	1.44e-08	3.87e-06	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022085	SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP025534	ALAESWNAAFLESSAK	Lung cancer	Large cell lung cancer	Lung	SPENT000681,SPENT000800,SPENT000684,SPENT000683,SPENT000685,SPENT000682	SPENG000526,SPENG001337,SPENG001701,SPENG003538,SPENG001276,SPENG000233	NONHSAG049179.2,lnc-GPRIN2-2,lnc-CRYGN-3,lnc-NPY4R2-569,HSALNG0077705,HSALNG0077731		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022104	SPENO002957	Anal canal cancer:SPENP024790;Colon cancer:SPENP007254,SPENP024149,SPENP001661,SPENP010616,SPENP000394,SPENP010615,SPENP014365
SPENP025535	ALAPTWEQLALGLEHSETVK	Lung cancer	Large cell lung cancer	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.7514	Others	0.9518	0.3507	0.5485	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022105	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP025536	ALCDLGPWVK	Lung cancer	Large cell lung cancer	Lung	SPENT006719,SPENT006274,SPENT006698	SPENG003942,SPENG003978	lnc-ZNF273-4,NONHSAG047803.3	-0.3531	Others	-1.176	0.2841	0.4898	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022106	SPENO006561,SPENO006627,SPENO007117	
SPENP025540	APSEEDSLSSVPISPYKDEPWK	Lung cancer	Large cell lung cancer	Lung	SPENT000211,SPENT000210	SPENG002300,SPENG000190	NONHSAG045884.2,NONHSAG043417.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022110	SPENO002003	
SPENP025550	ATLVCLISDFYPGAVTVAWK	Lung cancer	Large cell lung cancer	Lung	SPENT000080,SPENT000084,SPENT000203,SPENT000204,SPENT000079,SPENT000202,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	-2.216	Others	-0.9979	0.3919	0.5735	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022120	SPENO004816	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP028241;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP025575	DESSPYAAMLAAQDVAQR	Lung cancer	Large cell lung cancer	Lung	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.599	Others	1.6737	0.109	0.2875	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022145	SPENO003536	Breast cancer:SPENP022995,SPENP022994;Ovary cancer:SPENP029480;Bile duct cancer:SPENP013558;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP010781,SPENP007344
SPENP025576	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Lung cancer	Large cell lung cancer	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.6381	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022146	SPENO005833	Bladder cancer:SPENP028478,SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP025577	DFSPSGIFGAFQR	Lung cancer	Large cell lung cancer	Lung	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	0.3697	Others	1.1322	0.2668	0.4722	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022147	SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP025578	DFYPAIADLFAESLQCK	Lung cancer	Large cell lung cancer	Lung	SPENT002069	SPENG001770	NONHSAG021787.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022148	SPENO002442	Bladder cancer:SPENP017698
SPENP025585	DIQMTQSPSSLSASVGDR	Lung cancer	Large cell lung cancer	Lung	SPENT000841,SPENT000840	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	-0.2264	Others	-0.5492	0.5851	0.753	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022155	SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP025588	DKLNNLVLFDK	Lung cancer	Large cell lung cancer	Lung	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022158	SPENO003205	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP025589	DLEVVAATPTSLLISWDAPAVTVR	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.459	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022159	SPENO001233	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP025590	DLFTASNDPLLWR	Lung cancer	Large cell lung cancer	Lung	SPENT001218	SPENG003441	NONHSAG033755.2		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022160	SPENO005358	Lung cancer:SPENP002400;Kidney cancer:SPENP020168;Prostate cancer:SPENP012012
SPENP025596	DLSLGGVLLFPVDDK	Lung cancer	Large cell lung cancer	Lung	SPENT002176	SPENG002576	AC242426.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022166	SPENO002839	Bladder cancer:SPENP028494
SPENP025597	DLVHTEGQLQNEEIVAHDGSATYLR	Lung cancer	Large cell lung cancer	Lung	SPENT002082	SPENG002114	lnc-YIPF1-2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022167	SPENO000824	Anal canal cancer:SPENP024942;Colon cancer:SPENP006734,SPENP000577,SPENP007463,SPENP014621
SPENP025598	DMDLTEVITGTLWNLSSHDSIK	Lung cancer	Large cell lung cancer	Lung	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022168	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP025602	DRLPFPLLLLLPEGPLK	Lung cancer	Large cell lung cancer	Lung	SPENT006050	SPENG003793	HSALNG0016439		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022172	SPENO000131	Colon cancer:SPENP000435
SPENP025607	DTLTSRPAQGVVTTLENVSPPR	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.3136	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022177	SPENO001233	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP025608	DVAEAKPELSLLGDGDH	Lung cancer	Large cell lung cancer	Lung	SPENT002175	SPENG000523	NONHSAG026963.2	-0.0124	Others	-0.0378	0.9707	0.9966	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022178	SPENO003701	Anal canal cancer:SPENP024828
SPENP025618	EEAVQQMADALQYLQK	Lung cancer	Large cell lung cancer	Lung	SPENT005999,SPENT005978,SPENT006051,SPENT006033,SPENT006011,SPENT006053,SPENT005958,SPENT006073,SPENT005961,SPENT005987,SPENT005985,SPENT006104,SPENT006074,SPENT006092,SPENT006048,SPENT005965	SPENG003792,SPENG003766,SPENG003798,SPENG003847,SPENG003783,SPENG003856,SPENG003757,SPENG003815	lnc-WASHC1-4,WASH3P,NONHSAG000002.2,lnc-PLPP2-5,lnc-OR4F29-11,AL627309.1,lnc-OR4F15-4,lnc-SLC6A12-12		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	SmProt_literiture_mining	28137767	Immunogenic	SPENM022188	SPENO003821	Colon cancer:SPENP000395
SPENP025624	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Lung cancer	Large cell lung cancer	Lung	SPENT005913	SPENG001766	AL662884.2		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022194	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Tongue cancer:SPENP027609;Lung cancer:SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP025626	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-0.1745	Others	-0.2982	0.7723	0.8812	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022196	SPENO001233	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP025633	EGSLPLQYEWQK	Lung cancer	Large cell lung cancer	Lung	SPENT006219	SPENG004073	FP475955.3		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022203	SPENO006562	
SPENP025656	ESQVSILQSLFGER	Lung cancer	Large cell lung cancer	Lung	SPENT006382,SPENT006616	SPENG004051,SPENG004139	lnc-RELN-3,HSALNG0060261		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022226	SPENO006566,SPENO006759	
SPENP025658	ETPLPIDPSMFPTWPAK	Lung cancer	Large cell lung cancer	Lung	SPENT000135,SPENT000139,SPENT000137,SPENT000136,SPENT000138	SPENG000718,SPENG000848	AL031282.2,lnc-CDK11A-2	0.7416	Others	1.356	0.1939	0.3941	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM022228	SPENO003659	Bladder cancer:SPENP011592,SPENP017665;Colon cancer:SPENP008539,SPENP000431;Lung cancer:SPENP002667;Kidney cancer:SPENP020456
SPENP025659	ETSVTPSNLWGGQGLLGVSIR	Lung cancer	Large cell lung cancer	Lung	SPENT000615	SPENG001618	NONHSAG029796.2	0.9405	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022229	SPENO003428	Breast cancer:SPENP023091,SPENP023090;Colon cancer:SPENP001727,SPENP000530,SPENP006694;Lung cancer:SPENP028262;Prostate cancer:SPENP012117
SPENP025663	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-0.1049	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022233	SPENO001233	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP025685	FLTDLFAQLTDEATDEEK	Lung cancer	Large cell lung cancer	Lung	SPENT006288	SPENG003945	lnc-CCDC88C-3		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022255	SPENO006611	
SPENP025686	FNGEDIDTISPTLGFNIK	Lung cancer	Large cell lung cancer	Lung	SPENT005944,SPENT003327	SPENG000584,SPENG002171	ARL2-SNX15,NONHSAG008644.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022256	SPENO005309	
SPENP025703	GADPGMPEPTVLSLLWG	Lung cancer	Large cell lung cancer	Lung	SPENT000828	SPENG000141	HSALNG0056619	0.8038	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022273	SPENO004991	Anal canal cancer:SPENP024826;Colon cancer:SPENP001668,SPENP007309,SPENP014405,SPENP000410;Kidney cancer:SPENP020455
SPENP025704	GAEDDLNTVAAGTMTGMLYK	Lung cancer	Large cell lung cancer	Lung	SPENT005941,SPENT005909,SPENT005904,SPENT005905,SPENT005910,SPENT005907,SPENT005942,SPENT005906,SPENT005908	SPENG001535	TIMM23B-AGAP6		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022274	SPENO004905	Colon cancer:SPENP000514
SPENP025715	GETGPAGPAGPVGPVGAR	Lung cancer	Large cell lung cancer	Lung	SPENT005758	SPENG002845	COL1A1	-0.6502	Others	-1.893	0.0638	0.2215	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022285	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP025743	GQAGVMGFPGPK	Lung cancer	Large cell lung cancer	Lung	SPENT005758	SPENG002845	COL1A1	-0.6231	Others	-0.7124	0.4911	0.6705	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022313	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP025746	GSGQGDSLYPVGYLDK	Lung cancer	Large cell lung cancer	Lung	SPENT000814	SPENG001638	HSALNG0104943		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022316	SPENO005134	Kidney cancer:SPENP020374;Anal canal cancer:SPENP024782;Prostate cancer:SPENP018335;Colon cancer:SPENP001653,SPENP008500,SPENP014345,SPENP016058
SPENP025752	GTVLALTENNFDDTIAEGITFIK	Lung cancer	Large cell lung cancer	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022322	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP017850,SPENP028573;Lung cancer:SPENP002850;Liver cancer:SPENP000766;Colon cancer:SPENP000559,SPENP008691
SPENP025757	GYVSCALGCPYEGK	Lung cancer	Large cell lung cancer	Lung	SPENT000018	SPENG003202	HMGCL	-0.0554	Others	-0.2784	0.7833	0.8891	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022327	SPENO002963	Bladder cancer:SPENP017521;Kidney cancer:SPENP020258;Lung cancer:SPENP004194;Prostate cancer:SPENP018272;Colon cancer:SPENP015935,SPENP008384,SPENP010450,SPENP007157,SPENP000314,SPENP014251,SPENP010449;Leukemia:SPENP001146
SPENP025765	HPARSAGVEVSGGSAMVASSSGGQR	Lung cancer	Large cell lung cancer	Lung	SPENT006190,SPENT006242	SPENG003960,SPENG004249	lnc-GABRB1-4,HSALNG0034248		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022335	SPENO006530,SPENO006882	
SPENP025769	HVISYSLSPFEQR	Lung cancer	Large cell lung cancer	Lung	SPENT001666	SPENG002113	HSALNG0044883		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022339	SPENO003843	Breast cancer:SPENP005372,SPENP005373,SPENP005370,SPENP005371,SPENP022662,SPENP022663,SPENP005369;Skin cancer:SPENP019250,SPENP019252,SPENP019251,SPENP025184;Bladder cancer:SPENP011395,SPENP017466;Kidney cancer:SPENP015004;Bile duct cancer:SPENP013392;Anal canal cancer:SPENP024665;Lung cancer:SPENP007632,SPENP004059;Prostate cancer:SPENP018220;Colon cancer:SPENP007116,SPENP010253,SPENP010254,SPENP014181,SPENP008320
SPENP025776	IDDILQTLLDATYK	Lung cancer	Large cell lung cancer	Lung	SPENT000775	SPENG001919	lnc-LRRD1-2	0.2027	Others	0.2396	0.8202	0.9005	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022346	SPENO003078	Bladder cancer:SPENP017516,SPENP028593;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP001612,SPENP000320
SPENP025795	IQLSNATLYMYQALLR	Lung cancer	Large cell lung cancer	Lung	SPENT006034	SPENG003780	lnc-C11orf1-1	2.0379	Others	1.074	0.3433	0.5464	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022365	SPENO004768	Colon cancer:SPENP000400
SPENP025800	ISLPGQMAGTPITPLK	Lung cancer	Large cell lung cancer	Lung	SPENT000725,SPENT000615	SPENG001618	NONHSAG029796.2	0.6253	Others	2.7791	0.0089	0.0632	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	sORF.org_record	26527729	Immunogenic	SPENM022370	SPENO000363	Breast cancer:SPENP022897,SPENP022896;Colon cancer:SPENP006591,SPENP000379;Prostate cancer:SPENP012075
SPENP025801	ISSTLYQAAAPVLTPAK	Lung cancer	Large cell lung cancer	Lung	SPENT000826,SPENT000822,SPENT000825,SPENT000820,SPENT000824,SPENT000821,SPENT000823	SPENG001427,SPENG002266	lnc-KRTCAP2-1,HSALNG0007474	0.4125	Others	2.1526	0.0374	0.1676	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022371	SPENO004037	Breast cancer:SPENP022918,SPENP022919;Bladder cancer:SPENP017691;Kidney cancer:SPENP020430;Lung cancer:SPENP002663,SPENP004408;Prostate cancer:SPENP018374;Colon cancer:SPENP008536,SPENP000424,SPENP001671
SPENP025802	ITDPQYFLDTPQQAAAILQK	Lung cancer	Large cell lung cancer	Lung	SPENT006700	SPENG004144	lnc-MED8-4	-1.149	Others	-0.9926	0.3665	0.5569	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022372	SPENO006828	
SPENP025806	IVAFADAAVEPIDFPIAPVYAASMVLK	Lung cancer	Large cell lung cancer	Lung	SPENT000014	SPENG003410	ACAT1	-0.7846	Others	-1.875	0.0748	0.2334	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022376	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916,SPENP028612;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP025818	KSEIEYYAMLAK	Lung cancer	Large cell lung cancer	Lung	SPENT000907	SPENG001277	HSALNG0067186	-0.3039	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022388	SPENO000929	Breast cancer:SPENP022486,SPENP022487;Skin cancer:SPENP025143;Bladder cancer:SPENP011343;Lung cancer:SPENP007606;Colon cancer:SPENP023974,SPENP010163,SPENP010164,SPENP008226
SPENP025820	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Large cell lung cancer	Lung	SPENT005755,SPENT005753,SPENT005757	SPENG000084	FN1	0.6642	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022390	SPENO005245	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP025838	LEVPPEADGTLLTDLMPGVEYVVTVTAER	Lung cancer	Large cell lung cancer	Lung	SPENT005913	SPENG001766	AL662884.2		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022408	SPENO002584	Colon cancer:SPENP000605
SPENP025841	LGELPSWILMR	Lung cancer	Large cell lung cancer	Lung	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022411	SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP025842	LGELTVTDATPDSLSLSWMVPEGQFDHFLVQYR	Lung cancer	Large cell lung cancer	Lung	SPENT005913	SPENG001766	AL662884.2		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022412	SPENO002584	Colon cancer:SPENP014713,SPENP016410;Lung cancer:SPENP002981
SPENP025859	LLEIDNSELLHMLESPESLR	Lung cancer	Large cell lung cancer	Lung	SPENT004082	SPENG001703	HSALNG0067302		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022429	SPENO006263	Bladder cancer:SPENP028642,SPENP017783
SPENP025861	LLLDAPAEDPNYLPLPEEQPGPHLPPPQQ	Lung cancer	Large cell lung cancer	Lung	SPENT000870,SPENT000869,SPENT000871	SPENG002286	lnc-DERL3-1		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022431	SPENO001044	Colon cancer:SPENP001774;Lung cancer:SPENP004693
SPENP025875	LQAAQLPHTGVFGQSFSCPSDR	Lung cancer	Large cell lung cancer	Lung	SPENT000855	SPENG000474	AC016876.2	-0.56	Others	-1.698	0.1135	0.2907	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM022445	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP025895	LVILANNCPALR	Lung cancer	Large cell lung cancer	Lung	SPENT000907,SPENT000906,SPENT000909,SPENT000908	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	1.2823	Up-regulated in tumors	3.3352	0.0025	0.0259	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022465	SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP028660,SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP025913	MELENIVANTVLLK	Lung cancer	Large cell lung cancer	Lung	SPENT001256	SPENG001321	NONHSAG042355.2	-1.316	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022483	SPENO002906	Colon cancer:SPENP000301;Lung cancer:SPENP002477
SPENP025915	MESPIPILPLPTPDAETEK	Lung cancer	Large cell lung cancer	Lung	SPENT005893,SPENT005806	SPENG002111	AC000093.1		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022485	SPENO004356	Breast cancer:SPENP023013,SPENP005888,SPENP005885,SPENP023012,SPENP005884,SPENP005886,SPENP005887;Ovary cancer:SPENP016616;Kidney cancer:SPENP020518;Prostate cancer:SPENP018415
SPENP025921	MGMSIIEQLDPVSFSNYLK	Lung cancer	Large cell lung cancer	Lung	SPENT006295,SPENT005649	SPENG004204,SPENG000280	HSALNG0014049,lnc-CBR3-2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022491	SPENO002745,SPENO007028	
SPENP025932	MLISCLAPVEEK	Lung cancer	Large cell lung cancer	Lung	SPENT006471,SPENT006139,SPENT006308	SPENG003939	HSALNG0053908		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022502	SPENO006635,SPENO006881,SPENO006932	
SPENP025935	MLSAPHLYLSLEVK	Lung cancer	Large cell lung cancer	Lung	SPENT006259,SPENT006150	SPENG003899	HSALNG0094447		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022505	SPENO006749,SPENO006963	
SPENP025943	MSAAVQTTNLQVYGHSDFLF	Lung cancer	Large cell lung cancer	Lung	SPENT005009	SPENG000819	HSALNG0044274	-0.083	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022513	SPENO000637	Colon cancer:SPENP024236,SPENP000506
SPENP025944	MSGQVEIVICVQ	Lung cancer	Large cell lung cancer	Lung	SPENT006185	SPENG004007	LINC02268		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022514	SPENO007046	
SPENP025946	MTQSPSSLSASVGDR	Lung cancer	Large cell lung cancer	Lung	SPENT001469,SPENT001471,SPENT001472,SPENT001470,SPENT000960,SPENT001473	SPENG000667,SPENG002060,SPENG000381,SPENG000040,SPENG003099	lnc-RPIA-13,HSALNG0141192,lnc-GAB4-4,NONHSAG028467.3,lnc-GAB4-1	0.5533	Others	0.9918	0.3394	0.5435	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022516	SPENO003097	Breast cancer:SPENP005599,SPENP005602,SPENP005600,SPENP005603,SPENP005601;Thyroid cancer:SPENP012421,SPENP012420;Ovary cancer:SPENP016543;Bladder cancer:SPENP017549;Kidney cancer:SPENP020310;Gastric cancer:SPENP003594,SPENP003194,SPENP015340;Colon cancer:SPENP014308,SPENP007195,SPENP015983,SPENP006553,SPENP000343
SPENP025953	NCSDMTFYILSQWISQPGCIPK	Lung cancer	Large cell lung cancer	Lung	SPENT006170	SPENG004025	AC092807.3		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022523	SPENO006551	
SPENP025965	NNQLVAGYLQGPNVNLEEK	Lung cancer	Large cell lung cancer	Lung	SPENT001357	SPENG002580	NONHSAG028996.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022535	SPENO002732	Colon cancer:SPENP000479,SPENP014503;Lung cancer:SPENP028356,SPENP002759
SPENP025968	NQSLIPLLLEAR	Lung cancer	Large cell lung cancer	Lung	SPENT000215	SPENG001615	lnc-ACTA2-2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022538	SPENO004045	Lung cancer:SPENP002319,SPENP004035;Bladder cancer:SPENP011378;Colon cancer:SPENP010169,SPENP010170,SPENP000179,SPENP014158,SPENP008231;Leukemia:SPENP001056
SPENP025971	NSVLMSGFSHK	Lung cancer	Large cell lung cancer	Lung	SPENT001640	SPENG000521	AMPD2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022541	SPENO000624	Colon cancer:SPENP014033
SPENP025975	PLTCLLVGWTWPTNSELK	Lung cancer	Large cell lung cancer	Lung	SPENT006087	SPENG003831	HSALNG0032778		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022545	SPENO005421	Colon cancer:SPENP000469
SPENP025980	QALNLPDVFGLVVLPLELK	Lung cancer	Large cell lung cancer	Lung	SPENT001218	SPENG003441	NONHSAG033755.2		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022550	SPENO005358	Breast cancer:SPENP008975;Colon cancer:SPENP016179;Lung cancer:SPENP002749;Kidney cancer:SPENP020505
SPENP025987	QGLYELSASNFELHVAQGDHFIK	Lung cancer	Large cell lung cancer	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022557	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP025998	QRPSSYLNCKEGYLFH	Lung cancer	Large cell lung cancer	Lung	SPENT006427	SPENG004113	HSALNG0127342		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022568	SPENO006940	
SPENP026000	QTLSTPGTIILGTIPVPK	Lung cancer	Large cell lung cancer	Lung	SPENT000714,SPENT000713	SPENG002182,SPENG002141	HSALNG0011538,NONHSAG004654.2		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022570	SPENO004961	Bladder cancer:SPENP017735;Kidney cancer:SPENP015158;Bile duct cancer:SPENP013564;Lung cancer:SPENP002694,SPENP004453;Prostate cancer:SPENP012096;Colon cancer:SPENP001697,SPENP000454
SPENP026011	SAATDIFSYLVEYNPSMVR	Lung cancer	Large cell lung cancer	Lung	SPENT006288	SPENG003945	lnc-CCDC88C-3		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022581	SPENO006611	
SPENP026025	SGDRGETGPAGPAGPVGPVGAR	Lung cancer	Large cell lung cancer	Lung	SPENT005758	SPENG002845	COL1A1	-0.4524	Others	-1.034	0.3055	0.5169	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022595	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP026054	SSSTLPVPVFK	Lung cancer	Large cell lung cancer	Lung	SPENT001694,SPENT001693	SPENG000680	NONHSAG038276.2	0.8541	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022624	SPENO002677	Skin cancer:SPENP025112
SPENP026055	SSTSRPDAYEHTQMK	Lung cancer	Large cell lung cancer	Lung	SPENT000097,SPENT000096	SPENG000914	NONHSAG048518.2	-0.7337	Others	-1.782	0.087	0.2572	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022625	SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP004254
SPENP026056	STAAMSTYTGIFTDQVLSVLK	Lung cancer	Large cell lung cancer	Lung	SPENT001116,SPENT001117	SPENG001123	NONHSAG026012.2	-1.931	Others	-1.032	0.3174	0.5237	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022626	SPENO003134	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP026058	STNLLAAETASLEEQLQGWGEVMLMADK	Lung cancer	Large cell lung cancer	Lung	SPENT002231,SPENT002229,SPENT002230,SPENT000119	SPENG001917,SPENG000017	HSALNG0109962,lnc-SMG1-1	0.6172	Others	1.7282	0.0954	0.2701	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022628	SPENO005391	Breast cancer:SPENP006183,SPENP006180,SPENP009060,SPENP006182,SPENP006179,SPENP006181;Bladder cancer:SPENP017924;Kidney cancer:SPENP020670;Anal canal cancer:SPENP024956;Colon cancer:SPENP016365,SPENP007484,SPENP014656,SPENP000591
SPENP026071	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Lung cancer	Large cell lung cancer	Lung	SPENT005755,SPENT005753,SPENT005757	SPENG000084	FN1	1.0224	Others	1.4243	0.1698	0.3713	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022641	SPENO005245	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP026072	TDSTFNQVVLK	Lung cancer	Large cell lung cancer	Lung	SPENT002071	SPENG001428	lnc-CPHXL-5		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022642	SPENO004801	Bladder cancer:SPENP017275;Kidney cancer:SPENP019976;Anal canal cancer:SPENP024517;Colon cancer:SPENP006972,SPENP010062,SPENP010061
SPENP026076	TEQGPTGVTMTSNPITWGQIK	Lung cancer	Large cell lung cancer	Lung	SPENT005831,SPENT005828,SPENT004025,SPENT004024,SPENT005829,SPENT005827	SPENG002775,SPENG001268	ZNF8-ERVK3-1,HSALNG0127945		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	SmProt_literiture_mining	28137767	Immunogenic	SPENM022646	SPENO001153	Bladder cancer:SPENP017805
SPENP026078	TETITGFQVDAVPANGQTPIQR	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.6771	Others	1.916	0.0652	0.2215	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022648	SPENO001233	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP026080	TFLFSSQQYQK	Lung cancer	Large cell lung cancer	Lung	SPENT006602,SPENT006521	SPENG004111	HSALNG0042082		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022650	SPENO006528,SPENO006677	
SPENP026083	TGLDSPTGIDFSDITANSFTVHWIAPR	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.863	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022653	SPENO001233	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP026084	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Lung cancer	Large cell lung cancer	Lung	SPENT005752	SPENG000084	FN1	-0.7724	Others	-1.352	0.2034	0.397	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022654	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP026085	TGVHHYSGNNIELGTACGK	Lung cancer	Large cell lung cancer	Lung	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	1.5989	Up-regulated in tumors	4.5047	5.89e-05	0.0018	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022655	SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP028767,SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP026090	TKTETITGFQVDAVPANGQTPIQR	Lung cancer	Large cell lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-0.5183	Others	-1.488	0.1457	0.3434	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022660	SPENO001233	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP026093	TLTQESCDVSPVLTQAMEALQDRPVLYK	Lung cancer	Large cell lung cancer	Lung	SPENT006025	SPENG003760	HSALNG0096505		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022663	SPENO001730	Colon cancer:SPENP000599
SPENP026095	TNTNVNCPIECFMPLDVQADR	Lung cancer	Large cell lung cancer	Lung	SPENT000578,SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.6849	Others	0.8867	0.3844	0.5735	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022665	SPENO001233	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP026096	TNTNVNCPIECFMPLDVQADREDSRE	Lung cancer	Large cell lung cancer	Lung	SPENT000578,SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022666	SPENO001233	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP026100	TPTEALASFDYIVR	Lung cancer	Large cell lung cancer	Lung	SPENT001703,SPENT000964,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022670	SPENO003587	Breast cancer:SPENP022755,SPENP022754;Bladder cancer:SPENP028778;Lung cancer:SPENP004163;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP024064,SPENP007144
SPENP026110	TYLGDPIPYDPQITAEELAEK	Lung cancer	Large cell lung cancer	Lung	SPENT000853	SPENG001681	lnc-RPS20-4		Tumor-specific				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022680	SPENO003529	Colon cancer:SPENP001724
SPENP026112	TYLVSGQPLEEIITYYPAMK	Lung cancer	Large cell lung cancer	Lung	SPENT000965	SPENG000698	SLC25A25-AS1	1.0771	Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022682	SPENO005957	Breast cancer:SPENP023054,SPENP023055;Colon cancer:SPENP012846,SPENP007384,SPENP000498
SPENP026135	VLFGCVLYWDTVRGK	Lung cancer	Large cell lung cancer	Lung	SPENT003180	SPENG001801	AC106799.2	-1.172	Others	-2.372	0.023	0.1303	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022705	SPENO005953	Breast cancer:SPENP022789,SPENP022788;Bladder cancer:SPENP011505;Prostate cancer:SPENP009234;Colon cancer:SPENP010492,SPENP000334,SPENP010491
SPENP026142	VPFLVLECPNLK	Lung cancer	Large cell lung cancer	Lung	SPENT000354	SPENG002378	HSALNG0036293	1.2228	Up-regulated in tumors	4.3846	0.0001	0.0027	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022712	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP026173	YAASSYLSLTPEQWK	Lung cancer	Large cell lung cancer	Lung	SPENT000080,SPENT000084,SPENT000203,SPENT000204,SPENT000079,SPENT000202,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	-0.7237	Others	-3.142	0.0027	0.0267	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM022743	SPENO004816	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP026177	YFILPDSLPLDTLLVDVEPK	Lung cancer	Large cell lung cancer	Lung	SPENT000928	SPENG002213	HSALNG0120314	1.4202	Up-regulated in tumors	3.7837	0.0009	0.0111	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022747	SPENO000238	Bile duct cancer:SPENP013597;Tongue cancer:SPENP028202;Lung cancer:SPENP026636,SPENP001946;Skin cancer:SPENP025399
SPENP026183	YIMPFNCALR	Lung cancer	Large cell lung cancer	Lung	SPENT006370,SPENT006585	SPENG003940	HSALNG0119933		Others				IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM022753	SPENO006756,SPENO006905	
SPENP026184	YIMVPSGNMGVFDPTEIHNR	Lung cancer	Large cell lung cancer	Lung	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.3721	Others	1.0034	0.3298	0.5356	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022754	SPENO003817	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
SPENP026192	YQLDPTASISAK	Lung cancer	Large cell lung cancer	Lung	SPENT000102	SPENG002045	lnc-ACTR2-11	1.5025	Up-regulated in tumors	4.7901	0.0002	0.0035	IPX0001451001	Proteogenomic characterization analysis of human large cell lung cancer	LTQ Orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022762	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP026198	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Colon	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM020942	SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP026656,SPENP008661,SPENP010927,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP026228	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Colon	SPENT000841,SPENT000840	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM020972	SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP026279	ELSELVYTDVLDR	Colon cancer	Colon cancer	Colon	SPENT000916,SPENT000917	SPENG003022	lnc-PROB1-1	0.8261	Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM021023	SPENO002416	Breast cancer:SPENP008874;Ovary cancer:SPENP029484;Colon cancer:SPENP007120;Lung cancer:SPENP001862,SPENP026506
SPENP026309	GETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021053	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP026316	GSSVPSQPVSSPLQTPK	Colon cancer	Colon cancer	Colon	SPENT006456,SPENT006377,SPENT006347	SPENG003984	HSALNG0103371		Tumor-specific				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM021060	SPENO006405,SPENO006466,SPENO006632	
SPENP026362	MEHPVLLMLQTPLTFSSAPSWR	Colon cancer	Colon cancer	Colon	SPENT006506	SPENG004223	HSALNG0045970		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM021106	SPENO006875	
SPENP026375	MSPAEPGMSLFHLR	Colon cancer	Colon cancer	Colon	SPENT006457,SPENT006314,SPENT006148	SPENG003882	LINC00659		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM021119	SPENO006486,SPENO007073,SPENO007099	
SPENP026377	MSTPESLNTHLAHK	Colon cancer	Colon cancer	Colon	SPENT006417	SPENG004083	AC008738.4		Tumor-specific				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM021121	SPENO006502	
SPENP026408	RPQYSNPPVQGEVMEGADNQGAGEQGR	Colon cancer	Colon cancer	Colon	SPENT005333,SPENT003109	SPENG000587,SPENG003642	lnc-OR2S2-1,lnc-MAX-16	1.4588	Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM021152	SPENO005559	
SPENP026419	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Colon	SPENT005758	SPENG002845	COL1A1		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021163	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP026436	TCLHYLGEFGEDQIYEAHQQGR	Colon cancer	Colon cancer	Colon	SPENT000916,SPENT000917	SPENG003022	lnc-PROB1-1		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Non-validated			Immunogenic	SPENM021180	SPENO002417	Thyroid cancer:SPENP012600,SPENP012601;Colon cancer:SPENP012856;Lung cancer:SPENP001962
SPENP026461	VLQATVVAVGSGSK	Colon cancer	Colon cancer	Colon	SPENT000668,SPENT000773,SPENT000772	SPENG001842,SPENG000579,SPENG000801	HSALNG0101846,HSALNG0021384,lnc-SYNE2-4		Others				JPST000210	Phosphoproteomics data of colon tissues (tumor and non-tumor)	LTQ-orbitrap Velos	Label free		Validated	MS	28137767	Immunogenic	SPENM021205	SPENO001211	Breast cancer:SPENP005534,SPENP005538,SPENP008891,SPENP005537,SPENP005535,SPENP005536;Ovary cancer:SPENP016534;Kidney cancer:SPENP013802,SPENP013801;Gastric cancer:SPENP003581;Lung cancer:SPENP001882;Colon cancer:SPENP001599,SPENP012793
SPENP026477	AAGVNVEPFWPGLFAK	Lung cancer	Lung cancer	Lung	SPENT000959,SPENT000956,SPENT000958,SPENT000957	SPENG002082,SPENG000412,SPENG001664,SPENG001785	NONHSAG017284.2,HSALNG0011930,lnc-GREM2-13,lnc-EVX2-8		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024117	SPENO003329	Breast cancer:SPENP008943;Prostate cancer:SPENP009247,SPENP023710;Lung cancer:SPENP001909;Liver cancer:SPENP004882
SPENP026488	ALAPTWEQLALGLEHSETVK	Lung cancer	Lung cancer	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Non-validated			Immunogenic	SPENM024128	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP026506	ELSELVYTDVLDR	Lung cancer	Lung cancer	Lung	SPENT000916,SPENT000917	SPENG003022	lnc-PROB1-1		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Non-validated			Immunogenic	SPENM024146	SPENO005649	Breast cancer:SPENP008874;Ovary cancer:SPENP029484;Colon cancer:SPENP026279,SPENP007120;Lung cancer:SPENP001862
SPENP026511	EVVIFGAASELFTK	Lung cancer	Lung cancer	Lung	SPENT000018	SPENG003202	HMGCL		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024151	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP026813,SPENP010376
SPENP026517	FIYITPEELAAVANFIR	Lung cancer	Lung cancer	Lung	SPENT002729	SPENG003021	NONHSAG031147.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024157	SPENO002390	Liver cancer:SPENP000718
SPENP026519	FLEEYLSSTPQR	Lung cancer	Lung cancer	Lung	SPENT002760	SPENG002531	NONHSAG014457.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024159	SPENO003138	Skin cancer:SPENP025159;Kidney cancer:SPENP014941;Bile duct cancer:SPENP013357;Tongue cancer:SPENP027660;Lung cancer:SPENP007614,SPENP028269;Prostate cancer:SPENP012927
SPENP026533	GETGPAGPAGPVGPVGAR	Lung cancer	Lung cancer	Lung	SPENT005758	SPENG002845	COL1A1	-1.601	Down-regulated in tumors	-5.077	0.0007	0.0024	JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024173	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP026545	GQAGVMGFPGPK	Lung cancer	Lung cancer	Lung	SPENT005758	SPENG002845	COL1A1		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024185	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Tongue cancer:SPENP027753;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP026547	GTGLDEAMEWLVETLK	Lung cancer	Lung cancer	Lung	SPENT003105,SPENT003104,SPENT003106	SPENG001388,SPENG002402	HSALNG0093495,NONHSAG012072.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024187	SPENO002969	Breast cancer:SPENP008941;Liver cancer:SPENP000716
SPENP026552	IASGLGLAWIVGR	Lung cancer	Lung cancer	Lung	SPENT000592,SPENT000591	SPENG002721	HSALNG0008146		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024192	SPENO004752	Bile duct cancer:SPENP013396;Anal canal cancer:SPENP024640
SPENP026556	IPAFLNVVDIAGLVK	Lung cancer	Lung cancer	Lung	SPENT002261	SPENG002542	lnc-NDUFA6-1		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024196	SPENO005863	Breast cancer:SPENP008910;Colon cancer:SPENP012810;Prostate cancer:SPENP012998
SPENP026557	IPLLSDLTHQISK	Lung cancer	Lung cancer	Lung	SPENT000669	SPENG001255	NONHSAG054153.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024197	SPENO005158	Colon cancer:SPENP001582
SPENP026566	LGELPSWILMR	Lung cancer	Lung cancer	Lung	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024206	SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP027061,SPENP023902,SPENP006393,SPENP010048
SPENP026570	LLDGEAALPAVVFLHGLFGSK	Lung cancer	Lung cancer	Lung	SPENT000073,SPENT000072,SPENT000074	SPENG002534,SPENG000354	NONHSAG047943.2,lnc-STX1A-1		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024210	SPENO004128	Lung cancer:SPENP028320;Leukemia:SPENP001356
SPENP026578	MFQILLDFWEHSHQLDLK	Lung cancer	Lung cancer	Lung	SPENT005450	SPENG003405	NONHSAG045207.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Non-validated			Immunogenic	SPENM024218	SPENO006915	
SPENP026582	MLITILGTVKPNANR	Lung cancer	Lung cancer	Lung	SPENT000025,SPENT000026,SPENT000024,SPENT000309,SPENT000023	SPENG001332	NONHSAG015030.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024222	SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP026584	MQVTSSFLGNSLFSSIHWG	Lung cancer	Lung cancer	Lung	SPENT004628	SPENG003061	HSALNG0073522		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Non-validated			Immunogenic	SPENM024224	SPENO005562	Breast cancer:SPENP023016,SPENP023017
SPENP026585	MSWVSGSAADWMILGK	Lung cancer	Lung cancer	Lung	SPENT006690,SPENT006414	SPENG003989	HSALNG0002952	-1.463	Others	-0.8808	0.4433	0.4739	JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Non-validated			Immunogenic	SPENM024225	SPENO006754,SPENO007038	
SPENP026590	QATTIIADNIIFLSDQTK	Lung cancer	Lung cancer	Lung	SPENT003746	SPENG003260	HSALNG0061855		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024230	SPENO000664	
SPENP026594	QLLDQVEQIQK	Lung cancer	Lung cancer	Lung	SPENT002330	SPENG003513	lnc-DDX56-1		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024234	SPENO004588	Prostate cancer:SPENP009171
SPENP026599	SGDRGETGPAGPAGPVGPVGAR	Lung cancer	Lung cancer	Lung	SPENT005758	SPENG002845	COL1A1	-1.058	Down-regulated in tumors	-6.916	7.88e-08	2.44e-06	JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024239	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP026613	TPIGSFLGSLSLLPATK	Lung cancer	Lung cancer	Lung	SPENT000014	SPENG003410	ACAT1	0.9461	Others				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024253	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP026618	VALAGLLGFGLGK	Lung cancer	Lung cancer	Lung	SPENT003237	SPENG001444	lnc-OCIAD2-2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024258	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010336,SPENP010335,SPENP024026;Lung cancer:SPENP028394;Prostate cancer:SPENP018206,SPENP012954
SPENP026623	VLLESEQFLTELTR	Lung cancer	Lung cancer	Lung	SPENT000770,SPENT000771	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024263	SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP028401;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP026626	VMVQPINLIFR	Lung cancer	Lung cancer	Lung	SPENT002270,SPENT002272,SPENT002269,SPENT002267,SPENT002268,SPENT002271,SPENT002273	SPENG003098,SPENG003309,SPENG001915,SPENG003607,SPENG000941,SPENG003601,SPENG000906	lnc-ID2-3,lnc-ZC3H12D-15,HSALNG0054220,HSALNG0012839,lnc-FABP6-3,HSALNG0046238,lnc-GLDC-5		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024266	SPENO003493	Breast cancer:SPENP008819;Liver cancer:SPENP004794;Kidney cancer:SPENP014910;Tongue cancer:SPENP028143;Prostate cancer:SPENP012898
SPENP026634	WEAAEGLLQEALDK	Lung cancer	Lung cancer	Lung	SPENT006001,SPENT006080,SPENT006106,SPENT005969	SPENG003777	NONHSAG025152.2		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024274	SPENO004994	Liver cancer:SPENP000684
SPENP026635	YAASSYLSLTPEQWK	Lung cancer	Lung cancer	Lung	SPENT000080,SPENT000084,SPENT000204,SPENT000203,SPENT000202,SPENT000079,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	-0.8474	Others	-5.674	4.42e-06	6.85e-05	JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024275	SPENO005507	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP026636	YFILPDSLPLDTLLVDVEPK	Lung cancer	Lung cancer	Lung	SPENT000928	SPENG002213	HSALNG0120314		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024276	SPENO000238	Bile duct cancer:SPENP013597;Tongue cancer:SPENP028202;Lung cancer:SPENP026177,SPENP001946;Skin cancer:SPENP025399
SPENP026639	YLFLGDYVDR	Lung cancer	Lung cancer	Lung	SPENT006675	SPENG003933	HSALNG0036057		Tumor-specific				JPST000423	HumanLungCancer180521	Orbitrap XL	Label free		Validated	MS	28137767	Immunogenic	SPENM024279	SPENO006929	
SPENP026642	AAALVLQTIWGYK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005788	SPENG002233	AP001931.2	-0.1288	Others	-0.237	0.8221	0.9118	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021221	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP001574
SPENP026643	AAALVLQTIWGYKELR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005788	SPENG002233	AP001931.2	0.0693	Others	0.3094	0.7592	0.87	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021222	SPENO005858	Skin cancer:SPENP025298;Lung cancer:SPENP002589
SPENP026650	AAQAQGQSCEYSLMVGYQCGQVFR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005795,SPENT005796,SPENT005794,SPENT005785	SPENG001958	FBLN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021229	SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Tongue cancer:SPENP027496;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP026652	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005793,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.7089	Others	1.7732	0.1154	0.3896	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021231	SPENO005410	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP026656	ADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.3063	Others	0.7105	0.4876	0.7068	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021235	SPENO003536	Breast cancer:SPENP023086,SPENP023423,SPENP023087,SPENP009003;Skin cancer:SPENP019656,SPENP019657,SPENP025410,SPENP019655;Bladder cancer:SPENP011687;Bile duct cancer:SPENP013610;Lung cancer:SPENP025515,SPENP007848,SPENP001959,SPENP004564;Gastric cancer:SPENP009661;Prostate cancer:SPENP018456,SPENP013075;Colon cancer:SPENP008661,SPENP010927,SPENP026198,SPENP024260,SPENP001725,SPENP007423,SPENP010928;Leukemia:SPENP001352
SPENP026668	AGIPKEEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000014	SPENG003410	ACAT1	-0.5376	Others	-2.434	0.02	0.1705	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021247	SPENO003940	Kidney cancer:SPENP020648;Lung cancer:SPENP001976,SPENP004680,SPENP002913;Prostate cancer:SPENP018522;Colon cancer:SPENP016344,SPENP011064,SPENP008728,SPENP007478,SPENP011063;Leukemia:SPENP001390
SPENP026679	AITYNAMLAETSTVFHQNDVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000648	SPENG002439	NONHSAG050528.2		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021258	SPENO003505	Bladder cancer:SPENP017810;Colon cancer:SPENP000519;Lung cancer:SPENP004559
SPENP026680	AITYNAMLAETSTVFHQNDVKIPDAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000648	SPENG002439	NONHSAG050528.2	0.8265	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021259	SPENO003505	
SPENP026681	ALAPTWEQLALGLEHSETVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.424	Others	-1.856	0.0717	0.3013	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021260	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP024244,SPENP000507
SPENP026682	ALAPTWEQLALGLEHSETVKIGK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021261	SPENO005833	
SPENP026702	ARDMDLTEVITGTLWNLSSHDSIK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005788	SPENG002233	AP001931.2	-0.5284	Others	-0.952	0.369	0.6543	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021281	SPENO005858	Colon cancer:SPENP014616,SPENP016292,SPENP008706;Lung cancer:SPENP002874
SPENP026715	ATLVCLISDFYPGAVTVAWKADSSPVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000080,SPENT000084,SPENT000204,SPENT000203,SPENT000202,SPENT000079,SPENT000201,SPENT000082,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021294	SPENO003223	Breast cancer:SPENP021839,SPENP021837;Bladder cancer:SPENP011757;Gastric cancer:SPENP015453;Lung cancer:SPENP021838;Colon cancer:SPENP021836
SPENP026722	AVYTLTSLYR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000988	SPENG000380	lnc-DIABLO-1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM021301	SPENO003093	Bladder cancer:SPENP017167;Kidney cancer:SPENP019937;Lung cancer:SPENP002154;Prostate cancer:SPENP018082;Colon cancer:SPENP014012,SPENP008071,SPENP015676
SPENP026725	CDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005793,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021304	SPENO005410	Gastric cancer:SPENP009715,SPENP015467;Tongue cancer:SPENP027542;Leukemia:SPENP001397
SPENP026729	CPSIAAAIAAVNALHGR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000220,SPENT000234,SPENT000221	SPENG000739,SPENG000807	RBM39,lnc-NFS1-1	0.3881	Others	2.1951	0.039	0.2224	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021308	SPENO005081	Bile duct cancer:SPENP013527;Colon cancer:SPENP001673,SPENP000417;Lung cancer:SPENP004381;Kidney cancer:SPENP020438
SPENP026745	DFSPSGIFGAFQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.0902	Others	-0.5613	0.5784	0.7604	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021324	SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP028479,SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP024039,SPENP010274
SPENP026754	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000841,SPENT000840	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.6225	Others	1.1009	0.28	0.5938	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021333	SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP026755	DKLNNLVLFDK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	2.2316	Up-regulated in tumors	6.3299	5.27e-06	0.0022	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM021334	SPENO005025	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935;Leukemia:SPENP001004
SPENP026756	DKLNNLVLFDKATYDK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021335	SPENO005025	Breast cancer:SPENP023406
SPENP026758	DLDSLHRFVLSQAKDEL	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2	-1.198	Others	-1.057	0.3311	0.638	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021337	SPENO005833	
SPENP026761	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	2.0635	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021340	SPENO001233	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295
SPENP026776	DTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021355	SPENO001233	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP026787	EEVKEAYMGNVLQGGEGQAPTR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000014	SPENG003410	ACAT1	-0.1182	Others	-0.5532	0.5912	0.7677	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021366	SPENO003940	Colon cancer:SPENP010934,SPENP008671,SPENP016258,SPENP010933,SPENP014573,SPENP007438;Lung cancer:SPENP004605;Kidney cancer:SPENP020571;Prostate cancer:SPENP018468
SPENP026810	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	1.6917	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021389	SPENO001233	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP026813	EVVIFGAASELFTK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000018	SPENG003202	HMGCL		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021392	SPENO002963	Bladder cancer:SPENP017524;Prostate cancer:SPENP018279;Kidney cancer:SPENP020263,SPENP015038;Lung cancer:SPENP002520,SPENP001879,SPENP004190,SPENP026511;Liver cancer:SPENP004846;Colon cancer:SPENP010375,SPENP014262,SPENP015954,SPENP000323,SPENP008399,SPENP010376
SPENP026814	EVVIFGAASELFTKK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000018	SPENG003202	HMGCL	-0.5216	Others	-1.335	0.2016	0.5018	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021393	SPENO002963	Colon cancer:SPENP008419;Lung cancer:SPENP002543,SPENP007731,SPENP004268;Kidney cancer:SPENP020351;Prostate cancer:SPENP018293
SPENP026816	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021395	SPENO001233	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Tongue cancer:SPENP027645;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP011165,SPENP016403,SPENP014704
SPENP026817	EVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021396	SPENO001233	Bladder cancer:SPENP011810
SPENP026821	FALVFPLMYHTWNGIR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000626	SPENG001862	HSALNG0007932	0.0815	Others	0.455	0.6529	0.8056	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021400	SPENO003610	Colon cancer:SPENP001662;Kidney cancer:SPENP020411
SPENP026840	FLLYGLSGRK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913	SPENG001766	AL662884.2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021419	SPENO002584	
SPENP026841	FMPAGLIAGASLLMVAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT002584,SPENT002585	SPENG000664	HSALNG0048031		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021420	SPENO005766	Breast cancer:SPENP022925,SPENP022924;Colon cancer:SPENP007302;Kidney cancer:SPENP020457,SPENP015125;Prostate cancer:SPENP018363
SPENP026852	FTLFGIANKK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913	SPENG001766	AL662884.2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021431	SPENO002584	Colon cancer:SPENP015611;Lung cancer:SPENP002165
SPENP026880	GGPPPPNWRQPELPEVIAMLGFRLDAVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005788	SPENG002233	AP001931.2	0.6519	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021459	SPENO005858	
SPENP026891	GIQKFPGINYPVLTPNLK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000458,SPENT000018,SPENT000457	SPENG003202,SPENG001448	HMGCL,lnc-GALE-2	-0.031	Others	-0.0986	0.9269	0.9634	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021470	SPENO001216	Colon cancer:SPENP014465,SPENP016121,SPENP010748,SPENP010747;Lung cancer:SPENP002686;Prostate cancer:SPENP018387
SPENP026892	GIQKFPGINYPVLTPNLKGFEAAVAAGAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000018	SPENG003202	HMGCL	-0.1921	Others	-0.5912	0.5707	0.7526	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021471	SPENO002963	Liver cancer:SPENP004942
SPENP026906	GNSIIMLEALERV	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.6684	Others	4.4932	0.0001	0.027	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021485	SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Tongue cancer:SPENP027744;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP026916	GSLASLDSLRK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005788	SPENG002233	AP001931.2	-0.3484	Others	-1.305	0.2093	0.5018	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021495	SPENO005858	Colon cancer:SPENP014054,SPENP008125,SPENP015749;Bladder cancer:SPENP017222;Kidney cancer:SPENP020052;Prostate cancer:SPENP011932
SPENP026924	GYDQYAYDGKDYIALNEDLRSWTAADTAAQITQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000329	SPENG000108	NONHSAG046250.2	0.3348	Others	0.3649	0.7664	0.8742	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021503	SPENO005880	
SPENP026941	HRAQVIYTR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000022,SPENT000021	SPENG003042,SPENG003226	lnc-RPS25-2,lnc-ATG12-3	0.9365	Others	1.7406	0.1096	0.3761	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021520	SPENO003205	
SPENP026950	HVFTTFYAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000648	SPENG002439	NONHSAG050528.2		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM021529	SPENO003505	Colon cancer:SPENP001444;Bladder cancer:SPENP017134
SPENP026959	IALDFQRGNDVAFHFNPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000026,SPENT000023,SPENT000025,SPENT000024	SPENG001332	NONHSAG015030.2	0.3453	Others	0.5555	0.5858	0.7653	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021538	SPENO001262	
SPENP026963	IAYTYSVSFEEDDKIR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000984	SPENG002536	NONHSAG014060.2	0.1604	Others	0.7381	0.4774	0.7057	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021542	SPENO001987	
SPENP026975	IGGDRNDITLSGLESDHRYLVTLYGFSDGK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913	SPENG001766	AL662884.2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021554	SPENO002584	
SPENP026980	IGYNPDTVAFVPISGWNGNNMLEPSANMPWFK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005153	SPENG001303	lnc-ANKH-1		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021559	SPENO003081	Prostate cancer:SPENP012135
SPENP026983	IISLSWPHGFPYMPRKLS	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006703,SPENT006209	SPENG004064,SPENG004185	HSALNG0056433,lnc-PRPS1L1-2		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021562	SPENO006373,SPENO006773	
SPENP026986	ILQMAYHSYFFEILLLK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001889	SPENG003276	HSALNG0065862		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021565	SPENO004687	Lung cancer:SPENP004386
SPENP026987	IMLLNHPDKGGSPYIAAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000443,SPENT006629	SPENG000369,SPENG002203	HSALNG0031033,lnc-DNAJC19-5		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021566	SPENO000575,SPENO006642	
SPENP027027	KIGYNPDTVAFVPISGWNGNNMLEPSANMPWFK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005153	SPENG001303	lnc-ANKH-1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021606	SPENO003081	
SPENP027030	KLLEENTGEMLHNIDLGIIFNNKISK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006251,SPENT006411,SPENT006450,SPENT006425	SPENG003998	NONHSAG022639.2	-0.0626	Others	-0.3803	0.7076	0.8507	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021609	SPENO006441,SPENO006680,SPENO006735,SPENO006994	
SPENP027042	KVIEKVQHIQLLQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005797,SPENT005805	SPENG002649	FGA	-1.828	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021621	SPENO002211	Breast cancer:SPENP018642;Ovary cancer:SPENP018643;Colon cancer:SPENP007158;Tongue cancer:SPENP027839
SPENP027044	KVSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	0.416	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021623	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Tongue cancer:SPENP027841;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP027061	LGELPSWILMR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	-0.1442	Others	-0.6087	0.5469	0.7481	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021640	SPENO005239	Breast cancer:SPENP008838,SPENP022396,SPENP005245,SPENP005247,SPENP005246,SPENP005244,SPENP005248,SPENP022397;Skin cancer:SPENP025081;Bladder cancer:SPENP017228;Kidney cancer:SPENP020004;Lung cancer:SPENP025841,SPENP007580,SPENP003965,SPENP026566;Liver cancer:SPENP000646;Colon cancer:SPENP010047,SPENP023902,SPENP006393,SPENP010048
SPENP027068	LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021647	SPENO001233	Breast cancer:SPENP006272,SPENP022141,SPENP022143,SPENP006271,SPENP006269,SPENP006270,SPENP006273;Colon cancer:SPENP014738,SPENP022140,SPENP016436;Lung cancer:SPENP003011,SPENP022142
SPENP027069	LHLEGYHGTAGDSMSYHSGSVFSAR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913,SPENT005914	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021648	SPENO006142	Breast cancer:SPENP009044;Thyroid cancer:SPENP012644,SPENP012645;Bladder cancer:SPENP017892;Gastric cancer:SPENP003348;Lung cancer:SPENP002891;Colon cancer:SPENP016316
SPENP027070	LIDMLSEAGLSVIETTSFVSPK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000018	SPENG003202	HMGCL	-0.0556	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021649	SPENO002963	Bladder cancer:SPENP017838,SPENP011699;Kidney cancer:SPENP015209,SPENP020591;Lung cancer:SPENP002830;Liver cancer:SPENP000762;Colon cancer:SPENP007426,SPENP006707,SPENP014565,SPENP010942,SPENP008668,SPENP016255,SPENP010941,SPENP000542
SPENP027082	LLLYGLHHGK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913	SPENG001766	AL662884.2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021661	SPENO002584	Colon cancer:SPENP013978,SPENP015665;Lung cancer:SPENP002187
SPENP027088	LNNLVLFDKATYDK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021667	SPENO005025	
SPENP027092	LQAAQLPHTGVFGQSFSCPSDR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000855	SPENG000474	AC016876.2	0.1522	Others	0.2122	0.8668	0.9379	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM021671	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP001740
SPENP027108	LSWTVPEGQFDSFVVQFKDKDGPQVVPVEGHER	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913	SPENG001766	AL662884.2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021687	SPENO002584	
SPENP027148	MLITILGTVKPNANR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000025,SPENT000026,SPENT000024,SPENT000309,SPENT000023	SPENG001332	NONHSAG015030.2	-0.4931	Others	-2.422	0.0206	0.1705	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021727	SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Tongue cancer:SPENP027916;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP027149	MLITILGTVKPNANRIALDFQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000026,SPENT000023,SPENT000025,SPENT000024	SPENG001332	NONHSAG015030.2	-0.1742	Others	-0.6382	0.5319	0.7413	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021728	SPENO001262	
SPENP027162	MYLEFYFLLLSQSNAPQIFLM	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006290,SPENT006282,SPENT006188	SPENG003901,SPENG004261	HSALNG0004399,lnc-CTH-12		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021741	SPENO006617,SPENO006962,SPENO007104	
SPENP027186	NSIAYMDQASGNVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000926,SPENT005912,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021765	SPENO004565	Gastric cancer:SPENP003173,SPENP003573;Colon cancer:SPENP006520,SPENP007133;Lung cancer:SPENP004134,SPENP001874
SPENP027187	NSIAYMDQASGNVKK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000926,SPENT005912,SPENT000927	SPENG001257	NONHSAG030072.2		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021766	SPENO004565	Lung cancer:SPENP004216;Colon cancer:SPENP006562,SPENP007201;Gastric cancer:SPENP003588,SPENP003213
SPENP027188	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021767	SPENO001233	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP016437,SPENP014739,SPENP011218
SPENP027193	NTYVFKNIHHIIYFTVSH	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006600	SPENG003996	HSALNG0020634	0.3295	Others	2.642	0.0178	0.1705	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021772	SPENO006900	
SPENP027201	QGLYELSASNFELHVAQGDHFIK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.5037	Others	-2.8	0.0083	0.1197	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021780	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP000554,SPENP001744
SPENP027203	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021782	SPENO001233	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Tongue cancer:SPENP028002;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP011108;Leukemia:SPENP001395
SPENP027210	QPELPEVIAMLGFRLDAVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005788	SPENG002233	AP001931.2	-0.6964	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021789	SPENO005858	
SPENP027212	QSNNKYAASSYLSLTPEQWK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000080,SPENT000084,SPENT000204,SPENT000203,SPENT000202,SPENT000079,SPENT000201,SPENT000082,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	-1.768	Others	-2.759	0.0702	0.3013	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021791	SPENO003223	Breast cancer:SPENP023422;Thyroid cancer:SPENP012564,SPENP012565;Bladder cancer:SPENP011667;Bile duct cancer:SPENP013595;Lung cancer:SPENP001950,SPENP007827,SPENP004548,SPENP002774;Gastric cancer:SPENP015407;Colon cancer:SPENP010881,SPENP006682,SPENP010882
SPENP027217	QYNVGPSVSKYPLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021796	SPENO001233	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP027224	RLVQSPNSYFMDVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000045,SPENT000059,SPENT000412,SPENT000053,SPENT000065,SPENT000058,SPENT000051,SPENT000050,SPENT000411,SPENT000046,SPENT000414,SPENT000413,SPENT000334,SPENT000333,SPENT000332,SPENT000061,SPENT000054	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM021803	SPENO003973	Bladder cancer:SPENP017489;Tongue cancer:SPENP028015;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP010432,SPENP014253,SPENP006523
SPENP027236	SAIQNLHSFDPFADASKGDDLLPAGTEDYIHIR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452	1.2636	Others	2.9364	0.0218	0.1705	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021815	SPENO000819	Breast cancer:SPENP009082,SPENP023209,SPENP023208;Skin cancer:SPENP025485;Bladder cancer:SPENP011802;Kidney cancer:SPENP020699;Anal canal cancer:SPENP024964;Colon cancer:SPENP011167,SPENP011168
SPENP027253	SGDRGETGPAGPAGPVGPVGAR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005758	SPENG002845	COL1A1	0.3777	Others	0.595	0.5683	0.7526	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021832	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Tongue cancer:SPENP028039;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP027254	SGTLYSLTLYGLR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913,SPENT005914	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021833	SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Tongue cancer:SPENP028041;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP024013,SPENP014229
SPENP027255	SGTLYSLTLYGLRGPHK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005913,SPENT005914	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021834	SPENO006142	
SPENP027291	SSQSLVHSDGNTYLSWLQQRPGQPPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000862,SPENT005911	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.4362	Others	0.6675	0.541	0.7442	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021870	SPENO003879	Breast cancer:SPENP006150,SPENP006152,SPENP021825,SPENP006151,SPENP018700,SPENP006149,SPENP006153,SPENP021827;Thyroid cancer:SPENP012655,SPENP012654;Ovary cancer:SPENP018701;Kidney cancer:SPENP020640;Gastric cancer:SPENP015446,SPENP003694,SPENP003351;Lung cancer:SPENP002902,SPENP004667,SPENP021826;Colon cancer:SPENP016326,SPENP006743,SPENP014639,SPENP001762,SPENP021824
SPENP027292	SSQSLVYSDGNTYLNWFQQRPGQSPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021871	SPENO001239	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP028377,SPENP004666;Colon cancer:SPENP021828,SPENP016325,SPENP014630,SPENP006744
SPENP027293	SSTSRPDAYEHTQMK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000097,SPENT000096	SPENG000914	NONHSAG048518.2	0.9817	Others	1.2816	0.2195	0.5102	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021872	SPENO004421	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600,SPENP028748;Colon cancer:SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP027294	STATISGLKPGVDYTITVYAVTGR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.0601	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021873	SPENO001233	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP027295	STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.9637	Others	0.9586	0.3583	0.649	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021874	SPENO001233	Breast cancer:SPENP022121,SPENP022123;Colon cancer:SPENP022120;Lung cancer:SPENP022122
SPENP027296	STDTGVSLPSYEEDQGSK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	-0.1277	Others	-0.6224	0.5401	0.7442	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM021875	SPENO000724	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637,SPENP028750;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP027297	STDTGVSLPSYEEDQGSKLIR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	0.1688	Others	0.3365	0.7442	0.865	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM021876	SPENO000724	Lung cancer:SPENP004575
SPENP027298	STDTGVSLPSYEEDQGSKLIRK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2	0.1204	Others	0.1703	0.8841	0.9446	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM021877	SPENO000724	Liver cancer:SPENP004931
SPENP027301	STLVHSLFLTDLYKDR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001851,SPENT005893,SPENT005806	SPENG002111,SPENG000905	AC000093.1,HSALNG0134042		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021880	SPENO001224	Lung cancer:SPENP004334
SPENP027303	SVMLYAAEMIPK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000482,SPENT000486,SPENT000484,SPENT000487,SPENT000485	SPENG001407	HSALNG0044180		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021882	SPENO005423	
SPENP027309	SYLYFTQFKAEVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000153	SPENG003407	NONHSAG024537.2	0.4025	Others	1.3408	0.1926	0.4985	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021888	SPENO003100	
SPENP027313	SYTITGLQPGTDYKIYLYTLNDNAR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021892	SPENO001233	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Tongue cancer:SPENP028073;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP011036
SPENP027315	TAVAHRPGAFK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000153	SPENG003407	NONHSAG024537.2	-0.0044	Others	-0.0051	0.996	0.9979	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021894	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP028755,SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP006973,SPENP010065,SPENP023922
SPENP027316	TAVAHRPGAFKAELSK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000153	SPENG003407	NONHSAG024537.2	-0.3425	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021895	SPENO003100	Bladder cancer:SPENP011552;Lung cancer:SPENP004303
SPENP027319	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005755,SPENT005753,SPENT005757	SPENG000084	FN1	0.7473	Others	0.9994	0.3509	0.649	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021898	SPENO005834	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP000608,SPENP011123
SPENP027322	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	1.0644	Others	1.2262	0.239	0.5309	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021901	SPENO001233	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP027332	TGLDSPTGIDFSDITANSFTVHWIAPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021911	SPENO001233	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP027338	TIQQMTGKLYMQMRLPK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006300	SPENG004214	HSALNG0009449		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021917	SPENO006490	
SPENP027340	TKTETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021919	SPENO001233	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Tongue cancer:SPENP028096;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP027351	TNTNVNCPIECFMPLDVQADREDSRE	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000578,SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021930	SPENO002376	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP027356	TPIGSFLGSLSLLPATK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000014	SPENG003410	ACAT1	-0.2142	Others	-0.9545	0.3472	0.649	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021935	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700,SPENP028776;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP027360	TSNLLLSHAGILK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000137,SPENT000135,SPENT000136	SPENG000848	lnc-CDK11A-2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM021939	SPENO003659	Bladder cancer:SPENP017399;Colon cancer:SPENP008305,SPENP012777;Lung cancer:SPENP004077;Anal canal cancer:SPENP024668
SPENP027376	VAVNDAHLLQYNHRVK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000025,SPENT000026,SPENT000024,SPENT000309,SPENT000023	SPENG001332	NONHSAG015030.2	-0.2814	Others	-1.782	0.1728	0.4675	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021955	SPENO005335	Liver cancer:SPENP004879
SPENP027377	VDAVTTMPRAASGLSPTALIELCEK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006552,SPENT006514,SPENT006415,SPENT006120	SPENG004266,SPENG004141	lnc-GRID1-6,HSALNG0079382		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021956	SPENO006524,SPENO006533,SPENO006997,SPENO007124	
SPENP027382	VDLRNYLEGIYNVPVAAVR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT006013,SPENT003393	SPENG003837,SPENG002530	NONHSAG106238.1,MRPL23	0.0297	Others	0.1893	0.8515	0.9358	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021961	SPENO001980	
SPENP027398	VIEKVQHIQLLQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005797,SPENT005805	SPENG002649	FGA	-1.248	Others	-2.029	0.0606	0.2755	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021977	SPENO002211	Breast cancer:SPENP018628;Ovary cancer:SPENP018629;Tongue cancer:SPENP028137;Lung cancer:SPENP004130;Liver cancer:SPENP004831;Colon cancer:SPENP007070
SPENP027401	VKADRDESSPYAAMLAAQDVAQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000236,SPENT000237	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2	0.4566	Others	0.8944	0.4008	0.6739	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021980	SPENO003536	Breast cancer:SPENP023136,SPENP023137,SPENP023430;Skin cancer:SPENP025431;Bladder cancer:SPENP011714;Bile duct cancer:SPENP013626;Lung cancer:SPENP007862,SPENP004622,SPENP001966;Prostate cancer:SPENP018483;Colon cancer:SPENP001748,SPENP010970,SPENP007451,SPENP010969,SPENP024282;Leukemia:SPENP001373
SPENP027402	VKEVLPHVPLGVIQR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001183,SPENT001182,SPENT001274	SPENG000169	lnc-DQX1-1	-0.1042	Others	-0.1048	0.9262	0.9634	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021981	SPENO005264	Lung cancer:SPENP002546;Kidney cancer:SPENP020312;Prostate cancer:SPENP018303
SPENP027410	VLSPEYLWDQQLLGWPAVLRK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000795	SPENG002103	lnc-ABO-33		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM021989	SPENO001263	
SPENP027415	VPFLVLECPNLK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000354	SPENG002378	HSALNG0036293	-0.1936	Others	-1.089	0.2912	0.6053	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM021994	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP027420	VQASLAANTFTITGHTEAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005801	SPENG002115	AL136361.1	0.1761	Others	0.6492	0.5241	0.7373	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM021999	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP028409,SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP006664,SPENP010795,SPENP024214
SPENP027421	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000855	SPENG000474	AC016876.2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM022000	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP014703,SPENP016399,SPENP022020
SPENP027424	VRDKLNNLVLFDK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	0.6868	Others	2.3652	0.0288	0.1922	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022003	SPENO005025	Breast cancer:SPENP023352;Anal canal cancer:SPENP024649;Tongue cancer:SPENP028159;Lung cancer:SPENP002371;Prostate cancer:SPENP018239
SPENP027432	VSPHSGVVALTKPVPEPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005785	SPENG001958	FBLN1	0.4168	Others	0.9323	0.3712	0.6554	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022011	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Tongue cancer:SPENP028164;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP024200,SPENP016150,SPENP008580
SPENP027438	VTDATETTITISWR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.8678	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022017	SPENO001233	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP014254,SPENP015931
SPENP027448	VVSSVSKSAWLWPSCGLIPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT002514,SPENT002515	SPENG003593,SPENG001534	HSALNG0037864,lnc-FAM160A1-1	3.3817	Others	0.8972	0.3838	0.6583	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM022027	SPENO006211	
SPENP027466	YAASSYLSLTPEQWK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000080,SPENT000084,SPENT000204,SPENT000203,SPENT000202,SPENT000079,SPENT000201,SPENT000082,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	-0.8544	Others	-2.587	0.0141	0.1541	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	MS	28137767	Immunogenic	SPENM022045	SPENO003223	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572;Leukemia:SPENP001199
SPENP027467	YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.9026	Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022046	SPENO001233	Breast cancer:SPENP022147,SPENP022145;Colon cancer:SPENP022144;Lung cancer:SPENP022146
SPENP027468	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.8038	Others	0.7396	0.4807	0.7057	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022047	SPENO001233	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP016392
SPENP027469	YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	0.6541	Others	0.7409	0.48	0.7057	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022048	SPENO001233	Breast cancer:SPENP009079;Ovary cancer:SPENP016675;Colon cancer:SPENP014701;Lung cancer:SPENP004715,SPENP002976
SPENP027477	YIMVPSGNMGVFDPTEIHNR	Colon cancer	Colon cancer	Extracellular vesicles	SPENT001374,SPENT001373	SPENG003390	HSALNG0010955	0.2639	Others	0.6684	0.5115	0.7343	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022056	SPENO003817	Skin cancer:SPENP025395;Ovary cancer:SPENP029524;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511
SPENP027483	YQGPRDFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Others				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Non-validated			Immunogenic	SPENM022062	SPENO005833	
SPENP027484	YQLDPTASISAK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT000102	SPENG002045	lnc-ACTR2-11	0.3672	Others	1.6533	0.1075	0.3717	JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022063	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP027490	YTRPGLPTFSQEVLHK	Colon cancer	Colon cancer	Extracellular vesicles	SPENT005706	SPENG002661	AC074091.2		Tumor-specific				JPST000867	Tissue-exudative extracellular vesicles of colorectal cancer	Orbitrap Fusion Lumos	Label free	33579815	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM022069	SPENO005905	
SPENP027493	AAALVLQTIWGYK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005788	SPENG002233	AP001931.2	0.7207	Others	2.2694	0.0529	0.1789	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023387	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Lung cancer:SPENP002434,SPENP028224,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP027496	AAQAQGQSCEYSLMVGYQCGQVFR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005795,SPENT005796,SPENT005794,SPENT005785	SPENG001958	FBLN1	-1.505	Others	-1.965	0.0682	0.2002	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023390	SPENO005034	Breast cancer:SPENP021753,SPENP021755;Skin cancer:SPENP025445;Thyroid cancer:SPENP012629,SPENP012628;Ovary cancer:SPENP016651;Bladder cancer:SPENP017889,SPENP011736;Kidney cancer:SPENP020620;Lung cancer:SPENP007881,SPENP021754,SPENP004635;Gastric cancer:SPENP003686,SPENP009691,SPENP003339;Prostate cancer:SPENP013095;Colon cancer:SPENP024290,SPENP011022,SPENP021752,SPENP000569,SPENP026650,SPENP016285,SPENP011021,SPENP014605,SPENP008699,SPENP006724
SPENP027498	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.0787	Others	0.2318	0.8188	0.8659	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023392	SPENO001233	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP028437,SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP027510	AGSVPSLAAGLLFGSLAGLGAYQLSQDPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT002586	SPENG000664	HSALNG0048031	0.4172	Others	1.2409	0.3028	0.4417	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023404	SPENO005017	Colon cancer:SPENP014672;Prostate cancer:SPENP013112
SPENP027515	ALAPTWEQLALGLEHSETVK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.0401	Others	-0.1386	0.891	0.9187	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023409	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP028450,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP027525	ASADELTFHEFEEATNLLADTPDAATTSR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT001420	SPENG000627	lnc-TMED1-2	-2.064	Others	-2.859	0.0244	0.1205	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023419	SPENO002869	Bladder cancer:SPENP011780,SPENP017940;Kidney cancer:SPENP020673;Bile duct cancer:SPENP013670;Anal canal cancer:SPENP024958;Lung cancer:SPENP004697,SPENP002936;Colon cancer:SPENP016370,SPENP014673,SPENP011103,SPENP008750,SPENP011104
SPENP027527	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	1.4241	Others	1.8461	0.0784	0.2125	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023421	SPENO001233	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP028459,SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP027528	ATLVCLISDFYPGAVTVAWK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000080,SPENT000084,SPENT000203,SPENT000204,SPENT000079,SPENT000202,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	0.9473	Others	1.0253	0.3405	0.4717	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023422	SPENO004816	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Lung cancer:SPENP002771,SPENP001949,SPENP028241,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP027540	CDPHEATCYDDGKTYHVGEQWQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.5239	Others	1.9019	0.0704	0.2011	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023434	SPENO001233	Breast cancer:SPENP021675,SPENP021673;Bladder cancer:SPENP011716;Kidney cancer:SPENP020595;Lung cancer:SPENP004626,SPENP007863,SPENP021674;Gastric cancer:SPENP009679,SPENP003335,SPENP015427;Prostate cancer:SPENP009308,SPENP018487;Colon cancer:SPENP021672
SPENP027542	CDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.9758	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023436	SPENO001233	Gastric cancer:SPENP009715,SPENP015467;Colon cancer:SPENP026725;Leukemia:SPENP001397
SPENP027544	CFDHAAGTSYVVGETWEK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023438	SPENO001233	Breast cancer:SPENP005841,SPENP005839,SPENP005843,SPENP005842,SPENP005840;Gastric cancer:SPENP015390
SPENP027545	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	1.0315	Others	2.4456	0.0238	0.1205	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023439	SPENO001233	Bladder cancer:SPENP028467,SPENP017987;Kidney cancer:SPENP020712;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP027566	DIQMTQSPSSLSASVGDR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000841,SPENT000840	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.1111	Others	0.1587	0.8801	0.9172	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023460	SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP029375,SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP027569	DKLNNLVLFDK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	1.6408	Others	1.7357	0.1417	0.2795	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023463	SPENO005025	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Lung cancer:SPENP025588,SPENP028251,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP027573	DLEVVAATPTSLLISWDAPAVTVR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	1.0346	Others	1.8842	0.0728	0.2036	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023467	SPENO001233	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP027574	DLLAPFERLEEEAAVLAPTPTGK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006438	SPENG004138	HSALNG0131445	0.8087	Others	1.0791	0.3086	0.4471	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023468	SPENO007006	
SPENP027583	DMDLTEVITGTLWNLSSHDSIK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005788	SPENG002233	AP001931.2	0.2581	Others	0.749	0.4753	0.6038	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023477	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843,SPENP028495;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP027585	DQCIVDDITYNVNDTFHK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.4674	Others	1.366	0.2223	0.3554	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023479	SPENO001233	Bladder cancer:SPENP028500;Gastric cancer:SPENP009622,SPENP015378;Prostate cancer:SPENP009275
SPENP027590	DRDPNSLLISCAVSYR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005913,SPENT005914	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023484	SPENO006142	Thyroid cancer:SPENP012484,SPENP012485;Ovary cancer:SPENP016562;Kidney cancer:SPENP020383;Gastric cancer:SPENP003239,SPENP003612;Lung cancer:SPENP004327,SPENP002640;Colon cancer:SPENP016077,SPENP014375,SPENP008507,SPENP006600
SPENP027596	DTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005795,SPENT005796,SPENT005794,SPENT005785	SPENG001958	FBLN1		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023490	SPENO005034	Ovary cancer:SPENP016680;Bladder cancer:SPENP017986,SPENP011813;Gastric cancer:SPENP009723,SPENP003715,SPENP003385;Prostate cancer:SPENP018562;Colon cancer:SPENP008773,SPENP011199,SPENP014729,SPENP024344,SPENP011200
SPENP027597	DTLTSRPAQGVVTTLENVSPPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.75	Others	2.5015	0.0203	0.116	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023491	SPENO001233	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828,SPENP028504;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP027598	DTLTSRPAQGVVTTLENVSPPRR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.0892	Others	0.2534	0.8023	0.8527	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023492	SPENO001233	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Bladder cancer:SPENP028505;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP027603	EALCGCSINVPTLDGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000515	SPENG000486	NONHSAG001879.2		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023497	SPENO000704	Bile duct cancer:SPENP013493;Lung cancer:SPENP007733;Prostate cancer:SPENP018322,SPENP012067;Colon cancer:SPENP016075,SPENP007276;Leukemia:SPENP001237
SPENP027609	EEPPRPEFLEQPLLGELTVTGVTPDSLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005913	SPENG001766	AL662884.2		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023503	SPENO002584	Breast cancer:SPENP023189,SPENP023188,SPENP009059;Bladder cancer:SPENP017939;Kidney cancer:SPENP020656;Bile duct cancer:SPENP013662;Lung cancer:SPENP025624,SPENP002928;Colon cancer:SPENP011079,SPENP006757,SPENP011080,SPENP014647,SPENP016352,SPENP008743,SPENP000598
SPENP027612	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.6011	Others	1.147	0.281	0.4217	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023506	SPENO001233	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993,SPENP028515;Kidney cancer:SPENP020718;Colon cancer:SPENP016438,SPENP014740
SPENP027613	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.9247	Others	2.9301	0.008	0.0747	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023507	SPENO001233	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991,SPENP028516;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP027619	EINLAPDSSSVVVSGLMVATKYEVSVYALK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023513	SPENO001233	Breast cancer:SPENP021943,SPENP021941;Kidney cancer:SPENP015237;Lung cancer:SPENP021942;Colon cancer:SPENP021940
SPENP027620	EINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.8419	Others	1.0351	0.3276	0.4635	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023514	SPENO001233	
SPENP027621	EKFTTPIEETGGEGCPAVALIQ	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT003232,SPENT003231,SPENT003230,SPENT003213	SPENG000189	HSALNG0109104	-0.6226	Others	-1.122	0.2945	0.4326	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023515	SPENO002967	
SPENP027640	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.859	Others	1.6032	0.1232	0.2701	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023534	SPENO001233	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764,SPENP028539;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP027645	EVVPRPRPGVTEATITGLEPGTEYTIYVIALK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.4892	Others	1.3603	0.1882	0.3229	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023539	SPENO001233	Breast cancer:SPENP006240,SPENP006243,SPENP006241,SPENP006242,SPENP009078,SPENP022027,SPENP006239,SPENP022025;Skin cancer:SPENP025482;Bladder cancer:SPENP017965,SPENP011797;Kidney cancer:SPENP020696;Gastric cancer:SPENP015476;Lung cancer:SPENP022026,SPENP002977;Prostate cancer:SPENP018551;Colon cancer:SPENP024336,SPENP011166,SPENP022024,SPENP026816,SPENP011165,SPENP016403,SPENP014704
SPENP027660	FLEEYLSSTPQR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT002760	SPENG002531	NONHSAG014457.2	0.3841	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023554	SPENO003138	Skin cancer:SPENP025159;Kidney cancer:SPENP014941;Bile duct cancer:SPENP013357;Lung cancer:SPENP007614,SPENP028269,SPENP026519;Prostate cancer:SPENP012927
SPENP027676	FTTPIEETGGEGCPAVALIQ	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT003232,SPENT003231,SPENT003230,SPENT003213	SPENG000189	HSALNG0109104	-0.2523	Others	-0.5956	0.5647	0.6726	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023570	SPENO002967	
SPENP027698	GEFKCDPHEATCYDDGKTYHVGEQWQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	-1.826	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023592	SPENO001233	Gastric cancer:SPENP015457
SPENP027708	GETGPAGPAGPVGPVGAR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005758	SPENG002845	COL1A1	-0.0404	Others	-0.0991	0.9219	0.9397	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023602	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP028273,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP027744	GNSIIMLEALERV	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT001216,SPENT001214,SPENT001215	SPENG001199,SPENG001060	lnc-FAM136A-1,HSALNG0015798	0.8072	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023638	SPENO002613	Breast cancer:SPENP022629,SPENP022628;Skin cancer:SPENP025212;Bladder cancer:SPENP017449,SPENP011404;Kidney cancer:SPENP020224;Anal canal cancer:SPENP024675;Gastric cancer:SPENP009513;Lung cancer:SPENP004126,SPENP007658,SPENP002407;Prostate cancer:SPENP018216;Colon cancer:SPENP006490,SPENP007065,SPENP024034,SPENP026906,SPENP008313,SPENP010284,SPENP012786,SPENP010283,SPENP014226,SPENP000281,SPENP015902
SPENP027751	GPQRGGGNSPEAHSMALAGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006232	SPENG003943	HSALNG0115270		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023645	SPENO006819	
SPENP027753	GQAGVMGFPGPK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005758	SPENG002845	COL1A1	-0.9772	Others	-1.646	0.1239	0.2701	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023647	SPENO004941	Breast cancer:SPENP023326,SPENP022567,SPENP022566,SPENP008844;Skin cancer:SPENP025131,SPENP019206,SPENP019205,SPENP019207;Bladder cancer:SPENP017332;Kidney cancer:SPENP020123;Bile duct cancer:SPENP013348;Anal canal cancer:SPENP024613;Gastric cancer:SPENP009474;Lung cancer:SPENP025743,SPENP002297,SPENP004010,SPENP026545;Prostate cancer:SPENP018149;Colon cancer:SPENP014122,SPENP015773,SPENP008244,SPENP000178,SPENP010138,SPENP010137,SPENP023956
SPENP027756	GSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNAR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023650	SPENO002211	Gastric cancer:SPENP015485
SPENP027777	HHNQPYCGIAPYIR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000899	SPENG001988	NONHSAG026220.2		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023671	SPENO004425	Bladder cancer:SPENP011477
SPENP027780	HITLCDFIVPWDTLSTTQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT001377,SPENT001376,SPENT001375	SPENG001805,SPENG003577,SPENG001555	lnc-CEP295NL-1,NONHSAG022904.2,HSALNG0119072	-0.058	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023674	SPENO004184	
SPENP027784	HRPRPYPPNVGEEIQIGHIPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005753,SPENT005757	SPENG000084	FN1	0.4453	Others	1.202	0.2526	0.3857	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023678	SPENO005245	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bladder cancer:SPENP028586;Bile duct cancer:SPENP013614;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP027809	ILQAVNFPFLVK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006056	SPENG003803	PRKACA	0.1306	Others	0.4715	0.6474	0.7382	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023703	SPENO003870	
SPENP027827	KEEPPRPEFLEQPLLGELTVTGVTPDSLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005913	SPENG001766	AL662884.2		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023721	SPENO002584	Breast cancer:SPENP009063,SPENP023193,SPENP023192;Bladder cancer:SPENP017945;Kidney cancer:SPENP020674;Lung cancer:SPENP002933;Colon cancer:SPENP024322,SPENP008747,SPENP016368,SPENP014668
SPENP027831	KKTDELPQLVTLPHPNLHGPEILDVPSTVQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005753,SPENT005757	SPENG000084	FN1	1.1026	Others	3.1469	0.0047	0.06	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023725	SPENO005245	Breast cancer:SPENP023203,SPENP023202,SPENP022001,SPENP009073,SPENP022003;Skin cancer:SPENP025477;Thyroid cancer:SPENP012693,SPENP012692;Bladder cancer:SPENP017962,SPENP011794;Kidney cancer:SPENP020693;Bile duct cancer:SPENP013678;Gastric cancer:SPENP015469,SPENP003375;Lung cancer:SPENP004712,SPENP022002,SPENP002967,SPENP007916;Prostate cancer:SPENP009329,SPENP018548;Colon cancer:SPENP022000,SPENP024333,SPENP011148,SPENP006771,SPENP000615,SPENP011147
SPENP027833	KPSVPETEADGFVLLGDTTDEQR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT004088,SPENT004087	SPENG001565,SPENG001726	HSALNG0056067,AC007161.3	-1.847	Others	-2.094	0.0696	0.2002	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	31340039	Immunogenic	SPENM023727	SPENO000152	Bladder cancer:SPENP017851
SPENP027836	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005753,SPENT005757	SPENG000084	FN1	1.3045	Others	2.0454	0.0535	0.1789	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023730	SPENO005245	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP028622,SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP027837	KTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752	SPENG000084	FN1	1.5057	Up-regulated in tumors	6.0132	7.39e-05	0.0028	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023731	SPENO001233	Bladder cancer:SPENP017992;Gastric cancer:SPENP015491;Lung cancer:SPENP003010;Colon cancer:SPENP016433
SPENP027839	KVIEKVQHIQLLQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023733	SPENO002211	Breast cancer:SPENP018642;Ovary cancer:SPENP018643;Colon cancer:SPENP007158,SPENP027042
SPENP027840	KVSPHSGVVALTK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005785	SPENG001958	FBLN1		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023734	SPENO005034	Gastric cancer:SPENP003155
SPENP027841	KVSPHSGVVALTKPVPEPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005785	SPENG001958	FBLN1	-0.8535	Others	-1.49	0.1536	0.2884	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023735	SPENO005034	Breast cancer:SPENP021485,SPENP021487,SPENP023022,SPENP023023;Skin cancer:SPENP025382;Thyroid cancer:SPENP012562,SPENP012563;Ovary cancer:SPENP016612;Bladder cancer:SPENP011646,SPENP017749;Bile duct cancer:SPENP013580;Gastric cancer:SPENP003288,SPENP015393;Lung cancer:SPENP002754,SPENP021486;Colon cancer:SPENP021484,SPENP027044,SPENP010806,SPENP007359,SPENP010805,SPENP024223,SPENP006668
SPENP027850	LGHGELAEHFYLK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006273	SPENG004015	NONHSAG037429.2		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023744	SPENO006949	
SPENP027871	LQAAQLPHTGVFGQSFSCPSDR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000855	SPENG000474	AC016876.2	0.3671	Others	1.1087	0.285	0.4245	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM023765	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Lung cancer:SPENP025875,SPENP028330;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP027872	LQEVAEAANFLALR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006433	SPENG004155	NONHSAG017541.2	2.0551	Others	2.2481	0.0651	0.1956	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023766	SPENO006563	
SPENP027882	LSWTVPEGQFDSFVVQFK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005913	SPENG001766	AL662884.2		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023776	SPENO002584	Bladder cancer:SPENP017719;Kidney cancer:SPENP020466;Lung cancer:SPENP002728;Colon cancer:SPENP014455,SPENP016143
SPENP027909	MILNSLGNFLCMILVSGGC	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006684	SPENG003178	HSALNG0016180		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023803	SPENO006902	
SPENP027916	MLITILGTVKPNANR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000025,SPENT000026,SPENT000024,SPENT000309,SPENT000023	SPENG001332	NONHSAG015030.2	-1.255	Down-regulated in tumors	-3.329	0.003	0.0437	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023810	SPENO005336	Breast cancer:SPENP022768,SPENP008913,SPENP018660,SPENP022769;Skin cancer:SPENP019447,SPENP019445,SPENP019446,SPENP025261;Ovary cancer:SPENP018661;Bladder cancer:SPENP017563;Kidney cancer:SPENP020315;Bile duct cancer:SPENP013448;Anal canal cancer:SPENP024768;Gastric cancer:SPENP009568;Lung cancer:SPENP004239,SPENP001896,SPENP026582,SPENP007708,SPENP002533;Prostate cancer:SPENP018287,SPENP023698,SPENP012047,SPENP012991,SPENP009230;Colon cancer:SPENP027148,SPENP014302,SPENP006550,SPENP015993,SPENP012809,SPENP001636,SPENP010501,SPENP008461,SPENP010502,SPENP024133,SPENP007181
SPENP027919	MLTGFVIVVMDGTDRER	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006466,SPENT006544	SPENG004250,SPENG004075	HSALNG0140520,lnc-CXorf51B-2	-0.0532	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023813	SPENO006449,SPENO006691	
SPENP027924	MPSANLGCVLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006389	SPENG004039	HSALNG0137554		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023818	SPENO007121	
SPENP027925	MPSLCEATAPRSAGVTAPRR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006110	SPENG003893	HSALNG0018619		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023819	SPENO006794	
SPENP027931	MVSTCILAFTDHSGLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006396	SPENG004014	HSALNG0048733	-1.677	Others	-2.214	0.0577	0.1845	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023825	SPENO006608	
SPENP027957	NSITLTNLTPGTEYVVSIVALNGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.5661	Others	2.2583	0.0342	0.1445	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023851	SPENO001233	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP027958	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.3627	Others	1.2156	0.243	0.3765	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023852	SPENO001233	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994,SPENP028702;Kidney cancer:SPENP020717;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP027960	NSSFQKPQMTVPLSR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006601	SPENG003961	HSALNG0083682		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023854	SPENO006392	
SPENP027969	PGFGLSPIFPGGACLGK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005787,SPENT005792,SPENT005791,SPENT001282,SPENT005790,SPENT005786	SPENG001189,SPENG001044	NONHSAG047951.2,ELN	1.1532	Others	1.3409	0.2338	0.3664	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023863	SPENO001279	
SPENP027973	PGVTEATITGLEPGTEYTIYVIALK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.5491	Others	1.4192	0.1698	0.3012	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023867	SPENO001233	Breast cancer:SPENP006133,SPENP006130,SPENP006132,SPENP006131,SPENP006129;Gastric cancer:SPENP015445
SPENP027974	PGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023868	SPENO001233	
SPENP027980	PRPGVTEATITGLEPGTEYTIYVIALK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.5421	Others	2.5059	0.0201	0.116	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023874	SPENO001233	Breast cancer:SPENP006160,SPENP006163,SPENP006161,SPENP006159,SPENP006162;Gastric cancer:SPENP003359,SPENP015456;Prostate cancer:SPENP018526;Colon cancer:SPENP000587
SPENP027981	PRPGVTEATITGLEPGTEYTIYVIALKNNQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	-0.1894	Others	-0.2389	0.8152	0.8642	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023875	SPENO001233	Gastric cancer:SPENP015471
SPENP027983	PSASSLLSHVFFK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT001459,SPENT001460	SPENG001410,SPENG000853	lnc-SLC5A9-8,lnc-GIMAP6-4	-0.1533	Others	-0.503	0.6363	0.73	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023877	SPENO001993	Gastric cancer:SPENP003160
SPENP027985	PWLIYNGTSVMKK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT004103	SPENG000463	lnc-PLA2G4A-7		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023879	SPENO004954	Prostate cancer:SPENP018213
SPENP027997	QGLYELSASNFELHVAQGDHFIK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000040	SPENG000572	lnc-EEF1E1-2	-0.7766	Others	-2.044	0.0803	0.2149	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023891	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP028363,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP028002	QKTGLDSPTGIDFSDITANSFTVHWIAPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.6471	Others	1.7229	0.0989	0.2338	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023896	SPENO001233	Breast cancer:SPENP009064,SPENP021915,SPENP021913;Skin cancer:SPENP025469;Bladder cancer:SPENP011775,SPENP017941;Kidney cancer:SPENP020676;Lung cancer:SPENP021914,SPENP004695,SPENP002945;Gastric cancer:SPENP003366,SPENP015463;Prostate cancer:SPENP018537;Colon cancer:SPENP024323,SPENP011107,SPENP021912,SPENP027203,SPENP011108;Leukemia:SPENP001395
SPENP028008	QTYYTNYTYIFLYGVCTFQGETR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006601	SPENG003961	HSALNG0083682		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023902	SPENO006392	
SPENP028012	QYNVGPSVSKYPLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.9821	Others	2.3688	0.0275	0.1279	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023906	SPENO001233	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444,SPENP028721;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP028015	RLVQSPNSYFMDVK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000045,SPENT000059,SPENT000412,SPENT000053,SPENT000065,SPENT000058,SPENT000051,SPENT000050,SPENT000411,SPENT000046,SPENT000414,SPENT000413,SPENT000334,SPENT000333,SPENT000332,SPENT000061,SPENT000054	SPENG001895,SPENG001424,SPENG002815,SPENG000525,SPENG000913,SPENG003112,SPENG003710,SPENG002988,SPENG003527,SPENG003256,SPENG001333,SPENG002909,SPENG003320,SPENG002458	HSALNG0059584,HSALNG0033296,HSALNG0106470,HSALNG0093500,lnc-ZNF726-7,HSALNG0002636,lnc-RPS27L-3,lnc-PACRGL-9,lnc-DNALI1-1,lnc-SYT2-4,HSALNG0009725,lnc-CALCR-1,lnc-UTP20-1,HSALNG0125051		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023909	SPENO003973	Bladder cancer:SPENP017489;Lung cancer:SPENP004159;Prostate cancer:SPENP018273;Colon cancer:SPENP010431,SPENP015936,SPENP027224,SPENP010432,SPENP014253,SPENP006523
SPENP028018	RPHETGGYMLECVCLGNGK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.9042	Others	3.401	0.0026	0.0388	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023912	SPENO001233	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Bladder cancer:SPENP028724;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP028035	SFHFSLPSSWYYR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000758,SPENT000757	SPENG002919,SPENG002352	HSALNG0010097,NONHSAG004121.2	0.6987	Others	2.5752	0.0176	0.1066	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023929	SPENO003826	Skin cancer:SPENP025179;Bladder cancer:SPENP017472;Kidney cancer:SPENP020160;Lung cancer:SPENP002408;Prostate cancer:SPENP012965;Colon cancer:SPENP015909,SPENP001570,SPENP010328,SPENP010327,SPENP024046
SPENP028039	SGDRGETGPAGPAGPVGPVGAR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005758	SPENG002845	COL1A1	0.0432	Others	0.1338	0.8948	0.9187	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023933	SPENO004941	Breast cancer:SPENP023121,SPENP023427,SPENP023120,SPENP009022;Skin cancer:SPENP019671,SPENP019672,SPENP025426,SPENP019670;Thyroid cancer:SPENP012608,SPENP012609;Bladder cancer:SPENP011705,SPENP017832;Kidney cancer:SPENP015204,SPENP020585;Bile duct cancer:SPENP013622;Anal canal cancer:SPENP024914;Lung cancer:SPENP026599,SPENP004594,SPENP001964,SPENP002840,SPENP026025,SPENP007853;Gastric cancer:SPENP003676,SPENP003322;Prostate cancer:SPENP018475,SPENP013084,SPENP023776,SPENP012122;Colon cancer:SPENP012857,SPENP008673,SPENP010964,SPENP016263,SPENP010963,SPENP026419,SPENP000532,SPENP024268,SPENP027253,SPENP001733,SPENP006703,SPENP007433,SPENP014579;Leukemia:SPENP001364
SPENP028041	SGTLYSLTLYGLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005913,SPENT005914	SPENG003870,SPENG001766	AL662884.2,Lnc-DXO-2	2.6172	Others	2.1922	0.0709	0.2012	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023935	SPENO006142	Breast cancer:SPENP008873,SPENP022627,SPENP022626;Bladder cancer:SPENP017475;Kidney cancer:SPENP020166;Gastric cancer:SPENP003167;Lung cancer:SPENP002411;Colon cancer:SPENP015890,SPENP027254,SPENP024013,SPENP014229
SPENP028044	SITEIAPTGIESLPVNFALR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006406,SPENT006178,SPENT006349	SPENG003881	AC079594.1		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023938	SPENO006429,SPENO006789,SPENO007001	
SPENP028052	SLSLNPFLWSPFESLCEIGEKPDPDQTFK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005452	SPENG002651	lnc-CDC27-7		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023946	SPENO005295	Colon cancer:SPENP014676,SPENP016377
SPENP028055	SPDSQPRPMLLAAEDAFGSHQVSR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006381	SPENG004103	HSALNG0085700		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023949	SPENO006598	
SPENP028063	STATISGLKPGVDYTITVYAVTGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	-0.227	Others	-0.4586	0.651	0.7403	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023957	SPENO001233	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888,SPENP028749;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP028073	SYTITGLQPGTDYKIYLYTLNDNAR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.9837	Others	10.2935	0.0005	0.0118	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023967	SPENO001233	Breast cancer:SPENP021789,SPENP021791;Bile duct cancer:SPENP013645;Lung cancer:SPENP021790,SPENP004650;Colon cancer:SPENP011035,SPENP021788,SPENP024303,SPENP027313,SPENP011036
SPENP028076	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005753,SPENT005757	SPENG000084	FN1	0.6161	Others	1.3057	0.2091	0.3441	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023970	SPENO005245	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP028756,SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP028079	TETITGFQVDAVPANGQTPIQR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.3441	Others	0.9656	0.3486	0.4772	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023973	SPENO001233	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP028083	TFYSCTTEGRQDGHLWCSTTSNYEQDQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.7818	Others	1.5218	0.1885	0.3229	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023977	SPENO001233	Breast cancer:SPENP021883,SPENP021881;Bladder cancer:SPENP011773;Gastric cancer:SPENP015460;Lung cancer:SPENP021882,SPENP007899,SPENP004687;Colon cancer:SPENP021880,SPENP014658,SPENP016367,SPENP008740
SPENP028085	TGLDSPTGIDFSDITANSFTVHWIAPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.7103	Others	1.4755	0.1661	0.2978	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023979	SPENO001233	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920,SPENP028764;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP028086	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023980	SPENO001233	Breast cancer:SPENP022061,SPENP022063;Bladder cancer:SPENP028765;Lung cancer:SPENP022062;Colon cancer:SPENP022060
SPENP028090	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752	SPENG000084	FN1	1.364	Up-regulated in tumors	4.0175	0.0012	0.0222	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023984	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP028766,SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP028096	TKTETITGFQVDAVPANGQTPIQR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.2861	Others	0.9437	0.3556	0.4836	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023990	SPENO001233	Breast cancer:SPENP006121,SPENP006120,SPENP023152,SPENP006122,SPENP023153,SPENP009034,SPENP021713,SPENP006123,SPENP006119,SPENP021715,SPENP023434;Skin cancer:SPENP019692,SPENP019691,SPENP025446,SPENP019693;Thyroid cancer:SPENP012638,SPENP012639;Bladder cancer:SPENP011725,SPENP017885;Kidney cancer:SPENP020628;Bile duct cancer:SPENP013642;Anal canal cancer:SPENP024934;Gastric cancer:SPENP009687,SPENP003336;Lung cancer:SPENP002881,SPENP001967,SPENP004637,SPENP021714,SPENP007875,SPENP026090;Prostate cancer:SPENP018498,SPENP013099,SPENP009314;Colon cancer:SPENP006727,SPENP000570,SPENP011026,SPENP027340,SPENP011025,SPENP001754,SPENP021712,SPENP024293,SPENP007456
SPENP028100	TLGDAYEFAVDVR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT001725	SPENG003418	lnc-HSPB7-2		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023994	SPENO000209	Lung cancer:SPENP004086
SPENP028103	TNTNVNCPIECFMPLDVQADR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.2979	Others	0.7356	0.4697	0.6023	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023997	SPENO001233	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP028104	TNTNVNCPIECFMPLDVQADREDSR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	-0.5418	Others	-1.066	0.3	0.439	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023998	SPENO001233	Gastric cancer:SPENP009699;Prostate cancer:SPENP009320
SPENP028105	TNTNVNCPIECFMPLDVQADREDSRE	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.2404	Others	0.6926	0.4958	0.6205	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023999	SPENO001233	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP028773,SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP028110	TQFLPPNLLALFAPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000899	SPENG001988	NONHSAG026220.2		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024004	SPENO004425	Breast cancer:SPENP008905
SPENP028137	VIEKVQHIQLLQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005797,SPENT005805	SPENG002649	FGA		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM024031	SPENO002211	Breast cancer:SPENP018628;Ovary cancer:SPENP018629;Lung cancer:SPENP004130;Liver cancer:SPENP004831;Colon cancer:SPENP007070,SPENP027398
SPENP028143	VMVQPINLIFR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT002270,SPENT002272,SPENT002269,SPENT002267,SPENT002268,SPENT002271,SPENT002273	SPENG003098,SPENG003309,SPENG001915,SPENG003607,SPENG000941,SPENG003601,SPENG000906	lnc-ID2-3,lnc-ZC3H12D-15,HSALNG0054220,HSALNG0012839,lnc-FABP6-3,HSALNG0046238,lnc-GLDC-5	-0.4048	Others	-1.527	0.1557	0.2889	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM024037	SPENO003493	Breast cancer:SPENP008819;Liver cancer:SPENP004794;Kidney cancer:SPENP014910;Lung cancer:SPENP026626;Prostate cancer:SPENP012898
SPENP028157	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000855	SPENG000474	AC016876.2	-0.001	Others	-0.002	0.9984	0.9992	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM024051	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Lung cancer:SPENP022022,SPENP028410,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP028159	VRDKLNNLVLFDK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024053	SPENO005025	Breast cancer:SPENP023352;Anal canal cancer:SPENP024649;Lung cancer:SPENP002371;Prostate cancer:SPENP018239;Colon cancer:SPENP027424
SPENP028164	VSPHSGVVALTKPVPEPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005785	SPENG001958	FBLN1	-0.9023	Others	-1.766	0.0953	0.2312	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024058	SPENO005034	Breast cancer:SPENP021393,SPENP022988,SPENP022989,SPENP021395;Skin cancer:SPENP025365;Thyroid cancer:SPENP012509,SPENP012508;Ovary cancer:SPENP016597;Bladder cancer:SPENP017732;Kidney cancer:SPENP020495;Bile duct cancer:SPENP013549;Anal canal cancer:SPENP024848;Gastric cancer:SPENP003632,SPENP015383,SPENP003268;Lung cancer:SPENP004468,SPENP021394,SPENP002696;Prostate cancer:SPENP018399,SPENP009099;Colon cancer:SPENP014442,SPENP010735,SPENP006647,SPENP010736,SPENP021392,SPENP027432,SPENP024200,SPENP016150,SPENP008580
SPENP028169	VSYLEPQNLRGPQRGGGNSPEAHSMALAGR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT006232	SPENG003943	HSALNG0115270		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Non-validated			Immunogenic	SPENM024063	SPENO006819	
SPENP028171	VTDATETTITISWR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.4516	Others	0.5363	0.5976	0.7062	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024065	SPENO001233	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457,SPENP028810;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP028184	VYYTAGYNSPVK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000754	SPENG000115	HSALNG0053823		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024078	SPENO001372	Gastric cancer:SPENP003529;Lung cancer:SPENP001844,SPENP028417
SPENP028188	WKCDPVDQCQDSETGTFYQIGDSWEKYVHGVR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	-0.33	Others	-1.47	0.2015	0.3342	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024082	SPENO001233	Gastric cancer:SPENP015474
SPENP028195	YAASSYLSLTPEQWK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000080,SPENT000084,SPENT000203,SPENT000204,SPENT000079,SPENT000202,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	2.2209	Others	2.442	0.058	0.1845	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM024089	SPENO004816	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP028421,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP028200	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT005752,SPENT005753,SPENT005757,SPENT005756	SPENG000084	FN1	0.4815	Others	1.1094	0.2811	0.4217	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024094	SPENO001233	Breast cancer:SPENP009076;Bladder cancer:SPENP028831;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP016392,SPENP027468
SPENP028202	YFILPDSLPLDTLLVDVEPK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000928	SPENG002213	HSALNG0120314		Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024096	SPENO000238	Bile duct cancer:SPENP013597;Lung cancer:SPENP026636,SPENP026177,SPENP001946;Skin cancer:SPENP025399
SPENP028213	YMALSLQSFCPTTR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT001640	SPENG000521	AMPD2	0.4765	Others				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024107	SPENO000624	Bladder cancer:SPENP017484;Kidney cancer:SPENP020270
SPENP028219	YQLDPTASISAK	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000102	SPENG002045	lnc-ACTR2-11	0.5861	Others	2.5055	0.0292	0.129	MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024113	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395,SPENP028840;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP028220	YRDPTTVTTLR	Tongue cancer	Tongue cancer	Fibroblasts exosomes	SPENT000087	SPENG002460	PPP2R2A		Tumor-specific				MSV000081585	Proteomics of Cancer Associated Fibroblasts in Tongue Cancer	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024114	SPENO004740	Lung cancer:SPENP002286
SPENP028224	AAALVLQTIWGYK	Lung cancer	Lung cancer	Lung	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022765	SPENO005858	Breast cancer:SPENP022611,SPENP022610;Skin cancer:SPENP025213;Bladder cancer:SPENP017408;Prostate cancer:SPENP023634,SPENP018214;Kidney cancer:SPENP020217,SPENP014971;Anal canal cancer:SPENP024642;Tongue cancer:SPENP027493;Lung cancer:SPENP002434,SPENP004065;Liver cancer:SPENP004833;Colon cancer:SPENP006468,SPENP015886,SPENP010294,SPENP014174,SPENP010293,SPENP024020,SPENP026642,SPENP001574
SPENP028228	ACLDYPVTSVLPPASLCK	Lung cancer	Lung cancer	Lung	SPENT002507	SPENG002379	NONHSAG033050.2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022769	SPENO004482	Lung cancer:SPENP025512;Colon cancer:SPENP007326,SPENP006646;Bladder cancer:SPENP017716,SPENP011635,SPENP028438;Prostate cancer:SPENP009279
SPENP028237	ALTPAFLVCVGSSPFCK	Lung cancer	Lung cancer	Lung	SPENT005897,SPENT005899,SPENT005898	SPENG002951	MROH7-TTC4		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022778	SPENO004880	
SPENP028239	ARPSSPGFSVLTCSAFSFYPPELQLR	Lung cancer	Lung cancer	Lung	SPENT001923	SPENG003047	NONHSAG026245.2	-0.1886	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022780	SPENO000727	
SPENP028241	ATLVCLISDFYPGAVTVAWK	Lung cancer	Lung cancer	Lung	SPENT000080,SPENT000084,SPENT000203,SPENT000204,SPENT000079,SPENT000202,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	0.1981	Others	0.2191	0.8292	0.988	MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022782	SPENO004816	Breast cancer:SPENP023057,SPENP023056;Skin cancer:SPENP025406;Thyroid cancer:SPENP012580,SPENP012581;Bladder cancer:SPENP011660,SPENP017777;Kidney cancer:SPENP020534,SPENP015181;Bile duct cancer:SPENP013588;Anal canal cancer:SPENP024889;Tongue cancer:SPENP027528;Lung cancer:SPENP002771,SPENP001949,SPENP025550;Gastric cancer:SPENP015402;Prostate cancer:SPENP023762;Colon cancer:SPENP010877,SPENP014528,SPENP006681,SPENP010878,SPENP007406
SPENP028242	AVIVIQDIFGWQLPNTR	Lung cancer	Lung cancer	Lung	SPENT000070,SPENT000071,SPENT000069,SPENT000068	SPENG000619,SPENG000202	lnc-FAM173B-8,NONHSAG039866.2	1.1239	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022783	SPENO005495	
SPENP028243	AYCHILLGNYCVAVADAK	Lung cancer	Lung cancer	Lung	SPENT006474	SPENG004106	lnc-BAG1-2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022784	SPENO006613	
SPENP028251	DKLNNLVLFDK	Lung cancer	Lung cancer	Lung	SPENT000042,SPENT000022,SPENT000043,SPENT000021	SPENG003042,SPENG003226,SPENG001136	lnc-BBOX1-9,lnc-RPS25-2,lnc-ATG12-3	2.1266	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022792	SPENO003205	Breast cancer:SPENP022442,SPENP023288,SPENP022443;Skin cancer:SPENP025119;Bladder cancer:SPENP017308;Liver cancer:SPENP004801;Kidney cancer:SPENP020067;Bile duct cancer:SPENP013272;Anal canal cancer:SPENP024521;Tongue cancer:SPENP027569;Lung cancer:SPENP025588,SPENP003960,SPENP002274;Prostate cancer:SPENP018098,SPENP012900;Colon cancer:SPENP008178,SPENP000146,SPENP010115,SPENP001531,SPENP006955,SPENP010116,SPENP023935,SPENP026755;Leukemia:SPENP001004
SPENP028262	ETSVTPSNLWGGQGLLGVSIR	Lung cancer	Lung cancer	Lung	SPENT000615	SPENG001618	NONHSAG029796.2	0.4878	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022803	SPENO003428	Breast cancer:SPENP023091,SPENP023090;Colon cancer:SPENP001727,SPENP000530,SPENP006694;Lung cancer:SPENP025659;Prostate cancer:SPENP012117
SPENP028269	FLEEYLSSTPQR	Lung cancer	Lung cancer	Lung	SPENT002760	SPENG002531	NONHSAG014457.2		Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022810	SPENO003138	Skin cancer:SPENP025159;Kidney cancer:SPENP014941;Bile duct cancer:SPENP013357;Tongue cancer:SPENP027660;Lung cancer:SPENP007614,SPENP026519;Prostate cancer:SPENP012927
SPENP028273	GETGPAGPAGPVGPVGAR	Lung cancer	Lung cancer	Lung	SPENT005758	SPENG002845	COL1A1	0.1898	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022814	SPENO004941	Breast cancer:SPENP008961,SPENP022966,SPENP022967,SPENP023415;Skin cancer:SPENP019563,SPENP019564,SPENP019562,SPENP025368;Bladder cancer:SPENP017744,SPENP011633;Prostate cancer:SPENP018410;Kidney cancer:SPENP015144,SPENP020490;Bile duct cancer:SPENP013543;Anal canal cancer:SPENP024846;Tongue cancer:SPENP027708;Lung cancer:SPENP004465,SPENP001934,SPENP026533,SPENP002716,SPENP007795,SPENP025715;Gastric cancer:SPENP003280,SPENP003641,SPENP009636;Liver cancer:SPENP000733;Colon cancer:SPENP014468,SPENP000460,SPENP024209,SPENP010762,SPENP026309,SPENP001692,SPENP006648,SPENP007334,SPENP010761,SPENP008560,SPENP016124;Leukemia:SPENP001302
SPENP028280	GNEFLFSHLWPLIEK	Lung cancer	Lung cancer	Lung	SPENT002175	SPENG000523	NONHSAG026963.2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022821	SPENO003701	Breast cancer:SPENP008914,SPENP022826,SPENP022827;Kidney cancer:SPENP015069;Prostate cancer:SPENP023684
SPENP028282	GWAPTFLGYSMQGLCK	Lung cancer	Lung cancer	Lung	SPENT000866	SPENG001380	HSALNG0093396	-0.2545	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022823	SPENO003323	
SPENP028288	HEVTILGGLNEFVVK	Lung cancer	Lung cancer	Lung	SPENT002405	SPENG002844	HSALNG0061330	1.5987	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022829	SPENO003324	Breast cancer:SPENP005660,SPENP005662,SPENP005661,SPENP005659,SPENP005663;Colon cancer:SPENP008447
SPENP028299	ISQAEEEDQQLLGHLLLVAK	Lung cancer	Lung cancer	Lung	SPENT002815	SPENG000837	lnc-HINT2-1	0.6481	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022840	SPENO001580	Breast cancer:SPENP008997;Skin cancer:SPENP025405;Bladder cancer:SPENP028609;Lung cancer:SPENP007835;Prostate cancer:SPENP023755;Colon cancer:SPENP012845
SPENP028311	LDYFLLSHSLLPALCDSK	Lung cancer	Lung cancer	Lung	SPENT006647	SPENG001074	HSALNG0099800	1.2261	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022852	SPENO006588	
SPENP028314	LGALSGAAALGFASYGAHGAQFPDAYGK	Lung cancer	Lung cancer	Lung	SPENT000624,SPENT000623,SPENT000620,SPENT000622,SPENT000621	SPENG002150	lnc-PLSCR3-1		Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022855	SPENO000755	Breast cancer:SPENP006177,SPENP006178,SPENP006175,SPENP006176,SPENP006174;Skin cancer:SPENP019726,SPENP019724,SPENP019725;Thyroid cancer:SPENP012672,SPENP012673;Bladder cancer:SPENP017937;Kidney cancer:SPENP020660,SPENP015230;Lung cancer:SPENP002927;Prostate cancer:SPENP012134,SPENP013109,SPENP018531;Colon cancer:SPENP024318,SPENP001770,SPENP011098,SPENP011097,SPENP016349
SPENP028315	LHDVEHVLIDVGTGYYVEK	Lung cancer	Lung cancer	Lung	SPENT002156	SPENG002374	NONHSAG011229.2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022856	SPENO002604	Breast cancer:SPENP005896,SPENP005898,SPENP005894,SPENP005895,SPENP005897
SPENP028320	LLDGEAALPAVVFLHGLFGSK	Lung cancer	Lung cancer	Lung	SPENT000073,SPENT000072,SPENT000074	SPENG002534,SPENG000354	NONHSAG047943.2,lnc-STX1A-1		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022861	SPENO004128	Lung cancer:SPENP026570;Leukemia:SPENP001356
SPENP028325	LLLLESVSGLLQPR	Lung cancer	Lung cancer	Lung	SPENT001258	SPENG001048	lnc-CXCL16-3		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022866	SPENO003005	Colon cancer:SPENP010362,SPENP006509,SPENP010361;Lung cancer:SPENP002464
SPENP028330	LQAAQLPHTGVFGQSFSCPSDR	Lung cancer	Lung cancer	Lung	SPENT000855	SPENG000474	AC016876.2	0.7377	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM022871	SPENO004050	Thyroid cancer:SPENP012592,SPENP012593;Bladder cancer:SPENP017841;Kidney cancer:SPENP020579;Bile duct cancer:SPENP013624;Tongue cancer:SPENP027871;Lung cancer:SPENP025875;Prostate cancer:SPENP013085;Colon cancer:SPENP000538,SPENP027092,SPENP001740
SPENP028339	MLAGEMLAIQGSSGFIR	Lung cancer	Lung cancer	Lung	SPENT006631,SPENT006168	SPENG004062	lnc-ATP13A4-5		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022880	SPENO006798,SPENO006972	
SPENP028342	MPPSPDFLFFVGGQFSHVAQAGLK	Lung cancer	Lung cancer	Lung	SPENT006478	SPENG004008	HSALNG0055595		Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022883	SPENO007113	
SPENP028344	MSLSVNLGGWRYMPR	Lung cancer	Lung cancer	Lung	SPENT006129,SPENT006296	SPENG004205	EGOT	0.0769	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022885	SPENO006459,SPENO006641	
SPENP028348	NENALEAGDYFWTPASPSIVSAK	Lung cancer	Lung cancer	Lung	SPENT006570	SPENG003928	lnc-CTSZ-12		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022889	SPENO007013	
SPENP028352	NGMEAPGIWALGR	Lung cancer	Lung cancer	Lung	SPENT006492,SPENT006130,SPENT006270	SPENG003885	HSALNG0053931	-1.227	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022893	SPENO006421,SPENO006645,SPENO006978	
SPENP028356	NNQLVAGYLQGPNVNLEEK	Lung cancer	Lung cancer	Lung	SPENT001357	SPENG002580	NONHSAG028996.2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022897	SPENO002732	Colon cancer:SPENP000479,SPENP014503;Lung cancer:SPENP002759,SPENP025965
SPENP028358	NSITLTNLTPGTEYVVSIVALNGR	Lung cancer	Lung cancer	Lung	SPENT005757,SPENT005753,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	1.6765	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022899	SPENO005834	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP028362	NVQLLSQFVSPFTGCIYGR	Lung cancer	Lung cancer	Lung	SPENT000847	SPENG000825	HSALNG0035586		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022903	SPENO003852	Colon cancer:SPENP016180,SPENP014507,SPENP001705;Kidney cancer:SPENP020507
SPENP028363	QGLYELSASNFELHVAQGDHFIK	Lung cancer	Lung cancer	Lung	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022904	SPENO005833	Breast cancer:SPENP009031;Skin cancer:SPENP025434;Bladder cancer:SPENP017859;Kidney cancer:SPENP015212,SPENP020606;Bile duct cancer:SPENP013631;Tongue cancer:SPENP027997;Gastric cancer:SPENP003326,SPENP009677;Lung cancer:SPENP004616,SPENP025987,SPENP002847,SPENP007869;Liver cancer:SPENP004933,SPENP000765;Colon cancer:SPENP006711,SPENP008693,SPENP024275,SPENP027201,SPENP000554,SPENP001744
SPENP028377	SSQSLVYSDGNTYLNWFQQRPGQSPR	Lung cancer	Lung cancer	Lung	SPENT000750,SPENT000746	SPENG001679,SPENG000040	lnc-EIF2AK3-4,NONHSAG028467.3	0.2549	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022918	SPENO001239	Breast cancer:SPENP021829,SPENP018702,SPENP006158,SPENP006156,SPENP006154,SPENP021831,SPENP006157,SPENP006155;Thyroid cancer:SPENP012653,SPENP012652;Ovary cancer:SPENP018703;Kidney cancer:SPENP020643;Gastric cancer:SPENP015450,SPENP003357;Lung cancer:SPENP002908,SPENP021830,SPENP004666;Colon cancer:SPENP021828,SPENP027292,SPENP016325,SPENP014630,SPENP006744
SPENP028378	STAAMSTYTGIFTDQVLSVLK	Lung cancer	Lung cancer	Lung	SPENT001116,SPENT001117	SPENG001123	NONHSAG026012.2		Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022919	SPENO003134	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP029445,SPENP016232
SPENP028393	TYYMSGGLQPVPIVFR	Lung cancer	Lung cancer	Lung	SPENT005260	SPENG001570	lnc-ACOX2-2	0.3627	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022934	SPENO003207	Colon cancer:SPENP012817
SPENP028394	VALAGLLGFGLGK	Lung cancer	Lung cancer	Lung	SPENT003237	SPENG001444	lnc-OCIAD2-2	1.9646	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022935	SPENO002971	Breast cancer:SPENP022650,SPENP022651;Colon cancer:SPENP010336,SPENP010335,SPENP024026;Lung cancer:SPENP026618;Prostate cancer:SPENP018206,SPENP012954
SPENP028401	VLLESEQFLTELTR	Lung cancer	Lung cancer	Lung	SPENT000770,SPENT000771	SPENG003446,SPENG001736	HSALNG0105192,lnc-BMF-3		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022942	SPENO003633	Breast cancer:SPENP008897;Liver cancer:SPENP000690,SPENP004858;Gastric cancer:SPENP009529;Lung cancer:SPENP026623;Prostate cancer:SPENP012976,SPENP012026;Colon cancer:SPENP012790,SPENP001600
SPENP028404	VPFLVLECPNLK	Lung cancer	Lung cancer	Lung	SPENT000354	SPENG002378	HSALNG0036293	-0.3042	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022945	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP028804,SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP028409	VQASLAANTFTITGHTEAK	Lung cancer	Lung cancer	Lung	SPENT005801	SPENG002115	AL136361.1		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Non-validated			Immunogenic	SPENM022950	SPENO005109	Breast cancer:SPENP008979;Skin cancer:SPENP019583,SPENP019585,SPENP025371,SPENP019584;Bladder cancer:SPENP017761;Kidney cancer:SPENP020498;Anal canal cancer:SPENP024867;Lung cancer:SPENP004484;Prostate cancer:SPENP018425;Colon cancer:SPENP007364,SPENP008595,SPENP010796,SPENP016183,SPENP014495,SPENP027420,SPENP006664,SPENP010795,SPENP024214
SPENP028410	VQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQK	Lung cancer	Lung cancer	Lung	SPENT000855	SPENG000474	AC016876.2		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM022951	SPENO004050	Breast cancer:SPENP022023,SPENP022021;Tongue cancer:SPENP028157;Lung cancer:SPENP022022,SPENP002975;Prostate cancer:SPENP018550;Colon cancer:SPENP027421,SPENP014703,SPENP016399,SPENP022020
SPENP028411	VSSLPLLLPYWR	Lung cancer	Lung cancer	Lung	SPENT002175	SPENG000523	NONHSAG026963.2	0.4556	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022952	SPENO003701	Breast cancer:SPENP022518,SPENP022519
SPENP028414	VVLEGPAPWGFR	Lung cancer	Lung cancer	Lung	SPENT002977,SPENT002976	SPENG001612,SPENG001042	lnc-PDLIM7-3,NONHSAG042359.2	-0.3262	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022955	SPENO003881	Skin cancer:SPENP019123,SPENP025133,SPENP019122,SPENP019121
SPENP028416	VYADGIFDLFHSGHAR	Lung cancer	Lung cancer	Lung	SPENT006508,SPENT006532,SPENT006560	SPENG003967	lnc-TCTEX1D2-1		Tumor-specific				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022957	SPENO006465,SPENO006824,SPENO006991	
SPENP028417	VYYTAGYNSPVK	Lung cancer	Lung cancer	Lung	SPENT000754	SPENG000115	HSALNG0053823	1.7438	Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022958	SPENO001372	Gastric cancer:SPENP003529;Tongue cancer:SPENP028184;Lung cancer:SPENP001844
SPENP028421	YAASSYLSLTPEQWK	Lung cancer	Lung cancer	Lung	SPENT000080,SPENT000084,SPENT000203,SPENT000204,SPENT000079,SPENT000202,SPENT000082,SPENT000201,SPENT000083,SPENT000081	SPENG000666	NONHSAG033390.3	-0.0172	Others	-0.0153	0.988	0.988	MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	MS	28137767	Immunogenic	SPENM022962	SPENO004816	Breast cancer:SPENP022772,SPENP022773,SPENP005703,SPENP005702,SPENP005700,SPENP005699,SPENP023380,SPENP005701;Skin cancer:SPENP019464,SPENP019465,SPENP019463,SPENP025290;Thyroid cancer:SPENP012416,SPENP012417;Bladder cancer:SPENP011524,SPENP017569;Kidney cancer:SPENP015052,SPENP020356;Bile duct cancer:SPENP013455;Anal canal cancer:SPENP024763;Tongue cancer:SPENP028195;Lung cancer:SPENP001897,SPENP026173,SPENP007710,SPENP026635,SPENP002563,SPENP004286;Gastric cancer:SPENP015345;Prostate cancer:SPENP012054,SPENP023699;Colon cancer:SPENP007211,SPENP024106,SPENP010520,SPENP010519,SPENP014321,SPENP006572,SPENP027466;Leukemia:SPENP001199
SPENP028422	YAMVYGYNAAYNR	Lung cancer	Lung cancer	Lung	SPENT000923,SPENT000924,SPENT000922,SPENT000921	SPENG002810,SPENG000560	NONHSAG010580.2,HSALNG0089530		Others				MSV000083969	Lung cancer and Normal Lung Tissue LC-MS/MS	LTQ Orbitrap	Label free	4274035	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022963	SPENO005596	Breast cancer:SPENP022653,SPENP008864,SPENP022652;Skin cancer:SPENP025220;Bladder cancer:SPENP017428;Kidney cancer:SPENP020228,SPENP014990;Bile duct cancer:SPENP013403;Gastric cancer:SPENP003164;Lung cancer:SPENP004055,SPENP001858,SPENP007645,SPENP002412;Prostate cancer:SPENP012015;Colon cancer:SPENP015869
SPENP028437	AAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005793,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.978	Others	-1.752	0.1386	0.2119	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022978	SPENO001233	Breast cancer:SPENP023213,SPENP023212,SPENP022053,SPENP022055;Skin cancer:SPENP025488;Thyroid cancer:SPENP012701,SPENP012700;Ovary cancer:SPENP016679;Bladder cancer:SPENP011805,SPENP017977;Kidney cancer:SPENP020708,SPENP015241;Bile duct cancer:SPENP013690;Anal canal cancer:SPENP024966;Tongue cancer:SPENP027498;Gastric cancer:SPENP003379,SPENP003713,SPENP015480;Lung cancer:SPENP002992,SPENP022054,SPENP007921,SPENP004718;Prostate cancer:SPENP018558;Colon cancer:SPENP016413,SPENP022052,SPENP014717,SPENP024340,SPENP006776,SPENP026652,SPENP011182,SPENP007499,SPENP011181,SPENP001779
SPENP028438	ACLDYPVTSVLPPASLCK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002507	SPENG002379	NONHSAG033050.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM022979	SPENO004482	Lung cancer:SPENP025512,SPENP028228;Colon cancer:SPENP007326,SPENP006646;Bladder cancer:SPENP017716,SPENP011635;Prostate cancer:SPENP009279
SPENP028443	AGEVVPPAMYQFSQYVCQQTGLQIPQLPAPPK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT001685	SPENG001950	NONHSAG024572.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022984	SPENO006971	
SPENP028447	AGYEYVSPEQLAGFDK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005924	SPENG003747	HSALNG0013722		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM022988	SPENO004898	Anal canal cancer:SPENP024784;Colon cancer:SPENP007234;Bladder cancer:SPENP017634
SPENP028450	ALAPTWEQLALGLEHSETVK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2	0.6917	Others	2.1342	0.0768	0.2029	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM022991	SPENO005833	Breast cancer:SPENP021551,SPENP005945,SPENP023076,SPENP005946,SPENP023077,SPENP005947,SPENP008988,SPENP021549,SPENP005944,SPENP005948;Skin cancer:SPENP025391;Thyroid cancer:SPENP012577,SPENP012576;Bladder cancer:SPENP017799,SPENP011659;Prostate cancer:SPENP013068,SPENP023763;Kidney cancer:SPENP020535,SPENP015183;Bile duct cancer:SPENP013591;Anal canal cancer:SPENP024896;Tongue cancer:SPENP027515;Gastric cancer:SPENP003304,SPENP009657,SPENP003652;Lung cancer:SPENP021550,SPENP004513,SPENP002766,SPENP026488,SPENP007839,SPENP025535;Liver cancer:SPENP000750;Colon cancer:SPENP021548,SPENP008616,SPENP001720,SPENP007394,SPENP006684,SPENP026681,SPENP024244,SPENP000507
SPENP028459	ATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.611	Others	-2.935	0.0188	0.0799	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023000	SPENO001233	Breast cancer:SPENP006256,SPENP006255,SPENP006257,SPENP022065,SPENP022067,SPENP006254,SPENP006258;Bladder cancer:SPENP017983,SPENP011807;Kidney cancer:SPENP015242,SPENP020711;Tongue cancer:SPENP027527;Gastric cancer:SPENP015483,SPENP003382;Lung cancer:SPENP002998,SPENP022066;Colon cancer:SPENP016416,SPENP014720,SPENP011187,SPENP022064,SPENP011188
SPENP028463	AYPDVAALSDGYWVVSNR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006409	SPENG004147	lnc-TPP1-2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023004	SPENO006508	
SPENP028467	CFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005793,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.799	Others	-2.283	0.0835	0.2047	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023008	SPENO001233	Bladder cancer:SPENP017987;Kidney cancer:SPENP020712;Tongue cancer:SPENP027545;Gastric cancer:SPENP003386,SPENP009722,SPENP015486;Prostate cancer:SPENP018563;Colon cancer:SPENP011197,SPENP016424,SPENP011198,SPENP008772
SPENP028470	CLQMVDGHLFR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006470	SPENG004156	HSALNG0047988	-3.167	Others				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023011	SPENO006696	
SPENP028478	DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023019	SPENO005833	Bladder cancer:SPENP017970;Kidney cancer:SPENP020701;Bile duct cancer:SPENP013687;Anal canal cancer:SPENP024963;Lung cancer:SPENP002982,SPENP025576;Colon cancer:SPENP007496,SPENP008765,SPENP000622
SPENP028479	DFSPSGIFGAFQR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002364,SPENT001681	SPENG001530	lnc-ATP5MF-1	1.3752	Up-regulated in tumors	11.6646	2.66e-06	0.0003	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023020	SPENO005239	Breast cancer:SPENP022631,SPENP005431,SPENP005429,SPENP008871,SPENP005433,SPENP005430,SPENP022630,SPENP005432;Skin cancer:SPENP025171;Bladder cancer:SPENP017405;Kidney cancer:SPENP020167;Lung cancer:SPENP007650,SPENP025577,SPENP004072;Prostate cancer:SPENP023646;Colon cancer:SPENP006485,SPENP010273,SPENP026745,SPENP024039,SPENP010274
SPENP028483	DISILQCHGDCDPLVPLMFGSLTVEK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006385	SPENG004134	lnc-OGFRL1-9		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023024	SPENO006827	
SPENP028485	DLEVVAATPTSLLISWDAPAVTVR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	1.7719	Others	2.261	0.0473	0.1648	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023026	SPENO001233	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP029376,SPENP016295,SPENP026761
SPENP028494	DLSLGGVLLFPVDDK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002176	SPENG002576	AC242426.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023035	SPENO002839	Lung cancer:SPENP025596
SPENP028495	DMDLTEVITGTLWNLSSHDSIK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005788	SPENG002233	AP001931.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023036	SPENO005858	Breast cancer:SPENP023114,SPENP023115,SPENP009014;Bladder cancer:SPENP017843;Kidney cancer:SPENP020572;Anal canal cancer:SPENP024915;Tongue cancer:SPENP027583;Lung cancer:SPENP001965,SPENP002829,SPENP025598;Prostate cancer:SPENP023773;Colon cancer:SPENP008675,SPENP000537,SPENP001734,SPENP014577,SPENP006704,SPENP016247
SPENP028500	DQCIVDDITYNVNDTFHK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005793,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.216	Down-regulated in tumors	-10.77	1.31e-05	0.0005	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023041	SPENO001233	Tongue cancer:SPENP027585;Gastric cancer:SPENP009622,SPENP015378;Prostate cancer:SPENP009275
SPENP028504	DTLTSRPAQGVVTTLENVSPPR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.117	Others	-1.362	0.226	0.2657	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023045	SPENO001233	Breast cancer:SPENP021633,SPENP006026,SPENP006025,SPENP009023,SPENP023122,SPENP006024,SPENP006028,SPENP021635,SPENP023123,SPENP006027;Ovary cancer:SPENP016640;Bladder cancer:SPENP017828;Kidney cancer:SPENP015208,SPENP020575;Bile duct cancer:SPENP013618;Anal canal cancer:SPENP024918;Tongue cancer:SPENP027597;Gastric cancer:SPENP009671,SPENP003679,SPENP003325,SPENP015426;Lung cancer:SPENP004606,SPENP002825,SPENP007855,SPENP021634,SPENP025607;Prostate cancer:SPENP009302;Colon cancer:SPENP014570,SPENP007431,SPENP021632,SPENP010960,SPENP010959,SPENP008667,SPENP000534,SPENP024270,SPENP001737,SPENP016253,SPENP006702
SPENP028505	DTLTSRPAQGVVTTLENVSPPRR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-0.43	Others	-0.5652	0.5904	0.6033	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023046	SPENO001233	Breast cancer:SPENP006060,SPENP021677,SPENP006062,SPENP006061,SPENP021679,SPENP009033,SPENP023139,SPENP023138,SPENP006063,SPENP006059;Ovary cancer:SPENP016645;Kidney cancer:SPENP020607;Bile duct cancer:SPENP013634;Tongue cancer:SPENP027598;Lung cancer:SPENP007872,SPENP004625,SPENP021678,SPENP002858;Gastric cancer:SPENP003331,SPENP003683;Prostate cancer:SPENP009310,SPENP018482;Colon cancer:SPENP021676,SPENP010976,SPENP014592,SPENP026776,SPENP016275,SPENP007444,SPENP006719,SPENP024273,SPENP008681,SPENP010975;Leukemia:SPENP001374
SPENP028515	EESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.027	Others	-1.825	0.1458	0.2119	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023056	SPENO001233	Breast cancer:SPENP006282,SPENP006280,SPENP006279,SPENP006283,SPENP006281;Bladder cancer:SPENP017993;Kidney cancer:SPENP020718;Tongue cancer:SPENP027612;Colon cancer:SPENP016438,SPENP014740
SPENP028516	EEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWER	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.123	Others	-1.395	0.2206	0.2617	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023057	SPENO001233	Ovary cancer:SPENP016681;Bladder cancer:SPENP011818,SPENP017991;Kidney cancer:SPENP020713;Bile duct cancer:SPENP013698;Anal canal cancer:SPENP024970;Tongue cancer:SPENP027613;Gastric cancer:SPENP009724,SPENP015490,SPENP003388;Lung cancer:SPENP025626;Colon cancer:SPENP016432,SPENP014733,SPENP011215,SPENP007503,SPENP000628,SPENP011216,SPENP024347
SPENP028539	EVTSDSGSIVVSGLTPGVEYVYTIQVLR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.388	Others	-1.638	0.1606	0.2211	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023080	SPENO001233	Breast cancer:SPENP023175,SPENP006192,SPENP021893,SPENP009061,SPENP006191,SPENP023174,SPENP006193,SPENP006189,SPENP006190,SPENP021895;Bladder cancer:SPENP017929,SPENP011764;Kidney cancer:SPENP020669;Anal canal cancer:SPENP024953;Tongue cancer:SPENP027640;Gastric cancer:SPENP003364,SPENP003699;Lung cancer:SPENP002925,SPENP021894,SPENP025663;Colon cancer:SPENP026810,SPENP011088,SPENP011087,SPENP014650,SPENP016351,SPENP021892,SPENP000594
SPENP028544	FDDGEDPLDAESQQGGGGNPFHR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005266	SPENG000990	NONHSAG013996.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023085	SPENO002349	
SPENP028573	GTVLALTENNFDDTIAEGITFIK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000040	SPENG000572	lnc-EEF1E1-2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023114	SPENO005833	Breast cancer:SPENP023131,SPENP023130;Bladder cancer:SPENP017850;Lung cancer:SPENP002850,SPENP025752;Liver cancer:SPENP000766;Colon cancer:SPENP000559,SPENP008691
SPENP028586	HRPRPYPPNVGEEIQIGHIPR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757	SPENG000084	FN1	0.7245	Others	0.9038	0.4172	0.4392	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023127	SPENO005245	Breast cancer:SPENP023101,SPENP023100,SPENP009004;Bile duct cancer:SPENP013614;Tongue cancer:SPENP027784;Gastric cancer:SPENP003310,SPENP015414,SPENP009662;Lung cancer:SPENP002810;Prostate cancer:SPENP009297;Colon cancer:SPENP010919,SPENP016235,SPENP014549,SPENP024255,SPENP010920
SPENP028593	IDDILQTLLDATYK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000775	SPENG001919	lnc-LRRD1-2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023134	SPENO003078	Bladder cancer:SPENP017516;Liver cancer:SPENP000692;Kidney cancer:SPENP020245;Lung cancer:SPENP025776,SPENP002501;Prostate cancer:SPENP018266;Colon cancer:SPENP001612,SPENP000320
SPENP028603	IMDATNILVSPLVYLYPDIPK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006645	SPENG004092	lnc-STAT5B-3		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023144	SPENO006647	
SPENP028609	ISQAEEEDQQLLGHLLLVAK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002815	SPENG000837	lnc-HINT2-1		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023150	SPENO001580	Breast cancer:SPENP008997;Skin cancer:SPENP025405;Lung cancer:SPENP028299,SPENP007835;Prostate cancer:SPENP023755;Colon cancer:SPENP012845
SPENP028612	IVAFADAAVEPIDFPIAPVYAASMVLK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000014	SPENG003410	ACAT1		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023153	SPENO003940	Breast cancer:SPENP009057;Skin cancer:SPENP025459;Bladder cancer:SPENP017916;Kidney cancer:SPENP015228,SPENP020650;Anal canal cancer:SPENP024951;Lung cancer:SPENP025806,SPENP002911,SPENP001977;Colon cancer:SPENP000589,SPENP011062,SPENP006748,SPENP014644,SPENP007476,SPENP011061,SPENP016339
SPENP028622	KTDELPQLVTLPHPNLHGPEILDVPSTVQK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005755,SPENT005757	SPENG000084	FN1	-3.294	Others	-1.911	0.1506	0.2151	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023163	SPENO005245	Breast cancer:SPENP006217,SPENP009069,SPENP021975,SPENP006214,SPENP006215,SPENP023200,SPENP006218,SPENP006216,SPENP021973,SPENP023201;Bladder cancer:SPENP017950;Kidney cancer:SPENP015239;Bile duct cancer:SPENP013677;Tongue cancer:SPENP027836;Gastric cancer:SPENP003708,SPENP015464,SPENP003371;Lung cancer:SPENP004703,SPENP021974,SPENP025820,SPENP002962;Prostate cancer:SPENP009328;Colon cancer:SPENP021972,SPENP011128,SPENP016390,SPENP011127,SPENP014685,SPENP024325,SPENP000611,SPENP008757
SPENP028642	LLEIDNSELLHMLESPESLR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT004082	SPENG001703	HSALNG0067302		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023183	SPENO006263	Lung cancer:SPENP025859;Bladder cancer:SPENP017783
SPENP028653	LSTPIAGLDNINVFLK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT001322	SPENG002279	AL137782.1		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	29843593	Immunogenic	SPENM023194	SPENO003789	
SPENP028660	LVILANNCPALR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000907,SPENT000906,SPENT000909,SPENT000908	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023201	SPENO006213	Breast cancer:SPENP022475,SPENP022474;Skin cancer:SPENP025140;Bladder cancer:SPENP011359;Gastric cancer:SPENP009493;Lung cancer:SPENP025895,SPENP007608,SPENP001837;Prostate cancer:SPENP012928;Colon cancer:SPENP023964,SPENP010168,SPENP010167,SPENP008202
SPENP028673	MIFIPSSIAFLTTLER	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006715,SPENT002193,SPENT002194,SPENT006338,SPENT006125,SPENT002192	SPENG001124,SPENG004038	HSALNG0035699,lnc-HSD17B11-1		Others				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023214	SPENO000682,SPENO001948,SPENO004450,SPENO006783,SPENO006891,SPENO007072	
SPENP028680	MQLYFSFCHAHAFSQK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006265	SPENG003979	HSALNG0008999		Others				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023221	SPENO007010	
SPENP028684	MSSTIHVWK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006399,SPENT006686	SPENG004238	lnc-ARHGAP26-4		Others				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023225	SPENO006385,SPENO006910	
SPENP028687	NALDPMSVLLAR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002530,SPENT002606,SPENT002607	SPENG001378,SPENG000634	NONHSAG009217.2,lnc-FAM181B-5		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023228	SPENO003025	Breast cancer:SPENP023318;Colon cancer:SPENP007011,SPENP000193;Gastric cancer:SPENP009496
SPENP028694	NLNDQVLFIDQGNRPLFEDMTDSDCR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000161	SPENG003030	lnc-TIMM8B-2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023235	SPENO006100	
SPENP028700	NQLDQEVEFLSTSIAQLK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002156	SPENG002374	NONHSAG011229.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023241	SPENO002603	Colon cancer:SPENP012830;Bladder cancer:SPENP011631
SPENP028701	NSITLTNLTPGTEYVVSIVALNGR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.797	Others	-1.965	0.0778	0.2029	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023242	SPENO001233	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000,SPENP029429
SPENP028702	NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.503	Others	-2.328	0.0674	0.1965	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023243	SPENO001233	Breast cancer:SPENP006275,SPENP006277,SPENP006276,SPENP009093,SPENP006278,SPENP023214,SPENP023215,SPENP006274;Skin cancer:SPENP025496;Bladder cancer:SPENP017994;Kidney cancer:SPENP020717;Tongue cancer:SPENP027958;Lung cancer:SPENP003013;Colon cancer:SPENP011217,SPENP027188,SPENP016437,SPENP014739,SPENP011218
SPENP028704	NTLLMPLFCELF	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006240	SPENG004125	HSALNG0012529		Others				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023245	SPENO006564	
SPENP028721	QYNVGPSVSKYPLR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-0.7257	Others	-1.429	0.1909	0.243	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023262	SPENO001233	Breast cancer:SPENP021099,SPENP021097;Skin cancer:SPENP025236;Ovary cancer:SPENP016539;Bladder cancer:SPENP011444;Kidney cancer:SPENP020280;Bile duct cancer:SPENP013435;Anal canal cancer:SPENP024686;Tongue cancer:SPENP028012;Lung cancer:SPENP007669,SPENP021098,SPENP004156,SPENP002485;Gastric cancer:SPENP015322,SPENP003179;Prostate cancer:SPENP009224;Colon cancer:SPENP027217,SPENP024049,SPENP007165,SPENP008345,SPENP014245,SPENP021096,SPENP015967;Leukemia:SPENP001148
SPENP028724	RPHETGGYMLECVCLGNGK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005793,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.442	Others	-3.149	0.0246	0.1014	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023265	SPENO001233	Breast cancer:SPENP021431,SPENP021429;Ovary cancer:SPENP016611;Kidney cancer:SPENP020523;Anal canal cancer:SPENP024876;Tongue cancer:SPENP028018;Gastric cancer:SPENP015395,SPENP009642,SPENP003295;Lung cancer:SPENP021430;Prostate cancer:SPENP018420,SPENP009286;Colon cancer:SPENP016154,SPENP006666,SPENP008590,SPENP010826,SPENP014486,SPENP000490,SPENP021428,SPENP010825;Leukemia:SPENP001323
SPENP028727	SAIQNLHSFDPFADASK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000491,SPENT000493	SPENG001941,SPENG003603	NONHSAG021785.2,HSALNG0116452		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023268	SPENO000819	Skin cancer:SPENP019550,SPENP019552,SPENP019551;Anal canal cancer:SPENP024827;Colon cancer:SPENP024174
SPENP028732	SEIEYYAMLAK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000907	SPENG001277	HSALNG0067186		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023273	SPENO000929	Breast cancer:SPENP022399,SPENP022398;Colon cancer:SPENP010027,SPENP008174,SPENP010028;Skin cancer:SPENP025097
SPENP028737	SGLAIVSQHDLDQLQADAINAFGESLQK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002525	SPENG001064	HSALNG0061573		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023278	SPENO004542	Colon cancer:SPENP006753;Bladder cancer:SPENP011768
SPENP028739	SHIQSLPDLSLLPNVTGGLAPLPSAGDLFSTD	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006386	SPENG004066	HSALNG0129949		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023280	SPENO006526	
SPENP028748	SSTSRPDAYEHTQMK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000097,SPENT000096	SPENG000914	NONHSAG048518.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023289	SPENO002621	Breast cancer:SPENP005687,SPENP005688,SPENP005686,SPENP005684,SPENP005685;Bladder cancer:SPENP017600;Colon cancer:SPENP027293,SPENP000349,SPENP008454;Lung cancer:SPENP002547,SPENP026055,SPENP004254
SPENP028749	STATISGLKPGVDYTITVYAVTGR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.348	Others	-1.714	0.1467	0.2119	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023290	SPENO001233	Breast cancer:SPENP023156,SPENP009039,SPENP006127,SPENP006124,SPENP023157,SPENP006128,SPENP021741,SPENP021743,SPENP006126,SPENP006125;Skin cancer:SPENP025438;Bladder cancer:SPENP017888;Kidney cancer:SPENP015222,SPENP020618;Anal canal cancer:SPENP024931;Tongue cancer:SPENP028063;Lung cancer:SPENP002879,SPENP021742,SPENP001970;Gastric cancer:SPENP015435,SPENP003347;Prostate cancer:SPENP013097,SPENP009312;Colon cancer:SPENP024286,SPENP027294,SPENP014612,SPENP016304,SPENP011012,SPENP021740,SPENP000560,SPENP001750,SPENP011011;Leukemia:SPENP001380
SPENP028750	STDTGVSLPSYEEDQGSK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT001901,SPENT001900	SPENG002105	NONHSAG034881.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023291	SPENO000724	Skin cancer:SPENP019580,SPENP025351,SPENP019582,SPENP019581;Bladder cancer:SPENP017707,SPENP011637;Kidney cancer:SPENP020476,SPENP015156;Bile duct cancer:SPENP013550;Anal canal cancer:SPENP024855;Lung cancer:SPENP004437;Prostate cancer:SPENP018398,SPENP013048;Colon cancer:SPENP024196,SPENP010756,SPENP027296,SPENP010755,SPENP007328,SPENP006634,SPENP008567
SPENP028751	STLNELVDYITISR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002483	SPENG000098	lnc-WDR89-4		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023292	SPENO002146	Colon cancer:SPENP010417,SPENP010418
SPENP028755	TAVAHRPGAFK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000153	SPENG003407	NONHSAG024537.2	0.7992	Others	2.3859	0.0627	0.1868	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023296	SPENO003100	Thyroid cancer:SPENP012273,SPENP012272;Bladder cancer:SPENP017300;Kidney cancer:SPENP019966;Lung cancer:SPENP003961,SPENP002204,SPENP001825;Prostate cancer:SPENP023578;Colon cancer:SPENP015686,SPENP008128,SPENP001506,SPENP010066,SPENP027315,SPENP006973,SPENP010065,SPENP023922
SPENP028756	TDELPQLVTLPHPNLHGPEILDVPSTVQK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005755,SPENT005757	SPENG000084	FN1	-2.305	Others	-1.885	0.1162	0.2047	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023297	SPENO005245	Breast cancer:SPENP006207,SPENP006205,SPENP023197,SPENP021929,SPENP023196,SPENP009066,SPENP006208,SPENP021931,SPENP006206,SPENP006204;Thyroid cancer:SPENP012683,SPENP012682;Ovary cancer:SPENP016671;Bladder cancer:SPENP017947;Kidney cancer:SPENP015234,SPENP020672;Bile duct cancer:SPENP013669;Anal canal cancer:SPENP024959;Tongue cancer:SPENP028076;Gastric cancer:SPENP015462,SPENP003365,SPENP003707,SPENP009713;Lung cancer:SPENP026071,SPENP002935,SPENP004692,SPENP021930;Prostate cancer:SPENP009326;Colon cancer:SPENP008745,SPENP016375,SPENP024324,SPENP014677,SPENP011124,SPENP021928,SPENP027319,SPENP000608,SPENP011123
SPENP028760	TETITGFQVDAVPANGQTPIQR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.522	Others	-1.748	0.1396	0.2119	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023301	SPENO001233	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP029449,SPENP010943
SPENP028764	TGLDSPTGIDFSDITANSFTVHWIAPR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.696	Others	-1.497	0.1886	0.2423	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023305	SPENO001233	Breast cancer:SPENP009058,SPENP021875,SPENP006166,SPENP006164,SPENP006167,SPENP006165,SPENP023437,SPENP023167,SPENP021873,SPENP006168,SPENP023166;Skin cancer:SPENP025460;Bladder cancer:SPENP017920;Kidney cancer:SPENP020652,SPENP015227;Bile duct cancer:SPENP013657;Anal canal cancer:SPENP024950;Tongue cancer:SPENP028085;Gastric cancer:SPENP003698,SPENP009706,SPENP003358,SPENP015454;Lung cancer:SPENP002918,SPENP021874,SPENP001975,SPENP026083;Prostate cancer:SPENP013105;Colon cancer:SPENP016341,SPENP027332,SPENP000588,SPENP007477,SPENP011073,SPENP001768,SPENP014645,SPENP021872,SPENP006750,SPENP011074,SPENP008729,SPENP024310
SPENP028765	TGLDSPTGIDFSDITANSFTVHWIAPRATITGYR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.431	Down-regulated in tumors	-11.03	0.0001	0.0019	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023306	SPENO001233	Breast cancer:SPENP022061,SPENP022063;Tongue cancer:SPENP028086;Lung cancer:SPENP022062;Colon cancer:SPENP022060
SPENP028766	TGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005752	SPENG000084	FN1	-1.822	Others	-1.709	0.183	0.2406	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023307	SPENO001233	Breast cancer:SPENP022127,SPENP022125;Bladder cancer:SPENP017990;Kidney cancer:SPENP020714;Bile duct cancer:SPENP013697;Tongue cancer:SPENP028090;Gastric cancer:SPENP003716,SPENP009725,SPENP015489;Lung cancer:SPENP026084,SPENP022126,SPENP003008;Colon cancer:SPENP008774,SPENP014734,SPENP011214,SPENP011213,SPENP000630,SPENP022124,SPENP016430
SPENP028767	TGVHHYSGNNIELGTACGK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000951,SPENT000907	SPENG001400,SPENG001277	HSALNG0067186,lnc-RPL30-3	2.63	Up-regulated in tumors	5.1362	0.0013	0.0082	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023308	SPENO004512	Breast cancer:SPENP023007,SPENP023006;Bladder cancer:SPENP011645;Liver cancer:SPENP000737;Kidney cancer:SPENP015176;Lung cancer:SPENP001940,SPENP026085,SPENP007817;Prostate cancer:SPENP012110,SPENP013057;Colon cancer:SPENP010820,SPENP008607,SPENP010819,SPENP012841,SPENP024218
SPENP028772	TNTNVNCPIECFMPLDVQADR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000578,SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	-1.175	Others	-1.341	0.2373	0.2723	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023313	SPENO001233	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP029451,SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP028773	TNTNVNCPIECFMPLDVQADREDSRE	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000578,SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.3444	Others	0.6722	0.5313	0.5509	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023314	SPENO001233	Breast cancer:SPENP021805,SPENP021807;Ovary cancer:SPENP016663;Bladder cancer:SPENP017905,SPENP011750;Kidney cancer:SPENP020647;Bile duct cancer:SPENP013655;Tongue cancer:SPENP028105;Gastric cancer:SPENP015447,SPENP003696,SPENP009703,SPENP003356;Lung cancer:SPENP021806,SPENP007890,SPENP002907,SPENP026096,SPENP004665;Prostate cancer:SPENP018520;Colon cancer:SPENP011059,SPENP016334,SPENP021804,SPENP011060,SPENP027351,SPENP007472,SPENP024307,SPENP006746,SPENP014637,SPENP000584,SPENP008725
SPENP028776	TPIGSFLGSLSLLPATK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000014	SPENG003410	ACAT1		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023317	SPENO003940	Breast cancer:SPENP022961,SPENP022960,SPENP008957;Skin cancer:SPENP025333;Bladder cancer:SPENP017700;Kidney cancer:SPENP015123,SPENP020420;Bile duct cancer:SPENP013537;Anal canal cancer:SPENP024821;Lung cancer:SPENP002651,SPENP001925,SPENP004418,SPENP026613,SPENP007778;Prostate cancer:SPENP023732,SPENP018355,SPENP013030;Colon cancer:SPENP010706,SPENP008520,SPENP000442,SPENP014401,SPENP006622,SPENP001672,SPENP016082,SPENP010705,SPENP027356,SPENP007314,SPENP012823;Leukemia:SPENP001289
SPENP028778	TPTEALASFDYIVR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT001703,SPENT000964,SPENT000965	SPENG000698	SLC25A25-AS1		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023319	SPENO003587	Breast cancer:SPENP022755,SPENP022754;Lung cancer:SPENP004163,SPENP026100;Prostate cancer:SPENP023659;Colon cancer:SPENP000310,SPENP024064,SPENP007144
SPENP028779	TQSSLVPALTDFVR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000978,SPENT001597	SPENG002106	lnc-DAXX-2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023320	SPENO003629	Skin cancer:SPENP019295,SPENP019296,SPENP019297;Liver cancer:SPENP004856;Lung cancer:SPENP004155,SPENP007696;Gastric cancer:SPENP003574;Prostate cancer:SPENP009221;Colon cancer:SPENP024050,SPENP012789
SPENP028801	VLVDGEEHVGFLK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002650	SPENG003359	NONHSAG016482.2		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023342	SPENO002947	Colon cancer:SPENP007062
SPENP028804	VPFLVLECPNLK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000354	SPENG002378	HSALNG0036293	0.7425	Others	3.9162	0.0044	0.0207	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023345	SPENO003709	Breast cancer:SPENP022489,SPENP022488;Skin cancer:SPENP025137;Bladder cancer:SPENP017351,SPENP011354;Kidney cancer:SPENP020103,SPENP014934;Bile duct cancer:SPENP013344;Anal canal cancer:SPENP024594;Lung cancer:SPENP026142,SPENP002324,SPENP004022,SPENP007621,SPENP028404;Prostate cancer:SPENP018137,SPENP012932;Colon cancer:SPENP027415,SPENP010199,SPENP001542,SPENP007000,SPENP000222,SPENP014108,SPENP023975,SPENP015787,SPENP008250,SPENP010200,SPENP006429;Leukemia:SPENP001045
SPENP028809	VSLICWVFSK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT006486,SPENT006545	SPENG004032,SPENG004263	HSALNG0023889,lnc-SUMF1-19		Others				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Non-validated			Immunogenic	SPENM023350	SPENO006496,SPENO006656	
SPENP028810	VTDATETTITISWR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-1.607	Others	-1.435	0.2107	0.2565	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023351	SPENO001233	Breast cancer:SPENP022706,SPENP005505,SPENP005504,SPENP005508,SPENP021095,SPENP005507,SPENP008886,SPENP022707,SPENP005506,SPENP021093;Ovary cancer:SPENP016524;Bladder cancer:SPENP017498,SPENP011457;Kidney cancer:SPENP015018,SPENP020294;Anal canal cancer:SPENP024685;Tongue cancer:SPENP028171;Gastric cancer:SPENP003192,SPENP015325,SPENP003582,SPENP009528;Lung cancer:SPENP021094,SPENP002504;Colon cancer:SPENP021092,SPENP008391,SPENP024081,SPENP010442,SPENP000293,SPENP010441,SPENP007174,SPENP027438,SPENP014254,SPENP015931
SPENP028816	VVLLEDLASQVGLR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT002729,SPENT006463	SPENG003021,SPENG004163	NONHSAG031147.2,lnc-DDRGK1-1		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	MS	28137767	Immunogenic	SPENM023357	SPENO002390,SPENO006941	
SPENP028831	YEVSVYALKDTLTSRPAQGVVTTLENVSPPR	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT005757,SPENT005754,SPENT005756,SPENT005755,SPENT005752	SPENG000084	FN1	-2.367	Down-regulated in tumors	-4.753	0.0051	0.023	MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023372	SPENO001233	Breast cancer:SPENP009076;Tongue cancer:SPENP028200;Gastric cancer:SPENP015470,SPENP003372;Lung cancer:SPENP002973;Colon cancer:SPENP014687,SPENP024330,SPENP016392,SPENP027468
SPENP028840	YQLDPTASISAK	Bladder cancer	Bladder cancer	Extracellualr vesicles	SPENT000102	SPENG002045	lnc-ACTR2-11		Tumor-specific				MSV000087370	Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules	Q Exactive	Label free		Validated	Ribosome_profiling	31155234	Immunogenic	SPENM023381	SPENO000884	Breast cancer:SPENP008847,SPENP022484,SPENP022485,SPENP023320;Skin cancer:SPENP019091,SPENP019093,SPENP025136,SPENP019092;Thyroid cancer:SPENP012303,SPENP012302;Bladder cancer:SPENP011367,SPENP017395;Kidney cancer:SPENP020073,SPENP014958;Bile duct cancer:SPENP013307;Anal canal cancer:SPENP024566;Tongue cancer:SPENP028219;Lung cancer:SPENP001832,SPENP026192,SPENP002339,SPENP007619,SPENP003978;Prostate cancer:SPENP023593,SPENP012937,SPENP018140,SPENP011958;Colon cancer:SPENP008210,SPENP006989,SPENP010198,SPENP023950,SPENP010197,SPENP027484,SPENP001556,SPENP006445,SPENP000194,SPENP014146,SPENP015820;Leukemia:SPENP001036
SPENP029369	APVSWITPGLK	Colon cancer	Colon cancer	Blood serum	SPENT001457,SPENT001458	SPENG000652	AC012313.3	0.6022	Others	2.264	0.0863	0.4276	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM024806	SPENO002381	Ovary cancer:SPENP016479;Gastric cancer:SPENP003513
SPENP029375	DIQMTQSPSSLSASVGDR	Colon cancer	Colon cancer	Blood serum	SPENT000840,SPENT000841	SPENG003099,SPENG002224	lnc-GAB4-1,HSALNG0133844	0.2438	Others	0.6784	0.5348	0.7811	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Non-validated			Immunogenic	SPENM024812	SPENO005255	Breast cancer:SPENP018568,SPENP005870,SPENP008965,SPENP005872,SPENP021369,SPENP021371,SPENP022997,SPENP005869,SPENP022996,SPENP005873,SPENP005871;Skin cancer:SPENP019559,SPENP019561,SPENP019560,SPENP025357;Thyroid cancer:SPENP012537,SPENP012536;Ovary cancer:SPENP018569,SPENP016602;Bladder cancer:SPENP011622,SPENP017728;Prostate cancer:SPENP012875,SPENP012093;Kidney cancer:SPENP013864,SPENP013863,SPENP015147,SPENP020491;Bile duct cancer:SPENP013541;Anal canal cancer:SPENP024851;Tongue cancer:SPENP027566;Gastric cancer:SPENP003285,SPENP015385,SPENP003645;Lung cancer:SPENP021370,SPENP002719,SPENP004444,SPENP025585,SPENP007793;Liver cancer:SPENP000731;Colon cancer:SPENP026228,SPENP026754,SPENP006639,SPENP001696,SPENP021368,SPENP008585,SPENP014443,SPENP024206,SPENP000444,SPENP010789,SPENP010790,SPENP016111,SPENP007353
SPENP029376	DLEVVAATPTSLLISWDAPAVTVR	Colon cancer	Colon cancer	Blood serum	SPENT005753,SPENT005755,SPENT005756,SPENT005754,SPENT005752,SPENT005757	SPENG000084	FN1	0.0398	Others	0.1433	0.893	0.9497	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024813	SPENO005245	Breast cancer:SPENP006081,SPENP009038,SPENP023154,SPENP006080,SPENP023155,SPENP006082,SPENP006079,SPENP006083;Skin cancer:SPENP025441;Bladder cancer:SPENP017876,SPENP028485,SPENP011728;Kidney cancer:SPENP020614;Bile duct cancer:SPENP013637;Anal canal cancer:SPENP024935;Tongue cancer:SPENP027573;Gastric cancer:SPENP003688,SPENP009697,SPENP015443,SPENP003345;Lung cancer:SPENP002869,SPENP025589;Prostate cancer:SPENP013098;Colon cancer:SPENP011004,SPENP000573,SPENP014613,SPENP008709,SPENP011003,SPENP016295,SPENP026761
SPENP029418	MAPVSWITPGLK	Colon cancer	Colon cancer	Blood serum	SPENT001457,SPENT001458	SPENG000652	AC012313.3	0.8113	Others	6.7687	0.0025	0.0512	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	29843593	Immunogenic	SPENM024855	SPENO002381	Gastric cancer:SPENP003141,SPENP003523
SPENP029429	NSITLTNLTPGTEYVVSIVALNGR	Colon cancer	Colon cancer	Blood serum	SPENT005753,SPENT005755,SPENT005756,SPENT005754,SPENT005752,SPENT005757	SPENG000084	FN1	0.6673	Others	1.9045	0.1296	0.4306	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024866	SPENO005245	Breast cancer:SPENP009036,SPENP021719,SPENP006118,SPENP021717,SPENP006114,SPENP023158,SPENP023159,SPENP006117,SPENP006116,SPENP006115;Bladder cancer:SPENP011729,SPENP017882,SPENP028701;Kidney cancer:SPENP020630,SPENP015221;Tongue cancer:SPENP027957;Gastric cancer:SPENP009695;Lung cancer:SPENP028358,SPENP021718,SPENP002872;Prostate cancer:SPENP013091;Colon cancer:SPENP016284,SPENP000562,SPENP010999,SPENP014604,SPENP021716,SPENP011000
SPENP029439	RPSTDTITVMVENSHGLR	Colon cancer	Colon cancer	Blood serum	SPENT001619	SPENG003051	NONHSAG045779.2	-0.3134	Others	-0.9821	0.4959	0.7624	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Non-validated			Immunogenic	SPENM024876	SPENO003352	Gastric cancer:SPENP003642
SPENP029445	STAAMSTYTGIFTDQVLSVLK	Colon cancer	Colon cancer	Blood serum	SPENT001117,SPENT001116	SPENG001123	NONHSAG026012.2	-0.4846	Others	-1.476	0.2139	0.5374	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Non-validated			Immunogenic	SPENM024882	SPENO003134	Breast cancer:SPENP021581,SPENP023094,SPENP005979,SPENP023095,SPENP005982,SPENP021583,SPENP005983,SPENP005981,SPENP005980;Ovary cancer:SPENP016637;Bladder cancer:SPENP017826;Kidney cancer:SPENP015200;Gastric cancer:SPENP003662,SPENP003315;Lung cancer:SPENP028378,SPENP021582,SPENP002801,SPENP026056;Colon cancer:SPENP000521,SPENP021580,SPENP016232
SPENP029446	STATISGLK	Colon cancer	Colon cancer	Blood serum	SPENT005753,SPENT005755,SPENT005756,SPENT005754,SPENT005752,SPENT005757	SPENG000084	FN1	1.1737	Up-regulated in tumors	8.0649	0.0013	0.0402	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024883	SPENO005245	Breast cancer:SPENP005063,SPENP005062,SPENP005059,SPENP005060,SPENP005061
SPENP029449	TETITGFQVDAVPANGQTPIQR	Colon cancer	Colon cancer	Blood serum	SPENT005753,SPENT005755,SPENT005756,SPENT005754,SPENT005752,SPENT005757	SPENG000084	FN1	-0.3622	Others	-1.06	0.3491	0.5898	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024886	SPENO005245	Breast cancer:SPENP021645,SPENP021647,SPENP023105,SPENP006016,SPENP006015,SPENP006014,SPENP006017,SPENP006018,SPENP023104;Thyroid cancer:SPENP012595,SPENP012594;Ovary cancer:SPENP016641;Bladder cancer:SPENP028760,SPENP017845;Kidney cancer:SPENP015205;Bile duct cancer:SPENP013619;Anal canal cancer:SPENP024916;Tongue cancer:SPENP028079;Gastric cancer:SPENP009676,SPENP003317,SPENP003677;Lung cancer:SPENP026078,SPENP004608,SPENP002831,SPENP021646;Prostate cancer:SPENP009301;Colon cancer:SPENP021644,SPENP008676,SPENP007432,SPENP000536,SPENP027322,SPENP010944,SPENP014569,SPENP016246,SPENP010943
SPENP029451	TNTNVNCPIECFMPLDVQADR	Colon cancer	Colon cancer	Blood serum	SPENT005753,SPENT005755,SPENT005756,SPENT000578,SPENT005754,SPENT005752,SPENT005757	SPENG000084,SPENG001110	lnc-ABCA12-3,FN1	0.2908	Others	0.9532	0.3945	0.6474	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024888	SPENO002376	Thyroid cancer:SPENP012590,SPENP012591;Ovary cancer:SPENP016632;Bladder cancer:SPENP017816,SPENP028772;Kidney cancer:SPENP020563;Bile duct cancer:SPENP013612;Anal canal cancer:SPENP024902;Tongue cancer:SPENP028103;Gastric cancer:SPENP003312,SPENP009663,SPENP015417,SPENP003670;Lung cancer:SPENP002818,SPENP026095;Prostate cancer:SPENP009298;Colon cancer:SPENP010930,SPENP000520,SPENP007417,SPENP024251,SPENP010929,SPENP008656
SPENP029452	TQVVAGTNYYIK	Colon cancer	Colon cancer	Blood serum	SPENT002285	SPENG002633	HSALNG0028487	-0.4757	Others	-1.357	0.396	0.6474	PXD001794	Modulation of Serpin family levels detected by proteomics to monitor colorectal adenoma to carcinoma progression	LTQ Orbitrap	iTRAQ	27492143	Non-validated			Immunogenic	SPENM024889	SPENO000213	Breast cancer:SPENP008849,SPENP023317;Liver cancer:SPENP004809
SPENP029480	DESSPYAAMLAAQDVAQR	Ovary cancer	Ovary cancer	Ovary	SPENT000237,SPENT000236	SPENG001289,SPENG002490	HSALNG0045840,lnc-RPS14-2		Tumor-specific				PXD013311	Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer	Q Exactive	SILAC	31137727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024917	SPENO003536	Breast cancer:SPENP022995,SPENP022994;Bile duct cancer:SPENP013558;Lung cancer:SPENP025575;Prostate cancer:SPENP018402;Colon cancer:SPENP010782,SPENP024212,SPENP010781,SPENP007344
SPENP029484	ELSELVYTDVLDR	Ovary cancer	Ovary cancer	Ovary	SPENT000916,SPENT000917	SPENG003022	lnc-PROB1-1	3.3974	Others	1.634	0.2008	0.357	PXD013311	Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer	Q Exactive	SILAC	31137727	Non-validated			Immunogenic	SPENM024921	SPENO005649	Breast cancer:SPENP008874;Colon cancer:SPENP026279,SPENP007120;Lung cancer:SPENP001862,SPENP026506
SPENP029513	REETHLYERIVSLQSKGC	Ovary cancer	Ovary cancer	Ovary	SPENT006827,SPENT006826,SPENT006799,SPENT006837	SPENG004341,SPENG004338	HSALNG0013532,lnc-ATAD2B-8		Tumor-specific				PXD013311	Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer	Q Exactive	SILAC	31137727	Non-validated			Immunogenic	SPENM024950	SPENO006383,SPENO006699,SPENO006706,SPENO006839	
SPENP029515	SMLEVNYPMENGIVR	Ovary cancer	Ovary cancer	Ovary	SPENT006821	SPENG004339	lnc-GGT1-4		Tumor-specific				PXD013311	Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer	Q Exactive	SILAC	31137727	Validated	MS	28137767	Immunogenic	SPENM024952	SPENO006659	
SPENP029519	TTPHHHREQAGKTMGLAGQK	Ovary cancer	Ovary cancer	Ovary	SPENT006818,SPENT006836,SPENT006829,SPENT006804,SPENT006814	SPENG004340,SPENG004349,SPENG004343	NONHSAG043742.3,LINC00951	2.8364	Others				PXD013311	Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer	Q Exactive	SILAC	31137727	Non-validated			Immunogenic	SPENM024956	SPENO006415,SPENO006592,SPENO006719,SPENO006909,SPENO007014	
SPENP029524	YIMVPSGNMGVFDPTEIHNR	Ovary cancer	Ovary cancer	Ovary	SPENT001373,SPENT001374	SPENG003390	HSALNG0010955		Tumor-specific				PXD013311	Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer	Q Exactive	SILAC	31137727	Validated	Ribosome_profiling	31155234	Immunogenic	SPENM024961	SPENO003817	Skin cancer:SPENP025395;Bladder cancer:SPENP017787;Kidney cancer:SPENP015189,SPENP020531;Anal canal cancer:SPENP024890;Lung cancer:SPENP026184,SPENP004516,SPENP002770;Prostate cancer:SPENP018439;Colon cancer:SPENP008614,SPENP016203,SPENP007391,SPENP014512,SPENP000511,SPENP027477
